symptoms,0.21785104204829386,1.7565498352050781,3.3966994285583496,53dc8a27-b899-4fbb-97a7-f56aa1e8d457,comm_use_subset/A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior,"An effective CR2 targeting complement inhibitor can reduce the mortality, significantly improve clinical symptoms (decreased weight, lung index and hemagglutination titer) and lung tissue inflammatory injury of virusinfected model group. Therefore, CR2 targeting complement inhibitor is expected to be an ideal drug for viral pneumonia.",20.4712285346585,10.514542008576703
Advanced molecular diagnostic tests have to be interpreted in the context of available clinical and diagnostic information in order to improve clinical management,0.34015721420063627,1.9231669902801514,1.9196377992630005,f1d11f3d-78b5-42b8-8449-1333f617cad4,comm_use_subset/Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study,"Advanced molecular diagnostic tests have to be interpreted in the context of available clinical and diagnostic information in order to improve clinical management. The results confirmed the important role of clinical judgement for appropriate antibiotic prescriptions, with rtPCR providing additional information rather than being solely responsible for treatment decisions.",22.015982337886015,10.203416931463153
Quantification of genomic viral load might improve specificity of virus detection,0.2927596977066087,1.8634172677993774,2.7650084495544434,3364aabe-c553-47be-a24b-5179f3ee0525,comm_use_subset/Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study,"Quantification of genomic viral load might improve specificity of virus detection, with higher organism burden being associated with higher risk of complications and severe disease in adults and children [27, 28] . Unfortunately, quantitative results were not available with the applied assay. Similarly, optimal timing of molecular testing in relation to symptom onset and inclusion of an ever-expanding number of respiratory viruses might be important to further increase sensitivity [27] . However, to the authors' knowledge, it has not yet been studied whether either of these two factors would improve clinical management.",19.305767889179442,9.765495477492788
improve clinical management of cases,0.21725814975180324,0.6696996688842773,2.6997876167297363,a95db3ff-c180-4b46-9d87-c59e0d5308eb,comm_use_subset/BMC Public Health Beyond traditional surveillance: applying syndromic surveillance to developing settings -opportunities and challenges,"A meeting of the Pan American Health Organization on the Surveillance Network for Emerging Infectious Diseases in Amazon countries in 2005 recommended the development of early warning systems, adopting the syndromic approach to surveillance to heighten the sensitiv- ity of disease detection and improve clinical management of cases, such as the febrile icteric syndrome for yellow fever. Although in 2005 there were few guidelines for syndromic surveillance in the region, a recommendation to disseminate protocols was made [13] , and new applications have since been developed, as we discuss below.",18.602567648402996,8.701065412590157
increase vaccine efficacy and identification of found virus strains to support internal and external biosecurity measures on local farms,0.1895585982218024,2.376091241836548,2.962000846862793,c7976d0e-dbea-4aa7-b6d7-7bf415c22e66,comm_use_subset/Molecular characterization of type 1 porcine reproductive and respiratory syndrome viruses (PRRSV) isolated in the Netherlands from 2014 to 2016,"Future research will be focusing on PRRSV-1 recombination and its implication on genetic analysis. It is of upmost importance that the variation of circulating PRRSV is being monitored and genetically analyzed, in order to improve diagnostics, increase vaccine efficacy and identification of found virus strains to support internal and external biosecurity measures on local farms.",13.382858602403537,8.15376036849581
development of sensitive diagnostics,0.20884133937844768,2.2368392944335938,3.0573770999908447,dfa236cf-5692-48e3-ad15-05bc0be6a11e,comm_use_subset/Surveillance and response systems for elimination of tropical diseases: summary of a thematic series in Infectious Diseases of Poverty,"Among the original research articles providing the core of this collection, seven research priorities emerged: (i) dynamic mapping of the transmission potential of various diseases; (ii) providing tools in near real-time capture of population dynamics; (iii) modelling based on minimum, essential databases; (iv) implementation of mHealth; (v) development of sensitive diagnostics; (vi) design of response packages tailored to different transmission settings and levels; and (vii) validation of surveillance and responses packages.",13.000932478675152,7.991567023912188
effective control measures,0.3967982106196185,2.3486597537994385,3.4701132774353027,8164fb3f-b967-4810-9654-5f790966bfcb,comm_use_subset/Article 46 1 Original research of the US,"inTrODUcTiOn Although porcine reproductive and respiratory syndrome (PRRS) is, arguably, one of the most important diseases of swine affecting the North American industry, aspects of its transmission within production systems and within regions are not completely understood (1) . Even though PRRS is endemic in North America, recurrent emergence of new PRRS virus (PRRSV) strains results in an epidemiological dynamic that resembles an epidemic condition for the disease (2, 3) . PRRSV epidemics impact the swine industry and commonly require prompt mobilization of resources for diagnostics (i.e., sequencing of the virus), thorough investigations to understand the origin of the emerging PRRSVs, and implementation of effective control measures. Surveillance is an integral part of strategies for control and elimination of PRRSV. There are a number of surveillance activities currently in place in the US; however, because PRRS is not reportable, surveillance strategies vary dramatically according to factors such as region and production system. A few examples of such surveillance activities are ongoing monitoring in breeding herds and gilt development units, and passive surveillance triggered by clinical symptoms.",12.003333892974805,7.983369332843763
RNA purification methods could be optimized by using larger input volumes of the clinical samples,0.20721478435534924,3.1331591606140137,2.5003819465637207,ae450205-3a35-431b-bc6c-416e482b31a7,comm_use_subset/Assay optimization for molecular detection of Zika virus,"To ensure specific detection of the Zika virus, we evaluated all assays using 37 high-titred cell culture isolates of different flaviviruses or chikungunya virus (the list of tested isolates is available from the corresponding author). None of the published assays detected the co-circulating alphavirus chikungunya virus or any other flavivirus. As expected, an Asian Zika virus lineage-specific E-based assay 16 did not detect the African lineage despite very high concentrations of viral RNA in the sample. As intended, the new NS1-based assay cross-detected Spondweni virus, as well as Kokobera and Jugra virus. These viruses are predominantly animal-associated 23 and do not circulate in Latin America and hence do not affect people in the current Zika virus outbreak. 14 When we determined the lower limit of detection using the uncRNA, all but two assays showed comparably high analytical sensitivities of around 5-10 Zika virus RNA copies/reaction (Fig. 4 ). An NS2b-based assay recommended by PAHO showed a lower limit of detection of 17 copies/ reaction, 12 whereas an NS3-based assay showed a lower limit of detection of 1373 copies/reaction. 7 To exemplify the impact of technical sensitivity on clinical sensitivity, we extrapolated the lower limits of detection to clinical viral loads. As shown in Table 2 , an assay with a lower limit of detection of 5-10 copies/reaction has a clinical detection limit of about 1000 copies/ mL, whereas an assay with a lower limit of detection of 1000 copies/reaction has a clinical detection limit of about 10000 copies/mL. To improve clinical sensitivity, RNA purification methods could be optimized by using larger input volumes of the clinical samples (Table 2) .",11.937761250129727,7.840018157210931
building computational infrastructure to suit the needs and financial abilities of modern healthcare centers,0.15790428011653881,2.1993167400360107,3.1331212520599365,de4c6147-b6b2-4ff9-aabe-25e81e58e1bf,comm_use_subset/viruses Current Trends in Diagnostics of Viral Infections of Unknown Etiology,"Viruses are evolving at an alarming rate, spreading and inconspicuously adapting to cutting-edge therapies. Therefore, the search for rapid, informative and reliable diagnostic methods is becoming urgent as ever. Conventional clinical tests (PCR, serology, etc.) are being continually optimized, yet provide very limited data. Could high throughput sequencing (HTS) become the future gold standard in molecular diagnostics of viral infections? Compared to conventional clinical tests, HTS is universal and more precise at profiling pathogens. Nevertheless, it has not yet been widely accepted as a diagnostic tool, owing primarily to its high cost and the complexity of sample preparation and data analysis. Those obstacles must be tackled to integrate HTS into daily clinical practice. For this, three objectives are to be achieved: (1) designing and assessing universal protocols for library preparation, (2) assembling purpose-specific pipelines, and (3) building computational infrastructure to suit the needs and financial abilities of modern healthcare centers. Data harvested with HTS could not only augment diagnostics and help to choose the correct therapy, but also facilitate research in epidemiology, genetics and virology. This information, in turn, could significantly aid clinicians in battling viral infections.",11.270989864345722,7.410931147383368
"MPI implementation, we scattered the P table to all the processes in the beginning.",0.1094474932291914,0.7976922988891602,0.32965901494026184,f75ed41a-40ec-4284-b3b1-d076e97a2cd9,comm_use_subset/An OpenMP-based tool for finding longest common subsequence in bioinformatics,"For the calculation of the P table, each row is independent and can be calculated in a parallel way. Therefore, in our MPI implementation, we scattered the P table to all the processes in the beginning. After calculating the corresponding chunk values, process number zero gathers the partial results from all the other processes. For the calculation of score table R, elements in each row can be scattered among the processes and gathered afterwards. This scatter and gather operations need to be done for every row. Hence, the communication and synchronization overheads are expected to be higher for the MPI implementation approach.",17.292825273546207,6.785267199730296
coagulation analysis,0.19104236025071009,1.3605897426605225,1.4879554510116577,4ac4dd97-7d64-4406-ab2d-d28ae3c9f161,comm_use_subset/Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques,Blood chemistry profiles were determined using a Vitros 350 Chemistry system (Ortho Clinical Diagnostics) and coagulation analysis was performed using a Sysmex CA-560 (Siemens).,12.474803052004106,6.217735444088354
it is essential to continuously improve the health system,0.16692971426200404,0.23362307250499725,1.2753039598464966,c27ba19e-83d1-4e50-a547-bc9dae4dbdc2,comm_use_subset/Financing strategies to improve essential public health equalization and its effects in China,"According to local conditions, in terms of funding criteria as well as implementation schedule and goals, it is essential to continuously improve the health system [36] . In a large country with significant regional diversity, the key point is to increase local governments' incentives to promote equity of basic public health services [37] .",13.201019292561622,5.601159323425039
resilience to public health crises,0.1204507736384315,-0.4328612983226776,0.9868255257606506,2dea6a13-2e46-4dde-8f32-bbbf941adcdd,comm_use_subset/What makes health systems resilient against infectious disease outbreaks and natural hazards? Results from a scoping review,"Conclusions: An implementation-oriented health system resilience framework could help translate the important components of a health system identified in this review into specific capacities that actors in the health system could work to develop to improve resilience to public health crises. However, there remains a need to further refine the concept of resilience so that health systems can simultaneously achieve sustainable transformations in healthcare practice and health service delivery as well as improve their preparedness for emergencies.",12.989814052329052,4.90651166614985
"qualitative approach, particularly valuable when seeking to explore processes of implementation",0.20677223914048412,-0.4447082579135895,-0.34366488456726074,a99cfa7b-3649-4cdd-9dca-f707d492020a,comm_use_subset/Factors influencing integration of TB services in general hospitals in two regions of China: a qualitative study,"This study adopted a qualitative approach, particularly valuable when seeking to explore processes of implementation [25] .",15.412816241792761,4.882043142014914
distributed memory implementation is discouraged for the LCS algorithm,0.2452955263698382,-0.43237558007240295,0.11519298702478409,dc1802e5-dd6b-48d1-9760-1be61bcd163a,comm_use_subset/An OpenMP-based tool for finding longest common subsequence in bioinformatics,"For the MPI approach, we tuned for the number of processes and found that using 4 process gives better relative speedup. For the OpenMP approach, we tuned for the number of threads and the scheduling strategy (static, dynamic, and guided). We found that using 16 threads and a static scheduling of work sharing among the threads provided 7 times relative speedup (see Fig. 1a, b) . Finally, for the hybrid MPI-OpenMP approach, we used 4 processes (or nodes) and 16 threads. For comparison purpose, we experimented with a varying number of sequence lengths. Figure 2a , illustrates the execution times for different implementations where we can see that our OpenMP implementation outperforms all the other approaches and is almost 2 times faster than the best sequential version. However, the MPI approach provides poor results due to the increased amount of communication and synchronization overhead caused by m scatter and gather operations (blocking in nature). The hybrid MPI-OpenMP approach performs the worst. As in the hybrid approach, the number of scatter and gather operations is the same as the MPI approach, and it also adds synchronization overheads of the OpenMP, and therefore this implementation provides the worst result. This observation indicates that distributed memory implementation is discouraged for the LCS algorithm. In order to validate our results, we also experimented with the real-DNA sequence data (see Table 1 ). From Fig. 2b , we can see that even for the real data the OpenMP implementation is having at-least 2 times speedup from the best sequential version. For longer DNA sequences (SP 9, SP 10 in Fig. 2b) , the OpenMP speedups are even higher, whereas the MPI and the hybrid implementations took more than a week to complete.",12.740698009041672,4.253075617683633
"laboratory diagnostics, patient management and future outbreak response",0.24096257889972444,3.3917276859283447,5.216090202331543,3974a567-9435-4aaa-be1c-d7ef5e5eb285,comm_use_subset/Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet,"There is limited information on circulating enterovirus serotypes and associated clinical phenotypes from the Asia Pacific region, including Viet Nam. Such knowledge is essential for laboratory diagnostics, patient management and future outbreak response.",11.441059823516065,9.599452565599549
to benchmark different pipelines and ensure comparable results across sites in terms of performance,0.1203975680061307,1.862214207649231,3.6803011894226074,cf978cd4-6247-4803-ae29-2ed8e777b89d,comm_use_subset/Viral Metagenomics in the Clinical Realm: Lessons Learned from a Swiss-Wide Ring Trial,"Nowadays, as NGS for viral diagnostics is on the brink of being used in routine, laboratories currently perform viral metagenomics in a non-accredited context. The increasing number of laboratories implementing NGS for shotgun metagenomics calls for quality management and the implementation of ring trials to benchmark different pipelines and ensure comparable results across sites in terms of performance, within clinically-realistic costs and turnaround times. Ultimately, participating in such ring trials will be essential for laboratories to get accredited in using shotgun metagenomics for viral diagnostics.",15.155832011473363,8.907176212112372
High-throughput screening (HTS) of biomarkers,0.13467543604658666,2.185554265975952,2.4234445095062256,86db34b9-0cb7-49be-8619-3ad16d7c643f,comm_use_subset/molecules Fluorescence-Based Multiplex Protein Detection Using Optically Encoded Microbeads,"High-throughput screening (HTS) of biomarkers has great potential for clinical and genetic analysis, and medical diagnostics. Because proteins can indicate the state of disease progression and the functions of normal biological processes within the human body, HTS techniques that identify proteins and their expression levels are very important for early detection, diagnosis, and therapy [1] [2] [3] [4] [5] [6] [7] .",16.09569762118141,8.62934337147691
"patient management, and outbreak response",0.32696300147649315,2.8048043251037598,4.369948387145996,5a40857b-093c-4974-8cd8-12047d982594,comm_use_subset/Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet,"We describe the diverse spectrum of enteroviruses from patients with CNS and respiratory infections in Viet Nam between 1997 and 2010. These data confirm the global circulation of Enterovirus genera and their associations and are important for clinical diagnostics, patient management, and outbreak response.",11.23488598137539,8.595799356443727
routine clinical diagnostics,0.4034634943983736,2.0356643199920654,3.1004209518432617,49b69494-8162-45b4-bbaf-989cd496d7f4,"comm_use_subset/Single Assay for Simultaneous Detection and Differential Identification of Human and Avian Influenza Virus Types, Subtypes, and Emergent Variants","It has taken almost twenty-five years from the first research reports of the polymerase chain reaction [25] until recent regulatory clearances have enabled introduction specific PCRand RT-PCR-based diagnostic assays and instrumentation into clinical practice. Such a traditional regulatory clearance timeline may assure safety and efficacy of diagnostic devices beyond imaginable limits of liability, but it also assures that best practice standards for clinical diagnostics are constrained to technologies that perform with nearly obsolete capabilities and specifications. Within the last decade resequencing microarrays have been introduced for research applications and clinical research [26, 27, 28] . It would be disappointing to anticipate that another decade or more may pass before benefits from diagnostic implementations of RPM or other highly multiplexed sequencing-based platforms can be realized in routine clinical diagnostics. Table 1 ). Found at: doi:10.1371/journal.pone.0008995.s003 (0.06 MB DOC) ",12.774391756816183,7.809492541578626
electronic tendering processes,0.23107748912171083,2.04634690284729,2.838397979736328,51e30b7a-499f-4c7c-9bfa-b36fa6220d9b,"comm_use_subset/Vaccines, inspiring innovation in health q","I. Lewis gave an update on UNICEF's barcoding project. Countries' and manufacturers' awareness of CTC has been promoted, and CTC is now a tender-evaluation criterion from 2017. Additional projects support waste and carbon footprint reduction for safe injection equipment. The next tender round will require industry reporting on ''green-manufacturing"", implementation of weight, volume and local production criteria, and introduction of electronic tendering processes. A vaccine arrival report application has been tested and will be launched globally in 2018.",12.779276678899784,7.647831011294276
unbiased sequencing approach independent of probes,0.212940111048274,2.2618014812469482,2.9874730110168457,13ab6d7c-7261-4dcf-96c9-d91432981412,"comm_use_subset/deep sequencing in infectious diseases: immune and pathogen repertoires for the improvement of patient outcomes The inaugural workshop ""Deep Sequencing in Infectious Diseases: Immune and Pathogen Repertoires for the Improvement of Patient Outcomes"" was held in Singapore","For clinical pathogen diagnostics the most useful test would be an unbiased sequencing approach independent of probes, which always look for something specific. But we heard that host DNA and RNA produces such a high background that it seems impossible to find pathogen sequences without specific probes. Is there a solution to this problem?",11.511476361016513,7.441045146327246
strict biosecurity measures,0.16550144900803693,1.6533795595169067,2.381699800491333,cec39473-1427-4502-8f5e-1c2374101080,"comm_use_subset/Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments","The emergency pathogens could be counteracted by opting immediate and timely international collaborative efforts, cooperative efforts between human and animal health sectors. Other effective measures include One health approach, implementation of effective prevention and control strategies, rapid communication and networking, and exploring advances in science and technology for developing rapid and confirmatory diagnostics, enhancing disease surveillance and monitoring, implementation of strict biosecurity measures, and timely efforts toward designing appropriate and effective vaccines and therapeutics (Cheng et al. 2020; Cohen 2020; Cyranoski 2020; Lu 2020; Munjal et al. 2017; Singh et al. 2017) .",13.620241823421459,7.3898862222028665
harmonizing NGS practices in clinical viral metagenomics,0.1354253341936048,0.9470563530921936,2.308180332183838,b1d86863-1578-4f56-8133-12d604c7ffea,comm_use_subset/Viral Metagenomics in the Clinical Realm: Lessons Learned from a Swiss-Wide Ring Trial,"The SIB working group on ""NGS Microbes Typing and Characterization"" and the ring trial that we implemented aimed at harmonizing NGS practices in clinical viral metagenomics. Harmonizing means here for different clinical laboratories to achieve comparable results of high quality, irrespective of the methodology chosen at the experimental or bioinformatics levels, which may result in part from internal constrains as well (e.g., existing laboratory processes for nucleic acid extraction to be re-used as much as possible for metagenomics as well). Our results have highlighted various aspects that can impact the overall performance at the experimental, databases and bioinformatics levels, offering insights to each participating laboratory into processes where they may further improve their workflows. In order for others to also benefit from this study and test their own workflows, we have published with this manuscript the database and all the datasets that were generated (Datasets S1 and S2).",14.842701334674071,7.310849312565345
ease of use for bioapplications,0.13434763537215103,2.520556688308716,2.6168158054351807,24308529-826e-4d9b-be22-ba279cbd45e1,comm_use_subset/molecules Fluorescence-Based Multiplex Protein Detection Using Optically Encoded Microbeads,"Even though plenty of success has been, in order for bead-based assays to be more practically achieved in this field, several issues still need to be resolved, including a large number of optical codes, rapid readout method, safety, cost, sensitivity, and ease of use for bioapplications such as multiple protein detection in clinical diagnostics.",11.30277997049101,7.295265110605386
adequate control measures,0.4034178736464657,1.7590073347091675,1.9802712202072144,95376ff8-45a4-4b00-a2db-92abb1f42ad2,"comm_use_subset/GI-16 lineage (624/I or Q1), there and back again: The history of one of the major threats for poultry farming of our era","The insight provided by recent genetic studies [6, 7] raised new questions about the history, epidemiology and spreading of the GI-16 lineage around the world. The knowledge of these processes would be of interest not only for the particular case under investigation, but could also provide useful information on the general intra-and inter-continents viral dispersion patterns, aiding the development and implementation of adequate control measures.",12.925763435751286,6.954548263208597
"nucleotide content, expression levels, amino acid composition, protein length, hydrophobicity, and aromaticity to evaluate their relationships with codon selection",0.3240000395837979,1.2299542427062988,2.8268063068389893,fa932491-b18e-43d0-a3bb-d8cb4d794560,comm_use_subset/Analysis of codon usage patterns in Hirudinaria manillensis reveals a preference for GC-ending codons caused by dominant selection constraints,"In addition to identifying selection as the driving force behind codon usage bias in H. manillensis, we measured the effects of the factors that produce selection pressure on codon usage patterns. The overall effect of gene selection is the maintenance of efficient gene expression; however, selection pressure from previous translation processes, also known as the translation elongation rate, or certain subsequent protein products could also contribute to this selection process. Previous studies have shown that both conditions occur in different species. In many viruses such as bovine coronavirus or Zika [10, 37] , protein products are not contributing factors, whereas in plants like Zea mays [38] the effects of proteins products are significant. In our study, we investigated factors such as nucleotide content, expression levels, amino acid composition, protein length, hydrophobicity, and aromaticity to evaluate their relationships with codon selection. Of these factors, only protein length had selective effects on codon usage; however, the effects of protein length were strictly determined by CDS length and overall, attributable to the translation elongation rate. Thus, we conclude that codon usage bias in H. manillensis is shaped only by translational mechanisms, the final protein products of which may be sufficiently conserved to be excluded from evolutionary processes.",12.125779974344683,6.8809173482250765
Appointment-booking service,0.17067845043399926,1.7937538623809814,2.0402939319610596,dd116ab2-c44d-47a7-856f-d839f0a801ff,comm_use_subset/Public Perception on Healthcare Services: Evidence from Social Media Platforms in China,Optimize the layout of the facility and build a friendly service environment Appointment-booking service Promote utilization of clinical appointment services and guide patient flow Service efficiency Improve service efficiency and effectiveness by rational allocation of resources Information technology Take advantage of information technology to improve patient experience Inpatient service Promote inpatient service process reengineering and provide integrated healthcare service Nursing service Continuously improve quality of nursing care and enhance nursing workforce Patient safety Ensure patient safety by promoting adoption of standard operating procedures Humanistic care,11.101509017470004,6.377659222436828
expanded SARI surveillance,0.31041410873179764,1.0330255031585693,1.5619784593582153,88b3cff9-5369-4176-a3c0-3c5ff5e6997a,comm_use_subset/Expanding severe acute respiratory infection (SARI) surveillance beyond influenza: The process and data from 1 year of implementation in Vietnam,"To ensure accurate use of these diagnostic tests, CDC engaged the RIs in a series of trainings. This included a 4-day in-country training of didactic and laboratory instruction held at the PI-HCMC in August 2015. Topics covered laboratory safety; setup of a molecular diagnostics laboratory; appropriate specimen collection, transport, and storage; overview of real-time reverse transcriptase-polymerase chain reaction (rRT-PCR); software data analysis of rRT-PCR; and a discussion on the implementation of expanded SARI surveillance.",12.122713874137034,5.929702431583872
Demographic and clinical data were retrieved from medical records,0.16966656282905448,0.7189375162124634,1.0089823007583618,dc5dde2a-2eba-43b8-94b3-c032a3f990cd,comm_use_subset/H1N1pdm09 Adjuvanted Vaccination in HIV-Infected Adults: A Randomized Trial of Two Single versus Two Double Doses,"Demographic and clinical data were retrieved from medical records. HIV-1 RNA viral load (Versant HIV-1 RNA 3.0 Assay, Siemens H. Diagnostics, IL, USA) and CD4 cell counts (BD Biosciences, CA, USA) were measured at baseline, 21 and 42 days after baseline.",10.719751345085564,4.875060851810984
"current ARVs greatly improve the clinical outcomes of HIV positive individuals and limit disease transmission with improved safety, elevated tolerability, and high potency",0.15777210300718028,2.477874994277954,3.128727674484253,9f775cb4-c372-4d19-a7ef-9744d0fdff28,comm_use_subset/Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections,"There have been tremendous advances over the past years in the standard use of antiretroviral drugs (ARVs) for the treatment and prevention of HIV infection [4] . Indeed, current ARVs greatly improve the clinical outcomes of HIV positive individuals and limit disease transmission with improved safety, elevated tolerability, and high potency, especially if used early in the infection [5] .",20.115373374856553,10.684672415895228
"Improved LASV tests are needed for endemic clinical management, outbreak response and vaccine and therapeutic clinical trials",0.3423471713356148,4.1963419914245605,4.84049654006958,3aa5a6b0-a22f-4816-ae10-01f7b01ce1b4,comm_use_subset/Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings,"Diagnostics are essential for the recognition and control of outbreaks of LASV, one of the most widespread and genetically diverse agents of VHF. Improved LASV tests are needed for endemic clinical management, outbreak response and vaccine and therapeutic clinical trials. Surveillance across all LASV lineages and regions will continue to be important to rapidly identify 'hot spots' for intervention and containment, and to monitor genetic and geographical shifts in both human and animal reservoir populations. For vaccine development, diagnostics are fundamental to detecting and differentiating an infection challenge from vaccine immunity. Finally, there is strong consensus that early diagnosis and treatment increases the survival rate from LASV infection.",12.272978297275692,10.169487449517682
The use of humanized antibodies has helped greatly to improve clinical tolerance of mAb therapeutics,0.18061664236236805,2.7865278720855713,3.1384992599487305,07a9fc30-85de-47b4-9609-a7b53dc7b419,comm_use_subset/Development of therapeutic antibodies for the treatment of diseases,"The use of humanized antibodies has helped greatly to improve clinical tolerance of mAb therapeutics. Such intricate control over antibody sequences has opened the door to engineering mAbs for a wide range of possible applications in medicine. Currently, half of all mAbs used to treat humans are chimeric or humanized (Fig. 2 , Table 1 ). One of the most well-known humanized antibodies is Trastuzumab (Herceptin), which was approved in 1998 and achieved annual sales of over $7 billion in 2018 ( Table 2) . Trastuzumab is used for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer and gastroesophageal junction adenocarcinoma [57, 58] .",16.013097082233173,9.455851614603906
Implementation of diagnostics could be further refined with more detailed understanding of LASV kinetics across a range of sample types,0.20228628531572415,2.3113949298858643,2.6456775665283203,47ae1309-edb8-493c-8a98-f682ce708569,comm_use_subset/Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings,"This review has identified test resources for Lassa molecular diagnostics and serology and further described a large number of in-house LASV tests used across the international community. However, several gaps identified in the 2016 WHO R&D Blueprint remain. 8 145 Efforts should be made to advance existing diagnostic platforms towards clinical validation and regulatory approval. Implementation of diagnostics could be further refined with more detailed understanding of LASV kinetics across a range of sample types, and a more robust point-of-care or field-appropriate design where appropriate. Tests that are currently available could benefit from EQA with the goal of standardisation of test sensitivity, specificity and lineage/regional coverage.",17.254875229310382,9.261303452927853
to further improve our knowledge of the time/concentration relationships of hand rubs and hand wash products which reflect daily needs in clinical surroundings,0.21257685285594144,2.7025763988494873,3.5532026290893555,784a4b9f-0397-4c14-b03d-14a8ced1ce2c,"comm_use_subset/Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses","The results of suspension tests only allow the virucidal efficacy of a product to be predicted, and do not give information about its effectiveness in practice. In order to further improve our knowledge of the time/concentration relationships of hand rubs and hand wash products which reflect daily needs in clinical surroundings, more practical testing would be necessary. EN1500 [30] describes a bactericidal test simulating practical conditions in volunteers, however, there is no enveloped harmless virus available that can be used to inoculate the volunteers. More than 30 years ago, tests with vaccinia virus on the fingertips of volunteers were performed [31] , however today this can no longer be justified ethically.",12.54487390948833,8.456962236481164
cancer and infectious diseases,0.15392076492100282,1.8179535865783691,4.060234546661377,67466829-2e29-43e2-9651-4eb701994e31,comm_use_subset/Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs,"Since the emergence of hybridoma technology [1] , the research and the development of monoclonal antibodies (MAbs) has rapidly progressed. MAbs, well-characterized individual full or partial immunoglobulin molecules, are currently being developed for a broad range of indications, from diagnostics and imaging to the treatment of medical conditions such as cancer and infectious diseases. In recent years, MAbs and related products have been the fastest growing class of therapeutic agents [2] .",11.700631781458345,7.916043410116256
Development of new and improved LASV diagnostics could be facilitated by a clearly defined set of use cases to describe where and how diagnostic tests are most needed,0.2615809719575539,2.478638172149658,2.9181339740753174,cdcf1ad9-9cda-4fa2-bd1a-f6e5c8b7a9a3,comm_use_subset/Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings,"Given the challenges identified for LASV detection in endemic and often low-resourced settings, rapid on-site diagnosis of suspect cases may bridge the gap. A range of assays have been already developed for commercial point-of-care platforms, thus it is possible that current LASV assays could be adapted into a cartridge-based format. The combination of rapid, point-of-care antigen detection with a point-of-care confirmatory test has been suggested as an ideal implementation for early case detection and outbreak response. 108 146 147 Each of the aforementioned diagnostic use scenarios have different performance requirements for text complexity, sensitivity, specificity and turnaround time. Development of new and improved LASV diagnostics could be facilitated by a clearly defined set of use cases to describe where and how diagnostic tests are most needed, coupled with TPPs with detailed performance characteristics for the highest priority molecular and immunodiagnostics. 148 While numerous barriers to achieving regulatory approval exist, 142 initiatives from WHO and other organisations such as the Foundation for Innovative New Diagnostics (FIND) and CEPI are intended to make development and commercialisation of LASV diagnostics more feasible. 86 148-150 Contributors LTM contributed to drafting the manuscript and provided background research for the manuscript. CK-C contributed insight into diagnostic needs for outbreak pathogens. All authors reviewed, edited and approved the final version of the manuscript.",11.883786691748524,7.667227237158217
basic infection control measures at the university dental school Table 3 : Level of implementation of basic infection control measures at the university dental school,0.23036207783305707,1.6187137365341187,3.216815948486328,0c668c61-b75d-4ed5-b9a2-091ff06302cc,comm_use_subset/Awareness and compliance of dental students and interns toward infection control at Riyadh Elm University,"Results 309 questionnaires were answered by clinical dental students and interns from Riyadh Elm University. The distribution of respondents from male and female 4 th -, 5 th -, and 6 th -year students and interns is shown in Table 1 . The level of implementation of basic applied infection control measures was found to be good to excellent, except for HBV vaccine coverage and wearing protective eyewear. The results showed that only 76% of males and 83% of females had HBV vaccination, and only 30% of males and 26% of females always wore protective eyewear (Table 2 and Table 3) . A majority of dental students and interns complied well with different infection control measures during the treatment of patients and between patients, but there is still a need to raise their awareness and improve their attitude regarding infection control practices. The infection control practices followed by dental students and interns during the treatment of patients and between patients are shown in Table 4. 2/6 GMS Hygiene and Infection Control 2019, Vol. 14, ISSN 2196-5226 Table 1 : Distribution of respondents in the college to 4 th -, 5 th -, and 6 th -year students and interns both male and female Table 2 : Level of implementation of basic infection control measures at the university dental school Table 3 : Level of implementation of basic infection control measures at the university dental school ",12.825443357931782,7.631999470539414
Active mixing schemes,0.2320759186808922,2.1841988563537598,2.273909330368042,fb460530-6b70-4e4f-99d3-4618f9389329,comm_use_subset/Isothermal Amplification Methods for the Detection of Nucleic Acids in Microfluidic Devices,"Passive mixing principles are very attractive because they rely on diffusion or chaotic advection through specially-designed microchannels. They can also operated by avoiding the need of any external energy source. Active mixing schemes, on the other hand, improve the mixing performance by applying external forces to perturb sample flows and consequently to accelerate the diffusion processes. The latter configuration often leads to a complex device design [17] .",11.84151183290518,7.042299462885984
LASV,0.2746333799281867,0.46758002042770386,1.3906711339950562,1862c4ad-15bb-4ae4-9b3e-d86b674d7693,comm_use_subset/Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings,"Diagnostic test types differ in complexity, infrastructure requirements and appropriateness for a rapid response. An overview of the implementation requirements for the range of diagnostics available for LASV is shown in table 1.",16.585654693728564,7.012842393179792
MDI/spacers for asthma treatment,0.18579292429261937,1.4842655658721924,1.8896996974945068,10230845-ff7d-4f17-92f1-751bf7139191,comm_use_subset/Implementation Science Barriers and supports to implementation of MDI/spacer use in nine Canadian pediatric emergency departments: a qualitative study,"The dissemination of research evidence rarely is sufficient by itself to improve healthcare and specific interventions are needed to address local barriers and facilitators [20] . This is true with MDI/spacer adoption because, despite strong research evidence that MDI/spacer can produce results equivalent to nebulisers, adoption of MDI/spacers for the treatment of mild and moderate asthma has been slow. Building upon the findings of key articles in the field [16, 17] , we studied the natural evolution of diffusion patterns of MDI/spacers for the treatment of mild to moderate asthma in children in nine PEDs. Through this research, we developed new knowledge about the social and political nature (i.e., in terms of resource allocation and presence of champions) of the adoption process as well as complexity in terms of the number of factors and levels that innovation adoption demands. Clinical treatment and management of children's asthma exacerbations are engrained decisions and behaviours that are shaped by factors at the individual practitioner, department, and institutional levels. Adding to this complexity, parental perceptions and expectations weighed heavily into healthcare professionals' decision making processes and the overall adoption process. Generally speaking, the findings make important contributions to the complexity of innovation adoption processes on two fronts. First, awareness or knowledge of the innovation is not enough to change practitioner behaviour. Rather, of note, most practitioners knew of the merit of MDI/spacer use, however, this knowledge was not enough to independently propel successful adoption because of the magnitude of other unit level barriers. Second, there were no 'magic bullets' or patterns of barriers and/or facilitators that consistently led to adoption success at each of the adopter/ adopting sites. Rather, the unit/departmental barriers and facilitators interacted and interplayed with historical, contextual, and cultural values at each site. Our findings represent important knowledge for EDs preparing to implement MDI/spacers for asthma treatment, and potentially other innovation adoption decisions that are based upon strong research evidence. This study demonstrates the value of assessing the unit-specific barriers and facilitators prior to planned implementation change initiatives in order to tailor implementation strategies.",13.374346399004798,6.874098660840033
regulatory policies,0.3202910372930033,1.3994557857513428,2.1606552600860596,ea32f263-c190-4971-bfc3-a8eb5d2e61e6,comm_use_subset/Forensic genetics and genomics: Much more than just a human affair,"An area of growing interest is the detection of GMOs. The number of genetically modified plants has been growing in recent years despite the intense discussion about the benefits or damage that these organisms may have on humans and ecosystems. The detection of a GMO is carried out by targeting the genetic elements (promotors, protein-coding regions or terminators) that have been introduced artificially in the genome of the transgenic organism in order to improve a particular trait [242] . A curated list of transgenic reference sequences has been recently made available and is expected to facilitate the development of methods for testing GMOs and the implementation of regulatory policies [243] . The labelling and traceability of GMOs are important issues that are highly regulated. If the content exceeds a certain threshold, the product must be labeled accordingly. The most commonly used DNA-based methodology for GMO testing is PCR, although other techniques have been proposed [244] [245] [246] . The quantification of DNA targets is usually done by real-time PCR, where the copy number of the transgenic element detected is correlated to a common plant marker, allowing the determination of the GMO proportion in the sample [247, 248] . The correct detection of genetically modified materials is of forensic relevance not only due to strict legislation regarding the labelling of food products but also due to the type of materials from which DNA has to be extracted. For example, transgenic constructs have to be identified in DNA extracted from products like corn germ, flour, pasta, corn flakes, cookies, baked products, sugars derived from corn starch, soy cream or milk (liquid or lyophilized), tofu, meat products, lecithin, and even oil. Although most of the currently available GMOs are plants, the picture is expected to change soon. The first genetically modified animal (AquAdvantage salmon) is on the verge of being approved for human consumption in different countries [249] . New methods are being developed to detect the genetically modified salmon in food products [250, 251] . Strong legislation is expected to regulate the presence of this transgenic animal in foods and environmental samples [252, 253] and, consequently, reliable and sensitive methods for its detection will be required by regulatory and scientific agencies worldwide [245, 254] .",12.332789012585652,6.63054833419929
In 2009 we embarked on a project to improve the representation of viral processes in GO,0.1415933477018606,1.4991543292999268,1.9198685884475708,0b7f809c-aad1-4eeb-9d7a-531e44ae2246,comm_use_subset/Representing virus-host interactions and other multi-organism processes in the Gene Ontology,"Processes involving viruses were also sparse in early versions of GO. A set of classes was added in 2002 to accommodate a protein annotation set for Herpes simplex virus 1 (HSV-1), but not all of these classes were well suited for the annotation of other viral species, and the classes themselves were not well integrated with the rest of the biological process ontology. In 2009 we embarked on a project to improve the representation of viral processes in GO. This involved input from experts for a variety of viral species, including bacteriophages. We now report on the conclusion of these changes, including annotations for several viral species using the refactored terms.",12.019791590297984,6.429291953140167
Repurposing currently available antiviral medications,0.20055451859860293,2.315730333328247,0.7442737817764282,4c8cc64b-c6d4-4354-8a21-4930a0781632,"comm_use_subset/Open Peer Review Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China [version 2; peer review: 2 approved] , Cepheid, Danaher Diagnostic","Repurposing currently available antiviral medications Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication. Two classes of potential targets are viral polymerases 28 and protease inhibitors 29 , both of which are components of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antiviral regimens. Pilot clinical studies are already ensuing by desperate clinicians with various repurposed antiviral medicines. This has been done in every viral outbreak previously with limited success, outside of case reports 30 . Indeed, during the Ebola outbreak, none of the repurposed small molecule drugs were definitively shown to improve the clinical course across all patients 31 . The 2019-nCoV could be different, and there are initial positive reports that lopinavir and ritonavir, which are HIV protease inhibitors, have some clinical efficacy against 2019-nCoV, similar to prior studies using them against SARS 32 . Research should continue to be undertaken to screen other clinically available antivirals in cell culture models of 2019-nCoV, in hopes that a drug candidate would emerge useful against the virus that could be rapidly implemented in the clinic. One promising example could be remdesivir, which interferes with the viral polymerase and has shown efficacy against MERS in mouse models 33 . For further information, reviews of previous drug repurposing efforts for coronaviruses are provided 34,35 . Though these repurposed medications may hold promise, it is still reasonable to pursue novel, 2019-nCoV specific therapies to complement potential repurposed drug candidates.",12.228946334649894,6.2691338919455015
might even enhance its toxicity,0.1299957086367681,0.03796103224158287,1.2315689325332642,54d72c7d-193a-4e90-ac70-70dee56d4dba,comm_use_subset/Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs,"However, in a recently conducted anti-ricin study, contradicting results were obtained. Vance et al. showed that on one hand, the addition of a clearing Fc agent to double-tagged VHH heterodimers (enabling up to four Fc molecules to decorate each toxin molecule) significantly increased the protection of mice from ricin toxicity, likely via the promotion of toxin clearance [106] . On the other hand, the presence or absence of an anti-tag clearing Fc linked to a high affinity heterodimer consisting of two non-neutralizing VHHs afforded the mice no protection against ricin challenge. Because ricin is toxic to all cell types and preferentially targets macrophages, including Kuppfer cells in the liver [68] , the authors postulated that the accelerated FcÎ³R-mediated clearance of ricin in the absence of the inhibition of functional ricin domains may not improve the clinical results and might even enhance its toxicity [106] .",14.473126011700838,5.890788581198944
future investigations on PAD guideline implementation should consider focusing on specific recommendations or targeting long-term outcomes.,0.25241784168446907,2.094722032546997,2.3765058517456055,d3e0d767-325c-4b10-a087-e331d185e287,"comm_use_subset/ESICM LIVES 2016: part one Oral Sessions. ARDS: CLINICAL STUDIES A1 Identification of distinct endophenotypes in patients with acute respiratory distress syndrome by unbiased cluster analysis, and their association with mortality","Conclusions: This multifaceted implementation program was effective in improving adherences to multiple key PAD guideline recommendations. Delirium duration decreased significantly in spite of increased incidence probably due to improved screening. We observed differential effects of screening vs. further guideline implementation. However, these improved adherences to guideline recommendations did not translate into measurable improvements of short-term clinical outcomes. To improve clinical outcomes, future investigations on PAD guideline implementation should consider focusing on specific recommendations or targeting long-term outcomes.",26.812173584244483,12.29055887927576
"for training, supervision, purchase of equipment and pharmaceuticals",0.1665505885604275,1.3749666213989258,2.0131449699401855,bbdcf34a-f84e-4a54-8e20-9d610baf533f,"comm_use_subset/ESICM LIVES 2016: part one Oral Sessions. ARDS: CLINICAL STUDIES A1 Identification of distinct endophenotypes in patients with acute respiratory distress syndrome by unbiased cluster analysis, and their association with mortality","Results One time implementation costs of Â£23,406.7/hospital (Â£1,399.0-Â£31,793.0) for training, supervision, purchase of equipment and pharmaceuticals can be expected. However, these costs were offset after treating 26 patients, mainly due to reduced LOS and lower complication rates. The long-term model showed that the intervention is both more effective (2.4 month) and leads to lower costs to society (cost savings of Â£899.6/patient). The incremental cost-effectiveness ratio is Â£-4,015.9, meaning the new pathway is the dominant strategy and should be recommended to decision makers. Conclusion A bundled pathway to improve clinical care for patients undergoing emergency laparotomy has shown to reduce mortality, seems cost-effective and has the potential to improve clinical outcome and lower costs for society. Decision makers need to adopt a long-term vision and be prepared to make one off investments to lower future costs.",24.364424326654884,10.72982104869963
"improved adherence to the PAD guidelines and associated changes in delirium incidence and duration, length of ICU stay and hospital mortality",0.2625053879609237,2.0884974002838135,3.1772208213806152,8f375af9-f105-4e07-973b-f20c937ccdf8,"comm_use_subset/ESICM LIVES 2016: part one Oral Sessions. ARDS: CLINICAL STUDIES A1 Identification of distinct endophenotypes in patients with acute respiratory distress syndrome by unbiased cluster analysis, and their association with mortality","Conclusions: These results suggest that these immune stimulants, GM-CSF and IFNÎ³, exert their effects on monocyte antigen presentation through different signalling pathways. The increased gene expression associated with IFNÎ³ may be indicative of potential therapeutic benefit in reversing post-operative immune suppression. Introduction: Delirium in critically ill patients is associated with increased mortality and long-term cognitive decline. The recent Pain, Agitation and Delirium (PAD) guidelines include recommendations for delirium screening, prevention and management, which may help to improve clinical outcomes and reduce delirium burden. Objectives: We aimed to measure the effectiveness of a multifaceted implementation program for improved adherence to the PAD guidelines and associated changes in delirium incidence and duration, length of ICU stay and hospital mortality. Methods: A prospective multicenter before-after study was conducted in six ICUs in the Netherlands between March 2012 and April 2015. The intervention consisted of a two-phase multifaceted tailored implementation of the PAD guidelines. Multiple implementation strategies were applied to change clinical practice (Table 18) . Data of all adult ICU patients were collected during three four-month periods:",18.957134840663745,10.05771403831419
Several randomized controlled trials,0.26184162751235684,3.1801884174346924,2.8398096561431885,d732937c-facc-4e9b-b2df-7d9534c6ba82,comm_use_subset/P001 Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux P002 Lower serum immunoglobulin G2 level does not predispose to severe flu,"Selenium is an essential trace element with antioxidant and immunomodulatory effects. Several randomized controlled trials (RCT) and meta-analyses have demonstrated that parenteral selenium may be able to improve clinical outcomes in intensive care unit (ICU) patients and new trials have been published since our last update. Thus, we updated our data with this systematic review on parenteral selenium as single strategy or in combination with other antioxidant micronutrients in the critically ill.",17.36517622255532,9.990810425719985
"reduced use of antibiotics and ancillary testing, and more appropriate use of antiviral therapy",0.1680371022665111,3.6626594066619873,4.301093101501465,b5dabb8c-e2fe-4baa-927a-6e9b0d33d9f8,comm_use_subset/Estimating Sensitivity of Laboratory Testing for Influenza in Canada through Modelling,"Although influenza virus infection is associated with considerable morbidity and mortality [1] [2] [3] , laboratory confirmation of clinical illness is the exception rather than the rule. Clinicians do not routinely seek laboratory confirmation for several reasons: diagnosis will often not alter patient management, a paucity of real-time, accurate, inexpensive testing methods [4] and because influenza is not recognized as the etiology of the clinical presentation [5] . Accurate diagnosis of influenza-like illness, however, could improve clinical care through reduced use of antibiotics and ancillary testing, and more appropriate use of antiviral therapy [6] . Although rapid influenza tests such as pointof-care tests are purported to generate results in a timely fashion to influence clinical care, the performance characteristics of the currently available tests are sub-optimal [7] . New technologies with improved sensitivity such as reverse-transcriptase polymerase chain reaction (RT-PCR) [8] as well as the use of more effective collection systems such as the flocked nasopharyngeal swab compared to traditional rayon wound swabs, and the recommendation to collect more ideal specimens, such as nasopharyngeal swabs rather than throat swabs are likely to improve diagnostic sensitivity [9] [10] [11] [12] . The performance characteristics of currently available tests for influenza vary considerably and the overall sensitivities of these tests when used in routine practice are also dependent on the type of specimen collected, the age of the patient and point in their illness in which they are sampled [4, 9, [13] [14] [15] .",13.683823346186324,9.965777301471459
"In patients undergoing cardiac surgery, supplementation with omega-3 fatty acids",0.11663279732536232,0.8162009716033936,1.4663749933242798,e8a03556-3bdc-402f-90b4-bfdc5cff5469,comm_use_subset/P001 Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux P002 Lower serum immunoglobulin G2 level does not predispose to severe flu,"In patients undergoing cardiac surgery, supplementation with omega-3 fatty acids does not improve any clinical outcome in the postoperative period.",22.357237909869166,9.308707645657195
a set of sequential interventions,0.30774308622198515,1.8260678052902222,1.6637333631515503,491a46bf-62ce-40ed-a5de-1dcb764a042f,"comm_use_subset/ESICM LIVES 2016: part one Oral Sessions. ARDS: CLINICAL STUDIES A1 Identification of distinct endophenotypes in patients with acute respiratory distress syndrome by unbiased cluster analysis, and their association with mortality","Introduction Emergency laparotomy is associated with a high risk of mortality and morbidity, which leads to significant financial expenditures for the NHS. In a recent study, the Emergency Laparotomy Pathway Quality Improvement Care (ELPQUIC) program has shown that a set of sequential interventions have the potential to improve clinical outcome; however related costs or savings remain unknown.",18.938661184424248,8.896902174035638
develop appropriate strategies to facilitate their use,0.2521634674510731,2.5425994396209717,4.182300567626953,8cdc161d-9dd6-4bb3-bd90-2822d94221a0,comm_use_subset/What Synthesis Methodology Should I Use? A Review and Analysis of Approaches to Research Synthesis,"Research synthesis neither makes research more applicable to practice nor ensures implementation. Focus must now turn seriously towards translation of synthesis findings into knowledge products that are useful for health care practitioners in multiple areas of practice and develop appropriate strategies to facilitate their use. The burgeoning field of knowledge translation has, to some extent, taken up this challenge; however, the research-practice gap continues to plague us [133] [134] . It is a particular problem for qualitative syntheses [131] . Although such syntheses have an important place in evidenceinformed practice, little effort has gone into the challenge of translating the findings into useful products to guide practice [131] .",12.801273821991387,8.851630842408136
either propofol or dexmedetomidine may be preferred over sedation with benzodiazepine,0.19718598389902792,0.9518280625343323,1.7132374048233032,3e8a67e6-e81e-490c-9038-f18bcac7d469,"comm_use_subset/ESICM LIVES 2016: part one Oral Sessions. ARDS: CLINICAL STUDIES A1 Identification of distinct endophenotypes in patients with acute respiratory distress syndrome by unbiased cluster analysis, and their association with mortality",Conclusions We found evidence that ICU sedation with volatile ACD provides the shorter extubation time from termination of sedation and the ICU LOS Introduction The clinical practice guideline for the management of agitation of the American College of Critical Care Medicine suggests that either propofol or dexmedetomidine may be preferred over sedation with benzodiazepine to improve clinical outcomes in critically ill intubated patients.,19.554116293175746,8.576233256393973
phase II clinical trial for treatment of lupus erythematosus,0.1276257834978695,2.298877477645874,3.278702735900879,04093c91-ff98-41c4-ace5-d602a7f68dcf,comm_use_subset/Pharmacologic inhibition of host Phosphodiesterase-4 improves isoniazid-Mediated clearance of Mycobacterium tuberculosis,"The present study was undertaken to compare the impact of CC-3052 in the murine TB model with a second PDE4i (CC-11050), in preparation for a clinical trial of the latter drug in TB patients. CC-11050 shows improved stability over CC-3052, has demonstrated safety in humans, and has progressed to a phase II clinical trial for treatment of lupus erythematosus and a phase I trial in HIV-infected adults on antiretroviral therapy. To better understand the underlying molecular events associated with PDE4 inhibition during TB chemotherapy, we recently studied CC-11050 as an adjunct to INH treatment in the rabbit model of pulmonary TB. We showed that CC-11050 reduced inflammation and pathology in the lungs and increased the antibiotic responsiveness of the infecting Mtb (14) . Here, we describe the pharmacokinetics of CC-11050 in mice and show that the drug reduces the inflammatory response and improves INH-mediated bacillary clearance from the lungs. Taken together, the results of our studies indicate that CC-11050 is a promising candidate for HDT that may shorten the duration of treatment and improve clinical outcome in patients with pulmonary TB.",12.970486883219843,8.165097547932334
to challenge the animal reproduction,0.14124474348115998,1.5495953559875488,3.8140463829040527,1f8a2927-0113-4df6-9753-57a22a0b3e47,comm_use_subset/Molecular Sciences Theranostics Aspects of Various Nanoparticles in Veterinary Medicine,"Nanotechnology has opened up new era in various area of research interest biotechnology, biomedical sciences; veterinary and animal sciences by providing new, small scale tools and materials that are beneficial for living organisms. The varieties of nanomaterials that are used for disease diagnosis, treatment, drug delivery, animal nutrition, animal breeding, reproduction and value addition to animal products, and finally food safety by using liposomes, polymeric nanoparticles, dendrimers, metallic nanoparticles, carbon nanoparticles, quantum dots, carbon nanotubes, magnetic nanoparticles, and fullerenes [227] . Recently, the nanotechnology contributes to the development of non-toxic antimicrobial agents to overcome antibiotic resistance through the use of devastating dose of antibiotics used for against various pathogens causing chronic infections to livestock, including Brucella, Mycobacterium bovis, Streptococcus aureus, and Rhodococcus equi [227] . Furthermore, the use of nanomaterials as antiviral agents, rapid and sensitive detection of viruses in veterinary medicine seems to be an important player for animal health and reproduction. Nanobiosensors are very sensitive for environmental monitoring and clinical diagnostics and also it has been used for reproductive management, such as detection of oestrus, hormone levels, and metabolites profiles [228, 229] . Nanomaterials could be used for the cryopreservation of gonadal tissues, sperm, oocytes, and embryos, which are very essential in animal reproduction [230] . Finally, nanomaterials are being used in food technology including meat and meat products free from contaminations [231] . The nanomaterials would facilitate develop products and processes for animal health and production in line with economic, social, and environmental valuable materials to challenge the animal reproduction.",13.06499798641694,8.059116425525469
Enhance laboratory capacity and improve the availability of diagnostics tools,0.3598119118073063,1.4924211502075195,1.7369571924209595,80a0f7bd-3b7a-4510-abdc-72412468d291,comm_use_subset/Health Security Memos to the New Administration and Congress,â Enhance laboratory capacity and improve the availability of diagnostics tools.,16.64740429257231,7.92568742510882
"the presence of trained and well-equipped clinical sites, which are essential for the implementation of clinical trials",0.1478401797572791,1.0468052625656128,1.7385358810424805,c6630651-9a8f-40ba-a336-6ed89f646203,comm_use_subset/Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development,"There may also be opportunities to perform efficacy trials in regions endemic for CHIKF, but the typical misdiagnosis of CHIKF as dengue fever [56] will need to be overcome with improved surveillance and diagnostics to identify such opportunities. Finally, CHIKF will continue to occur mainly in poor-resource countries located in tropical areas, where the presence of trained and well-equipped clinical sites, which are essential for the implementation of clinical trials, can be challenging. However, there may be opportunities to capitalize on sites already developed for dengue vaccine trials, which are generally in locations endemic for both viruses.",17.127886312124883,7.8052319525889695
SARS-CoV-2 diagnostics does not replace nor exclude diagnostic capacity for other respiratory viruses,0.18467974228074824,1.187895655632019,1.7832173109054565,7b5b686e-bd0f-41c8-94d0-8af6dbee468a,comm_use_subset/Authors' response: Plenty of coronaviruses but no SARS-CoV-2,"While the current response strategy is still focused on containment, it is becoming increasingly clear that the epidemic may turn global, in which case mitigation will be the next option to control the impact of the pandemic. Substantial autochthonous circulation in Italy, Iran and South Korea has been reported by now, while there is increasing evidence that subclinical infections occur and people may be infectious before symptoms appear [8] [9] [10] . These developments indicate that the window of opportunity to contain and eradicate is rapidly narrowing. [11] . Therefore, it is needless to state that for each phase in the control and mitigation of a novel emerging pathogen, adequate laboratory preparedness and response are crucial. The readiness survey that we performed served the important purpose of mapping the initial response capacities in Europe and identifying barriers to diagnostic implementation. Therefore, we maintain that the urgent implementation and monitoring of diagnostic capacities and capabilities for SARS-CoV-2 in Europe is proportional to the containment and expected mitigation phase of the global public health response and is critical for care of local patients. The implementation of SARS-CoV-2 diagnostics does not replace nor exclude diagnostic capacity for other respiratory viruses. Moreover, it explicitly does not disregard the importance of other seasonal respiratory pathogens for public and patient health. This is clearly illustrated by the authors themselves, who indicate that they have tested thousands of samples of patients suspected of respiratory viral disease not only for common respiratory pathogens but also for SARS-CoV-2. The fact that Colson et al. found a wide range of seasonal respiratory viruses indeed underlines the impact of such pathogens. Furthermore, it clearly shows that diagnosis of respiratory viruses cannot be done syndrome-based and supports the need for the availability of diagnostics for a panel of pathogens including SARS-CoV-2.",12.677101104026452,6.368208814658617
renewed efforts to improve the national and global institutional framework for its implementation,0.11818856587876495,0.41445693373680115,1.4374581575393677,fbca5e73-fada-4e36-b0a3-5e72221bad13,comm_use_subset/the ebola virus Disease Outbreak in West Africa: A Wake-up call to revitalize implementation of the international Health regulations,"In the absence of better alternatives and in view of the good results achieved by the IHR in previous PHEICs, a well implemented IHR is the most credible option for improving the response to PHEICs. This highlights the need for renewed efforts to improve the national and global institutional framework for its implementation (8) . New and innovative policies, strategies, and concerted efforts are, therefore, required from all SPs to promote and strengthen implementation of the IHR.",14.086141356248936,6.133894284016637
"combination therapy of ""Licartin"" and transcatheter arterial chemoembolization (TACE)",0.15969157315325297,2.1845428943634033,2.851229429244995,28a00718-87d5-4b41-97ab-f5f11073e2da,comm_use_subset/Development of Monoclonal Antibodies in China: Overview and Prospects,"The following examples are used to provide a holistic view of mAbs research development in China. BioTech Pharmaceutical funded the Cancer Center in the Radiology Department of Sun Yat-Sen University to conduct open and multicenter clinical research on the efficacy of cis-platinum combined with Nimotuzumab as the first line treatment of NPC. This clinical research will help shed light on the possibility of ""Taixinsheng"" combination therapy. Similarly, Chengdu Huasun Bio-Tech funded Fudan University to conduct intervention study to improve clinical outcomes of the combination therapy of ""Licartin"" and transcatheter arterial chemoembolization (TACE). These involve eight clinical trials which evaluate the clinical effectiveness of mAbs in combination therapies. This is an indication that mAbs as part of a combination therapy has become the new and alternative trend in future research.",18.868747212420313,9.877313534692568
permanent expansion of functional and point-of-care diagnostics,0.18290476009634477,3.688164710998535,4.614594459533691,4d468976-b019-4047-b647-e61afb7b50ad,comm_use_subset/Markers and Biomarkers of Endothelium: When Something Is Rotten in the State,"A biopsy is the gold standard in diagnosing many chronic diseases, though morphological methods are not a common tool in clinical diagnostics. Due to the invasiveness, these techniques are not suitable for continuous monitoring. Moreover, many diseases may not have a morphological analog of the ""gold standard,"" which necessitates the permanent expansion of functional and point-of-care diagnostics in clinical practice [214, 215] . The search for safe, reliable, and inexpensive methods has resulted, for example, in the development of a large number of biomarkers for noninvasive assessment of liver fibrosis representing both simple, directly measurable parameters and their derivatives (indices or ratios), which increase the sensitivity and/or specificity of assessment (diagnosis): the ratio of the level of AST to the level of ALT-the so-called De Ritis ratio; the ratio of AST to the number of platelets; PGA index-the ratio of prothrombin time and the level of GGT and apolipoprotein A1 (the PGA index was later modified due to Î±-2-macroglobulin and became known as the PGAA index); and the FibroTest, known as FibroSure in the US, including Î±-2macroglobulin, apolipoprotein A1, GGT, haptoglobin, and total bilirubin [216] .",11.435123456817923,9.39908667073222
"Notable achievements in critical care medicine, emergency response, and general practice",0.3341818850897563,2.755643129348755,3.3425467014312744,e0bcf547-0410-4a3f-82ed-65bf03fc7eed,"comm_use_subset/Geospatial Science and Point-of-Care Testing: Creating Solutions for Population Access, Emergencies, Outbreaks, and Disasters","The objectives were to improve awareness of POCT as a new medical field, to solidify relationships among POC professionals, and to identify potential for advancing medical applications, economic benefits, and patient impact through timely decision making for evidence-based medicine. POCT now is being written into a professional textbook in medical schools in China. POCareology is the outcome of evolution in intelligent diagnostics encompassing all forms of POC technologies. Notable achievements in critical care medicine, emergency response, and general practice have resulted from the implementation of POCT over the past four decades. As a new discipline, POCareology will contribute to key medical areas, such as disaster preparedness and public health. The creation of this new specialty is justified by trends in modern medicine with improved service to the public and by parallel technological advances that empower health care providers at sites of need to deliver complete care cycles quickly and effectively.",15.165898873051656,9.2718879955751
accelerate care and minimise transmission risk,0.26395125092419175,3.0194993019104004,5.105703353881836,bb105c9d-087b-447c-8280-67e4718f1f86,comm_use_subset/Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease Analysis,"Development of novel and next-generation diagnostic technologies for CCHF would benefit from a refined set of target product profiles (TPP) with detailed clinical and operational design specifications, including a range of minimal to optimal performance characteristics. Application-driven TPPs can be designed to support the development of CCHF diagnostics that have been identified here to accelerate care and minimise transmission risk: POC diagnostics for patient triage, screening and field testing; syndromic PCR panels for expediting differential diagnosis of CCHF from other VHF pathogens; and NGS to monitor circulating strains and viral mutations, particularly to assess the sensitivity of probe design used in molecular diagnostics. Ongoing initiatives include a CCHF-specific TPP currently being developed by WHO as part of their roadmap. 112 Contributors LTM contributed to drafting the manuscript and provided background research for the manuscript. CK-C contributed insight into the diagnostic needs for outbreak pathogens. Both authors reviewed, edited and approved the final version of the manuscript.",11.385163128816302,9.26618882135066
clinical symptoms are treated,0.2874795449022127,3.9117510318756104,3.7205052375793457,ed645277-7e80-4404-83a3-feb325614945,"comm_use_subset/Participatory epidemiology at the neotropics: study of diseases of backyard livestock and description of hunting patterns in UaxactÃºn, Maya Reserve Biosphere, Guatemala","Concerning human diseases, no relevant diseases were mentioned among villagers other than respiratory symptoms or diarrohea. There are no definitive diagnostics for these problems and only clinical symptoms are treated. Disease surveillance in humans is required to reveal factors influencing the appearance and frequency of diseases in the region.",11.651778208135838,9.039088947993264
they may improve the clinical symptoms,0.18565106461547773,2.964691162109375,3.7802114486694336,d66e19d0-03ed-4354-85cd-799e4920a3ea,comm_use_subset/The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome,"Feline Chronic Gingivostomatitis Syndrome (FCGS) is a common disease in clinical practice. Among the therapeutic options available, long-acting corticosteroids are frequently used due to their anti-inflammatory and immunosuppressive properties. Although they may improve the clinical symptoms, they can lead to a progressive form of the disease that becomes refractory to treatment. Furthermore, their direct relationship with type II diabetes mellitus (DM) is well known. Consequently, these drugs are controversial and not recommended for routine management of FCGS. Recombinant feline interferon-omega (rFeIFN-Ï) is an immunomodulatory compound. Recently, its daily oral administration has been shown to be successful in treating refractory cases of FCGS. This case study describes two clinical cases of type II DM complicated by FCGS. Both animals were calicivirus positive and they had been previously treated with long-acting corticosteroids, which may have been the major cause of DM. The two cats were treated with glargine insulin (Lantus, starting dose 1 IU/cat twice daily (BID)), achieving remission 10 and 18 weeks later respectively. Considering the difficulty with control of FCGS in these animals, an oral daily dose of rFeIFN-Ï was started as an alternative to long-acting corticosteroids. In both cats oral clinical signs gradually improved and 60 days after the start of therapy the owners reported a significant relief of pain during mastication. According to the authors' knowledge, this is the first case report that describes the successful use of rFeIFN-Ï in the management of FCGS in type II diabetic cats, in which long-acting corticosteroids are contraindicated.",13.123816731428409,8.977522553006168
APP signalling and processing,0.5191583156380104,3.5668022632598877,3.533241033554077,a8eae9c5-f36c-4530-bdae-aaa66c01a614,"comm_use_subset/Article ID 140539, 17 pages Polygenic Pathways, Flat 4, 20 Upper Maze Hill, Saint Leonard's on Sea","The type of viral homology for various different protein classes is shown in Table 3 . These classes include products involved in APP signalling and processing (BACE1 and 2 and gamma-secretase components), cholesterol and lipoprotein function, tau function, inflammation, and oxidative stress, all of which are key processes disrupted in the Alzheimer's disease brain.",11.61109922063698,8.67891287015202
To better estimate the current state of VRI in PSPs and to improve clinical management,0.25663480298895563,2.6128060817718506,3.0965781211853027,15874890-c6cb-4dd4-abfa-8ce61d49221b,comm_use_subset/Respiratory virus associated with surgery in children patients,"The issue of preoperative VRI screening among children undergoing surgery is unclear and complex. If children with VRI presented with obvious symptoms (fever, cough), it would be an easy decision for the surgeon or anesthesiologist to delay surgery if appropriate. In cases of children with mild or no symptoms, it becomes very difficult for doctors to make the right decision. A few studies have investigated VRI associated with a limited number of respiratory viruses and have demonstrated an increased length of stay (LOS) and increased postoperative complication rates in pediatric cardiac surgical patients [15, 16] . The data for VRI among the PSPs is not performed systematically recorded and thus detailed etiologic data are lacking. To better estimate the current state of VRI in PSPs and to improve clinical management, this study aims to investigate the incidence of VRI in the mild symptomatic and asymptomatic pediatric surgery population after surgical procedures and to evaluate the impact of VRI on postoperative outcomes. We analyzed detailed symptom data using a standardized symptom survey and quantitative viral load using multiple qRT-PCR to determine the associations between viruses, symptoms and viral quantity.",12.933726561580473,8.237904028475315
"resource planning, allocation, and implementation in response to infectious diseases",0.37995324829285787,2.8185720443725586,3.6941239833831787,9ff15165-b6a0-4a7a-9629-c11efd269450,comm_use_subset/Perspective Piece What is a Hotspot Anyway?,"Spatial heterogeneity in disease processes is a growing field of study. The identification of hotspots of all types can play an important role in research, policy, and practice, particularly in resource planning, allocation, and implementation in response to infectious diseases. However, public health, like all fields, is subject to fads in concepts and terminology. Hotspot is an evocative term for important concepts, but a useful term should not be rendered useless by imprecision or overuse. Policy makers and public health researchers should be sensitive to its multitude of uses within the health sciences, and take care in their own use of the term.",11.28730839014272,8.18381035459118
to aid containment of the virus and lower the threat of a influenza pandemic,0.2930990827717431,1.9747278690338135,3.4195802211761475,b85445b2-e3b7-4b05-a214-94c759e73dd9,comm_use_subset/BMC Infectious Diseases Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay,Background: Continuous outbreaks of the highly pathogenic H5N1 avian influenza A in Asia has resulted in an urgent effort to improve current diagnostics to aid containment of the virus and lower the threat of a influenza pandemic. We report here the development of a PCR-based assay that is highly specific for the H5N1 avian influenza A virus.,12.956456984645431,8.041060203262376
"Implementation of appropriate education program might improve compliance to infection control measures, and willingness to work in a pandemic",0.13439946510688766,1.9804030656814575,2.456855297088623,c8fae08e-600c-4b4f-9195-f3a5f9b1055f,comm_use_subset/Knowledge and attitudes of healthcare workers in Chinese intensive care units regarding 2009 H1N1 influenza pandemic,"Conclusion: Critical care clinicians reported poor knowledge of H1N1 influenza, even though most finished a relevant knowledge training program. Implementation of appropriate education program might improve compliance to infection control measures, and willingness to work in a pandemic.",13.88991327915855,7.7456875835060455
respiratory infections,0.17156285665422696,1.76637601852417,2.966665744781494,ff523941-931d-4657-8e6e-8fa7169a6483,comm_use_subset/Evaluation of a multiplex PCR assay for detection of respiratory viruses and Mycoplasma pneumoniae in oropharyngeal swab samples from outpatients,"In conclusion, the performance of ResP showed a high-degree agreement with pathogen-specific PCRs in oropharyngeal swabs from outpatients. The implementation of ResP may facilitate the diagnosis of respiratory infections in a variety of clinical scenarios.",11.979950617206821,7.269459862171068
optimization of aerosol drug delivery that can achieve better drug concentrations at the target sites and potentially improve clinical outcomes,0.10169214403003539,0.8056548833847046,2.6294803619384766,5df22c14-49f3-48f7-98b2-293e6ff82522,comm_use_subset/Fundamentals of aerosol therapy in critical care,"Drug dosing in critically ill patients is challenging due to the altered drug pharmacokinetics-pharmacodynamics associated with systemic therapies. For many drug therapies, there is potential to use the respiratory system as an alternative route for drug delivery. Aerosol drug delivery can provide many advantages over conventional therapy. Given that respiratory diseases are the commonest causes of critical illness, use of aerosol therapy to provide high local drug concentrations with minimal systemic side effects makes this route an attractive option. To date, limited evidence has restricted its wider application. The efficacy of aerosol drug therapy depends on drug-related factors (particle size, molecular weight), device factors, patient-related factors (airway anatomy, inhalation patterns) and mechanical ventilation-related factors (humidification, airway). This review identifies the relevant factors which require attention for optimization of aerosol drug delivery that can achieve better drug concentrations at the target sites and potentially improve clinical outcomes.",13.246763836692747,6.869205252302528
emergency response plans,0.18240407523764823,1.0508720874786377,1.0550202131271362,a3dd68bb-2e9b-4d7a-b2a4-2e45ff73c23d,"comm_use_subset/Coordination and resource-related difficulties encountered by Quebec's public health specialists and infectious diseases/medical microbiologists in the management of A (H1N1) - a mixed-method, exploratory survey","This paper is one of the few reporting on physicians' perceptions on management of public health emergencies. Important highlighted areas were coordination between all involved, decision-making transparency, greater collaboration of health professionals in decisionmaking, greater flexibility, and a better definition of roles and credentials. Results emphasize the need to improve transparency and build stronger working relationships between physicians and health authorities. In times of emergency, a greater involvement of professional associations both in the planning of services and as a communication channel should be considered. Studies based on other qualitative research approaches (e.g., grounded theory) are needed to further understand how healthcare systems can improve the implementation of emergency response plans and empower stakeholders involved. It would also be useful to study identified gaps between national health authorities' pandemic plans and what actually happened in response at the different levels of implementation.",14.296528100181144,6.372614830457153
to target broad consensus sequences within the S segment,0.1355446034825945,0.7530167102813721,1.7436250448226929,38754a98-e06a-4506-8cfe-68963fe51352,comm_use_subset/Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease Analysis,"There are many inhouse laboratory tests, some with primers designed for regional circulating strains (table 2). 53 59 85 86 Several commercial RT-PCR kits are available, typically with primers designed to target broad consensus sequences within the S segment, including several European Commission marked (CE) diagnostics and research use-only (RUO)-labelled products in standalone and multiplex test formats (online supplementary table S1).",11.412804551340505,5.617298733786819
Improve the clinical course of moderate to severe bronchiolitis (assessed by supplemented oxygen requirement and length of hospital stay,0.23420767767187414,2.413978338241577,2.989047050476074,526bf734-e633-420f-8f8b-06ce174c1ba3,comm_use_subset/An Intervention study for bronchiolitis: Improving the management and outcomes for infants hospitalised with bronchiolitis (ABIS) Clinical study protocol -Field Version Version 2 -2 nd,Assess the efficacy of a single dose of Azithromycin (30mg/kg) to a) Improve the clinical course of moderate to severe bronchiolitis (assessed by supplemented oxygen requirement and length of hospital stay). b) reduce the risk of further respiratory illness within 6 months of this bronchiolitis episode. c),21.636296838613717,11.084670396181274
general intensive care measures,0.3713174792229001,3.9287774562835693,3.655233144760132,cd156a70-d673-4940-96c1-8083fb268112,comm_use_subset/3 Infrastructure and Organization of Adult Intensive Care Units in Resource-Limited Settings,"Our literature search did not identify any randomized controlled trials evaluating the effects of mechanical ventilators on mortality in critically ill patients both in resourcelimited and resource-rich settings. However, mortality of patients with hypoxemia who do not receive mechanical ventilatory support is extremely high, suggesting that mechanical ventilation associates with a survival benefit [152] . Observational evidence from ICUs in Vietnam suggest that general intensive care measures, including mechanical ventilation, can improve clinical outcomes [154, 155] . A structured ICU training program that included modules on mechanical ventilation improved overall ICU mortality in two of three ICUs in India, Nepal, and Bangladesh [156] .",15.850246424308299,10.47719313918631
"The combined anti-microbial and anti-inflammatory properties of a macrolide, azithromycin, will improve clinical outcomes",0.1171641083223867,1.3840315341949463,1.3709259033203125,84aaa399-2abc-4aad-a6fa-1891bd951980,comm_use_subset/An Intervention study for bronchiolitis: Improving the management and outcomes for infants hospitalised with bronchiolitis (ABIS) Clinical study protocol -Field Version Version 2 -2 nd,"The combined anti-microbial and anti-inflammatory properties of a macrolide, azithromycin, will improve clinical outcomes for infants hospitalised with moderate to severe bronchiolitis.",24.04281252366038,10.20570671766605
Innovative new therapeutic approaches to block these invasive cells are needed in order to improve clinical outcome,0.2441396068994368,3.224879741668701,2.8818094730377197,abeb5e4c-9fa5-4ad1-b646-08ed06f17ac3,comm_use_subset/Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma,"Introduction Glioblastoma multiforme (GBM) is the most aggressive form of primary brain tumor and is characterized by rapid proliferation and aggressive invasion [1] . Poor clinical outcomes of glioblastoma are due to aggressive brain infiltration, driven in part by microRNA-mediated alterations in protein levels [2] , leading to inevitable recurrence after surgery [3] . Conventional treatment methods such as surgery, primary treatment method, radiotherapy and chemotherapy have not proven to be effective [4] for this aggressive disease with a median survival time of approximately 15 months from the time of diagnosis [5] [6] [7] . In particular, invasive GBM cells, described as ""guerrilla-like warriors"", can escape surgery and are protected behind the blood-brain barrier (BBB) and survive biochemical attacks from chemotherapy [8, 9] . Innovative new therapeutic approaches to block these invasive cells are needed in order to improve clinical outcome [10] .",16.267932882971973,9.663124498599364
an ASP can improve clinical outcomes in patients while reducing adverse drug reactions,0.22723476979148866,2.0035946369171143,2.775465488433838,eeaaccf6-0714-4413-9d6b-0f2aa853cc72,"comm_use_subset/Clinical Medicine Impact of an Infectious Disease Specialist on an Antimicrobial Stewardship Program at a Resource-Limited, Non-Academic Community Hospital in Korea","An antimicrobial stewardship program (ASP) is one of the most important strategies for preventing AMR [5, 6] . In addition, an ASP can improve clinical outcomes in patients while reducing adverse drug reactions [7] . With the proven advantages of ASPs, the necessity for such programs has been realized in most hospitals, regardless of bed size or teaching status. The importance of the role of an infectious disease specialist (IDS) in implementing a successful ASP has been proven through previous studies [8] [9] [10] . However, most of these studies evaluated the role of an IDS and the effects of an ASP in large, academic hospitals.",17.93944847809341,9.385196048810812
"undermines ethical principles of justice-fairness, equity, and maximization of benefit",0.31901257575764713,3.234265089035034,3.2244231700897217,96a9ee8b-ea07-42e6-bf3c-5fe9c2888b81,"comm_use_subset/viruses Perspective Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections","It is vitally important that pregnant women be considered in the design, clinical trial, and implementation of vaccine candidates for 2019-nCoV. In examining the history of vaccine design, it is clear that the needs of pregnant women have rarely been prioritized in either the preclinical development or the clinical trial phases of production. Today, pregnant women are usually excluded from experimental trial of drugs and vaccines that do not target obstetric conditions [69] . Excluding pregnant women and their infants from participation in vaccine development and implementation undermines ethical principles of justice-fairness, equity, and maximization of benefit-and potentially places their health at risk during outbreaks and other health emergencies [69] [70] [71] .",11.900260835195725,8.363238660749595
collagen-induced arthritis (CIA) rats,0.2647996313614206,2.2118074893951416,1.9684489965438843,cfa183b6-c463-4da1-aef7-b5b70fca4717,"comm_use_subset/A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats RL, a traditional remedy for Rheumatoid arthritis (RA), comprises two edible herbs, Rosae Multiflorae Fructus and Lonicerae Japonicae Flos. We have reported that RL could inhibit the production of inflammatory mediators in immune cells. Here we investigated the effects and the mechanism of action of RL in collagen-induced arthritis (CIA) rats. RL significantly increased food intake and weight gain of CIA rats without any observable adverse effect; ameliorated joint erythema and swelling; inhibited immune cell infiltration, bone erosion and osteophyte formation in joints; reduced joint protein expression levels of TLR4, phospho-TAK1, phospho-NF-ÎºB p65, phospho-c-Jun and phospho-IRF3; lowered levels of inflammatory factors (TNF-Î±, IL-6, IL-1Î², IL-17A and MCP-1 in sera and TNF-Î±, IL-6, IL-1Î² and IL-17A in joints); elevated serum IL-10 level; reinvigorated activities of antioxidant SOD, CAT and GSH-Px in the liver and serum; reduced Th17 cell proportions in splenocytes; inhibited splenocyte proliferation and activation; and lowered serum IgG level. In conclusion, RL at nontoxic doses inhibited TLR4 signaling and potently improved clinical conditions of CIA rats. These findings provide further pharmacological justifications for the traditional use of RL in RA management","prescribed by Chinese medicine practitioners for treating various inflammatory disorders including RA [14] [15] [16] . Extracts/constituents of these two herbs attenuate animal arthritis and inhibit TLR4 signalling [17] [18] [19] [20] [21] [22] . We have previously reported that RL, a herbal formula composed of these two herbs, could inhibit various components of the TLR4 signalling pathways 23, 24 . Therefore, here we examined if RL could improve clinical conditions in collagen-induced arthritis (CIA) rats, a model that is well established for studying human RA, and investigated the involvement of TLR4 signalling in the effects of RL.",15.918909127362712,8.288784910437316
local manufacturing facilities and veterinary medicinal products quality,0.38084767752137366,2.800746202468872,2.7881269454956055,30d02d51-730c-461b-b408-52d1d1965061,comm_use_subset/National post-market surveillance assessment of veterinary medicines in Korea during the past decade,"Meanwhile, local manufacturing facilities and veterinary medicinal products quality have improved owing to the implementation of Korea Veterinary Good Manufacturing Practice (KVGMP) on 1988-05-18 in accordance with the ""KVGMP requirement for quality control"" resulting in the gradual decrease of the government testing rejection rate [3, 4] . Accordingly, testing of antibiotics by PMGTS was abolished from 2000 to 11-07, while some biologics received partial exemptions from PMGTS as of 2005-04-09. The latter exemptions are limited to KVGMP-designated manufacturers. For biologics, PMGTS is performed on newly approved products, which become exempt from government testing after 10 or more consecutive lots are found to be acceptable. Following acquisition of exempt status, these products are still subject to spot-check government testing when necessary. Moreover, in the case of new antibiotics, the first 5 manufactured lots are designated as priority collection items and collected for testing [3, 5] .",12.206089239629325,7.904898780047175
improve care of critically ill and sepsis patients,0.18539316643586062,0.1959112584590912,1.7084406614303589,24b7fd4e-a363-4e7e-bdb0-9cc926497197,comm_use_subset/3 Infrastructure and Organization of Adult Intensive Care Units in Resource-Limited Settings,"Although implementation of protocols, bundles, and checklists into clinical practice requires a variable amount of funding, preliminary results of studies from resource-limited settings suggest that these interventions may prevent adverse events and complications [231, 232] . A delicate and important challenge of implementing protocols, care bundles, and checklists into clinical practice in ICUs in resourcelimited settings is the lack of safety data. Different disease pathologies, as well as absent treatment options (e.g., airway protection and mechanical ventilation), could well explain why certain interventions that were shown to improve patient outcome in resource-rich settings increased morbidity and mortality in resource-limited settings [215, [245] [246] [247] . This underlines the urgent need to test the efficacy and safety of adjusted care bundles and protocols to improve care of critically ill and sepsis patients in settings where resources are constrained [215, 248] . Another consideration is that quality control measure implementation may divert financial resources from clinical care. Although long-term reduction savings may occur due to avoidance of adverse events, the up-front expenditure may prove burdensome.",15.971479759626792,6.82784666379752
The RVP employs a multiplex PCR with labelled primers and a single-step hybridization of PCR products to the fluorescent bead array,0.22849500214799154,2.1139039993286133,1.980582356452942,04e6086d-a61e-47ac-b378-64d25361c860,"comm_use_subset/Comparison of three multiplex PCR assays for the detection of respiratory viral infections: evaluation of xTAG respiratory virus panel fast assay, RespiFinder 19 assay and RespiFinder SMART 22 assay","The nucleic acid extracts were tested using the RVP assay (Abbott Molecular, Wiesbaden, Germany) according to the manufacturer's instructions. The RVP employs a multiplex PCR with labelled primers and a single-step hybridization of PCR products to the fluorescent bead array. The detection was performed using the xMAP 100 IS instrument (Luminex Molecular Diagnostics Inc., Toronto, Canada) and the analysis was performed using TDAS RVP FAST software (version 2.0, Abbott Molecular).",11.6755758433485,6.747867676429987
"Initiatives to improve understanding either at school, through doctors or in the media",0.14875473806014644,0.9820430278778076,0.9027978777885437,b07b956e-779f-4802-840a-51049c7582f7,comm_use_subset/BMC Public Health What infection control measures will people carry out to reduce transmission of pandemic influenza? A focus group study,"Initiatives to improve understanding either at school, through doctors or in the media were considered valuable methods to facilitate implementation of the recommended behaviours.",15.023794923056006,6.48347481175273
to improve health outcomes,0.15941298701939655,0.7599197626113892,1.1221126317977905,93b51a0f-01c9-49af-8b91-12d18ae89174,comm_use_subset/A look at the ASEAN-NDI: building a regional health R&D innovation network,"To address the unmet public health needs of the ASEAN nations through the advancement of the ASEAN-led health product innovation in the areas of drugs, vaccines, and diagnostics in order to improve health outcomes in the ASEAN region and beyond, and to support sustainable regional economic development.",14.133636711702506,6.170093905461844
"The ASEAN member states can facilitate the exchange of expertise, resources, and health products as they have been working in other initiatives to improve the region",0.3252984429806723,1.3504416942596436,1.649428129196167,28f5b902-7752-4a5f-a544-f4d466ff58ac,comm_use_subset/A look at the ASEAN-NDI: building a regional health R&D innovation network,"The extensive collaboration among the ASEAN member states and with other major research centers in the world indicates that the ASEAN countries have the capacity to pursue collaborative R&D activities on health products development (see Figures 4 and 5) . The ASEAN has been used in several free trade agreements and harmonization initiatives. Hence, embarking on an ASEAN initiative that will strengthen the scientific ties to address neglected diseases will not be difficult. The ASEAN member states can facilitate the exchange of expertise, resources, and health products as they have been working in other initiatives to improve the region. Under the ASEAN umbrella where harmonization and collaboration are the key elements, these arrangements can be easily addressed [10] .",11.752356831285434,6.063240276196179
high quality and efficiency but not seen as a challenge due to cost or time.,0.1051818058455939,0.11737088114023209,2.139726161956787,df92a88c-126f-44be-ad6f-0a1c53672c94,"comm_use_subset/BMC Public Health Gatekeepers of health: A qualitative assessment of child care centre staff's perspectives, practices and challenges to enteric illness prevention and management in child care centres","In CCCs, staff require resources that they can use and adapt as needed. For example, improved record-keeping forms could be developed that are visual and easy for all staff to complete and which could improve challenges associated with time. The information collected on the forms is invaluable in illness surveillance for the entire centre. Staff were very aware of the children they work with but enhancing awareness and communication among staff could ensure the rapid implementation of preventative measures such as increased cleaning throughout the entire centre. This could be accomplished by exchanging information on a regular basis with staff in a consistent manner, through a regularly scheduled briefing session or standard communication log. Staff overwhelmingly expressed the desire for tools that would make the process of cleaning easier. This information is useful for public health officials and CCC management to consider when developing guidelines or providing guidance on cleaning methods and products that staff could use which are of high quality and efficiency but not seen as a challenge due to cost or time.",12.703900658275437,5.913478308409465
collaborative research in health products,0.16243212740680169,0.5983172059059143,0.8279742002487183,b32777ce-3a95-4fff-bf42-ce2cbc1ededb,comm_use_subset/A look at the ASEAN-NDI: building a regional health R&D innovation network,The roadmap for the ASEAN-NDI has been laid out. The ASEAN is now awaiting its full implementation to achieve its goal of becoming the premier facilitator for collaborative research in health products in Southeast Asia.,14.190610441194542,5.8938030684186
"inform public health policy, and direct prevention efforts",0.15589620408998733,2.8955233097076416,4.761120319366455,7ecd5c48-cce8-4761-93cc-8f30a54a0682,"comm_use_subset/Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015","As malaria incidence continues to decrease throughout the tropics, a new area of research has focused on identifying etiologies of non-malaria, acute febrile illness (AFI) [1, 2] . Knowledge is limited in this area, in large part because AFIs often have similar non-specific clinical presentations early in the clinical course when most patients are likely to present for care. In addition, rapid point-of-care diagnostics are often not readily available. Surveillance for AFIs, if done, is largely passive and relies on clinical identification of cases and voluntary case reporting. Therefore, burden of disease for the etiologic agents of AFI are likely underestimated. An improved understanding of the major causes of AFI is important to guide clinical management, develop diagnostics, inform public health policy, and direct prevention efforts [3] .",13.697538872389742,9.770956964234573
by informing clinicians on appropriate antiviral and antibiotic treatment during the patient's visit,0.1869158638340878,3.0368549823760986,3.4311304092407227,c4d347d4-5eb9-4ff7-b76b-6f0703b8195f,comm_use_subset/Epidemiology of Pathogen-Specific Respiratory Infections among Three US Populations,"Although nothing will replace the accuracy of laboratory diagnostics, a broader understanding of seasonality, clinical presentation, demographics, and coinfection rates of pathogen specific respiratory diseases can improve diagnosis and treatment, by informing clinicians on appropriate antiviral and antibiotic treatment during the patient's visit. This can ultimately reduce the number of lost work days and transmission. Additionally, describing baseline of disease and seasonality for specific pathogens can improve our ability to detect outbreaks. Identifying the percent positivity of each pathogen, coinfection rates, and risk factors for disease will help inform vaccination programs, and possible investment in the development of future vaccines or treatments.",15.403808903984537,9.59552362094552
PCR primer design,0.3401168972973975,2.229652166366577,3.4988560676574707,5b383b38-3c30-4534-9546-6fd6c8f2935d,comm_use_subset/Open Access Optimization and clinical validation of a pathogen detection microarray,"DNA microarrays used as 'genomic sensors' have great potential in clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization effects, and inadequate microarray analysis, however, limit detection sensitivity and specificity. Here, we have studied the relationships between viral amplification efficiency, hybridization signal, and target-probe annealing specificity using a customized microarray platform. Novel features of this platform include the development of a robust algorithm that accurately predicts PCR bias during DNA amplification and can be used to improve PCR primer design, as well as a powerful statistical concept for inferring pathogen identity from probe recognition signatures. Compared to real-time PCR, the microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be used for the robust and accurate diagnosis of pathogens, and further substantiate the use of microarray technology in clinical diagnostics.",15.139116464512352,9.022221114694954
earlier adenovirus PCR blood testing allowing earlier treatment to prevent further increases in viral load,0.22089794389613518,2.751976728439331,2.8717665672302246,33525098-0836-402e-b045-5c060ac5ee75,comm_use_subset/Case report: a fatal case of disseminated adenovirus infection in a non-transplant adult haematology patient,"Although fatal adenovirus infection has been reported in non-transplant paediatric and adult patients on chemotherapy [5] [6] [7] [8] , there is still no consensus on how to deal with an isolated adenovirus positive result in a peripheral (non-blood) sample type on a routine basismany such patients also have asymptomatic adenovirus infections. From a virological viewpoint, since all systemic antiviral drugs are only virostatic and not virucidal, earlier adenovirus PCR blood testing allowing earlier treatment to prevent further increases in viral load, may improve clinical outcomes [1] . However, due to the severe nephrotoxic nature of the mainstay treatment, intravenous cidofovir, most transplant teams are reluctant to prescribe this drug empirically, unless a definitive upward trend is seen in the adenovirus blood levels. This is often the cause of delays in commencing therapy with this drug for disseminated adenovirus infection.",15.259099715065542,8.99611804245815
"researchers to investigate the use of innovative treatments when the first line of therapy has failed, in order to improve clinical outcomes",0.12556496032797498,1.3708288669586182,3.002004623413086,32719f18-d701-48f5-b7ee-bd0ab7714c0e,comm_use_subset/Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy,"Glioblastoma multiforme (GBM) is the most common and the most aggressive type of brain cancer. The median length of survival time is approximately 12 to 15 months following diagnosis. GBM is characterized by anaplasia, nuclear atypia, cellular pleomorphism, mitotic activity, and more importantly, alternating phases of rapid proliferation and aggressive invasion into the surrounding brain tissue. This leads to an inevitably critical recurrence even after the surgical resection of the main tumor mass [1, 2] . The mainstay of treatment for GBM is surgery, followed by radiotherapy and chemotherapy. Despite advances in these approaches, glioma cells can still invade the neighboring tissues beyond detection leading to tumor recurrence. High probability of main treatment failure also encourages researchers to investigate the use of innovative treatments when the first line of therapy has failed, in order to improve clinical outcomes [3] .",14.889929542442992,8.053817108596656
an extension of the panel to include these bacterial agents might improve the clinical utility of the test,0.20627479445585467,2.0843472480773926,3.393733024597168,bc193865-7b59-490b-a23c-c6fc69e01281,"comm_use_subset/Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial","Systematic testing for bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis was not conducted in this study. These bacteria may act as potential respiratory pathogens (PRPs) harbouring in the upper respiratory tract, and an extension of the panel to include these bacterial agents might improve the clinical utility of the test. However, the interpretation of the detection of bacterial pathogens in nasopharyngeal samples in heterogeneous syndromes such as ARTIs is unclear. Cultured S. pneumoniae from the nasopharynx of adults has been shown to have high specificity but low sensitivity for the diagnosis of pneumococcal pneumonia [28] . PCR-based detection of S. pneumoniae from the oropharynx and nasopharynx without codetection of other commensal Streptococcus spp. poses technical difficulties. Lieberman et al. [29] reported higher sensitivity in using nasopharyngeal washing compared to nasopharyngeal swabs in the detection of PRPs. To keep sampling simple, nasopharyngeal washing was not used in this study, which may constitute a study limitation. However, we used flocked nasopharyngeal swabs, which probably yield higher detection rates than previously reported in studies in which cotton-tipped nasopharyngeal swabs were used [30] . The study population consisted of patients with a broad spectrum of clinical manifestations, many of whom had mild symptoms. However, since the prescription of antibiotics for these patients is not uncommon, this was a deliberate study design.",12.779942875421986,8.03373218363616
clinical trials of novel therapeutic approaches and implementation strategies are required to ensure the 'right solution for the right setting,0.1664712531847383,1.5495400428771973,2.409022569656372,76f19332-30b5-4876-a7ef-2e4fec27c14c,comm_use_subset/Resource-Limited Settings,"Triage decisions for ICU admission are required because demand commonly exceeds supply, even outside pandemics or mass casualty disasters [62, 63] . Importantly, these criteria should take into account patient autonomy, which may vary based on cultural and other local factors and should incorporate regional policies. Unfortunately, adequate tools for resource-limited settings are very limited. Even when evidence from resource-rich settings exists, implementation is challenging [65] . Barriers include lack of equipment (e.g., mechanical ventilators to support patients with acute respiratory failure), medications (e.g., antibiotics for multidrug resistant bacteria), diagnostics (e.g., equipment for repeated measurements of lactate and blood gases to guide treatment of sepsis or ARDS), trained personnel, and quality improvement systems. Therefore, clinical trials of novel therapeutic approaches and implementation strategies are required to ensure the 'right solution for the right setting'.",15.159397404622938,7.878854789764848
"all aspects of the hospital services were involved. Pharmacy, environmental services, engineering/facilities support, and pastoral care/counseling were especially important.",0.12435672316366649,1.0625858306884766,1.2612625360488892,9486f77b-943d-49e0-bee2-5c42f2e3435c,comm_use_subset/Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa,"â¢ The hospital support team was led by the CEO of EUH. The chief medical and nursing officers of EHC and EUH, and in particular the vice president of operations of EUH, were also heavily involved in leading the support efforts. During the care and treatment of the EVD patients, an operations team of key administrators and nursing and physician leadership met twice a day. Despite the extensive preplanning, opportunities to refine and improve both clinical and operations were noted, and all aspects of the hospital services were involved. Pharmacy, environmental services, engineering/facilities support, and pastoral care/counseling were especially important.",18.10146610838815,7.84601457631514
Implementation of ventilator associated pneumonia prevention bundles decreases the incidence of VAP,0.18293823167150508,2.6524722576141357,2.5529284477233887,9e1f27c4-534d-4ab4-b650-307e314c2210,comm_use_subset/Goal-Oriented Respiratory Management for Critically Ill Patients with Acute Respiratory Distress Syndrome,"Incorporation of modified risk factors such as acute increase of respiratory rate, presence of tachypnea, detection of pulse oximeter desaturation, increased necessity of oxygen supplementation, presence of low pH, acidosis, or hypoxemia in an arterial blood gas sample in clinical practice can improve the clinicians' ability to perform early diagnosis and prompt therapeutic intervention in ARDS [17] . The presence of these modified risk factors may alert physicians to avoid secondary hospital exposures, such as blood products transfusions, excessive fluid administration, infusion of potentially toxic drugs, high tidal volume mechanical ventilation, and gastric aspiration. Implementation of ventilator associated pneumonia prevention bundles decreases the incidence of VAP and can lower the incidence of ARDS [17] . Implementation of automated ARDS electronic screening in USA hospitals such as ""ASSIST"" (electronic alert from laboratory when the arterial blood gas analysis shows hypoxemia and the radiology department when chest X-ray shows bilateral pulmonary infiltrates) to identify intubated patients with ARDS in medical and surgical ICUs showed a sensitivity of 97.6% (95% CI, 96.8-98.4%) and specificity of 96.8% (95% CI, 96.8-98.4%) when compared to a manual screening algorithm that had a sensitivity of 57.1% (95% CI, 54.5-59.8%) and specificity of 99.7% (95% CI, 99.4-100%) in 1270 ICU patients over a 21-week period during enrollment in ARDSNet trials [23] . The results of this study indicated the advantages of having an in-hospital automated screening of ARDS over manual screening. The automated screening can increase the chances of ARDS diagnosis, alert the clinicians, and elicit the rapid response from the hospital team of intensivists to initiate clinical protocols and ARDS therapeutic interventions [24] .",12.716159261477687,7.834166199986582
to evaluate viral RT-PCR diagnostics for ARI in pediatric patients,0.2324028759974138,1.6248104572296143,3.206676959991455,8eb943fa-4ce6-4cb0-a7c9-a8c73d09c9d8,comm_use_subset/Single-and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen,"This study is part of the EVIDENCE-trial (Evaluation of Viral Diagnostics on Respiratory Infections in Children), a multi-center, controlled clinical trial to evaluate viral RT-PCR diagnostics for ARI in pediatric patients [15] . In summary, the trial was conducted during two consecutive winter seasons (2007-2008 and 2008-2009 ) in two Dutch teaching hospitals with comparable populations: the Reinier de Graaf Hospital in Delft joined in the second season by the Groene Hart Ziekenhuis in Gouda. The EVIDENCE study-protocol was approved by the regional Medical Ethics Committee (CCMO number NL13839.098.06). In the current study, a selection of the EVIDENCE-dataset is used to analyze the clinical aspects in relation to the viral pathogens.",12.989765833078632,7.686884862771216
identify its strengths and weaknesses in order to improve it,0.16358487909213135,0.9893481135368347,2.4365599155426025,a727487a-bede-4a10-abae-a7330f42d31d,"comm_use_subset/Evaluation of the influenza-like illness surveillance system in Tunisia, 2012-2015",the first evaluation of the Tunisian influenza surveillance system since its implementation in 1980. We specifically aimed to: (i) provide a comprehensive understanding of how the Tunisian surveillance system operates; (ii) assess its performance and (iii) identify its strengths and weaknesses in order to improve it.,13.53063026833407,6.962560812818559
overcome some of the current thresholds for implementation in clinical diagnostics.,0.10905009426186785,-0.5457645058631897,1.1567269563674927,148ad550-4158-4520-b822-13e787f8c03a,comm_use_subset/The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease,"Though mNGS renders the possibility to detect all viruses in direct respiratory material, this revolutionary method is not yet used as routine accredited diagnostic procedure for pathogen detection. Before mNGS can be implemented as a routine diagnostics, the optimal protocol must be defined and analysis and interpretation of the metagenomic data must be standardized, followed by external quality assessment. This study demonstrates good performance of our mNGS protocol, in line with other studies [37, 38, 47, 48] and seems to overcome some of the current thresholds for implementation in clinical diagnostics.",18.63226531608639,6.918418453458033
"Heuristics and diagnostics, together with a discussion of computational issues",0.3968631029466709,0.8003520369529724,0.6706148982048035,db379b16-9d7f-4080-a71b-7ac785c89530,comm_use_subset/Plug-and-play inference for disease dynamics: measles in large and small populations as a case study,"We used the implementation of iterated filtering contained in the software package POMP ) written for the R statistical computing environment (R Development Core Team 2006) . This implementation follows the algorithm described by King et al. (2008, supplementary information therein) . Heuristics and diagnostics, together with a discussion of computational issues, can be found in Ionides et al. (2006) ; a theoretical treatment is given by Ionides et al. (2009) .",15.843109250620843,6.501216745569849
interventions that improve outcomes in patients from resource-rich settings,0.10763957010885185,1.0463666915893555,1.2578834295272827,4535c895-0178-48c4-a631-66a8268bd175,comm_use_subset/Resource-Limited Settings,"Given that data on treatment outcomes generated by local clinical trials is rarely available, health professionals in resource-limited settings must rely on literature from developed countries. However, interventions that improve outcomes in patients from resource-rich settings may not always be relevant; prominent examples include the higher mortality of septic children and adults treated with aggressive fluid resuscitation in Africa [46] [47] [48] . Local characteristics require that bundles and protocols developed in resource-rich countries be adapted before implementation in resource-limited settings [49, 50] . For example, most sub-Saharan countries lack resources to implement all components of the Surviving Sepsis Campaign Guidelines, but local modification might allow the implementation of specific life-saving interventions [51] . New trials may also inform appropriate modifications to guidelines; for example, routine measurement of central venous pressure is no longer a recommendation in recent Surviving Sepsis guidelines [52] , which may improve adherence to sepsis bundles where central venous catheters are not routinely used or available [53] .",13.683091554831675,6.286844622916901
more research is urgently required.,0.2311732405819974,0.6480994820594788,1.5451306104660034,2e93ccb0-486c-4b67-9c1a-0afe280b7f56,comm_use_subset/P1 Cerebral autoregulation testing in a porcine model of intravenously administrated E. coli induced fulminant sepsis,"We found that there is poor management of nutrition in the CCU. This is paired with limited knowledge and low confi dence in management amongst the attending staff . Evidence would suggest that the development and dissemination of clear hospital guidelines could improve rates of correct management [2] . However, the lack of uniform guidance based on strong evidence from the leading global authorities on nutrition suggests that, in order to improve implementation of adequate nutrition, more research is urgently required.",13.72321506368961,6.228724832432927
Real-time PCR,0.38984489037018,2.656791925430298,2.0750415325164795,76a06e1c-3c2b-42a2-984a-16de652c6421,comm_use_subset/Annals of Clinical Microbiology and Antimicrobials Predicting the sensitivity and specificity of published real-time PCR assays,"We show that current methods for real-time PCR assay design have unacceptably low sensitivities for most clinical applications. Additionally, as new sequence data becomes available, old assays must be reassessed and redesigned. A standard protocol for both generating and assessing the quality of these assays is therefore of great value. Real-time PCR has the capacity to greatly improve clinical diagnostics. The improved assay design and evaluation methods presented herein will expedite adoption of this technique in the clinical lab.",27.258039794773367,12.616005675836083
to enhance and stimulate their immunity cells functions acting on both adaptive and innate immunity,0.17160619962147802,1.6109378337860107,2.375088691711426,ae5dd3bd-aff1-4333-bf7f-f1ec6089f061,comm_use_subset/R E V I E W Open Access Immunostimulants in respiratory diseases: focus on Pidotimod,The common end-point of these studies is that Pidotimod has an immunomodulatory activity which is able both to improve the clinical conditions of patients and to enhance and stimulate their immunity cells functions acting on both adaptive and innate immunity [1] .,22.684241709841345,10.530401840017804
Improved etiological insight is needed to improve clinical management and prevention,0.15525828566685781,1.2174534797668457,2.4650444984436035,1137b5c8-b744-4409-a1e8-b155ee668c6c,"comm_use_subset/Viral Etiology of acute respiratory tract infections in hospitalized children and adults in Shandong Province, China","The dominant viral etiologies responsible for acute respiratory infections (ARIs) are poorly understood, particularly among hospitalized patients. Improved etiological insight is needed to improve clinical management and prevention of ARIs.",22.552078369191566,10.286851115053839
"Understanding of actual situations, experienced and perceived by patients with AD and their caregivers, is essential to improve clinical outcomes and satisfaction in real practice",0.17789709333585274,1.2379415035247803,1.9477277994155884,d6f2d530-9d64-418b-b1e4-99b591e9dd52,comm_use_subset/A1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts,"The Background: The effective management of atopic dermatitis (AD) adjusted to individual clinical courses and demands can be challenging for both patients and physicians. Understanding of actual situations, experienced and perceived by patients with AD and their caregivers, is essential to improve clinical outcomes and satisfaction in real practice.",22.648141239481554,9.997534480729783
Considerations for the evaluation of One Health,0.49851471084230015,2.9594671726226807,4.172457695007324,0dcf7ca7-bbff-4c9a-8a26-e343a72e8f15,"comm_use_subset/United States of America, 5 One Health Country Operations Team, Department of Country Health Emergency Preparedness and IHR, World Health Organization","Considerations for the evaluation of One Health. Despite an emphasis on the importance of iterative improvements to collaboration, the implementation of monitoring and evaluation activities was one of the major gaps in the reports of One Health collaboration. The majority of articles reviewed never discussed the evaluation of either the process of collaboration or the resulting outputs or outcomes. This creates a pivotal challenge in understanding how to improve One Health operations. It became clear in the literature review that there was no standard framework for how to evaluate One Health processes [12, 36] . Although networks and collaborators such as the Network on the Evaluation of One Health are making important advances, practical evaluation tools are still needed [83] . Some authors from public affairs, such as Emerson and Nabatchi (2015) et al. [19] have proposed a framework for evaluating outputs, outcomes, and what they refer to as ""adaptations"" of collaborative processes [18, 19] . Their work is one of the first to propose an integrated framework that captures collaborative results at all levels of the system, from the target population to the participating organizations, and the network as a whole. The results of this scoping review are intended to support the next steps in supporting One Health evaluation.",13.973138426217206,9.526349613135526
Broad spectrum PCR targeting conserved bacterial genes like the 16 s rDNA could improve bacterial diagnostics,0.31274921051396576,2.9306490421295166,3.935781717300415,3ec9b804-5c95-49e8-9b11-fd568972e13f,comm_use_subset/Microbial Translocation Contribute to Febrile Episodes in Adults with Chemotherapy-Induced Neutropenia,"Collectively, our findings suggest that in these patients, translocation of bacterial products, rather than whole bacteria, from the intestines has occurred. Correlation of our findings with enterocyte function and integrity could provide more insight into the possible mechanisms of translocation and should be considered for future studies. Arguably, bacterial findings based solely on positive bacterial cultures could lack sensitivity and be an underestimation of episodes with blood-borne bacterial findings. Broad spectrum PCR targeting conserved bacterial genes like the 16 s rDNA could improve bacterial diagnostics once the inherent difficulties with cross-contamination and false positivity have been resolved. [32] Regardless, PCR diagnostics is a viable option to circumvent this limitation and should be considered for future studies. In this study, we have chosen to follow conventional clinical bacteriological routines in order to obtain the current clinical picture. Given the transient nature of circulating endotoxins and sCD14, care had been taken to ensure samples were obtained within a 72 hr window within which, no sampling bias was observed. Additional information with regards to mucositis grading was unfortunately unavailable in this study and should be considered for inclusion in future studies as a measure of mucosal damage. Further, it would have been desirable to perform longitudinal studies in order to determine if there were correlations between endotoxin concentrations and progression to severe infection or, even septic conditions. Unfortunately, this was not possible with the current study but should be considered in other studies with the same patient cohort. In this cross-sectional study, our findings suggest that in the absence of microbiological findings, microbial translocation could contribute to febrile episodes in an adult neutropaenic cohort. This not only adds to the repertoire of potential causes of fever, it also indicates the urgency for suitable biomarkers to distinguish between drug and tumour related fevers (DTRF) and fevers of infectious causes. Further, an association between prophylactic antibiotic use and increased plasma endotoxin concentrations was observed.",13.795285639666627,9.291529967512774
in endemic areas,0.18604542712868344,1.7681984901428223,3.6192588806152344,3bfa4f23-d3bf-45fd-ac27-54d5edd72652,comm_use_subset/Issue 1 | e3 Neglected Diseases Citation,"Finally, we should not overlook the fact that plague has been weaponised throughout history, from catapulting corpses over city walls, to dropping infected fleas from airplanes, to refined modern aerosol formulations [60, 61] . The weaponisation research on plague carried out from before World War II until the 1990s fuelled a fear of biological warfare that may actually have stimulated research into surveillance and response strategies. More recently, however, fear of small-scale bioterrorism and the desire of governmental authorities to more fully control all access to plague materials risks stifling the research on plague ecology, epidemiology, and pathophysiology that is required to improve its clinical management in endemic areas. Terrorist use of an aerosol released in a confined space could result in significant mortality and widespread panic [60, 61] , and no one would wish plague weaponisation knowledge and material to fall into terrorist hands. However, the need for scientifically sound studies on the dynamics of infection, transmission, outbreak management, and improved surveillance and monitoring systems has never been greater.",15.141696775534044,8.801441162429652
will help improve the sensitivity of local molecular diagnostics,0.07958854835373749,1.9946420192718506,3.4971628189086914,e7d747bd-e1b9-4481-876c-e9f09ec09fc4,comm_use_subset/Human Rhinovirus B and C Genomes from Rural Coastal Kenya,Primer-independent agnostic deep sequencing was used to generate three human rhinovirus (HRV) B genomes and one HRV C genome from samples collected in a household respiratory survey in rural coastal Kenya. The study provides the first rhinovirus genomes from Kenya and will help improve the sensitivity of local molecular diagnostics.,13.319025172929926,8.231331955342826
Whether this adaptation will improve the success of implementation over the longer term,0.35305497288113435,1.3845959901809692,1.8405810594558716,a3bb6ddb-82ea-4c60-be96-adb29339050b,comm_use_subset/Fading vision: knowledge translation in the implementation of a public health policy intervention,"The perceived complexity of an intervention will negatively influence implementation [8] . If the innovation can be reinvented (i.e., adapted or modified) then implementation is more likely to occur [9] . In 'the double bind' many participants felt overwhelmed by the complexity of the CF Framework and managed this by clustering programs to reduce the demands of implementation. Whether this adaptation will improve the success of implementation over the longer term remains to be seen.",17.128144920856712,8.091215804563795
we do not know how the use of KT or implementation frameworks might improve the process.,0.19329752886466778,1.753971815109253,1.8910504579544067,790f9c87-81b0-46a0-a34a-f9fb91751ddf,comm_use_subset/Fading vision: knowledge translation in the implementation of a public health policy intervention,"There is widespread acknowledgement of the importance of evidence-based practice and policy, yet the research-practice gap remains a significant problem [14, 15] . Theories, frameworks, and models have been developed to guide and explain the implementation and KT process [8, [15] [16] [17] [18] . KT is a process of closing the gap between the evidence generated in research and its application for frontline health systems delivery [19] . Here, 'application' or what we call 'implementation' is considered part of the KT process. Unfortunately, implementation and KT frameworks have not been used widely by organizations prospectively to plan implementation of new policies or programs [16, 18] . We know that few policies and programs in the 'real world' are fully implemented as intended [20] , but we do not know how the use of KT or implementation frameworks might improve the process.",14.80374345176686,7.55057468560978
quality assurance and control processes must still be used for all WHO information products,0.2388762097098525,1.485910177230835,1.7597715854644775,13f3ee3b-de9e-4a61-9931-8b31df791484,comm_use_subset/An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks,"Despite the WHO GRC's responsibilities, only three guidelines were approved by the quality assurance agency. The specific reasons were unclear, although the pressure to produce guidelines quickly could lead to ad hoc and variable processes and procedures. Nonetheless, quality assurance and control processes must still be used for all WHO information products.",14.217839662077928,7.085937027479227
"administrative directives and processes interact with contextual, socio-economic, cultural and political aspects to shape implementation.",0.11774252729200045,0.04075245186686516,0.7121739983558655,a2b6b13f-3414-4f16-a5e2-132bdb6e88e9,"comm_use_subset/Street-level diplomacy and local enforcement for meat safety in northern Tanzania: knowledge, pragmatism and trust","In many countries, the implementation of government policy and regulation, and extension officers' work has been recognised as challenging and often inadequate [21, 25, 26] . Theoretical policy implementation literature shows, in keeping with this, that this is seldom unproblematic, with frequent 'implementation failures' [27, 28] . In seeking to understand these failures, attention has focused on how administrative directives and processes interact with contextual, socio-economic, cultural and political aspects to shape implementation. Bringing the topdown, 'highly scripted' dimension of policy implementation together with its bottom-up, informal dimensions has introduced new emphasis on governance arrangements, policy networks, and institutional relationships [27] . The space between these top-down and bottom-up dimensions is occupied by frontline actors, or 'street-level bureaucrats' [29] , who have degrees of 'decisional latitude' to determine which policy directives they respond to and how they satisfy government objectives while accommodating local, contextual factors, and retaining professional autonomy [27, 30, 31] . These frontline actors bring their own values, knowledge, and norms to bear as they enter into processes of 'negotiation and bargaining' with people who form the policy target [32] . Despite widespread recognition of frontline actors' discretionary roles in mediating 'technically complex policy matters' , the ways in which they undertake policy implementation remain 'opaque' [31] , especially in LMICs.",15.819927911689305,6.026376961736031
All information products developed in response to an emergency,0.14851760866760227,1.163699746131897,0.4032594859600067,87b2a938-1622-4250-a66f-b3e6afa05cc7,comm_use_subset/An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks,"A clear indication of plans for updating recommendations is a critical issue in the emergency context, as the evidence base and other considerations such as those related to implementation are continually evolving. All information products developed in response to an emergency, particularly those labelled ""interim"", should have a ""review by"" date and sufficient resources must be available to evaluate and update information products as required.",14.179255816679628,5.981263036697607
clinical guidelines,0.19062056077747289,0.8243785500526428,0.8106383681297302,d6991491-c0fb-4c5c-b66c-fa4d54b0ae7b,comm_use_subset/Re-engineering the Cypriot healthcare service system,"â¢ Quality improvement leads in each hospital that will coordinate clinical audit, clinical guidelines implementation etc.",13.798405146359661,5.892202798044424
development of guidelines,0.1271803914312346,-0.2538897693157196,0.8183541893959045,332f72dd-e2c9-498e-b1aa-caf1abef876d,comm_use_subset/An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks,We identified 175 information products of which 87 were classified as guidelines. Table 1 summarizes the characteristics of all information products. Table 2 outlines the methods and processes used in the development of guidelines specifically.,14.498234148396714,5.441283824990969
length of stay in hospital and duration of oxygen supplementation,0.24670577220209228,1.7857701778411865,1.9241689443588257,ac8f72b6-e56d-42ce-b525-130a1a989099,comm_use_subset/Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol,"Our primary research question is: Amongst hospitalised Indigenous infants with bronchiolitis, does azithromycin (compared to placebo) improve clinical outcomes (length of stay in hospital and duration of oxygen supplementation)? Our primary hypothesis is that: The anti-microbial and anti-inflammatory properties of the macrolide, azithromycin, will improve the clinical outcomes of Indigenous infants hospitalised with bronchiolitis.",27.16622666247782,11.919639761297244
Noninvasive ventilation has been proven to be useful as a means to avoid intubation and improve clinical outcomes in certain conditions,0.374140327163457,3.4393820762634277,3.767505645751953,c5e4ca12-b49a-4f41-bfd8-407c3c5a9067,comm_use_subset/Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome,"Noninvasive ventilation has been proven to be useful as a means to avoid intubation and improve clinical outcomes in certain conditions, generally, with the possibility for rather rapid reversal of respiratory failure-for example, pulmonary edema due to congestive heart failure, and respiratory failure due to COPD exacerbations. 22, 23 For conditions that typically worsen or do not improve in the range of many hours (eg, most causes of pneumonia), there appears to be little advantage in using NIV as a means to avoid intubation. 9, 24, 25 In choosing to use NIV for as initial treatment for patients with hypoxemic respiratory failure, there is a practical risk of patients worsening on NIV and requiring intubation at a time when they already have more advanced organ failure.",18.439399965460044,11.138267007221012
Improved etiological insight is needed to improve clinical management and prevention,0.21023227334842576,1.2298239469528198,2.730863571166992,e267a52e-8577-4709-87bb-a7b641f5d872,comm_use_subset/Viral Etiologies of Acute Respiratory Infections among Hospitalized Vietnamese Children in Ho Chi Minh City,"The dominant viral etiologies responsible for acute respiratory infections (ARIs) are poorly understood, particularly among hospitalized children in resource-limited tropical countries where morbidity and mortality caused by ARIs are highest. Improved etiological insight is needed to improve clinical management and prevention.",21.257947039905634,10.01472835074485
Purification and sequencing,0.3754125356009619,3.4427030086517334,3.5073790550231934,4345ae7c-1f13-4963-a5aa-89c10ed73a92,comm_use_subset/Polymerase cross-linking spiral reaction (PCLSR) for detection of African swine fever virus (ASFV) in pigs and wild boars,"Purification and sequencing of PCLSR products. The PCLSR products were purified using DNA extraction. The DNA from the reference virus stock as well as the whole blood from wild boars and pigs was extracted using High Pure PCR Template Preparation Kit, accordingly to the manufacturer's procedure (Roche Diagnostics, Basel, Switzerland). The extracted DNA was stored at â 20 Â°C for further testing.",13.853018420045164,9.36610978840451
the integrative medicine could improve clinical symptoms,0.1879790673224042,3.3690688610076904,2.7351694107055664,1f258a3e-a697-4157-9313-240f8f0a6aa7,comm_use_subset/Review Article Current Situation and Perspectives of Clinical Study in Integrative Medicine in China,"Severe acute respiratory syndrome (SARS) has aroused international attention for strong infectiousness, rapid progression, poor prognosis, and high mortality, which has no special effective therapy yet. 524 patients of SARS in China were divided into integrative medicine treatment group (n = 318) and western medicine treatment group (n = 206). The existence rates for the symptoms of weakness, short breath, dyspnea in the first group were significantly lower than that in the second group after treatment. The duration of weakness was averagely shortened by 1.5 days in the first group. And short breath, dyspnea, and muscle aching pain were averagely shortened by 2 days, 1 day, and 2 days, respectively. Researches showed that the effect of integrated therapy of TCM and WM for treating SARS was superior to WM treatment alone, and the integrative medicine could improve clinical symptoms such as weakness, short breath, and dyspnea [59] [60] [61] . The exact clinical curative effect was also recognized by World Health Organization (WHO).",15.10846625226526,9.255718064906457
infectious disease diagnostics and patient care,0.23958568765330013,2.3062140941619873,3.9306228160858154,9b8e4c8f-acb0-46b2-a747-7513bb706b1e,comm_use_subset/Highlighting Clinical Metagenomics for Enhanced Diagnostic Decision-making: A Step Towards Wider Implementation,"More recently, CMg has been employed to detect the first case of gastrointestinal basidiobolomycosis [124] . A 41-year-old HIV-positive female from Cameroon presented to the hospital with a 2-month history of abdominal pain. A sizable (inflammatory) mass was seen on her abdomen by CT-scan and histopathological examination revealed large hyphae that were encased by a thick eosinophilic material. Sanger sequencing of the ITS results were inconclusive however, ultra-deep pyrosequencing of the ITS2 region revealed 4 fungal species with B. meristoporus representing 80% of the sequences. The authors concluded that this approach is ready to be integrated into clinical microbiology laboratories to improve infectious disease diagnostics and patient care.",14.129673578491364,8.99932974413305
effective removal of the infected nodes,0.3262287172221068,2.7506861686706543,3.0911240577697754,f54deecb-b28b-4b75-9c4e-809139784179,comm_use_subset/The Impact of Farmers' Strategic Behavior on the Spread of Animal Infectious Diseases,"Factors that limit the speed of detecting infections are an obstacle for implementation of the MRP. The MRP becomes significantly less efficient when infected nodes that have not been detected spread the disease through both trade and geographic networks. The distribution of the time between the infection and control events has previously been highlighted as a crucial ingredient to identify for effectively managing disease spreading [30] . Factors that can limit the rate of detection include a high rate of subclinical cases, long incubation periods, and poor detection tools. The detection period can also be lengthened by the absence of active surveillance activities or lack of declaration in cases of clinical suspicion. For cow-calf systems or for dry dairy cows, farmers may easily miss some moderate clinical signs on some animals and not identify cases until clinical signs have become severe. Note that in the present study, changes in the efficiency of implementation of the control policy (Î±) have analogous results to changes in the detection rate (Î³), since the effective removal of the infected nodes depends on the product Î±Ã Î³.",11.87101214133731,7.952030896654337
improve the clinical outcomes of Indigenous Australian infants hospitalised with bronchiolitis.,0.16232600556112023,0.9745981693267822,3.121049165725708,fdf85fc3-4b9e-4cc1-9cad-4a3ef85e709c,comm_use_subset/Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol,"Background: Acute lower respiratory infections are the commonest cause of morbidity and potentially preventable mortality in Indigenous infants. Infancy is also a critical time for post-natal lung growth and development. Severe or repeated lower airway injury in very young children likely increases the likelihood of chronic pulmonary disorders later in life. Globally, bronchiolitis is the most common form of acute lower respiratory infections during infancy. Compared with non-Indigenous Australian infants, Indigenous infants have greater bacterial density in their upper airways and more severe bronchiolitis episodes. Our study tests the hypothesis that the anti-microbial and anti-inflammatory properties of azithromycin, improve the clinical outcomes of Indigenous Australian infants hospitalised with bronchiolitis.",14.615302409872767,7.777526611239587
"BSV-based research to monitor endemic diseases in order to differentiate between natural, accidental, and deliberate outbreaks",0.22221448761016468,1.732529640197754,3.3074655532836914,152eb97e-4e75-4b2e-b1ba-8a2f28412ae4,comm_use_subset/MINI REVIEW Reassessing Biological Threats: Implications for Cooperative Mitigation Strategies,"Cooperative Biological Engagement Program employs several core strategies in working with a partner country to enhance BSV capacity and capability, including building secure laboratory infrastructure and identifying and training laboratory personnel and clinicians to conduct safe and secure diagnostics, especially when working with dangerous and highly infectious pathogens. CBEP also supports the implementation of BSV-based research to monitor endemic diseases in order to differentiate between natural, accidental, and deliberate outbreaks, as well as information system networks to manage health-related data, critical to BSV, for the purpose of analysis and reporting to the authorities responsible for implementing specific biological mitigation strategies.",11.91225065495008,7.445284604995467
more targeted research,0.23456600712448553,1.948246955871582,2.4485325813293457,a52b359b-49e9-4e4e-ae49-9fd5c7f2dadd,comm_use_subset/Dogs (Canis familiaris) as Sentinels for Human Infectious Disease and Application to Canadian Populations: A Systematic Review,"The objectives of this review were to identify the available literature supporting the use of dogs as sentinels so that further, more targeted research could be planned to assist with its implementation. Anticipated actions resulting from such sentinel surveillance include warnings of pathogen activity to physicians in order to improve detection of human cases and consideration of other differential diagnoses, and to epidemiologists in order to detect ongoing and new pathogen or vector activity and predict peaks in transmission and human cases.",12.360027645219382,7.183916375007387
to evaluate which clinical specimen had the highest yield for ARI diagnostics,0.14753123419066788,1.7841811180114746,3.108421802520752,119cc23a-e792-45b2-a646-eeca7f591794,comm_use_subset/Viral Etiologies of Acute Respiratory Infections among Hospitalized Vietnamese Children in Ho Chi Minh City,"Here we performed a 3-year prospective descriptive study to report on viral aetiologies, clinical features and epidemiological patterns of ARIs in hospitalized Vietnamese children using established commercially available and in-house nucleic acid amplification techniques. In addition, we used these techniques to evaluate which clinical specimen had the highest yield for ARI diagnostics by comparing nasopharyngeal aspirates and individual or combined throat and nasal swabs.",11.326152214754032,7.144345173509858
"regular meetings, formalized MoUs, and data sharing",0.3224065259513894,2.0202934741973877,1.7409290075302124,ebd9dc36-d70d-4137-993f-1826c419054a,comm_use_subset/Building the road to a regional zoonoses strategy: A survey of zoonoses programmes in the Americas,"Our results allow the identification of regional vulnerabilities (both disease-specific and across diseases), as well as of countries lagging behind the region's benchmark. Although not presented here, individual countries and Ministries can be profiled to help identify potential vulnerable hot-spots that warrant technical cooperation from neighboring countries and international agencies. Regional and country-specific profiles allow comparisons with the countries responses to the annual IHR Core Capacity Implementation Survey. In 2013, 97% of the countries within the Americas region reported coordination within government for the detection and response to zoonotic events, and 97% had functional mechanisms for collaboration between animal and human health units such as intersectoral surveillance units and laboratories [22] . These compare with the results of the present survey where Ministries were asked to rank the relationship with their counterparts. None of the Ministries ranked their collaboration with the other Ministry as non-existent. In fact, the majority of Ministries ranked the collaboration as very or overall productive (69%). Yet, many Ministries suggested improvements through regular meetings, formalized MoUs, and data sharing. The latter entails a highly evolved relationship and well developed processes between parties and is uncommon, as reported by Vrbova et al. [23] who found that only 19% of the surveillance systems for emerging zoonoses considered both human and animal data. On a related topic, albeit less demanding of sophisticated structures and processes to support useful data sharing, the 2013 IHR Core Capacity Implementation survey reported that 80% of countries in the Americas had a timely and systematic exchange of information between the animal and human sectors [22] . Because so few MAgs have a dedicated zoonoses group (20%), the collection and sharing of data beneficial to both parties is likely to remain a challenge. For emerging zoonoses, given the low proportion of respondents that replied that they had an MoU with their counterpart (Fig 6) , opportunities to improve this specific capacity appear possible. This is likely to hold true only for those zoonoses that have both a significant public health and an economic impact (e.g. BSE, AI). For other conditions, MoH may not perceive much benefit in establishing an MoU with MAgs, due to the little involvement of the latter in the control of zoonoses, e.g leptospirosis.",12.059888094861991,6.665755446324637
lysis buffer can be added to clinical specimens manually prior to the transfer of the sample and buffer mixture to the automated instrument for further downstream processing,0.15491754798289048,0.03246374800801277,2.5913121700286865,4291d221-0fe4-4f1c-bde5-689077114c71,comm_use_subset/BMC Infectious Diseases Automated extraction protocol for quantification of SARS-Coronavirus RNA in serum: an evaluation study,"According to the manufacturer's information, 2 kits, namely the MagNA Pure LC total nucleic acid isolation kit (Roche Diagnostics) and the MagNA Pure total nucleic acid large volume isolation kit (Roche Diagnostics), are recommended for use with the MagNA Pure LC instrument for the extraction of viral DNA or RNA from serum or plasma. The main differences between the two kits lie in the starting sample volume and whether an external lysis protocol is available. The former kit processes 200 ÂµL of serum and is compatible with the use of an external lysis protocol preinstalled in the accompanying software (MagNA Pure LC Software v.3.0, Roche Applied Science) of the MagNA Pure LC instrument. The latter kit, however, processes 1000 ÂµL of serum and no external lysis protocol had been predefined. External lysis is a processing step whereby lysis buffer can be added to clinical specimens manually prior to the transfer of the sample and buffer mixture to the automated instrument for further downstream processing. External lysis is a desirable step for the processing of potentially infectious specimens whereby the specimens could be processed according to the recommended biosafety precautions until the pathogens are lysed and the specimen rendered safe for further processing by the MagNA Pure LC instrument.",13.578935217369983,6.458081672803348
Stochastic dynamics,0.5375957849713454,1.3226220607757568,1.1036487817764282,c55ad63c-cce8-4f05-aa86-daaea985d6de,comm_use_subset/The Impact of Contact Tracing in Clustered Populations,"Stochastic dynamics. We simulate SIS dynamics with tracing on a network using a standard continuous-time algorithm [27] . The implementation of such algorithms, and the differences between them and discrete-time equivalents, in the context of epidemic models is discussed in [28, Chapter 6] . Since the two contact processes involved (infection and tracing) both involve the explicit network, our model is essentially individual based.",12.816615393494498,6.062891435381994
a long way has yet to be completed before the implementation of these antiviral strategies in clinical practice,0.15048201384740842,1.0764358043670654,1.4929310083389282,0a826462-fb90-4d1b-8705-8b6c3edca3d4,comm_use_subset/pharmaceuticals Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses,"In any case, and although a long way has yet to be completed before the implementation of these antiviral strategies in clinical practice, the current scenario and their potential benefits support future research efforts aimed to repositioning of lipid metabolism modulators as antiviral compounds. ",11.895143735565552,5.833388735706839
epidemiological surveys,0.24439946692306153,3.3418829441070557,5.6861982345581055,c347f0f7-d170-4d51-bc51-f6fb17a6726c,comm_use_subset/Epidemiology and Immune Pathogenesis of Viral Sepsis,"The main differences between Sepsis-3 and previous versions are that Sepsis-3 eliminated the terms sepsis syndrome and severe sepsis, and introduced a new definition of sepsis, which is more comparable to the older definition of severe sepsis. In addition, the systemic inflammatory response syndrome (SIRS) criteria, which were the essential elements of Sepsis-1 and Sepsis-2, are no longer used to define sepsis, but they still play a role in the recognition of infection and warrant early intervention for possible sepsis (1, 4) . Sepsis-3 provides a more specific and universal definition for sepsis, which would improve clinical management and facilitate epidemiological surveys. It also has better predictive ability for in-hospital mortality (1) .",17.493889875760686,11.991114222648594
microarrays,0.41743360411896924,3.4997575283050537,4.487304210662842,0481fcba-3f7b-43c3-b4c2-a78adfa163ab,comm_use_subset/Protein Microarrays and Biomarkers of Infectious Disease,"As an alternative to full-length polypeptides, expression and purification of protein domains may improve yield of stable products for use in microarrays. In one reported study, a total of 212 protein domains (SH3, SH2, PDZ etc.) were immobilized on nitrocellulose and screened with peptides [55] . The results proved that the immobilized domains were stable and could be used for binding studies.",11.293139384545492,9.144188914920054
can largely avoid the overuse or even abuse of the antibiotics and improve the clinical care of patients,0.23203796939383986,2.272202730178833,4.017937183380127,c3856f20-afdb-42d3-bcc1-bc858951cd08,comm_use_subset/Rapid detection of respiratory organisms with the FilmArray respiratory panel in a large children's hospital in China,"Acute respiratory tract infections (RTIs) are the leading causes of outpatient visits and hospitalizations in all age groups, especially during winter and spring. For children under 5 years of age, RTIs are the second leading cause of death [1] . Most acute RTIs in children are caused by respiratory viruses, such as respiratory syncytial virus (RSV), adenovirus (ADV), rhinovirus (RV) and influenza viruses. In addition to viruses, atypical pathogens are major causes of pediatric RTIs. One of the most common atypical pathogens is Mycoplasma pneumoniae (M. pneumoniae), accounting for 10-40% of hospitalized children with community-acquired pneumonia [2, 3] . In addition to M. pneumoniae, the incidence of pertussis in China has significantly increased since 2010. Nevertheless, multiple epidemiological studies have suggested that the incidence of pertussis in China has been significantly underestimated [4, 5] . The early diagnosis of the pathogen is beneficial for the precise selection of medication, which can largely avoid the overuse or even abuse of the antibiotics and improve the clinical care of patients. More importantly, the early diagnosis of contagious pathogens, such as Bordetella pertussis (B. pertussis) and influenza viruses, can enable early isolation of patients, thus reducing the spread of pathogens.",12.528735843295035,8.473648488966585
it was also shown to improve clinical outcomes in MERS-CoV-infected non-human primates,0.15740996419391715,1.8079783916473389,2.9928665161132812,95422714-937b-4f1e-8c44-1a771f479104,comm_use_subset/MERS-CoV: Understanding the Latest Human Coronavirus Threat,"Interestingly, combination treatment with ribavirin and interferons inhibits MERS-CoV replication in vitro, and it was also shown to improve clinical outcomes in MERS-CoV-infected non-human primates. However, this treatment in the rhesus macaques was initiated very soon after viral challenge (~8 h), resulting in reduced disease severity in the rhesus macaque model. This appears to simulate mild-to-moderate human MERS-CoV cases, making it difficult to extrapolate the outcome of this early intervention in severe human cases. Even though the authors recommended that combined IFN-Î±2b and ribavirin therapy should be considered as an early intervention therapy for MERS-CoV [115] , we also need to keep in mind that, due to the limited effective therapeutic window of opportunity, broad spectrum antivirals might not be sufficient to treat severe MERS-CoV patients [122] .",14.854885365231313,8.319759067875363
Diagnostic applications include biochemical analysis and imaging,0.15239472162012546,3.034133195877075,3.139946222305298,836e8d69-b0aa-4c4d-851a-f68fd5ef4b71,comm_use_subset/Antibody Engineering for Pursuing a Healthier Future,"MAb-based products exhibit superior specificity for a particular antigen. This characteristic feature of the immunoglobins makes them an ideal tool for many applications including disease diagnosis and therapy ( Table 2 ; Modjtahedi et al., 2012; Redman et al., 2015; Steplewski et al., 2015) . Diagnostic applications include biochemical analysis and imaging. It involves a number of immunoassays for the detection of hormonal, tissue, and cell products. Imaging is carried out using radiolabeled mAbs for diagnostics of infectious diseases. Therapeutic mAbs have a wide range of applications. They are used in the treatment of cancer, transplantation of bone marrow and organs, autoimmune diseases, cardiovascular diseases, and various infectious diseases. Targeting agents in therapy Toxins, drugs, radioisotopes etc., can be attached or conjugated to the tissue-specific mAbs and carried to target tissues for efficient action.",10.906039353806982,7.8302653956509864
Antibody development against every human protein,0.44848917458578047,2.6357645988464355,2.7359657287597656,bb82309a-02ea-4341-932c-42b868a56068,comm_use_subset/Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen,"A crucial challenge of the proteome era is to use the genome information for a better understanding of protein expression, protein cellular distribution and functionality discovery not only in normal but also in pathological processes [1, 2] . Antibody development against every human protein is a prerequisite to improve this knowledge. Several high-throughput alternatives have been developed to generate antibodies to the entire proteome [3] [4] [5] . The Human Protein Atlas initiative (http://www.proteinatlas.org/) [3, 4] , the Sanger Institute Antibody Atlas Database, the NCI Clinical Proteomics [5] , the HUPO human antibody initiative (http://www. hupo.org/research/hai/) [6] , and several EU-funded consortia (ProteomeBinders, AffinityProteome, Affinomics [7] [8] [9] ; http://www.proteomebinders.org) are all good examples of these alternatives.",12.209347203539318,7.764896234182792
routine clinical viral diagnostics,0.30545113322468204,0.6286625266075134,1.2035975456237793,acc3d337-ef61-42cd-b3c7-0491079f7574,comm_use_subset/Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples,"In conclusion, Panther Fusion was validated alongside Allplex as a sensitive and specific assay for detecting the most common viruses responsible for respiratory infections, allowing a fully automated rRT-PCR process and random access with a clinically appropriate turnaround time, and thus is a suitable method for implementation in routine clinical viral diagnostics. ",18.152779633345034,7.544441918621102
routine laboratory practice,0.23405764653923236,1.6323535442352295,2.3585689067840576,e30854e8-c694-475a-aef0-0da4032eb7c6,comm_use_subset/Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples,"Respiratory viral infections are a major global health problem today [21] , and they require accurate diagnostic tools which must be thoroughly evaluated prior to their implementation in routine laboratory practice. In this study, we compared the performance of the Panther Fusion assays with Allplex respiratory panels (approved by ConformitÃ© EuropÃ©enne-in vitro diagnostics [CE-IVD]), using R-GENE technology as a reference method.",13.160696115714348,7.200343233662558
blood transfusion a safer form of therapy,0.21903621592063488,1.7452170848846436,2.757551431655884,2e72b59e-dcbc-4d96-aeb3-6e326894f8ba,comm_use_subset/Journal of Translational Medicine Transfusion-transmitted infections,"The general public may be idealistic in their belief that risk-free blood products are achievable in today's world. In fact, the threat of infectious agents entering the blood supply is not static and may evolve as new pathogens emerge or as old ones change their epidemiological pattern. Nevertheless, the goal of a safe and affordable blood supply that can meet the growing global demands may be reached by the coordinated optimization of each step in the transfusion chain, including the careful consideration of donor eligibility criteria, adherence to rigorous rules during donation, processing and storage, the optimal implementation of available screening tests, the use of suitable pathogen inactivation methods and finally the vigilance of prudent physicians, who evaluate the necessity of each transfusion. Efforts invested in providing lowest possible risk blood products need to be matched by the diligence of physicians administering the transfusions who need to report adverse consequences of blood transfusions. Hence, national haemovigilance systems linked to an international network are becoming indispensable elements of blood product safety and quality. Combined with the development and implementation of sensitive and affordable detection and inactivation approaches, these measures can make blood transfusion a safer form of therapy even in places where the risks to date have to be considered significant [5, 6, 144, 145] .",12.009026408071446,7.1299587785763485
"improve the quality of its guidelines, and help to ensure that its guidelines are appropriately adapted and result in appropriate actions and health improvements",0.22837084456221712,1.3869800567626953,2.5290439128875732,13e4192a-a10c-418e-95f0-438cfb869343,"comm_use_subset/Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation","with other organizations, WHO could capitalise on this experience, improve the quality of its guidelines, and help to ensure that its guidelines are appropriately adapted and result in appropriate actions and health improvements. Similar suggestions have been made previously by investigators involved with WHO guideline projects. For example, ""Countries should discuss and find ways of collaboration and formation of linkages and support with National HIV/AIDS program in order to enhance the implementation of IMCI algorithm which includes HIV/ AIDS"" [11] .",12.520086594333181,6.927445888289288
positive control,0.2201203110856637,0.5239699482917786,1.7997173070907593,2e1c5237-30c6-4186-b856-07566ca7e515,comm_use_subset/Rapid communication,"Three of 38 laboratories that had implemented diagnostics did the implementation without a positive control. Indicated sources for positive controls were the European Virus Archive (EVAg) (synthetic 2019-nCoV E-gene, SARS-CoV RNA) (n = 23) [9] , or own stocks, i.e. SARS-HCoV RNA and/or synthetic RNA (n = 15).",14.753358464939142,6.674072178727349
good geographical coverage for testing,0.18393648417787264,0.9708044528961182,2.5707623958587646,adf66b09-16bb-4dd7-96a9-90536b46d894,comm_use_subset/Rapid communication,"This rapid assessment of the readiness of EU/EEA laboratories for molecular detection of 2019-nCoV demonstrated a fast implementation of molecular diagnostics by the European specialised laboratory networks with a good geographical coverage for testing. Among both laboratory networks in this study, protocols were shared rapidly and there was an early availability of positive controls and CoV specificity panels via EVAg. Furthermore, the survey indicated a great willingness of laboratories to provide international diagnostic support [10] and to share sequences to contribute to the monitoring of virus evolution and trace transmission chains.",12.456333286810054,6.661735102074193
"their safety and superiority over existing vaccine formulations have been demonstrated, implementation of these novel vector-based vaccines may be considered.",0.0881336612924519,1.4565503597259521,2.3335671424865723,3bc4af39-4098-4f79-bcc3-3579d143b258,comm_use_subset/Viral vector-based influenza vaccines,"In the future, more novel vector-based influenza candidate vaccines will be developed and tested in clinical trials. There is potential for improvement by the modification of viral antigens, like the 'headless' or 'shielded' HA constructs, to broaden the reactivity of vaccine induced antibodies. In addition to modifying influenza virus antigens, post-translational modifications and modifications to promoter sequences could also alter and improve the immunogenicity. 226, 227 The biggest challenge of taking vector-based vaccines to the market may be obtaining approval from the regulatory authorities. Only when their safety and superiority over existing vaccine formulations have been demonstrated, implementation of these novel vector-based vaccines may be considered. Disclosure of potential conflicts of interest GF Rimmelzwaan is employed as a consultant to Viroclinics Biosciences B.V. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",11.835997957591758,6.606175661595256
"without a proper hint of where to go with the diagnostics, clinical or environmental samples may turn out difficult to diagnose by NAT",0.12934380314908328,1.5962908267974854,2.1025307178497314,5a2826b8-dafa-4dc6-8277-d5e05699128a,comm_use_subset/viruses Rapid Viral Diagnosis of Orthopoxviruses by Electron Microscopy: Optional or a Must?,"Last, but not least, without a proper hint of where to go with the diagnostics, clinical or environmental samples may turn out difficult to diagnose by NAT, especially when inhibitory substances are present [114] . Moreover, seeing the culprit provides a strong memory hook because virus morphology is easily remembered together with other pieces of structure-function information.",11.953435769219482,6.587936523247509
eff ective implementation strategy,0.10921223132480523,1.035811424255371,2.6207456588745117,5c7831b1-d224-40ed-96f2-b40cfabcdd9a,comm_use_subset/Sepsis and the heart,"Introduction The beliefs, knowledge and practices regarding ICU delirium among ICU professionals may vary. This may interfere with the implementation of the Dutch ICU Delirium guideline. We aimed to get insight into potential barriers and facilitators for delirium guideline implementation that may help to fi nd an eff ective implementation strategy.",10.86292827860999,6.178787001547921
6,0.22345800129346788,1.9160338640213013,3.28214168548584,3da8f0d8-ebac-4664-bb32-f438e18b37e6,comm_use_subset/Peripheral blood AKAP7 expression as an early marker for lymphocyte- mediated post-stroke blood brain barrier disruption OPEN,"The inflammatory state which persists at the level of the neurovascular unit following ischemic stroke can drive delayed disruption of the blood brain barrier (BBB) within and around the infarcted region. Heightened activity of proteinases disrupt the pericellular junctions of the endothelium and allow for migration of peripheral immune cells into the damaged brain parenchyma; this process inherently compromises the integrity of the BBB and increases the risk of edema and hemorrhagic transformation 1, 2 . By nature, administration of thrombolytic therapies can exacerbate the risk of such adverse events and worsen outcome in patients who develop complications 3-5 . Early identification of patients who are at risk for the development of BBB complications can inform acute clinical decisions regarding thrombolytic intervention, and ultimately improve clinical management and patient outcome 6 . Unfortunately, the diagnostic tools presently available to clinicians to identify patients at risk for post-stroke BBB complications are limited.",15.247778675814839,8.715536643714834
Antifragility would thus be a way to implement a form of epigenetic memory and contribute to the overall mechanisms of network epistasis,0.2587543046928406,2.8882498741149902,4.030115127563477,e1da2072-eb44-45ab-9b9e-c4c0161fa382,comm_use_subset/Antifragility and Tinkering in Biology (and in Business) Flexibility Provides an Efficient Epigenetic Way to Manage Risk,"Extending the concept of induced-fit, we can see antifragile flexible structures and processes as molded on particular ordered structures and processes of the organism. Antifragility could use pre-set properties selected during evolution, such as the retention of asparagine or aspartate residues at specific positions in proteins, and a context-dependent ability to cyclize. This way, the cell could learn and memorize a particular moment in its history, and fixate it so that it could be recalled later on when similar conditions appear. Antifragility would thus be a way to implement a form of epigenetic memory and contribute to the overall mechanisms of network epistasis [50] . In the present context it has properties similar to those used in the market of financial derivatives: the cell develops a diverse population of molecules of processes such that, under challenging conditions, one or more will emerge and improve the cell's fate in a much better way than a uniform population would have [14] . At this point, an aged cell, when facing suddenly a medium where it could reproduce, would initiate a round of replication. We did not discuss here the corresponding required processes and functions, which may underlie the widely spread observation of VBNC [18] , but the present view should be seen as a pre-requisite to explore this stage of life that represents up to 99% of the bacteria present in the environment.",11.131170344494201,8.392846871663973
In order to improve clinical management and prevention of viral infections in hospitalised children,0.17894982222451408,3.013291120529175,3.7315194606781006,ef52ca27-35e9-4e3f-b174-e8905ee78d00,comm_use_subset/Aetiology of Acute Respiratory Tract Infections in Hospitalised Children in Cyprus,"In order to improve clinical management and prevention of viral infections in hospitalised children improved etiological insight is needed. The aim of the present study was to assess the spectrum of respiratory viral pathogens in children admitted to hospital with acute respiratory tract infections in Cyprus. For this purpose nasopharyngeal swab samples from 424 children less than 12 years of age with acute respiratory tract infections were collected over three epidemic seasons and were analysed for the presence of the most common 15 respiratory viruses. A viral pathogen was identified in 86% of the samples, with multiple infections being observed in almost 20% of the samples. The most frequently detected viruses were RSV (30.4%) and Rhinovirus (27.4%). RSV exhibited a clear seasonality with marked peaks in January/February, while rhinovirus infections did not exhibit a pronounced seasonality being detected almost throughout the year. While RSV and PIV3 incidence decreased significantly with age, the opposite was observed for influenza A and B as well as adenovirus infections. The data presented expand our understanding of the epidemiology of viral respiratory tract infections in Cypriot children and will be helpful to the clinicians and researchers interested in the treatment and control of viral respiratory tract infections.",10.813615566192237,8.168892325952012
"to optimize care, and to improve clinical outcomes",0.16990572385496797,1.8762798309326172,3.149109125137329,fbdf0836-3ed6-401b-b18c-9c7db9b6e284,"comm_use_subset/A Combined Syndromic Approach to Examine Viral, Bacterial, and Parasitic Agents among Febrile Patients: A Pilot Study in Kilombero, Tanzania","Recent epidemiological data suggest that because of the adoption of aggressive vector control measures, there has been a stark decline in malaria incidence across sub-Saharan Africa, particularly in Tanzania. [1] [2] [3] [4] [5] [6] In Tanzania's South-Central region, data regarding the cause of nonmalarial febrile illness are currently lacking. At present, the malaria rapid diagnostic test is the only diagnostic tool used to direct febrile patient management in this region. [7] [8] [9] Thus, when a patient presents with fever and tests negative for malaria, clinical care providers must rely upon symptomatic conditions alone to define provisional diagnoses and determine appropriate treatment regimens. [10] [11] [12] Stakeholders have therefore recognized the need to improve knowledge surrounding the etiology of febrile illness, to optimize care, and to improve clinical outcomes. 3, 13, 14 In the regions of sub-Saharan Africa where viral, bacterial, and parasitic infections are not well-quantified, pathogenspecific diagnostic approaches to syndromic surveillanceevaluating only one or few pathogens-are inadequate. Most of these pathogen-specific studies have solely targeted malaria, and thus failed to consider other causative agents of febrile illness. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Given that multiple coinfections may contribute to morbidity, the detection of a single agent may not provide a complete understanding of disease etiology.",14.001205311794035,8.166924680573377
Implementation of the plan is the most critical and challenging aspect of the strategic planning process,0.3319869860230293,2.918233633041382,2.918226957321167,4783be16-b399-4692-8afb-94fa77cebf94,comm_use_subset/Print) 2225-2002 in Africa in the Global Health Security era,"It is important to note that a Strategic Plan is not an implementation plan -it merely provides the strategic initiatives on which the implementation plan for the development of the laboratory network is based. Based on the Strategic Plan initiatives, a variety of planned activities will be needed to address gaps in current systems. Activities must be prioritised as certain activities are required in order for others to take place. For example, a commodities list cannot be developed until the equipment plan for the network is finalised. An implementation plan must be developed with action plans for activities that are required to accomplish key strategies. Estimated costing information is required for all activities in the implementation plan for the first three years, at a minimum. Adequate funding of the plan is essential for its success. Ideally, an implementation team would be led by assigned laboratory leadership and a technical working group in consultation with implementation consultants. Implementation of the plan is the most critical and challenging aspect of the strategic planning process. Top laboratory leadership will need to own the implementation plan and monitor progress regularly. Plan implementation requires a separate monitoring and evaluation plan to determine whether planned targets are being met; Strategic Plans must be reviewed at least annually for progress made toward objectives. The plan may need to be updated as circumstances change or at regular intervals.",11.110611682932337,7.682413472761974
clinical trials trying to improve severe viral infections or ARDS outcomes by targeting host pathways have not resulted in approval of new drugs,0.19639951319662569,1.9565114974975586,2.99904727935791,88067e64-3fbc-4d72-8565-70ba65d7e939,comm_use_subset/The impact of the interferon/TNF- Related Apoptosis-inducing Ligand Signaling Axis on Disease Progression in Respiratory viral infection and Beyond,"Respiratory viral infections are major causative agents for lung injury and ARDS; however, in many cases antivirals are not sufficient to limit disease (208). Besides the fact that most viruses are subject to strong selective pressures that favor quickly evolving, drug-resistant virus variants, recent advances in understanding the processes that contribute to tissue injury and ARDS highlight a crucial role of immune-related, IFN-driven events. Therefore, novel therapeutic strategies often aim to improve the outcome of severe respiratory infection by modulating host cell responses; however, to date, clinical trials trying to improve severe viral infections or ARDS outcomes by targeting host pathways have not resulted in approval of new drugs (122) .",12.691376140315505,7.663094854066481
Increase the access to health services and products within communities to improve population health and reduce the likelihood of an outbreak,0.22859040156689092,0.8580823540687561,2.0182971954345703,14dcf188-dfbc-4425-b6a0-082efd1fd1ae,comm_use_subset/Community Health Workers and Pandemic Preparedness: Current and Prospective Roles,â¢ Increase the access to health services and products within communities to improve population health and reduce the likelihood of an outbreak â¢ Communicate important public health concepts in a culturally appropriate fashion â¢ Reduce the burden felt by formal healthcare systems and improve the quality of clinical care,16.14554657446618,7.520588008240326
"Therapeutic use of nitazoxanide (15 mg/kg, bid, PO, 10 days) did not improve the clinical appearance",0.15618458851757724,1.8035621643066406,1.4640504121780396,d0ddd90d-dc7f-4445-b46b-110a5bd7ac74,comm_use_subset/R E V I E W Open Access Advances in prevention and therapy of neonatal dairy calf diarrhoea: a systematical review with emphasis on colostrum management and fluid therapy,"Routine use of AB in diarrhoeic calves cannot be recommended due to increased levels of antibiotic resistance. However, systemically ill calves (depression, anorexia, fever) often suffer from E. coli septicaemia and thus parenteral Gram-negative-spectrum AB are advised to treat these calves. Antimicrobial susceptibility testing methods should be performed on the herd level at a regular basis [99, 100] . As mentioned, halofuginone lactate is the only registered product for prevention and treatment of C. parvum in Europe. In 2009 a meta-analysis for the effects of therapeutic halofuginone treatment was conducted [21] . Their results were considered as uninterpretable because of a lack of sufficient data. Azithromycin (1,500 mg/ d, 7 days, per oral (PO) and lasalocid (8 mg/kg, sid, 3 days, PO) reduce oocyst shedding [101, 102] . Therapeutic use of nitazoxanide (15 mg/kg, bid, PO, 10 days) did not improve the clinical appearance, nor the intensity of oocyst excretion [103] . In contrast, calves of the therapeutic group showed a longer diarrhoeic episode compared to the untreated control group. Antiviral drugs to treat rota-and coronavirus are not commercially available. Non-steroidal anti-inflammatory drugs (NSAID) like meloxicam (0.5 mg/kg, one-shot, SC) improve appetite and growth rate, probably because NCD is accompanied by malaise and gastrointestinal discomfort [39] . Despite their widespread use, there is no valid recent research available to recommend products reducing intestinal motility (e.g. hyoscine N-butylbromide).",15.362094271883715,7.500681169874342
electronic tendering processes,0.23107748912171083,2.04634690284729,2.838397979736328,0720a6a4-c3c0-425d-b409-00d6aa530648,"comm_use_subset/Vaccines, inspiring innovation in health q","I. Lewis gave an update on UNICEF's barcoding project. Countries' and manufacturers' awareness of CTC has been promoted, and CTC is now a tender-evaluation criterion from 2017. Additional projects support waste and carbon footprint reduction for safe injection equipment. The next tender round will require industry reporting on ''green-manufacturing"", implementation of weight, volume and local production criteria, and introduction of electronic tendering processes. A vaccine arrival report application has been tested and will be launched globally in 2018.",12.147408463644176,7.426677135954813
microbial diagnosis in clinical practice,0.13599329152153922,0.3900081515312195,1.5684267282485962,9fb78e97-5637-428a-80ba-b0bf0ac6bf87,comm_use_subset/A fatal case associated with respiratory syncytial virus infection in a young child,Combining NGS with metagenomic analysis provides an important clinical tool to identify unexpected or novel pathogens in patients. The advantage of this methodology is maximized when the causative pathogen presents a low-level signal compared to all other signals representing environmental and commensal pathogens. Improving the optimization and implementation of protocols suitable for clinical samples will no doubt improve microbial diagnosis in clinical practice.,17.20089817695301,7.2932970337904335
virological outcome.,0.4412892694392818,1.4933319091796875,3.0737342834472656,c51e0a52-41d7-4c61-b789-f85dc588ef2a,comm_use_subset/Elevated dietary zinc oxide levels do not have a substantial effect on porcine reproductive and respiratory syndrome virus (PPRSV) vaccination and infection,"Background: Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important infectious agents for the swine industry worldwide. Zinc (Zn) salts, which are widely used as a dietary supplement in swine nutrition, have shown antiviral effects in vitro as well as in vivo. The purpose of this study was to determine the influence of dietary zinc oxide supplementation on vaccination and challenge infection with PRRSV. Findings: The clinical course of PRRS and the success of vaccination with an experimental inactivated vaccine were compared between animals receiving a conventional diet (50 ppm Zn, control group) and diets supplemented with Zn oxide (ZnO) at final Zn concentrations of 150 or 2,500 ppm. Pigs receiving higher dietary Zn levels showed a tendency towards higher neutralizing antibody levels after infection, while dietary Zn levels did not substantially influence the number of antiviral IFN-gamma secreting cells (IFN-gamma-SC) or percentages of blood immune cell subsets after infection. Finally, feeding higher dietary Zn levels reduced neither clinical symptoms nor viral loads. Conclusions: Our results suggest that higher levels of dietary ZnO do not have the potential to stimulate or modulate systemic immune responses after vaccination and heterologous PRRSV infection to an extent that could improve the clinical and virological outcome.",12.290883206027402,7.27040214731711
"Increased efforts to improve PCP familiarity with the plan, and improve PPE preparedness, are needed.",0.16156479453874076,1.7757766246795654,2.5434250831604004,a8c23e6b-6e2c-4847-aa17-6c2841804f5f,comm_use_subset/Insufficient preparedness of primary care practices for pandemic influenza and the effect of a preparedness plan in Japan: a prefecture-wide cross-sectional study,"The threat of pandemic influenza is persistent, and PCPs, which will be at the front line of any responses to pandemic influenza, need to properly prepare for pandemic influenza. This research provides information about pandemic preparedness and response of PCPs in Okinawa Prefecture, Japan. We assessed whether the institutional setting is associated with preparedness. PCPs, especially clinic-based PCPs, were inadequately prepared with regard to PPE. Results from this study suggest that pandemic preparedness plan awareness is likely to promote the implementation of BCPs by PCPs. Increased efforts to improve PCP familiarity with the plan, and improve PPE preparedness, are needed.",11.88090394113516,6.9657974894932835
developing multivalent binders with high affinities,0.12989887358047086,0.5851693153381348,2.4464592933654785,0eac3c13-ff5a-4562-9143-c81767846953,comm_use_subset/Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding,"The antibody derived peptide PeB and its mutant variant PeB GF are promising hemagglutinin binding peptides, which both could have potential for application in viral diagnostics and therapeutics. Infection inhibition could be achieved at micromolar concentrations. Strategies to improve the peptide structure and to apply the peptides for developing multivalent binders with high affinities are discussed.",12.844935096726765,6.466285879511716
exemplary policy implementation strategies,0.23315006933359933,1.7012081146240234,1.3958998918533325,a7467021-c72c-42a2-87f8-9618deb3da65,"comm_use_subset/antibiotics Combating Antimicrobial Resistance in Singapore: A Qualitative Study Exploring the Policy Context, Challenges, Facilitators, and Proposed Strategies","Many participants proposed the idea that Singapore can serve as a research hub owing to its unique positioning and research capacity. Sharing innovative findings both on science, clinical practice and exemplary policy implementation strategies could prove helpful to neighboring countries that share some contextual factors with Singapore.",11.165098660889093,5.920904735521464
improve progress toward global OM prevention,0.1159243012217344,0.027915308251976967,1.734218955039978,6b09bba6-2008-4b95-8df7-5921a4f93119,comm_use_subset/Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review,"Otitis media (OM) is amongst the most common childhood diseases and is associated with multiple microbial pathogens within the middle ear. Global and temporal monitoring of predominant bacterial pathogens is important to inform new treatment strategies, vaccine development and to monitor the impact of vaccine implementation to improve progress toward global OM prevention.",12.339293649225707,5.464140048368768
detection and separation of target bio-particles,0.3715480529962809,3.606731414794922,5.3596601486206055,d3f62dae-1073-4afd-b19a-44d927f0e511,comm_use_subset/Dielectrophoresis for Biomedical Sciences Applications: A Review,"In addition to all the advantages of DEP techniques discussed earlier in each application, DEP techniques assist and improve the clinical sample sensitivity in detection and separation of target bio-particles [189, 190] . Currently, the normal standard of dengue infection detection is by using protein expression of antibody and antigen such as ELISA, Haemaaggluitination Inhibition (HAI) and reverse transcriptase-polymerase chain reaction (RT-PCR) techniques [191] [192] [193] [194] [195] . However, recently the DEP techniques have shown to be promising diagnostic tools by manipulating the dielectric properties of the cell cytopathic effect in infection [18, 196] . Conversely, the DEP techniques also provide a great advantages by preserving the correlation of specificity and sensitivity forcing the compromise of high-throughput and highly specific isolation of bio particles label free applications with minimal sample preparations [197] . The high specific and specificity identification of target bio-particles from complex biological fluid such as blood [198] and urine [199] can be used as a solid proof that DEP methods have broad potential as powerful diagnostic tools.",11.8116832996397,9.962243671093987
earlier administration and longer duration of azithromycin is beneficial to improve the clinical and microbiological outcomes of acute bronchiolitis,0.14276807648974474,2.925691604614258,2.8682334423065186,fb14ed08-3c7f-4e49-8e1c-a11d026805c7,"comm_use_subset/A Single Dose of Azithromycin Does Not Improve Clinical Outcomes of Children Hospitalised with Bronchiolitis: A Randomised, Placebo-Controlled Trial","In children hospitalised with moderate to severe bronchiolitis and requiring supplemental O 2 , we found that a large single dose of azithromycin (compared to placebo) did not have any clinical benefit to reduce LOS, duration of O 2 requirement or readmission rates within 6 months of hospital discharge. Azithromycin reduced the proportion of bacterial carriage, but had no significant effect on reducing proportion of viruses. Further research is required to determine whether earlier administration and longer duration of azithromycin is beneficial to improve the clinical and microbiological outcomes of acute bronchiolitis, associated co-morbidities and prevent ongoing respiratory morbidity in this population.",17.4605060806515,9.877228408726529
To improve the clinical management and limit the complications associated with NEC,0.2526336856221222,1.9532771110534668,3.377246379852295,961779cf-a9e3-45bd-a094-e597aaa710f1,comm_use_subset/Update in Pathogenesis and Prospective in Treatment of Necrotizing Enterocolitis,"A better understanding of the early mechanisms at the basis of NEC development will offer new and innovative therapeutic approaches to this severe condition. To improve the clinical management and limit the complications associated with NEC, future studies should start from the central role of the epithelium, innate immunity, and microbiota. It would be essential to explore the interaction between these main pathogenetic factors in order to hypothesize new efficacious therapeutic strategies. Further well-designed trials in selected populations are advocated to verify the efficacy of the new pharmacological and nutritional approaches hypothesized in this review.",17.37646703916306,9.546603732795816
"For pneumonia patients with comorbidities, ceftobiprole with the strong bactericidal effect can quickly improve clinical symptoms",0.1760471610996305,2.834657907485962,3.1376733779907227,af47bcaa-d70c-4575-af43-36df7f74176b,comm_use_subset/Pharmacotherapy of Lower Respiratory Tract Infections in Elderly-Focused on Antibiotics,"(1) Novel mechanism of action: ceftobiprole with a strong affinity for the PBPs, is responsible for the antibacterial activity of staphylococci and pneumococci (Falco et al., 2018) . For pneumonia patients with comorbidities, ceftobiprole with the strong bactericidal effect can quickly improve clinical symptoms and ensure a better prognosis. (2) Frequency of interactions: ceftobiprole elimination is not expected to be significantly affected, as this is a minor elimination route, but dose adjustment is necessary for subjects with the renal impairment (Pfaller et al., 2019) . (3) Side effects: for comorbid patients older than 75 years old, the incidence of adverse events caused by ceftobiprole is similar to that of non-high-risk patients, suggesting that ceftobiprole is safe and effective for high-risk groups. In addition, ceftobiprole is less likely to cause an antibiotic-related intestinal flora disorder (Horn et al., 2017) .",13.926742073946894,8.756375061441258
Development of a specific anti-EV71 drug may improve the clinical outcomes in infected patients.,0.2919720625283724,3.35840106010437,4.116580963134766,6b74c2c9-50e7-47e7-975f-f3a2059d8c41,comm_use_subset/Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo OPEN,"Enterovirus 71 (EV71) is a non-enveloped, positive-sense single stranded RNA virus belonging to the family Picornaviridae, and is one of the major pathogens that causes hand, foot and mouth disease in young children, especially those under 5 years old 1 . EV71 transmits from person to person by direct contact saliva, nasal mucus, stool and blister of infected patients 2-4 . Most of EV71 infections are mild and self-limiting. These infected individuals have slight fever, herpangina, and rash on the mouth, hand and body. Some severe cases may progress to Published: xx xx xxxx OPEN www.nature.com/scientificreports/ 2 Scientific RepoRts | 7: 935 | develop aseptic meningitis, encephalitis, and polio-like symptoms. The central nervous system (CNS) infections can result in pulmonary edema, pulmonary hemorrhage and lung collapse 5-8 , which may be fatal to patients. The survivors of severe EV71 infections may have irreversible neural sequelae 9 . Three large outbreaks of EV71 have been recorded in recent decades. In 1998, 129,106 individuals were infected, and 78 fatal cases were reported in Taiwan 1 . EV71 caused 126 deaths in 2008 and 567 victims in 2012 in China 10, 11 . No antiviral drug is available for treating EV71 infection. Development of a specific anti-EV71 drug may improve the clinical outcomes in infected patients.",10.68303247541136,8.597799681499414
to change healthcare workers' behavior and improve hand hygiene compliance,0.32688273661116884,2.31846022605896,3.4327094554901123,7fed0968-567b-4909-ac65-bb4dc9d29bce,comm_use_subset/Impact of a hospital-wide hand hygiene promotion strategy on healthcare-associated infections,"The WHO Multimodal Hand Hygiene Improvement Strategy comprising a Guide to Implementation and a range of tools constructed to facilitate implementation of each component was used in a 1600-bedded acute tertiary care general hospital in Singapore [1] . The objective is to change healthcare workers' behavior and improve hand hygiene compliance. During the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003, a high compliance of close to 90% in healthcare workers to hand hygiene was achieved. However, this was primarily driven by fear for transmission of pathogens to self. Following the closure of the SARS outbreak globally, we noted that the hand hygiene compliance decreased to that of the baseline before the SARS outbreak i.e. the high hand hygiene compliance was not sustainable.",12.278186425014034,8.035625541761808
"enhancing body weight gain, improve gut microbial balance, improve reproductive performance, and increase overall productivity",0.168046774720093,1.9354493618011475,3.0832481384277344,a276cd19-d551-42fa-85cc-e07b0612eb67,comm_use_subset/Benefits and Inputs From Lactic Acid Bacteria and Their Bacteriocins as Alternatives to Antibiotic Growth Promoters During Food-Animal Production,"In addition to the above listed positive effects attributed to LAB potentially utilizable as probiotics, we noted further beneficial effects on the health of various livestock animals and quality of animal products. These effects are animal-dependent and consist of enhancing body weight gain, improve gut microbial balance, improve reproductive performance, and increase overall productivity (Figure 2 ).",13.341840598378313,7.931797584581183
ARTIs,0.1278790309984721,2.1519463062286377,3.7153208255767822,003a0e43-9fbe-40de-9f84-86868b43c933,comm_use_subset/Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21 OPEN,"The roles of specific HRV genotypes in patients suffering from ARTIs have not been well established. We recruited 147 adult inpatients with community-acquired pneumonia (CAP) and 291 adult outpatients with upper ARTIs (URTIs). Respiratory pathogens were screened via PCR assays. HRV was detected in 42 patients, with 35 species A, five B and two C. Seventeen genotypes were identified, and HRV-A21 ranked the highest (9/42, 21.4%). The HRV-A21-positive infections were detected in four patients with CAP and in five with URTIs, all without co-infections. The HRV-A21 genome sequenced in this study contained 12 novel coding polymorphisms in viral protein (VP) 1, VP2 EF loop, VP3 knob and 3D regions. The infections of HRV-A21 virus obtained in this study could not be neutralized by antiserum of HRV-A21 prototype strain (VR-1131), indicating remarkable antigenic variation. Metagenomic analysis showed the HRV-A21 reads were dominant in bronchoalveolar lavage fluid of the three HRV-A21positive patients with severe CAP, in which two dead. Our results highlight an unexpected infection of genotype HRV-A21 in the clinic, indicating the necessity of precise genotyping and surveillance of HRVs to improve the clinical management of ARTIs.",11.289850580629473,7.765171338893838
The development of a large number of rational inhibitors that have the ability to modulate the activity of such receptors,0.16264638699570824,2.6810662746429443,2.7873687744140625,ecaa8c66-3d3b-4203-8af2-904e68d272bd,comm_use_subset/3D Structure Prediction of Human Î²1- Adrenergic Receptor via Threading-Based Homology Modeling for Implications in Structure-Based Drug Designing,"The role of Î²-ARs in cardiovascular function and disease is also highlighted by the significant roles of drugs whose actions are based on binding to the Î²-ARs blockers (Î²-blockers). Î²blockers represent first line therapy for the management of chronic heart failure, hypertension, acute and post myocardial infarction patients, chronic stable angina, and unstable angina [11] . They are also commonly used to control the symptoms of atrial fibrillation and other arrhythmias [11] . There are no cardiovascular drugs that have a wider range of indications than Î²blockers, making them a critical drug class for the management of cardiovascular disease. The availability of uses for Î²-blockers also suggests that the activation of Î²-ARs, or the sympathetic nervous system (SNS), plays an essential function in most cardiovascular diseases. The fact that Î² 1 -AR selective antagonists are equivalent to non-selective blockers in essentially all situations provides additional evidence that Î² 1 -ARs are the more important Î²-receptors with respect to cardiovascular disease. The development of a large number of rational inhibitors that have the ability to modulate the activity of such receptors has been a major goal for the pharmaceutical industries to improve the clinical treatment of various disease including hypertension, heart failure and asthma [12] . However, finding specific drug against a particular Î²-ARs drug target is a slow and laborious process. Furthermore, the lack of 3D structure of hsADRB1 is an obstacle in the identification of specific drug like molecules.",11.61986668326008,7.621436121028083
microbial diagnosis in clinical practice,0.13076943245788974,0.18196161091327667,1.4356603622436523,4ed57bda-e5a9-4958-96be-4710f7a51bfe,comm_use_subset/Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21 OPEN,"Metagenomic analysis has been widely used for viral identification, sequencing, characterization, and origin tracing 23 . The implementation of such methodologies has greatly improved the identification of pathogens, especially for mutant strains and novel viruses. For example, deep sequencing data has been used as direct evidence to identify an H10N8 influenza virus infection in a single human case 24 . Optimization and implementation of the protocols suitable for clinical samples will no doubt improve the microbial diagnosis in clinical practice.",18.04558732133119,7.36740984501792
mRNA,0.17756702813869285,2.419290781021118,2.542144298553467,e56d83d9-f6dd-4c4d-ad28-ab02e61b47ac,comm_use_subset/A Comparison of Plasmid DNA and mRNA as Vaccine Technologies,"Just as DNA vaccines, after more than 25 years since the first publication of preclinical protective efficacy, are still a work in progress in improving potency and finding the right antigens and targets, there remain challenges for mRNA to become clinical products. For both DNA and mRNA vaccines (and monoclonal antibodies and bi-specific antibodies before them), a simple concept may have a challenging path to reality, and the technology may not be totally generic. mRNA may be even more complex than plasmid DNA because of the modifications (modified nucleosides) plus the formulations needed for stability, delivery, and the need to control the innate immunostimulatory activity of the mRNA. However, it also offers advantages in terms of manufacture that avoids the need for any animal or cellular products. The hope is that once the fundamental key challenges are solved for both plasmid DNA and mRNA, the clinical successes will come rapidly, although that has not occurred for moving from the veterinary licensed products for DNA vaccines into humans, demonstrating how much still needs to be understood, not just about the technologies but about the diseases that are being treated or prevented.",10.865213226683867,7.027757431062834
building tools to mine the GO database,0.1782285441547961,1.0750247240066528,2.116100788116455,dc18fd2d-7bb8-4bf9-85ec-1bfeda347c17,comm_use_subset/Integration of the Gene Ontology into an object-oriented architecture,"The Gene Ontology project is a collaborative effort that addresses the need for a controlled vocabulary that provides a consistent description of gene products in different databases [1] . The GO collaborators are developing three structured, controlled vocabularies that describe gene products, which have been classified into molecular function, biological process, and cellular component domains. GO terms are organized in structures called directed acyclic graphs (DAGs), which differ from hierarchies in that a 'child' (more specialized term) can have many 'parents' (less specialized terms). As part of these graphs, each component is given a GOid (unique identifier), and is associated with a GO definition. Collectively, these agreed upon terms are being developed to help explain various aspects of biology. When applied to a gene, that gene is annotated with a concise description of its molecular function, cellular location and associated biological processes. However, the GOC never intended to represent gene products or correlate ontological terms with these gene products [1] . To address this need, a Gene Ontology Annotation database [3] has been created to associate the GO terms with their gene product counterparts. With sustained effort, the descriptions of these gene products will ultimately be established. Still, much of the current bioinformatics work regarding GO has focused on constructing databases [4] [5] [6] [7] , applying it to other research areas [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , and building tools to mine the GO database. (For a description of some of these tools see [23] .)",10.748324987162011,5.836145328386724
reverse-engineering biological gene products as objects in an object-oriented system,0.19258617984388113,0.9394176006317139,2.0300703048706055,5086b6a4-0e06-42a5-be1d-6652c4232f23,comm_use_subset/Integration of the Gene Ontology into an object-oriented architecture,"Here, we have demonstrated that Gene Ontology terms can be integrated into an object-oriented model. Furthermore, the object-oriented technology and methodologies used for this integration should improve the usability of these terms, and increase the depth of information that they contain. This work also serves as a framework for reverse-engineering biological gene products as objects in an object-oriented system. Together, this should facilitate additional collaborations between biologists and computer scientists.",10.911094182118873,5.7490501023181135
new medicines and evaluate existing therapies,0.16660399769346798,-0.32592475414276123,1.8095113039016724,c879e935-0a8f-4935-a0ca-d936aca46c02,"comm_use_subset/Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise","This protracted period from concept to publication is further exacerbated by the slow and limited uptake of research findings into practice. Balas and Boren have estimated that it takes approximately 17 years from concept to evidence implementation for the 14% of evidence that progresses to implementation [5] . A recent report from the President's Council of Advisors on Science and Technology (PCAST) estimated that 3,000 treatments are in development and concluded that major upgrades are needed in the research system to evaluate these treatments [6] . An Institute of Medicine report on clinical trials states that ""recognition is growing that the clinical trials enterprise in the United States faces substantial challenges impeding the efficient and effective conduct of clinical research to support the development of new medicines and evaluate existing therapies [7] ."" Clearly, our current research enterprise is too slow, inefficient, and cumbersome to meet the rapidly evolving demand.",12.402778492686409,5.305303729783534
ARDS is a multifactorial disease with a heterogeneous pathogenesis and variable timing and clinical presentations,0.13613995936221868,1.148313283920288,1.0808759927749634,473d7e59-3edb-49ff-9e85-902234b6a7a8,comm_use_subset/Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy,"ARDS is a multifactorial disease with a heterogeneous pathogenesis and variable timing and clinical presentations. Therefore, one specific therapy is unlikely to improve outcomes. Rather than excluding single therapeutic options, identifying patients' risk factors and the individual ARDS stage may be more important for successful outcomes. We report here in our retrospective analysis that intravenous IgM administration in the initial stages of severe ARDS did not improve overall outcomes or the severity of disease. ",10.793261166397663,5.2266144380910955
"improve clinical case management, early detection and optimization of laboratory diagnosis",0.5414871312376953,4.101891040802002,5.297388076782227,d96e74e6-2490-4e77-af9d-26d9a431987e,comm_use_subset/Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance,"In summary, SHIVERS is expected to provide extensive data to guide improved methods for disease surveillance; improve clinical case management, early detection and optimization of laboratory diagnosis; inform vaccine strain selection and vaccine development; guide targeted vaccination strategies for population and subgroups; understand host immune responses and identify better immune diagnostic markers. Korrapadu, Louise Optland, Cecilia Dela Cruz. Special thanks to IT staff and SARI surveillance participants. Also, a special thanks to Dr Dean Erdman from Gastroenteritis and Respiratory Viruses Laboratory Branch, the U.S. Centers for Disease Control and Prevention who provided the real-time PCR assay for non-influenza respiratory viruses. Support in kind is provided by the NZ Ministry of Health.",14.828499345132286,11.299506197226048
Innovative treatments like virus-specific T cells,0.20122920905038372,2.4339821338653564,2.474149703979492,9332f328-2fbe-473b-8d81-5d41a4acc8a9,comm_use_subset/Spectrum of Viral Infections Among Primary Immunodeficient Children: Report From a National Registry,Viral infections in PIDs should be treated aggressively with appropriate antiviral medications and definitive treatments like HSCT when possible since failure to eradicate viral pathogens creates an inflammatory environment that promotes cell survival and proliferation and may predispose to malignancy (18) . Innovative treatments like virus-specific T cells should be explored to improve clinical outcomes for this group of patients (19) .,19.436770793757816,9.993155472414387
limiting their capacity to be scaled up for handling large numbers of samples,0.20054962376371194,2.537963390350342,2.979994297027588,94faa28e-9c9a-4f90-adc2-98281ac2fd94,comm_use_subset/Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system,"The ability to quickly confirm or clear suspected cases is crucial during global outbreak scenarios, especially when clinical manifestations are difficult to distinguish from other respiratory infections such as influenza, molecular diagnostics is key for detection of the emerging virus. A variety of suitable assays were made available early on during the course of the outbreak, notably by Corman et al. and others [4, 5] . However, their implementation in the diagnostics laboratory usually relies on manual PCR setups requiring a high degree of human interaction for execution and interpretation, thus limiting their capacity to be scaled up for handling large numbers of samples.",17.75135003944486,9.799645010601354
bioinformatics introduction will make standards and performance higher and improved.,0.34044115580963596,3.1453826427459717,3.316359043121338,18bbfc10-35bc-4deb-acf8-b2a06063fb2c,comm_use_subset/diagnostics Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy,"Personalised medicine, with the help of biosensors, lab-on-chip systems, individual genetics, smartphones monitoring parameters, and microfluidic devices, will improve the primary healthcare system. Moreover, it allows clinicians to be accurate, to be more consistent, to capture clinical data quickly, provide patient satisfaction, and streamline workflow. Salivary diagnostics' impact on the healthcare system is enormous, being non-invasive, convenient, and well-credentialed, while bioinformatics introduction will make standards and performance higher and improved.",15.682839131088237,9.689125791694634
jeopardizes recognition of outbreaks with foodborne pathogens,0.20159486643176439,2.2517926692962646,3.3651084899902344,f8fe7e78-6867-4373-9068-f0f8e5f2808a,comm_use_subset/Investing in Public Health Microbiology Laboratories in Western Balkan Countries Enhances Health Security From Communicable Disease Threats in Europe,"Moreover, in a number of countries, business continuity is a problem for diagnostic services because of complex procurement processes or insufficient funding, and lack of appropriately trained staff. In particular, there is a lack of support for clinical and reference laboratories for enteric disease/diarrhea diagnostics, which jeopardizes recognition of outbreaks with foodborne pathogens.",17.034596836624402,9.613094646354766
"for advancing basic scientific understanding; and for evaluating the products of enhanced diagnostic, drug and vaccine development pipelines",0.21590617385591848,2.431978940963745,3.9746193885803223,4701c7e9-a892-4b2e-9052-4346a832cf97,comm_use_subset/Modernising epidemic science: enabling patient-centred research during epidemics,"Preparing ourselves adequately for these threats demands action on many fronts, including the strengthening of health systems, improved surveillance and response capabilities, and better pipelines for developing diagnostics, therapeutics and vaccines. 'Patient-centred' research needs to be included as one key pillar of an enhanced outbreak investigation, response and control system. Patients are the primary source of much of the information (e.g. clinical presentation and outcomes) and materials (e.g. pathogens and antibodies) that is vital for both clinical and public health decision-making; for advancing basic scientific understanding; and for evaluating the products of enhanced diagnostic, drug and vaccine development pipelines. We argue that our thinking should therefore converge on the patient and we should address the needs of all disciplines within a strengthened and unified framework.",13.785116045179556,8.98907953001649
EUCAST clinical breakpoints for standardized antimicrobial susceptibility testing,0.31448120031183086,1.9670770168304443,3.325570583343506,41fdb0cc-5b43-4af6-8b32-e5d287d16ea6,comm_use_subset/Investing in Public Health Microbiology Laboratories in Western Balkan Countries Enhances Health Security From Communicable Disease Threats in Europe,"The evaluation (performed in 2014) of the pilot initiative and implementation of related country action plans in six Western Balkan countries suggested that establishing the Observer role to NMFP facilitated national efforts to improve antimicrobial resistance surveillance. A majority of countries reported that being part of the ECDC microbiology expert network helped them to prepare for implementation of EUCAST clinical breakpoints for standardized antimicrobial susceptibility testing and to become familiar with EU-level standards as per the EU protocol for harmonized monitoring of antimicrobial resistance in human Salmonella and Campylobacter isolates to enable One Health collaboration between colleagues from the human health and veterinary medicine sector (4). This observer role to the network also facilitated participation in WHO/Europe coordinated Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) network (5) , and assisted in the establishment of inter-sectorial committees on antimicrobial resistance at the national level.",14.692713376038597,8.582670621726576
coinfections,0.22642865985070396,2.9501781463623047,3.151022434234619,2cb8fa6b-c0bd-4b3b-8764-078d5d9407f0,comm_use_subset/Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness,"Limitations of our study include the retrospective design and the institutional differences in pertussis diagnostics, diagnostics for coinfections, and registration of clinical and laboratory disease characteristics. The 50% participation rate of hospitals might have influenced our results, but participating hospitals were spread over the country and showed a good representation of tertiary, top clinical, and local hospitals in the Netherlands. Results might have been influenced by the incomplete reporting of hospital diagnoses at discharge, assessed in a recent capture-recapture analysis [8] . We could not stratify this underreporting by GA, but the good representation of tertiary, top clinical, and local hospitals in our study probably led to inclusion of a representative variety in the spectrum of pertussis disease. This conclusion is underlined by our finding that preterms are overrepresented, as found by other studies.",13.068447148091215,8.539736879219927
Early diagnosis is likely to improve clinical outcomes 18 and reduce the economic and physical burden of a disease,0.23170308401243317,1.7744991779327393,2.699324607849121,71f07611-c6f2-4f42-abee-3f04c03e6d82,comm_use_subset/Factors associated with recovery delay in a sample of patients diagnosed by MERS-CoV rRT-PCR: A Saudi Arabian multicenter retrospective study,"The time interval from presentation to initial rRT-PCR diagnosis (diagnosis delay) was positively correlated with the time interval from initial rRT-PCR diagnosis to recovery (recovery delay). Early diagnosis is likely to improve clinical outcomes 18 and reduce the economic and physical burden of a disease. 25, 26 Early diagnosis requires full utilization of hospital resources. Individuals at high risk of MERS-CoV infection should be promptly screened after arrival at the healthcare facility, monitored for progression, and then having a prompt decision made for whether further rRT-PCR testing is needed.",15.935918325884925,8.485556874817933
reduce hospital stays by replacing it with chairside screening,0.16090521866594037,1.6899807453155518,2.9733381271362305,24312806-4564-40ea-8087-6705429bf0f2,comm_use_subset/diagnostics Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy,"Salivary diagnostics is an emerging field for the encroachment of point of care technology (PoCT). The necessity of the development of point-of-care (PoC) technology, the potential of saliva, identification and validation of biomarkers through salivary diagnostic toolboxes, and a broad overview of emerging technologies is discussed in this review. Furthermore, novel advanced techniques incorporated in devices for the early detection and diagnosis of several oral and systemic diseases in a non-invasive, easily-monitored, less time consuming, and in a personalised way is explicated. The latest technology detection systems and clinical utilities of saliva as a liquid biopsy, electric field-induced release and measurement (EFIRM), biosensors, smartphone technology, microfluidics, paper-based technology, and how their futuristic perspectives can improve salivary diagnostics and reduce hospital stays by replacing it with chairside screening is also highlighted.",14.08511257311571,7.960946667684157
RDT introduction and implementation must be culturally sensitive and accompanied by an inter-connected system to monitor the necessary processes,0.20674886710068513,0.8292844891548157,1.1884936094284058,f0b9b98e-5ec2-4623-8081-3c2cc47954db,comm_use_subset/Re-imagining the future of diagnosis of Neglected Tropical Diseases,"The barriers faced in implementing testing at the point-of-care are often not technological, but constraints inherent in the health care system. To implement a successful POC diagnostics programme, the engagement of policy makers, stakeholders and partners to ensure buy-in and align necessary resources is a critical first step. Training and certification of vast number of health care providers to use POC diagnostics, and ensuring an effective supply chain for tests and drugs across the country present an enormous challenge to health systems that are already suffering from a critical shortage of human resources. Quality assurance systems, that include providing proficiency testing, sites visits, and corrective action, are essential to ensure that accurate results are being used to guide treatment decisions, and to ensure that control strategies are based on accurate surveillance data. Studies have shown that deployment of POC diagnostics can be an opportunity to improve health outcomes and strengthen health systems [29] [30] [31] . Overcoming challenges will in turn motivate health care workers and increase capacity and efficiency to test and treat appropriately. RDT introduction and implementation must be culturally sensitive and accompanied by an inter-connected system to monitor the necessary processes. Another key barrier to the appropriate use of POC diagnostics is the need to train clinicians to create a demand for them and then use the test results to effectively manage the patients. Improving the laboratory-clinician interface is an important but often neglected aspect of testing introduction.",18.729877329672842,7.8670128294645885
The revised IHR outline specific minimum core public health capacities and implementation processes that nations need to adequately address acute public health threats,0.3154497701493472,1.205538034439087,2.5350308418273926,cbf3bfcc-5407-4032-9836-e10817b5f62a,comm_use_subset/Health Security Memos to the New Administration and Congress,"Following global missteps in controlling the spread of the SARS virus in 2003, the 2005 World Health Assembly adopted revisions to the International Health Regulations (IHR) with the aim of improving national and international efforts to detect and respond to events like SARS and other public health emergencies of international concern. The revised IHR outline specific minimum core public health capacities and implementation processes that nations need to adequately address acute public health threats. Although 194 states parties signed onto this legally binding treaty, progress toward implementation of the IHR has been very slow. The initial target for full IHR implementation was 2012; however, even by 2014, only 33% of nations indicated that they had successfully implemented these minimum requirements. 4 To jumpstart stalled progress toward implementation of the IHR, the Global Health Security Agenda (GHSA) was established in 2014 with the goal of increasing national government support for IHR implementation and fostering a multilateral and multisectoral approach to developing health security capacity. Currently consisting of more than 50 countries, and with support from intergovernmental organizations (IGOs) and nongovernmental organizations (NGOs), the GHSA provides support for nations to assess their existing health security capabilities, identify gaps, and formulate plans to fully implement the IHR to ensure domestic and international capacity to detect, prevent, and respond to health security threats. One of the driving principles of the GHSA is building interagency coordination at the national level, and particularly improving the links between health and security authorities, to facilitate information sharing and improve response to a wide range of biological events, including the deliberate use of dangerous pathogens.",15.026143432780284,7.69051997104631
ELISAs have been integrated with a micro/nano system to increase the surface/volume ratio and improve reaction kinetics,0.23491947708848587,1.170093059539795,2.716479778289795,c1ac00a8-dde0-4d75-bc5f-652929e51c40,comm_use_subset/A Compact Immunoassay Platform Based on a Multicapillary Glass Plate,"The development of simple, rapid immunoassay approaches is of tremendous importance for on-site diagnostics and for monitoring highly infectious diseases [1] . Infectious diseases, such as the avian influenza virus, severe acute respiratory syndrome (SARS), hand-foot-and-mouth disease, influenza H1N1 and H7N9 are all threats to human health/life and collectively cause losses to social/economic development [2, 3] . Therefore, developing methods for the rapid on-site assay of these diseases at an early stage is extremely important. The enzyme-linked immunosorbent assay (ELISA) is one of the most widely used approaches in clinical diagnostics, food safety testing, and environmental monitoring [4, 5] . The technique is usually carried out in a 96-well microtiter plate and involves a series of tedious processes, including sample introduction, incubation and washing. Moreover, substantial amounts of sample are consumed and the method is time-consuming and sometimes suffers from low sensitivity [6] . In order to overcome these drawbacks, various efforts have been devoted to developing new methods for diagnostic immunoassays. For example, ELISAs have been integrated with a micro/nano system to increase the surface/volume ratio and improve reaction kinetics [7] [8] [9] . A variety of materials, such as quantum dots [10] , photonic crystals [11] , membranes [12] or papers [13] , have also been used in conjunction with immunoassays.",14.492231066147085,7.598553217740713
Detection of respiratory viruses could enable estimation of the local epidemiology of respiratory viral infection and help pediatricians to improve their clinical judgments,0.14563039145541956,0.556682288646698,2.6460375785827637,f48c9c63-0933-4554-a762-cc7439ac1896,comm_use_subset/Increased Detection of Viruses in Children with Respiratory Tract Infection Using PCR,"A previous study conducted in Taiwan found that RSV was the most common pathogen (41.7%), followed by MPV (27.1%), Boca (6.3%), and EV (6.3%) [33] . Some important studies investigating the epidemiology of respiratory tract infection are summarized in Table 4 [4, 6, 13, 15, 23, 34, 35] . RSV is always the most common pathogen in young children worldwide, but the accompanying pathogens are not always the same [4, 5, 7, 13, 36, 37] . Virus detection was more common in summer and autumn in our study. Taiwan is located in a subtropical zone, where there are no swift changes in temperature amplitudes. Although RSV infections occur biennially, with peaks reported in the spring and autumn in Taiwan, variations in RSV infections are not particularly large [38] [39] [40] . Detection of respiratory viruses could enable estimation of the local epidemiology of respiratory viral infection and help pediatricians to improve their clinical judgments.",13.918190612691951,6.953134628141333
an age-specific contact network that allows to express individual differences relevant to the transmission processes,0.21197144534879628,0.8850002884864807,2.231806755065918,649b0b56-3677-45e6-8b7a-6fa772fb23f3,comm_use_subset/High-resolution epidemic simulation using within-host infection and contact data,"Background: Recent epidemics have entailed global discussions on revamping epidemic control and prevention approaches. A general consensus is that all sources of data should be embraced to improve epidemic preparedness. As a disease transmission is inherently governed by individual-level responses, pathogen dynamics within infected hosts posit high potentials to inform population-level phenomena. We propose a multiscale approach showing that individual dynamics were able to reproduce population-level observations. Methods: Using experimental data, we formulated mathematical models of pathogen infection dynamics from which we simulated mechanistically its transmission parameters. The models were then embedded in our implementation of an age-specific contact network that allows to express individual differences relevant to the transmission processes. This approach is illustrated with an example of Ebola virus (EBOV).",13.90962492232519,6.894293301122875
increased monitoring and early applied organ support,0.24114843054728835,3.4693384170532227,3.4928715229034424,cc8b6ac9-d1d4-4a42-9bbf-e1ca648317ef,comm_use_subset/Characteristics of fever and response to antipyretic therapy in military personnel with adenovirus-positive community- acquired pneumonia,"If Adv infection can be diagnosed early, increased monitoring and early applied organ support may improve the clinical outcome of these patients. However, sufficient data on the distinctive characteristics of Adv infections in immunocompetent patients is currently unavailable. We previously observed that adenoviruspositive community-acquired pneumonia (CAP) patients have a high fever and respond differently to antipyretic treatment compared to CAP patients who test positive for other viruses or bacteria. Therefore, the primary goal of this study was to compare the clinical characteristics of Adv-and Non-Adv-positive CAP patients among immunocompetent military personnel and to identify the distinctive characteristics.",17.403173619259082,10.61654722771251
"by adopting an aggressive diagnostic approach, that is, mechanical ventilation with a lung-protective strategy, and the early institution of immunosuppressive therapy",0.2918154074503019,2.4917728900909424,2.397158622741699,261eeb73-dfbb-44f3-a458-68fd169db184,comm_use_subset/Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders,"interstitial acute inflammation [28] . In the organizing phase of DAD (approximately 5-10 days after injury), alveolar septal thickening with loose organizing fibrosis, type II pneumocyte hyperplasia, and patchy or diffuse airspace organization can be found (Figure 1(c) ). The prognosis of AIP is dismal and the mortality high. It has been suggested that by adopting an aggressive diagnostic approach, that is, mechanical ventilation with a lung-protective strategy, and the early institution of immunosuppressive therapy it may be possible to improve the clinical outcome of AIP [29] [30] [31] .",17.72754039586852,9.3824446218952
border controls to prevent the crossing of infected products,0.2613743160089794,2.327228546142578,4.0154194831848145,075c801d-24d5-4156-9a78-88f0f0fd7273,comm_use_subset/Transboundary spread of pig diseases: the role of international trade and travel,"The main hazards associated with trade in pork and pork products are the viral agents of FMD, CSF, ASF and swine vesicular disease (SVD) [41] . Pathogens like Table 1 Main introduction and exposure pathways for transboundary swine diseases into free areas ASFV are particularly problematic due to their prolonged infectiousness in meat products [1] . This is exemplified by the repeated detection of ASF viral DNA within pork products imported into the Russian Federation from Belarus. Each time, the meat has been effectively traced back to a number of meat processing plants in Belarus [100] . Although the presence of ASF in Belarus prevents the exporting of pigs or pork products to most countries, the fact that both countries belong to the Eurasian Economic Union (EEU), hinders the implementation of border controls to prevent the crossing of infected products.",13.254965805411437,8.761959250956808
The availability of products with no risk of pathogen transmission may improve patient compliance,0.2010186778866163,2.8552327156066895,3.2539968490600586,bc7550cf-6b1f-412c-9801-9639bd45cfdd,comm_use_subset/Biotechnology Journal,"Another important factor to consider is that the fear of exposure to potential pathogens in serumcontaining therapeutics may cause some patients to forgo prescribed treatment. The availability of products with no risk of pathogen transmission may improve patient compliance, leading to better treatment outcomes and improved quality of life.",12.032800011126511,8.182479220927664
Allocating research efforts to evaluating the implementation processes of interventions is an important step in improving the control of emerging and re-emerging diseases,0.17419862101915928,1.0615538358688354,2.2290196418762207,c990e52b-21b4-428a-82c5-8743bac5ad27,comm_use_subset/Containment measures for emerging and re-emerging vector-borne and other infectious diseases of poverty in urban settings: a scoping review,"The results of this review demonstrate that there is an important lack of good quality evidence to guide infectious disease containment measures. The majority of interventions included this review were complex, which was further complicated by the setting or context where the intervention was implemented. There are actions that should be taken to improve the quality of the evidence and to account for the context through comprehensive and standard reporting. Allocating research efforts to evaluating the implementation processes of interventions is an important step in improving the control of emerging and re-emerging diseases. ",16.54398382739125,7.9292671001212245
A systematic collection of human lung tissue and cell material would significantly improve the clinical-radiological-histopathological interpretation,0.24496374872676982,2.518483877182007,3.281993865966797,4c546f70-fd8c-4f21-9f2a-340242ad17a7,comm_use_subset/Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders,"It is evident that interstitial lung diseases represent a very heterogenous group of lung diseases, including lung diseases with known reasons such as allergic alveolitis, connective tissue diseases associated with lung diseases and infectious lung disorders and in all of these the acute reaction within the lung may be similar, namely, DAD. This reaction can be postulated as representing one of the fundamental injurious responses of the lung. However, the pathogenetic mechanisms underlying DAD are still mostly unknown, especially in humans. Most experimental studies have been conducted with animals exposed to toxins, lipopolysaccharide, and so forth, and these reactions cannot be directly extrapolated to human lung since lung reactions occurring in mice and rats do not resemble exactly those encountered in human lung. Another limitation for studying DAD in human lung is the rarity of those diseases. It is very difficult, virtually impossible, to gather large numbers of patients/samples of DADassociated lung diseases during their acute exacerbations without international collaboration involving several specialities. It can be argued that the study of DAD-associated lung diseases is even more difficult than that of IIPs or other types of relatively rare lung diseases, because DAD is confined to unpredictable periods of various diseases. A systematic collection of human lung tissue and cell material would significantly improve the clinical-radiological-histopathological interpretation especially if combined with experimental in vitro studies in cells established from human lung.",11.56514450456853,7.818111109645708
improve the ability of public health practitioners to conduct informed interventions,0.19607708571899873,1.6412808895111084,3.355538845062256,68867708-9a5a-464e-af6f-3fb2c1245383,comm_use_subset/Containment measures for emerging and re-emerging vector-borne and other infectious diseases of poverty in urban settings: a scoping review,"Lastly, both researchers and public health practitioners would benefit from more theory-informed approaches for disease control [54, 55] . Studies based on mathematical models and implementation theories would help to define factors mediating the speed and effectiveness of containment measures and would improve the ability of public health practitioners to conduct informed interventions. Similarly, evidence-based lessons and recommendations are needed to enable the development of more useful policies and guidelines.",11.848860974780234,7.395034168645768
provide a better account of complex phenomena,0.19059618623541255,0.8445541262626648,2.087120532989502,83bcd1ae-d115-479c-960c-10983f0d0372,comm_use_subset/Containment measures for emerging and re-emerging vector-borne and other infectious diseases of poverty in urban settings: a scoping review,"Multifactorial issues associated with conducting research in real-world settings, such as context-specific issues related to the implementation of the research project also inhibited the ability to evaluate the effectiveness of interventions. Real-world scenarios and settings present the challenge of adapting theoretical (and idealistic) strategies to practical (and sometimes far from ideal) scenarios [52] , which usually interfere with the development, success, and therefore evaluation of intervention studies. Checklists such as the TIDieR and ASTAIRE can be used to document information regarding the description, implementation processes, and transferability of those interventions [16, 18] . For the studies included in this review, the quantity and the quality of information on the interventions' implementation processes, as well as on intervention modifications and intervention fidelity, were insufficiently described. This lack of information is problematic considering the importance of gathering information on the implementation process of real-world interventions to provide a better account of complex phenomena [51] . As a result, the complexity of the context in which the interventions took place could not be assessed in most cases, thus drastically reducing the transferability of the interventions.",15.255809771036423,7.2451219483766565
standardised protocols,0.3558524779972637,1.820349097251892,2.4166207313537598,2fa6bb75-8391-4a3d-96ca-1763ce31396d,comm_use_subset/Correspondence to: An evidence-based framework for priority clinical research questions for COVID-19,"Based on a systematic review of other severe coronaviruses, we summarise the state of clinical research for COVID-19, highlight the research gaps, and provide recommendations for the implementation of standardised protocols. Databased on internationally standardised protocols will inform clinical practice real-time.",12.231199941096005,7.034950367977276
The principle of national self-sufficiency in blood supply and plasma products has been considered an important way of maximising blood safety,0.1363155727537987,1.5169775485992432,2.1920011043548584,dfda1c29-6693-4a0e-850d-74dade0002fe,comm_use_subset/Risky Bodies in the Plasma Bioeconomy: A Feminist Analysis,"The principle of national self-sufficiency in blood supply and plasma products has been considered an important way of maximising blood safety but, as this plasma manufacturer explained, manufacturing processes have advanced and plasma products are: 'Very safe. Very safe. In terms of viral transmission . . . [and] in terms of infectivity the products are very, very safe' (Int. 27, Plasma manufacturer). He described how the US donor management programmes enhance the safety profile of sourced plasma within the global industry. With respect to the prevention of transmission of the prion implicated in vCJD, his view was that: 'The technology for removing those is only just being developed' and would need to be suitable for use in largescale manufacturing processes. Therefore, governing risk in blood services and the plasma industry poses technical challenges but also raises ethical and political concerns. The commonly expressed view above (typical in Europe) is that paying donors increases the potential threats to blood safety and is unethical. Moral issues are deeply entwined with constructions of risk and safety.",12.821951923477553,6.898519297637309
SARS-CoV-2 diagnostics does not replace nor exclude diagnostic capacity for other respiratory viruses,0.18467974228074824,1.187895655632019,1.7832173109054565,7a21c033-92c9-4469-b882-3381471df1d1,comm_use_subset/Authors' response: Plenty of coronaviruses but no SARS-CoV-2,"While the current response strategy is still focused on containment, it is becoming increasingly clear that the epidemic may turn global, in which case mitigation will be the next option to control the impact of the pandemic. Substantial autochthonous circulation in Italy, Iran and South Korea has been reported by now, while there is increasing evidence that subclinical infections occur and people may be infectious before symptoms appear [8] [9] [10] . These developments indicate that the window of opportunity to contain and eradicate is rapidly narrowing. [11] . Therefore, it is needless to state that for each phase in the control and mitigation of a novel emerging pathogen, adequate laboratory preparedness and response are crucial. The readiness survey that we performed served the important purpose of mapping the initial response capacities in Europe and identifying barriers to diagnostic implementation. Therefore, we maintain that the urgent implementation and monitoring of diagnostic capacities and capabilities for SARS-CoV-2 in Europe is proportional to the containment and expected mitigation phase of the global public health response and is critical for care of local patients. The implementation of SARS-CoV-2 diagnostics does not replace nor exclude diagnostic capacity for other respiratory viruses. Moreover, it explicitly does not disregard the importance of other seasonal respiratory pathogens for public and patient health. This is clearly illustrated by the authors themselves, who indicate that they have tested thousands of samples of patients suspected of respiratory viral disease not only for common respiratory pathogens but also for SARS-CoV-2. The fact that Colson et al. found a wide range of seasonal respiratory viruses indeed underlines the impact of such pathogens. Furthermore, it clearly shows that diagnosis of respiratory viruses cannot be done syndrome-based and supports the need for the availability of diagnostics for a panel of pathogens including SARS-CoV-2.",13.386541816717038,6.616513064100323
global health is taught in medical schools in the North,0.12908817585497523,1.0721567869186401,1.2247388362884521,adf4928e-f10d-4fa4-a744-1bd967140733,comm_use_subset/Protecting health workers from infectious disease transmission: an exploration of a Canadian-South African partnership of partnerships,"The model we adopted can be characterized as a community of practice in which the members of the Northern partnership work directly not only with the stronger Southern partner but also with their local counterparts. In this model, the value of peer-to-peer interactions can be fostered not only at the micro and meso levels but also at the macro scale -essential for effectively addressing implementation challenges. The consciousness-raising that occurred through this partnership has already led to calls to improve the way global health is taught in medical schools in the North [72] . Johnson (2007) 's conceptualization of communities of practices as ""an action learning space [with] mutual engagement, shared enterprise and shared repertoire as dynamic processes subject to a range of social relations and differences between actors"" provides a useful perspective for considering how the partnership principle of ""joint learning"" that is put forward by the Tropic Health and Education Trust (THET) can be operationalized, especially recognizing the different scales that must be addressed for sustainability (another THET principle) [11] .",14.211558924268559,6.467027778578606
interventions as well as their comprehensive and systematic description using validated checklists,0.17008139054378651,0.9140455722808838,1.8300210237503052,a8164cc3-1d84-45cf-939e-e6a2dcfbe71a,comm_use_subset/Containment measures for emerging and re-emerging vector-borne and other infectious diseases of poverty in urban settings: a scoping review,Conclusions: Our results highlight the difficulty of establishing causation when assessing the effect of containment measures. Studies that extend beyond solely reporting on effectiveness and take into account the complexity of real-world settings are urgently needed. We recommend the allocation of research efforts to the evaluation of the implementation processes of interventions as well as their comprehensive and systematic description using validated checklists.,12.361831505991038,6.110284314517136
multidisciplinary emergency preparedness and response teams in each district,0.2302068902784342,0.8206725716590881,1.4693446159362793,5357ea9d-f4aa-4ad6-96c5-8a39b91629bb,comm_use_subset/Revitalization of integrated disease surveillance and response in Sierra Leone post Ebola virus disease outbreak,"Rapid response teams, comprising of health officials from the district health office, and WHO officials were formed in each district, to investigate and respond to suspected outbreaks. To improve emergency preparedness and response a national emergency preparedness plan was developed. Implementation of this plan resulted in the formation of multidisciplinary emergency preparedness and response teams in each district.",12.913506476426269,6.008238438686183
The ability of WGS to improve the sensitivity and specificity of such challenging outbreak investigations,0.1242648198368313,0.5983155369758606,0.6344502568244934,95f5b2ec-fb4c-472b-96b1-d40d67ce9338,comm_use_subset/Moving pathogen genomics out of the lab and into the clinic: what will it take?,"The ability of WGS to improve the sensitivity and specificity of such challenging outbreak investigations is acting as a strong driver for the implementation of WGS services by public-health authorities worldwide. Notably, the Global Microbial Identifier project (http:// www.globalmicrobialidentifier.org/People), which was established to support the development of an international system of genomics-based infectious disease surveillance, has members from 42 nations.",12.699553591531139,5.246141523006129
This research will improve the clinical outcome,0.22064515581322425,2.143758535385132,3.433450222015381,5b1ba597-0da4-4bbe-bbd5-62965c25670f,"comm_use_subset/Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses","On the basis of laboratory-confirmed deaths and the number of survivors, we examined human HPAI and LPAI infections in terms of the overall population, pediatric and clustered cases, with the aim of identifying the high-risk factors that are associated with fatal outcomes. This research will improve the clinical outcome and will also be helpful in decreasing the disease burden for these novel avian influenza viruses.",21.371106843952482,11.105073087693702
to start treatment early to optimize the chance to improve the clinical course of a cold,0.24516720478434456,2.0961668491363525,4.194613456726074,5adad0c1-79b1-4a41-bfc5-b5cb884d0632,comm_use_subset/Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial,"Inclusion criteria constructed similarly to the previous 3 clinical trials conducted with I-C. Patients with high symptom scores (â¥9) were excluded in order to recruit only patients in the early stages of a cold and exclude subjects with later infections. This strategy was designed to start treatment early to optimize the chance to improve the clinical course of a cold. This early intervention strategy may have been partially responsible for lowering the power of the study, since the proportion of patients in the trial who did not develop full-blown colds was relatively high (reflected by only about 24 % rhinovirus-positive patients; see Results and Discussion).",19.30151011596309,10.844535739397658
establishing partnerships and collaboration with potential product development partners,0.2705360943984714,3.4117910861968994,4.510207176208496,fc599161-c835-43fe-8851-4c1a7c1842ee,comm_use_subset/Leitthema Developing vaccines against epidemic-prone emerging infectious diseases,"CEPI has limited funding for diagnostics-related activities; therefore, the diagnostic work is mainly accomplished through establishing partnerships and collaboration with potential product development partners. The Foundation for Innovative New Diagnostics (FIND) and CEPI have developed a partnership framework called CEPI.dx to address diagnostic needs for priority pathogens, and CEPI recently funded FIND with a total of US$1 million to support the evaluation of serological assays (IgG, IgM ELISA), clinical trial site development, and laboratory capacity strengthening in Lassa-affected countries. CEPI has also actively supported FIND's application for the mobilization of a total of â¬4.2 million from the Federal Ministry for Education and Research (BMBF) of the German government. This funding has been used to support clinical evaluation of the Altona RealStar Lassa Virus RT-PCR Kit 2.0 (Altona Diagnostics, Hamburg, Germany), strengthening outbreak surveillance, research capacity, and activities related to biobanking in Lassa-affected countries.",12.814051398906257,9.634216860180697
redesign the routine diagnostic assays,0.20891913718877306,1.8587524890899658,3.7425804138183594,5cddcf50-79eb-48d3-a6a3-e29e6f9c9fc0,comm_use_subset/Identification and characterization of unrecognized viruses in stool samples of non-polio acute flaccid paralysis children by simplified VIDISCA,"Our data support that VIDISCA may be of great utility for the identification of viruses that escaped conventional diagnostics. Furthermore, avoiding the cost, time, labor and use of specialized equipments made it an efficient and powerful diagnostic tool for resource poor countries. Finally, our findings also provide confidence to improve and redesign the routine diagnostic assays which might lead to additional detection of previously undiagnosed viruses in clinical samples of patients.",15.722358914211966,9.1436920068646
policy implementation,0.1996835579799357,2.0514955520629883,2.7841947078704834,94711328-e565-425f-9da9-672fe9f1d316,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"Participant demographics will be presented followed by results, using illustrative participant quotes, related to: 1) how the OPHS (policies) were disseminated; 2) awareness of policies; 3) general opinions about the policies; 4) processes used for policy implementation; and 5) internal and external factors influencing policy implementation.",15.218678890693296,8.46973628069941
research into practice,0.1749512752399813,0.7433439493179321,1.7725281715393066,71139477-33c9-46c0-a1a7-2328ef40fe04,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"Our study showed that policy implementation was heavily integrated into health unit planning processes. Operational planning and strategic planning documents often referenced the OPHS. Greenhalgh's model [22, 23] does not discuss the influence of planning processes in terms of implementation. However, the process of implementation, including the constructs of planning, engaging, executing, reflecting and evaluating was identified by Damschroder and colleagues [40] as a key domain in their consolidated framework for implementing research into practice. Planning processes were highly apparent influencing implementation in most health units. Planning documents were tied to financial costs and public health human resource allocation. Others have reported value in participating in joint planning processes such as the creation of community health profiles and policy dialogues to support implementation of integrated community plans [41] .",17.621285739606698,7.8027668874195495
Understanding the process of policy implementation in practice settings can provide valuable learning for other jurisdictions undergoing similar public health policy renewal processes,0.1383832189867934,2.386824607849121,3.251800775527954,91f39b51-c1a2-4f04-9faa-b21260b9f913,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"Public health systems in Canada have undergone significant renewal over the last decade in response to various threats to the public's health such as severe acute respiratory syndrome (SARS) [1, 2] , water contamination [3] , and Hepatitis C in the blood supply [4] . In Ontario (ON), Canada, renewal efforts have involved the review and subsequent revision of public health policies that ""establish the minimum requirements for fundamental public health programs and servicesâ¦"" to be delivered by ON's 36 boards of health [5] . There is limited research on how these policies have been implemented or what has influenced their implementation. Understanding the process of policy implementation in practice settings can provide valuable learning for other jurisdictions undergoing similar public health policy renewal processes, and is the focus of this paper.",11.473656067416002,7.6808861227906995
OPHS implementation was facilitated by the explicit integration of the policy in program planning processes including decision making around the use of resources.,0.32004995779182716,2.2197883129119873,2.6910932064056396,ef0ddfcb-8648-49f2-998a-8fc543ee88b5,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"Health units reported on the explicit application of the OPHS in planning processes and/or documents. The policies were used by HUs most often to justify programs as well as to guide operational planning and other program planning processes (balanced scorecards and the budgeting process). This was in addition to the application of various forms of evidence to inform planning (e.g., literature reviews, environmental scans, other health unit activities). Formal planning tools and planning processes were generally used (e.g., logic models, work plans, service plans, and internal planning processes). A number of participants reported making explicit reference to the OPHS in planning documents. One director explained how the relationship between the OPHS and financial resources was explicitly noted in planning documents: ""We'll show what percentage [of our budget] is going to Foundational Standard or different Standards."" OPHS implementation was facilitated by the explicit integration of the policy in program planning processes including decision making around the use of resources.",12.70480308251894,7.638754066438086
The implementation processes and routinization component of the model involves having senior and middle management and leadership support and commitment to the innovation to influence uptake,0.17912361131848076,1.3902528285980225,2.231627941131592,07268302-50c3-41a7-8d29-055e8933e29a,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"The implementation processes and routinization component of the model involves having senior and middle management and leadership support and commitment to the innovation to influence uptake [23] . Leadership is also noted as an important system antecedent in the model which can help influence receptivity for change in the organization [23] . Alignment with the goals of leaders and the innovation is also important but the evidence for this association is not as strong. Others identify that having leaders set priorities and manage the process of implementation is important [30, 36] . In this study, the role of leaders in policy implementation was critical not only in providing direction for staff, but also in supporting their implementation efforts. Staff had varying opinions on the style of leadership and management approaches. How management styles influenced policy implementation was not clear, however, and deserves more exploration. Medical Officers of Health were seen as having great influence on program and services directions. Not surprisingly, a lack of leadership (a vacancy in senior leadership) or local municipal pressures were seen as a barrier to implementation. This tension was seen in some health units more than others. Participants expected more 'top down' direction and support from their leaders in these health units.",13.609986143647898,7.117717650601014
routinization,0.10770082805312198,1.167159080505371,1.3727890253067017,9f75deb3-7445-422e-9b95-371a175082b1,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"Factors that were most clearly linked to the OPHS policy implementation and components in the model and demonstrating a powerful influence on implementation will be highlighted. These include: attributes of the innovation itself; adoption by individuals; diffusion and dissemination; the outer context -interorganizational networks and collaboration; the inner setting -implementation processes and routinization; and, linkage at the design and implementation stage. We discuss each of these components followed by implications for practice and policy, and study strengths and limitations.",15.163088471443128,6.958047233782942
best practice evidence and networks,0.15446063983234615,0.9477342963218689,0.8790422081947327,5e1f3bbe-989a-4ee5-95dc-ef693b5857e2,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"This study explored processes and factors influencing implementation of a new provincial public health policy in Ontario, Canada. Although many health unit service providers were unaware of the policy change, engagement in developing the policy or provision of feedback by health unit staff at the front line as well as the management level was positively received. Implementation of the policy was most evident in planning processes that incorporated many internal stakeholders as well as community partners. The policy was also incorporated in operational planning documents such as logic models. Factors influencing implementation were closely aligned to components of Greenhalgh and colleagues' Diffusion of Innovations in Service Organizations framework. Most notably, the nature of the policy itself (e.g., its prescriptiveness), organizational leadership, planning processes, governance, health human resources, local and regional economics, as well as provincial and national factors such as other policies, best practice evidence and networks had an influence on implementation. Our results provide empirical support for components of Greenhalgh et als' framework [23] and suggest that two additional components be consideredthe role of external partnerships with other sectors and the influence of planning processes. The constructsplanning processes and cosmopolitanism (links to external organizations)are identified in the more recent Consolidated Framework for Implementation Research [40] . These influences are important to consider by public health organizations when implementing new or revised provincial public health policies given that they constantly change and evolve over time. The RePHS team will continue to explore changes in policy implementation and impact over time in ON as well as BC.",16.1164600642767,6.828165750432635
external organizational collaborations and partnerships as well as planning processes,0.1346953034957638,1.1627216339111328,1.6504628658294678,f73fae2e-e2a2-4000-83d1-413187b92432,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,Conclusions: Multiple factors influenced public health policy implementation. Results provide empirical support for components of Greenhalgh et al's framework and suggest two additional componentsthe role of external organizational collaborations and partnerships as well as planning processes in influencing implementation. These are important to consider by government and public health organizations when promoting new or revised public health policies as they evolve over time. A successful policy implementation process in Ontario has helped to move public health towards the new vision.,13.677466719322714,6.615683276594341
-SP(9) was able to improve production titers up to 354 % compared to standard SP,0.27172168761385945,0.7579048871994019,1.1754035949707031,0f4a5ec4-8823-4714-bbd3-dbffca68d52b,comm_use_subset/Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative Therapies O-001 CRISPR-Cas based synthetic transcription factors: A strategy for improving bioproduction in CHO cells,"In the second approach, the enhancing capacity of SP(9) on secretion of four other IgG products (named product B to E, Table 1 ) was further evaluated. An improved performance was observed for all products when comparing SP(9) and the standard SP in a fed batch process (Fig.  1) . With an increase in average final fed-batch titers ranging from 28 to 354 % and up to 290 % in cell-specific productivities. Taken together, with a positive influence on the final concentrations of all tested products, the results obtained with SP(9) contribute to -Signal peptide SP(9) was identified as a promising candidate with an average 2.4-fold titer increase during screening of four signal peptides. -SP(9) was able to improve production titers up to 354 % compared to standard SP. -SP(9) was able to improve cell-specific productivities up to 290 % compared to standard SP. -Future usage of SP (9) contributes to the further optimization of Sartorius Stedim Cellca's standard cell line development process.",12.709172069601477,5.704860737771085
Boards had the ability to raise the profile of PH by putting PH issues on the political agenda in various cities and regions,0.1629329918220112,0.6722617745399475,0.9994086623191833,812564ca-ceff-4ba8-ba5c-2dcbeb64b000,comm_use_subset/Moving towards a new vision: implementation of a public health policy intervention,"Elements of governance by the Boards, which serve to establish norms and structures through management practices, polices and processes, had an influence on the implementation of the OPHS. Many respondents' comments reflected a perception that public health was generally well supported by their Board of Health. In reference to the OPHS, a manager explained that: ""â¦ [The Board members] believe in public health. They believe in us. They have confidence in the workers in public health"", implying that trust in public health work extended to the implementation of new practices. This was reflected in a true desire to see positive community outcomes, to be ""making a difference in the population's health."" Further, there was evidence of a reciprocal relationship between staff and the Board; as a senior manager said, ""I'm really happy with [â¦] the quality of questions and inquiry and interest in public health. The majority of the board members seem to come with that real interest and engagementâ¦"" This generally positive interaction led to ""pretty high standards"" or expectations from public health staff with respect to OPHS implementation. In turn, Boards had the ability to raise the profile of PH by putting PH issues on the political agenda in various cities and regions which was an unexpected, immediate impact of implementation.",12.576196475818232,5.488254550494816
drug treatments,0.16985608424929105,0.21876494586467743,1.083813190460205,c4886b98-a0fc-4761-b08c-089260789e31,comm_use_subset/Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination,"The three existing LF models employed for this study included EPIFIL, a deterministic Monte Carlo population-based model, and LYMFASIM and TRANSFIL, which are both stochastic, individual-based models. All three models simulate LF transmission in a population by accounting for key biological and intervention processes such as impacts of vector density, the life cycle of the parasite, age-dependent exposure, density-dependent transmission processes, infection aggregation, and the effects of drug treatments as well as vector control [4, 21, 38-40, 42, 43, 49] . Although the three models structurally follow a basic coupled immigration-death model formulation, they differ in implementation (e.g. from individual to population-based), the total number of parameters included, and the way biological and intervention processes are mathematically incorporated and parameterized. The three models have been compared in recent work [8, 12] , with full details of the implementation and simulation procedures for each individual model also described [6, 8, 12, 21, 39, 42, 43, 49, 50] . Individual model parameters and fitting procedures specific to this work are given in detail in S1 Supplementary Information.",12.51414463170003,5.226626409706184
Timely identification of pneumonia aetiology could improve clinical management including decisions about the use of antibiotics,0.27754157762966275,3.7889606952667236,4.2306365966796875,efcbf785-c067-4068-9f37-47ce38e20e81,comm_use_subset/Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children,"This study describes the clinical characteristics of children with radiologically confirmed pneumonia, and assesses the utility of serum biomarkers and clinical signs and symptoms for differentiating definite bacterial from other pneumonias in a highly vaccinated population. There were few differences between children with definite bacterial pneumonia, and those with presumed viral pneumonia, and other pneumonias which were neither definite bacterial nor presumed viral. CRP, WCC and ANC were higher in definite bacterial pneumonia and the CRP had value for distinguishing these from presumed viral and other pneumonias. The combination of high CRP with either fever â¥38.0Â°C or with absence of rhinorrhoea increased the specificity and PPV compared to elevated CRP alone with little loss in sensitivity, suggesting that combining biomarkers with clinical features is of diagnostic value. Timely identification of pneumonia aetiology could improve clinical management including decisions about the use of antibiotics. In line with previous studies, the clinical signs and symptoms among cases of definite bacterial and presumed viral pneumonia overlapped and were insufficiently specific in themselves to reliably differentiate one from the other [5, 24] . Our findings are mostly consistent with previous studies which have associated viral pneumonia with low grade fever, tachypnoea, rhinorrhoea and wheezing [4, [25] [26] [27] . We did not attempt to distinguish cases based on specific radiographic features, but others have not found any radiographic feature that can reliably distinguish bacterial from viral pneumonia [14, 28, 29] .",13.638078377736452,9.986065671972925
better targeting therapies,0.26778072813963805,2.2933349609375,4.2190470695495605,6c5b10ef-b9b7-4cd8-8749-11b9b73b3d6b,comm_use_subset/Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children,"Empiric use of antibiotics remains as cornerstone of treating pneumonia in the absence of effective point-of-care diagnostics for differentiating bacterial from viral infection. Many children who have viral pneumonia will continue to receive antibiotics without benefit. Early reliable detection of viral pneumonia, or early exclusion of bacterial pneumonia, could reduce unnecessary antibiotic therapy, thereby mitigating the risk of emerging antibiotic resistance [36] . While we have been unable to identify a single biomarker or clinical feature that could be used to confidently distinguish bacterial from viral pneumonia, our findings suggest there may be utility in more sophisticated algorithms that integrate a number of clinical, microbiological, inflammatory biomarker, or radiological factors to improve pneumonia diagnostics and better targeting therapies.",16.42734770304903,9.98262001588375
identification of pathogens,0.20726538156942104,2.0073111057281494,3.5821924209594727,361a9299-abe4-47e9-a18d-bd0312b1e8f7,comm_use_subset/Deep Sequencing to Identify the Causes of Viral Encephalitis,"Deep sequencing technologies are changing rapidly and the analysis of the deep sequencing data is becoming more efficient. As sequencing technologies improve and become more cost effective, their application in clinical diagnostics may become commonplace, especially for the identification of pathogens. [23, 24, 25] This study demonstrates the feasibility of using deep sequencing to identify viral causes of encephalitis.",16.124417375360387,9.27672337372309
"the use of supportive diagnostic tools (RDTs, microscopy, radiology, and microbiology laboratory) should be strengthened in order to improve clinical care",0.244647481084279,2.2650272846221924,1.7120028734207153,2979001c-88e2-40f0-83ae-160555c54a2f,comm_use_subset/causes of fever in Gabonese children: a cross-sectional hospital- based study,"We described the distribution of pathogens causing fever in children, ill enough to be hospitalized in LambarÃ©nÃ©. We found that malaria remained the most important cause of fever, followed by respiratory tract infections. Both conditions were also the leading cause of severe illness manifestations. We advocate that diagnosis and management should be tailored to the facilities and resources available locally; the use of supportive diagnostic tools (RDTs, microscopy, radiology, and microbiology laboratory) should be strengthened in order to improve clinical care in LambarÃ©nÃ© and similar African settings.",18.818304240464606,9.171476086890502
speed up and improve the management of this ongoing outbreak,0.2259247440275608,1.987224817276001,2.254042148590088,125f52d7-a08a-48cb-b492-55ef5bf04ab2,comm_use_subset/Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Timely implementation of molecular diagnostics for SARS-CoV-2,diagnostics quickly and act fast. Assay optimisation will further speed up and improve the management of this ongoing outbreak.,16.43961368440826,8.510688317355848
resistant bacterial infections,0.43145402774949626,2.9606168270111084,3.6108813285827637,0b6df057-2724-46cb-8ff9-86c225e43a68,comm_use_subset/Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response,"The recently launched CARB-X is fulfilling a similar role to CEPI with respect to promoting early R&D of biomedical countermeasures for resistant pathogens (96) . CARB-X provides financial, scientific, and business support for antibiotics, vaccines, rapid diagnostics, and other products for resistant bacterial infections. As with CEPI, there is reason to question whether CARB-X, which plans to invest up to $500 million between 2016 and 2021, has enough funding to make a meaningful impact on the anticipated global AMR burden. In addition, CARB-X may be unnecessarily excluding potential high-impact AMR interventions from consideration for financial support. To qualify for funding through CARB-X, research must target pathogens on the AMR priority pathogen lists established by the WHO and the U.S. Centers for Disease Control and Prevention. Based on this criterion, some products that could have a significant AMR impact, such as a universal (or improved seasonal) influenza vaccine, are ineligible. In general, CARB-X may do well to diversify its investment portfolio, which currently contains only one vaccine (97) .",11.193853832378942,8.189322642468646
"if used therapeutically, improve clinical outcome in dengue disease.",0.3006334966198483,2.2733287811279297,2.8074498176574707,b22e752b-b11e-44a1-bf28-723917776072,comm_use_subset/Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients,"Dengue is the most prevalent mosquito-born viral disease affecting humans, yet there is, at present, no drug treatment for the disease nor are there any validated host targets for therapeutic intervention. Using microarray technology to monitor the response of virtually every human gene, we aimed to identify the ways in which humans interact with dengue virus during infection in order to discover new therapeutic targets that could be exploited to control viral replication. From the activated genes, we identified three pathways common to in vitro and in vivo infection; the NF-kB initiated immune pathway, the type I interferon pathway, and the ubiquitin proteasome pathway. We next found that inhibiting the ubiquitin proteasome pathway, or activating the type I interferon pathway, resulted in significant inhibition of viral replication. However, inhibiting the NF-kB initiated immune pathway had no effect on viral replication. We suggest that drugs that target the ubiquitin proteasome pathway may prove effective at killing the dengue virus, and, if used therapeutically, improve clinical outcome in dengue disease.",12.99969351391981,7.852398819082444
its main goal is to widen the spectrum of therapy,0.13370544627378458,2.7953412532806396,2.967660665512085,80595971-2132-4863-ad08-0a9c9edfcfb4,comm_use_subset/Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-Series,"CAT is often chosen as a strategy to improve the outcome in those cases of IMI with severe clinical course: its main goal is to widen the spectrum of therapy, to lower the risk of resistance and to exploit the synergism between some drugs.",10.841950578494313,7.54063394968828
"The hard core represents the actual intervention or goal, e.g. implementation of a preparedness plan",0.2022583819015509,1.5155376195907593,2.470057964324951,a3e0f325-1b14-4fbc-9674-0646c499c765,comm_use_subset/'Tiny Iceland' preparing for Ebola in a globalized world,"'Getting the job done' (theme 1) refers to the multitude of tasks and considerations that surrounds and feeds into the preparedness plan itself and are necessary for successful planning and implementation. Using the metaphors of 'hard core' and 'soft periphery', Langley and Denis [37] emphasize the importance of relatively 'peripheral' concerns and processes for planning and implementation of new interventions. The hard core represents the actual intervention or goal, e.g. implementation of a preparedness plan. The soft periphery refers to all the contextually important networking, negotiations, and agreements necessary to deliver the hard core. If the soft periphery is neglected, it will cause multiple challenges in the implementation process, and the benefit of the hard core, the intervention itself, may not transpire as anticipated. Due attention to the soft periphery may, however, considerably promote the delivery of an innovation, and secure support from important stakeholders. In our data, one manager speaks of the preparedness process as dealing with a three-headed monster where every solution was followed by new problems. The data indicate that the process of dealing with 'the three headed monster' was given due attention as a means to successfully develop Iceland's preparedness plan. Comprehensive consultations and the involvement of many associated institutions were mentioned. Still ambiguity remained with some staff in terms of division of responsibilities and taskse.g. when transporting a patient potentially infected with Ebola from the airport to the hospital, and other such activities.",13.294873889911111,7.243842991014101
great potential for both developed and low-resource areas,0.16951224692930403,0.7457435131072998,2.6180288791656494,a1b4524b-6ddd-4435-8311-fe15e79f61f3,comm_use_subset/Advances in Directly Amplifying Nucleic Acids from Complex Samples,"As we enter the age of electronic, mobile, and personalized medicine, there remains much room for creativity and innovation in the design of NAATs and POC diagnostics. Molecular diagnostics, as the highest-growing segment of all in vitro diagnostic products [226] , truly have great potential for both developed and low-resource areas. The diagnostic community continues to strive for tests that are reliable against variable electrical resources, water quality, trained staff, or harsh environmental conditions [227, 228] . Researchers continue to seek approvals such as the FDA's CLIA waivers or the WHO's ASSURED (affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free, and delivered to end-users) criteria. In this regard, direct NAATs present a promising approach. Through this review, it is our hope to stimulate the discussion on direct NAATs and their potential as POC diagnostics. Ultimately, we seek to help accelerate the development of POC diagnostics that can be CLIA waived and/or meet the WHO ASSURED criteria, thereby ushering in the next revolution in healthcare.",14.113524777433717,7.126185727079218
"'nursing bodies are transformed into instruments of preparedness', and become part of infrastructural arrangements",0.13470443295634693,2.29095721244812,2.7704875469207764,5e1b347d-4d38-4e8b-bf3f-fb344e84e846,comm_use_subset/'Tiny Iceland' preparing for Ebola in a globalized world,"Anthropological work on emergency preparedness emphasizes the connectedness between health professionals, technological devices, and knowledge as a prerequisite for successful preparedness. Wolf and Hall present preparedness efforts as a form of governance that involves human bodies (those of health professionals), clinical architectures (e.g. isolation wards), and technical artefacts (gloves, protective suits, disinfectants, etc.) [47] . During preparedness training and implementation, 'nursing bodies are transformed into instruments of preparedness', and become part of infrastructural arrangements. Health professionals are, here, both vulnerable and powerful tools in the management of contamination. The authors argue that successful planning, training, and implementation of a preparedness plan require such intrinsic connectedness. In the case of Ebola preparedness in Iceland, health professionals draw our attention to dilemmas of connectedness, and their assessment of the fact that these shortcomings might hamper the mobilization of 'preparedness within the human body'that is, the embodied experience, routine, and tacit knowledge which Wolf and Hall state are key to successful implementation. Repeated enactment of receiving and treating a patient with Ebola within experienced and trustful teams would probably enhance such embodiment, provided that there is justified trust in the involved technology. In addition, repetition would also strengthen the 'soft periphery' of preparedness, and divisions of responsibilities would be clearer manifested.",10.894160463414078,7.10289525578471
effective public health responses,0.4279178085975445,1.7626969814300537,2.0273842811584473,32632694-c36f-4c78-addc-f3c6dcf32323,"comm_use_subset/Anticipation and response: pandemic influenza in Malawi, 2009","Having effective and efficient laboratories in the country depends on how well these areas are funded. It is critical that countries have local influenza systems in place, in addition to the IDSR, to improve surveillance activity, situation monitoring, assessment and reporting. Viral surveillance is important to assist and facilitate prompt detection of influenza A viruses and other highly infectious viruses, in order to accelerate the implementation of effective public health responses [29] . Preventing and controlling influenza outbreaks in domestic animal populations are also important.",11.567408463917195,6.512145783053544
It may be a potential and powerful tool for clinical diagnostics in the future.,0.1476455563821996,1.8371319770812988,1.9748417139053345,de648d45-70cf-4cbc-976f-cd50671f062a,comm_use_subset/DNA transducer-triggered signal switch for visual colorimetric bioanalysis OPEN,"Aim to develop a versatile colorimetric biosensor by reusing the circuit's module to detect various inputs through the use of a transducer. In this study, a novel colorimetric sensing strategy by combining the signal transducer and CHA is developed for detecting the part of lytA gene of S. pneumoniae 25, 26 and the whole cell of Salmonella Typhimurium 27 . The method reveals a great potential to adapt CHA to support even more robust analytical applications, and construct a label-free, enzyme-free, visual, simple, rapid, sensitive and specific platform for the development of low-cost and point-of-care diagnostics. It may be a potential and powerful tool for clinical diagnostics in the future.",11.281616260747727,6.426348590403016
It is significant to develop a green and efficient method to extract GCA from Flos Lonicera japonica,0.12641266864547568,1.2686116695404053,0.7849394083023071,a4f940b2-f3a4-48c8-a14f-296b83da9333,comm_use_subset/Ionic liquid-based enzyme-assisted extraction of chlorogenic acid from Flos Lonicera Japonicae Open Access,"Background: In recent years, ionic liquids and enzymes have been widely used in the separation and extraction processes of natural products. Chlorogenic acid (CGA) has important biological and pharmacological activities. It is significant to develop a green and efficient method to extract GCA from Flos Lonicera japonica (FLJ) by integrating the advantages of the ionic liquids and enzymes.",11.335578436646209,5.302260653423936
improve global resources for pandemic preparedness and responses,0.2255256360855194,-0.1262105256319046,2.005978584289551,f180b55f-8f6a-46b9-b30d-868c81953760,"comm_use_subset/Is the global health community prepared for future pandemics? A need for solidarity, resources and strong governance","Unfortunately, many developing countries are not sufficiently prepared to deal with an emerging pandemic owing to limited resources, competing priorities and lack of political commitment. An ongoing concern, for example, is the weak and patchy implementation of the IHR, which would better prepare these countries for dealing with pandemics (Lancet, 2014). To underline this urgent need to upgrade public health infrastructure and capabilities of low-and middleincome countries, a recent report proposed spending US$3.4 billion/year to improve global resources for pandemic preparedness and responses (GHRF Commission, 2016) .",11.396523990351582,5.210632634750524
"these molecules have even shown to improve clinical outcomes with the support of other compounds, like protein kinase R",0.151122994348908,1.939490795135498,3.053295135498047,880413d0-53d8-4523-abb2-8edaf34c9ba3,"comm_use_subset/Molecular Sciences Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models","Only four works investigated such diseases in humans, all of which dealing with COPD. Overall, the studies highlighted a positive contribution of antagomiRs in decreasing the clinical symptoms of the disease. In some cases, these molecules have even shown to improve clinical outcomes with the support of other compounds, like protein kinase R (see Hsu et al. 2016 [76] ).",22.65055402669214,11.173004764254053
"In clinical simulations, use of such a system appeared to improve clinical decision-making",0.2510391625312139,2.3153862953186035,2.860811471939087,459e7472-54fe-4c05-97eb-694d0b6c568b,comm_use_subset/Open Access Prospective evaluation of an internet-linked handheld computer critical care knowledge access system,"A handheld computer system is feasible as a means of providing point-of-care access to medical reference material in the ICU. During this study acceptance of this system was variable, and improved training and more advanced technology may be required to overcome some of the barriers we identified. In clinical simulations, use of such a system appeared to improve clinical decision-making.",22.182986886390218,11.128573958954075
"Processes are typically developed for a single adenovirus serotype -transgene combination, requiring extensive further optimization for each new vaccine",0.1864296187925484,3.3258097171783447,4.849210739135742,4c6e4be4-bbd3-4bce-9bb5-6649009475ac,comm_use_subset/Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components,"A variety of Good Manufacturing Practice (GMP) compliant processes have been reported for production of non-replicating adenovirus vectors, but important challenges remain. Most clinical development of adenovirus vectors now uses simian adenoviruses or rare human serotypes, whereas reported manufacturing processes mainly use serotypes such as AdHu5 which are of questionable relevance for clinical vaccine development. Many clinically relevant vaccine transgenes interfere with adenovirus replication, whereas most reported process development uses selected antigens or even model transgenes such as fluorescent proteins which cause little such interference. Processes are typically developed for a single adenovirus serotype -transgene combination, requiring extensive further optimization for each new vaccine.",10.443725076885437,8.96906707351406
"Processes are typically developed for a single adenovirus serotype -transgene combination, requiring extensive further optimization for each new vaccine",0.1864296187925484,3.3258097171783447,4.849210739135742,e5eec108-4127-4648-8d63-b1dc9e059fc4,comm_use_subset/Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components,"A variety of Good Manufacturing Practice (GMP) compliant processes have been reported for production of non-replicating adenovirus vectors, but important challenges remain. Most clinical development of adenovirus vectors now uses simian adenoviruses or rare human serotypes, whereas reported manufacturing processes mainly use serotypes such as AdHu5 which are of questionable relevance for clinical vaccine development. Many clinically relevant vaccine transgenes interfere with adenovirus replication, whereas most reported process development uses selected antigens or even model transgenes such as fluorescent proteins which cause little such interference. Processes are typically developed for a single adenovirus serotype -transgene combination, requiring extensive further optimization for each new vaccine.",10.443725076885437,8.96906707351406
Early diagnosis and intensive treatment protocols,0.23971896545869079,3.1141531467437744,2.7665271759033203,15b09a43-8f71-4db8-9789-2b68361c61f7,comm_use_subset/Article 123 1 Current Concepts in Immunology and Microbiology,"Early diagnosis and intensive treatment protocols can stabilize or even improve the clinical prognosis of children with bronchiectasis (6, 7) . Over the decades, considerable advances have been made in identifying the pathogens associated with recurrent or chronic infection. However, understanding the host immunologic mechanisms that contribute to recurrent infection and prolonged inflammation has been identified as an important area of research that would contribute substantially to effective prevention strategies for children at risk of bronchiectasis (8, 9) . This review will begin by exploring the role of the child's immune response in establishing an environment conducive to the recurrent infection and chronic inflammation characteristic of bronchiectasis. This will be followed by a discussion of the important pathogens associated with bronchiectasis in children and the obstacles in treating and preventing these infections. The review will conclude with ""the road forward"" areas of research identified by the authors as important for the advancement of understanding and addressing the pathogenesis of bronchiectasis in children.",14.651106356889507,8.95032943463194
emergency response capabilities in China,0.23558106073291304,3.5955023765563965,3.7860989570617676,25a8ed4b-9595-46a3-93e2-df6fd637c411,comm_use_subset/Determinants of emergency response responsibility perceptions in the local public health workforce after China's health sector restructuring,"In comparison, health sectors in Canada and the United States have clearly outlined roles, with no cross-functional associations and relatively independent work [22] . In Australia, the existing health supervision and management systems were adopted from the British. Here, health supervision and other regulations have implementation details, and are founded by strong operational regulations, system, and hierarchy. We can learn and implement much from the Federal Emergency Management Agency in the United States: increase tasks not agencies, but feel free to adjust the goals, focus, and department in accordance with the actual situation to improve emergency response capabilities in China [23] [24] [25] [26] .",11.483368409900095,8.817219810316839
abrogation of IL-6 would reduce symptom severity and improve clinical outcome,0.30689377962792097,1.8176013231277466,2.962557315826416,d1fed21a-3886-44cd-bdda-ec6f5c8f39c4,comm_use_subset/Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection,"Increased IL-6 expression in both patients hospitalized with H1N1pdm and mouse models of H1N1pdm implicated IL-6 in the host response to infection. Given the known proinflammatory properties of IL-6 [20, 21] , we hypothesized that IL-6 may play a pathogenic role in H1N1pdm infection. Thus, abrogation of IL-6 would reduce symptom severity and improve clinical outcome. Wild-type C57BL/6J (IL-6 wild-type) mice (n = 22) and IL-62/2 mice (n = 34) were infected intranasally with 10 4 EID 50 A/ Mexico/4108/2009 (H1N1pdm), and observed for fourteen days pi.",15.75396813733586,8.620991963387757
microfluidic concentrators suitable for diagnostics makes the analysis of nucleic acid targets that are present in low levels,0.14532565357419935,3.1395256519317627,3.490567207336426,85093836-3fa7-40c8-8396-a3d664fbd2d4,comm_use_subset/Detection of Zika virus using reverse- transcription LAMP coupled with reverse dot blot analysis in saliva,"Salivary testing for diagnosis has advantages over other bodily fluids [21, 42] but in particular in ZIKV diagnosis it is beneficial because ZIKV RNA can only be detected in the blood from 1-7 days after the clinical onset during acute infection, but persists longer in saliva, semen and urine [43] [44] [45] suggesting that saliva could be a preferred specimen to use for ZIKV diagnostics. Drawbacks to saliva as a test matrix are that the concentration is frequently lower than typically found in serum and circadian variations in analyte concentrations can make the sensitivity lower [46] . However recent development of microfluidic concentrators suitable for diagnostics makes the analysis of nucleic acid targets that are present in low levels [47] possible.",11.650356001663484,8.387184959106541
tannins can improve animal performance,0.2193447254026964,3.52848744392395,3.201207399368286,d6bb7f2f-0dfc-4c04-a80c-5eb7e24ec8cd,comm_use_subset/Oral administration of chestnut tannins to reduce the duration of neonatal calf diarrhea,"Tannins are a complex group of polyphenolic compounds which are present in several plants as secondary metabolites against pathogens [12] . In ruminants, in vitro and in vivo trials have demonstrated that tannins can improve animal performance and reduce the impact of gastrointestinal parasitism, nitrogen pollution, and methane emission from rumen fermentation [13, 14] . Tannins may interfere with digestive processes by binding dietary protein, by modulating the activity of rumen micro-organisms, and by reducing the growth of the bacterial population [15] [16] [17] .",10.555860094784157,8.068852681314409
implementing thresholds enables utilization of continuous data,0.36143378774930596,2.122713565826416,3.0349385738372803,ec77740d-2801-46d8-8cb4-addc7f4c244b,comm_use_subset/Clinical Infectious Diseases PERCH Integrated Analysis for Etiology Estimation â¢ CID 2017:64 (Suppl 3) â¢ S213 Bayesian Estimation of Pneumonia Etiology: Epidemiologic Considerations and Applications to the Pneumonia Etiology Research for Child Health Study,"Currently the PERCH integrated analysis is tailored for binary (positive/negative) test results so that continuous data such as pathogen density must be categorized into above and below a threshold. Although continuous measurements are becoming more of interest in diagnostics, most traditional test results are still binary, and implementing thresholds enables utilization of continuous data. However, extending the model to include categorized data (eg, low, medium, high) is relatively easy and may further improve estimation.",12.94074463729062,7.88173451383312
low false positive rates and a high degree of predictive accuracy,0.11770411008364079,-0.13694919645786285,1.5162534713745117,57dfff8f-caa8-4820-a4d8-8f0e3766f174,comm_use_subset/Nonparametric methods for the analysis of single-color pathogen microarrays,The acceptance of microarray use for routine clinical diagnostics will require that the technology be accompanied by simple yet reliable analytic methods. We report that our implementation of the chi-square test yielded a combination of low false positive rates and a high degree of predictive accuracy.,19.52429033146158,7.730049394707374
lack of enforcement of the NIH Revitalization Act has led to worsened health outcomes among patients,0.17246702395601496,2.51651930809021,2.6552584171295166,4a7c81ef-20cc-4d0b-97c1-1eda939ff2f8,comm_use_subset/Towards Equity in Health: Researchers Take Stock The PLOS Medicine Editors are,"The PMI Cohort Program set an ambitious goal of recruiting one million volunteers that reflect the diversity of the US. However, to accomplish this goal, the NIH must improve its performance over an earlier, unsuccessful commitment to include minorities in clinical and biomedical research, the 1993 Congressionally mandated NIH Revitalization Act. The poor implementation and lack of enforcement of the NIH Revitalization Act has led to worsened health outcomes among patients and, as a result, greater racial/ethnic health disparities. African American patients, and by proxy their family members, are more likely than Whites to be incorrectly diagnosed as having a serious heart disease, hypertrophic cardiomyopathy, because the diagnostic clinical studies underlying the test for this life-threatening heart condition did not include enough African Americans as healthy controls [12] . Similarly, the widely successful heart drug clopidogrel (Plavix) was developed mostly among Whites yet was successfully marketed in Hawaii, a Pacific Island, despite being ineffective for 45% of Asians and 77% of Pacific Islanders [13] . On the other hand, clinical studies that embrace the ethos of the NIH Revitalization Act ultimately benefit all people. The discovery of PCSK9 missense mutations in African Americans with unusually low LDL cholesterol allowed for the development of a new class of drugs that have revolutionized cholesterol therapy regardless of race/ethnicity [14] .",12.435846388767644,7.714201757461497
"increasingly long supply chains for delivery of animal products and creating new and diverse interactions between humans, livestock, and livestock products",0.16141882899462925,2.7193105220794678,3.2047605514526367,85fd67e6-5662-4001-82df-a0a11f6eb6b2,comm_use_subset/Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries,"The ecological and biological processes linking livestock production and zoonotic diseases have developed over thousands of years. Domestication of wild animals brought them into close contact with human populations, which themselves were growing more dense as agriculture permitted local population growth, resulting in greater opportunities for transmission and persistence of diseases across humans and domestic and wild animals (Diamond 2002; Wolfe et al. 2007 ). With subsequent industrialization and urbani za tion, consumer populations became separated from livestock production, leading to increasingly long supply chains for delivery of animal products and creating new and diverse interactions between humans, livestock, and livestock products.",10.73591297359793,7.608215738555144
increasing use of recombinant clotting factors instead of plasma-derived products,0.17606238460730975,1.590158224105835,2.408440589904785,a35558e4-ca46-4d7d-aac9-19f8dfe22165,comm_use_subset/PARV4: An Emerging Tetraparvovirus,"Parvoviruses are potentially resistant to traditional viral inactivation methods employed for plasma-derived products [1, 11, 14] . In the Western world, these risks are mitigated by modern virus inactivation procedures that are likely to be effective against parvoviruses and by the increasing use of recombinant clotting factors instead of plasma-derived products. However, transfusion-mediated transmission remains a potential issue in developing countries. The extent of this concern is uncertain given the doubts over the clinical significance of PARV4 infection.",10.396385144695547,6.237824029750344
"Following written consent from the parent/caregiver, demographics, immunization history and clinical data were collected",0.1292329945159459,2.275587558746338,1.281032681465149,6b807c70-d8fe-4752-9ef4-ba5695441640,comm_use_subset/An observational study of febrile seizures: the importance of viral infection and immunization,"Following written consent from the parent/caregiver, demographics, immunization history and clinical data were collected. Results of all investigations carried out in the course of clinical care were recorded. Per-nasal samples were collected by trained healthcare staff using nasopharyngeal aspirate (NPA) or nasopharyngeal FLOQSwabâ¢ (Copan Diagnostics Inc. Murrieta, CA). Stool or per-rectal swabs were collected where possible by trained healthcare staff and placed in viral transport media immediately after collection then transferred to the laboratory.",11.119608182422692,6.203666019985408
preventive measures aimed to control the disease,0.3572997959416808,2.865757703781128,3.4981000423431396,1275e53d-2207-477d-a6d9-4db8fab35aa1,"comm_use_subset/Epidemiology, Molecular Epidemiology and Evolution of Bovine Respiratory Syncytial Virus","In summary, the study of the molecular epidemiology of BRSV has evolved considerably over the past two decades. The information generated by the study of the molecular characterization, phylogenetics and evolution of BRSV strains have broadly advanced our understanding of the molecular mechanisms controlling virus transmission and disease spread. However, this field requires extensive research to unveil the means exploited by the virus to attain persistence in a given population. The establishment of molecular surveillance of BRSV in different geographical regions will likely improve the identification of outbreaks, resulting in the implementation of preventive measures aimed to control the disease. The advent of next-generation sequencing platforms on the eve of the ""DNA-sequencing era"" could also provide a unique opportunity for the discovery of the underlying processes responsible for viral replication and survival in the host.",13.442964707890253,8.841545182742362
infectious disease diagnostics and patient care,0.23958568765330013,2.3062140941619873,3.9306228160858154,e732b3ec-4e32-4dbf-b8b9-aa587cf76987,comm_use_subset/Highlighting Clinical Metagenomics for Enhanced Diagnostic Decision-making: A Step Towards Wider Implementation,"More recently, CMg has been employed to detect the first case of gastrointestinal basidiobolomycosis [124] . A 41-year-old HIV-positive female from Cameroon presented to the hospital with a 2-month history of abdominal pain. A sizable (inflammatory) mass was seen on her abdomen by CT-scan and histopathological examination revealed large hyphae that were encased by a thick eosinophilic material. Sanger sequencing of the ITS results were inconclusive however, ultra-deep pyrosequencing of the ITS2 region revealed 4 fungal species with B. meristoporus representing 80% of the sequences. The authors concluded that this approach is ready to be integrated into clinical microbiology laboratories to improve infectious disease diagnostics and patient care.",13.47252131957189,8.769326453511233
could enable healthcare providers to offer a differential diagnosis of fever syndrome and more appropriate care and treatment.,0.1706055671394737,2.838409662246704,3.869584798812866,06932d17-4674-41ea-8d57-5c60380bbc36,"comm_use_subset/A diagnostic and epidemiologic investigation of acute febrile illness (AFI) in Kilombero, Tanzania","In low-resource settings, empiric case management of febrile illness is routine as a result of limited access to laboratory diagnostics. The use of comprehensive fever syndromic surveillance, with enhanced clinical microbiology, advanced diagnostics and more robust epidemiologic investigation, could enable healthcare providers to offer a differential diagnosis of fever syndrome and more appropriate care and treatment.",11.85113293367519,8.508092926475037
the use of probiotic antagonist microorganisms and their metabolic products represents a promising approach for the treatment of viral diseases,0.24040529617267833,2.2084529399871826,3.15496826171875,c2677a21-bee6-49f9-bcb8-280fbf8bb790,"comm_use_subset/medicina Antiviral Activity of Exopolysaccharides Produced by Lactic Acid Bacteria of the Genera Pediococcus, Leuconostoc and Lactobacillus against Human Adenovirus Type 5","Currently, the use of probiotic antagonist microorganisms and their metabolic products represents a promising approach for the treatment of viral diseases [12] . Lactic acid bacteria (LAB), which can be found in the microbiota of the mucous membranes of the nose and mouth, and the gastrointestinal and urinary tracts, have a positive effect on these ecosystems as they stimulate the immune system and increase resistance to infections of bacterial and viral origin. LAB are the sources of multiple biologically active substances that vary in chemical structure and action spectrum [13] . During metabolic processes, lactic acid bacteria produce vital substances, including vitamins, amino acids, enzymes, fatty acids, exopolysaccharides, lactic acid, bacteriocins, and hydrogen peroxide, and significantly improve the intestinal absorption of micro-and macro-elements essential for the organism. It was also shown that exopolysaccharides that are secreted during the cultivation of LAB, in addition to their probiotic activity, can act selectively on pathogenic microbes and viruses without significant disturbances of the microbiocenosis and the development of inflammatory processes that occur during the use of broad-spectrum antibiotics and chemical antiviral agents [14] . As a result, exopolysaccharides can be used as a base for the production of harmless, non-toxic and acellular probiotic products and drugs that have a targeted therapeutic effect.",13.822931346738656,8.324249752467386
We demonstrated predominant use of rapid diagnostic tests for influenza and RSV,0.16011323006986472,2.9077422618865967,2.4324989318847656,b5e1ff19-adfe-421e-a056-00c0eb832eae,"comm_use_subset/Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-2013","We demonstrated predominant use of rapid diagnostic tests for influenza and RSV during 2012-2013 among hospitals and laboratories from 15 states. While the use of molecular diagnostic assays for detection of influenza virus infection at hospital and associated commercial laboratories increased modestly since 2006-2007, the availability of influenza molecular diagnostics for clinical care at hospitals was still limited; only 26% of hospital laboratories reported availability of molecular diagnostic assays. Laboratory diagnostics for respiratory viruses other than influenza and RSV were uncommonly available. Also, a minority of hospitals included in our survey had policies in place to systematically test patients with acute respiratory infections (ARI) seen in the ED with influenza diagnostics during influenza season. As the number and type of commercially available laboratory diagnostics for respiratory pathogens evolve, an updated survey is warranted. We showed that in most (67%) hospitals included in FluSurv-NET, a U.S. population-based surveillance network involving 15 states, RIDT was the clinician's primary or only option for influenza diagnostic testing. RIDTs are easy to use and have rapid turnaround time for results. However, RIDTs have been shown to have suboptimal sensitivity (40-70%) compared to RT-PCR or viral culture. [10] [11] [12] [13] Several studies suggest that healthcare providers are more likely to prescribe antiviral drugs with a positive RIDTs. 13, 14 Therefore, a falsenegative result may affect clinicians' decision to provide appropriate treatment and infection control among patients with influenza. Given the suboptimal sensitivity of RIDT, patient management should not depend upon a positive RIDT result. If patient management depends upon a diagnosis (or rule out) of influenza, additional confirmatory test with a more sensitive assay is warranted and the initiation of antiviral treatment and implementation of infection control should be started empirically and not delayed while awaiting confirmation. 15 In our survey, only 31% of laboratories had protocols for confirmatory testing with a more sensitive assay following a negative rapid test result. This may reflect the limited usefulness of receiving testing results late in clinical care. Also, in our survey, the laboratories confirming RIDT test results reflects shipment of specimens to state public health laboratories as part of FluSurv-NET surveillance, in addition to clinician practice. New molecular assays may improve the accuracy of influenza diagnosis, but timeliness and cost of these new assays could affect future use.",13.470662980250232,8.185888819038967
"can require sophisticated equipment, infrastructure, skilled laboratorians, and a robust quality management program",0.24885057600585603,2.205397367477417,2.399116277694702,0cf1446c-8f6a-4bdf-8fc9-b9302abc5218,comm_use_subset/Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings,"An accurate and rapid diagnostic test can facilitate better patient care by informing prompt and appropriate treatment, leading to decreased morbidity and mortality while saving money and preventing improper use of antimicrobial drugs [1] . Rapid diagnostics are also critical to identify pathogens for which targeted public health interventions can be employed to control disease transmission in the community. Nucleic acid amplification technologies (NAAT) to identify common pathogens have become a routine approach for infectious disease diagnosis in high-income countries. Many NAAT products now exist that have been cleared or approved by national health authority agencies, in addition to a variety of qualified laboratory-developed methods used in some facilities [2, 3] . Although various amplification methodologies have been developed, RT-PCR is the predominant NAAT used for diagnostic testing [4] . The implementation of NAAT in clinical diagnostic laboratories is complex and can require sophisticated equipment, infrastructure, skilled laboratorians, and a robust quality management program [5] . These requirements present insurmountable challenges when trying to diagnose infectious diseases in the resource limited settings (RLS) of low and middle-income countries (LMIC), especially in rural environments where operational and logistical limitations further challenge implementation [4, 6] . Patients with communicable diseases in these locations would greatly benefit from rapid on-site diagnosis and timely linkage to care, resulting in improved individual outcomes and better infectious disease control.",14.323724395251986,8.006237407700073
protocols are reproducible,0.14200407400777582,2.0891168117523193,3.4601542949676514,6c45968f-aaf0-41ff-abc8-3e31c472d466,comm_use_subset/PEGylated Adenoviruses: From Mice to Monkeys,"Since the early studies with PEGylated viruses were initiated in the year 2000, a significant number of reports in the literature have made it clear that covalent attachment of many different forms of poly(ethylene) glycol can significantly attenuate the immune response against the virus capsid and improve transduction efficiency in some tissues alone or with the addition of homing ligands to virus modified with heterofunctional chemistries in both mice and non-human primates. Additional bodies of evidence support the notion that much of the toxicity associated with use of the adenovirus is also eliminated by this modification. Despite all these favorable attributes, very few if any of these chemically modified viruses are under consideration for clinical use. Many pre-clinical studies to date suggest that several variables such as the molecular weight and shape of the polymer as well as the conjugation chemistry profoundly dictate the immunological and pharmacokinetic profile of the adenovirus. Further refinement of PEGylation chemistry to improve both site-specific attachment to the virus capsid and homing ligands will minimize the potential for generating mixtures of viruses with different PEG and ligand to virus ratios. Evaluation and validation of additional highly sensitive assays to characterize PEGylated viruses and large scale PEGylation processes will be vital to ensure that protocols are reproducible and that preparations consist of vectors that are modified to the same degree and are free of extraneous reaction byproducts.",11.952867523777284,7.79052985269003
improved TTR due to new diagnostic tools,0.18632236330281526,2.3352291584014893,2.6329524517059326,293b59bc-dff1-45d7-b574-6b850e6474fb,comm_use_subset/control of infectious Diseases in the era of european clinical Microbiology Laboratory consolidation: New challenges and Opportunities for the Patient and for Public Health surveillance,"However, improved TTR due to new diagnostic tools, e.g., molecular diagnostics or the Matrix Assisted Laser Desorption Ionization-Time Of Flight Mass Spectrometry, will only have clinical impact if used by without delay; therefore, good communication between health professionals remains fundamental. Only a few studies have evaluated the true impact of rapid microbial identification (RMI) including direct DNA identification from positive blood cultures (36) (37) (38) . For example, it has been demonstrated that most clinical changes involved treatment escalation in the general patient population and treatment de-escalation in the oncological patient population (39) . In the pediatric population, RMI is particularly helpful in quickly confirming contamination by cutaneous bacteria. In some studies, it was shown that the delay in administering the modified treatment was high (>4 h in ap. 50% of cases), suggesting that communication between health professionals can improve further (39) . These observations underline the different impact of the RMI across various hospitals, but also emphasize the important role of clinical pharmacists who can contribute to better coordination of care (40) .",12.709190472969617,7.677534712109189
the development and clinical implementation of novel anti-viral drugs may improve patient outcomes,0.17091688126763457,1.5836288928985596,2.529832601547241,bea59404-0b13-49ef-80b8-79c1062e9964,comm_use_subset/Inflammatory monocytes and the pathogenesis of viral encephalitis,"While the development and clinical implementation of novel anti-viral drugs may improve patient outcomes, it is becoming increasingly clear that therapies targeting pathogenic elements of the host immune response may be critical for successful intervention during infection [10] [11] [12] [13] [14] . Monocyte infiltration is a hallmark of central nervous system (CNS) inflammation, including viral infection. These cells migrate into the infected brain, where they differentiate into dendritic cell (DC), macrophage and, arguably, microglial populations. Once differentiated, these cells engage in a number of potent effector functions including antigen presentation and T cell stimulation, the production and secretion of numerous pro-inflammatory mediators as well as reactive oxygen species (ROS), all of which are focused on viral containment and clearance (Table 1) . However, unbalanced and poorly controlled migration and effector functions of these cells may result in immune-mediated pathology, resulting in tissue damage and destruction during some infections (Table 1) . Therefore, it is of high importance to understand the processes driving monocyte development, recruitment, differentiation and function, to aid in the development of novel therapeutics that inhibit immunopathological responses.",12.755615283703413,7.1382153206859655
long-term and standardized implementation of individual monitoring,0.16897401419494767,1.708980917930603,2.080799102783203,4974fe2e-5a88-495f-885b-d0a7b7ca96f9,"comm_use_subset/Individual Monitoring and Occupational Dose Record Management in China: History, Current Status and Perspectives","Efforts should be made to improve the supervision and enforcement of radiation health, give necessary administrative punishment to those who are involved in intentional exposure, artificial exposure, or refuse to carry out the required individual monitoring so as to correct problems existing in the management of individual doses promptly, and provide legal guarantee for long-term and standardized implementation of individual monitoring.",13.308071801060132,7.1211821438350205
sustaining innovations improve disrupting technologies or processes,0.291857623643549,1.5626509189605713,2.3367083072662354,429b6267-6da9-4aec-ae38-b19c4ddb7a56,comm_use_subset/Disruptive innovation can prevent the next pandemic,"Transforming PHS to meet the needs of the twenty-first century requires novel approaches. A helpful concept to understand and chart this future is disruptive innovation -a term first introduced by Clayton Christensen to describe innovations in technology and processes that disrupt existing markets (8) . Disruptive innovations occur when advances in technologies or processes create markets in existing industries. This differs from sustaining innovations, where existing practices are incrementally improved to meet the demands of existing customers; in contrast, newly introduced innovations with disruptive potential (typically unrefined, simple, and affordable in character) target lower-end market needs or create entirely new market segments. As sustaining innovations improve disrupting technologies or processes, these new innovations will meet increasingly greater needs, capture greater market share, and eventually reshape the industry. Christensen uses the example of increasingly smaller disk sizes in the hard disk drive industry, the introduction of hydraulic technology in the mechanical excavator industry, and the rise of minimills in the steel industry to demonstrate the impact of disruptive innovations (8) . Here, we describe the need for disruptive innovation in PHS and identify opportunities for disruption in PHS structures and processes.",12.140882709461188,6.783892445358839
may improve our understanding of the etiology of SARI,0.15570241798545753,1.152868390083313,2.5783190727233887,e7faff6c-541f-48a2-b7e5-3d25cb7c744a,"comm_use_subset/Human bocavirus, coronavirus, and polyomavirus detected among patients hospitalised with severe acute respiratory illness in South Africa, 2012 to 2013","Conclusion: Inclusion of laboratory tests for hBoV, hCoV-229E, and hPyV-WU in differential testing algorithms for surveillance and diagnostics for suspected cases of respiratory illness of unknown cause may improve our understanding of the etiology of SARI, especially in a country like South Africa with a high number of immune compromised persons. ",11.964650564507513,6.612899548401986
completeness and timeliness of PHS data,0.15686603334092883,0.5017735362052917,1.746936559677124,6692cad3-1fe0-40e2-b755-3c333b9ba4d6,comm_use_subset/Disruptive innovation can prevent the next pandemic,"Following sustained efforts toward PHSS, PHS can leverage novel, disruptive e-Surveillance approaches using informatics and analytics. Use of improved informatics techniques have been shown to improve completeness and timeliness of PHS data, but this depends critically on uniform standards of reporting, efficient workflow processes, and the willingness of practitioners to adopt disruptive technologies and processes (24, 25) .",14.044626811000084,6.3772809461736
"innovative approaches toward e-Surveillance, like participatory systems and mobile health, can be leveraged to drastically improve detection of public health emergencies",0.18992294983626315,0.8861331343650818,2.297595739364624,860a0b50-1a0e-4f61-878d-ba8b02909eb4,comm_use_subset/Disruptive innovation can prevent the next pandemic,"The desire for comprehensive PHS with interoperable electronic systems and data captured from many sources and across many diseases is not new but is still far from being realized (34) . Disrupting the structures and processes of PHS with novel technologies and processes will help achieve this vision. Strong and sustained investments in PHSS leveraging opportunities in One Health and applied epidemiology training programs will bolster the structures for prevention and response to public health emergencies. As PHSS takes hold, innovative approaches toward e-Surveillance, like participatory systems and mobile health, can be leveraged to drastically improve detection of public health emergencies. The developing world, with limited resources and infrastructure capabilities, and less access to higher market end traditional PHS systems, stand to benefit the greatest from these disruptions. Together, disruptions in structures and processes leading to PHSS and e-Surveillance promise to transform current practice; a new vision emerges where the PHS workforce implements the latest technologies and processes, and the information required to make informed decisions is available when it is needed, where it is needed.",12.017856367303008,6.275673496480362
Disruptive innovation of the informatics and analytics used by PHS can address these gaps and impediments and improve IDSR,0.15258430925824432,-0.3667987585067749,1.4612901210784912,264c7a18-1ca4-4145-b043-ff750f4cd1fb,comm_use_subset/Disruptive innovation can prevent the next pandemic,"Globalization has drastically changed our interactions with the biological world. A novel pathogenic infection discovered in one part of the globe can be easily carried thousands of miles away in a single day. Yet our implementation of the processes of PHS, including various advances in informatics and analytical tools, remains underutilized. As an example, the Integrated Disease Surveillance and Response (IDSR) regional framework, adopted in 1998 by the African regional office for the WHO, is a novel attempt at strengthening PHS capabilities at all levels in Africa (22) . However, as recent studies reveal, this paper-based framework lacks timely reporting of PHS data and has been reported to be generally inefficient, error-prone, incomplete, and untimely (23) . Disruptive innovation of the informatics and analytics used by PHS can address these gaps and impediments and improve IDSR. Developments in electronic health records, interoperability, information exchange, public information sharing, decision support, and cloud technologies are pushing ICT capabilities faster than PHS can evolve for the prevention, detection, and response. Once these advances are implemented, e-Surveillance can be fully realized and leveraged.",12.40148236203575,5.051938212384128
bronchodilators may improve clinical symptom scores,0.43800017033308236,3.176786184310913,3.7766928672790527,2e287ece-349c-4de4-b4be-e3ea32d2f45f,comm_use_subset/Risk factors for bronchiolitis severity: A retrospective review of patients admitted to the university hospital from central region of Slovenia,"Our study also showed that the proportion of children who received bronchodilators was statistically different in the PED, WARD and PICU group (Table 1) . This is probably due to the common practice in several countries (such as United States, Switzerland and Belgium) that children exhibiting a moderately severe bronchiolitis are more often given bronchodilators than those with mild or severe disease. [41] [42] [43] The data on the efficiency of bronchodilators in bronchiolitis are conflicting. 41 Many studies agree that bronchodilators may improve clinical symptom scores, but they do not affect disease resolution, need for hospitalization, or length of stay. 5 interpretation. In addition, children with performed viral diagnosis were younger and were treated in the high seasonal months.",15.429690403407893,9.92015302472624
concomitant blocking of CEACAM1 and immunotherapy with adoptive cellular transfer (ACT),0.2766696231646204,3.0463907718658447,3.1950111389160156,66f09a18-4dc3-4948-ab6f-c9a38e853f72,comm_use_subset/CEACAM1: Expression and Role in Melanocyte Transformation,"In vitro and in vivo studies on melanoma xenografts show that antibodies built to target the extracellular portion of CEACAM1 and to block the N-domain of CEACAM1 (MRG1, a murine IgG1 monoclonal antibody against human CEA-CAM1) did not influence the proliferation rate but facilitate melanoma cell elimination by T cells and have no agonistic effect. Regarding the safety concerns about MRG1 antibody's effect on normal epithelial cells that express CEACAM1 or the effect of activated T cells on normal CEACAM1 positive cells and autoimmune events, it did not directly affect CEACAM1 positive cells and it did not induce nonspecific activation of T cells [53] . It is thought that concomitant blocking of CEACAM1 and immunotherapy with adoptive cellular transfer (ACT) might improve the clinical response [41] .",14.295245502309976,9.060247167816701
significantly reduce mortality of patients infected with the highly pathogenic or pandemic influenza by controlling the fatal CS side effects of disease,0.20805911299310267,2.199706554412842,4.215240001678467,1fad0135-5396-4a8e-868d-7b5e970adc13,comm_use_subset/Medicinal Chemistry Special Report part of,"Mechanistic studies in mice have demonstrated that the efficacy of S1P1R agonist in suppressing CS occurs as a consequence of the systemic inhibition downstream of the myeloid differentiation primary response gene (MyD88) and IFN-Î² promoter stimulator-1 signaling [21] . MyD88 a key component of the innate immune system was identified in the study as the adaptor molecule of the TLR signaling pathway responsible primarily for the cytokine amplification following pathogenic influenza virus challenge. S1P1R agonist AAL-R has shown to significantly reduce the release of inflammatory cytokines while maintaining protective antibody and cytotoxic T-cell responses in mice [21] . These preclinical data highlight the promise of these drugs for treating acute viral infections and suggest that S1P1R agonists could improve clinical outcomes and significantly reduce mortality of patients infected with the highly pathogenic or pandemic influenza by controlling the fatal CS side effects of disease. S1P1R agonists will now be required to undergo future development leading to safety and dose toler-ability testing in Phase I clinical trials before consideration can be given to their use in humans. However, if these potential drug products are found to have good safety profiles there will be a compelling justification for these candidate drugs to be taken forward for full regulatory approval. If these drugs should reach licensure it would greatly enhance our pandemic preparedness not only against influenza but also potential for combating other emerging viral diseases that induce CS (e.g., Ebola, MERS-CoV and SARS).",13.91962831467509,9.041585171595631
applied clinical decision-making and surveillance tools,0.1712303185149832,3.6295244693756104,3.348539113998413,d90db368-7c06-49c5-bbe8-73f7a0e6df87,comm_use_subset/Can an Infectious Disease Genomics Project Predict and Prevent the Next Pandemic?,"Technological advances for basic scientific discovery (such as next-generation sequencers, microarrays, mass spectrometers, cell-based assay methods, and other tools for transcriptome, metabolome, and proteome discovery), novel techniques to increase throughput and/or decrease the cost of analysis, and applied clinical decision-making and surveillance tools (point-of-care diagnostics, rapid multipathogen assays) are in progress and should be supported actively. The IDGP should be informed by and incorporate emerging technology platforms to rapidly develop more accurate field diagnostics and to identify new opportunities for vaccine and drug development.",11.320860145521447,8.498042380125622
veterinary interventions to protect and improve human health,0.25026078344455793,2.1364409923553467,3.9049549102783203,a9d8bfcc-1b0e-4e20-bacf-fc8e14f03ae3,comm_use_subset/Re-imagining the future of diagnosis of Neglected Tropical Diseases,"In 2013, WHO defined a Road Map including five key interventions to help countries reach the 2020 goals [3] . These are: (i) preventive chemotherapy based on large-scale use of safe, single-dose medicines at regular intervals (i.e. mass drug administration, MDA); (ii) innovative and intensive case management; (iii) vector ecology and management; (iv) improvements in water, sanitation and hygiene in NTD-endemic areas; and (v) veterinary interventions to protect and improve human health [2, 3] . While substantial progress has been made in the last decade with chemotherapy reaching a billion people in 2014 [5] , the same cannot be said of diagnostics needed to guide chemotherapy and for surveillance, largely due to the perceived lack of a commercially viable market for NTD diagnostics.",11.593508547852748,7.984635328460346
RDT introduction and implementation must be culturally sensitive and accompanied by an inter-connected system to monitor the necessary processes,0.20674886710068513,0.8292844891548157,1.1884936094284058,e79defe0-692f-49c5-8644-e894aa69eec0,comm_use_subset/Re-imagining the future of diagnosis of Neglected Tropical Diseases,"The barriers faced in implementing testing at the point-of-care are often not technological, but constraints inherent in the health care system. To implement a successful POC diagnostics programme, the engagement of policy makers, stakeholders and partners to ensure buy-in and align necessary resources is a critical first step. Training and certification of vast number of health care providers to use POC diagnostics, and ensuring an effective supply chain for tests and drugs across the country present an enormous challenge to health systems that are already suffering from a critical shortage of human resources. Quality assurance systems, that include providing proficiency testing, sites visits, and corrective action, are essential to ensure that accurate results are being used to guide treatment decisions, and to ensure that control strategies are based on accurate surveillance data. Studies have shown that deployment of POC diagnostics can be an opportunity to improve health outcomes and strengthen health systems [29] [30] [31] . Overcoming challenges will in turn motivate health care workers and increase capacity and efficiency to test and treat appropriately. RDT introduction and implementation must be culturally sensitive and accompanied by an inter-connected system to monitor the necessary processes. Another key barrier to the appropriate use of POC diagnostics is the need to train clinicians to create a demand for them and then use the test results to effectively manage the patients. Improving the laboratory-clinician interface is an important but often neglected aspect of testing introduction.",18.30834744752285,7.71947737071209
contribute to the prediction and prevention of epidemics,0.2000535623420664,1.3172001838684082,2.6958723068237305,12cbaee1-ae1e-4ffd-b793-48baa224625c,comm_use_subset/Can an Infectious Disease Genomics Project Predict and Prevent the Next Pandemic?,"N A range of products that use infectious disease genomic information routinely-such as vector maps, early warning systems, diagnostics, vaccines, and drugs-contribute to the prediction and prevention of epidemics.",14.582451796142353,7.712355247599714
"The project is being implemented in partnership with MOH and C3: Collaborating for Health, UK",0.19993386401829627,3.2960286140441895,2.3246500492095947,5e2a5798-089b-4a38-97da-1cf67867f0c2,comm_use_subset/R E V I E W partnership: experiences of co-learning and supporting the healthcare system in Uganda,"NTU, the lead UK project partner and grant holder, works closely with MakSPH which is the lead Uganda partner responsible for the day-to-day running of activities. To enable smooth implementation of project activities, NTU and MakSPH signed a sub-contract in addition to the funder's contract with NTU. The subcontract stipulates the duties, expected outputs and timelines for both partners. The project is being implemented in partnership with MOH and C3: Collaborating for Health, UK. MOH being the national policy formulation institution provides support in the overall management of the project including planning and implementation of activities. C3 is involved in project management and brought to the partnership a wealth of experience of working with communities in Uganda. Wakiso district health department is involved in project planning and implementation of activities notably training of CHWs and their supervision. All partners are involved in all stages of the project which include preparation, implementation and evaluation. The preparatory phase (November 2014 to April 2015) was completed; implementation phase (May 2015 to October 2016) is currently ongoing; and the evaluation phase (November 2016 to April 2017) will be conducted on completion of implementation of activities.",10.749393085146052,7.415728710916078
Availability of more Aichivirus C sequences will help understand genetic diversity of this virus and facilitate development of appropriate diagnostic assays,0.21906554172005394,2.279099225997925,3.9945273399353027,08928298-86c6-499b-a7be-f1ea3290a942,comm_use_subset/Metagenomic analysis of the RNA fraction of the fecal virome indicates high diversity in pigs infected by porcine endemic diarrhea virus in the United States,"In addition to obtaining mixed viral infection profiles of each sample, complete genome sequences of Aichivirus C and PSV were obtained and further characterized in this study. The clinical significance of PSV has not been confirmed to date, but this complete US PSV genome sequence can facilitate PSV diagnostics and future molecular epidemiological studies of PSV in US swine. It was also demonstrated in this study that there are at least two genogroups of Aichivirus C (PKV-1) circulating in US swine. Currently, Aichivirus C-specific virological and serological diagnostic assays have not been available in most veterinary diagnostic laboratories. Availability of more Aichivirus C sequences will help understand genetic diversity of this virus and facilitate development of appropriate diagnostic assays. The clinical significance of Aichivirus C also remains to be elucidated.",9.06365948301434,7.250138086911617
current systems,0.2896924047187216,2.14699387550354,3.1995434761047363,d5aa80ef-0a1d-41bc-9431-722b39f78ed8,comm_use_subset/Can an Infectious Disease Genomics Project Predict and Prevent the Next Pandemic?,"The data collected must be connected to all relevant information and analytical tools in a single, easy-to-use, open-source, real-time interface. Such a system would improve on current systems by: gathering data across the public domain and working with companies/institutions to harness information in the private domain; linking accurate, annotated sequencing information to functional genomic and proteomic/functional proteomic information; attaching scientific literature associated with all levels of information; and including a self-sustaining financial mechanism potentially based on royalties from commercial products generated from the use of this system.",10.17076144029002,7.035015782646887
"prioritize and advance the development of diagnostics, vaccines, and therapeutics",0.14037043420432188,1.6109340190887451,3.285290241241455,49eab102-649b-4ac5-bfad-5258026345f5,comm_use_subset/Core Minimal Datasets to Advance Clinical Research for Priority Epidemic Diseases,"Ebola virus disease constitutes but one of the priority diseases that the World Health Organization (WHO), in their Blueprint for Action to Prevent Epidemics, suggests poses a severe public health risk and for which there are insufficient countermeasures [1] . The purpose of this priority list is to identify high-threat pathogens for which there is a need to prioritize and advance the development of diagnostics, vaccines, and therapeutics. Any diagnostics, drugs, or vaccines that are developed as a result of this and other initiatives, such as the Coalition for Epidemic Preparedness Innovation, will need to be fully evaluated in diagnostic evaluation studies or phase II and III clinical trials.",10.645377638122397,6.908427942557469
strengthening the collection and curation of epidemiological and observational data that can improve the conception and design of clinical research,0.14427032927901454,1.415921688079834,2.6538782119750977,8bcb12e8-b0c9-463a-a374-9b381fe5d81a,comm_use_subset/Core Minimal Datasets to Advance Clinical Research for Priority Epidemic Diseases,"The Ebola virus disease outbreak in west Africa has prompted significant progress in responding to the clinical needs of patients affected by emerging infectious disease outbreaks. Among the noteworthy successes of vaccine trials, and the commendable efforts to implement clinical treatment trials during Ebola outbreaks, we should also focus on strengthening the collection and curation of epidemiological and observational data that can improve the conception and design of clinical research.",10.43420409608866,6.2973413686667365
IDSR implementation is to strengthen the district level,0.2457159781794229,1.5993366241455078,3.136484146118164,ff02a04f-164b-41f1-bb00-96baf8294a4d,comm_use_subset/Strengthening systems for communicable disease surveillance: creating a laboratory network in Rwanda,"Because a major focus in IDSR implementation is to strengthen the district level, the ongoing decentralization process provides a good opportunity for expanding IDSR implementation in all districts. Recently, a Field Epidemiology and Laboratory Training Program was established which will eventually result in considerable capacity building, especially if the applied training program is accompanied by a well-structured human resources plan for a career path through and retention of competent laboratory staff at all levels of the network.",9.154918323582791,6.282504913925363
steroid treatment did not improve clinical outcomes,0.1832362595031149,1.906595230102539,1.8819143772125244,88094e6d-a2c4-4d94-9172-8f097d1d9f25,comm_use_subset/Medicinal Chemistry Special Report part of,"A number of anti-inflammatory drugs (administered as either as mono-or combination therapies) have been evaluated for the treatment of CS during infections with influenza. However, one example illustrates the therapeutic challenges associated with administering anti-inflammatory drugs as monotherapies for treating acute viral infections. It was found that glucocorticoid treatment administered for the suppression of cytokine production did not protect mice from lethal infection with HPIA (A/Vietnam/1203/04 H5N1) [16] . Further, in human case studies during the H5N1 outbreaks in Southeast Asia patients who were treated with steroids such as dexamethasone and methylprednisolone (with or without the antiviral drug oseltamivir) were found to have high mortality rates and steroid treatment did not improve clinical outcomes [9] . The use of COX-2 inhibitors (celecoxib, mesalazine), both as a monotherapy and in combination with the antiinfluenza drug (neuraminidase inhibitor zanamivir), has also been considered within experimental models of influenza. It was found that COX-2 inhibitors enhanced the antiviral efficacy of zanamivir in the treatment of mice against infection with influenza A/H5N1 virus [17] . In this study, all treatments were administered at 48 h post challenge to mimic the timely lines associated with diagnosis in a clinical setting. Under this treatment regimen, the use of zanamivir alone did not result in significant improvement in the survival rate (13.3%), but enhanced survival (10.7 days) when compared with the untreated control group (0% survival at 6.6 days) [17] . Zanamivir alone did reduce virus load in the lungs, but not inflammation and mortality. Similarly, the use of COX-2 inhibitors alone (celecoxib or mesalazine, or both) did not provide any improvement in the survival rate (0% survival) but prolonged survival time (between 8.5 and 9.5 days compared with 6.6 days for control). However, when the infected mice were treated with a triple combination of zanamivir, celecoxib and mesalazine administered at 4 h post virus challenge, there were significant improvements in the survival rate (53.3%), prolongation of [29] Combination therapy Antiviral plus anti-inflammatory drugs Zanamivir plus COX-2 inhibitors Oseltamivir plus S1P1R agonists",9.044813587663786,5.628216000437116
"there is a strategic plan with defined goals for IDSR in place, implementation of the plan has yet to be fully implemented",0.1136218169498615,0.1940344125032425,1.4032145738601685,61f74eee-63bc-492a-afd9-e475357d7fa9,comm_use_subset/Strengthening systems for communicable disease surveillance: creating a laboratory network in Rwanda,"One of the major limitations cited by participants has been the delayed implementation of IDSR in Rwanda. Without a functional IDSR strategy in place, health staff reported that the role of laboratory is not well understood in its context of a broader public health surveillance network. While there is a strategic plan with defined goals for IDSR in place, implementation of the plan has yet to be fully implemented. At the time of this review, the surveillance and reporting system was using multiple forms from a variety of implementing partners resulting in a duplication of effort and resources.",9.012630007264885,4.192632343678927
Future studies for rapid point-of-care testing for respiratory viruses might improve clinical care by reducing unnecessary antibiotic use,0.16525996784402888,0.7982203364372253,1.9452098608016968,e9c859d3-5a18-4d70-95f4-f24579e0cc4a,custom_license/The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programs,Future studies for rapid point-of-care testing for respiratory viruses might improve clinical care by reducing unnecessary antibiotic use [18] . Future cost-effective studies for the implementation of MRT will be useful.,30.06770035418501,12.306924752170053
algorithm adherence needs to improve,0.38962006676286565,4.336513519287109,4.087090015411377,205fe2d0-c8f1-4b1a-9516-1b9d4f1798fa,custom_license/Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial,"Nevertheless, the lessons learned from this study should facilitate the design of larger, definitive US trials. Although our study clearly demonstrates the feasibility of performing PCT trials in the United States, a number of factors need consideration. First, hospital stays for nonpneumonic LRTI tend to be brief, and thus the opportunity to intervene is limited. To maximize impact on antibiotic exposure, the intervention should begin early, ideally in the emergency department. Second, algorithm adherence needs to improve, although clinical judgment remains the cornerstone of good medical care, and 100% compliance should not be the goal. Future trials should therefore incorporate strategies to influence physician behavior, such as the use of antibiotic stewardship teams to reinforce PCT algorithm recommendations. Because a study effect appeared to be an important impediment to demonstrating a significant difference in antibiotic exposure or the independent effect of viral testing, future trials may need to use separate but comparable study sites for the intervention and nonintervention groups. Finally, once the safety of PCT-guided care in patients with LRTI at lower risk for bacterial infections has been established, its use should also be explored for subjects with pneumonic disease.",12.310378482015743,9.783974766259526
"exploited polymerases to incorporate, from triphosphates, the isoC:isoG pair into duplex products",0.27551699621053977,2.657329559326172,3.4648895263671875,7bfe4aef-2de1-4e14-9233-f3ab438c52e0,custom_license/Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA HHS Public Access,"The AEGIS:AEGIS isoC:isoG pair was introduced a decade ago into a diagnostics kit that exploited polymerases to incorporate, from triphosphates, the isoC:isoG pair into duplex products [5] . Unfortunately, isoG exists (~10% of the total) in a minor tautomeric form that is complementary to natural thymidine, not to IsoC. This required those tools to add isoGTP opposite isoC in a template and not the reverse; if isoG were in the template, T would be mis-incorporated opposite isoG a substantial fraction of the time. Nevertheless, even with this constraint, assays were commercialized that combined the isoGTP:isoCTP pair with polymerases to detect nucleic acids from a panel of respiratory disease agents [6] .",11.246876170133332,7.91584906524735
There are two commercial products presently available for diagnosis of cryptosporidiosis,0.31566973719751357,2.005812883377075,3.2250216007232666,e3def1b4-eab3-4f65-a011-d7f8fb3e0b5f,custom_license/Cryptosporidiosis in Idaho lambs: Natural and experimental infections,"Most clinical laboratories attempt diagnosis by fecal examination. These lab oratories use acid-fast staining methods on fecal samples and may or may not attempt concentration of the oocysts in the stool. However, immunofluorescent microscopy, which has great sensitivity and specificity, is the method of choice for examination of fecal and environmental samples. There are two commercial products presently available for diagnosis of cryptosporidiosis. MeriFluor Cryp tosporidium is an immunofluorescent assay system based on an oocyst-specific monoclonal antibody that is produced by Arrowood and Sterling Arrowood and Sterling, 1989) . It is marketed by Meridian Diagnostics, Inc.",12.809537579951265,7.883380567648165
provides reviewers with knowledge to understand the products they regulate,0.31954653854058757,1.9745337963104248,2.4939041137695312,deac8a52-2646-4d08-9b49-c0a5f3c00b87,custom_license/C O M M E N TA RY C O M M E N TA R Y npg,"For those who want to further their careers as researchers, an important feature that distinguishes the FDA is that scientists conduct research in parallel with their regulatory review duties or are in direct contact with teams of reviewers for products under clinical development. Thus, they are uniquely positioned to understand the challenges that limit the clinical development or regulation of therapeutic products. Accordingly, research projects are geared toward the acquisition of critical knowledge in areas that facilitate the development of novel regulatory paradigms and provide scientific support for the development and application of new regulatory policy and decision-making. While undertaking a dual role as a researcherreviewer can be challenging, the hands-on expertise in bioanalytical methods in silico and in vitro, as well as in animal models that can be used to improve product characterization, provides reviewers with knowledge to understand the products they regulate. Conversely, the firsthand experience with regulatory submissions allows researchers to formulate questions that address scientific gaps that needed to be filled to support regulatory decision-making.",13.836941175566453,7.74741405300023
the reaction conditions were optimized by varying the catalysts,0.16221855418848435,2.7653160095214844,3.091386556625366,d30e2efe-5b23-4885-b61c-e636e0a56f5b,"custom_license/Facile cleavage of CeC bond: conversion of pyrane derivative to 1,3-oxazin derivative","In the initial studies, the mixtures of compound 1 and acetic anhydride 3 were heated at the temperature in the range of 60e120 C without a catalyst. Only trace amount of products were formed even extending the reaction time to 12 h. To improve the yield, the reaction conditions were optimized by varying the catalysts. The results showed that the pyridine-catalyzed reaction gave the highest yields, as illustrated in Table 1 .",11.23298606326124,7.738401790136887
"Interaction with WHO's IPAC and PQ teams will increase going forward, to strengthen the link between product development and programmatic requirements",0.1774861548035022,1.8084206581115723,3.05782413482666,33cc739f-854a-4c2f-8c90-7d303b0816ff,custom_license/the WHO Product Development for Vaccines Advisory Committee 1,"With RSV, TB, HIV and enteric candidates approaching pivotal data points, understanding what data are needed to support earlier policy implementation and outcomes will be key, as well as understanding the potential impact of vaccines within the broader control strategy -including diagnostics and other preventatives -for these pathogens. Vaccine impact modelling, and understanding the composite set of cost drivers through to vaccine delivery will be important. Interaction with WHO's IPAC and PQ teams will increase going forward, to strengthen the link between product development and programmatic requirements.",13.064568057233874,7.735657935441707
These products also should be carefully evaluated for their composition and concentration by the investigators of the clinical trials to ensure efficacy and reproducibility of results,0.16375629607296727,1.4872862100601196,3.267857313156128,7285dc4b-518f-4f98-b2cf-e5ba69873522,custom_license/Probiotic Use in Horses -What is the Evidence for Their Clinical Efficacy?,"Based on lack of regulation regarding quality control of commercial products, use of over-the-counter products is questionable, particularly in the absence of scientific information on safety and clinical efficacy. Efficacy trials should be conducted and published in peer-reviewed journals before recommending use. These products also should be carefully evaluated for their composition and concentration by the investigators of the clinical trials to ensure efficacy and reproducibility of results.",11.618665866705463,7.157376343437472
microbiologic diagnostics,0.25153548144785765,1.5808143615722656,2.219564914703369,7b3d33fa-3b58-43e4-9e9c-08c7067e9069,custom_license/Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy,"Because of this assay and other advances in microbiologic diagnostics (eg, PCR testing [4] ), bronchoscopy has supplanted surgical lung biopsy as the first-line invasive diagnostic procedure for the evaluation of pulmonary lesions in HCT recipients. Early diagnostic bronchoscopy is now recommended over empiric treatment in HCT recipients with evidence of specific pulmonary processes [23] and is likely to have higher yield when clinical suspicion of infection is high [24] . This shift in practice is illustrated by the increasing proportion of lung biopsy recipients who underwent an antecedent bronchoscopy with BAL in the late cohort compared with the early cohort. As a consequence, the cohort of patients who underwent surgical lung biopsy performed in the latter cohort are likely to be a highly selected group for whom empiric therapy with anti-infective agents did not improve the infiltrates, bronchoscopy did not yield a diagnosis, or surgery was performed for therapeutic intent. Most surgical procedures for fungal disease were performed for therapy of established Mucorales spp. infection, which were the most common invasive fungal disease in the late cohort. This epidemiology is consistent with the use of empiric voriconazole compared with the early cohort, given that Mucorales spp. are not susceptible to voriconazole [25] .",12.551764772383269,6.863364199913306
the systems could yield numerous destructive or useless gene products,0.2914982239012748,2.194533109664917,2.125258445739746,d3819dec-8020-4c73-b838-669075d51d96,custom_license/In Silico Models: From Simple Networks to Complex Diseases Chapter Outline,"Within biological systems, several activities involving the basic units of a gene take place. Such processes as DNA replication, and RNA translation and transcription into proteins must be controlled; otherwise, the systems could yield numerous destructive or useless gene products. Transcriptional control networks, also called gene regulatory networks, are segments within the DNA that govern the rate and product of each gene.",10.77961640020505,6.580730251084798
now commercially available.,0.14436422678180721,-0.8969574570655823,0.5531777739524841,a808be45-b727-40c4-aefb-591c589fca79,custom_license/In Silico Models: From Simple Networks to Complex Diseases Chapter Outline,"Animal biotechnology is a source of innovation in production and processing, profoundly impacting the animal husbandry sector, which seeks to improve animal product quality, health, and well-being. Biotechnological research products, such as vaccines, diagnostics, in vitro fertilization, transgenic animals, stem cells, and a number of other therapeutic recombinant products, are now commercially available. In view of the immense potential of biotechnology in the livestock and poultry sectors, interest in animal biotechnology has increased over the years.",19.26539695344315,6.519432139681588
The Cartagena Protocol on Biosafety was recently adopted by many countries in an attempt to standardize risk management,0.12209582878623232,1.2333757877349854,1.889397144317627,f31b862e-3e20-4e06-bc47-708255a638b6,custom_license/Risk analysis for plant-made vaccines,"The Cartagena Protocol on Biosafety was recently adopted by many countries in an attempt to standardize risk management for products such as PMVs. It is heavily dependant on the definition and use of the Precautionary Principle. As reviewed by Conko (2003) , this principle is one of risk management rather than risk assessment per se, and is used most frequently for 'cases such as the introduction of entirely new products and technologies'. The variety of possible definitions and subjective application of the Precautionary Principle provide significant doubt for how PMVs might be regulated in many countries, particularly developing countries. Conversely, the existing premarket review and approval processes in the US are well established and expected to adapt to new technologies for transgenic plant products.",11.626790981413091,6.099179249328779
China s u m m a r y Objectives: To understand the advancements in and barriers to the implementation of measures to improve basic public health services,0.22725667475021108,0.4065382480621338,0.3352762758731842,0320ef4f-58e5-49b3-ae58-31612570aff7,custom_license/Basic public health services delivered in an urban community: a qualitative study,China s u m m a r y Objectives: To understand the advancements in and barriers to the implementation of measures to improve basic public health services in an urban Chinese community.,15.92917332846576,6.057390105520972
"heat stability, oral administration, and exclusion of contaminants such as prions",0.1675912983204714,1.443938970565796,1.6405795812606812,fc5bbc83-17b6-4698-91fb-214600c26d1f,custom_license/Risk analysis for plant-made vaccines,"The potential benefits of PMVs have been widely discussed and include heat stability, oral administration, and exclusion of contaminants such as prions. Advantages pertaining to cost of production have also been stated, but recent cost modeling suggest that this assumption may be premature for freeze-dried products (Kirk & Webb, 2005) . The conventional framework for risk analysis does not look outwardly from the technology to ask what external forces may risk the implementation or success of new opportunities, which in turn would deny the potential benefits. As part of this discussion we propose two global risks to the technology.",10.726571040047439,5.759236922703813
hospitals are able to improve their operating efficiency without sacrificing their healthcare quality,0.2178342181247761,1.6073529720306396,1.1703952550888062,27216b7a-2fb8-46fb-8496-c5023ac059ff,custom_license/Taiwan quality indicator project and hospital productivity growth,"The goal of TQIP is to promote overall healthcare quality. In this study, we empirically evaluate the impact of TQIP adoption on hospital productivity and healthcare quality. Using the empirical data on 31 TQIP regional hospitals in Taiwan over the periods 1998-2004, we examine the impact of TQIP on productivity change, quality change, and relative efficiency change. In particular, we analyze the changes in efficiency and quality derived from the Malmquist productivity change index. Our results indicate that hospitals had improved their healthcare quality, efficiency, and total productivity from the pre-TQIP period (1998) to the post-TQIP implementation period (2002 and 2004) . Efficiency and quality improve concurrently after TQIP participation, which coincides with the philosophy of TQM. That is, hospitals are able to improve their operating efficiency without sacrificing their healthcare quality.",10.778946559466288,5.578167643440841
could potentially reduce mortality and improve clinical outcomes.,0.22819287677090902,1.6157188415527344,3.2800192832946777,f02350e8-7da3-4d99-ac12-c63a9aca5a6b,custom_license/Point-of-Care Device Design 1457 2. Inorganic Biomarkers of Infectious Diseases 1458 2.1. Hemozoin 1458 2.2. Iron in Schistosome Eggshells 1460 3. Metal-Based Sample Preparation 1461 3.1. Metal-Affinity Separation 1462 3.2. IMAC on Magnetic Particles 1463 4. Metal-Based Signal,"Finally, the continually increasing connectivity in low-and middle-income countries coupled to sensitive diagnostics will allow for real-time disease surveillance, intervention analysis, and epidemiological studies. ""Connected"" diagnostics have the potential to accelerate communications between field workers, local health outposts, district hospitals, and national health ministries. The ability to rapidly convey diagnostic results could not only enable active case detection strategies but also would provide faster responses to epidemics such as the 2014â 2016 Ebola and 2015â2016 Zika outbreaks. These faster responses could potentially reduce mortality and improve clinical outcomes.",23.52651415195195,11.416509734334001
decision-making,0.23288267047873912,2.0181527137756348,3.6800761222839355,060db223-5e84-4fde-bcca-a3550799aa88,"custom_license/Saudi Arabia b King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia c King Fahad General Hospital","Despite these limitations, the model developed shows promise for the identification of suspected MERS-CoV cases in clinical practice. This model could be applicable in various healthcare settingsinpatient, outpatient, and emergency departmentsbecause no extensive laboratory testing is required and samples may be available within short turnaround times. This may allow rapid evaluation and improve clinical decision-making.",20.411376544204472,10.847830533910285
Implementation of mobile communication platforms may significantly improve the management of infectious diseases,0.18975391948277717,3.347118377685547,4.474616527557373,5509f862-e4cb-4d4e-a1cd-9504fcd53023,custom_license/Hot topics in infection control,"Currently, Labor Berlin is serving 12 hospitals in Berlin comprising three campuses of the CharitÃ© -University Medicine Berlin, nine community hospitals of the Vivantes Group Berlin, and an increasing number of hospitals inside and outside of Berlin, the majority of which representing tertiary and specialty care hospitals. We are in the process of implementing full microbiology laboratory automation to provide timely information relevant for patient care. So far, the majority of processes are controlled by a laboratory information system (LIS) that is also transmitting the results to the hospital information system (HIS). At present, urgent results, such as the identification of bacteria causing bloodstream infections or the antimicrobial susceptibility data of multiresistant pathogens are communicated via phone by clinical microbiologists, which also regularly participate on clinical rounds to discuss critical patients. However, the mere number of hospitals and there geographic distribution makes direct communication ever more difficult. We are, hence, forced to apply new information technology to collect clinical data required both for prioritizing tests and for interpreting test results. This requires an intelligent, versatile and open middle ware that not only controls the lab organization but also communicates with existing laboratory or clinical information systems without compromising data safety and security or strangling the capacity of exiting IT divisions. The use of smartphones or other personal digital assistants over wireless broadband or 3G networks represents a promising way for real-time clinical alerts with or without decision support both for antimicrobial therapy or hospital hygiene. Implementation of mobile communication platforms may significantly improve the management of infectious diseases thus preventing further development and spread of antimicrobial resistance.",13.690596635928397,9.875836510982836
(4) integration into current health systems,0.2775991250159534,2.5632824897766113,3.472842216491699,77c0fe76-f1f2-49a8-85b6-e326d8e33908,custom_license/Point-of-Care Device Design 1457 2. Inorganic Biomarkers of Infectious Diseases 1458 2.1. Hemozoin 1458 2.2. Iron in Schistosome Eggshells 1460 3. Metal-Based Sample Preparation 1461 3.1. Metal-Affinity Separation 1462 3.2. IMAC on Magnetic Particles 1463 4. Metal-Based Signal,"Review and (4) integration into current health systems. Most of the metal-based strategies for improved infectious disease diagnostics presented in this review have demonstrated some level of feasibility in a small set of patient or mock clinical samples. However, new technology must be clinically validated on a large set of patient samples from endemic regions before implementation. Such studies provide insight into the diagnostic performance and tolerance of day-to-day and interpatient variation in the appropriate clinical context. This rigor can draw attention to challenges and weaknesses that would otherwise go unnoticed in a research laboratory setting.",15.31233153985097,9.282797098022241
When antibody testing is desired in order to evaluate a possible poststreptococcal illness,0.1869249238758886,3.1648473739624023,4.083725929260254,10a7fb71-e5c0-4f2f-bd1c-69f9f7b82093,custom_license/Sore Throat,"Testing patients for serologic evidence of an antibody response to extracellular products of GAS is not useful for diagnosing acute pharyngitis. Because it generally takes several weeks for antibody levels to rise, streptococcal antibody tests are valid only for determining past infection. Specific antibodies that are often measured in the appropriate clinical setting include antistreptolysin O (ASO), anti-DNase B, and antihyaluronidase (AHT). When antibody testing is desired in order to evaluate a possible poststreptococcal illness, more than one of these tests should be performed to improve sensitivity.",12.543303961545003,9.101729033635477
Strategies to improve the timely implementation of appropriate antimicrobial therapy are clinically warranted,0.29527488863879864,3.2541635036468506,3.0525054931640625,75b82f56-a8e7-431c-824f-e236a0a84929,custom_license/Hot topics in infection control,"Conclusion: All published studies report a positive save-cost difference for intervention control interventions aimed at prevention and eradication of MRSA in hospitals. Objectives: Recent data showed that the burden of multidrug-resistant microorganism is going to exponentially increase in a few years. Therefore, a significant implementation of isolation procedures in Gram-negative bacilli (GNB). Strategies to improve the timely implementation of appropriate antimicrobial therapy are clinically warranted. TheraDoc Ã is an electronic data capture system that has the ability to send real-time alerts to clinicians via email or electronic page when culture information is updated. The objective of this study was to assess if TheraDoc Ã could be utilized to decrease TTAT and improve outcomes of patients with GNB.",13.756266816276703,8.91402823362394
map the process of prescribing an antibiotic and design tests of change to improve clinical practice,0.2549424961400476,1.8980796337127686,3.6543242931365967,d7095640-1215-4b41-a3b8-7fff6dd634fa,custom_license/Hot topics in infection control,"Results: By March 2011 CDI rates in Scotland had reduced by 77%. For indicator A, in acute admission units median compliance was 93% for indication documented and 83% for compliance with local policy. For indicator B compliance was >90% in a variety of surgical specialties. Following revision of the indicators, in September 2011 for indicator A median compliance was 93% for indication documented and 83% for compliance with local policy and analysis of information on deviation from policy showed common themes. A breakthrough collaborative of clinical teams comprising managers, medical, nursing and pharmacy staff was set up to map the process of prescribing an antibiotic and design tests of change to improve clinical practice. For indicator B, by September 2011 median compliance with antibiotic policy was 100% and median compliance with single dose was 95%. The measures are being integrated within the surgical checklist to achieve sustainability. Conclusion: Prescribing indicators are an effective means of improving antimicrobial prescribing. The combination of measures for scrutiny with improvement methodology can lead to reliable and sustainable improvements in prescribing practice.",14.6974441439611,8.753168002838471
to improve the detection of respiratory viral pathogens,0.18759159830451475,1.2892906665802002,4.051265239715576,366fcafd-e71e-4379-8249-af7db94b9261,custom_license/Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus,"In conclusion, RSV infection is frequent in adults with CAP in Santiago, Chile. Sensitive complementary methodologies for detecting RSV should be included in the laboratory tests for identifying the etiologic agents of pneumonia in adults. Molecular diagnostics such as rtRT-PCR is one such test that should be implemented in clinical viral laboratories to improve the detection of respiratory viral pathogens. In addition, serologic assays, especially the microneutralization test, complement molecular diagnostics. Newer, faster, and easier serologic methods, such as flow cytometry-based assay to detect RSV-specific neutralizing antibody [30] , could facilitate the use of serology as a reliable diagnostic method. A safe and effective RSV vaccine would also be beneficial for the adult population. ",13.616631924271108,8.237182512587143
therapeutic strategies that might be used to improve the clinical prognosis of these infections.,0.19908999180722872,1.5223848819732666,2.836867094039917,dc8d634f-d15c-45e6-a1e3-2071fd24a086,custom_license/The cytokine storm of severe influenza and development of immunomodulatory therapy,"In the event of influenza infection, the severity of disease is the result of the interplay between viral virulence and host resistance. In mild infection, the host has a limited or moderate resistance, so the disrupted homeostasis is restored rapidly. However, for infections caused by the 1918 H1N1 or the H5N1 influenzas virus, the resistance became hyperactive, resulting in an excessive inflammatory reaction known as the cytokine storm phenomenon. 6 Several experimental studies and clinical trials suggested that cytokine storm correlated directly with tissue injury and an unfavorable prognosis of severe influenza. 7 However, our understanding of the mechanism that promotes a cytokine storm remains limited. In this review, we focus on the potential mechanisms responsible for severe influenza-induced cytokine storm and the therapeutic strategies that might be used to improve the clinical prognosis of these infections.",15.32431181652964,8.197022920193943
so that they are compatible with PAPRs,0.31788472736704154,1.4617633819580078,2.7830395698547363,60f1bfe0-1f6c-4afa-906f-0a2fed0d61d4,custom_license/Airborne Precautions and Personal Protective Equipment: The Powered Air-Purifying Respirator-Only Approach,How do we improve products such as stethoscopes so that they are compatible with PAPRs?,14.633854403013036,7.880970959732846
lateral flow assays for companion diagnostics or as ASSURED devices in low resource settings,0.2078354794015302,1.8858988285064697,2.9096856117248535,1e9ece30-fa63-4478-8c85-9cd1891e7fae,"custom_license/Recombinase polymerase amplification: Basics, applications and recent advances","The focus of a large number of RPA related publications details the use of RPA in lateral flow formats, but to date there is no report of a completely integrated paper analytical diagnostic device, which only requires end-user addition of blood/saliva/urine/food/ environment sample. Innovative approaches for the application of temperature to facilitate efficient execution of RPA at the point-ofneed/care have been reported and cost-effective, efficient solutions are available. As yet RPA has not been approved by the FDA and is destined for research only applications and it can be expected that the technique will be validated and approved for medical diagnostics in the near future, facilitating the true implementation of RPA in lateral flow assays for companion diagnostics or as ASSURED devices in low resource settings.",12.572211459344661,7.517403896920991
efficient and selective cellsurface protease-catalyzed reactions in biological processes,0.10504297135823658,1.4427353143692017,2.7738490104675293,6e3edb5e-0ee1-41f0-99c5-d7cb3408fa3d,custom_license/Distinct cellular functions mediated by haemopoietic cell-surface proteases,A current speculation concerns cell-surface proteases and their contribution in the conversion of peptides and proteins. Further studies are needed to improve the 'planning' of efficient and selective cellsurface protease-catalyzed reactions in biological processes.,12.926180829774443,7.2649431015649295
Tourism demand recovery processes by Model 3 were simulated under the following simulation conditions,0.28402648839446537,1.7497525215148926,1.116674542427063,a4582e4d-f61b-478c-b311-630cbbeb9067,custom_license/Analysis of optimal timing of tourism demand recovery policies from natural disaster using the contingent behavior method,"Tourism demand recovery processes by Model 3 were simulated under the following simulation conditions (SCs). Here, the interpretations for the superscripts and subscripts of SCs are same as IPA and IPB variables, as mentioned earlier. A policy variable that equals 1 (e.g., IP safe Â¼ 1) refers to an implementation of the policy, and 0 (e.g., IP safe Â¼ 0) refers to no implementation. For simplicity, the policy effect was assumed to sustain from the starting point (1st week) to the terminal point (52nd week). For example, the effect of safety information beginning at the 1st week continues until the 52nd week.",13.330013703441022,6.5286823877666285
Identification of barriers to an early switch strategy,0.32957719621534215,1.4447319507598877,1.4589539766311646,a25f9a3e-d304-4f6d-954d-7777889b2c9c,custom_license/Hot topics in infection control,"Identification of barriers to an early switch strategy may form the basis of a targeted intervention to improve implementation. Objectives: To evaluate whether physicians base the switch to oral treatment on guideline advice, which patient and physician factors influence a switch to oral treatment and whether physicians perceive barriers to an early switch.",12.471978786091825,6.252588427936322
Lattice Boltzmann methods have been popular due to their ability for parallelization,0.12520334647003353,1.4721951484680176,0.6500639319419861,b68eb932-a717-428e-bfa7-c1b4db4cc88f,custom_license/Constructing Markov matrices for real-time transient contaminant transport analysis for indoor environments,"There have been some promising advances that enable simulating fluid behavior in real time. These include Fast fluid dynamics, lattice Boltzmann methods, and Markov methods. Fast fluid dynamics (FFD) [36] uses a set of low order schemes and a semilagrangian approach for advection to reduce computing cost. Comparisons of FFD and CFD along with implementation of FFD on graphical hardware with promising results have been recently accomplished by Zuo et al. [45, 46] . The lattice Boltzmann method uses kinetic theory to incorporate physics of micro/mesoscopic processes on the behavior macroscopic modules [9] . Lattice Boltzmann methods have been popular due to their ability for parallelization and implementation on graphical processing units (GPU)s [4, 42] . The third alternative is Markov matrices methods that are the focus of the current work.",12.453539817513864,5.738207338396354
"Since the late 2000s, commercial manufacturers of in vitro diagnostic products have invested significant resources into the development of Disclosure Statement",0.33306494395602126,4.392768383026123,4.924979209899902,1ba9dc3a-87af-4357-aa39-71882ad63247,custom_license/Direct-from-Specimen Pathogen Identification Evolution of Syndromic Panels,"Clinical laboratory testing for pathogens associated with a specific syndrome have historically relied on multiple different analytical approaches to maximize broad pathogen detection. This is especially true for organisms for which culture was not a feasible modality, and instead culture-independent methods such as antigen detection, direct staining, or targeted polymerase chain reaction (PCR) were the aggregate conventional methods. Since the late 2000s, commercial manufacturers of in vitro diagnostic products have invested significant resources into the development of Disclosure Statement: M.R. Couturier receives household income from BioFire diagnostics and is involved in clinical trials activities with Luminex (Verigene). J.D. Bard is a consultant for Bio-Fire Diagnostics and Accelerate Diagnostics and is involved in clinical trials activities with Bio-Fire Diagnostics, Luminex Corporation and DiaSorin Molecular. a ARUP Laboratories, University of Utah, 500 Chipeta Way, Salt Lake City, UT 84108, USA; b Microbiology and Virology Laboratories, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Boulevard MS#32, Los Angeles, CA 90027, USA multiplex molecular diagnostic assays that are capable of detecting a broad array of pathogens that collectively could cause a single clinical syndrome. This became known as the syndromic panel approach to pathogen testing, and this avenue of test design and development has carried through the recent decade with an evergrowing portfolio of offerings from various in vitro diagnostic manufacturers.",14.882168437080402,11.265294888380058
systemic corticosteroids improve the clinical outcome,0.2028624162034466,1.541009545326233,2.1866135597229004,e0365315-a3df-494c-8c56-370ed2dd2cda,custom_license/Adjunctive therapies and immunomodulatory agents in the management of severe influenza,"Although numerous RCTs have suggested that systemic corticosteroids improve the clinical outcome in patients hospitalized with community-acquired pneumonia (CAP) (Nie et al., 2012) , it must be pointed out that these studies included predominantly CAP cases with bacterial that had received appropriate antibiotic therapy; the favorable results therefore cannot be generalized to CAP with viral (Lee and Hui, 2011) .",20.291408223805988,9.524947896614032
microbiologic eradication was significantly greater in the patients receiving aerosolized antibiotics.,0.19971652502463064,2.1968894004821777,2.416757822036743,d8556c38-3823-4a31-a9b7-6cad0e2e4ea9,custom_license/Antibiotic Use in the Mechanically Ventilated Patient,"In mechanically ventilated patients, local antibiotic administration, by instillation or nebulization, has been used to prevent pneumonia. In general, this approach is not recommended, because even when it has been successful, there has been concern about the emergence of MDR gram-negative bacteria in patients who subsequently do develop infection, and these organisms may be difficult to treat. Only one prospective randomized trial has examined the impact of the adjunctive use of locally instilled tobramycin with intravenous agents in the management of VAP. 21 Although the addition of endotracheal tobramycin did not improve clinical outcome compared with placebo, microbiologic eradication was significantly greater in the patients receiving aerosolized antibiotics.",16.76113308396741,8.865267274025893
the control of pathogens and (iv) industrial purification processes,0.12610945329945072,2.89346981048584,3.7620482444763184,ffddca4b-c982-43f3-8e44-4c0db74b98cd,custom_license/Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticals,"With a short period of time, the production of recombinant plant-derived antibodies has moved from theory to Phase II clinical trials. According to the Pharmaceutical Research and Manufacturers of America (see http://www.pharma.org), recombinant antibodies represent the single largest group of biotechnology-derived molecules in clinical trials occupying 20% of all biopharmaceuticals and are expected to reach five billion dollars prospective market by 2005. This is likely due to the fact that antibodies have a large diversity of potential applications including use in -medical diagnosis and therapy, -the detection and removal of environmental contaminants, -the control of pathogens and (iv) industrial purification processes. Among the products with significant potential are the following:",11.879021977014101,8.483744427680339
Implementation of such methods into routine diagnostic of highly dangerous pathogens,0.22220765759612787,1.7147325277328491,2.7105162143707275,83ccd168-b512-4e5a-b7d1-253d87b1140c,custom_license/The utility and perspectives of NGS-based methods in BSL-3 and BSL-4 laboratory -sequencing and analysis strategies,"Modern diagnostics is in general based on molecular biology methods. Nowadays sequencing-based methods, especially whole genome sequencing, are becoming increasingly important. Implementation of such methods into routine diagnostic of highly dangerous pathogens, like Bacillus anthracis, Francisella tularensis, Yersinia pestis, Ebola virus, MERS, Lassa virus etc. would be very helpful. The best diagnostic strategy would be the metagenomic sequencing directly from the clinical sample. Implementation of majority of currently available WGS platforms inside the BSL-3 or 4 laboratory is impractical because of the size of the equipment and time consuming wet lab part (e.g. library preparation). Nowadays there is a possibility to implement pocket size MinION -real time whole genome sequencer into BSL-3 and 4 laboratory for rapid and precise diagnostic purposes.",14.7151158179745,8.0267022186584
all will be called on to provide care for an overwhelming number of critically ill patients.,0.2968548243943297,2.606264352798462,3.1105949878692627,3c1430bb-16fb-413e-af72-aa0c3a4c0627,custom_license/Definitive Care for the Critically Ill During a Disaster: Medical Resources for Surge Capacity*,"The use of specially trained physicians to care for critically ill patients is becoming the norm for ICUs and has been recommended as a model to improve critical care for the future. 65 Intensivists come from a variety of backgrounds, including internal medicine, subspecialty-trained internists (most commonly pulmonologists, but also cardiologists, nephrologists, and infectious disease specialists), anesthesiologists, emergency medicine physicians, and general or specialty-trained surgeons. During EMCC implementation, all will be called on to provide care for an overwhelming number of critically ill patients.",11.871030028845574,7.870819081529971
diagnostic accuracy of the POCT need to improve and the impact of POCTs on clinical decision making should be further assessed.,0.141661933656577,2.3033359050750732,1.7269797325134277,92f20995-4d1a-4f9e-b43b-c3944545206c,custom_license/Diagnostic performance and clinical feasibility of a point-of-care test for respiratory viral infections in primary health care,"In summary, diagnostic POCTs for respiratory viruses might contribute to a precise and evidence-based diagnosis of RTIs. In this prospective study we determined the diagnostic performance and clinical feasibility of the mariPOC Â® , a POCT for the detection of respiratory viruses, in a Dutch family practice. Although the availability of a POCT was appreciated by both patients and GPs, sensitivity of the test was lower than expected. Before implementation of diagnostic POCTs in primary health care, diagnostic accuracy of the POCT need to improve and the impact of POCTs on clinical decision making should be further assessed.",14.532598266438349,7.706114557685947
routine diagnostics of class 3 and 4 pathogens,0.11027511739623815,1.8741681575775146,2.849306106567383,42cfed43-3e50-4511-8cb9-4d4fa64e87ce,custom_license/The utility and perspectives of NGS-based methods in BSL-3 and BSL-4 laboratory -sequencing and analysis strategies,"There are also some disadvantages of implementation of WGS analysis for routine diagnostics of class 3 and 4 pathogens. First of all such diagnostics usually should be as fast as possible. The time needed for whole protocol (isolation of good quality DNA, constructing the library and sequencing itself) can be estimate for at least 2-3 days [11] . Analysis of RNA viruses, like Ebola or Lassa viruses would last even longer because of the need of cDNA synthesis [15, 29] . Another weakness, but more debatable one, of this kind of analysis is its unit cost. First of all the cost of the sequencing platform and every other necessary equipment is still high. Additionally, cost of single analysis can be much lower than 100 Euro, but it usually requires a large number of analysis for maximum flow cell filling. Diagnostics of most dangerous pathogens is not required quite often, what it is good from the public health reasons, but unfortunately can substantially rise the unit price. In a larger scientific centres, with WGS techniques implemented for routine analysis, it should not be a problem to sequence already prepared probe on one flow cell with other samples to lower the sequencing costs.",12.840996543156184,7.5646070617988475
improving the analytical performance,0.20129734790370082,1.734935998916626,3.387519359588623,04c5ccd4-7958-4f19-9b62-77cdea9b7889,custom_license/Surface plasmon resonance applications in clinical analysis,"In this review, we considered a panel of analytes of interest for clinical diagnostics, also focusing on emerging technological innovations such as coupling between SPR and nanoparticles, microfluidics, or new chip design, for improving the analytical performance.",11.947636073507162,7.511268608755919
aptamers and MIPs,0.15627914263136536,1.7524561882019043,2.1775524616241455,5314e644-e27e-4f04-93e1-3aef60ae14d1,custom_license/Surface plasmon resonance applications in clinical analysis,"Interesting applications to clinical diagnostics have recently been reported for synthetic receptor such as XNA, but still very few are using aptamers and MIPs instead.",12.57682922650707,6.956395851664407
The effect on emission-reduction,0.2657672600262529,1.7302985191345215,1.451582431793213,31c9cdd0-dcbb-4c45-a8fa-ffb127d2b1f9,custom_license/A system dynamics approach to scenario analysis for urban passenger transport energy consumption and CO 2 emissions: A case study of Beijing,"The effect on emission-reduction from the implementation of PDPT after the former implementation of TDM, TP and ARM TDM TDMÃ BAUÂ¼ ÎTDM The effect on emission-reduction from the implementation of TDM after the former implementation of BAU TDMÃ PDPT Â¼Î(PDPT Ã¾ TDM) Ã ÎPDPT The effect on emission-reduction from the implementation of TDM after the former implementation of PDPT TDMÃ TP Â¼ Î(TDM Ã¾ TP)Ã ÎTP The effect on emission-reduction from the implementation of TDM after the former implementation of PT TDMÃ AR Â¼ Î(TDM Ã¾ARM) Ã ÎARM The effect on emission-reduction from the implementation of TDM after the former implementation of ARM TDMÃ (PDPT Ã¾ TP)Â¼ Î(PDPT Ã¾TDMÃ¾ TP) Ã Î(PDPT Ã¾TP)",12.578766928518156,6.4707910430843825
The effect on emission-reduction,0.3677327887117026,1.638159990310669,1.4744088649749756,195b25b1-4275-4dd1-8a91-0208cbe371f8,custom_license/A system dynamics approach to scenario analysis for urban passenger transport energy consumption and CO 2 emissions: A case study of Beijing,"The effect on emission-reduction from the implementation of TDM after the former implementation of PDPT, TP and ARM TP TP Ã BAUÂ¼ ÎTP The effect on emission-reduction from the implementation of TP after the former implementation of BAU TP Ã PDPTÂ¼ Î(PDPT Ã¾TP) Ã ÎPDPT The effect on emission-reduction from the implementation of T TP after the former implementation of PDPT TP Ã TDMÂ¼ Î(TDMÃ¾ TP) Ã ÎTDM The effect on emission-reduction from the implementation of T TP after the former implementation of TDM TP Ã ARMÂ¼ Î(TPÃ¾ ARM) Ã ÎARM The effect on emission-reduction from the implementation of TP after the former implementation of ARM TP Ã (PDPT Ã¾TDM) Â¼ Î(PDPT Ã¾TDMÃ¾ TP) Ã Î(PDPT Ã¾TDM)",12.605892351527803,6.4352320789704
The missing value analysis using the EMA method helped to improve the data and to handle missing values,0.13016659325758523,1.2955467700958252,1.7376092672348022,059f5021-d384-4443-b95d-7c0f576130f3,custom_license/Design and validation of a questionnaire to measure the attitudes of hospital staff concerning pandemic influenza,"The data collected through this survey represented a wide range of professions and age groups from both genders and employment states. The missing value analysis using the EMA method helped to improve the data and to handle missing values. We aimed to generate a validated questionnaire that provides the required information with the lowest number of questions. The questionnaire was validated using various processes and statistical methods, as discussed in the ''Results'' section. Based on these results, some changes were suggested to improve this questionnaire.",12.304723074098398,6.278204500199347
BAUÂ¼ ÎARM,0.1445066446998781,0.6477488875389099,1.2785910367965698,352961b7-1dc7-44a9-b1ed-928fb2ccae46,custom_license/A system dynamics approach to scenario analysis for urban passenger transport energy consumption and CO 2 emissions: A case study of Beijing,"The effect on emission-reduction from the implementation of TP after the former implementation of PDPT, TDM and ARM ARM ARM Ã BAUÂ¼ ÎARM The effect on emission-reduction from the implementation of ARM after the former implementation of BAU ARM Ã PDPTÂ¼ Î(PDPT Ã¾ARM) Ã ÎPDPT",11.998363868034877,5.451548304630269
Clinical management,0.14051171244212884,0.4977984130382538,0.6899539232254028,68ced408-9812-4323-82f1-fc753478ba79,"custom_license/MERS: Progress on the global response, remaining challenges and the way forward FAO-OIE-WHO MERS Technical Working Group","iii. Product research and development needs: Clinical management, diagnostics and medical interventions",12.768956655351454,5.241173847944386
"The combination therapy of corticosteroid with lopinavir, ribavirin and ritonavir can improve clinical response and reduce mortality rates",0.24085158147559857,3.1259446144104004,4.670159339904785,ad938abc-9aaf-4402-9d78-c0664e0ce085,custom_license/Generation of predictive pharmacophore model for SARS-coronavirus main proteinase,"The infection of the newly emerged severe acute respiratory syndrome coronavirus (SARS-CoV) is characterized by acute flu-like symptoms that progress to acute lung injury or acute respiratory distress syndrome with over 10% of mortality [1] . To date there are no universally recommended therapy for the disease. Many scientists are now making efforts to develop effective drugs against SARS. The combination therapy of corticosteroid with lopinavir, ribavirin and ritonavir can improve clinical response and reduce mortality rates apparently [2, 3] . Cinatl et al. [4] found that ribavirin, azauridine, pyrazofurin and glycyrrhizin are active against SARS-CoV. Barnard et al. [5] reported that calpain inhibitors and b-D-N 4 -hydroxycytidine exhibit inhibitory effects on SARS-CoV.",14.984379574108043,10.312000421242686
"the implementation of appropriate infection control measures as soon is possible, is critical for preventing spread of the infection especially in hospitals",0.1495864554273898,2.6998116970062256,3.693317413330078,614c4f7a-327f-4d09-981f-14b27e18bbf6,custom_license/The Middle East Respiratory Syndrome Coronavirus -A Continuing Risk to Global Health Security,"The clinical management of patients with MERS is largely symptomatic and aimed to reduce the risk of most severe complications, such as secondary infections, and to support renal and respiratory function (Reviewed in Zumla et al. 2015a; WHO 2015b, c; Lessler et al. 2016; Rabozzi et al. 2012; ISARIC and Public Health England 2014; CDC 2016) . Seriously ill patients should receive intensive care. Moreover, the implementation of appropriate infection control measures as soon is possible, is critical for preventing spread of the infection especially in hospitals. Whilst a range of treatments (CDC 2016; WHO 2015b; de Wilde et al. 2013; Falzarano et al. 2013a, b; Chan et al. 2013; Omrani et al. 2014; Shalhoub et al. 2015; Zumla et al. 2016 ) may be useful (Table 2) , currently there are no specific treatments for MERS-CoV infections and no controlled randomized clinical trials of any therapeutic have been conducted to date. A whole range of treatments have been used empirically for serious cases of MERS but there is no solid evidence that any of them can improve the clinical outcome. A range of anti-MERS-CoV drugs and host-directed therapies are in the pipeline [61] ), properly designed, randomized, controlled clinical trials are required to be performed.",15.95377323559568,9.739354554177085
"sequencing technologies continue to improve, so will the value of whole-genome sequencing to both clinical and basic virology research",0.1577707994532074,2.3036694526672363,2.5974199771881104,27677556-adb5-4983-8649-fd5e431a09df,custom_license/Sherlock Genomes -viral investigator,"Fast, whole-genome sequencing of viruses is important for improved diagnostics, accurate geographical mapping of viral spread, and drug treatments. As sequencing technologies continue to improve, so will the value of whole-genome sequencing to both clinical and basic virology research.",18.275208379095943,9.582031062089555
serum cystatin C determinations,0.3376898767554889,1.728701114654541,2.24885892868042,abf03719-8aee-4350-853d-9ab3282b3b82,custom_license/CYSTATIN C--PROPERTIES AND USE AS DIAGNOSTIC MARKER,"It should also be emphasized that although the precision of the automated particle-enhanced immunometric methods is higher than that of the enzymeamplified single radial immunodiffusion first used to quantitate serum cystatin C, it is still lower than that for most methods for determination of serum creatinine. Moreover, the data for the intraindividual variation of serum cystatin C strongly indicate that a higher precision of the method would markedly improve the clinical usefulness of serum cystatin C determinations according to the criterion of Cotlove (N6).",19.50094854066704,9.410746017401188
if information technology is chosen according to the needs of its business processes,0.13912391475992156,2.71305513381958,3.816588878631592,5d223e11-771c-4be4-b612-85dd0b62a76b,custom_license/ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model,"In the conceptual model that has been defined, social media functionality can be used for several functions that will link one account with another [8] . By using a function that can connect one account with another, this can be very useful for managers of the industrial sector, one of which is SMEs. In addition to using social media, SMEs business processes can be defined based on the Process Classification Framework (PCF). As in the research conducted [11] , the business processes described based on PCF can be supported by the use of IT. The use of IT can improve SMEs performance if information technology is chosen according to the needs of its business processes. Social media is included in IT that can support all or several domains of business processes. For example, SMEs use social media to promote goods while, the purchase can be done directly in the offline store, the website, and e-commerce of the SMEs.",12.371067077287751,8.574142085143976
TTFs affect the use of IT in an organization and it may impact individual performance,0.3065892780200657,1.9108433723449707,2.5174946784973145,a38ba470-6107-4038-9d98-817f407bd3ec,custom_license/ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model,"In paper [10] studied the use of social media used by a charity engaged in the food distribution for poor populations. Social media is applied to improve the efficiency and effectiveness of supply chain management within the organization. The study focused on social media that is utilized to help integrate supply chain management systems, it can be measured the suitability of IT use in business processes that will be run by an organization. The function of social media is chosen according to its function which will later have a performance impact on an organization. Furthermore, there is also research conducted by [11] which stated that IT implementation aims to prove that TTFs affect the use of IT in an organization and it may impact individual performance. However, in the previous TTF study, there was no discussion on the suitability of social media usage and how it may impact the performance of SMEs business processes.",14.732199501731511,8.034689558653515
probiotic supplementation in dogs with food-responsive diarrhoea,0.2115957116735044,2.2926199436187744,2.3892414569854736,59cc5763-4a95-41f3-bb5b-0d858f6a28ec,custom_license/A case-control study of pathogen and lifestyle risk factors for diarrhoea in dogs,"Regular contact with cattle/sheep or horse faeces appeared to be associated with a reduced risk of diarrhoea, having a strong association in the univariable analysis and a marginal association in the multivariable model. Horse faeces have been suggested to contain probiotic bacteria which discourage gut colonisation of several pathogenic bacteria, including Escherichia coli, Clostridium difficile and Salmonella spp. (Weese et al., 2004) , whilst probiotic supplementation in dogs with food-responsive diarrhoea has been shown to improve clinical signs of disease (Sauter et al., 2006) . In addition, it has been suggested that the consumption of cellulose may reduce the water content of faeces (Wichert et al., 2002) . The question asked was limited to whether the dog had had contact with the faeces, rather than whether it had consumed them; therefore whilst it is possible that there is some genuine protective effect evoked by the contact with or consumption of some herbivore faeces in the dog, this would require further study.",13.987570811571802,7.9388596944428915
"Process automation, on the other hand, refers to the development and implementation of IT systems that support the process that will occur",0.24399771839407888,1.7405790090560913,1.8787280321121216,b709c646-a80a-4d92-9dc6-4e7c935bf0b5,custom_license/ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model,"This phase identifies changes to address existing problems. The output of this phase is the measurement of several candidate processes for the basis of the next phase. e Process Implementation This phase makes necessary changes to transition from the as-is process to the to-be process. Organizational change management refers to the arrangement of activities needed to change the way all participants work related to the process. Process automation, on the other hand, refers to the development and implementation of IT systems that support the process that will occur. f Monitoring and Control Processes After the redesign process runs, relevant data were collected and analysed to determine how well the process was being adjusted to the measurement of performance and performance targets. New problems can reappear in the same process or other processes, which requires continuous cycle repetition.",15.445839880627151,7.758593534978841
"TTF, which affects the use of IT in an organization, can have an impact on the individual performances",0.15348214566180124,-0.8837911486625671,1.2494431734085083,ec0d6650-58ef-499a-9c5c-97db17e9441c,custom_license/ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model,"The use of social media in SMEs should be aligned with the needs of existing business processes in SMEs. Suitability between IT and the supported business processes can be measured using the Task-Technology Fit (TTF). In a study conducted by [10] , social media was applied to improve the efficiency and effectiveness of supply chain management within the organization. Research conducted by [11] stated that the implementation of IT was intended to prove that the TTF, which affects the use of IT in an organization, can have an impact on the individual performances. After measuring the suitability of business processes with information technology, business process performance is measured.",17.62522526631951,6.406502659296691
"safe, practical, and effective infection prevention strategies tailored specifically to the ED is fertile grounds for future research",0.17637780196139843,1.1427417993545532,1.4461369514465332,5a5daef1-9973-46b3-8b9e-f513067acfee,custom_license/Infection Prevention in the Emergency Department,"In conclusion, the innovation and implementation of safe, practical, and effective infection prevention strategies tailored specifically to the ED is fertile grounds for future research and will have a lasting impact on patient safety in emergency care. Table 2 Interventions to improve adherence to standard precautions in emergency and trauma care. Table 3 Interventions to reduce infection related to medical devices use in emergency care. Table 4 Practical interventions to improve infection prevention in the ED.",13.121860469222401,6.275422352248547
"Pennsylvania F i g u r e 2. Sample HL7 admission, discharge, and transfer (ADT) message from an emergency department",0.19214849073442344,1.0333359241485596,1.8123489618301392,81939f3c-f38f-4914-a8b9-3fe236fb25f1,custom_license/Technical Description of RODS: A Real-time Public Health Surveillance System,"All of the RODS processes can be run on a single computer, but in our current implementation-serving Pennsylvania F i g u r e 2. Sample HL7 admission, discharge, and transfer (ADT) message from an emergency department. The circled fields are age, gender, home zip code, admitted date and time, and free-text chief complaint, respectively.",12.640798393514492,6.273974613616226
look-back function,0.23611609419727894,1.238347053527832,1.7215811014175415,23ad5e47-a136-4123-8f65-7799f4bcbe98,custom_license/Technical Description of RODS: A Real-time Public Health Surveillance System,"Our future plans are to meet our initial design objective to develop early-warning capability for a large, outdoor release of anthrax, especially ensuring that the data and analysis produced by RODS are reviewed by public health. This goal will require improvements in the interfaces and the detection algorithms to reduce false alarms and to vastly improve the efficiency with which anomalies are evaluated by use of multiple types of data, better interfaces, and implementation of the look-back function. We would like to enlarge as quickly as possible the application service provider to include more states and more types of clinical data so that states will be in a position to prospectively evaluate the detection performance from different types of data on naturally occurring outbreaks.",12.241559373426739,6.208499081413851
early detection of disease outbreaks,0.20490816566588618,0.09266762435436249,1.9951014518737793,28766122-78b3-4907-8b60-a865a38e3cea,custom_license/Technical Description of RODS: A Real-time Public Health Surveillance System,"A b s t r a c t This report describes the design and implementation of the Real-time Outbreak and Disease Surveillance (RODS) system, a computer-based public health surveillance system for early detection of disease outbreaks. Hospitals send RODS data from clinical encounters over virtual private networks and leased lines using the Health Level 7 (HL7) message protocol. The data are sent in real time. RODS automatically classifies the registration chief complaint from the visit into one of seven syndrome categories using Bayesian classifiers. It stores the data in a relational database, aggregates the data for analysis using data warehousing techniques, applies univariate and multivariate statistical detection algorithms to the data, and alerts users of when the algorithms identify anomalous patterns in the syndrome counts. RODS also has a Web-based user interface that supports temporal and spatial analyses. RODS processes sales of over-the-counter health care products in a similar manner but receives such data in batch mode on a daily basis. RODS was used during the 2002 Winter Olympics and currently operates in two states-Pennsylvania and Utah. It has been and continues to be a resource for implementing, evaluating, and applying new methods of public health surveillance.",11.759812881428646,5.472984408048317
business process management must be adapted to the conditions of each SME,0.20797585506641036,-0.13610760867595673,0.9724424481391907,e9c930de-c192-4121-81ce-e06313ff0429,custom_license/ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model ScienceDirect Impact of Alignment between Social Media and Business Processes on SMEs' Business Process Performance: A Conceptual Model,"The results of the literature review and analysis related to social media research on SMEs, business processes and also the suitability of information technology applied to produce the conceptual model illustrated in Fig. 5 . In general, this conceptual model is based on the principle of Task-Technology Fit proposed [21] . This principle emphasizes that IT implementation must be aligned with business processes. Organizational contexts include size, strategy, industry, market, business process objectives, and internal factors within the company. This principle is important since failure in implementing business process management in organizations is triggered by, one of which, the application of uniform business process management to all organizations and not paying attention to existing conditions [24] . Therefore, the implementation of business process management must be adapted to the conditions of each SME. This has been related to [13] who conducted research related to the use of social media which had an impact on financial and non-financial management in SMEs.",12.833042913747692,5.035182665462793
simulation results,0.2681394209790821,-0.5460273623466492,0.2765018045902252,721dca69-3fdd-43f6-b92f-e0434953f40a,"custom_license/Modeling triple-diffusions of infectious diseases, information, and preventive behaviors through a metropolitan social networkdAn agent-based simulation","To fill the knowledge deficit, this research proposes a conceptual framework to integrate the three diffusion processes, and develops a triple-diffusion model in a realistic urban area. Following sections discuss the conceptualization, formulation, and implementation of the model, and evaluate the simulation results.",13.564602400325299,4.572419227572178
infection prevention and antimicrobial stewardship,0.3985518250312406,4.809300899505615,5.095803737640381,6a405573-ddfb-44f7-a8b3-ae5754aa9c59,custom_license/The Journal of Infectious Diseases S588 â¢ JID 2017:216 (Suppl 5) â¢ McQuillen and MacIntyre The Value That Infectious Diseases Physicians Bring to the Healthcare System,"While a career in infectious diseases (ID) has always been challenging and exciting, recognition of the value that ID physicians provide to the healthcare system as a whole, over and above the value they provide to individual patients, has been poor in this system. In response to this disparity, the Infectious Diseases Society of America Clinical Affairs Committee has long endeavored to quantify the value of ID physicians to the system, which is challenging in part because of the many avenues through which they influence healthcare. We discuss data showing that ID physicians improve clinical outcomes, positively impact transitions of care, and direct system-level improvements through infection prevention and antimicrobial stewardship. We identify areas where value-based care provides additional future opportunities for ID physicians. A Clinical Affairs Committee-sponsored study of ID physicians' positive impact on patient outcomes shows that few medical specialties are better positioned to positively impact the Triple Aim approachbetter health, better care, and lower per capita cost-that is the principle tenet of healthcare system reform.",12.864163118149252,10.940775105497135
acquired demyelinating disorders,0.16206710330996943,0.9566740393638611,2.3977084159851074,4f2fa8fe-9c68-4ad8-8051-234af06fcea4,custom_license/Acute disseminated encephalomyelitis,"The proposed criteria were designed to improve the clinical characterization of acquired demyelinating disorders, including ADEM, as it has been shown in some pediatric cohorts where the consensus definitions were applied (Dale and Pillai, 2007; Alper et al., 2009 ).",20.61392602764687,9.395222705653234
"invasive diagnosis is often required for specific microbiological diagnosis, to minimize side effects of therapy, and to improve clinical responses",0.16745520254834934,1.7548038959503174,2.8036537170410156,9403bdec-381c-42cd-91f0-55b006545164,custom_license/InfectIon In KIdney transplant recIpIents,"The spectrum of infection in the immunocompromised host is quite broad. Given the toxicity of antimicrobial agents and the need for rapid interruption of infection, early, specific diagnosis is essential in this population. Advances in diagnostic modalities (e.g., CT or magnetic resonance imaging, molecular microbiologic techniques) may greatly assist in this process. The need for invasive diagnostic tools cannot be overemphasized, however. Given the diminished immune responses of the host, and the frequency of multiple simultaneous processes, invasive diagnosis is often required for specific microbiological diagnosis, to minimize side effects of therapy, and to improve clinical responses. The initial, empiric therapy is broad by necessity, with a rapid narrowing of the antimicrobial spectrum as data become available.",18.243513943332665,9.3482273286108
"bronchodilators may improve clinical symptom scores in the short-term, they do not improve overall outcomes",0.15872739130664457,2.87064528465271,2.5794126987457275,437d5f23-70d7-418a-b141-d86632899d70,custom_license/Improving Evidence Based Bronchiolitis Care,"The most recent guidelines regarding bronchiol itis management, including AAP Clinical Guidelines Consistent clinical benefit has not been shown with the use of -or -adrenergic agents in random ized controlled studies. While bronchodilators may improve clinical symptom scores in the short-term, they do not improve overall outcomes, the need for LOS. 7,44-46 hospitalization, or hospital Moreover, clinical symptoms scores are not validated measures of efficacy, do not correlate with objective measures (pulmonary function tests) and are subject to interuse variability. 7 Albuterol A Cochrane systematic review of albuterol use in bronchiolitis demonstrated potential adverse effects and increased cost of care without any clear clinical benefit. 5 The review assessed bronchodilator use on oxygen saturations in 30 randomized controlled trials including 2000 children in 12 countries. The heterogeneity of the studies was significantly re duced by sensitivity analysis. Overall, the review showed no benefit, and those studies that did show benefit had weaker methodology and included older children with history of recurrent wheeze.",16.319550616409792,9.25438040495241
Pelleted and extruded products can increase bulk density and improve handling along with improving protein digestibility,0.2827279934415255,2.984384059906006,3.883810043334961,228f8685-3cea-46dc-ac25-4e50eccca6c1,custom_license/Physical and Chemical Methods for the Reduction of Biological Hazards in Animal Feeds,"The production of finished feeds ready for consumption by the animal can occur on the farm, in a feed mill, or at a pet food manufacturing facility. In all cases, raw materials are received and included in species-specific formulations. Animal diet formulations take into account the required nutrients of the animal and the nutrients provided by the raw ingredients. The manufacture of raw ingredients into complete finished feeds can include multiple processes. These processes can include grinding, mixing, pelleting, and/or extrusion. Grinding can be done through a roller mill or hammer mill. The goal of grinding is to ensure all components for the finished feed have a similar particle size for uniform distribution during further processing and consumption. Following grinding, all ingredients must be mixed or blended for uniform distribution. Uniformly blended feeds can be further processed by pelleting or extrusion, both thermally intensive processes. During both pelleting and extrusion, the ground ingredients are passed through a mixing chamber and pushed through a die of a desired size. Pelleted and extruded products can increase bulk density and improve handling along with improving protein digestibility. The form of the complete finished diets can vary, from ground mash types to pelleted. Finished pet foods can also be in various forms, from kibbles to pate with gravy to jerky type.",13.02371055336142,9.022624860783125
utilization as a cancer biomarker,0.27609030145560176,3.2226245403289795,3.5987486839294434,a8573378-6388-415d-8a34-b15ffbf2fdb5,custom_license/Mini-review The functional role of the novel biomarker karyopherin a 2 (KPNA2) in cancer,"Due to its function in nucleocytoplasmic transport, where it mediates the translocation of a multitude of proteins, KPNA2 is involved in many cellular processes. Nonetheless, the association with cancer appears to be very prominent, considering the aberrantly high levels of KPNA2 observed across cancers of diverse origin. Importantly, the altered expression pattern is associated with adverse patient characteristics. This spurs the idea that KPNA2 may hold a role in carcinogenesis. This idea is supported by the cellular studies of KPNA2 which have indicated that the protein may play a role in the malignant transformation of cells. The association with adverse cancer characteristics establishes KPNA2 as a potentially relevant therapeutic target. However, targeting of the protein will be complicated by the great number of conventional cellular processes which are also associated with KPNA2. Instead, utilization as a cancer biomarker may well be the first clinical implementation of KPNA2. Considering the results described here, obtained in a variety of cancer forms, this vision appears promising. Further prospective clinical studies are required to fully demonstrate the biomarker potential of KPNA2, and, in fact, KPNA2 is part of a Fig. 1 . Cellular processes and interaction partners associated with KPNA2. Details concerning the listed interaction partners can be found in the text. Note that, albeit interaction with KPNA2 has been demonstrated, alternate karyopherins may also partake in the translocation of the listed proteins. translational effort in bladder cancer and is currently being investigated in ongoing multi-center prospective studies [105] .",12.625901726897656,8.852958200182155
statins improve the clinical outcome of respiratory infections,0.23171109593638195,2.7307989597320557,3.4429309368133545,ae410d5b-cd50-49ea-8c64-688d58e238dd,custom_license/Host-directed therapies for bacterial and viral infections,"First-line drugs include isoniazid, rifampin, pyrazinamide and ethambutol, and constitute standard therapy for drug-sensitive tuberculosis (TB). macrophages in vitro and in vivo in experimental mouse models [52] [53] [54] . Treatment with simvastatin in combination with canonical drugs, such as isoniazid, rifampin and pyrazinamide, shortens therapy duration in murine TB 55 . Moreover, a retrospective investigation in a large patient cohort that comprised more than 8,000 new TB cases and 800,000 control patients revealed that there is no risk of TB reactivation upon statin intake 56 . This study was prompted by epidemiological observations that statins improve the clinical outcome of respiratory infections. Because of their widespread use and good safety profile, statins remain attractive HDT candidates for TB.",13.260116089229506,8.653965063984844
Products often combine transgenic and native traits.,0.40005786508915053,3.363298177719116,1.804979681968689,f4f7e1a1-4148-4dde-88a0-325db99bdf09,custom_license/Biochemical aspects of coronavirus replication and virus host-interaction,"Multiple approaches have been used to discover and develop traits to improve production agriculture crops. The technologies employed have included genetically based trait selections, such as screens of activation-tagged libraries of over-expressed genes, the testing of candidate gene leads developed through literaturegenerated hypotheses, through transcript and metabolite profiling experiments and/or through bioinformatic analyses, and native trait selection based on the incorporation of favorable alleles from diverse germplasm sources. For transgenic crop development, candidate genes are typically first tested in model plants. Gene shuffling technologies can be applied to screen for variation that can further improve trait functionality. Leads are transformed into elite germplasm and tested using surrogate screens in greenhouses. The transgenic plants are further assessed in managed and production field environments for reproducibility of the desired phenotype, for the absence of unwanted pleiotropic effects, and for yield potential. Alternatively, association mapping, linkage mapping and positional cloning technologies are employed to identify native genes that can be bred into elite lines, using molecular markers to introgress the trait of interest without unwanted surrounding genetic material; such products are non-transgenic. Products often combine transgenic and native traits. Robust intellectual property protection throughout the discovery and development processes is necessary to ensure that costs can later be recovered through trait premiums. To be competitive in the market, products need to carry multiple traits to confer tolerance to an ever-evolving array of pests and to abiotic stress factors, which has necessitated the development of trait stacking technologies. The use of molecular markers and doubled haploids in conjunction with contra-seasonal seed production accelerates trait integration and breeding timelines. For transgenic crops, field and laboratory data are assembled into complex regulatory dossiers for government approval processes. Finally, extensive field efficacy and multi-location breeding trials must be conducted to ensure that products meet performance standards. ",14.444909430784621,8.415098909571691
"to optimize the accumulation of total mRNA levels, and to improve mRNA translation",0.22062441037727207,2.12834095954895,3.429469108581543,c047f323-69ae-4ebc-a21d-906e2ec1aaf6,custom_license/Virus-based vectors for gene expression in mammalian cells: Coronavirus,"To optimize expression levels it is essential to improve virus vector replication levels without increasing virulence, to optimize the accumulation of total mRNA levels, and to improve mRNA translation. These results can only be achieved by determining the mechanism involved in these processes. A brief review of the mechanism of mRNA transcription in coronavirus and arterivirus is described to help achieve this goal.",12.977140711811746,8.154575793418932
"days of hospitalization, use of ICU",0.1432649822080769,1.7928905487060547,1.6636375188827515,bf244af8-b2ee-4887-835c-ebf44d3cfbc3,custom_license/Mini review First International Symposium on Influenza and Other Respiratory Viruses: summary and overview Kapalua,"Although prophylaxis has shown efficacy, treatment with these preparations appears less promising (Hemming et al., 1987 ). An early trial found that human IVIG treatment appeared to reduce virus shedding and to improve oxygen saturation in young infants hospitalized with RSV infection. However RSVIG containing high titers of neutralizing antibody to RSV reduced pulmonary virus titers but did not improve clinical outcome such as days of hospitalization, use of ICU or need for intubation in hospitalized infants Rodriguez et al., 1997) . A recent study, with monoclonal antibody to RSV F protein in intubated children found similar negative results.",16.237341917084276,7.929812914912221
"In the near future, it may be possible to exploit this information in several ways to improve clinical care",0.36366260008702517,1.5533393621444702,1.6286834478378296,2dc95e2e-5a11-46ce-8705-01c690debe9e,"custom_license/POLD1: central mediator of DNA replication and repair, and implication in cancer and other pathologies HHS Public Access Author manuscript","The integration of high throughput sequencing technologies with functional studies probing protein function have assigned POLD1 an important role at the junction of DNA replication with repair and the maintenance of genome integrity. In the near future, it may be possible to exploit this information in several ways to improve clinical care. For instance, as mutation of the DNA repair protein BRCA1 predicts tumor sensitivity to specific DNA-damaging agents (O'Connor, 2015) , identification of damaging mutations in POLD1 may be used to optimize administration of DNA damaging chemoradiation and targeted therapies.",15.93045498977795,7.643974072910776
quality assurance,0.2970224955709962,1.720116376876831,2.345231771469116,580104ce-5556-4b40-9802-efd68fec43dc,custom_license/The spray-drying process is sufficient to inactivate infectious porcine epidemic diarrhea virus in plasma,"The design and configuration of the particular spraydryer utilized and the specific spray-drying process have been shown to affect the efficacy of virus inactivation. Therefore, it has been suggested that it may not be appropriate to fully extrapolate data obtained through use of the bench-top laboratory spray dryer to the commercial spray drying processes (Thybo et al., 2008) . In general, laboratory spray dryers have less capability of viral inactivation compared with commercial spraydriers (Shen et al., 2011) . Therefore the results from the present study are encouraging as they indicate complete inactivation of infectious PEDV even under less stringent conditions supporting an overall low risk that infectious PEDV, if present, may survive the commercial spraydrying process. In the present study, the outlet temperature used was the same as suggested for spray-dried plasma production under commercial processes, as this parameter has been shown to have the single major effect on microorganism viability (Ananta et al., 2005) . Usage of different spray-drying conditions or lapses in the consistency of the processes could potentially lead to an incomplete viral inactivation and further work needs to be done to understand and perhaps improve the quality assurance of the processes utilized by the SDPP industry. Alternatively, contamination of PEDV in SDPP and by-products may occur post-processing as suggested by recovery of infectious PEDV from feed without inclusion of animal by-products (Dee et al., 2014) . Additionally, PEDV has been demonstrated to become aerosolized and transported up to 10 miles from infected sites (Alonso et al., 2014) thereby showing a great potential for wide spread and environmental contamination.",13.35543102180369,7.316877154056158
Technology implementation Assign specific processes to specific personnel or groups to maintain accountability for each of the industrial practices,0.22959077602764402,1.467667818069458,2.1429061889648438,d2ab336b-3359-4f80-8303-a89cb2b9dd7e,custom_license/Revisiting the melamine contamination event in China: implications for ethics in food technology,Technology implementation Assign specific processes to specific personnel or groups to maintain accountability for each of the industrial practices. Allocate sufficient resources (e.g. technology support and personnel) to ensure that the technology can be fully implemented. Assess costs and impacts on different parties and prerequisites for resources when the technology is in use.,14.034971605818832,7.259113166608887
ad hoc implementation of molecular diagnostics was feasible and successful.,0.2917260619588465,1.417945384979248,1.473021388053894,d4eb9b0e-e188-4124-a0f1-8c7f15e3acc8,custom_license/Coordinated Implementation of Chikungunya Virus Reverse Transcription-PCR,"A preformulated chikungunya virus real-time reverse transcription-PCR, quality-confi rmed oligonucleotides, and noninfectious virus controls were distributed by the European Network for the Diagnosis of Imported Viral Diseases. An international profi ciency study with 31 participants demonstrated that ad hoc implementation of molecular diagnostics was feasible and successful.",14.475707204421326,6.945625924019007
multiplex PCR assay,0.17077324133108956,0.7731238007545471,1.424709677696228,25d89009-4eb6-40c6-91d1-723e642637fc,custom_license/Surveillance of upper respiratory infections using a new multiplex PCR assay compared to conventional methods during the influenza season in Taiwan,"Clinical samples were analyzed using the BioFire FilmArray Respiratory Panel (BioFire Diagnostics, Salt Lake City, UT, USA). This panel was used in a multiplex PCR assay that detects 20 respiratory Diagnostics, 2013; Poritz et al., 2011) .",14.495831691165897,6.502132852901068
obtaining participant insights about their perceptions of the clinical research experience will provide the necessary data to allow institutions and investigators to improve the clinical research experience,0.19786274760869013,0.9300935864448547,2.533618688583374,dd49bacc-4e7d-47c3-a6cb-9951f8d58d24,custom_license/Managing Clinical Risk and Measuring Participants' Perceptions of the Clinical Research Process,"Developing clinical research programs include: structured approaches to obtain reliable information about the factors contributing to process failures and adverse events (including careful root cause analyses); mechanisms for assessing trends in process and outcome failures, structured approaches to identifying risk points prior to study implementation (e.g., failure mode and effects analysis); and obtaining participant insights about their perceptions of the clinical research experience will provide the necessary data to allow institutions and investigators to improve the clinical research experience. We believe this will increase substantially the likelihood of successful completion of clinical studies.",22.854475921897105,10.250479551432335
speed up operational processes,0.23379724106112812,1.7080193758010864,2.622342348098755,4316abaf-4c23-4262-8779-f209ce49af5b,custom_license/RFID-enabled process reengineering of closed-loop supply chains in the healthcare industry of Singapore,"RFID technology can improve the traceability of products and speed up operational processes such as tracking, shipping, check out and counting processes that leads to improved inventory flows and more accurate information (Lee et al., 2005; Chow et al., 2006; Tajima, 2007; Whitaker et al., 2007) . Further, reorganizing processes using RFID technology can also lead to a large gain in the overall supply chain effectiveness (Langer et al., 2007; McFarlane et al., 2003) . Reengineering the processes of distribution centres and retailers increase possible benefits gained through RFID (Dutta et al., 2007; Bottani and Rizzi, 2008) .",17.35997026981527,8.890724714970242
to improve the overall quality of the clinical research process,0.15943894287913105,2.020066738128662,3.601482391357422,c5579d32-6d92-4794-b193-6f09250c48e1,custom_license/Managing Clinical Risk and Measuring Participants' Perceptions of the Clinical Research Process,Analysis indicates that the factors that most positively influence participants' perceptions of their research experiences include: their relationship with the research staff; the quality and attentiveness of the medical care provided to the patient in the context of the study; and the opportunity to learn more about their disease processes. Factors that were most frequently associated with negative perceptions of the clinical research process were: pain and discomfort; logistical inconveniences; and unprofessional or dismissive behavior by members of the research staff. 94 Analysis of these focus group data will lead to the development of a survey to be used by clinical research professionals to measure participants' perceptions of the clinical research experience. The ultimate goal of the project is to use data from these surveys to inform efforts to improve the participant experience as well as to improve the overall quality of the clinical research process.,14.583712256108647,8.75830622380398
adaptability and applicability to routine clinical usage,0.2321504403404224,2.416912317276001,3.772430658340454,dca87a3f-83d3-4c8a-a4cc-128d8c9cabc2,custom_license/Nucleic acid-based diagnostics for infectious diseases in public health affairs,"Infectious diseases, mostly caused by bacteria and viruses but also a result of fungal and parasitic infection, have been one of the most important public health concerns throughout human history. The first step in combating these pathogens is to get a timely and accurate diagnosis at an affordable cost. Many kinds of diagnostics have been developed, such as pathogen culture, biochemical tests and serological tests, to help detect and fight against the causative agents of diseases. However, these diagnostic tests are generally unsatisfactory because they are not particularly sensitive and specific and are unable to deliver speedy results. Nucleic acid-based diagnostics, detecting pathogens through the identification of their genomic sequences, have shown promise to overcome the above limitations and become more widely adopted in clinical tests. Here we review some of the most popular nucleic acid-based diagnostics and focus on their adaptability and applicability to routine clinical usage. We also compare and contrast the characteristics of different types of nucleic acid-based diagnostics.",13.19359947032993,8.640832748766172
Bortezomib to improve clinical outcomes,0.23565375141284586,2.0485455989837646,2.822744369506836,27b92202-aa8a-410c-a561-6c542da777b3,custom_license/The Ubiquitin-Proteasome System (UPS) as a Cancer Drug Target: Emerging Mechanisms and Therapeutics,"To avoid resistance to proteasome inhibitors, and to limit the off-target effects, the development of compounds acting in a non-competitive way that do not directly interact with the active catalytic Î² subunit's site, has been considered. These compounds could potentially be used in combination with Bortezomib to improve clinical outcomes. For example, Rapamicin and PR -39 are compounds that bind to the Î±7 subunits, thereby producing a disruption in the interaction between 20S and 19S regulatory subunits that blocks the entry of the substrate (Gaczynska et al. 2003 ) . 5 -amino -8 -hydroxyquinoline also interacts with the Î±-subunits inside the proteolytic chamber; while being cytotoxic for myeloma and leukemia cells in vitro, it has also been shown to decrease tumour size in xenograft tumour growth in vivo (Li et al. 2010 ) , and overcomes resistance to Bortezomib in cultured cell lines.",14.726833062135938,8.320730051266468
"Genomic, proteomic and metabolomic technologies are making their way into clinical diagnostics",0.2990520077756253,2.8382790088653564,2.7598538398742676,a373f8e9-9bf8-461c-bb64-ee6930f1687f,custom_license/Nucleic acid-based diagnostics for infectious diseases in public health affairs,"What is the ideal diagnostic technology? Many promising candidates have been developed toward an ASSURED standard, such as protein chips, tissue chips and LOAC. Genomic, proteomic and metabolomic technologies are making their way into clinical diagnostics. Personalized medicine and proper diagnostics accompanied by personalized therapy represent the future of medicine. The ideal future diagnostic tool, therefore, should be multiplexed and gather information from the genome, the proteome and the metabolome, and also provide this information quickly and easily at an affordable cost. Many hurdles must be overcome before these techniques can be transformed from research tools into routine clinical practices.",12.801594156165441,8.11934430633866
It can improve the efficiency and effectiveness of hospitals,0.16099444268491803,1.8744380474090576,3.3320140838623047,e6eb0f8b-7fed-4beb-bf06-06b3893ea72f,custom_license/RFID-enabled process reengineering of closed-loop supply chains in the healthcare industry of Singapore,"Historically, the healthcare industry has viewed itself as being operationally different from other businesses. Executives and logisticians state that they cannot predict their patient mix and ultimately their supply consumption. Because of this assumption, most researchers have evaluated selected supply chain process improvement (Zhang, 2001) . Although the escalation of medical cost has been the number one issue in healthcare for the last four decades, most researchers have not considered reorganizing processes using RFID technology in hospital supply chains. RFID is a recent innovative technology that has been applied in logistics and manufacturing and is likely to be among the most exciting and fastest-growing technologies in terms of scope application (Heinrich, 2005; Gaukler and Seifert, 2007) . Healthcare providers must maintain distribution and inventory systems similar to those in the manufacturing industry. It can improve the efficiency and effectiveness of hospitals in numerous ways, such as better inventory management (medicine, linens, beds, etc.) and smarter physical flows (patients, beds, etc.) (Banks et al., 2007; Sarac et al., 2010) . Although it has been found that the paramount problem in IT implementation in healthcare systems is the high initial cost (Kumar et al., 2008) , healthcare has been forecast to be the next home for RFID (Erickson and Kelly, 2007) . In the following subsections, a brief overview of RFID and its implementation in inventory management, process reengineering and healthcare is presented.",13.144357128855948,7.984718880425968
a new research protocol,0.21298618879106948,1.5717308521270752,2.7498703002929688,d78c208b-2169-44d7-b566-800e9498606c,custom_license/Managing Clinical Risk and Measuring Participants' Perceptions of the Clinical Research Process,"The development of a complete listing of the essential clinical processes that need to be in place is a critical first step to prepare appropriately for the implementation of a new research protocol. As was the case with the SARS protocol, this process can be daunting. Focusing an organization's finite resources to assure that appropriate attention is paid to the most critical and potentially riskiest care processes is a challenge for most organizations. A variety of tools exist to guide the objective prioritization of what may ultimately be a very long list of critical issues that must be addressed. The failure mode and effects analysis (FMEA) is a powerful risk assessment tool that is used proactively, both to assess complex processes to identify potential vulnerabilities before errors occur as well as to guide development of interventions to mitigate identified risks. 16, 18, 19, 20, 21, 22, 28, 29, 30 Historically, FMEA has been used in the engineering environment to assess high risk processes associated with power generation in the commercial nuclear power industry; in aviation to assess the acceptability of aircraft designs; and in the automotive industry to establish manufacturing requirements for cars and trucks. 16, 19, 22 DeRosier and colleagues at the Veteran's Administration's Center for Patient Safety are credited with moving the techniques of FMEA to the bedside, applying the concept of prospective risk analysis to health care processes. 31, 32 In 2002, the use of FMEA in health care further expanded with the issuance of a Joint Commission requirement that all health care organizations seeking accreditation conduct at least one proactive risk assessment on a high-risk clinical process every 18 months. 33 Clinical care practitioners as well as clinical research professionals can use FMEAs to identify risk and to avert adverse events, errors and other system failures in a variety of health care settings. 16, 17, 19, 20, 21, 22, 30 In a complex care environment such as that of the NIH Clinical Center, where risk is compounded by the interplay of clinical medicine and clinical research, the FMEA is a useful tool to guide risk mitigation by identifying critical risk points in clinical care and clinical research processes. In the case of the SARS protocol described above, the FMEA was used as a compass to guide the work of the team charged with facilitating the implementation of the protocol. As mentioned previously, some investigators complained publicly about the prospect of the elective admission of highly infectious patients into an environment that housed patients with impaired host defenses. In discussions with both the practitioners who were adamantly opposed to admitting SARS patients and the investigators who supported the protocol implementation, one issue heightened the collective community's anxiety more than any other issue discusseddthe safe transfer of the patients throughout the NIH Clinical Center. Practitioners, even those not enamored of the idea of admitting SARS patients, generally were comfortable that safe care could be delivered to the patient once the patient was safely ensconced in a functioning isolation room; however, the perceived risk that an inadvertent exposure might easily occur while transporting the patient in the hospital was paralyzing to most practitioners. Not only would an exposure have a potentially catastrophic effect on a patient's health and well-being, but such an exposure could compromise the integrity of several research protocols (including the protocols in which the SARS patients were participating) and could pose a significant risk to the community.",14.580215331017072,7.912116114929004
to improve the processes involved continually,0.11141047732016829,0.06922277063131332,2.227419137954712,06f95929-b1bc-4c6d-abb4-0d79fa166adf,custom_license/Managing Clinical Risk and Measuring Participants' Perceptions of the Clinical Research Process,"Patient safety, clinical quality, and efficient and effective processes of care delivery are of equal import to clinical care and clinical research. Irrespective of the approach taken, we believe that clinical researchers and institutions involved in clinical research must collect data from a variety of sources, including the solicitation of perceptions from participants and staff input about their research experiences, to improve the processes involved continually.",18.183679262355195,7.857104982405234
the use of TPO mRNA instead of TG would improve the clinical usefulness of this method.,0.11084593417051238,0.8181198239326477,1.759308099746704,3290d8b7-948e-4ce8-96db-866f5c5b4e69,custom_license/Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy,"The use of TPO mRNA in the detection of thyroid carcinomas has also been reported in conjunction with some studies. However, our preliminary data showed that TPO mRNA was detectable by RT-PCR in all the samples tested, including those from healthy subjects and patients after total thyroidectomy without distant metastasis (data not shown). Considering that TPO mRNA are usually less abundant than TG mRNA in thyroid cells, it is not likely that the use of TPO mRNA instead of TG would improve the clinical usefulness of this method.",17.53701290943815,7.813282668694931
Unload to Shelf and Scan Linens when collected and stations-Conveyor,0.3026007128121155,2.0332179069519043,2.0574193000793457,e866a5e8-255a-4b0f-bf20-6838089fadc3,custom_license/RFID-enabled process reengineering of closed-loop supply chains in the healthcare industry of Singapore,"Tables 3 and 4 display the simulation results before and after the implementation of RFID respectively. For clean linens process, the time taken for the clean linens before RFID implementation is 339.75 min (Table 3) while that after RFID implementation is 371.23 min (Table 4 ). With the additional processes -Unload to Shelf and Scan Linens when collected and stations-Conveyor (see Fig. 7 ), the process took 31.48 min more to be completed. Time delay is due to the scanning of the RFID tags on each individual packed linen when unloaded into the shelf and when linens are needed in the wards. This time delay of 31Ã¾ minutes will increase the labour cost by $20 per day considering a staff hourly wage of $38. For the clean linens process before RFID implementation, the numbers of packed linens is not recorded. In the process after RFID implementation, the packed linens are counted and recorded.",13.99210272392287,7.556150137943316
Interventions have been implemented and improvements have been measured,0.23149171458356696,2.083078384399414,1.5071407556533813,ef3734f9-f0af-457e-8e63-8c22c4524890,custom_license/Managing Clinical Risk and Measuring Participants' Perceptions of the Clinical Research Process,"For the past 15 years the NIH Clinical Center has used these data to identify opportunities to improve our patient/ participants' experiences. Issues such as communication with clinical staff, attention to emotional support, and the participant's understanding about the point at which he or she can cease participation in a study have been identified as areas that required focused review and attention. These issues and others have been addressed using the NIH Clinical Center's organizational performance improvement structure. Interventions have been implemented and improvements have been measured. Many of these issues would not have been identified as problematic had the NIH Clinical Center leadership not actively queried their research participants about their perceptions of these processes.",13.856313168091553,7.183352049866361
intrinsic clinical care activities that are essential to the successful implementation of a study,0.20343803132889754,0.5240809321403503,2.7789077758789062,d9356b02-9cf9-40e6-9735-24a753b45633,custom_license/Managing Clinical Risk and Measuring Participants' Perceptions of the Clinical Research Process,"Clinical research programs must, therefore, embrace a systems approach to managing risk associated with the conduct of clinical research. For the purposes of this chapter, the term ""conduct of clinical research"" refers both to activities outlined in the research study as well as those intrinsic clinical care activities that are essential to the successful implementation of a study but that may not be explicitly described in the research protocol. Examples of such clinical care activities include infection control measures, medication management procedures, the design of the physical environment, and information management. These critical clinical care functions often are assumed to be present and functioning at an optimal level to support the investigator's study; however, investigators and/or institutional review boards (IRBs) may lack formal processes to assess the capacity of the clinical environment to support the study under review. The research team must engage the clinical care organization proactively to assure that the appropriate infrastructure is in place to provide care safely and efficiently to study participants. In collaboration with the health care team, the research team should have processes in place to: l identify clinical care functions that are critical to the success of the protocol; l identify and assess critical risk points of the clinical care processes that might place participants at undue clinical risk and/or compromise the integrity of the study; l monitor the clinical environment continually for adverse events, errors, near misses and process failures; l assess systematically and thoroughly errors that occur; and l establish an armamentarium of process improvement tools to use to manage process and system issues when they are identified.",13.794510320235688,6.975021272295007
Figs. 6 and 7 show Arena models of clean linens process before and after the RFID implementation,0.11354613028113383,0.6258889436721802,1.278444766998291,8497e639-e379-4a62-ac04-e18c49ef3c89,custom_license/RFID-enabled process reengineering of closed-loop supply chains in the healthcare industry of Singapore,"From the standard procedure for linens inventory control, the Arena simulation models are also categorized into soiled and clean linens processes and are modelled separately for accuracy of data collection and clearer visibility of linens flow. Despite the fact that the soiled and clean linens processes occur in parallel, they have two distinct flows with no interaction in any of the procedures. Figs. 4 and 5 illustrate the Arena models of soiled linens process before and after the RFID implementation. Figs. 6 and 7 show Arena models of clean linens process before and after the RFID implementation.",15.397691933450036,6.627009088643319
different diagnostic approaches,0.2881291131223501,0.38689395785331726,1.8038980960845947,f2e45d5f-5418-4d4d-9b19-30fd04fb28f8,custom_license/Detection and monitoring of virus infections by real-time PCR,"Necessary prerequisites for the generation of diagnostic RQ-PCR results comparable between laboratories include the use of quality control reagents and calibrated standards, and participation in multi-center quality control programs. Due to the lack of standardized reference material and the absence of international accrediting bodies, different programs for quality control in clinical virology, such as the Quality Control for Molecular Diagnostics (QCMD) (URL: <http://www.qcmd.org/>), have been established. This activity was supported by the European Commission and endorsed by the European Society for Clinical Virology (ESCV) and the European Society for Clinical Microbiology and Infectious Disease (ESCMID). The QCMD is an independent, non-profit organization that designs, develops and provides QC materials and proficiency programs for an increasing number of viral targets. However, the number of currently available internationally accepted controls and standardized QC reagents is limited and restricted mainly to blood-borne viruses, such as HIV-1, HBV, and HCV. Certification and accreditation of diagnostic laboratories are becoming increasingly important in order to document the expertise and quality of work. Widely accepted criteria for quality assurance and the certification of clinical laboratories include the ISO standards 9001 and 15189. According to these guidelines it is necessary ''to apply other methods to calibrate the measuring systems and to participate in inter-laboratory comparison programs or alternative mechanisms that can assure the quality of analytical procedures''. Examples of such collaborative efforts in Europe supported by the European Commission include Concerted Actions focusing on the standardization and clinical implementation of different diagnostic approaches. This kind of international collaboration may serve as a good example for future efforts aiming at the development of widely applicable concepts for quantitative virus diagnostics based on the real-time PCR technology.",12.673991017923061,5.859911691332714
earlier appropriate antibiotics should improve clinical outcomes including mortality and length of stay,0.2683382922919516,3.5959861278533936,2.6460108757019043,28989d3c-bf10-45f5-98b7-01370f044b07,custom_license/Rapid syndromic molecular testing in pneumonia: The current landscape and future potential,"The impact of this improved use of antibiotics are twofold: firstly, earlier appropriate antibiotics should improve clinical outcomes including mortality and length of stay. Secondly, it prevents unnecessary broad-spectrum antibiotic use, which facilitates antibiotic stewardship and reduces antibiotic related adverse events.",21.208216207268627,11.480173724854962
improve clinical outcomes in patient with pneumonia,0.09596571805481215,0.5871530771255493,2.333263874053955,62f26db2-3d8c-4cee-9d6c-a7a253dece0d,custom_license/Rapid syndromic molecular testing in pneumonia: The current landscape and future potential,Rapid syndromic molecular tests for pneumonia have improved diagnostic accuracy compared to the current gold standard of culture and can provide results in real time. In the era of widespread AMR their use has the potential to dramatically improve the rational use of antibiotics and to improve clinical outcomes in patient with pneumonia. High quality data from well conducted randomised controlled trials are now urgently needed to assess the impact of these platforms on antibiotic use and patient outcome.,19.586214910156997,8.753446236821626
customized immunization schemes of cows has been designed with the purpose of raising specific antibodies,0.2643832466867853,3.3600738048553467,3.826803684234619,382272f0-9939-4b3f-8b71-f157ad479f68,custom_license/Milk immunoglobulins for health promotion,"Considerable progress has been made in isolation and enrichment techniques of immunoglobulins from bovine colostrum and cheese whey. This has enabled the development of commercial Ig preparations targeted at health promotion in farm animals and humans. In order to improve the efficacy of such preparations customized immunization schemes of cows has been designed with the purpose of raising specific antibodies. The enhancement of specific antibody activities of milk Igs through targeted immunization and isolation/concentration technologies may in future have remarkable potential in producing Ig products for human health care, not only as part of a health-promoting diet, but also as an alternative or supplement to the medical cure of specified human diseases. In clinical trials, the Ig preparations have seldom caused any undesired symptoms and the health risks are mainly due to allergenic properties of whey proteins (Bernhisel-Broadbent, Yolken, & Sampson, 1991; Gingerich & McPhillips, 2005) . However, the regulatory status of these products is still unclear in many countries or they are treated as pharmaceuticals (for a case study, see Hoerr & Bostwick, 2002) .",11.469880841221531,8.685928662336014
cardiac markers should be tested and monitored in order to improve clinical management and outcomes,0.14893249417921528,1.7857227325439453,3.759023666381836,3cf6f453-8e2d-493c-a572-9ba88b07d196,"custom_license/Journal Pre-proof Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China Title Page Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China","Meanwhile, it is worth noting that the elevation in cardiac troponin I and NT-pro BNP peaked within one-week preceding death of the patients. Cardiac troponin I is a sensitive marker for myocardial injury[24] and NT-pro BNP is an optimal biomarker for heart failure [25] . Myocardial injury and heart failure presented before death may be attributed to other reasons, like severe hypoxia induced myocardial ischemia, management of mechanical ventilation or ECMO, multiple organ failure requiring kidney or liver replacement therapies, severe water and electrolyte unbalance or irreversible metabolic acidosis and coagulation dysfunction, which would cause severe systemic disorders in patients with COVID-19. All these conditions may have influences on the heart and cause secondary myocardial injury and heart failure. Though this was not the presence of the novel coronavirus directly attacking the heart, the elevation in cardiac markers should be considered as a warning sign, highly suggesting for recent adverse clinical outcomes of patients with COVID-19. Once the conditions of patients have become severe, such as the decline of blood oxygen saturation, the cardiac markers should be tested and monitored in order to improve clinical management and outcomes for these patients.",13.27524173760789,8.25041976746452
"use of in-hospital isolation facilities, oseltamivir and antibiotic usage, and other clinical outcomes in immunocompromised patients",0.17156890104219846,1.5777053833007812,3.627706289291382,e08f6291-bf6c-42f9-bdd1-623f55fc5465,custom_license/More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients,"Background: Immunocompromised adults are more vulnerable to a complicated course of viral respiratory tract infections (RTI). Objectives: Provide evidence on the effect of implementation of rapid molecular diagnostics for viruses on use of in-hospital isolation facilities, oseltamivir and antibiotic usage, and other clinical outcomes in immunocompromised patients. Study design: A before-after study during two consecutive respiratory viral seasons, including immunocompromised adult patients presenting at a tertiary care emergency department with clinical suspicion of RTI. During the first season (2016/2017), respiratory viruses were detected using inhouse real-time PCR. The second season (2017/2018), we implemented a diagnostic flowchart including a rapid molecular test for 15 respiratory viruses (FilmArrayÂ®). We assessed the effect of this implementation on need for isolation, antivirals and empirical antibiotics. Results: We included 192 immunocompromised adult patients during the first and 378 during the second season. Respiratory viral testing was performed in 135 patients (70%) during the first and 284 (75%) during the second season (p = 0.218) of which 213 (75%) using the rapid test. After implementation, use of in-hospital isolation facilities was reduced (adjusted odds ratio 0.35, 95%CI 0.19-0.64). Furthermore, adequate use of oseltamivir improved, with fewer prescriptions in influenza negative patients (0.15, 95%CI 0.08-0.28) and more in influenza positive patients (11.13,. No effect was observed on empirical antibiotic use, hospital admissions, length of hospital stay or safety outcomes. Conclusions: Implementation of rapid molecular testing for respiratory viruses in adult immunocompromised patients results in more adequate use of oseltamivir and in-hospital isolation facilities without compromising safety.",12.925351537069417,7.907390625159202
nanomaterials possessing novel optical and electrical properties has begun to open up many new opportunities for pathogen sensing,0.20482563700180864,2.0751988887786865,3.4754419326782227,dfe39815-754a-494d-a3f5-a32c5ac68f01,custom_license/Bioaffinity detection of pathogens on surfaces,"The surface bioaffinity sensing schemes discussed in the previous section typically lack the sensitivity necessary for routine measurements at concentrations below the nanomolar level. The continual development of new probes and their surface immobilization is important to improve specificity, however, will not improve sensitivity by orders of magnitude. Recently, the implementation of nanomaterials possessing novel optical and electrical properties has begun to open up many new opportunities for pathogen sensing. In this section, we highlight recent efforts aimed at novel signal amplification strategies based on (i) the use of biofunctionalized nanomaterials as an amplification tool, (ii) designing new optical and electrical based detection methodologies, and (iii) developing miniaturized on-chip detection systems which also integrate sample processing.",11.590452478348912,7.66457490136911
cost and multiplexing capability,0.22070983655098808,2.4089972972869873,2.450364589691162,45e536ec-47ef-4b84-ac5b-b6706721a50d,"custom_license/Molecular-based diagnostics, including future trends","As these technologies develop and diagnostics companies offer increasing choice, cost and multiplexing capability is likely to improve. The speed and cost of whole genome sequencing, including deep sequencing to analyse whole populations of organisms, are rapidly improving and this technique is likely to be adopted into routine practice in the near future. The computing power and bioinformatics available to analyse the resulting data are likely to be the limiting factors in its widespread adoption.",12.465394564182954,7.521473323999832
maximize the potential effect of rapid testing,0.16110804283253094,2.243572473526001,3.1252236366271973,0d50cbac-0686-47e7-b572-d8dcf2d08c65,custom_license/More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients,"To our knowledge, this is the first study to assess the effect of regular care implemented rapid molecular testing for respiratory viruses in immunocompromised adult patients. Other studies have focused on immunocompetent patients, which make former results less applicable in tertiary care centers with a large proportion of immunocompromised patients. Furthermore, with our non-randomized design in which the implementation of the rapid diagnostics for respiratory viruses during the second season was not 100%, we provide a truthful reflection of daily practice. Our study also has several limitations. First, given the before-after design of the study, outcomes can be biased due to residual confounders. However, we thoroughly adjusted our analyses for differences at baseline using a liberal p-value to select confounding factors and differences in viral pathogens for certain clinical outcomes. We thereby reduced the effect of confounders more thoroughly than former before-after studies on rapid molecular testing [14] [15] [16] [17] [18] 41] . Second, differences between the two seasons might also have been affected by trends in time not resulting from the diagnostic intervention per se. Adjustment for any possible trends in time with an interrupted time series analysis would have been appropriate. However, due to the short timeframe in this study and a limited number of patients per time point, this analysis was not feasible [44] . Also, we tried to maximize the potential effect of rapid testing by accompanying the implementation of this assay with specific instructions for the ED, by which we limited the possibility to distinguish the effect of the instructions and the rapid test as a sole intervention. Finally, our study was a single center study and clinical outcomes as antibiotic and antiviral prescriptions might be influenced by local protocols and guidelines, making results potentially less generalizable to other settings.",11.376383775202497,7.471451792920453
Zika virus products,0.10359908048738478,1.7773411273956299,2.134108543395996,d9ddf0b2-2901-4322-8bf2-06df2e07df9b,custom_license/The European Virus Archive goes global: A growing resource for research-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/). T,"Since November, 2015, the EVAg has received 260 enquiries for more than 400 products to be distributed in 30 countries. A total of 168 products were provided in February, 2016 alone, with the highest demands in the USA, Singapore, Netherlands, Germany, France and China. In its interim guidance for Zika virus laboratory testing (March 23, 2016), WHO identified the EVAg as the provider for PCR quality-control material (Corman et al., 2016) . This emergency situation and the resulting need for a coordinated distribution logistic was very challenging. Consequently, the management team introduced procedures to alleviate the burden on partners and to improve product access. This was achieved by establishing additional distribution hubs for Zika virus products obtainable from: the Centre for Molecular Diagnostics and Therapy (CRIE), Moscow, Russia; Wuhan Institute of Virology (WIV), Wuhan, Southern China; National Institute of Infectious Diseases (NIID), Tokyo, Japan. The management team also negotiated a common Material Transfer Agreement (MTA), with industry on behalf of all consortium members and a centralised exchange logistics platform was established. This experience underlines the reality that anticipation and preparedness are key components for an effective response to public health emergencies.",13.296895261582545,7.1963556275684475
evaluating effects within a research setting,0.23180414242636396,2.2793195247650146,2.2391862869262695,5f66b17d-5528-4bc1-a7bc-75889bc9ccfe,custom_license/More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients,"Respiratory viruses are increasingly recognized as important causative pathogens in acute respiratory tract infections (RTI) in up to 50% of patients, depending on the season in which these viruses are detected [1] [2] [3] . Moreover, the number of immunocompromised patients is increasing due to ageing of the population, increased prevalence of chronic diseases as well as treatment with immunosuppressive agents [4, 5] . Although immunocompromised patients have similar etiologies of acute RTI when compared to immunocompetent patients [6] , they more often have a complicated course of the disease leading to high healthcare burden, especially in secondary and tertiary care settings [7, 8] [9, 10] . Rapid and accurate detection of respiratory viruses by molecular diagnostics might lead to more targeted use of in-hospital isolation facilities [11] and improvement of other clinical outcomes due to more targeted antibiotic and antiviral therapy [12] . However, current evidence on the effect of implementation of rapid molecular testing on clinical outcomes and hospital resource use is heterogeneous and inconclusive. Most studies only focus on immunocompetent patients, do not specifically address the viral respiratory season, are of low quality due to their design or lack of proper adjustment for potential confounders [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , whereas randomized studies [11, [23] [24] [25] [26] evaluating effects within a research setting with perfect implementation of diagnostic assays, may lead to over-optimistic results.",11.84550970259053,7.08295717350602
they perceived new possibilities for obtaining large variety and quantity of products by fermentative processes.,0.20753629005958948,1.585554838180542,2.1389200687408447,529ef3a3-01c4-4c33-a3fc-65498d880807,custom_license/Main Groups of Microorganisms of Relevance for Food Safety and Stability: General Aspects and Overall Description,"The use of microorganisms to obtain different types of food, such as beer, wine, bread, cheeses, and fermented milk is very old. There have been reports of application of fermentation processes for the production of foods from times before Christ. In the 20th century, the industrial microbiology expanded even more, because they perceived new possibilities for obtaining large variety and quantity of products by fermentative processes.",12.810907443044105,6.9047262945643375
other countries around the world,0.12758144125597978,1.3074264526367188,2.1965346336364746,6cddaefa-4a9a-4afc-bf26-f93aa2d51872,custom_license/Shared Longitudinal Health Records for Clinical and Population Health,"shared, longitudinal health records in a health system? What benefits do these stakeholder receive from access to SHRs? 2. How would the implementation of an SHR system in the United States differ from an implementation in other countries around the world? 3. What advantages does an HMIS component offer over traditional sources of health indicator data such as population-based surveys? 4. What are some of the benefits of NoSQL DBMS in comparison to an RDBMS for managing clinical data?",12.823756166905415,6.7658893644944715
available personnel and clinical use,0.1546447307090199,0.534872829914093,1.7838033437728882,d15263ae-b50e-4c32-bb84-9643449c85ff,custom_license/2015 RAD-AID Conference on International Radiology for Developing Countries: The Evolving Global Radiology Landscape,"Full PACS platform with enterprise VNA or local PACS storage Note: These stages of implementation represent progressive levels of technical complexity that factor in site infrastructure, hardware constraints, study volume, available personnel and clinical use. Each stage has varying implementation requirements that are minimal at stage 1 and most comprehensive at stage 3. VNA Â¼ vendor-neutral archive.",13.760221169655734,6.323216922276045
reorganization and consolidation of pathology laboratories to improve efficiency and quality,0.1447515516169028,0.07483617961406708,1.6554213762283325,a95266ce-4f94-4f4d-b3a9-0a1b6c0e37d4,"custom_license/Molecular-based diagnostics, including future trends","The move towards reorganization and consolidation of pathology laboratories to improve efficiency and quality may be a driving force in the adoption of these newer techniques and could potentially open up new models of diagnostic testing (for example, point-of-care or near-patient diagnostics).",14.503840599443445,6.201011621102765
first-generation IoT services and products,0.2920078442867807,0.6001145243644714,0.7496623396873474,4d67d8b4-7cba-4f29-88f4-efca3135a8c8,custom_license/ADVANCED MANUFACTURING PROCESSES AND TECHNOLOGIES 2 CHAPTER OUTLINE,"The introduction of both CPS and the IoT, where things are supposed to initiate both a process of preparation, design, planning, optimization, tasks for tools, and humans if necessary, is leading in a fourth industrial revolution referring to the future (Mrugalska and Wyrwicka, 2017) . This idea is represented schematically through Table 2 .3. Qian et al. (2017) consider that the intrinsic safety of the manufacturing process as well as enterprise information security must be ensured, and to realize the safe running of manufacturing processes by means of fault diagnoses and self-healing control techniques. For example, with advancements in networking and Internet technologies, cyberattacks on physical systems are becoming a growing phenomenon (DeSmit et al., 2017). Tarkoma and Ailisto (2013) indicate that recent advances in radio, network, mobile, and cloud technologies have supported the development of the first-generation IoT services and products. These authors consider that IoT as a concept is not new as it was proposed over 10 years ago in the MIT Auto-ID Center, so that the concept has since gained momentum and importance, and now it is considered in Europe, the United States, and Asia, not only on the implementation and deployment level but also on the societal level.",11.710737454288745,4.976113070634743
Corticosteroids,0.45743436258147907,1.9925936460494995,1.8760147094726562,61fe8357-756c-4c14-9e2b-120b4b5e1f29,custom_license/39. The cat with tremor or twitching Diseases causing tremor or twitching COARSE TREMOR AND TWITCHING (INTENTIONAL),Corticosteroids (prednisolone 1-2 mg/kg q 12 h) may reduce peritumoral edema and improve clinical signs.,24.653062983502096,11.143167475315135
Treatment with corticosteroids,0.26811547395201424,1.5588290691375732,1.9786673784255981,18a271a8-4c62-4bb6-a6ed-3f8ed2028b36,custom_license/39. The cat with tremor or twitching Diseases causing tremor or twitching COARSE TREMOR AND TWITCHING (INTENTIONAL),Treatment with corticosteroids (prednisolone 2 mg/kg q 12 h initially) may improve clinical signs.,24.45614101546873,10.859022046330118
"The FCTC should harness new technologies to monitor treaty implementation, particularly for the illicit trade Protocol",0.3227008756623691,3.460800886154175,3.84859561920166,b47fe443-70d5-4a1b-81d2-e284878369e7,"custom_license/The global health law trilogy: towards a safer, healthier, and fairer world","As tobacco companies diversify into novel nicotine delivery devices, regulatory responses have lagged. Although companies claim, for example, that electronic cigarettes reduce harm, they aggressively market to adolescents using familiar strategies (cartoons, video games, and candy flavouring). 10 The FCTC targets traditional tobacco products, but it has struggled to regulate novel technologies. This contributes to governments' continued divergent approaches to electronic cigarettes, ranging from outright bans and regulation (as prescribed smoking cessation products) to no regulation. The FCTC should harness new technologies to monitor treaty implementation, particularly for the illicit trade Protocol. Tracking import and sale of unlawful tobacco products is complex and expensive, and beyond the capacity of governments in low-income countries. Tobacco companies capitalise on poor tobacco surveillance by offering partnership programmes. The COP has urged Parties to support Protocol implementation, but it cannot require them to provide financial or technical assistance. 11",14.147708430942936,9.702805679311322
"detection, diagnosis, and management of new MERS-CoV cases",0.19546772589511544,2.3033668994903564,4.360074520111084,51c6c700-977c-4eb1-900e-cfc2215eaede,"custom_license/Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences","As age increases by one year, the health-system delay in diagnosis tends to increase by 1.1%. A large proportion of the MERS-CoV patients are older [5] , which indicates the necessity of prompt investigation to reduce health-system delay in this vulnerable group. Saudi Arabia as a reporting country was a significant predictor of shorter diagnostic, patient, and health-system delays. Unlike the other countries, Saudi Arabia has experienced multiple MERS-CoV outbreaks, and the majority (83%) of cases reported were from Saudi Arabia (WHO, 2018). The lessons learned from these outbreaks may help the health system in Saudi Arabia to improve clinical experience in detection, diagnosis, and management of new MERS-CoV cases [13] .",14.162011647959798,9.287940999526866
Many clinicians administer corticosteroids in an attempt to halt disease progression and to improve clinical outcomes.,0.329389684572404,2.2440106868743896,2.8900797367095947,dc6876e0-5447-40b7-9e81-a0f17a4c9368,custom_license/The role of adjuvant immunomodulatory agents for treatment of severe influenza,"Systemic corticosteroids are widely prescribed in patients with influenza complicated by critical illness (Delaney et al., 2016) , based on the findings that marked elevation of pro-inflammatory cytokine levels was associated with a high mortality rate in severe influenza virus infections due to A(H5N1) (de Jong et al., 2006; Carter, 2007) , A(H7N9) , and A(H1N1)pdm09 virus (Lee et al., 2011a) . Many clinicians administer corticosteroids in an attempt to halt disease progression and to improve clinical outcomes.",15.930494248963246,8.912831762466725
combination treatment with ribavirin and interferons,0.40520936683644937,3.5843570232391357,3.923877716064453,b946c815-274a-4321-bc25-7995ce7b6501,custom_license/MERS-CoV vaccine candidates in development: The current landscape,"Despite past efforts to develop coronavirus countermeasures in response to the SARS-CoV pandemic, there are currently no prophylactic or therapeutic interventions of proven efficacy for MERS-CoV or any other coronavirus infection. Although combination treatment with ribavirin and interferons were shown to improve clinical outcomes in MERS-CoV-infected non-human primates (NHPs), treatment was initiated very soon after viral challenge (â¼8 h) and results have not been replicated in humans [22] . In fact, no experimental interventions have demonstrated appreciable benefit in acutely ill patients in a consistent or controlled manner. Rapidly scaled treatments based on naturally occurring neutralizing antibodies such as convalescent plasma or hyperimmune globulin, on the other hand, have demonstrated mortality reductions for other respiratory infections and may hold promise for MERS-CoV as well [23] . Their development, however, is limited by logistical challenges, local technical capacity, and donor supply. Supportive management, adapted from guidelines developed for SARS-CoV, has thus far been the mainstay of MERS-CoV treatment.",11.4588525535318,8.890950974283463
can streamline and improve reliability of PCR detection and diagnostics,0.1925797674673916,2.1680972576141357,2.9476358890533447,4a6c8187-5daf-47cb-8abf-383654782942,"custom_license/A multi-target, non-infectious and clonable artificial positive control for routine PCR-based assays","This study described the concept, development and functional validation of fully synthetic APCs, designed and constructed using a novel design involving cloning of custom and de novo synthetic DNA inserts constructed of either primer sequences from multiple genomic targets or existing priming sequences of value for detection and diagnostics. This approach offers the possibility of engineering single controls for a large number of predetermined targets. If adopted, this concept will find applications in many areas of microbiology. Moreover, APC constructs would be used in conjunction with EICD or alternative dry or paper based storage technology to facilitate preservation, shipping and commercialization. The implementation of APCs can eliminate biosafety risks associated with in vivo positive controls, can streamline and improve reliability of PCR detection and diagnostics, and offer new opportunities for development of synthetic positive control combinations to fulfill the demand of different health, forensics or agricultural markets.",15.104034693246119,8.611638687970004
co-infections will be noted more often,0.4142710917018259,2.9051263332366943,3.7201180458068848,467742c8-9867-4374-82f7-9eec195c7452,"custom_license/Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0-6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics","Recently, many new or novel methods with a syndromic approach have been presented and have shown good sensitivity; some of them have already been FDA approved (74, 75) . With the implementation of such methods, co-infections will be noted more often. In order to obtain a more balanced delineation of a potential pathogen role in the disease, information on (viral) burden would be helpful and the inclusion of a control group(s) is needed. However, the most powerful combination for accurate diagnostics remains a combination of reliable analytical data in conjunction with careful clinical observations. A limitation of our study was the relatively low number of controls, which were not precisely matched, resulting in a significant difference in age in sex between cases and controls. The observed boy predominance in the control group was probably due to sexrelated differences in elective surgical procedures, such as inguinal hernia repair, which has been shown to be more prevalent in boys than in girls and testicular retention surgery.",11.965364742747564,8.494286506339975
antihistamine decongestants did not improve clinical cure,0.35932386081040507,2.4265482425689697,2.2191638946533203,f56a6a24-6ede-44e7-8560-42bc64664388,custom_license/Treatment of pediatric sinusitis,"The AAP guidelines do not specifically recommend any adjuvant therapies. One study [35] did suggest that topical steroid spray (budesonide) might improve symptoms during the second week of therapy when combined with appropriate antibiotics, although a larger multicenter trial in older children [36] showed no effect. Topical sympathomimetics often are used in ARS, although oxymetolazine actually has been shown to increase inflammation in a rabbit model, possibly due to decreased blood flow [37] . Saline spray is helpful in clearing out purulent secretions, although one in vitro study [38] suggested that only isotonic saline had no adverse effects on ciliary function, whereas isotonic and hypertonic saline actually decreased ciliary function. One study showed that antihistamine decongestants did not improve clinical cure in ARS [39] , although this study included an abnormally low number of children with allergy, and the antihistamine preparation was a first-generation antihistamine that may have had anticholinergic drying effects.",15.24944307578847,8.357017965720452
cDNA products were stored at 4Â°C until analyzed by PCR,0.339326000735547,2.715764284133911,3.076087474822998,d1e022c8-70a8-4405-81ab-3a084bad8234,custom_license/SARS-associated Coronavirus Replication in Cell Lines SARS-associated Coronavirus Replication in Cell Lines,"A 300-ÂµL volume of lysis buffer containing guanidinium thiocyanate and Triton X-100 (Roche Diagnostics, Mannheim, Germany) was added to 200 ÂµL supernatant from cell cultures that had either been infected with SARS-CoV or were mock-infected. These samples were removed from the PC4 laboratory to a PC2 laboratory, where they underwent nucleic acid extraction with a MagNA Pure LC Total Nucleic Acid Isolation Kit with a MagNA Pure LC automated extraction robot (Roche Diagnostics). A 10-ÂµL volume of eluate was treated for 10 min at 65Â°C and added to 12 mL reverse transcription master mix containing 5.2 A 260 U/mL random hexamers (Roche Diagnostics), 0.17 Âµmol/L deoxynucleoside triphosphates (Roche Diagnostics), and 7.5 U AMV-RT enzyme (Promega, Madison, WI, USA). After incubation at 42Â°C for 30 min, then 100Â°C for 10 min, cDNA products were stored at 4Â°C until analyzed by PCR.",12.642114039868877,8.189443557276098
hepatic and renal organ dysfunction,0.3273527411774413,1.2256669998168945,2.54972505569458,9ef5674d-98fb-4702-9e33-8060bc99b7a7,custom_license/The role of adjuvant immunomodulatory agents for treatment of severe influenza,"In a multicenter trial in which patients with sepsis-associated ARDS randomly assigned to receive either enteral rosuvastatin or placebo, rosuvastatin did not improve clinical outcomes in patients with sepsisassociated ARDS and might have contributed to hepatic and renal organ dysfunction (National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, 2014). A one year follow up of the same cohort has shown no significant difference in cumulative survival in the rosuvastatin group vs placebo (58% vs 61%; p = .377) (Dinglas et al., 2016) . Another RCT in adults with suspected ventilator associated pneumonia has shown that adjunctive simvastatin therapy did not reduce day-28 mortality in comparisons with placebo (Papazian et al., 2013) .",15.609686715666863,7.9173951865658605
"They should be stable, simple, robust, reliable, and affordable and also have high detection capability",0.29393166449196334,2.796832323074341,2.1324777603149414,7505ae53-f04d-4fa6-b7e8-d69bac59d0c6,custom_license/Virus detection using nanosensors Chapter Outline,"Clinical diagnostic systems have a huge research area that still has to deal with many unmet disputes necessary to develop and commercialize the nanosensors. They should be stable, simple, robust, reliable, and affordable and also have high detection capability, especially in clinical applications. Nanosensor feasibility also seems to begin leaving the proof of concept, and several analytes have already been detected to demonstrate the versatility of the nanosensors. In some particular cases the validation with real samples in clinical scenarios strengthens nanosensors suitability. There are still some doubts to overcome as some portable nanosensors have recently been studied at the research level. Though the progression is quite slow, a significant advancement in smartphone technology has helped mobile health diagnostics to deploy at developing countries. The exponential increase in mobile application development and the affordability of these platforms have revolutionized health delivery and opened a new window in global health access. In this review the current developments of nanosensors were summarized in clinical application for virus detection. In comparison with conventional techniques, these nanosensors demonstrate more favorable applications to improve human health.",12.67919705319855,7.641770522822526
improve clinical outcome,0.18977442890856352,1.4178770780563354,2.4810030460357666,7c67ed01-f6ae-425b-8c6c-b43c14d3cbb6,custom_license/The role of adjuvant immunomodulatory agents for treatment of severe influenza,"The polymyxin (PMX) B-immobilized fiber column, first introduced in Japan in 1994, is an extracorporeal device using PMX-B fixed to polystyrene-derived fibers, which can remove circulating endotoxin and reduce various cytokines through direct hemoperfusion (Ronco and Klein, 2014) ). Three case reports suggest that PMX column hemoperfusion could reduce hypercytokinemia (elevated IL6, IL8, interferongamma, and high-mobility group box-1) and improve clinical outcome in patients with A(H1N1)pdm09 (Takeda et al., 2010; Binh et al., 2015) or A(H5N1) virus infection (Kudo et al., 2012b) complicated by ARDS despite treatment with NAI. It has been suggested that treatment with PMX hemoperfusion and oseltamivir is effective in improving ARDS due to influenza only if initiated early (Binh et al., 2015) .",13.717846697700276,7.335518424854962
corticosteroid therapy should be slowly tapered (over months) to prevent recurrence,0.17507766756451568,1.5760915279388428,2.2868149280548096,a1d7bbdf-03e9-4ff7-a287-1175a703e3c7,custom_license/39. The cat with tremor or twitching Diseases causing tremor or twitching COARSE TREMOR AND TWITCHING (INTENTIONAL),"If clinical signs improve, the corticosteroid therapy should be slowly tapered (over months) to prevent recurrence.",11.40060718846122,6.5011017123573005
policy making and implementation in Taiwan,0.15118386719916987,0.16604101657867432,0.8794957995414734,20f7d99e-64b5-4031-80ad-8a9dbe8f4a89,custom_license/Studying up harm reduction policy: The office as an assemblage,"The research, designed as a multi-sited qualitative study on harm reduction, aims to examine the processes of policy making and implementation in Taiwan (Chen, 2009 ). The fieldwork was undertaken mostly in Taipei and Taoyuan, two major residential areas in northern Taiwan, as well as in Kaohsiung and Tainan, cities of southern Taiwan.",12.722685684770848,5.132538920147892
Low-cost diagnostics would allow farmers and entrepreneurs in the developing world to assess the quality of their products and mitigate potential risks,0.3522530137394924,3.7782046794891357,4.649493217468262,e530c4b5-012c-4ff7-976b-4d0a936c47b4,custom_license/Point-of-Care Diagnostics,"While the main application of rapid tests is in medical diagnostics, such assays are also necessary for veterinary testing, environmental monitoring and food quality testing. Low-cost diagnostics would allow farmers and entrepreneurs in the developing world to assess the quality of their products and mitigate potential risks due to enterohemorrhagic strain of E. coli (O157:H7) and Salmonella in undercooked meat and poultry products [17] . Low-cost diagnostics are also required in testing water supplies. Inadequate environmental monitoring capabilities were highlighted by the cholera epidemic in Haiti after the earthquake in 2010 [20] [21] [22] [23] [24] . Although the cholera epidemic took most people by surprise, it wasn't totally unexpected since Haiti ranked last out of 147 countries surveyed in the 2002 Water Poverty Index [25] . Due to globalisation, such epidemics also concern the developed nations. The development of low-cost, rapid quantitative diagnostics will aid in screening large regions and populations. For the development of rapid diagnostics, WHO has outlined a set of criteria corresponding to the acronym ASSURED: Affordable, Sensitive, Specific, User-friendly, Rapid and Robust, Equipment free and Deliverable to those who need it [10] . For the developing world, the trend towards low-cost is a priority; however, clinically useful sensitivity and specificity from rapid diagnostics assays are also required. Operating with lowvolume samples without manual manipulation, being portable and functioning without sharps such as needles are considered desirable characteristics of rapid assays. Hence, the development of robust diagnostic tests can enable individuals and local communities to monitor their health condition and timely mitigate the spread of diseases.",13.041567711294835,10.0425523319755
improve the clinical outcome of patients,0.24621179780031843,2.050276517868042,3.650113821029663,4cc490ca-c883-43a6-95cd-7c0919c630d3,custom_license/Developments towards antiviral therapies against enterovirus 71,"There is currently no effective vaccine or antiviral against EV71. Treatments for acute EV71 infections with neurological manifestations mainly aim to alleviate symptoms. Mechanical cardiopulmonary support systems and the administration of milrinone, a positive inotropic agent, have been used to prevent cardiopulmonary failure and thus improve the clinical outcome of patients [7] . The lack of antiviral treatment options against EV71 remains a worrying situation, however, because EV71 has been found to circulate endemically with peak activity in warmer seasons (e.g. summer to fall) [8] . Considering the propensity of EV71 to cause severe neurological diseases in children, there is a need to develop effective antiviral treatment options to prevent or reduce EV71related deaths and long-term neuropathy in the next EV71 global outbreak.",15.664304792911727,9.187760397802613
To improve clinical management of infectious diseases at the individual level and at the population level,0.2834804873015517,2.5133581161499023,2.687436103820801,e66b18ef-0147-471b-b942-e7c98873f975,custom_license/Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings HHS Public Access,"To improve clinical management of infectious diseases at the individual level and at the population level, accurate, cost-effective and timely diagnosis is the key [7] [8] [9] [10] [11] . Given sustained financial support and well-equipped laboratory infrastructure in resource-rich settings (RRS), traditional diagnostic methods such as enzyme-linked immunosorbent assay (ELISA), cell culture, flow cytometry, biopsy, polymerase chain reaction (PCR) and sequencing are widely implemented. On the contrary, clinical symptoms and signs are often used by physicians to make empirical diagnosis with minute aid of lab tests (e.g. lateral flow assays) in RLS, thus leaving infected individuals under-diagnosed and/or loss of follow-up and permitting further disease transmission in the general population. Considering the weakness of health care systems and financial status in RLS, point-of-care (POC) diagnostic technologies are preferred to aid timely diagnosis and treatment of patients in primary care settings, as they can rapidly provide laboratory evidence without reference to sophisticated laboratory infrastructure and well-trained operators [12, 13] . Although tremendous efforts have been made in material science, engineering and nanotechnology towards developing POC diagnostic devices, only few of them can meet the WHO criteria for POC testing, that is, affordable, sensitive and specific, user-friendly, rapid and robust, equipment-free, and delivered to those who need it (ASSURED) [14] . [30, 31] from various clinical sample matrices. Among the developed POC diagnostic technologies (Table 1) , paper-based assays such as lateral flow strips and dipsticks are the most widely used assays in the clinic because of its simple working procedure, scalable manufacturing capability and low cost [32] . In contrast, the other POC diagnostic technologies are still under development, where technical challenges are yet to be overcome, or clinical validations are needed. Here, we summarized the technical challenges that are confronted during assay development and reviewed new research approaches that may provide viable solutions to developing quality-assured POC diagnostics. Because of the unavailability of systematic reports on POC diagnostics from industry perspectives, we limited our literature search to POC diagnostics for infectious diseases in PubMed and Web of Science.",15.108454624773888,8.668475361651819
RNA as a target for routine diagnostics,0.20273314898528733,2.877185106277466,3.2762393951416016,ceec8bb5-cc37-4390-851a-074eac4a5064,custom_license/Neurodegeneration as an RNA disorder,"The main challenge using protein as a target for routine diagnostics is low sensitivity, reproducibility and specificity. By contrast, RNA as a target for routine diagnostics gives the information of clinical activity, regulation or processes in addition to higher or equal sensitivity, reproducibility and specificity compared to DNA as target. New methods of isolation, purification and stabilization of mRNA have been recently developed for routine diagnostics making the RNA very much suited as a marker for new methods and drugs (Bustin, 2002) . Non-neuronal cells and tissues such as fibroblasts, lymphoblasts, and muscle biopsies can be explored for RNA expression biomarker discovery. Nucleic acids can be identified in most bodily fluids, including blood, urine, and cerebrospinal fluid (CSF), and have been adopted for use as diagnostic biomarkers for diseases (Xiang et al., 2003; Li et al., 2004) . In fact, the composition of fluids reflects levels of hormonal, immunological, toxicological and infectious disease markers. If present, mRNA may provide potential biomarkers to identify populations and patients at high risk for oral and systemic diseases.",12.562612774065354,8.396640396845267
"industrial partners are seeking technologies that have improved capabilities, sensitivity, specificity, and compatibility with the existing manufacturing processes",0.20517323552623062,1.9502564668655396,2.5343616008758545,9a9f508d-b74b-4215-bf73-c6aaf4e2b665,custom_license/Point-of-Care Diagnostics,"Existing prototypes need to be transformed into highly reproducible diagnostic devices. Having performance data does not always yield efficacy after deployment. Possible small-scale trials should experiment with the feasibility and cost-effectiveness after scaling up. The ultimate test in the realisation of diagnostics depends on the acceptance from experts in the commercial diagnostics industry. Today, the rapid diagnostics business is based on a standard lateral flow format, involving the use of nitrocellulose as the reaction matrix. The lateral-flow format is the only ubiquitous, universally applicable platform that can be utilised for simple, qualitative, low cost point-of-care applications, while also having enough capability to be functionalised for highly sensitive, fully quantified, multiplexed assays. Hence, the industrial partners are seeking technologies that have improved capabilities, sensitivity, specificity, and compatibility with the existing manufacturing processes. Only low cost is not enough to achieve market penetration in diagnostics. The value of the low-cost and multiplexed diagnostics will be realised upon reaching communities, where they are needed the most.",13.535361356093587,7.65237821866466
pharmaceutical production processes,0.20177982759505214,1.4106340408325195,2.2051477432250977,996113ff-633e-45ce-8abe-4204c44e618e,custom_license/EUFEPS-Publication Position Paper: EUFEPS Network on Veterinary Medicines Initiative: An interdisciplinary forum to support Veterinary Pharmacology and promote the development of new pharmaceuticals for Animal Health,This Network powers science-based process understanding and quality-by-design for medicines. It also contributes to education and training in the field and fosters hands-on implementation of systems approaches and emerging technologies in pharmaceutical production processes.,14.99658973533919,7.5990645670061685
"IVIG could transiently improve the clinical condition, HSCT is the most effective therapy for this disease at present.",0.1860067440461276,2.254136800765991,1.9940083026885986,ff5aa239-28ad-42c3-9e33-d4838e34c713,custom_license/Heterozygous Mutations in OAS1 Cause Infantile-Onset Pulmonary Alveolar Proteinosis with Hypogammaglobulinemia,"Lung transplantation is a curative treatment for GPAP caused by mutations in genes encoding surfactant proteins or genes encoding a surfactant phospholipid transporter in alveolar type II epithelial cells. 34 On the other hand, HSCT is effective for GPAP caused by mutations in genes that could be responsible for surfactant catabolism in AMs. 35 In this study, two affected individuals (B-II-1 and C-II-1) received successful HSCT and recovered completely from PAP. C-II-1 has had cord blood engraftment for 2 years without any respiratory symptoms. It has been reported that AMs are derived from precursor cells in bone marrow. 36 Pulmonary transplantation of differentiated wild-type AMs derived from bone marrow in GM-CSF receptor-b-deficient mice showed long-term effectiveness due to proliferation of transplanted AMs. 37 Although IVIG could transiently improve the clinical condition, HSCT is the most effective therapy for this disease at present.",13.348946249538823,7.433425504584071
Implementation of a BOS enables the portability of business processes,0.15415944054851224,1.993600606918335,2.7452425956726074,517add78-6c05-42d4-8eab-6b720d2f1a2a,custom_license/Smart business networks: Concepts and empirical evidence,"The third research stream will focus on the network platform with a networked Business Operating System (BOS). Most of the network scientists analyze the structure and dynamics of the business networks independent of the technologies that enable it to perform. It concentrates on what makes the network effective, the linked relationships between the actors, and how their intelligence is combined to reach the network's goals. Digital technologies play a fundamental role in today's networks. They have facilitated improvements and fundamental changes in the ways in which organizations and individuals interact and combine as well as revealing unexpected capabilities that create new markets and opportunities. The introduction of new networked business operating systems will be feasible and these operating systems will go beyond the networked linking of traditional Enterprise Resource Planning (ERP) systems with Customer Relationship Management (CRM) software packages. Implementation of a BOS enables the portability of business processes and facilitates the end-to-end management of processes running across many different organizations in many different forms. It coordinates the processes among the networked businesses and its logic is embedded in the systems used by these businesses.",12.319784080849692,7.3921725099815045
Low-cost diagnostics that can allow local communities in developing regions to improve healthcare,0.33005086292452596,2.1774606704711914,2.3357503414154053,8be8716a-8781-46da-b62f-f830229f8fdb,custom_license/Point-of-Care Diagnostics,"limited [6, 7] . Other trends include increase in healthcare associated infections [8, 9] , preservation of the life span of cost-effective drugs [10] , increase in spurious/ counterfeit medicines [11] , and mitigating the epidemic-to-pandemic transitions of infectious diseases [12] . In terms of impact, low-cost diagnostics will reach underserved communities. Low-cost diagnostics that can allow local communities in developing regions to improve healthcare [13] , environmental safety [14] , animal health [15, 16] , and food quality [17] will play key roles in the United Nation's Post-2015 Millennium Development Goals.",12.35413153593895,7.257533195304919
Metagenomic sequencing has not yet been implemented as a routine tool in clinical diagnostics of viral infections,0.2538018599762311,1.9601811170578003,1.9608697891235352,8048795f-56fd-4573-8054-3456e4267e96,custom_license/Retrospective Validation of a Metagenomic Sequencing Protocol for Combined Detection of RNA and DNA Viruses Using Respiratory Samples from Pediatric Patients,Metagenomic sequencing has not yet been implemented as a routine tool in clinical diagnostics of viral infections. Such ,12.479915143500508,6.916653389243046
their functionalisation to increase the capabilities and the performance,0.11098118593329329,0.9312770962715149,2.344571113586426,c2eec402-6acf-4254-a164-9264e0beb35f,custom_license/Point-of-Care Diagnostics,"Rapid tests that are low-cost and portable are the first line of defence in healthcare systems. Dipstick and lateral-flow are the two universal assay formats as they are lightweight and compact, and provide qualitative results without external instrumentation. However, existing formats have limitations in the quantification of analyte concentrations. Hence, the demand for sample preparation, improved sensitivity and user-interface has challenged the commercial products. Recently, capabilities, sensors and readout devices were expanded to multiplexable assays platforms, which might transcend the capabilities of existing design format of diagnostic tests. This chapter outlines the evolution of diagnostic devices and current trends in the development of qualitative and quantitative sensing devices for applications in healthcare, veterinary medicine, environmental monitoring and food safety. The chapter also discusses design parameters for diagnostics, their functionalisation to increase the capabilities and the performance, emerging sensing platforms and readout technologies. The factors which limit the emerging rapid diagnostics to become commercial products are also discussed.",12.169473831528796,6.38861717744274
sanitation and hygiene,0.1759515540792937,0.5689043402671814,1.289381980895996,73dbb49c-ce6a-47f5-a056-8b6be1521848,custom_license/Environmental and Occupational Health Learning Objectives,"By 1900, however, the incidence of many of these diseases had begun to decline because of public health improvements, implementation of which continued into the twentieth century. Local, state, and federal efforts to improve sanitation and hygiene reinforced the concept of collective 'public health' action (e.g., to prevent infection by providing clean drinking water).",13.376229884844573,5.889566568451666
alone or in combination with interferon beta,0.21651664023064315,0.44678887724876404,1.3774069547653198,954babf2-cc8e-435b-8be5-3ce4cb4a7b89,custom_license/Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations,"Second candidate identified for rapid implementation in clinical trials, alone or in combination with interferon beta, by WHO; 66 ",13.030688039115333,5.74646810449952
Environmental impact statements are required for major construction and public works programs,0.11457144396163713,0.589533805847168,0.6687839031219482,5309e209-f525-4b69-9084-7731a93f181f,custom_license/Environmental and Occupational Health Learning Objectives,"The US National Environmental Policy Act (NEPA), passed in 1970, made protection and restoration of the environment matters of national policy. NEPA required all federal agencies to take environmental considerations into account in decision-making processes and program implementation. Environmental impact statements are required for major construction and public works programs, delineating positive impact, possible adverse effects, alternatives, and any irreversible effects. This legislation resulted in changes in many national projects and promoted a governmental regulatory approach to supervision, control, and prevention of pollution with materials and processes that could harm human health and the environment.",12.947016921617795,5.349362433396154
comparability and consistency in SARI reporting,0.16021303796442063,-0.6181462407112122,1.3492618799209595,32904066-0ff9-46a3-b97e-9bb4d9c4b82b,custom_license/Epidemiology and Infection Seeking out SARI: an automated search of electronic health records,"The World Health Organization (WHO) developed a surveillance definition for SARI to improve comparability and consistency in SARI reporting. This definition starts with the case definition of ILI as an acute respiratory infection in a person with a fever (â©¾38Â°C), cough and onset within the past 10 days. A SARI is defined as an ILI requiring hospitalisation [3] . This definition was chosen because of its feasibility in worldwide implementation. However, the correlation between SARI and patient outcomes has not been evaluated.",12.125772810513663,4.719245649166117
"multidisciplinary research in population genomics, can improve clinical care through understanding of the genetic variation in populations that contributes to complex disease.",0.20149740826546222,3.2674875259399414,2.958526611328125,bdee4a0c-b447-435e-8540-5c13e8a9a553,custom_license/Public and Population Health Genomics Chapter Outline,"In this chapter we have explored how the integration of genomic, population, and social sciences in population genomics can improve health through examples in pharmacogenomics, population variation, and genetic pleiotropy. We have also investigated cross cutting issues in global health and population versus individual health where population genomics can play a crucial role in the translation of genomic health discoveries worldwide and population screening can work together with genomic medicine to provide the greatest health benefit to both individuals and populations at large. Thus, multidisciplinary research in population genomics, can improve clinical care through understanding of the genetic variation in populations that contributes to complex disease.",19.183343668794194,10.76107947330221
molecular technologies into clinical virology has resulted not only in the improvement of diagnostics for a number of viruses using the quantitative detection of nucleic acids,0.1259737712575279,1.8236838579177856,3.249413013458252,e17cb3fc-64ca-4ebb-b4be-37f515c2499a,custom_license/Clinical virology in real time,"The implementation of molecular technologies into clinical virology has resulted not only in the improvement of diagnostics for a number of viruses using the quantitative detection of nucleic acids and the monitoring of antiviral therapy, especially for HIV-1, HBV, and HCV, but also in the development of an amplification assay for almost every human virus. Also for those viruses that can be cultured relatively easily, like e.g. HSV types 1 and 2 (Espy et al., 2000) . These new molecular technologies do have several advantages, definitely in those settings in which routine virus culture is not available. However, it should also be noted that an improved sensitivity is observed in most instances. The implementation of molecular diagnostics into routine clinical diagnostic virology will proceed and could ultimately replace or reduce virus culture techniques. The implementation of automated extraction and detection technologies, combined with an extensive quality control program, should ultimately convince both clinicians and virologists that molecular diagnostics is a strong cornerstone in clinical virology. The final critical remark often mentioned that not all positive results should have a clinical significance, will be counter-parted by good clinical and epidemiological information, combined with quantitative information on one or more viruses present. However, the ability to exclude viral infections has the advantage that unnecessary therapeutic options are avoided, which inevitably will reduce overall costs for patient care. But we do need financial figures to prove this. Thus with an improved accuracy and sensitivity combined with a more rapid turn around time, these molecular technologies are important for clinical patient care providing information for the best therapeutic options.",18.928393004404313,9.922450517935934
Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management,0.33582026348154703,3.289912223815918,3.1613337993621826,ca3716b6-cd34-450d-92e9-79452c729535,custom_license/The polymerase chain reaction and pathology practice,"Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management. The polymerase chain reaction (PCR) is foremost amongst these techniques. This review explains the principles of PCR and the methodological factors that contribute to a successful assay. Key PCR technique variations, such as reverse transcription (RT)-PCR and quantitative real-time (q) PCR, are described and an overview is provided of how PCR products are analysed. The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases, for tumour diagnostics and in molecular forensic applications such as specimen identity confirmation.",15.112497261069391,9.482683956440052
clinical laboratories move toward implementation of array technology,0.16997029887937581,2.7254605293273926,2.678907871246338,6f80737d-7c22-49d9-81af-aced1debe592,custom_license/Field evaluation of TaqMan Array Card (TAC) for the simultaneous detection of multiple respiratory viruses in children with acute respiratory infection,"We were not able to compare the TAC performance directly with other array technologies such as the FilmArray Â® Respiratory Panel (BioFire Diagnostics, Inc., Salt Lake City, UT) or the Luminex xTAG Â® Respiratory Viral Panel (Luminex Corporation, Austin, TX). The daily throughput of patient samples may be several-fold greater with the TAC assay, but the instrumentation costs may be greater as well. As clinical laboratories move toward implementation of array technology, such inter-assay comparative data would be informative.",15.23776897125277,8.846058600311395
CMV infection diagnostics is detection of viral DNA by the polymerase chain reaction PCR,0.18740114431702593,2.6395161151885986,3.3817100524902344,52faed56-20ff-4e37-a393-0333a0baece6,"custom_license/Health care issues, public health, pharmaco-economics R1949 Malaria problem in Afghanistan: malaria scanning results of the Turkish medical aid group after the war","Objectives: One of the most perspective methods in CMV infection diagnostics is detection of viral DNA by the polymerase chain reaction PCR. It is very actual for early differential diagnostics of the arising acute rejection crisis and CMV clinical syndrome after transplantation. Treatment strategy of these clinical syndromes is different: in the crisis of acute rejection, immunosuppressive treatment is intensified, while on the onset of the CMV clinical syndrome-minimised with additional administration of specific antiviral treatment.",13.753317594845804,8.727458167187272
the investigators propose three strategies to improve clinical trial design,0.24258463776821054,1.7986335754394531,2.5834383964538574,56367f25-1887-4fb0-9130-cd613e330b52,"custom_license/Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola","Another group of investigators has taken up the challenge of ""rethinking strategies"" for clinical trial design by contrasting ""lumpers"" and ""splitters"" (260) . Lumpers assemble heterogeneous groups of patients using simple syndromic definitions, but they are unable to identify subgroups within trial populations that have specific dysregulation of immune pathways or poorer outcomes. By contrast, splitters are interested in identifying specific subtypes in order to ""match the right treatment to the right patients"" (260) . To address these conflicting views, the investigators propose three strategies to improve clinical trial design: practical enrichment (i.e., decrease ""noise"" in clinical trials), prognostic enrichment (i.e., identify subgroups at higher risk) and predictive enrichment (i.e., identify patients who will respond best to treatment). They believe that ""different treatments require different target populations"" (260) . Because these populations cannot be identified beforehand, they argue that high-throughput searches can be used to identify biomarkers of therapeutic responsiveness that could inform clinical trial design. They believe that ""tightly defined criteria enriching for treatment benefit will be the key to advancing treatment for sepsis and ARDS"", and advocate moving beyond a ""one-size-fits-all"" approach to treatment research (260) .",15.560313640734993,8.2944565559879
the potential of blood-borne transmission led to the early implementation of measures such as exclusion of possibly exposed individuals from the donor pool,0.13539743964376405,1.7477012872695923,2.9099559783935547,89a267cc-6a48-4058-acc7-d210510a1eb5,custom_license/Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection à¬,"Blood transfusions or administration of blood products have not been implicated in transmission anywhere. This is despite the demonstration of viraemia during the clinical phase of the illness, albeit at low to moderate titres (Drosten et al., 2003a) . Nevertheless, the potential of blood-borne transmission led to the early implementation of measures such as exclusion of possibly exposed individuals from the donor pool.",14.952963347036691,8.261014394143887
The implementation of nucleic acid technology into routine diagnostics,0.2659083347075402,2.0215280055999756,3.1116416454315186,40299b8e-39f1-4a0e-b14e-5f47e3d621c4,custom_license/Clinical virology in real time,"Several achievements have been made during the last decade enabling the sensitive detection and characterization of viral nucleic acids. Amplifica-tion technologies, like polymerase chain reaction (PCR) and nucleic acid sequence-based amplification (NASBA) make the amplification of in principle any target of interest, possible. Furthermore, technological improvements in sequence detection systems enable the fully characterization of a virus, and to determine for instance the subtype, genotype, variants, mutants, and genotypic resistance patterns. The implementation of nucleic acid technology into routine diagnostics has made a great step forward with the introduction of real time technologies, which makes the detection of amplified products relatively easy (Niesters, 2001; Mackay et al., 2002) . Furthermore, this technology is able to quantify target nucleic acids in a single sample over a larger dynamic range than most other quantitative technologies, although qualitative detection is of course also possible. Since both amplification and detection can currently be performed automatically, the most labor intensive and critical step remaining is the efficient extraction of nucleic acids from different clinical samples.",13.413379649697621,8.031243150564638
Prolonging the gene silencing effect of a specific siRNA formulation,0.12056979398894396,1.873272180557251,1.7130229473114014,41707640-86e5-431c-a6ad-b22dcf17f661,"custom_license/Scientific Research in Industry and Agriculture, he obtained his PhD in 1995 at Ghent University. He received the Scott Blair Biorheology Award","To extrapolate RNAi from bench to bedside, it is imperative to consider not only the gene knockdown intensity but also the dynamics of gene silencing [12] . On the one hand, precise control over the duration of RNAi gene knockdown can provide new information on complex cellular pathways implying interactions between multiple genes, without having to rely on more elaborate transgene technologies. On the other hand, from a therapeutic point of view, being the main focus of this review, it may be relevant to silence a pathogenic gene for a longer period of time, to improve the clinical outcome. Prolonging the gene silencing effect of a specific siRNA formulation may be beneficial for chronic patient adherence if the administration frequency in the dosing schedule could be significantly scaled down.",16.261164838484135,8.02249952658407
to gain a positive perception from end users and healthcare providers,0.4051354976243902,1.3378653526306152,2.832892894744873,e976caa6-3a1e-4753-95c1-660e2398a5fb,custom_license/Molecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics,"Interest and expectation around POC disease diagnostics are increasing. Specifically, there has been an exponential growth of near-POC or POC developments based on PCR and isothermal amplification technologies for diagnosis of infectious diseases in the last years. Because of their competitive advantages, isothermal technologies are likely to become reference chemistries for future POC applications and could gradually displace PCR-based solutions. Diverse isothermalbased technologies are tacking technical challenges at the micro-scale and finding their way to market. Low sample volume handling, low concentration of target, complex signal amplification due to Table 2 . low concentration, target instability and compatibility and integration of the various device subsystems have been identified as major hurdles for the development of POC assays. It appears that LAMP has reached a higher degree of maturity than other isothermal techniques to overcome such hurdles, according to the number of related developments and products. However, technical potentialities of LAMP or any other competing chemistries do not automatically guarantee their future adoption. In addition to further validation in clinical labs to obtain solid results, a range of cultural, organizational, economic and regulatory barriers may undermine successful deployment of diagnostics at the point of care, either isothermal or based on other technologies. One of the main challenges for effective implementation in the upcoming years will be to gain a positive perception from end users and healthcare providers. Since rapid diagnosis by POC assays alleviates patient anxiety and eliminates return visits for results, it appears that delivery of diagnosis on site will be well accepted by end users. However, acceptance of decentralized diagnostics by healthcare providers will imply important changes in clinical practices, workloads and logistics. New frameworks will need to be designed at the point of contact between the patient and the healthcare system to ensure adequate on-site sample collection, test performance and quality control of results [84] .",15.072866829614982,7.986496251159311
there is a large and growing list of viruses for which the implementation and use of these nucleic acid technologies are advantageous,0.2309407581666038,2.0432097911834717,2.156637668609619,c79f2e11-344b-470a-818a-2919fff4f640,custom_license/Clinical virology in real time,"There are however a number of problems that need to be solved before molecular diagnostics should really be implemented routinely (Table 1) . First, it is well recognized that for the clinical laboratory commercially standardized assays are available for a limited number of viral targets only. And it is unlikely that the number of target viruses will increase rapidly in the near future. However, it should be emphasized that there is a large and growing list of viruses for which the implementation and use of these nucleic acid technologies are advantageous. In Table 2 , a tentative list of (what I call) commercially interesting viruses versus viral targets with limited commercial interest is given.",14.77459931456006,7.9010106089615295
It would be invaluable to determine the effects on EVD outcome of readily available clinical products that affect aspects of these processes,0.14952824025213585,1.8491389751434326,3.022270679473877,d2d5366f-dd10-4676-b322-4155fee6e5ad,custom_license/Ebola Virus Disease in Humans: Pathophysiology and Immunity,"A complex interplay of activated endothelial cells, activated platelets, inflammation, and coagulopathy is clearly at work during EVD. How intervening in any one aspect of the network impacts human disease is still unknown. It would be invaluable to determine the effects on EVD outcome of readily available clinical products that affect aspects of these processes. Some compounds of interest are statins, which stabilize the endothelium; soluble GPIba, which inhibits the interaction between platelets and vWF; and sCD40L, which appears to be consumed during severe disease.",13.206592515390788,7.7887236558880275
"increased distances to which food products are transported, the increasing global mobility of populations, and the many processes and locations that are often involved in food preparation",0.2505624383339794,0.9962435960769653,1.8969407081604004,c91f7382-e2f0-4845-a7f5-be9313b4bb94,custom_license/Routes of Transmission in the Food Chain,"Understanding the transmission routes of foodborne pathogens is a challenging, thought-provoking, and critical aspect for food sciences, clinical medicine, and public health. While identifying the source of an outbreak is decisive for successfully limiting it and for preventing recurrences, implementation of the interventions is often delayed or complicated by various factors, such as the increased distances to which food products are transported, the increasing global mobility of populations, and the many processes and locations that are often involved in food preparation. This is compounded by the existence of several transmission routes and various transmission vehicles that can be exploited by certain pathogens. More than 250 known foodborne diseases affect one-third of the world population, and some segments of the population, particularly the very young, the elderly, pregnant women, and immunocompromised individuals, are an a heightened risk, pointing toward the relevance of these conditions for medicine and public health. Foodborne illnesses can be transmitted through vectors, fomites, contaminated food products, directly by person-to-person contact, from animals, or through the airborne route. As an additional layer of complexity in transmission at the level of populations, in what became known as the ""20/80 rule,"" for most infectious disease outbreaks that have been studied, a minority of hosts was found to be responsible for most transmission events.",14.131321737284289,6.826532405803788
the protection of human subjects and scientific integrity of the trial design and documentation are the overarching goals of any clinical research protocol,0.1544200360472445,0.8064751029014587,0.9674056172370911,0ed57907-fd76-415e-a621-986d22326fa1,custom_license/Clinical Trials of Vaccines for Biodefense and Emerging and Neglected Diseases 12 12 Introduction Historical Considerations Regulatory issues Ethical issues Stages of Vaccine Development Overview Pre-IND stage IND stage Phase 1 clinical trials Phase 2 clinical trials Phase 3 clinical trials Phase 4 clinical trials Clinical Trial Protocol Development Background and rationale Objectives and purpose Study design Study population Study agent/interventions Study procedures and evaluations Study schedule Assessment of safety Clinical monitoring Statistical considerations Quality management Ethics/protection of human subjects Data management and record keeping Other considerations II. FUNDAMENTAL ASPECTS OF VACCINOLOGY CLINICAL TRIALS OF VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES 158,"The success of any clinical trial hinges on the development of a carefully designed protocol. Although discussion of clinical trial implementation is beyond the scope of this chapter, it is clear that the protection of human subjects and scientific integrity of the trial design and documentation are the overarching goals of any clinical research protocol. The clinical trial protocol must document the processes that will be used to ensure that these goals are attained. Conscientious supervision of clinical trial activities is a shared responsibility of the investigators, the IRB, the sponsor, the CRO, the DCC, the safety oversight committee, and all other partners who are participating in the trial. While meticulous attention to detail and strict protocol compliance are essential, the entire study team must be flexible and prepared to respond in a timely fashion to unexpected findings. Novel approaches to the development of vaccines for biodefense and emerging and neglected diseases will continue to evolve and will require ongoing reconsideration of the ethical and regulatory principles and practices that guide the conduct of clinical trials. ( FDA, 1996 ) .",13.189261038073465,5.76926383141577
"Governments and organisations need to bridge the gaps between policies and their implementation, and address deeper sources of policy failure that can undermine health development",0.15230502967179863,0.34296587109565735,0.8952738046646118,e99e81b8-118f-43b7-b580-ecaad0fc8ba5,custom_license/Population and Public Health,"It is also important to recognise the importance of sound governance, leadership and political will in order to improve the health of communities, whether from a national, state, or organisational perspective. Governments and organisations need to bridge the gaps between policies and their implementation, and address deeper sources of policy failure that can undermine health development.",13.894719522879825,5.668007622252113
"asthma, it led to decreased unjustified prescribing of antibiotics. We believe that this in turn will improve clinical outcomes",0.22123333363701056,0.7558292746543884,1.6814262866973877,66395635-0e2a-43c4-a573-8f9f979c41e1,custom_license/Antimicrobial Stewardship Program Using Plan-Do-Study-Act Cycles to Reduce Unjustified Antibiotic Prescribing in Children Admitted With an Asthma Exacerbation,"In the setting of asthma, it led to decreased unjustified prescribing of antibiotics. We believe that this in turn will improve clinical outcomes, ensure appropriate antibiotic use, minimize antibiotic resistance, and reduce health care costs.",24.41634352264292,10.129936347803675
"physical planning, implementation and integration of WGS diagnostics may be unlikely to succeed without carefully planned introduction and continued training of its user base",0.2705049389182363,2.809296131134033,2.463805913925171,915ab8c3-82a7-4f22-a8e3-e0b648dd8487,custom_license/From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the Clinic,"The lack of uptake of WGS-based diagnostics may also be in part due to an understandable desire to maintain the 'status quo' in a busy hospital environment with already established treatment and intervention systems. Additionally, and perhaps significantly, it also highlights the difficulty to communicate the potential benefits of WGS to the day-to-day life of a clinic. The main proponents of WGS tend to be based in the public health/research environment and are rarely actively involved in clinical decision-making. This in itself can present something of a language barrier, challenging meaningful dialogue over how adoption of new approaches can lead to quantifiable improvements in existing systems. Further, the physical planning, implementation and integration of WGS diagnostics may be unlikely to succeed without carefully planned introduction and continued training of its user base. This is of course challenged by the already resource-limited infrastructure of many clinical settings.",16.815813364821132,9.31305100697588
clinical trials and active surveillance over time to assess the properties and potential complications of each of these products,0.18412816651317393,1.9961116313934326,3.159602165222168,f411dd08-47d8-410b-be88-aa5d2ae6a333,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"The characteristics of PI products can vary considerably depending on the process by which they are manufactured. Solvent/detergent plasma from one manufacturer could be very different biochemically from another manufacturer's SD plasma product. Such differences relate to processing parameters such as the hold time before extraction and the different chemicals and/or enzymes used in the extraction process. One cannot therefore assume that all SD-processed plasma products are equivalent. Hence, there is a need for clinical trials and active surveillance over time to assess the properties and potential complications of each of these products. It was therefore suggested that manufacturers should be encouraged to work together in an effort to standardize their processes so the available products are comparable.",15.442899861786731,8.756228919425496
solution position control and signal capture,0.4247545924835109,2.7312324047088623,3.2946369647979736,3ef230b9-b8ec-41d9-be38-4edb27752660,"custom_license/Microarray-in-a-Tube for Detection of Multiple Viruses Background: The detection of multiple viruses is im- portant for pathogenic diagnosis and disease control. Microarray detection is a good method, but requires complex procedures for multiple virus detection. Methods: We developed a novel PCR assay, the microar- ray-in-a-tube system, which integrates multiple PCR processes and DNA microarrays for multiple virus de- tection. A 5 Ø 5 oligonucleotide microarray for detecting 4 respiratory tract viruses (severe acute respiratory syn- drome-associated coronavirus, influenza A virus, influ- enza B virus, and enterovirus) with inner controls was arranged on the inner surface of a specially designed Eppendorf cap with a flat, optically transparent window. Results: We were able to perform all detection processes in the encapsulated system without opening the cap. The 4 viruses were successfully amplified by one-step reverse transcription-PCR in the encapsulated tube. After the PCR process, the microarray-in-a-tube was inverted, and the fluorescence-labeled PCR products were directly hybridized on the microarray. Hybridiza- tion signals were obtained with an ordinary fluorescent microscope. The sensitivity of the system for virus detection reached 10 2 copies/L. With the help of inner controls, the system provided reliable results without false negatives and false positives. Conclusions: The microarray-in-a-tube system is a rapid, labor-saving tool for multiple virus detection with several advantages, such as convenience, preven- tion of cross-contamination of the PCR products, and potential for multiple-gene detection","The practical application of most reported PCR microfluidic devices integrated with microarrays is limited because they must be equipped with complicated pumps and valves to drive the reagents, delicate temperaturecontrollers to perform on-chip PCR processes, and optical instruments to read the fluorescent signals. Some devices need high air pressure, special pumps, or special design implementation for solution position control and signal capture (7, 8 ) .",12.268753953846456,8.210878974025704
WEBERT ET AL different ages and different states of health,0.28248936409700165,2.1663546562194824,2.7818551063537598,ba6ac40c-4766-4a11-a8d4-1b7c8cc6c763,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"WEBERT ET AL different ages and different states of health. Important considerations on implementation of such processes include the efficacy of the PI process against pathogens; the efficacy of the treated product; the safety to handlers of the PI chemicals, to the environment, and to the recipients of treated products; and, as a result of potential decreased product efficacy, the impact on the blood supply and of increased patient exposure to blood products. From the FDA's perspective, the aim of PI validation will be to provide direct evidence that the PI process will effectively inactivate or reduce pathogens that could be transmitted by the transfusion product and indirect evidence that the pathogen reduction process has the capacity to inactivate or reduce novel or yet-unidentified agents. In vitro studies on efficacy should demonstrate log kill of pathogens in a transfusion product in the range of 6 to 10 logs; include evaluation for viral, bacterial and protozoal pathogens; and be demonstrated with the final marketed device. It is acknowledged that conducting clinical studies to determine infectivity rates in a patient population would require extremely large numbers because of the current low rates of infection in the setting of NAT and would not be a requirement for approval.",14.036806530001881,8.129218631173266
develop new processes,0.20238401769329836,0.46567121148109436,2.603102207183838,9b872e0c-5e30-483d-8aef-0f1935209d8e,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"As was the case with the implementation of NAT, close collaboration between blood bankers, governmental regulators, and the private sector will be required to make universal PI of blood products a reality. The goal should be a practicable multicomponent system that will maximize safety, maintain adequate product yield, and have acceptable toxicity. Accomplishing this in a reasonable period will require additional governmental funding, both to improve existing technologies and to develop new processes, particularly with regard to PI of RBCs. However, we must not make the perfect the enemy of the good. Until this idealized multicomponent system is a reality, existing pathogen reduction technologies should be implemented for platelets and transfusable plasma, an approach already undertaken in many parts of Europe. Taking this next step in North America will require an investment of resources and political willpower and, perhaps most importantly, a change in our collective mindset regarding the notion of acceptable risk. Pathogens in blood components may be intracellular or extracellular, and techniques to inactivate or remove them should not incur any significant biologic or chemical alterations upon the therapeutic product itself. Success is thus predicated on the existence of specific targets in the pathogens, which are absent in, or irrelevant to, the component's function.",15.798803309323251,7.524283880395343
plasma PI processes include an additional step to remove these chemicals from the final product,0.1529332772977472,2.7250661849975586,2.08258056640625,032f0796-48f7-4f08-a65e-d482f4e8525e,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"Because the chemical agents required to inactivate pathogens may also be harmful to transfusion recipients, all of the aforementioned plasma PI processes include an additional step to remove these chemicals from the final product. In vitro studies have demonstrated that the residual concentration of these substances is far below those that animal studies would suggest are toxic doses. Moreover, clinical experience with these products suggests they are safe: at the time of writing, more than 6 million units of SD plasma and 3 million units of MB-treated plasma have been transfused without any apparent toxicity to recipients. There is less clinical experience with amotosalen-treated plasma, with only about 5000 U infused at the time of writing.",12.398107469525442,7.46430800274638
solvent/detergent (SD) method of PI by the plasma fractionation industry,0.10848236380883189,1.203042984008789,1.7147793769836426,60938395-fd3e-4d2c-afb5-20927fa95832,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"In the face of such a stark choice, PI technologies are an attractive third option. Moreover, they have already proven their value. Transfusion-transmitted WNV, for example, infected 23 people in the United States, including 16 with neurologic disease, before the implementation of a donor screening assay in 2003. 5 An estimated 3200 other patients experienced subclinical disease. None of these infections, however, occurred via fractionated plasma products, because of the prior implementation of a solvent/detergent (SD) method of PI by the plasma fractionation industry. It is sobering to contemplate how much harm could have been avoided had this additional safety measure been implemented in the early 1980s, when the hemophilia community was just beginning to be ravaged by HIV and HCV. Although SD treatment is not applicable to cellular blood products, such as RBCs and platelet concentrates, other processes that target nucleic acids (eg, amotosalen or riboflavin) are now available. In addition to blocking transmission of both known and unknown pathogens, including viruses, bacteria, spirochetes, and protozoa, PI may also prevent transfusion-associated graft-vs-host disease (GVHD) by disabling donor lymphocytes.",14.978001757511864,7.138885149774233
monitoring of different types of processes,0.17707776991266805,0.5575348734855652,2.1670219898223877,7cef147c-9ac8-4e4e-8810-e24f20d5c36c,custom_license/-13 - Market Size and Economics for Biosensors 318 13. Market Size and Economics for Biosensors,"One of VTT's area in biosensor research is the development of advanced systems for sensing phenomena at the molecular level. Tailored coatings with functional molecules are placed/immobilized/adsorbed on appropriate substrates to promote molecular recognition. This sensing is aided by case-specific transducers. The company's immuno-and DNAbased sensors, as well as their chemical sensors find applications in the areas of biomedical engineering, clinical diagnostics, and in the monitoring of different types of processes.",15.294666911777547,7.12409538027231
maintenance of multiple inventories of the various blood components,0.25054376951275803,1.5293354988098145,2.3101823329925537,5c9c44b3-76d2-4619-b6c9-d5a114a7d6de,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"One participant felt that it was essential that countries introducing PI technology have an active surveillance system in place before PI implementation. It was noted that the benefit and margin of safety of PI products may differ for the different patient groups; for example, the risk associated with transfusion of PI products may be higher in the neonatal population than for adults because of their higher life expectancy. Such considerations may therefore necessitate the maintenance of multiple inventories of the various blood components.",12.97869249133284,7.0382289626380325
Per-genome sequencing and analysis costs are likely to be even higher in a clinical diagnostics environment due to the need for highly standardised and accredited procedures,0.1595301490544809,1.7403991222381592,2.207310914993286,3110c45d-a89b-4643-b4da-c99f0d3ef855,custom_license/From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the Clinic,"Such indirect costs are difficult to estimate precisely in an academic setting but are far from trivial. Per-genome sequencing and analysis costs are likely to be even higher in a clinical diagnostics environment due to the need for highly standardised and accredited procedures. However, a micro-costing analysis covering laboratory and personnel costs estimated the cost of clinical WGS to Â£481 per M. tuberculosis isolate versus Â£518 applying standard methods, representing relatively marginal cost savings but with significant time savings [63] . WGS does indeed represent a potentially cost-effective and highly informative tool for clinical diagnostics, but for microbiology-scale sequencing we seem to be in a post-plummeting-costs age.",12.540612421335549,6.955225871667881
The feasibility and repeatability of FCSQ as an intervention should be given more attention in future clinical research,0.2117003800080031,1.1638092994689941,1.1232357025146484,76f6e274-f5a6-4e0e-9518-98c501e9b4e8,custom_license/Does the traditional Chinese medicine theory of five circuits and six qi improve treatment effectiveness? A systematic review of randomized controlled trials,"Objective: To evaluate whether the traditional Chinese medicine (TCM) theory of five circuits and six qi (FCSQ) is beneficial in terms of improving clinical effectiveness. Methods: Randomized controlled trials (RCTs) evaluating the clinical value of FCSQ theory were reviewed. Multiple databases (China Network Knowledge Infrastructure, Chinese Scientific Journals Database, Wanfang Data, SinoMed, Cochrane Library, PubMed, and Embase) were systematically searched from inception to June 12, 2018. Two authors independently extracted the data and performed a methodological quality assessment of the RCTs. RevMan 5.3 software was used for the data analysis. The effect sizes for the primary outcome measures were expressed as relative risks or mean differences with 95% confidence intervals. Results: A total of 13 RCTs were selected, involving 12 types of diseases and 4695 patients. The methodological quality of the RCTs was generally low. Five studies compared the effectiveness of TCM treatments guided by FCSQ theory with conventional TCM therapies, and the remaining eight studies compared the effectiveness of TCM treatments guided by FCSQ theory with biomedical treatments. All of the RCTs reported that the effectiveness of the treatment intervention was better than that of the intervention in the control group. Conclusion: Because of many methodological problems in existing clinical studies, it remains impossible to definitively conclude that FCSQ theory can improve clinical effectiveness. It is difficult to unify the clinical application of FCSQ theory. The feasibility and repeatability of FCSQ as an intervention should be given more attention in future clinical research. Future work should also follow international norms for clinical research implementation and reporting to provide high-quality evidence for evaluating the clinical value of FCSQ theory.",15.528542002907813,6.921568952307102
The widespread implementation of PI technologies would considerably change the nature of blood products,0.21040687376314487,0.8534387946128845,0.9902928471565247,79458c0c-e1b9-4103-a19e-e73d7e3855d4,custom_license/T RANSFUSION M EDICINE R EVIEWS Proceedings of a Consensus Conference: Pathogen Inactivation- Making Decisions About New Technologies 2 WEBERT ET AL 3 PROCEEDINGS OF A CONSENSUS CONFERENCE 4 WEBERT ET AL 6 WEBERT ET AL 7 PROCEEDINGS OF A CONSENSUS CONFERENCE 11 PROCEEDINGS OF A CONSENSUS CONFERENCE,"The widespread implementation of PI technologies would considerably change the nature of blood products as we know them today. It was thus suggested that PI should, therefore, not be pursued without adequate public consultation as well as the introduction of active surveillance. The latter must involve the follow-up of large cohorts of transfusion recipients. Many surveillance systems currently in place are voluntary and passive in approach. Surveillance of potential complications arising from 28 WEBERT ET AL the widespread introduction of PI technology must be active and must also have regulatory oversight. In addition, such surveillance must be long term, following recipients for many years. There was considerable discussion around the level of informed consent necessary for postmarketing surveillance. It was pointed out that precedents exist in some countries, such as Canada, where active surveillance for severe adverse reactions to vaccinations is carried out without the requirement for specific informed consent. Another ethical consideration raised concerned the approach to be taken in the event that universal implementation of PI technologies is not feasible. Ideally, a universal approach to implementation of PI should be pursued; however, with the limitations of currently proposed PI technology, a universal approach to PI of all blood components would probably not be possible at this time. For example, obstacles to the PI of RBCs remain substantial. Under these circumstances, implementation of PI technology would likely result in 2 levels of safety for the different blood components, and the attendant needs to continue to perform microbiological screening of RBC components. If universal implementation of PI for all blood components were not possible, the ethical considerations of selective implementation of PI technology would have to be addressed, including issues relating to varying the levels of the safety of blood products and the need for explicit informed consent by the patient receiving the PI products. For example, would it be appropriate to offer PI-treated products to the pediatric population exclusively, similar to the approach taken in the United Kingdom with the transfusion of MB-treated plasma to persons younger than 16 years? Similar concerns could arise during the crossover from the existing inventory to a PI inventory. Moreover, if significant differences were known to exist between PI and non-PI products, this could become an important element of informed consent for transfusion. It was also pointed out that policy makers must retain flexibility in making decisions with respect to the appropriate allocation of limited resources if a universal approach to PI is not attainable.",14.126042914539147,6.142540587238818
applying existing WGS pipelines developed for fundamental research is unlikely to produce the fast and robust tools required,0.15446097023127914,1.0122706890106201,0.8950620293617249,c9348337-7990-4555-bc5a-030a2b3d6aeb,custom_license/From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the Clinic,"Thanks to progress in high-throughput sequencing technologies over the last two decades, generating microbial genomes is now considered neither particularly challenging nor expensive. As a result, whole-genome sequencing (WGS) (see Glossary) has been championed as the obvious and inevitable future of diagnostics in multiple reviews and opinion pieces dating back to 2010 [1] [2] [3] [4] . Despite enthusiasm in the community, WGS diagnostics has not yet been widely adopted in clinical microbiology, which may seem at odds with the current suite of applications for which WGS has huge potential, and which are already widely used in the academic literature. Common applications of WGS in diagnostic microbiology include isolate characterization, antimicrobial resistance (AMR) profiling, and establishing the sources of recurrent infections and between-patient transmissions. All of these have obvious clinical relevance and provide case studies where WGS could, in principle, provide additional information and even replace the knowledge obtained through standard clinical microbiology techniques. This review reiterates the potential of WGS for clinical microbiology, but also its current limitations, and suggests possible solutions to some of the main bottlenecks to routine implementation. In particular, we argue that applying existing WGS pipelines developed for fundamental research is unlikely to produce the fast and robust tools required, and that new dedicated approaches are needed for WGS in the clinic.",12.235882583320825,5.522325171104312
applying existing WGS pipelines developed for fundamental research is unlikely to produce the fast and robust tools required,0.15446097023127914,1.0122706890106201,0.8950620293617249,a8937a5b-31a3-4d4d-b58f-2e67159aa668,custom_license/From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the Clinic,"Thanks to progress in high-throughput sequencing technologies over the last two decades, generating microbial genomes is now considered neither particularly challenging nor expensive. As a result, whole-genome sequencing (WGS) (see Glossary) has been championed as the obvious and inevitable future of diagnostics in multiple reviews and opinion pieces dating back to 2010 [1] [2] [3] [4] . Despite enthusiasm in the community, WGS diagnostics has not yet been widely adopted in clinical microbiology, which may seem at odds with the current suite of applications for which WGS has huge potential, and which are already widely used in the academic literature. Common applications of WGS in diagnostic microbiology include isolate characterization, antimicrobial resistance (AMR) profiling, and establishing the sources of recurrent infections and between-patient transmissions. All of these have obvious clinical relevance and provide case studies where WGS could, in principle, provide additional information and even replace the knowledge obtained through standard clinical microbiology techniques. This review reiterates the potential of WGS for clinical microbiology, but also its current limitations, and suggests possible solutions to some of the main bottlenecks to routine implementation. In particular, we argue that applying existing WGS pipelines developed for fundamental research is unlikely to produce the fast and robust tools required, and that new dedicated approaches are needed for WGS in the clinic.",12.235882583320825,5.522325171104312
Our data support further investigations to better understand the clinical utility and significance of targeting ACE2 pathways for therapeutic interventions,0.18171739252493607,2.973682165145874,3.924041748046875,1976b9c4-6c90-43db-acb3-5b0e4d8eca86,custom_license/Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure: Insights Into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin- Aldosterone System,"Association between plasma sACE2 activity and plasma BNP provides an objective validation of the association between the systemic release of ACE2 and HF severity. As the detection of sACE2 activity likely signifies the activation of counter-regulatory mechanisms, the ultimate clinical utility of measuring sACE2 activity may depend on our ability to possibly target activation of the ACE2-Ang(1-7)-Mas pathway rather than to improve the clinical diagnosis of HF in the acute setting, the latter task in which plasma BNP testing has been well validated to perform. Our data support further investigations to better understand the clinical utility and significance of targeting ACE2 pathways for therapeutic interventions.",18.93735860650748,11.111596055852905
they must be sold to a traditionally conservative medical community,0.3647943741552976,3.8442509174346924,3.3259544372558594,db6a8103-663d-4467-84f7-54ec1b92936c,custom_license/Biochip Platforms for DNA Diagnostics,"The impact of diagnostic biochips in molecular diagnostics must await the results of further research and targeted product development. Several companies, including Millennium Predictive Medicine, Abbott Diagnostics, Bayer, and ABTECH Scientific are actively pursuing such diagnostic products. Once these products are developed, validated, clinically tried, and approved by the FDA, they must be sold to a traditionally conservative medical community. This community has been slow to adopt new diagnostic paradigms which are due, in part, to many overhyped claims for other approaches in the past. Genomics-derived molecular diagnostics are likely to have a significant impact on the market by the end of the current decade.",16.02828039937672,10.270531620330711
facilitating early selection of appropriate antimicrobials,0.2804983014320364,2.8863627910614014,4.063586711883545,b57defb5-0f3a-4378-9faf-18dd5bfb18d6,"custom_license/MassTag Polymerase-Chain-Reaction Detection of Respiratory Pathogens, Including a New Rhinovirus Genotype, That Caused Influenza-Like Illness in New York State during 2004-2005","Discussion. ILI is a significant cause of morbidity and mortality in the United States, accounting annually for â¼36,000 deaths, â¼150,000 hospitalizations, and up to $12 billion in direct and indirect costs [14] . The advent of sensitive, affordable methods for differential diagnosis of the infectious pathogens that can cause ILI has the potential to reduce the economic burden afforded by these pathogens and to improve clinical outcomes by facilitating early selection of appropriate antimicrobials. The importance of developing strategies for triage of patients with acute respiratory infection to specific treatment regimens is underscored in the context of pandemic-influenza preparedness and the limited supply of influenza antiviral drugs.",15.758047739554108,10.032783885758153
antivirals can significantly improve clinical outcomes,0.14803941451256816,2.205463409423828,2.2787373065948486,12e87c6f-6896-4d0f-8971-8f48768444b7,custom_license/Coronavirus disease 2019 (COVID-19): A literature review,"Drugs are being evaluated in line with past investigations into therapeutic treatments for SARS and MERS [61] . Overall, there is not robust evidence that these antivirals can significantly improve clinical outcomes A. Antiviral drugs such as oseltamivir combined with empirical antibiotic treatment have also been used to treat COVID-19 patients [7] . Remdesivir which was developed for Ebola virus, has been used to treat imported COVID-19 cases in US [62] . A brief report of treatment combination of Lopinavir/Ritonavir, Arbidol, and Shufeng Jiedu Capsule (SFJDC), a traditional Chinese medicine, showed a clinical benefit to three of four COVID-19 patients [63] . There is an ongoing clinical trial evaluating the safety and efficacy of lopinavir-ritonavir and interferon-Î± 2b in patients with COVID-19 [56] . Ramsedivir, a broad spectrum antivirus has demonstrated in vitro and in vivo efficacy against SARS-CoV-2 and has also initiated its clinical trial [64, 65] . In addition, other potential drugs from existing antiviral agent have also been proposed [66, 67] .",15.365405447689263,8.29262237210338
clinical molecular diagnostics,0.1950938751096769,2.2049100399017334,1.6268521547317505,e7c06661-f97f-4e94-bc1b-bc70958929d7,custom_license/Biochip Platforms for DNA Diagnostics,"The era of personalized molecular medicine is here (38) . Ushered in by a now universal appreciation of the molecular basis of disease, molecular analyses, both genetic or proteomic, to improve a patient's outcome in the management of his disease, is revolutionizing healthcare. With the potential to (i) optimize therapy and enable appropriate patient dosing, (ii) detect diseases when in their early stages, (iii) greatly reduce adverse drug reactions and drug-drug interactions, and (iv) potentially improve patient compliance, clinical molecular diagnostics is a reality of growing significance (39) .",16.124525739553633,8.134229435355536
diagnostic biochips will likely have more impact in the area of drug development,0.1526177673832807,2.0524637699127197,2.5704526901245117,0b78f6ff-5108-413f-a5cd-6c161b252fa7,custom_license/Biochip Platforms for DNA Diagnostics,"Opportunities for applications of DNA biochips are most attractive in the area of human health and specifically in the area of personalized medicine. The R&D investments, marketing, and sales and distribution costs, given today's models for development of technologically driven companies, do not support similar opportunities in the environmental or industrial biotechnology sectors. The human health sector presents opportunities for near-patient (bedside), physician's office, clinical laboratory, and molecular diagnostics laboratory (hospital). In the short term, diagnostic biochips will likely have more impact in the area of drug development than in clinical molecular diagnostics. However, clinical molecular diagnostics represents a looming opportunity separated only by the regulatory challenges and broader societal concerns.",13.507468902180943,7.73250981478753
multiplex PCR products of clinical samples with optimized separation conditions,0.15513955865325335,1.2477272748947144,2.8758418560028076,95f9ea99-13d9-4c9c-acbb-f4a0279ce15d,custom_license/Analysis of multiplex PCR fragments with PMMA microchip,"In this work, a method for mass production of PMMA chip was introduced, and the PMMA microchip was used for the detection of multiplex PCR products of clinical samples with optimized separation conditions. The experimental results showed that the microchip electrophoresis with high sensitivity and high resolution could significantly improve the detection rate.",14.178202832084871,7.642690926313094
real-time nucleic acid amplification chemistries permitted both faster pathogen detection and the enablement of nucleic acid quantitation [8],0.1362601106696426,2.562798261642456,2.4856679439544678,d45b3fa1-e4e3-4ea5-b8f2-c3b752227f8c,custom_license/Syndromic and Point-of-Care Molecular Testing,"In the 1990s, the era of molecular diagnostics was ushered in with the introduction of nucleic acid analysis methods, including the hybridization protection assay (eg, AccuProbe, Salem, MA) for the identification of isolates and polymerase chain reaction (PCR) for the detection of pathogens directly from patient specimens [1] [2] [3] [4] [5] [6] [7] . Later, the implementation of real-time nucleic acid amplification chemistries permitted both faster pathogen detection and the enablement of nucleic acid quantitation [8] . These methods quickly migrated from research laboratories into clinical laboratories, first as laboratorydeveloped tests or so-called home brew tests. This revolution enabled laboratorians to more precisely identify the causes of infectious diseases by detecting pathogenspecific nucleotide sequences in cultured isolates and clinical specimens. Many of these methods proved to be far superior in terms of accuracy and result TAT compared with cultivation-dependent approaches, especially for the identification of viruses. Over time, these methods also underwent refinements that included the adaptation of several assays to automated platforms, allowing users to minimize the manual handling of specimens and reaction components.",11.890466327101489,7.4431662481235215
Clinical Diagnostics) has sensitivity close to PCR assays,0.14446304072293706,1.7320104837417603,2.3913488388061523,dd6e8ed6-309d-44d0-8ca3-62f48261d0da,custom_license/Molecular Virology,Clinical Diagnostics) has sensitivity close to PCR assays in diagnosing acute HCV inf~ctio~s during the window period (before HCV antibodies develop),12.233307078854054,6.961841037255062
stepwise processes used to make decisions during the SARS outbreaks and the implementation of the decisions made.,0.11822268119156104,0.9313809275627136,2.098447561264038,237c8823-941a-4e5b-b132-70b3977d260a,custom_license/MANAGING OBSTETRICAL PATIENTS DURING SEVERE ACUTE RESPIRATORY SYNDROME OUTBREAK,"Strategies, devised using information about the coronavirus available at the time, as well as epidemiologic and infectious disease containment measures, were initiated to protect obstetrical patients and staff. In the first outbreak. the obstetrical unit of an affected Toronto hospital was kept open while other clinical services were closed. In the second outbreak, the obstetrical unit was closed along with all other clinical activities. This report details the stepwise processes used to make decisions during the SARS outbreaks and the implementation of the decisions made. It is recommended that these or similar protocols be used when an obstetrical unit is confronted with a large-scale nosocomial infectious outbreak that has a mechanism of transmission similar to that of SARS.",14.226773674305921,6.948759303744461
improve our knowledge in biological sciences,0.3467711457424765,0.893827497959137,2.260000467300415,14408ba0-edb0-49da-8e51-ca0e555a6035,"custom_license/Biobanking in microbiology: From sample collection to epidemiology, diagnosis and research","This review presented the state of the art in staff and equipment necessary to set up a biobanking facility, in the problems related to sample collection and processing of various cell types or cellular components, and in data management and quality control. Microbiology laboratories rely even more frequently on biological bank specimens for diagnostics and research. To ensure quality, a biobanking facility must organize the space, equipment and personnel, adopt strict protocols for proper handling of the specimens, set up a quality program including periodic controls of the instrumentation, training of the laboratory staff, and quality control of stored specimens. Because biological banks constitute an invaluable resource for research and diagnostics, it is conceivable that they will require, in the near future, additional investments in terms of human and material resources. Single laboratories may be unable to support their own biobanking facility and institutional or multi-laboratory approaches will be the future of biobanking. The Commission of the European Community has already recognized the need to dedicate a financial contribution for the implementation of European quality standards for biobanking, aiming at supporting large scientific projects involving common diseases. It is conceivable that similar examples may allow the creation of reliable biobanking facilities providing materials that support research projects and thus improve our knowledge in biological sciences.",13.122473842840893,6.6428540224130215
haart switch for implementation in clinical practice of HIV-infected individuals,0.23335380865702066,1.0332438945770264,1.1226122379302979,b477081c-4e1a-4d69-bf49-4ac4f1a499b9,custom_license/The effect of chlortracycline treatment on enteric bacteria in pigs SoA1.3 Delsol AA a Analysis of Helicobacter pylori resistance to antimicrobial agents in Polish children SoA4.2,Radata */communication internet platform management of resistance analysis guided haart switch for implementation in clinical practice of HIV-infected individuals SoA9.3,12.477772034254249,5.768526698118748
nucleic acid (both DNA and RNA) amplification and hybridization methodologies,0.2548574049574797,0.9498966932296753,1.3134900331497192,b474a38b-8d30-4b90-8319-09ce050cc678,custom_license/Molecular Virology,"â¢ However, the routine implementation of nucleic acid (both DNA and RNA) amplification and hybridization methodologies is associated with limitations, particularly in the clinical laboratory. The se limitations and pitfalls include, but are not limited to:",12.199080789694174,5.7408796485395674
PHPI production,0.12638115040303743,0.7071118354797363,1.371584415435791,e8d0b0d8-bdd1-4cd1-91ae-f41c7485a3cb,custom_license/National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities,"We report the methods and results of a common manufacturing protocol, representing the convergence of several years of teamwork by eight academic institutions to optimize and standardize processes, criteria, and test methods across islet transplantation centers. A major standardization effort was undertaken to ensure product and process consistency and to test method reproducibility across participating manufacturers. The CIT collaborative effort resulted in the implementation of a defined set of critical process parameters and in-process controls for PHPI production reflected in the common MPBR and SOPs executed at the eight CIT processing facilities.",11.49208567979053,5.373382551021779
comparability and consistency in SARI reporting,0.16021303796442063,-0.6181462407112122,1.3492618799209595,d9fec66c-4bdd-46b5-9240-53444ff28b50,custom_license/Epidemiology and Infection Seeking out SARI: an automated search of electronic health records,"The World Health Organization (WHO) developed a surveillance definition for SARI to improve comparability and consistency in SARI reporting. This definition starts with the case definition of ILI as an acute respiratory infection in a person with a fever (â©¾38Â°C), cough and onset within the past 10 days. A SARI is defined as an ILI requiring hospitalisation [3] . This definition was chosen because of its feasibility in worldwide implementation. However, the correlation between SARI and patient outcomes has not been evaluated.",12.275109821908053,4.771513603154154
to improve clinical symptoms and signs,0.45422069601796194,3.668347120285034,4.6158366203308105,4656c716-395b-4240-8b53-f8646065cea6,custom_license/Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America,"GAS is the most common bacterial cause of acute pharyngitis, responsible for 5%-15% of sore throat visits in adults and 20%-30% in children [9, 10] . Accurate diagnosis of streptococcal pharyngitis followed by appropriate antimicrobial therapy is important for the prevention of acute rheumatic fever; for the prevention of suppurative complications (eg, peritonsillar abscess, cervical lymphadenitis, mastoiditis, and, possibly, other invasive infections); to improve clinical symptoms and signs; for the rapid decrease in contagiousness; for the reduction in transmission of GAS to family members, classmates, and other close contacts of the patient [11] ; to allow for the rapid resumption of usual activities; and for the minimization of potential adverse effects of inappropriate antimicrobial therapy. Although acute pharyngitis is one of the most frequent illnesses for which pediatricians and other primary care physicians are consulted, with an estimated 15 million visits per year in the United States [10] , only a relatively small percentage of patients with acute pharyngitis (20%-30% of children and a smaller percentage of adults) have GAS pharyngitis. Moreover, the signs and symptoms of GAS and nonstreptococcal pharyngitis overlap so broadly that accurate diagnosis on the basis of clinical grounds alone is usually impossible [12] .",12.951155725217827,9.917623935226537
improve entomological indices and decrease the incidence of dengue,0.15338947429287372,1.4933916330337524,3.9649789333343506,5d6c620b-2582-4e3a-b0ae-3efd682bc1a9,custom_license/Editor Anthony Vere Hodge Guest editor Graciela Andrei Â©International Society for Antiviral Research IN THIS ISSUE,"Of a total number of 1,826 complete-text assessed studies, 75 were included, and 9 cluster randomized clinical trials were included for meta-analysis. We did not identify any interventions supported by a high certainty of evidence. Health education and community engagement may probably reduce the entomological indices, as well as insecticide-treated materials. Likewise, the use indoor residual spraying and the management of containers may also improve them, although the confidence interval includes both a reduction and an increase in the indices. We found low certainty of evidence supporting the use of ovitraps or larvitraps, and integrated epidemiological surveillance to improve entomological indices and decrease the incidence of dengue. The degree of implementation of these interventions was variable in the different countries and settings.",13.894517367796245,8.411021946867953
"outpacing implementation, and clinical utility studies",0.16034629384193508,2.021000385284424,1.8102725744247437,c7702712-76b7-4879-820b-ebe75cf6caf6,custom_license/Appropriate Use and Future Directions of Molecular Diagnostic Testing,"Purpose of Review Major technologic advances in two main areas of molecular infectious disease diagnostics have resulted in accelerated adoption or ordering, outpacing implementation, and clinical utility studies. Physicians must understand the limitations to and appropriate utilization of these technologies in order to provide cost-effective and well-informed care for their patients. Recent Findings Rapid molecular testing and, to a lesser degree, clinical metagenomics are now being routinely used in clinical practice. While these tests allow for a breadth of interrogation not possible with conventional microbiology, they pose new challenges for diagnostic and antimicrobial stewardship programs. This review will summarize the most recent literature on these two categories of technologic advances and discuss the few studies that have looked at utilization and stewardship approaches. This review also highlights the future directions for both of these technologies. Summary The appropriate utilization of rapid molecular testing and clinical metagenomics has not been well established. More studies are needed to assess their prospective impacts on patient management and antimicrobial stewardship efforts as the future state of infectious disease diagnostics will see continued expansion of these technologic advances.",15.636686664836597,7.963167756503768
"surveillance, controls on the products before the commercialisation and awareness",0.20782310622570707,1.632117748260498,2.86539363861084,ce1447ea-4426-4422-94d0-0d3ef300f8b1,custom_license/Detecting virus contamination in seafood,"One key element in reducing foodborne spread of viruses is the implementation of surveillance, controls on the products before the commercialisation and awareness. Additionally, consumer-information campaigns must be strengthened, including the promotion of suitable procedures of food preparation and consumption.",13.369010400217398,7.602536041542459
"IVIG could transiently improve the clinical condition, HSCT is the most effective therapy for this disease at present.",0.1860067440461276,2.254136800765991,1.9940083026885986,3babf566-183d-4d8b-b2c6-7959fae554c2,custom_license/Heterozygous Mutations in OAS1 Cause Infantile-Onset Pulmonary Alveolar Proteinosis with Hypogammaglobulinemia Web Resources,"Lung transplantation is a curative treatment for GPAP caused by mutations in genes encoding surfactant proteins or genes encoding a surfactant phospholipid transporter in alveolar type II epithelial cells. 34 On the other hand, HSCT is effective for GPAP caused by mutations in genes that could be responsible for surfactant catabolism in AMs. 35 In this study, two affected individuals (B-II-1 and C-II-1) received successful HSCT and recovered completely from PAP. C-II-1 has had cord blood engraftment for 2 years without any respiratory symptoms. It has been reported that AMs are derived from precursor cells in bone marrow. 36 Pulmonary transplantation of differentiated wild-type AMs derived from bone marrow in GM-CSF receptor-b-deficient mice showed long-term effectiveness due to proliferation of transplanted AMs. 37 Although IVIG could transiently improve the clinical condition, HSCT is the most effective therapy for this disease at present.",13.611279011380724,7.525241971228737
fast and efficient clinical diagnostics,0.2357419781366061,2.873067855834961,2.1246469020843506,b67f6b53-6cfa-4000-ab93-720e080180ba,custom_license/Nanowire BioFETs: An Overview Chemical vapor deposition SAED Selected-area-electron diffraction,"In this chapter, the biosensing as a key element of nanotechnology and commanding a wide range of applications is discussed, e.g., fast and efficient clinical diagnostics, health care, security, environmental monitoring, etc. The operation and sensing mechanism of BioFETs and ion-sensitive FETs are elaborated on a molecular level, based upon the molecular recognition between target and probe molecules and the input gate voltage and output ON current of the conventional FETs. In particular, the extended roles of the gate electrode of BioFETs as the probing surface are highlighted, in comparison with the conventional gate electrode, together with the physical and biological processes for detecting target molecules. Moreover, the bottom-up syntheses of vertical and horizontal nanowires are presented and the ensuing nanowires are characterized. Also, the top-down and bottom-up approaches for processing nanowires are compared by taking as criteria the process complexity and quality of the nanowires produced. Finally, the future prospects of bio-sensing are presented.",11.920574931416112,7.420715818643192
"manufacturing processes, product uniformity and safety profiles",0.17692676043956412,1.4100372791290283,2.860968589782715,0f769497-afb0-4544-b1d8-881b1cc5a24a,custom_license/Editor Anthony Vere Hodge Guest editor Graciela Andrei Â©International Society for Antiviral Research IN THIS ISSUE,"they are no longer in production. Instead, they have been replaced by 2 nd -and 3 rd -generation vaccines, in an attempt to improve manufacturing processes, product uniformity and safety profiles (11; 12).",13.253547046964318,7.4148952812301445
to make the processes more acceptable.,0.12677701220130524,1.4118428230285645,2.557129383087158,d4491cd7-2528-4532-82c9-72039b1a97fa,custom_license/OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011,"The choice of methods used in the sentinel surveillance system in Madagascar was based on the capabilities of the volunteer healthcare providers and the financial resources available. The Madagascan network has grown over the years and its expansion is probably now limited by the human resources required to manage the network and data analysis. We have found that progressive step-by-step implementation is best, with assessment of the various processes, evaluations of network management capacity and the training of healthcare workers, to make the processes more acceptable.",13.623643015961154,7.348106989561623
good manufacturing practices,0.3064852357741395,2.118072271347046,2.4161596298217773,6cdce3e8-d196-4d1f-8144-fe4f1fe95a95,custom_license/Mini-review Assessment of the viral safety of antivenoms fractionated from equine plasma,"Considerable experience has been gained in recent years on the viral safety of human IgG preparations and other human plasma-derived products. Historical perspectives on these products help in assessing the viral safety of antivenoms. The safety of human plasma products results from the combination of overlapping strategies that include: (a) selection of donors, (b) viral testing procedures on single donations (e.g. serological tests) and plasma pools (e.g. nucleic acid tests) to exclude donations contaminated by viruses, (c) processing and purification steps to inactivate and remove viruses, and (d) implementation of good manufacturing practices [80] . Whenever feasible, similar approaches should be used for the manufacture of animal plasmaderived products.",12.474057040489264,7.313170699930978
validated and supervised processes,0.16290961470023899,1.4707145690917969,2.013521671295166,79cb42ae-d1aa-4e9b-b80c-e8671e4ee9f1,custom_license/Pathogenic Agents,"â¢ Occurrence of pathogens and indicators depends on the type, origin, and microbiological properties of the raw material. â¢ Microbiological analysis is influenced by the different products (e.g., growth inhibition). â¢ Valuable only if applied on products from validated and supervised processes.",13.576184120823878,7.0164179985398825
some pollution ways and laws data are not sufficient and the basic research is still needed.,0.17000505735787602,0.9151735901832581,1.4691870212554932,893fed14-7e7d-4e96-8f8a-8c9a2e5c4dad,custom_license/Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development,"The international experience shows that the realization of the whole process of management ""from farm to fork"" and the establishment of monitoring system from the source to final consumption are very important for food safety. The application of some advanced food safety control technology in food, such as ""good agricultural practice (GAP)"", ""Good Manufacturing Practice (GMP)"", ""good hygiene practices (GHP)"" and ""harm analysis critical control point (HACCP)"" are very effective to improve the quality of food business and the safety and quality of products. Strengthen the analysis of key factors that affect the agricultural quality during the production process, and enhance the research of pollution ways of toxic and hazardous substances in agricultural products will provide technical support for the base of pollutionfree agricultural products, green food product and organic food. For the implementation of source control, some pollution ways and laws data are not sufficient and the basic research is still needed.",14.380729888663534,6.583089858467425
improve the monitoring of the key factor of production processes,0.2273894437369505,0.7825661897659302,1.9733058214187622,f7e58940-915c-41b9-aaa1-a4de3e8b716e,custom_license/Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development,"(1) The key area of information technology system Reveal the metabolism and regulatory mechanism of nutrients of agricultural products, analyze the theoretical basis of the agricultural products, establish the precise and rapid design platform and production technology system; reveal the cycle and transformation mechanism of the environmental harmful substances of producing area, establish the technology system for the continuous, remote monitoring of environmental quality and remediation of contaminated soil, fully implement the comprehensive remediation of contaminated soil and construct the ecological environment for sustainable development; reveal the metabolic mechanism of biological toxins and the antagonistic mechanism between the insect pests and their natural enemies, improve the dynamic model of agricultural pests and diseases of early warning, establish the entire process of digital file management procedures for the agricultural production and agricultural safety, the tracking system can be traced back (TRACEFISH) and risk assessment systems, as well as the digital monitoring and early warning systems of the foods from farm to fork; clarify the antagonistic mechanism and co-evolution law of the pests and their natural enemies, establish the industrialized breeding technology system of the natural enemies; improve the early warning and prevention system of animal disease; improve the standards of application of veterinary medicine, feed and feed additives, and the monitoring system of animal food safety; establish the agricultural products on-line in situ detection technology, improve the monitoring of the key factor of production processes; establish the rapid or nondestructive testing technology of quality of agricultural products and nutrition index, according to agricultural products their own electrical and optical properties and composition changes; establish the expression database of the risk of human health, which is caused by the law of metabolism of agricultural risk factors, with the application of modern molecular biology and information science and technology. Roadmap 2050 (2) The key research and development area of diversity of nutritional food Using high-tech bio-technology and new process technology to develop various food nutrition fortifier and multi-functional processed foods, such as rich in amino acids, protein, vitamins, mineral nutrients, trace elements (iron, calcium, zinc, selenium, etc.) and antioxidants (poly)phenols, flavonoids, carotenoids, flower pigments), to improve the diet constitution and meet the requirements of different groups for various health nutrients.",13.17084169075735,6.401111399035122
"all manufacturing processes are clearly defined, systematically reviewed in the light of experience and shown to be capable of consistently manufacturing medicinal products of the required quality",0.1774835272063645,1.0476925373077393,1.5310903787612915,9b00dcee-7d58-49fb-9495-bfc6d387f8ff,"custom_license/Ensuring Quality, Safety and Efficacy 4.1. Pre-marketing and Post-marketing Duties","all manufacturing processes are clearly defined, systematically reviewed in the light of experience and shown to be capable of consistently manufacturing medicinal products of the required quality and complying with their specifications; ii. critical steps of manufacturing processes and significant changes to the process are validated;",13.362876306745385,6.353215602805754
wastewater discharge standards,0.17132329066879262,0.5230379700660706,1.4082813262939453,a7d3965e-a858-439e-9ab2-b598a914e03b,custom_license/Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development,"(2) The water quality and safety For the key areas or key territorial water, to carry out the investigation of water quality and the research on the pollution process, conduct the assessment of water quality and zoning. Establish the scientific and reasonable standards of water quality and risk assessment methods; set up the planning and zoning of agricultural products production; construct quality monitoring technology and system; strict implementation of the wastewater discharge standards, develop the related technologies of water pollution control, and gradually improve the water quality of rivers and lakes in our country, meet the safe water supply of crop, animal and aquaculture.",13.401842128850229,5.946002287731591
sustainable agricultural development strategies,0.23357999432558313,0.9688181281089783,0.5075363516807556,31d338dd-3c88-47f5-bb2a-08f1b1e82316,custom_license/Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development Roadmap 2050 6 Roadmap of Agricultural Production and Food Safety Science and Technology Development,"The implementation of sustainable agricultural development strategies and the development of ""Green Agriculture"" will be the developmental direction of the agricultural economic for every country in the world. Currently, the world economic development and consumer market is undergoing profound changes; the natural and pollution-free products have become a kind of new consumption fashion. The future agricultural production must be in clean soil and produced with clean manner to produce safe food (green food) to meet the global food consumption in the quantity and quality needs. China's Ministry of Agriculture officially launched the Pollution-free Food Action Plan in 2001. This plan focused on the control of pollution at resource, vigorously promote standardization of agricultural production, and comprehensively improve the quality and safety of agricultural products. The research and demonstration of the green and safety production techniques have been greatly improved. From the controlling technique of the quality of producing area conditions, the green controlling technique of production process, the high efficient utilization technique of recycling resources, quality evaluation technology to the establishment of the standardization of quality control and production techniques of agricultural products have been greatly developed and demonstrated. ""The People's Republic of China Agricultural Product Quality Safety"" has been come into force on November 1, 2006, and the safe production of agricultural products will be standardized from the legal point of view.",12.81041980224924,5.443277342650561
Intrapleural fibrinolysis using streptokinase has been used in an attempt to improve clinical outcomes,0.19937040525385472,2.052081346511841,2.653988838195801,8a1d5378-0f7a-41b0-836d-1b5a04d386f5,custom_license/Pneumonia in the immunocompetent patient,"Intrapleural fibrinolysis using streptokinase has been used in an attempt to improve clinical outcomes in cases of parapneumonic effusion and empyema. However, a large randomised controlled trial found that there was no evidence of a reduced need for surgical drainage, mortality or length of hospital stay after the administration of streptokinase [59] . Work is ongoing to see if selected clinical subgroups will benefit from intrapleural streptokinase or if combining streptokinase with other agents such as deoxyribonuclease will be of any benefit [60] .",21.84362380276358,10.704213951027219
EAE,0.21454577411267708,2.803753137588501,3.8104522228240967,3663fd57-91c8-4a52-ab76-c203abc49c52,custom_license/A comparative study of experimental mouse models of central nervous system demyelination HHS Public Access Author manuscript,"IL-4 is a pleiotropic lymphokine synthesized primarily by activated T H 2 lymphocytes 59, 60 . The levels of IL-4, have been reported to be lower than normal in the sera of patients with MS 61, 62 . Recombinant IL-4 (rIL-4) has been shown to diminish demyelination and improve the clinical course of mice with EAE, apparently by influencing developing T cells to assume a protective role 40 . When fed to mice, retinoids, a group of chemicals that increase IL-4 and TGF-Î±, also improve the course of EAE 63 . In addition, it has been shown that CNS gene therapy with HSV-1 vectors expressing IL-4 protected rhesus monkeys 39 and mice 40, 41 from autoimmune encephalomyelitis. However, in this study a recombinant HSV-1 expressing murine IL-4 (HSV-IL-4) did not block CNS demyelination in the MOG model. Similarly, we reported previously that CNS demyelination was not blocked in mice co-infected with HSV-IL-2 and HSV-IL-4 25 . The discrepancy between the results of this study and previous studies could be due to the type of antigen, strain of mice, and dose of infection.",14.044532147874335,9.214819736024205
Future studies aimed at addressing all the above issues as well as identifying novel biocompatible or even better biodegradable compounds,0.18605931195937808,1.584324836730957,1.9360020160675049,14d1ab34-5308-41ed-ac95-f2d6c105386e,custom_license/Nanoparticle Delivery of Antisense Oligonucleotides and Their Application in the Exon Skipping Strategy for Duchenne Muscular Dystrophy,"Future studies aimed at addressing all the above issues as well as identifying novel biocompatible or even better biodegradable compounds will doubtless improve the clinical applicability of these delivery vehicles. Such novel delivery systems are also expected to open up enticing new avenues in terms of administration route, with a move toward noninvasive skin and oral administration. Progress in these areas made to date indicates that a real revolution in RNA therapy, with particular reference to DMD, is just around the corner.",19.43100775124312,9.089065167254091
Technological opportunities speed up discovery and translation of new products,0.24561880611802253,3.079087495803833,3.488935708999634,716c283f-bab6-46e7-9878-048c82204c5d,custom_license/Personal View Disease X: accelerating the development of medical countermeasures for the next pandemic,"The product development cycle remains lengthy for de novo medical countermeasures: diagnostic tests typically take 2-5 years to develop and 5-10 years to complete development, before procurement can be initiated. The timeline for vaccines and small molecules is even longer, largely because of the requirement for human safety and efficacy data. Here, we list technological and process opportunities for shortening the development times of diagnostics, vaccines, clinical trials, and small molecules for Disease X (table 1). Technological opportunities speed up discovery and translation of new products. Process opportunities facilitate early alignment and more effective collaborations. These opportunities cover both nearterm (ie, immediately) and mediumterm (ie, over 5-10 years), and are intended to be unaffected by the knowledge of the specific identity of the pathogen.",12.100680216830785,8.504453159013028
Consider how to remove cold-chain requirements or make the product suitable for a wider range of temperatures,0.181396077751923,0.9231685996055603,2.414726495742798,41d0dc2a-8923-48db-87da-70bf41d2dcaf,custom_license/Personal View Disease X: accelerating the development of medical countermeasures for the next pandemic,"Consider how to remove cold-chain requirements or make the product suitable for a wider range of temperatures. For example, refrigerated products might be preferable to frozen products. Point-of-care diagnostics that have been validated for use for up to 40Â°C might be preferable for tropical climates.",15.06234457849596,7.441452414450019
epidemic response and control strategy,0.25781078895266546,1.4099066257476807,1.8370672464370728,50520c7e-2028-42e1-b023-39d748385466,custom_license/Personal View Disease X: accelerating the development of medical countermeasures for the next pandemic,"Response tools Select a combination of diagnostics, vaccines, and therapeutic products on the basis of the epidemic response and control strategy",14.639630834272195,7.234403808915358
Development of written protocols,0.13459203321537844,2.5592052936553955,2.2878990173339844,c2efe54b-9719-47fc-9ad1-c859ad10bf27,custom_license/High-Containment Pathogen Preparation in the Intensive Care Unit,"Development of written protocols facilitates identification of care processes that might place health care workers at increased risk of exposure. These processes can then be modified to mitigate risks. 40 Outlining individual steps of otherwise routine procedures allows clinical stakeholders to closely review and vet processes, standardizes expectation among staff, and provides a template for staff training and proficiency testing.",11.638664359274316,7.224150327889108
expanding open plug andplay platforms that can be multiplexed,0.3100863101828057,2.546682596206665,2.180241107940674,13c1eef0-11af-4d17-a6f9-3915309b82dc,custom_license/Personal View Disease X: accelerating the development of medical countermeasures for the next pandemic,"Similar technological opportunities are also available for diagnostic products, including expanding open plug andplay platforms that can be multiplexed. 29 Ideally, these systems would be designed with prequalified reagents that are readily available for assay development. These systems require minimal customisation and can be quickly validated to develop and manufacture pointof care diagnostics that are easy to use. Prevalidated components can also enable stockpiling of common reagents, which reduces the burden to coordinate the supply chain and distribution of multiple assay com ponents during an emergency.",11.025814879245416,6.931535615431666
microarrays can be used to monitor differential expression profiles and for clinical diagnostics,0.16866219546775904,1.7491254806518555,2.781460762023926,738c7a8a-b352-454e-a072-33bfb9fd5fc4,custom_license/Protein Microarray Technology Types of protein microarrays,"These types of microarrays can be used to monitor differential expression profiles and for clinical diagnostics. Examples include profiling responses to environmental stress and healthy versus disease tissues (Sreekumar et al., 2001) .",11.276161223224712,6.891537485867907
Viruses not only interfere with host translational processes to improve competition for factors,0.23478672946843068,1.3607761859893799,3.0144965648651123,f1044648-c4b6-49f2-ac81-d80ba6dc9ed6,custom_license/Viral Strategies to Subvert the Mammalian Translation Machinery,"Viruses not only interfere with host translational processes to improve competition for factors, etc., but they must also respond to a number of host antiviral ''attacks''-this means that viruses have evolved ways in which to manipulate the host to ensure their replication is not inhibited. Viral countermeasures against host attack, and the delicate balance between the host and virus, are only beginning to be understood and it is likely that we will learn much more about this in the future.",11.313927968185912,6.803802076920489
To improve the quality of the laboratory support during outbreaks,0.20487960362768468,1.9105112552642822,2.450643539428711,ee07f94b-d237-4a2d-a4e3-3b6006945de3,custom_license/Critical Contribution of Laboratories to Outbreak Response Support for Middle East Respiratory Syndrome Coronavirus,"To improve the quality of the laboratory support during outbreaks, it is vital to combine the collected clinical data with epidemiological data and to communicate in a timely manner.",10.777036808343624,6.606713499470714
"research should be implemented on step 1 in order to understand, predict and control emergence processes",0.1678497391759769,1.6790390014648438,1.677698016166687,ccee6a32-b95c-42ef-beeb-4b1a3016f294,custom_license/Epidemiological Interaction at the Wildlife/ Livestock/Human Interface: Can We Anticipate Emerging Infectious Diseases in Their Hotspots? A Framework for Understanding Emerging Diseases Processes in Their Hot Spots,"In order to improve the efficiency and reduce the cost of health interventions, research should be implemented on step 1 in order to understand, predict and control emergence processes and to prevent amplification events (step 2) or prepare the health sector to control them (Barclay 2008) .",12.39939262572814,6.521666480465344
the continued enhancement of this platform,0.201283967949004,0.6645117998123169,2.6500110626220703,0e2b73a2-c6c7-4d78-9cd3-b1eb2eb6f1ce,custom_license/DNA vaccines: ready for prime time? NIH-PA Author Manuscript,"However, the next 2 years of clinical testing of new and more complex DNA vaccines will be pivotal for either generating a true clinical success based on immune potency, or for telling us that we still have much further to go. Previous clinical disappointments highlight the likelihood that complexity in DNA vaccine design -including better and improved formulations, better delivery technologies, enhanced plasmid and delivery approaches, and more judicious clinical implementation -will be a staple for the continued enhancement of this platform. The further advancement of the DNA platform will continue to be an exciting and highly productive adventure that illustrates the best in academic creativity and translational science. Its success will be built on a high level of cooperation between industry, the regulatory authorities, funding by non-governmental organizations, the public and academicians.",10.594579988804327,5.8625428566638655
Tools are being developed to track these parameters and transmit data to a central site for monitoring,0.13981986462782264,0.45484328269958496,1.629512071609497,d5a33ebd-2912-466e-bf32-a4bc6ac89e44,custom_license/Perspectives on Global Public Health Informatics,"The main disadvantage is that synchronization requires more technical support than a standard installation, an issue we are still working to improve. As OpenMRS is rolled out to additional sites, it will be particularly important to track system performance, including down time, data entry and completeness, and daily use, and to evaluate the cost of system implementation and support. Tools are being developed to track these parameters and transmit data to a central site for monitoring.",12.636338667790909,5.777549514027721
the network provides important capacity to address aspects of IHR (2005) implementation,0.21424623344057395,0.8863385319709778,0.6091481447219849,79f846bd-7dd9-4b23-8168-ad7d27b922a3,custom_license/The Global Outbreak Alert and Response Network,"The findings of these two review processes and their recommendations have been supportive of GOARN's core activities with respect to outbreak responses and in humanitarian crises where there was a potential for outbreaks of disease. They also recognise that the network provides important capacity to address aspects of IHR (2005) implementation. They clearly demonstrate that GOARN has been a major asset to WHO, and the partners have supported WHO in fulfilling its role of assisting the member states in containing and controlling epidemic-prone and emerging diseases, as well as providing a response mechanism to assist in other public health emergencies.",11.19329754846747,4.88972048181404
Characterising viral isolates from successive generations of human infections will be key to updating diagnostics and assessing viral evolution,0.350497187540402,4.168208599090576,5.955591201782227,65efa06d-8b20-4724-b7b5-fc4350a6abea,custom_license/Comment 470 www,"The availability of the virus' genetic sequence and initial data on the epidemiology and clinical consequences of the 2019-nCoV infections are only the first steps to understanding the threat posed by this pathogen. Many important questions remain unanswered, including its origin, extent, and duration of transmission in humans, ability to infect other animal hosts, and the spectrum and pathogenesis of human infections. Characterising viral isolates from successive generations of human infections will be key to updating diagnostics and assessing viral evolution. Beyond supportive care, 17 no specific coronavirus antivirals or vaccines of proven efficacy in humans exist, although clinical trials of both are ongoing for MERS-CoV and one controlled trial of ritonavir-boosted lopinavir monotherapy has been launched for 2019-nCoV (ChiCTR2000029308). Future animal model and clinical studies should focus on assessing the effectiveness and safety of promising antiviral drugs, monoclonal and polyclonal neutralising anti body products, and therapeutics directed against immunopathologic host responses.",12.033668772515679,10.792253940947809
Specifi c research needs have been highlighted to further improve the effectiveness of these products,0.3294787722616334,3.4556477069854736,2.6706383228302,577b26cb-4a5b-44b1-8f8f-f3478cda933f,custom_license/Composite nonwovens in medical applications,"This chapter reviews the role of composite nonwovens in medical applications. It covers surgical gowns, clinical wearable products, wipes, wound dressings, pads, swabs, scaffolds for tissue engineering, hernia meshes, fi ltration materials, and incontinence products. Commercially available, innovatively designed composite nonwovens for various medical applications are improving the quality of life of many people. Specifi c research needs have been highlighted to further improve the effectiveness of these products. The chapter ends with some perspectives for the use of composite nonwovens in medical applications in the future.",14.960516681137932,9.218266757778464
to improve the clinical management of bronchiolitis,0.16990259593170756,0.6607886552810669,2.496938467025757,5b7d3a74-f577-4463-ba1e-55ef2baefc7b,custom_license/Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus,"In conclusion, our results showed that RSV load has a signiWcant impact on the clinical and immunological parameters of hospitalized infants suVering from bronchiolitis and underline the importance of implementing diagnostic tools for a rapid, sensitive and quantitative RSV detection in order to improve the clinical management of bronchiolitis. Further larger scale studies are needed to support the predictive value of measuring RSV load on the clinical course of bronchiolitis and to establish the actual ""cutoV value"" of RSV load associated to disease severity.",19.151812161609996,8.755656886062933
to improve vaccine and immunotherapy delivery technologies,0.3842477528451788,2.9487497806549072,4.077678680419922,925d4666-0f7d-405d-a2ac-dbc8ec8e47b0,custom_license/Engineering self-assembled materials to study and direct immune function â-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/),"An emerging technology that can enable the rational, tunable, welldefined nature discussed above is self-assembly. In this review, we discuss the unique features of self-assembly as a means to study immune function, to enhance immunosensing and diagnostics, and to improve vaccine and immunotherapy delivery technologies. We begin with brief background on the immune system and the characteristics of self-assembled materials, then describe key examples from recent literature highlighting how the unique advantages of self-assembly are and can be exploited to probe and control immune function. Throughout the review, we emphasize new ways in which self-assembly might be applied to current clinical challenges, as well as some of the hurdles self- Fig. 1 . The immune system operates under a dynamic mix of maintenance processes, pro-immune functions, and tolerogenic functions. The balance between these functions is dictated by how antigen-presenting cells, such as dendritic cells (DCs), encounter antigens and integrate inflammatory or regulatory signals present in the local microenvironment. For example, during infection or inflammatory disease, DCs detect antigen in the presence of inflammatory or danger signals, which drives the expansion of effector T cells (T EFF ) and triggers antibody responses. In contrast, during tolerance, detection of antigen in the presence of a regulatory environment can lead to the expansion of regulatory T cells (T REGS ), the induction of anergic T cells (T AN ), or the deletion of T cells. Typically, following a perturbation that skews immune functionsuch as an infection, or the administration of a vaccinethe immune system returns to a resting or homeostatic state. assembly might help tackle from the viewpoint of manufacturing and the regulatory process.",11.395432779463835,8.555579972510982
early intervention may improve the clinical outcomes of patients with AIP.,0.24372666121394693,1.860410213470459,1.698657751083374,dace999b-496c-4211-b828-e7f544e62daf,custom_license/Early Intervention Can Improve Clinical Outcome of Acute Interstitial Pneumonia*,"In summary, we have reported on the favorable management outcome of AIP patients, which included the prompt investigation for respiratory infection as a potential etiology for ARDS, the application of mechanical ventilation with a lungprotective strategy, a rapid confirmatory diagnosis of DAD by surgical lung biopsy, and the early initiation of high-dose steroid pulse therapy. These results suggest that early intervention may improve the clinical outcomes of patients with AIP.",17.72185040612016,8.516041819102048
plan for pandemic product deployment,0.3009586199918831,3.001213788986206,3.393111228942871,630bbc0c-14e7-40c3-9393-16a459b6ace4,"custom_license/Hazard Management, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt b Global Influenza Programme, Workd Health Organization","As part of the benefit-sharing established under the Framework, countries are supported to enhance their capacity to detect, prepare for and respond to pandemic influenza. PIP funds are used to improve L&S capacities, estimate burden of disease, strengthen regulatory capacities, plan for pandemic product deployment, and establish risk communication capacities. From 2014 to 2017, PIP funds for these five areas of work were implemented in line with a partnership contribution implementation plan [6] . For L&S capacity-building under the implementation plan, WHO implemented activities globally and in each region to support all countries in pandemic preparedness. Additionally, 43 countries considered in most need of L&S capacity-building support were targeted for country-specific work plans. In the Eastern Mediterranean Region, seven countries were identified: Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Morocco and Yemen.",11.471425702853445,8.171310257652605
to evolve and adapt to clinical and laboratory needs,0.21723588193060872,2.418551206588745,3.1466774940490723,0f19e081-e45f-43fc-b821-6904beb65344,custom_license/Clinical Applications of Quantitative Real-Time PCR in Virology 5,"The objective of test innovation is to evolve and adapt to clinical and laboratory needs. As patient outcome gaps are identified, and as we gain greater understanding and insight into the clinical progression of disease and disease management, technological achievements facilitate advancements in quality of diagnostics and patient outcomes. Life-threatening illnesses convert to chronic/manageable disease with the aid of viral load monitoring. And pressure exists to develop more precise, accurate, sensitive assays, which, in turn, drives the development of more efficacious drugs. This synergy demonstrates the value of diagnostics: it is an integral part of the patient care continuum.",12.290750196707519,7.919161224262213
provides reviewers with knowledge to understand the products they regulate,0.33429175369162495,1.9658420085906982,2.513125419616699,54dd6483-cedf-4517-b298-fd3cf090fe4a,"custom_license/Immunology careers at the NIH, FDA and CDC: different paths that focus on advancing public health HHS Public Access Author manuscript","For those who want to further their careers as researchers, an important feature that distinguishes the FDA is that scientists conduct research in parallel with their regulatory review duties or are in direct contact with teams of reviewers for products under clinical development. Thus, they are uniquely positioned to understand the challenges that limit the clinical development or regulation of therapeutic products. Accordingly, research projects are geared toward the acquisition of critical knowledge in areas that facilitate the development of novel regulatory paradigms and provide scientific support for the development and application of new regulatory policy and decision-making. While undertaking a dual role as a researcher-reviewer can be challenging, the hands-on expertise in bioanalytical methods in silico and in vitro, as well as in animal models that can be used to improve product characterization, provides reviewers with knowledge to understand the products they regulate. Conversely, the first-hand experience with regulatory submissions allows researchers to formulate questions that address scientific gaps that needed to be filled to support regulatory decision-making.",14.17536935739448,7.872708103422877
therapy is effective in eliminating B. pertussis from patients with the disease,0.17524223653106422,1.3739013671875,1.7530673742294312,88dbf9cf-e0aa-411c-8467-1269b08347db,custom_license/Pertussis CASE PRESENTATION 1,"A 2007 Cochrane Review 29 looked at 13 trials with 2197 participants: 11 trials investigated treatment and two trials investigated prophylaxis. Short-term macrolide antimicrobial use (azithromycin for 3 to 5 days, or clarithromycin or erythromycin for 7 days) were as effective as long term (erythromycin for 10 to 14 days) in eradicating B. pertussis from the nasopharynx and had fewer side effects. Trimethoprim/sulfamethoxazole for 7 days was also effective. There were no differences in clinical outcomes or microbiological relapse between short-and long-term antimicrobial use. Indeed, while therapy is effective in eliminating B. pertussis from patients with the disease, rendering them non-infectious, treatment does not alter the subsequent clinical course of the illness. The review also found that contact prophylaxis of contacts older than 6 months of age with antimicrobials did not significantly improve clinical symptoms or the number of cases developing culturepositive B. pertussis.",16.45975708931396,7.793444663180891
Implementation of rapid molecular diagnostics in bloodstream infections could significantly improve speed of diagnosis,0.18093013298843993,2.4994547367095947,2.7767863273620605,71f8a9a4-3d2c-41d4-8629-382f15285819,custom_license/R2250 H1N1 virus infection: review of chest radiographic findings,"The GenoType Â® Cdiff assay for the direct detection of Clostridium difficile and major ribotypes from stool shows rapid, sensitive and specific results. The DNA isolation is fully automated. The turnaround time (including hands on time) is approximately 1.5 hours for DNA isolation, 2 hours for amplification and 2 hours for hybridization. The assay provides more information (ribotypes, toxins, binary toxins and Moxifloxacin resistance) as any presently available commercial CD test. Objectives: Implementation of rapid molecular diagnostics in bloodstream infections could significantly improve speed of diagnosis, and thereby outcome. Current molecular tests directly on whole blood samples have suboptimal sensitivity, due to the use of small volumes. Larger volumes show an inhibitory effect of human DNA. The Sepsitestâ¢-assay (Molzym, Germany) incorporates a pre-test enrichment method, which selectively eliminates human cells. This may lead to an increase in input volume and subsequent diagnostic sensitivity. We investigated the use of this assay in a cohort of patient with sepsis on the ICU.",12.259922538232022,7.720529580027783
Countries were supported to strengthen influenza diagnostic capacities to improve detection,0.18968014716470769,1.743437647819519,3.609938621520996,a82b06b8-d004-4cd0-9b83-402fbe6d09f5,"custom_license/Hazard Management, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt b Global Influenza Programme, Workd Health Organization","During the four years of implementation, US$ 2.7 million was invested in regional capacity-building through the Regional Office, and US$ 4.6 million was invested directly in the seven L&S PIP priority countries. Countries were supported to strengthen influenza diagnostic capacities to improve detection, enhance influenza surveillance systems including sentinel surveillance for severe acute respiratory infection (SARI) and influenza-like illness (ILI), and increase global sharing of surveillance data and influenza viruses through GISRS. This paper highlights the achievements and challenges faced to improve influenza preparedness and response specifically in L&S capacities and influencing influenza disease control policy in the Eastern Mediterranean Region from 2014 to 2017.",11.449572015198854,7.487044780390933
Evaluation often requires tailoring to specific situations,0.207064718935708,2.3748183250427246,2.1455867290496826,9eb2900f-bf4e-49ee-ab26-5ad662be9206,custom_license/DIAGNOSIS OF NEONATAL PIG DIARRHEA,Diagnosis of preweaning diarrhea in swine continues to be a part of day-to-day swine practice regardless of the management system or antibiotic availability. Often a broader approach to diagnosis beyond simple bacterial culture and a few snips of intestine for histopathology is required. The following is an attempt to streamline an approach to swine diarrhea diagnostics with the acknowledgment that situations or conditions can vary. Seldom are disease processes singular in any given unit. Evaluation often requires tailoring to specific situations in which case discussion with a diagnostic pathologist is encouraged to provide a source of appropriate tests for you and your client's needs.,11.90654885343023,7.105555383860645
disrupting how traditional clinical microbiology workfl ows and processes are set up,0.20378811733612406,0.60824054479599,2.3905630111694336,049798a5-f244-41a6-be21-e2ab32c9ba4f,custom_license/Utilization Management in the,"As technology advances, the traditionally "" agrarian society "" of the laboratory is becoming more industrialized with the implementation of automation, molecular based testing, and use of mass spectrometry ( MALDI-TOF -Matrix-Assisted Laser Desorption Ionization-Time of Flight). Many of these advances are revolutionizing how microbiology testing is performed and disrupting how traditional clinical microbiology workfl ows and processes are set up. However, all of these technological advances are shortening the time for a laboratory diagnosis and ultimately maximizing the impact to patient care and how physicians at a large community hospital will utilize the more rapid microbiology laboratory services.",13.14087086676242,6.548527114744372
firefighting foams,0.21304815773589988,1.3431551456451416,1.4569083452224731,d1598bee-2dc6-4335-a236-fd328f193112,custom_license/References -63 . Fig. 2.1 UK Government AIDS awareness leaflets,Answers v Exercise 2.1 (A) Temporal marker: Perfluoroalkyated substances have been used since the 1950s. Dose marker: People have had considerable exposure to these substances in a range of common household products as well as industrial processes and firefighting foams.,13.371657286429993,6.500121319314447
Clinical interpretations were made according to Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI VET01S).,0.1868888118996931,1.6510170698165894,1.3054403066635132,22189975-7f00-4fbf-9688-56d269db3673,custom_license/Influence of the intestinal microbiota on disease susceptibility in kittens with experimentally-induced carriage of atypical enteropathogenic Escherichia coli,"Antimicrobial susceptibility testing was performed by the Clinical Microbiology and Molecular Diagnostics Laboratory at North Carolina State University. The minimum inhibitory concentration of each E. coli isolate was determined by microbroth dilution using a commercial platform (COMPAN2F plates; Trek Sensitre, ThermoFisher Scientific) and manufacturer-provided methodology. Clinical interpretations were made according to Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI VET01S).",11.254845137642002,5.8608930928867675
"AI is increasingly being deployed to improve clinical decision-making, enhance personalized care and public health outcomes",0.19779959843040879,2.3535995483398438,3.455488920211792,1adca3b3-806e-4029-9c19-dad03b41b10c,custom_license/Artificial Intelligence Applications in Tracking Health Behaviors During Disease Epidemics,"There is no doubt that AI is and will continue to revolutionize healthcare and population health. From prevention and health promotion to diagnosis and treatment, AI is increasingly being deployed to improve clinical decision-making, enhance personalized care and public health outcomes. In particular, AI offers enormous potential for cost-savings on therapeutic care given its predictive accuracy of potential outbreaks and epidemics and ability to enhance positive health seeking behaviors (at individual and population levels) during epidemics predicated upon robust infodemiology and infoveillance frameworks supported by expert systems, machine learning algorithms and mobile applications. Amazing as the future of AI in healthcare seems, there are significant legal and ethical concerns that need to be addressed in order to pave way for robust implementation and scalability across a variety of socio-cultural, epidemiological, health system and political contexts.",18.404587780160412,10.217513227614708
entering the health biotech space and generating short-term revenues,0.33381640484593633,3.2588508129119873,4.976801872253418,6db4f608-81fd-45da-8fd2-6c6500f12985,"custom_license/Chinese health biotech and the billion-patient market Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits","Given China's current financial environment, a pure R&D business model is unsustainable and nearly impossible. As a result, several of China's small and innovative biotech companies are generating revenues by selling noninnovative products, providing services and/or outsourcing their early products. These strategies exploit the low-cost advantage of doing research in China and the significant size of the domestic market. Selling noninnovative products, such as biogenerics and simple diagnostics, is a low-risk strategy for entering the health biotech space and generating short-term revenues. Thus, Amoytop Biotech, United Cell Biotech and Sunway Biotech entered the market with biogenerics; Beijing Wantai and Huaguan Biochip entered the diagnostics market with relatively simple products. Fudan-Yueda Bio-Tech sells the immunology reagents that make up its therapeutic HBV immunological complex for research purposes and Genon Bio-Engineering sells animal protein products. Companies that have turned to offering research services on a contractual basis while maintaining in-house R&D groups include Shanghai Genomics, HD Biosciences, SinoGenoMax and Starvax International.",13.567858477454788,10.10192471246669
Plasma therapy and immunoglobulin intervention on 2019-nCoV infected patients could improve clinical outcome,0.2120979529826971,2.2638773918151855,2.5128278732299805,1228c969-e28c-4ab3-8bac-3e7bb2412f2a,custom_license/The possible of immunotherapy for COVID-19: A systematic review,"Plasma therapy and immunoglobulin intervention on 2019-nCoV infected patients could improve clinical outcome. The vaccines and ACE2 immunoadhesin have not been tested yet. As the preferred immunotherapy method, monoclonal antibody has performed only for SARS; however, this method has not yet been tested. Most articles in this field are review articles recommending immunotherapy for 2019-nCoV with reasons and evidence of previous studies on two other coronaviruses SARS-CoV and MERS-CoV.",18.466284851776905,9.568058120401274
Every viral outbreak provides an opportunity to learn important lessons to improve clinical care and reduce future viral outbreak transmission,0.23541931533466698,2.5202980041503906,3.4861011505126953,953f0f53-d61d-4108-bf37-c00443d614a6,custom_license/Journal Pre-proof Anaesthesia and COVID-19: infection control Anaesthesia and COVID-19: infection control,"Anaesthetists need to participate in an encompassing and hierarchical strategy to contain COVID-19 viral transmission. This includes organisational adaptation (e.g. use of appropriate processes for transferring patients around the hospital, engineering control of pressure in isolation rooms); ensuring early isolation control of infected patients; and supporting effective decontamination of equipment and healthcare environments. 29 Every viral outbreak provides an opportunity to learn important lessons to improve clinical care and reduce future viral outbreak transmission. However, many lessons, like early isolation, have only limited windows to be applied before they become redundant. The COVID-19 pandemic is fast-changing, and our response must be equally dynamic and responsive if we are to counter the spread of this important new pathogen.",15.86022353763196,9.45523768870219
reduce health care costs,0.38005512178605183,2.1961770057678223,3.3860087394714355,0b221053-5a25-4f19-8be0-719b00955710,custom_license/KEYWORDS Ventilator-associated pneumonia Ventilator-associated tracheobronchitis Ventilator-associated respiratory infection Microbiologic criteria for diagnosis Endotracheal aspirates Bronchoalveolar lavage antibiotics Multidrug-resistant bacteria,"Early, appropriate antibiotic therapy, as emphasized in the 2005 American Thoracic Society/ Infectious Diseases Society of America guidelines, is associated with improved patient outcomes. 4 These guidelines recommend broad-spectrum, empiric antibiotic therapy until culture and antibiotic sensitivity data are available, and then de-escalation of antibiotics based on the microbiologic data. However, for intubated patients, the use surveillance EA may provide earlier information on colonization with MDR pathogens that could be used for targeted antibiotic therapy. This approach could reduce inappropriate antibiotic therapy, reduce overuse of antibiotics that can result in selection of MDR pathogens, improve clinical outcomes, and reduce health care costs.",14.452222142171316,8.686698484165477
Nonnovel products,0.21673971467697598,3.3053035736083984,3.2203571796417236,8385a19a-5cf3-4d16-9b1c-7cb01363dd85,"custom_license/Chinese health biotech and the billion-patient market Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits","Nonnovel products. Biogenerics make up the majority of China's biopharmaceutical market, accounting for >90% of the $3 billion market in 2006 (refs. 4,7) . China's population size creates a significant need for low-cost products. Generic products represent a less risky entry point for private companies into the biotech industry. Amoytop Biotech (Xiamen), for example, manufactures several recombinant biopharmaceutical products under Chinese cGMP (current good manufacturing practice) conditions, including interleukins (ILs), interferons (IFNs) and others ( Table 1) . The company is working to improve the stability and delivery of these products by developing PEGylated versions of several of them.",12.472493302637849,8.607052145535826
Protein-coding sequence alignments,0.55149190591685,1.9447728395462036,2.140859603881836,44ae761b-22bc-4411-a5b3-faa8117a5a36,custom_license/An empirical test of the midpoint rooting method,"DNA sequences were retrieved from the NCBI molecular database as indicated by the authors. Protein-coding sequence alignments were performed with ClustalW (Higgins, Thompson & Gibbs, 1994) implementation in DAMBE, version 4.2.13 (Xia & Xie, 2001) , based on their respective amino acid products. Noncoding sequences, such as rRNA genes and the mitochondrial D-loop region, were also aligned with the ClustalW implementation present in the DAMBE software. All alignments were performed using default parameters, and they were visually inspected and corrected whenever appropriate.",13.21980371466806,7.282592388362047
embed them,0.15009657090344442,-0.7709817290306091,1.2863305807113647,29bf2fc9-64e0-4313-b190-1fe468568ab2,"custom_license/Oral presentations Abstract ID: 4444 Outbreak of Panton-Valentine Leucocidin- associated Staphylococcus aureus (PVL-SA) skin infection linked to a diving club at a national sports centre: Case management, environmental assessment and control measures","Five tests of change proved successful and were ramped up through the PDSA cycles to develop products, improve and embed them. These were education around sampling myths, a daily bay challenge to identify patients in bays with diarrhoea, a sticker affixed to faecal specimen pots to assist in documentation processes, the inclusion of side room usage on the daily ward huddle sheet and a revised diarrhoea care plan. Together these five products have formed the ""C the difference"" toolkit.",18.151712944829256,6.68807628428273
decontamination and the opportunity to standardise products across the organisation,0.170639906086797,1.364488124847412,2.0482382774353027,154718a1-ee48-4306-9fcd-c1a7175f1058,"custom_license/Oral presentations Abstract ID: 4444 Outbreak of Panton-Valentine Leucocidin- associated Staphylococcus aureus (PVL-SA) skin infection linked to a diving club at a national sports centre: Case management, environmental assessment and control measures",Collaborative working with IPT and Procurement enabled the exploration of a single-stage process for decontamination and the opportunity to standardise products across the organisation. The costs for using the single-step and two-stage processes were compared.,12.223951196545642,6.496655080274739
ring-C aromatized products.,0.1302525656808591,0.8427101969718933,1.8729666471481323,f1d3cda9-18c6-4acc-823f-02862063c7dc,custom_license/CHEMICAL AND BIOLOGICAL ASPECTS OF NARCISSUS ALKALOIDS,"In the plant, the alkaloid lycorine (1) is particularly vulnerable to oxidation processes, giving several ring-C aromatized products.",13.471102389826843,6.480075785117411
"A process for validation of new methods prior to implementation as well as processes for continued validation of accuracy, precision, and reliability to meet regulatory standards",0.17500676516513883,1.166886329650879,1.3752771615982056,5753b50c-f6a9-4df4-b145-0912fec05e1d,custom_license/6 Laboratory Processing of Specimens,"All testing methods require the laboratory to have a quality management plan available to meet Clinical Laboratory Improvement Amendments (CLIA) regulations. These include performing quality control and proficiency testing and documentation that personnel have relevant laboratory education and experience qualification to perform the tests. A process for validation of new methods prior to implementation as well as processes for continued validation of accuracy, precision, and reliability to meet regulatory standards also needs to be considered. Furthermore, instruments will also require an ongoing maintenance plan as required by the manufacturer.",13.649574707797452,6.429757417041013
reflexive monitoring),0.19666144938268187,1.301854133605957,1.931844711303711,df4227cc-3432-4f68-bafe-715451510f5d,"custom_license/Oral presentations Abstract ID: 4444 Outbreak of Panton-Valentine Leucocidin- associated Staphylococcus aureus (PVL-SA) skin infection linked to a diving club at a national sports centre: Case management, environmental assessment and control measures","Normalisation process theory (NPT) (May et al, 2009 ) has been used to study the implementation of complex healthcare interventions in a variety of healthcare areas. Using qualitative methodology, semi-structured interviews were conducted with 26 clinical leaders responsible for implementation, from 15 NHS Boards using NPT as a guiding framework. Framework analysis methods were applied to explore how clinical leaders make sense of the work of implementing the CAUTI care bundle (coherence); how they engage with it (cognitive participation); enact it (collective action) and appraise its effects (reflexive monitoring).",12.350176287666924,6.424465949874708
Public investment in education and research will improve the safety and accessibility of blood and blood products for all our citizens,0.12140140167097563,1.1567814350128174,1.3232983350753784,fa90632e-1cc3-4375-a21e-11233b345518,custom_license/A Prescription for the Next Health Care Crisis BLOOD PRODUCT SAFETY,â¢ Public investment in education and research will improve the safety and accessibility of blood and blood products for all our citizens.,13.3470351873049,6.283514166114042
Invest in basic and applied research to improve the care and treatment of those requiring blood and blood products,0.273935430109387,1.1712311506271362,1.5574357509613037,cc0fc9ac-3d9d-422d-8036-8f438484af98,custom_license/A Prescription for the Next Health Care Crisis BLOOD PRODUCT SAFETY,"â¢ Enhance educational efforts to remove the stigma of infectious disease and instill tolerance toward those that are afflicted, and â¢ Invest in basic and applied research to improve the care and treatment of those requiring blood and blood products.",12.053175915284179,5.9922450563819485
CAUTI care bundles,0.2560314166590776,0.5195341110229492,1.0102301836013794,e786b289-ec6b-465e-8570-58edceb81478,"custom_license/Oral presentations Abstract ID: 4444 Outbreak of Panton-Valentine Leucocidin- associated Staphylococcus aureus (PVL-SA) skin infection linked to a diving club at a national sports centre: Case management, environmental assessment and control measures",This paper will present findings illustrating key barriers and enablers to the introduction of CAUTI care bundles from the perspective of clinical leaders responsible for implementation.,12.031658463514699,5.205427253735958
immune system processes,0.25965862425033964,4.368725299835205,5.1099138259887695,829665fd-9411-461c-852a-1714222f14c2,custom_license/Lysosomes as a therapeutic target,"Discovered in the 1950s by Christian de Duve, lyso somes are membrane bound vesicles containing numerous hydrolytic enzymes that can break down biological polymers such as proteins, lipids, nucleic acids and polysaccharides 1,2 . Lysosomes have long been known to have a key role in the degradation and recycling of extracellular material via endocytosis and phagocytosis, and intracellular material via autophagy (reviewed elsewhere 2-5 ) (Fig. 1 ). The products of lyso somal degradation through these processes can be trafficked to the golgi apparatus for reuse or for release from the cell through lysosomal exocytosis, which is important in immune system processes. In addition, it has become clear more recently that lysosomes have an important role in other cellular processes including nutrient sensing and the control of energy metabolism 3,5-7 (Fig. 1) .",11.055848477500295,10.030662398910687
The development of novel diagnostic tools for influenza and other respiratory illnesses will enable rapid diagnosis leading to earlier treatment,0.21398927490699918,4.026700496673584,4.2314558029174805,3ab64918-b0ea-4dc7-8403-cc5456181999,"custom_license/The Acute Respiratory Infection Consortium: A Multi-Site, Multi-Disciplinary Clinical Research Network in the Department of Defense","While these comparative evaluations are necessary, they do not eliminate the need for more accurate, sensitive and rapid bench-top diagnostics for respiratory infections. Research is needed to assess whether the use of bioinformatics and other novel approaches can improve the accurate and rapid detection of ARI-associated pathogens. The development of novel diagnostic tools for influenza and other respiratory illnesses will enable rapid diagnosis leading to earlier treatment, possibly improved clinical outcomes, and lessened transmission of ARI, especially in congregate military settings Next Generation Sequencing While ARIs are a leading cause of morbidity in armed services personnel, a causative agent is frequently not identified using standard diagnostic tools. Given the high proportion of undiagnosed ARI cases in this population, we are collaborating with USU researchers on the Next Generation Sequencing, a novel diagnostic platform for identifying ARI etiology, for characterization of viral respiratory infections and gauging whether or not its ability to detect pathogens exceeds that of current tool diagnostic platforms. The qPCR assay developed for this study detected a previously unidentified agent (i.e., anelloviruses). 21 Further studies are needed to investigate the frequency and clinical relevance of these viruses.",10.032386119700872,8.879136736629498
policies that will mitigate the negative consequences of globalization and enhance its potential positive influences,0.20746335198717722,2.077866315841675,3.41638445854187,abf6dffc-722b-4c01-b749-935952e9b13f,custom_license/Chapter 2 Macrosocial Determinants of Population Health in the Context of Globalization,"Although the existence of global influences on individuals and populations is clear, the effect of globalization on individual well-being and population health is not well established. Empirical evidence suggests both positive and negative effects of globalization on health, but there is no simple equation that can encapsulate how globalization may improve, or harm, population health. Instead it is likely that myriad processes comprise globalization, and each may influence the health of populations through multiple pathways. The challenge lies in elucidating the mechanisms by which globalization affects health. An understanding of these mechanisms will inform the decision-making process and enable implementation of policies that will mitigate the negative consequences of globalization and enhance its potential positive influences.",14.81705374675624,8.757231814713988
cobalamin supplementation can improve clinical signs,0.22293556563493094,2.4115748405456543,2.7903401851654053,8a83749a-9b26-4aca-b8b6-4afa780a5592,custom_license/Diagnosis of Small Intestinal Disorders in Dogs and Cats INTRODUCTION: DIAGNOSTIC WORKUP OF SMALL INTESTINAL DISORDERS,"Serum cobalamin concentration has long been known to be an important negative prognostic factor in cats with chronic enteropathies. 15 The prevalence of decreased serum cobalamin concentrations in cats with chronic gastrointestinal signs has Small Intestinal Disorders in Dogs and Cats been reported to be up to 16.5%. 16 In cats, it has also been reported that cobalamin supplementation can improve clinical signs regardless of the underlying diagnosis, and even if given as the sole treatment for their disease. 15 It is therefore recommended that cats with chronic intestinal disease are supplemented with cobalamin regardless of whether a specific cause for the disease can be identified.",15.221514028139556,8.708774676561033
infection prevention investigators together with frontline staff may be able to create and implement solutions that increase hand hygiene compliance and improve clinical workflow.,0.2077435193688635,0.8206750750541687,2.7045364379882812,f2b85e8b-3b83-425f-9a8c-154525f790a3,custom_license/Role of Human Factors Engineering in Infection Prevention: Gaps and Opportunities,"Every infection prevention study need not assess all components in a system, but investigators must assess the interaction of critical system components if they want to address latent and deep-rooted human factors problems. For example, a task analysis might identify details about how and when healthcare workers do or do not practice hand hygiene, the number of hand hygiene opportunities in different clinical settings, barriers intrinsic to the hand hygiene process, inefficiencies in current workflow patterns, and design flaws that discourage healthcare workers from doing hand hygiene. Given this information about the overall system, infection prevention investigators together with frontline staff may be able to create and implement solutions that increase hand hygiene compliance and improve clinical workflow.",15.10948259025535,7.579706390066964
our data showed high sensitivity and specificity of these products as well as the ease of use,0.19746296719481785,2.189258337020874,3.0209765434265137,5f20ee07-1493-44d6-bb81-80b397c8ca94,custom_license/Diagnostic Molecular Microbiology: A 2018 Snapshot,"Our high-throughput laboratory (>200 blood cultures per day) was an early adapter of the staphylococcal, enterococcal, and candida probes, although we do not currently use those for bacteria owing to the availability of more sensitive platforms with the ability to detect a great number of pathogens involved in bacteremia and sepsis. Multiple PNA-FISH assays received FDA clearance, including the assay for the detection of Staphylococcus aureus/coagulase-negative Staphylococcus, Enterococuus fecalis/E faceium, gram-negative traffic light (identification of E coli, Klebsiella penumoniae, and Pseudomonas aeruginosa) and yeast traffic light (identification of Candida albicans, C krusei, C tropicalis, C glabrata, and C parapsilosis). Our laboratory has been involved in clinical trials of AdvanDx PNA-FISH products and our data showed high sensitivity and specificity of these products as well as the ease of use. [13] [14] [15] [16] Although the popularity of PNA-FISH as a diagnostic test in large laboratories is declining, the FISH technique is being used by Accelerate Diagnostics (Tucson, AZ) to facilitate organism identification in positive blood culture bottles.",11.076137191351483,7.26330068926382
initiatives involving local institutions have demonstrated the feasibility of implementing PBM programs,0.22132795729821989,2.5370919704437256,2.4332427978515625,6743bf66-9393-4002-99b0-b7618d879ff4,custom_license/.1 Key Points,"It must be stated that benefi ts, effectiveness, and cost-effectiveness of complete PBM programs have been not fully proven yet. It is diffi cult to argue against the overall benefi cial outcomes of a program encompassing several measures, all aimed to reduce ABT, improve clinical outcomes, and reduce costs. Nevertheless, although the effects of single measures are mostly known, we cannot really anticipate the effect of a complex of measures, possibly being addictive, synergistic, or even paradoxically counteracting. Studies involving a large population are needed in order to address this question, in the form of CRTs, targeting clinically relevant outcomes, or in the form of registries collecting safety and effectiveness data on patients managed in a PBM program . So far, initiatives involving local institutions have demonstrated the feasibility of implementing PBM programs, achieving extremely relevant goals such as fewer transfusion administered, reduced mortality and complications, lenght of stay (LOS), readmissions, and costs (KotzÃ© et al. 2012 ; Leahy et al. 2012 ) . A recently published study (So-Osman et al. 2014a ) , combining restrictive transfusion thresholds, erythropoietin administration, and/or autologous blood reinfusion, reports effectiveness (but not costeffectiveness) of erythropoietin administration, but it shows lack of benefi t for cell salvage/drain reinfusion in patients with Hb levels 10-13 g/dl.",10.995818611711542,7.079254113490977
several optimizing processes,0.18798064938974013,1.6186187267303467,2.488502264022827,41bc336f-c5ba-4096-85db-002af21cf593,custom_license/Language model-based automatic prefix abbreviation expansion method for biomedical big data analysis,"2. Theoretical analysis of the time complexity of the automatic expansion method is presented, and several optimizing processes are proposed to improve the effective of expansion set and the time complexity of method.",12.351846067117997,6.992774767480862
"In the second half of the 1990s, authorities shifted regulatory emphasis from a scientific review of the processes to a focus on compliance to current good manufacturing practice",0.13673807310643799,1.1376121044158936,2.91692852973938,ec4a4b26-6e24-44d5-b9d4-2980cdfc4a70,custom_license/2 Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates,"From the very beginning of the clinical use of plasma-derived protin concentrates severe noninfectious adverse events (AEs) and transmission of pathogens by plasmaderived protein concentrates were threats to recipients (see Chap. 10 for additional information). First anti-infectious plasma potein concentrates were the ""standard IgG"" preparations. They were produced by the cold-ethanol fractionation methods and did not make an exception to the above: noninfectious severe AEs occurred while infectious AEs were rarely reported. Indeed, prior to the introduction of mass screening for infection markers of plasma donations, inadvertent transmission of HIV to recipients of factor VIII and factor IX concentrates did occur, while IgG concentrates obtained from the same plasma pool did rarely transmit HIV (Morgenthaler 2001) . Rare transmissions were restricted to products not exposed to low pH. The very few incidences of HIV and some incidences of HCV transmission by IgG concentrates in the early 1990s, together with many cases of coagulation factor concentrates transmitted viral disease, clearly demonstrated the need to establish standardized measures to render plasma products pathogen safe. In the second half of the 1990s, authorities shifted regulatory emphasis from a scientific review of the processes to a focus on compliance to current good manufacturing practice (cGMP). The focus on cGMP compliance was applied to all aspects of plasma fractionation and the clinical use of plasma products. Court injunctions and warning letters were the consequences of this paradigm shift by authorities. This in turn resulted in a paradigm shift how the modern plasma industry operates (Steinhardt 1998) .",10.57757832925319,6.337603827439544
intra-hospital transfers,0.46643104444724953,1.6329476833343506,1.9199451208114624,763d0f9d-42e6-426b-b27d-017c1d732f6b,custom_license/Journal Pre-proof Contingency management strategies of the Nursing Department in centralized rescue of patients with coronavirus disease 2019 Author Statement. Contingency management strategies of the Nursing Department in centralized rescue of patients with coronavirus disease 2019,"Actual status in front-line work was investigated to optimize. For example, details of patient information were filled on the hospitalization application form, especially noting ""suspected"" or ""confirmed"". One-way flow of the patient admission was confirmed. After patients being released by the fever clinic, the nurse at desk of the isolation ward would be notified in a timely manner to receive the patient for treatment. Preparation of protection and isolation should be completed before implementation of intra-hospital transfers. All documentary processes and the address list were sent to all nurse stations in the hospital.",11.505747770495,6.336392042368028
organization of continue education and controlled communication processes,0.15833576070332464,1.6621273756027222,1.9522042274475098,220a621b-2a13-4f92-b444-b10c8c6afcfd,custom_license/.1 Key Points,"As mentioned above, PBM is a multiprofessional and multidisciplinary strategy; therefore, from a managerial standpoint, its implementation will require drawing a new pathway for patients candidate for elective orthopedic surgery, with involvement of different specialists, among which anesthetists are to play a major role. The draw should be robust, including detailed algorithms for the management of patients with different features and needs, going through the various steps (e.g., see KotzÃ© et al. 2012 ) . Also, organization of continue education and controlled communication processes should be included.",11.374679260603708,6.330453283193949
PBM programs,0.19730398273326663,1.0818506479263306,2.099436044692993,4ada2469-bdc7-4fda-a5af-07524e28fc2d,custom_license/.1 Key Points,"â¢ PBM strategy has been developed because of concerns about safety of blood transfusion, future blood supply shortage, and escalating costs. â¢ Presently, PBM strategy is ""patient centered,"" aiming not only to avoid blood transfusion but also target patient clinical outcomes. â¢ PBM implementation requires a solid design, including algorithms for management of all kinds of patients and taking into account educational and communication issues. â¢ Priority must be given to the treatment of preoperative anemia, improving anemia tolerance, reduction of blood loss by means of blood-sparing surgical techniques and careful hemostasis, and adherence to protocols for administering ABT. â¢ Despite scarcity of evidence concerning the whole protocol of PBM, adequate rationale exists for promoting wide implementation of PBM programs. Further studies are needed in order to target relevant clinical outcomes.",11.160676152189428,5.97407300346886
benefi cial and cost-effective PBM pathways,0.20867582237130428,1.6233140230178833,1.9203301668167114,1fce87e1-8029-4ae9-bdac-19dad16e3546,custom_license/.1 Key Points,"In conclusion, in this discussion we have focused on the philosophy of PBM and on the instruments that can be used when drawing PBM programs. Aware of diffi culties that may hamper their implementation, we solicit managers of public and private institutions to actively promote projects for implementation of benefi cial and cost-effective PBM pathways.",10.417435690310416,5.949471215001132
"laboratory diagnostics, and treatment and prophylaxis of bacterial, viral, and parasitic infections",0.18431813015832976,0.7506744265556335,1.0806076526641846,f45eba12-315f-48f3-91a0-4485ea7ad18a,custom_license/Case Study -Bulgaria Raynichka Mihaylova-Garnizova and Kamen Plochev,"The NCIPD has the status of scienti fi c organization of the Ministry of Health, which aims to develop a scienti fi c basis for the fi ght against infectious diseases and methods for its implementation. Therefore, the areas of intensive research are: infectious diseases, immune reactivity, epidemiology, laboratory diagnostics, and treatment and prophylaxis of bacterial, viral, and parasitic infections. NCIPD includes all National Reference Laboratories (NRL) in various bacterial, viral and parasitic infections.",13.05195094718688,5.75851618300829
automated hand hygiene monitoring systems,0.1399995128055616,-0.023271331563591957,0.8756415247917175,46b76c4d-41bf-4f9d-862a-229078ba8db0,custom_license/Role of Human Factors Engineering in Infection Prevention: Gaps and Opportunities,"Conway [21â¢â¢] recently reviewed significant HFE issues associated with implementation of automated hand hygiene monitoring systems. She noted that the system must ""minimize disruption to the physical structure and to clinician workflow"" and fit with the ""organization's culture and budget."" Leaders must obtain ""buy-in"" from front-line workers and address their concerns about data accuracy and about ""how the data will be used."" Leaders also must provide hand hygiene data to healthcare workers such that they can use the data to improve compliance [21â¢â¢] .",11.289571195786737,4.505390544123639
intensive care may improve clinical outcomes,0.3030201198598567,3.6007206439971924,3.68894624710083,ef1f1c27-af1e-4427-883c-7a8704905492,custom_license/Clinical Management of Patients Infected with Highly Pathogenic Microorganisms 9,"Supportive treatment should be based on clear plans and guidelines, such as those for intensive care and sepsis management (http://www.survivingsepsis.org). Furthermore, national and international (WHO) specific guidelines and therapeutic recommendations for the particular disease should be consulted. Intensive care largely depends on available resources in the limited nursing setting. There are indications that intensive care may improve clinical outcomes: Out of 20 patients who were medically evacuated during the 2013-2016 EVD outbreak, 16 survived, yielding a case-fatality ratio (CFR) of 20% [13] . On the other hand, the overall case-fatality ratio for all confirmed cases in Guinea, Sierra Leone, and Liberia with recorded clinical outcomes was 63% [14] . Even more, case fatality ratios for Marburg virus disease (MVD) fluctuate between~22% for an outbreak which occurred in West Germany in 1967 (supportive treatment and frequent blood samplings for clinical surveillance were performed at that time) and 88% for an outbreak in UÃ­ge/Angola in 2005 [15, 16] .",14.759670576636804,9.904168181036596
"ulcerative colitis, and hasten colon healing",0.19773344189901346,2.623992681503296,3.229020595550537,05a626f1-0078-49ec-b25b-31789055e6ff,custom_license/Disorders of the Gastrointestinal System,"Psyllium mucilloid can be added to the diet (5 tablespoons every 12-24 hours) to increase the production of SCFAs in the colon. Amylase-resistant fermentable fiber such as psyllium is hydrolyzed by colonic bacteria to SCFAs such as butyrate, which represent a major energy source for colonocytes. Butyrate and other SCFAs hasten epithelial maturation and stimulate salt (and thus fluid) absorption in the colon, improve the clinical course of ulcerative colitis, and hasten colon healing. 747 Psyllium is itself a source of butyrate in the colon and also promotes the movement of amylase-sensitive carbohydrates into the distal colon, which are then fermented to SCFAs. Psyllium is thought to be clinically useful for promoting mucosal healing in colitis.",16.8688823619093,9.708567456753247
"will greatly improve human, animal and food safety",0.1482123127388022,2.7508609294891357,4.567249298095703,2bc41fdb-0357-42a6-b82b-b1a3a7ff146c,custom_license/One Health and Food Safety,"Surveillance should be done at relevant levels of the chain, at the farm level by the veterinary system, and at the food production stage by food-scientist. Findings should be shared and compared with the findings in human medicine, to be able to make decisions about potential risks for human health. Thus the animal, food and human sectors need working together, to collect and to share data in such a way that they may be compared. As there are still many different techniques used in all three fields, it is still difficult to compare data. An important development in infectious disease diagnostics will be the introduction of WGS techniques, and the construction of a global, open-access genomic database for microorganisms. In a One Health manner, the latter would take diagnostics to a new level, and will greatly improve human, animal and food safety.",13.098529204107141,9.341256869367644
"models of climate, hydrology and ecosystem simulation",0.2907935933317299,2.202873945236206,3.5376453399658203,782112de-a400-499e-b7b9-d278361d3ad8,custom_license/Sugita),"In the general category of surface-atmosphere interaction studies, some new techniques such as the use of the scintillometer, the CBL variance methods, the energy balance model with remote sensing data as inputs, to evaluate regional fluxes have been made within RAISE. Each of them appears to be promising. However, they are still in the research phase, and the utilization of these novel techniques or their products in other research areas or in an operational system is still not ready for full implementation, and their actual usage needs to be explored further. One obvious op-tion would be the usage of these products as inputs or validation data for models of climate, hydrology and ecosystem simulation. The surface-atmosphere interaction processes are a common interface which all models include as a relevant feature. Perhaps through off-line comparison or eventually on-line coupling, new findings and newer approaches of the atmosphere-interaction studies can be fully utilized.",15.526289913466186,9.165539005094482
mRT-PCR of HRSV and HMPV from clinical samples,0.1681518031731873,2.6184356212615967,2.512777805328369,7c7b808f-9963-4010-9b38-89e9bf4bde60,custom_license/Development of a multiplex RT-PCR for simultaneous diagnosis of human metapneumovirus (HMPV) and human respiratory syncytial virus (HRSV) from clinical specimens,"The rRT-PCR assays for single tube detection of HRSVA and HRSVB was done using the RealStar RSV RT-PCR Kit 1.0 (Altona diagnostics GmbH, Germany). RealStar hMPV RT-PCR Kit 1.0 (Altona diagnostics GmbH, Germany) was used to detect HMPV from the clinical samples. Twenty microliters of extracted eluent was used as a template for PCR amplification for both the rRT-PCR Fig. 1 Agarose gel analysis of PCR products from mRT-PCR of HRSV and HMPV from clinical samples. Two H1N1 positive clinical samples were used as controls for testing primer specificity assays following manufactures instruction using the Rotor gene 5plexHRM real-time platform (QIAGEN, Germany) ( Fig. 2a, b) .",16.272877668558312,9.030795911278886
"local project design, implementation, and management",0.4539872083125077,2.3991425037384033,3.357938766479492,9a40c54a-86dc-48be-88fd-fecdab04da55,custom_license/21 The US CDC Global AIDS Program in China,"In May 2004, NCAIDS of China CDC initiated the ""Provincial Project Management Training Project (PPMTP)"" with the support of GAP. They aimed to strengthen capacity of provincial (and autonomous region and municipality) HIV/ AIDS prevention and control project management staff to improve local project design, implementation, and management. Project management staff responsible for HIV/AIDS prevention and control projects at the provincial level were trained to increase their capacity for project design, planning, implementation, monitoring and evaluation, management, and on-the-spot problem-solving. They were also trained to build up knowledge and skills on HIV/AIDS prevention, intervention, treatment, and care. The PPMTP also established a communication platform between provincial CDCs and NCAIDS and a network among provincial CDCs.",12.818435922777308,8.22855539861369
Our findings will facilitate understanding of the pathogenesis of COVID-19 and improve clinical strategies against the disease.,0.18329638696504866,1.6802074909210205,3.6624083518981934,f4b27e7e-b4ba-4535-8198-904fe40ad5b5,custom_license/Pathological findings of COVID-19 associated with acute respiratory distress syndrome,"Since late December, 2019, an outbreak of a novel coronavirus disease (COVID-19; previously known as 2019-nCoV) 1,2 was reported in Wuhan, China, 2 which has subsequently affected 26 countries worldwide. In general, COVID-19 is an acute resolved disease but it can also be deadly, with a 2% case fatality rate. Severe disease onset might result in death due to massive alveolar damage and progressive respiratory failure. 2, 3 As of Feb 15, about 66 580 cases have been confirmed and over 1524 deaths. However, no pathology has been reported due to barely accessible autopsy or biopsy. 2, 3 Here, we investigated the pathological characteristics of a patient who died from severe infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by postmortem biopsies. This study is in accordance with regulations issued by the National Health Commission of China and the Helsinki Declaration. Our findings will facilitate understanding of the pathogenesis of COVID-19 and improve clinical strategies against the disease.",13.444275527470506,8.178196732447166
"Credibility, transparency and explicitness in the decisionmaking process will improve understanding and uptake of policy decisions",0.33870647060444253,2.162048816680908,3.0357019901275635,4a51d8ac-ac4a-4cba-9e21-f971354161dd,custom_license/Pandemic H1N1 in Canada and the use of evidence in developing public health policies e A policy analysis,"Credibility, transparency and explicitness in the decisionmaking process will improve understanding and uptake of policy decisions. In particular, our analyses revealed that when and why evidence/advice is or is not considered needs to be clearly articulated. This includes outlining steps, logic, key assumptions, limitations and trade-offs considered, evidentiary or otherwise. The role of ideological perspectives and prior beliefs should also be made explicit given how influential they are in defining decisions from the outset. We acknowledge that detailed recording of evidencebased or consensus-derived decisions to ensure transparency may be idealistic in the face of time and other pressures during a crisis. One possible recommendation could be a more rigorous use of Incident Management System (IMS) processes which would serve not only to improve processes but also to ensure better documentation. At the minimum, critical post-outbreak analyses of detailed real-time records of the meetings and transcripts should occur to improve future public health actions. Finally, with many different groups addressing the same questions, inefficiencies still exist. The public health system needs to leverage existing relationships rather than create new structures during a pandemic. In addition, better clarity on who is responsible for answering what questions is needed to avoid duplication and mixed messages. Addressing inefficiencies will require trust and collaboration, supporting the themes identified around credibility.",12.768909699201355,7.847656419145981
Lack of commitment from all parties often translates into poor implementation of PROMs in clinical trials leading to suboptimal data and missed opportunities,0.16019376429811968,0.6102949976921082,1.482277274131775,20144294-3eeb-4ed5-96c6-ca5987fc6920,custom_license/Integration of patient-reported outcomes in multiregional confirmatory clinical trials â,"Whereas agreement would be clearly delineated when PRO is the primary endpoint, it may not be so when PRO is a nonprimary endpoint unless internal processes are in place to seek timely agreement. Lack of commitment from all parties often translates into poor implementation of PROMs in clinical trials leading to suboptimal data and missed opportunities.",17.70114674595117,7.5555733377684335
safety and effectiveness of medical products,0.139172092408615,0.7004110217094421,2.6636288166046143,7f97da04-83db-4401-9dfe-f35366999212,custom_license/Integration of patient-reported outcomes in multiregional confirmatory clinical trials â,"To improve the efficiency of efforts to develop and validate PROMs that meet regulatory requirements, there are collaborative initiatives in both the US and Europe. These collaborations between industry, regulatory bodies, and academia are distinct departures from the traditional approach of a single sponsor developing a measure for a single, specific drug development program within the confines of the competitive environment and move PROM development into a precompetitive environment where stakeholders recognize the value of pooling resources and expertise to enable successful development of PROMs. These collaborations also include close involvement by regulators and focus on improving testing methods and processes to evaluate the safety and effectiveness of medical products.",14.006831157975578,7.089016800195589
hematologic parameters when given shortly (15 minutes) after LPS infusion,0.1874575790122317,0.809890627861023,1.9777884483337402,51d95924-24b6-496e-ba8e-33873fe3753e,custom_license/Disorders of the Gastrointestinal System,"Monoclonal and polyclonal antibodies against equine TNF have been evaluated in horses. [420] [421] [422] Administration of a monoclonal antibody preparation before LPS infusion resulted in significantly reduced plasma TNF activity, improved clinical abnormality scores, lower heart rate, and higher leukocyte count compared with controls. 421 Plasma concentrations of lactate and 6-keto-PGF1Î± were reduced significantly, whereas TXA 2 production was not affected. 420 In another study 422 administration of a rabbit polyclonal antibody against recombinant human TNF did not improve clinical and hematologic parameters when given shortly (15 minutes) after LPS infusion, although inhibition of TNF activity was present in vitro. 422, 423 Findings in horses are in agreement with studies in other species and suggest that beneficial effects of TNF inhibition may be limited to administration before LPS exposure. Widespread clinical use therefore is unlikely to become feasible. Clinical trials in septic human patients have not shown significant benefits of TNF antibody treatment. 424, 425 ",14.887054491048325,7.02246047139351
lower plasma concentrations of HCQ,0.19554948068858966,1.7947193384170532,1.0238059759140015,1a0ea69b-1612-4fce-a2e7-a54193f30c58,custom_license/To appear in: One Health,"https://www.pdr.net/drug-summary/Plaquenil -hydroxychloroquine-sulfate-1911 (accessed 29 March 2020)) . HCQ is administered orally in doses ranging from 100 to 600 mg daily. HCQ has also been tested for other indications such as cancers (28) , multiple sclerosis, and diabetes mellitus (29) . In the current context of this extreme worldwide emergency, it is reasonable to propose that even if we could only reduce 10 to 30% in virus replication there would likely be a significantly reduce the transmission and severity of COVID19, and improve the clinical outcome. By using EC50, we are describing the proposed thresholds of efficacy at values that exceed those values, specifically, we are describing that these 4-aminoquinoline drugs could decrease virus replication or viral survival J o u r n a l P r e -p r o o f by 50%. Based on that proposal, lower plasma concentrations of HCQ, which we can easily obtain from a standard dosage regimen, is likely to be of significant clinically and public health impact.",14.380710915308278,6.865290274673082
their performance and impact on patient management,0.24744242742081649,1.446486473083496,2.203205108642578,7108965e-6612-42e8-b455-e3ca04b4fbbb,custom_license/Journal Pre-proof Rapid diagnostic tests for infectious diseases in the emergency department Rapid diagnostic tests for infectious diseases in the emergency,"Background: Rapid diagnostic tests (RDTs) for infectious diseases, with a turn-around time 37 <2 hours, are promising tools that could improve patient care, antimicrobial stewardship and 38 infection prevention in the emergency department (ED) setting. Numerous RDTs have been 39 developed but not necessarily for the ED environment. Their successful implementation in 40 the ED relies on their performance and impact on patient management. 41",12.60407906145096,6.783727199629784
where the need is greatest if these are to truly deliver,0.16722694289571954,1.4519410133361816,1.7025446891784668,17f0a6b6-2a90-415e-b27c-615f3e5ba2da,custom_license/A new twenty-first century science for effective epidemic response,"Key governance components include drafting policies in advance and being willing to implement those policies for data collection and sharing during epidemics. They must be flexible enough to enable affected communities and nations to retain ownership of the response, while drawing on international expertise to find the best possible response. Governance should also include processes for vaccine and therapeutic approvals during outbreaks. However, it is clear that the centre of gravity for leadership, governance and implementation must be where the need is greatest if these are to truly deliver.",12.969665210073153,6.589798530160125
Designing strategies to prevent the occurrence of NEC and to improve outcomes,0.16176486468918225,0.9987916350364685,0.8567132353782654,f698159d-e207-4b96-840b-2fd034eeeb99,"custom_license/A Clinical Perspective of Necrotizing Enterocolitis: Past, Present, and Future","Conversely, NEC involves both infectious and inflammatory mechanisms. 138 Designing strategies to prevent the occurrence of NEC and to improve outcomes of infants who develop NEC should consider these diagnoses as fundamentally different disease processes.",12.90796873673955,5.723867223628419
increase the speed of the FDA review and decrease the likelihood of a termination for commercial reasons,0.13996973829804205,2.7043752670288086,4.039012908935547,2820a5a6-ddac-407d-8f7d-a3d7e0b861ef,custom_license/Anti-infective monoclonal antibodies: perils and promise of development,"Approval success calculations were based on products with a known fate (US approval or discontinuation). Percent completion was defined as the percent of products with a known fate in a given cohort. Phase-transition probabilities were calculated as follows: the number of products that completed a given phase and entered the next was divided by the difference between the number of products that entered the phase and those that were still in the phase at the time of the calculation. Transitions occurring between phases of clinical studies conducted worldwide were included. (hepatitis C, HIV). Available only since 1997, fast-track designation is intended to facilitate the development of medicinal products that might be improvements over the existing therapies available for patients with serious or life-threatening diseases. Companies sponsoring fast-track products are eligible for frequent and timely interactions with FDA. Fast-track product applications are eligible for 'rolling review', in which sections can be filed over time. Although these benefits will obviously not affect the overall safety or efficacy of the products, they might improve the quality of the clinical development programme and marketing application, increase the speed of the FDA review and decrease the likelihood of a termination for commercial reasons.",22.494692278327328,12.256344611791395
hygiene practices could complement government efforts by advertising the benefits of their products,0.1721152754096161,2.6831881999969482,3.051619052886963,0ce93dc3-50b3-4774-ac8f-89e70f607b51,custom_license/Health shocks and their long-lasting impact on health behaviors: Evidence from the 2009 H1N1 pandemic in Mexico,"Furthermore, our results from Google searches indicate that agents seek information broadly by using search engines. Thus, the information to help address their demand does not need to be provided exclusively by the government. During these emergencies, profit-seeking firms could provide a public health service too. This is consistent with the points made by Mathios (1990, 1995) indicating that when producers are allowed to reveal the advantages of their products, firms could provide key information to consumer who then react to this news. For example, producers and sellers of hand sanitizers or other products that improve hygiene practices could complement government efforts by advertising the benefits of their products, especially when government's health budgets are small as in the case of many developing countries. An open research question is whether market friendly policies, such as low entry costs, could complement government efforts during health emergencies by allowing more firms to enter the market and supply the demand for health products that consumers are seeking, as shown by our findings.",20.027860265279408,10.737375807222335
The recent introduction of anti-influenza A and B therapies has led to a proliferation of commercial products capable of rapidly detecting both viruses in clinical specimens,0.241760098943074,3.0929949283599854,4.355634689331055,04a90a7c-7922-4a9a-aa0a-747c6ea359ec,custom_license/LABORATORY DIAGNOSIS OF RESPIRATORY TRACT INFECTION COMMUNITY-ACQUIRED LOWER,"The recent introduction of anti-influenza A and B therapies has led to a proliferation of commercial products capable of rapidly detecting both viruses in clinical specimens.8, Unfortunately, their usefulness is hindered by a lack of sensitivity and clinical benefit studies. NP aspirates improve the sensitivity compared with swabs of the nasopharynx or throat. Influenza therapies are time-dependent and useful only if administered within the first 48 hours of illness. The majority of patients with influenza do not present to their physicians within 48 hours, so any therapeutic intervention based on these rapid tests would be too late for the therapies.",13.197110854779801,9.460598050672107
to improve the specificity of the case definition,0.12551134974752376,1.118725061416626,2.561641216278076,58de555b-72e4-42f4-9765-bf62e4e1f5f9,custom_license/Review Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group,"In research studies, investigators should also consider appropriate clinical elements and ancillary diagnostics to improve the specificity of the case definition.",20.081769055301752,9.42085724985717
pharmacological regulation of glial inward rectifier potassium channel,0.18488623450113056,2.391488790512085,2.909292459487915,d7e73227-d2c5-4c24-9aee-0e2f97707aca,custom_license/0th Course of the European School of Neuroimmunology 623 Regeneration and the immune system,"There is a growing evidence that the modulation of microglial potassium channels is as a good approach to regulate its activation. In the present study we demonstrate that pharmacological regulation of glial inward rectifier potassium channel is effective to improve clinical and histological parameters in Experimental Autoimmune Encephalomyelitis (EAE) induced-mice. Daily oral administration of NT-KC-003 reduces the clinical score of EAE mice, decreases microglia activation, white matter demyelinization and the area of cell infiltration and inhibits inflammatory response when compared to control animals that received vehicle. Tissue integrity and neuronal viability on the spinal cord is also better preserved in treated mice.",16.249890047911673,9.132969329269086
mice suffering from lupus-like disease,0.238326061702802,1.5856239795684814,3.6956706047058105,a3ba827d-9a64-49f0-9265-42aa81eb81b1,custom_license/0th Course of the European School of Neuroimmunology 623 Regeneration and the immune system,"Pregabaline's adverse effects are importantly determined because these are used for a long time for chronic pain patients. In this study pregabaline's adverse effects were detected but there were those that were not very important so that pregabaline administration in some patients had to be ceased. Recently the proteasome inhibitor Bortezomib, has been reported to reduce autoantibody titers and to improve clinical condition in mice suffering from lupus-like disease (Neubert et al., 2008) . Bortezomib depletes both short and long-lived plasma cells, which normally survive the standard immunosuppressant treatments. These findings encouraged us to test the potential effects of Bortezomib in the experimental autoimmune myasthenia gravis (EAMG) model.",16.14856397239211,9.08483887011553
"Epitope mapping and evaluation of the potential for immunogenicity on an ""immunogenicity scale",0.2859813868456832,2.700601816177368,2.857269287109375,0c3fca5d-b320-47a8-bf2f-53d47bf35ed8,custom_license/T cell epitope: Friend or Foe? Immunogenicity of biologics in context â,"The use of cytokines, growth factors, and monoclonal antibodies in clinical settings is often associated with the development of antibodies directed against therapeutic proteins. Therefore, diminishing the immunogenicity of therapeutic proteins without hindering their function may improve clinical outcomes [72] . Epitope mapping and evaluation of the potential for immunogenicity on an ""immunogenicity scale"" is one approach; the same tools can be used to identify clusters of epitopes for removal. As described previously, reduction in T cell epitope content has been associated with reduced immunogenicity. This can be accomplished by substitution of key amino acids in the T cell epitope sequences which abrogate binding to HLA and thereby attenuate epitope potential to trigger a T cell response. Altered T cell epitopes no longer bind to HLA. Therefore, uncovering the immunogenic regions and specific amino acid residues involved in binding to HLA can allow protein therapeutics developers to abrogate T-dependent antibody responses, reducing the immunogenicity of their candidate drug. Such epitope-modifications are easily evaluated in vitro and in vivo prior to release of the protein therapeutic for clinical development. This method of reducing immunogenicity, also known as de-immunization, is described in detail in [72] .",13.237190017323783,8.245632723199707
success rates,0.31336235832821835,1.9030930995941162,3.347902536392212,ff2cb783-d93d-478a-9fe5-1d25cd809385,custom_license/Anti-infective monoclonal antibodies: perils and promise of development,"Success rates cannot be calculated for antiinfective mAbs comprising the current 2000s cohort because all of the agents are still under clinical study. Predictions based on success rates for the 1990s cohort suggest that two or three of the products might be approved. However, due to the small size of the 1990s cohort, this result must be considered an estimate. In addition, a number of factors might improve success rates for the 2000s cohort, which includes more human mAbs and a number of mAbs with fast-track designation.",12.717561661003936,7.864293744742491
"homebrew"" (see below) assays without substantial support",0.19261798859846133,1.774707317352295,2.852128744125366,c5337740-efdb-4de4-9c3d-55a5759269f4,custom_license/Laboratory diagnosis of viral infection,"These techniques do not lend themselves to the development of ""homebrew"" (see below) assays without substantial support. Additionally, other molecular methodologies have been described, and some of these are used in other areas of clinical diagnostics. However, none has been developed for viral diagnosis.",12.585039534240343,7.412207276944599
post-cardiac arrest processes of care. Further work is underway to identify factors that infl uenced implementation,0.22790357367865777,-0.24536600708961487,0.9494583010673523,9fd48010-a459-4052-9f9a-289f5e2a5f9d,"custom_license/Minimising prescribing errors in the ICU DJ Melia, S Saha Queen' s Hospital, Romford, UK Critical Care",Conclusion PACT was associated with reduced WLST <72 on the basis of neuroprognostication but did not improve other important post-cardiac arrest processes of care. Further work is underway to identify factors that infl uenced implementation. This will guide future consideration of the PACT model in other settings.,19.25706683664515,7.197633383911333
post-process handling of the products.,0.12927416243232956,1.244251012802124,2.1916730403900146,69b7dcc9-56e8-4028-87cc-dfec7ea8794c,custom_license/ENVIRONMENTAL AND SAFETY ISSUES WITH NANOPARTICLES,"Most of these processes are performed in a closed reaction chamber installed in a cleanroom or associated controlled environment. Human exposure to these engineered particles does not take place during synthesis unless there is an unexpected system failure (e.g. rupture of a seal). Human exposure is more likely to occur after the manufacturing when opening the reaction chamber, drying the products, or in the post-process handling of the products.",13.201969776770348,6.854040056444512
Designing strategies to prevent the occurrence of NEC and to improve outcomes of infants who develop NEC,0.13776502564189305,1.075857162475586,2.023301839828491,c7dcd583-0b12-49b2-9e41-36dcdf7d1d3e,"custom_license/A Clinical Perspective of Necrotizing Enterocolitis Past, Present, and Future","Clinical studies suggest that the isolated perforation occurs when the intestinal mucosa has been weakened by processes, such as local ischemia-reperfusion or thromboembolism. Conversely, NEC involves both infectious and inflammatory mechanisms. 137 Designing strategies to prevent the occurrence of NEC and to improve outcomes of infants who develop NEC should consider these diagnoses as fundamentally different disease processes. The focus of NEC research is shifting from concentrating on the distinct nature of this disease to understanding the unique characteristics of immune-naÃ¯ve premature patients. Hence, investigative and interventional techniques aimed at ensuring a more appropriate and mature intestinal immune response should be tested as preventative strategies.",13.542554470433128,6.754347416149245
the objective of personalised molecular medicine can be achieved.,0.13606999979563017,1.108418345451355,2.478018045425415,155ae0ef-b318-48a0-abda-1da9b747d86f,custom_license/Genomic and proteomic approaches for studying human cancer: Prospects for true patient-tailored therapy,"Global gene expression analysis is beginning to move from the laboratories of basic investigators to large-scale clinical trials. The potential of this technology to improve diagnosis and tailored treatment of human disease may soon be realised, now that several comprehensive studies have demonstrated the utility of gene expression profiles for the classification of tumours into distinct, clinically relevant subtypes and the prediction of clinical outcomes. In addition, new data from the emerging proteomics platforms add another layer of molecular information to the study of human disease, as scientists attempt to catalogue a complete inventory of the proteins encoded by the genome and to establish a 'biosignature' profile of human health and disease. As a result, it is anticipated that, together, these technologies will facilitate the comprehensive study of genes, gene products and signalling pathways so that the objective of personalised molecular medicine can be achieved. This paper will review the studies that best demonstrate how genomics and proteomics technologies can be used to improve cancer diagnosis and treatment it will specifically highlight the important work being incorporated into clinical trials.",12.467007042197617,6.694636118839067
"At enrollment, demographic information and clinical symptoms were collected by interview",0.1427775026216743,0.9160146117210388,1.3682318925857544,7584fd5f-a901-4b15-9324-f34367a32000,"custom_license/Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults Rhinovirus among adults and children","At enrollment, demographic information and clinical symptoms were collected by interview. A nasopharyngeal specimen was collected using a nylon flocked swab (Copan Diagnostics, Corona, CA). Participants returned at days 3 Â± 1, 7 Â± 2 and 28 Â± 7 for collection of clinical symptoms and a nasopharyngeal swab at each visit.",12.192552311395756,5.7521535367879295
Implementation of IVD tests requires limited internal validation studies,0.13901982567840418,0.9271506071090698,1.2788176536560059,873a4b13-193b-4265-882d-36ab29b9fc76,custom_license/Laboratory diagnosis of viral infection,"Regulations and test approval processes in different parts of the world affect test availability. In the United States, the FDA approves test kits. For in vitro diagnostic (IVD) use, kits must undergo rigorous testing by the companies that have developed them. Kit quality control is performed by the manufacturer. Implementation of IVD tests requires limited internal validation studies by the diagnostic laboratory.",12.131926303720661,5.680053575799531
"to increase awareness of the current and potential value of infectious diseases diagnostics for patient care and public health, and to promote further development of needed diagnostics",0.14735726564294344,3.737499952316284,4.532278060913086,a0f0b962-962e-4e0b-aa12-3b1d0398053d,"custom_license/Better Tests, Better Care: Improved Diagnostics for Infectious Diseases","Diagnostic tests play a major role in the clinical care of patients with infectious diseases, including detection of specific pathogens, discovery of new pathogens, determining appropriate therapy, monitoring response to therapy, assessing prognosis, and disease surveillance. Despite the increased use of rapid tests and the availability of molecular and proteomics-based tests, diagnostics are not being integrated into clinical care optimally. Integration is influenced by the clinical syndrome, the availability of and access to appropriate diagnostics, the place of service, and the experience and knowledge of the healthcare provider. The goal of this paper is to increase awareness of the current and potential value of infectious diseases diagnostics for patient care and public health, and to promote further development of needed diagnostics.",13.732986076865693,10.181900835502082
The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens,0.1834385631296974,0.9708092212677002,1.5072247982025146,f84a8149-b47e-4b76-a3c7-7d48bdbbfb5b,custom_license/Antimicrobial prescribing in Australian hospitals; antimicrobial choice and indications for inappropriate prescribing,Background: The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia.,23.7969520091211,9.939655315848025
Ursodeoxycholic acid (UDCA) may significantly improve clinical status,0.3265885977524534,2.659874439239502,3.1594204902648926,e05b122c-7a3e-4fa3-ba5a-fbf817b4c37f,custom_license/Developmental and Inherited Liver Disease,"Medical therapy is mainly supportive, with attention to malabsorption associated with severe cholestasis. Ursodeoxycholic acid (UDCA) may significantly improve clinical status and liver test results in some children, but no beneficial effect was shown in children with the most severe liver disease. The drug 4-phenylbutyrate has been proposed often small size of the extrahepatic biliary tree in patients with Î±1-AT deficiency, likely because of disuse atrophy secondary to cholestasis. Inexperienced surgeons may misinterpret operative cholangiograms from these patients as showing biliary atresia and perform an unnecessary Kasai portoenterostomy.",17.104870474436673,9.769246370230693
training hospitals improve clinical skills,0.2920832956946028,3.7619030475616455,2.6984028816223145,23afce18-bd9a-4032-934d-733e053b1137,custom_license/Assessment of nursing students perceptions of their training hospital's infection prevention climate: A multi-university study in Saudi Arabia,"The infection prevention climate dimensions ""Prioritization of Quality"" and ""Improvement Orientation"" received the highest dimensions. This statement implied a clear understanding of infection prevention climate in the organization. This result is consistent with the previous study of Colet et al. (2017) , wherein nursing students have a great understanding and adherence regarding training hospitals' policies in providing quality patient safety and care. Mosadeghrad (2014) suggested that training hospitals improve clinical skills and positively impact the overall quality of care among health care professionals. Nursing students, as a training hospital beneficiary, have increased learning opportunities, and are also capable of identifying the influencing factors of their training hospitals' infection prevention climate.",14.5250717668203,9.282973972356679
"to develop rapid, reliable, accurate, simple tests that will reduce time to a diagnosis and truly improve the quality of care and patient outcomes",0.15123172009509533,2.513404369354248,2.3213367462158203,e48cb368-a220-4b11-852b-96946a989c40,"custom_license/Better Tests, Better Care: Improved Diagnostics for Infectious Diseases","In this policy paper, IDSA reviews the current state of diagnostics and the unmet clinical needs, assesses new technologies that could address these needs, and investigates barriers to the development and adoption of new diagnostics. A broad range of recommendations are provided to address the identified challenges (Table 5 ). There needs to be a comprehensive commitment to developing technologies that will allow testing to move from highly complex laboratories to all laboratories or to the bedside, creating programs to educate clinicians on the proper use and interpretation of tests, investing in cost-effectiveness and clinical outcomes studies, and further advancing information systems to allow not only for the rapid communication of test results to healthcare providers and public health agencies, but also for a rapid action in response to the test result. It is important to consider the public health implications of these innovations as they are developed to ensure that there are no unintended negative effects on our capacity to identify, respond to, and track infectious public health threats. Progress will require the engagement and coordination of a number of stakeholders including funding agencies, regulatory agencies, public health agencies, diagnostic companies, healthcare systems, clinical microbiology laboratory professionals, clinicians, and professional societies. Congress must play a role in increasing funding for diagnostics research and enacting legislation that addresses identified challenges. Successful implementation of these recommendations will require a commitment from all stakeholders, and will open the door for remarkable progress in the field of diagnostics and resulting impact on many infectious diseases. As technologies advance, there is a critical window of time to harness and direct development of new diagnostics to benefit patients. The goal is not just to create more tests, but to develop rapid, reliable, accurate, simple tests that will reduce time to a diagnosis and truly improve the quality of care and patient outcomes while reducing healthcare costs.",16.29954053607538,8.847420912746927
to minimize the risk for the patients and improve the effectiveness of the manufacturing processes,0.25189295996459193,1.9679080247879028,3.496422290802002,197165a7-d905-4cbe-92ed-3e9a8acd87cc,custom_license/New regulatory strategies to manage medicines shortages in Europe,"A medicine shortage may be caused by a blockage of the production for different causes (e.g., the unavailability of raw materials, qualityfailures, GMP no-compliance, quality defects). In this context, considerable efforts have been made from Regulatory Authorities and professional associations to improve the quality in the pharmaceutical processes to minimize the risk for the patients and improve the effectiveness of the manufacturing processes (ISPE, 2014; PDA, 2014; EMA, 2019c; Various Associations, 2019b) . For example, a nine-fold increase in the EMA quality guidelines was observed between 2005 and 2015.",13.583077792683103,8.305891932572525
"Rapid diagnostics that substantially improve upon the ""time to result"" metric of currently approved tests",0.2418018997677541,1.9727234840393066,2.233506202697754,0a61290e-b9ba-410a-be6e-5dff3c798c5e,"custom_license/Better Tests, Better Care: Improved Diagnostics for Infectious Diseases","(g) Rapid diagnostics that substantially improve upon the ""time to result"" metric of currently approved tests;",15.825803804281659,8.27308062787767
Improved care products and equipment,0.40824870621369713,1.760128140449524,1.7784277200698853,98d358e0-e7ea-4dd8-a17d-3d43e460ee70,custom_license/Antimicrobial prescribing in Australian hospitals; antimicrobial choice and indications for inappropriate prescribing,"Improve the integrity of oral care for nurses in the prevention of ventilator-associated pneumonia Shwu-Hwa Leu 1 *, Mei-Ju Su 1 , Li-Yao You 1 , Shu-Chun Chang 1 , Yueh-Chen Fu 1 , Hsia-Ling Wu 1 , Li-Chu Li 1 , Chin-Yu Chen 2 , Tzu-Ping Shih 2 , Wen-Chih Wu 3 , Cho-ching Sun 4 Background: The use of ventilator-associated pneumonia (VAP) for the intensive care unit quality indicators to monitor important items,not only will extend the hospital stay will increase the cost of medical care (Ashraf & Ostrosky-Zeichner, 2012), so there is a systematic introduction to prevent the combination of care, remodel the correct concept of staff care, the implementation of unified and more effective care measures in the combined care, but also to respirator patients with oral care is more important, Expect effective prevention of VAP, improve patient cleaning and comfort, in order to enhance the professional care and service quality. In April 2016, The team used technical audit and observation methods. The average correct rate of nursing staff was 73.3%, and the integrity of oral care was only 68.7%. First, the newly transferred personnel to protect the lack of awareness (19.7%); Second, the lack of appropriate care products can be used (21.8%);Third, there is no relevant care operation check mechanism and standard operating practices (16.2%), so the purpose of this project is to improve the integrity of oral care to 95%. Methods: In order to improve the integrity of oral care for nursing staff, improvement measures are made every month from June to September, 2016. 1. Participate in TRM competition and external expert clinical guidance. 2. Improved care products and equipment, use multi-functional aspiration toothbrush,oral denture and 0.2% Chlorhexidine oral cleaning gel to mouthwash. 3. System to prevent the prevention of VAP care standards: revised special oral care technology, and develop the use of breathing apparatus operating instructions. 4. Implementation of VAP care check and reward: internal check, outside the hospital inspection counseling, Bundle protection angel recognition and implementation of the incentive system. Results: June 2016-May 2017prevention of VAP care integrity check results care integrity 99.4%, Nurses' knowledge of oral care increased from 81.2% to 100%; And maintain VAP zero case. Conclusion: Since the introduction of modular care, the unit has been effective in preventing infection and significantly improving peer awareness and care skills. Effective teamwork can increase the efficiency of the work, in the process of care, while buy and use the new improved care products, not only more convenient and effective; the current hospital has been promoted to the implementation of the respiratory care ward, To share the unit to promote the implementation of experience, in order to achieve the purpose of maintaining patient safety and improve the quality of medical services.",16.96909298989705,8.239243855801583
Evaluation Phase,0.36565504505521396,2.3851282596588135,2.4104325771331787,23fa66ca-9ab4-4496-809d-ff42c13d8b9f,custom_license/Original Article,"Evaluation Phase. This was a huge project with an objective to influence and evaluate a system's delivery of palliative care between 2002 and 2004. The evaluation timelines were predicated on the implementation timelines but also limited by the duration of the grant funding. Numerous systems' related factors that were beyond the control of the PCIP had an impact on the implementation of the project. This in turn meant that the planned evaluation measures occurred before the full uptake of the implementation and before some processes, for example, documentation, were in place at certain sites.",14.387329884511544,8.152680003493835
"MAHs to qualify at least two suppliers of drug substance, the stockpiles' expansion and the implementation of the manufacturing technologies and risk assessment tools",0.2640753816899208,1.9524763822555542,2.637472629547119,1e8142a0-7c5b-4a17-aadc-84c26f2cbdbd,custom_license/New regulatory strategies to manage medicines shortages in Europe,"In this context, the proposed algorithm can be applied to enforce the gradual implementation of the pharmaceutical quality systems for MAHs most vulnerable to shortage risks. As shown in Fig. 3 , the obligations for MAHs are determined based on the shortage impact score. For products with a high shortage impact, the establishment of a shortage prevention plan seemed essential to ensure an appropriate and continued supply to fulfil patients' needs. For such products, manufacturer's resilience should be improved by more onerous provisions, such as the obligation for MAHs to qualify at least two suppliers of drug substance, the stockpiles' expansion and the implementation of the manufacturing technologies and risk assessment tools. In this context, the establishment of ad hoc agreements between European countries and MAH to conduct exceptional manufacturing activities in specific National sites can also be pursued. As an example, in Italy, National military manufacturing site has been involved in such activities to mitigate the impact of severe shortage, especially in the case of old and low-cost medicinal products (Di Giorgio et al., 2019) . On the other side, if the shortage impact of medicinal products on the public health is low, it is not reasonable to charge the MAHs with additional costs and, therefore, affect the economic sustainability for the implementation of quality assurance systems that may have a limited positive impact on the continuity of care.",13.533954827099228,7.720351047156466
"enforcement, monitoring, eval uation",0.15356021637013142,1.5282090902328491,0.5790286064147949,27b151f9-a26d-4e2e-bd8a-1d601c8dddaf,custom_license/The Lancet Commissions The legal determinants of health: harnessing the power of law for global health and sustainable development Executive summary,"Enacting a good health law is only the first step towards building an effective legal environment. Laws that are defined as on the books must be supported by effective processes for their drafting (including public participation), implementation, enforcement, monitoring, eval uation, and ultimately their revision or repeal where necessary ( figure 6 ). Ongoing evaluation and continuous quality improvement lead to legislation and regulations that demonstrably improve the public's health and safety.",16.733446293087255,7.226410705401507
documentation,0.23844696167495744,0.7337332367897034,1.1637853384017944,7cdf8523-2360-4780-93f7-8cadbbd9fb56,custom_license/Original Article,"''Champions'' were recruited from each of the participating sites to help with education, implementation, and documentation. A customized education format was developed by the educator/clinical leads for their organization that used the standardized materials Once the CCPs and SMGs were developed, a one-month pilot study was conducted to test the format of the assessment tools, CCPs and the SMGs, the documentation processes, and the education processes in each participating organization.",16.205046696734783,6.905153417731647
help others set up similar services or networks,0.18285834421935077,0.6996142268180847,1.7125812768936157,42028eb1-5a8b-434c-9534-702b34360113,custom_license/Original Article,"It was posited that the development of the appropriate project infrastructure, processes, and operational plan would ensure timely decision making, unquestionable implementation, maximized shared ownership, and evolve into expanded and sustainable palliative care best practices at a regional level. A formative evaluation framework was chosen to: 1) enhance program development and improvement, and 2) help others set up similar services or networks. This article details this framework and describes the infrastructure, development and implementation processes, and evaluation of the KFL&A PCIP. A previous published article delineates the PCIP outcome evaluation. 6 ",14.438672381173784,6.62146241082343
Care Integration Project,0.3538442200354613,1.4224704504013062,1.1062253713607788,f8345bdb-90ba-4249-901f-7efa04276859,custom_license/Original Article,"Care Integration Project). Four organizations participated in the pilot study that tested the format of the assessment tools, CCPs and SMGs and the documentation and education processes. The obtained written feedback was used to revise the resource materials, documentation, and educational processes before full implementation.",14.193094459305492,6.611235344902277
A formative evaluation framework,0.16337320334204183,0.13153564929962158,0.09179142862558365,871d4cfb-2156-4a8c-86d9-5e18689d57c5,custom_license/Original Article,"As stated earlier, these findings were recently published. 6 A formative evaluation framework was used to evaluate the structure and processes for the development and implementation of the PCIP in the KFL&A region over the two-year period (2002e2004). This evaluation framework provided ongoing feedback about the various aspects of the implementation process to the participating organizations. The key findings are discussed here.",13.616923779703585,4.911085923547638
infection control measures and prompt diagnostics are the cornerstones to prevent further transmission of MDR and XDR pathogens in healthcare settings,0.1564534823010374,4.3300700187683105,4.665483474731445,0edad81a-0774-4ef5-ad4c-156e00caaeaf,custom_license/Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria,"Current clinical practice relating to critically ill patients has been extremely challenged by the emergence of multidrug resistance among the commonly encountered pathogens. Treatment options seem to be more optimistic for Gram-positive pathogens (including C. difficile), for which the pipeline is more promising; however, the recently launched anti-MRSA agents have not been extensively investigated in critically ill populations. In the field of Gram-negative MDR infections there is great concern about the therapeutic future, as only a handful of the upcoming agents will address the unmet medical needs. Associations of beta-lactams with beta-lactamase inhibitors seem promising against Gram-negative MDR pathogens, but their real clinical utility will be known only after results of large clinical trials are available. Currently, the most effective approach is the PK/PD optimization of the available antibiotics, particularly given the increasing awareness of the pharmacokinetic alterations that occur in the critically ill patient. Combination treatments seem to be important, at least in the empirical phase of treatment, to ensure adequate coverage of the patient and improve clinical outcome. However, randomized clinical trials are urgently needed to define the possible benefit from combinations in various settings. Most importantly, infection control measures and prompt diagnostics are the cornerstones to prevent further transmission of MDR and XDR pathogens in healthcare settings and to optimize early antimicrobial treatment. ",17.27297092878031,11.89264959584795
The ability to detect nucleic acids,0.24013124669854174,3.067789316177368,3.4224138259887695,d1870a5f-5ccb-455f-9814-652b30feabb3,custom_license/Future Veterinary Diagnostics,"The rapidly advancing field of diagnostics, tests used to detect a medical condition or causative pathogen responsible for an infection, will drastically change the practice of veterinary medicine in the near future. The ability to detect nucleic acids has had and still has a major impact on diagnostic processes in clinical medicine. 1 Classical pathogen detection and identification are based on culture methodology, biochemical tests, and microscopy. The culture method is still a core technology in many clinical laboratories because it can provide important information about the viability of the pathogen and its susceptibility to therapeutic agents. Likewise, the historic gold standard for diagnosing viral infection has been selective cultivation followed by electron microscopy. Recovery of the live virus remains a very slow, technically demanding, and expensive diagnostic tool.",12.392403698051863,8.55597333672614
euthanasia may be warranted if animals fail to improve,0.22087018720886165,3.50011944770813,3.06099271774292,96438b6c-271d-4a18-bcd9-7cb8051c85c7,"custom_license/Sphenisciformes, Gaviiformes, Podicipediformes, Procellariiformes, and Pelecaniformes","Eastern equine encephalitis (EEE) is an alphavirus. Clinical signs in African penguins include anorexia, antisocial behavior, mild lethargy, intermittent vomiting (Tuttle et al., 2005) . Severely affected animals become recumbent and secondary infections may develop. Clinical signs start to resolve 14 days after onset, but euthanasia may be warranted if animals fail to improve. Gross findings are minimal. Histologic examination reveals severe, chronic, multifocal, lymphoplasmacytic encephalitis with prominent perivascular cuffing. Lesions are notable in the cerebellum where mineralization of dendritic processes, focal infiltrates of mononuclear and glial cells, and loss of Purkinje cells are detected in folia; vacuolation, axonal degeneration, demyelination, and gitter cells are seen in cerebellar white matter. Mild necrotizing and histiocytic myocarditis occurs. Antibodies to EEE have been detected in pelicans, but clinical disease has not been identified.",11.804197334384178,8.396191974577643
greatly improving their quality of life,0.1287264798624268,1.9856016635894775,3.3017780780792236,b6037494-a202-4cb3-9e95-acf8b002e1aa,custom_license/Patient Preference and Adherence Dovepress The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial,"Breast cancer remains the most common form of cancer to affect women. 1 While cancer itself is a life-threatening disease, treatments for cancer can produce very unpleasant complications and side effects, including fatigue, anxiety, menopausal symptoms, nausea, lymphedema, and dermatitis. Such complications result in poor psychological adjustment, vitality status and quality of life. 2 Mounting evidence indicates that herbal therapy is effective in alleviating anxiety, lessening cancer treatment-related side-effects, and facilitating rehabilitation. [2] [3] [4] The mushrooms yunzhi (Coriolus versicolor) and danshen (Salviae miltiorrhiza) are two commonly-used herbs for cancer prevention. 5 The results of clinical trials have further shown that the addition of yunzhi to radiotherapy and chemotherapy treatment for cancer patients could greatly improve their clinical symptoms and stabilize their immune function, thus greatly improving their quality of life. [5] [6] [7] [8] However, methodological flaws in these studies, including a small sample size, have limited the generalizability of their findings. Evidence for the effects of danshen (Salviae miltiorrhizae) on cancer patients is less This article was published in the following Dove Press journal: Patient Preference and Adherence 3 July 2010 Number of times this article has been viewed submit your manuscript | www.dovepress.com Dovepress Dovepress substantial. In 1996, a preclinical study showed that danshen had an antioxidative effect which could promote the immune system indirectly so as to facilitate rehabilitation and improve the quality of life in patients with cancer. 9, 10 Using danshen as a supplement may further promote the immunomodulatory activities of yunzhi.",13.307215455032207,8.094322241345928
the implementation of pathogen inactivation technology for blood/plasma-derived products has further reduced the risk of transmission of both known and emerging pathogens,0.22560813637267524,2.032907724380493,3.218857526779175,94fbec21-3756-44fe-8955-e8079fa04815,custom_license/Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders â-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/),"Historically, the risk of transmission of infectious agents via blood/ plasma-derived products has been of great concern to the medical community. This risk has reduced dramatically since the implementation of stricter donation screening/donor selection procedures and improved purification procedures, but cannot be fully eradicated. Furthermore, the implementation of pathogen inactivation technology for blood/plasma-derived products has further reduced the risk of transmission of both known and emerging pathogens, although results can be variable according to the methods used [9, 10] . However, it is important to note that patient risk is highly dependent on the circumstances under which blood products are collected, handled and used. In general, clinicians assess the level of risk associated with the use of blood/ plasma-derived products by evaluating factors such as patient characteristics (e.g. age, immune status, geographical location, lifestyle) and the nature of the pathogen (e.g. physical characteristics, level of virulence, chronicity of infection, prevalence). The presence of a particular pathogen within blood/plasma-derived products may pose a significant threat to specific patient groups (e.g. the elderly or immunocompromised), while being of low risk to the general population (e.g. HEV).",12.52765884420026,7.798328008723875
the use of recombinant products may be limited by higher costs and perceived problems of inhibitor formation,0.1324569188257858,1.8411204814910889,2.9757134914398193,d12dbd00-585e-484f-ae4f-e0829563babb,custom_license/Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders â-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/),"The WFH strongly recommends the use of plasma-derived or recombinant products in preference to cryoprecipitate or fresh frozen plasma, as the infectious load of any infectious human pathogen is lower in plasma-derived products than in cryoprecipitate, and even lower in recombinant products [2] .In some European countries, recombinant products have almost completely replaced plasmaderived products [12] . The use of recombinant products, which have been manufactured and formulated with minimal addition of human/animal-derived materials, greatly reduces the risk of recipient exposure to plasma-derived infectious agents and after they have undergone virus removal/inactivation processes, recombinant products can be considered to be as safe as currently possible [83] . Despite these benefits, the use of recombinant products may be limited by higher costs and perceived problems of inhibitor formation [83] . For indications where no recombinant factor concentrates are available, the use of inactivated plasma-derived concentrates is safer than fresh frozen plasma and will reduce the risk of other adverse effects such as hypervolemia, transfusion-related lung injury (TRALI) and hypersensitivity [84] .",11.442774902594016,7.135913298312996
"focusing on diseases affecting the developing world, prioritizing TB, HIV, and malaria",0.20892627714369497,1.4679136276245117,2.539140224456787,7a2361f6-539d-423d-9cb9-18fe16060cf6,"custom_license/The art of partnerships for vaccines q,qq","D. Robinson (BMGF) commented that innovative simplified processes can translate into capital savings and product costs in the developing world. Further, the recently founded Gates Medical Research Institute (GMRI) will take a small biotech approach to innovation for drugs, diagnostics and vaccines, to be transferred to manufacturers, focusing on diseases affecting the developing world, prioritizing TB, HIV, and malaria.",12.580426828507424,7.007734393830442
"The current testing algorithm is an orthogonal approach consisting of testing raw materials directly, testing bulk products for adventitious agents",0.1055236557848764,1.4800267219543457,2.155900716781616,431d997b-7cbf-4475-bdf8-c065b53f1a59,custom_license/Evaluation of the Human Host Range of Bovine and Porcine Viruses that may Contaminate Bovine Serum and Porcine Trypsin Used in the Manufacture of Biological Products NIH Public Access,"The current testing algorithm is an orthogonal approach consisting of testing raw materials directly, testing bulk products for adventitious agents, monitoring of manufacturing processes for unexpected results (e.g. fermentor failures) and evaluation of the clearance of specific viruses by the manufacturing processes. This approach seems to have, for decades, prevented contamination that could have resulted in human disease. The recent finding of PCV genomic DNA in live rotavirus vaccines is of concern for product purity and quality.",11.853502391962806,6.512078672365357
facilitywide infection-control precautions,0.14967118725085504,1.933740496635437,1.7415720224380493,04696ce5-79bf-49ba-87d2-d2c19679f3b1,"custom_license/Lack of SARS Transmission among Healthcare Workers, United States EMERGENCE OF SARS EMERGENCE OF SARS Search past issues of EID at www.cdc.gov/eid","However, current levels of adherence to infectioncontrol practices in the United States may not be sufficient if many high-risk patients or procedures are encountered. Unprotected exposures among healthcare workers may still occur despite implementation of facilitywide infection-control precautions. Therefore, new initiatives for infection control should include measures to improve compliance with personal protective equipment overall, in addition to specifically focusing on patients and events that have the highest risk for transmission. ",11.494480485605877,6.412021307359822
products made of asbestos 28,0.16721761837922122,1.3898968696594238,2.337881565093994,be6fd15f-f929-4c7c-9a21-0291706fb76b,custom_license/New Academic Partnerships in Global Health: Innovations at Mount Sinai School of Medicine NIH Public Access Author Manuscript,"hazardous industrial processes no longer tolerated in North America or Western Europe are exported to developing countries, where populations are exposed to lead, 26 highly toxic pesticides, 27 and products made of asbestos 28 in circumstances where protective controls are weak or nonexistent. The consequences include cancer, birth defects, and sterility.",11.382319796349725,6.4068679113121245
Improve communication between laboratory and clinical staff,0.1593862390366931,1.550147533416748,1.6809474229812622,8ff10c19-d486-43fb-bb4c-b6bc31c7cc5d,custom_license/Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria,"Head of ICU should endorse the responsibility for implementing specific antibiotic stewardship Direction of the institution should be supportive and provide resources required to implement and follow the ICU antibiotic stewardship Regular feedback on the impact of the ICU antibiotic stewardship should be supported by both hospital and ICU directions Improve communication between laboratory and clinical staff Implement local resistance data for developing local antibiotic guidelines Multidisciplinary approach A multidisciplinary team including infectious diseases specialists, microbiologists, pharmacists, and ICU physicians and nurses should be in charge of developing a specific ICU antibiotic stewardship Weekly round for cases discussion Implementation based on specific education and training of ICU physicians (and all new introduced HCWs) about resistance and optimal prescribing including the following items: Aggressive good quality microbiological sampling to document the microorganism potentially responsible for the infection (blood cultures; distal airway sampling; urine culture; systematic sampling of wound, drain discharge, and any collection suspected of infection) Selection of empirical antimicrobials according to the clinical documentation of any suspected site of infection (clinical examination, adequate imaging), to the presence of risk factors for resistant microorganisms, and to the local epidemiology of the microorganism Achievement of adequate pharmacokinetic/pharmakodynamic parameters of the antimicrobial agents used Systematic de-escalation (see specific paragraph) Systematic reduction of the duration of antimicrobial treatment according to the clinical evolution and the kinetics of biomarkers such as procalcitonin Software-implementation of alerts in the prescription software to help clinicians in several issues of antibiotic prescription Monitoring and feedback",12.199407322867472,6.370004284662322
Filter media producers adopt plasma coating to improve the quality,0.21377655108265736,2.07746958732605,1.5815807580947876,00b04328-3f89-400e-be29-a79b165fa6ff,custom_license/Composite nonwovens in fi lters: applications,"It is interesting to note that the improvement of composite material performance via the use of low pressure plasma for coatings is gaining increasing interest. Filter media producers adopt plasma coating to improve the quality of their products. Innovative plasma processes allow depositing coatings with high levels of hydrophobicity and/or oleophobicity for use in gas fi ltration, or coatings with permanent hydrophilic effect for liquid fi lter media and battery separators. The use of low pressure plasma for surface modifi cation of fi lter media becomes more widespread because it is a dry and clean technology. The coatings applied by low pressure plasma polymerization also give good resistance to abrasion and washing. At the same time, it helps these companies to save costs because of a lower consumption of energy and chemicals (Legein, 2011) . A well-known application of plasma coating is found in the production of blood fi lter media, respiratory mask, fi lter for HVAC, etc. ",11.397555509860137,6.367527152974592
to create a coordinated scientifically based good practice to provide consensus reference to industry and governmental agencies in order to improve safety and quality standards,0.13119196945202483,1.0392156839370728,1.2541371583938599,5ab9fe7c-e18c-4019-9815-8ee0b95e11f6,custom_license/Quality control and testing evaluation of pharmaceutical aerosols,"In addition to these pharmacopoeias and regulatory bodies, European pharmaceutical aerosol group (EPAG), International Pharmaceutical Aerosol Consortium on Regulation and Science are scientifically investigating the standard and regulations of operating and testing the procedure of aerosols products, including clinical aspects as appropriate, figure consensus and contributes toward operative regulations and standards through sharing the consequences of its research via technical journals, scientific pharmaceutical conferences, and discussions and negotiations with regulatory bodies. The aim is to create a coordinated scientifically based good practice to provide consensus reference to industry and governmental agencies in order to improve safety and quality standards and to recommend harmonized standards and methodology .",11.172476085025538,5.401045977274045
identification of associated molecular mechanisms will allow for the development of more precise diagnostics,0.11137891251922281,-0.32917270064353943,0.9996686577796936,297d3d2c-fe61-4499-9e78-a8f54300f920,custom_license/Future Veterinary Diagnostics,"A canine-specific microarray using mRNA and expressed sequence tag sequences has been developed. 49 The elucidation of these biological networks (e.g., disease, development, nutrition) and identification of associated molecular mechanisms will allow for the development of more precise diagnostics for these processes. 49",13.50498856137651,5.162568368620279
reduced laboratory and clinical TAT,0.21531220051968292,-0.06071687117218971,1.4782975912094116,303aa3b7-4736-4c7e-b492-dfc02f67d6f0,custom_license/Health service impact of testing for respiratory pathogens using cartridge-based multiplex array versus molecular batch testing,"The pre-implementation period corresponded to the earlier part of the Australian winter season (July-August) and the post-implementation period corresponded to the latter part of the season (September-October). We found that detection of influenza A, as a total proportion of respiratory target detections, was lower in the postimplementation compared to the pre-implementation Fig. 1 Flow diagram describing the process of selection of appropriate specimens for the study. Specimens received with a request for 'respiratory PCR' were assessed for eligibility during both the pre-implementation and post-implementation periods. Specimens were excluded if the patient was admitted under the Oncology, Haematology or Bone Marrow Transplant unit, had a hospital length of stay (LOS) greater than 48 h at the time of specimen request, were private patients or outpatients, or had duplicate or inappropriate specimens (only nasopharyngeal swabs or aspirates were accepted). After applying exclusions, 200 specimens were included for the pre-implementation phase. These specimens had the in-house respiratory PCR performed. During the post-implementation phase, 124 specimens were included following exclusion. These specimens had both in-house respiratory PCR and FilmArray performed. period. Along with other studies that have shown early detection of influenza A is most likely to influence healthcare resource utilisation (such as earlier discharge or use of isolation rooms), 4,6 we noted a decreased hospital and isolation bed LOS for patients with a positive influenza diagnosis ( Table 3 ). The reduced number of influenza A detections in the post-implementation period may have impacted our ability to detect the health service outcomes of reduced laboratory and clinical TAT. However, we still noted no change in LOS for the post-implementation group, even after accounting for this potential confounder.",11.517449307723572,4.952534725727444
LTCI is reported to improve clinical and hematologic parameters,0.4225264427525755,2.6200878620147705,4.16982889175415,17e671d5-230d-47d1-a359-8ad5163366d4,custom_license/Current Clinical Applications of Molecular Assays in Feline Medicine,"Lymphocyte T-cell immunomodulator (LTCI; ProLabs, St. Joseph, Mo.) is a product of the thymic stromal epithelial cells that is now commercially available for feline retrovirus-infected cats. It enhances interleukin-2 and interferon production by T-helper lymphocytes, which, in turn, enhances cytotoxic T-lymphocyte activity. 90 LTCI is supplied in 1-mL single dose vials for SC injection, and the recommended protocol is an initial three-dose regimen given at weekly intervals, with further treatments as necessary. LTCI is reported to improve clinical and hematologic parameters. However, controlled clinical trials have not been published.",18.548833360298985,10.905537566054443
Immunotherapy is currently used in combination with radio-and chemotherapy in order to improve the clinical outcome after surgical resection,0.20563794222491394,3.072258949279785,2.8811540603637695,591e158e-34e0-4fe5-9687-a0b6cf3b2309,custom_license/P001 IFN-K4 HAS A POTENT ANTIPROLIFERATIVE ACTIVITY IN B-CELL LYMPHOMA AND HEPATOMA CELL LINES HCV CORE PROTEIN TRIGGERS IL-1B PRODUCTION VIA THE NLRP3 INFLAMMASOME P004 LOSS OF IRF5 INDUCES SPONTANEOUS MAMMARY TUMORIGEN- ESIS P005 PROTEOLYTIC ORIGIN OF THE SOLUBLE HUMAN IL-6R IN VIVO AND A DECISIVE ROLE OF N-GLYCOSYLATION DISTINCT ROLES FOR IRF5 IN MAMMARY EPITHELIAL CELLS AND HOST TUMOR IMMUNITY: LOSS OF IRF5 IN EITHER COMPART- MENT LEADS TO TUMORIGENESIS SEXUALLY DIMORPHIC ROLES OF STAT3 IN PEDIATRIC BRAIN CANCER P008 DISRUPTION OF PD-1/PD-L1 SIGNALING IN 2D VS. 3D COLORECTAL CANCER COCULTURE MODEL REVEALED BY RNAI HIGH THROUGH- PUT SCREEN,"Conclusion: Therefore, type III IFNs may exert a double-edged action in the GI tract by restricting of RV replication on the one hand, but promoting the intestinal pathology on the other. Introduction: Immunotherapy is currently used in combination with radio-and chemotherapy in order to improve the clinical outcome after surgical resection. IL-15 is of particular interest, as it targets and stimulates the immune system, but the optimal dosing regimen still needs to be determined. The aim of the present study is to define these treatment modalities with an IL-15 agonist.",18.270516260595294,10.264399147476663
"Clinical diagnostics requires easy-to-handle experimental procedures, robustness, accuracy, sensitivity, and comparable or lower costs compared to existing diagnostic approaches",0.27601685604364923,3.343435049057007,3.5498406887054443,7b6970ab-9838-4d51-8aa5-fd6b5265cfa6,custom_license/Microarrays as Research Tools and Diagnostic Devices,"Currently, NGS technologies are getting cheaper and easier to handle and also might be the molecular assay of choice in the future in the clinic. Clinical diagnostics requires easy-to-handle experimental procedures, robustness, accuracy, sensitivity, and comparable or lower costs compared to existing diagnostic approaches. Although, recent developments in NGS have led to small instruments that allow flexible throughput and short run times, current drawbacks of NGS approaches are their high investment and running cost, elaborate library preparation, and complex data analysis. Detached from these shortcomings, with the possibilities of NGS, novel diagnostic scales are thinkable not only for diagnostics of cancer, mitochondrial disorders, or hereditary diseases where the assay time is in general not critical but also for assays in clinical microbiology like the detection of MRSA or sepsis causative organisms. Within the scientific community, workshops and symposiums are held everywhere dealing with the topic how NGS can be validly used for clinical diagnostics. The FDA also looks deeper into this subject and performs public workshops that focus on the evaluation of the use of NGS technologies for clinical diagnostics (e.g., Ultra High Throughput Sequencing for Clinical Diagnostic Applications-Approaches to Assess Analytical Validity: Report from the Public Meeting (June 23, 2011), http://www.fda.gov/Medical Devices/NewsEvents/WorkshopsConferences/ucm284442.htm and Public Workshop-Advancing Regulatory Science for High Throughput Sequencing Devices for Microbial Identification and Detection of Antimicrobial Resistance Markers, April 1, 2014, http://www.fda.gov/MedicalDevices/NewsEvents/Workshops Conferences/ucm386967.htm). These activities indicate a strong competition of this new technology in the field of diagnostics.",14.050075020504382,9.398155486722127
Extraction of the viral DNA or RNA is a critical step in the whole procedure of viral diagnostics,0.44684971431868187,3.3204433917999268,4.169927597045898,c6ce2843-13d7-4974-bef2-fdd504ed6ef9,custom_license/Chapter 3 Virology,"Viral diagnostics are performed on a wide range of clinical materials, including (EDTA) plasma, whole blood, faeces, respiratory or genital swabs, cerebrospinal fluid (liquor), urine, tissue samples or biopsies, broncho-alveolar lavage fluids, etc. Extraction of the viral DNA or RNA is a critical step in the whole procedure of viral diagnostics. For some materials, pre-treatment of the sample is necessary to disrupt the tissue, release the virus or deactivate inhibitory factors. Inhibitory factors for PCR are for instance bile in faeces or haemoglobin in blood samples. Some viruses are not stable and clinical materials have to be processed within several hours to ensure optimal test results. Especially in case of viral load determination, accurate and timely sample processing is essential. This applies for instance to HIV viral load testing in plasma.",11.517858293738927,8.89999154555841
Current applications include: (1) The detection of (unknown) viral infections in clinical samples,0.1187000565575303,2.7586448192596436,3.4167914390563965,ac550e7f-6f89-49e3-90a8-380dbec9b744,custom_license/Chapter 3 Virology,Molecular techniques have become indispensable in viral diagnostics. Current applications include: (1) The detection of (unknown) viral infections in clinical samples. (2) Quantitative monitoring of viral load. (3) Genotyping of viral strains.,12.111872910376084,8.253189086537056
the prospective follow-up of a cohort of HSCT recipients may improve the clinical management of PC,0.23504791725058338,2.1439998149871826,2.8634815216064453,d56f1bb0-1fd3-4aca-b927-0d97dad3ffa4,custom_license/Pulmonary complications in hematopoietic SCT: a prospective study,"Pulmonary complications (PCs) are among the most common and lethal complications suffered by hematopoietic SCT (HSCT) patients. [1] [2] [3] [4] The increasing number of indications and the selection of more debilitated patients as potential candidates for HSCT seem to be changing the epidemiology of PC. 5, 6 Studies have shown that in immunocompromised patients an early identification of the etiology of PC improves survival. 7, 8 Fiberoptic bronchoscopy (FOB) has an important role in the diagnosis of PC; 9-12 however, detractors of this technique consider that the information provided may be also obtained by different non-invasive explorations. [13] [14] [15] The majority of the studies evaluating the etiology, diagnosis and prognosis of PC in patients with hematologic diseases are retrospective, 4, 6, 16 and include both non-transplantation and transplantation recipients. 2, 7 We hypothesized that the prospective follow-up of a cohort of HSCT recipients may improve the clinical management of PC. First, the knowledge of the epidemiology of the PC with the different prevalence of infectious and non-infectious etiologies can be accurately determined. Second, predetermined criteria for performing a FOB should clarify the role of this technique by better defining the diagnostic yield, clinical implications and potential complications. Finally, the identification of prognostic factors is much more precise when data are recorded prospectively in a homogeneous group of immunocompromised patients.",13.293302875082514,7.907518875064737
the first steps are being taken in the development of diagnostic microchip-based products.,0.25346080714809455,0.9647595882415771,1.671258807182312,fb4a04b0-850f-4a98-a26e-dc14793e6360,custom_license/Miniaturized detection technology in molecular diagnostics,"The clinical laboratory has a history of quickly replacing old technologies with new technologies that offer advantages in terms of scope of testing, improved sensitivity and specificity, and convenience and adaptability to automation. Microtechnology has many beneficial attributes that recommend it for use in the clinical laboratory. Integration of the individual steps in multistep genetic tests into a single easy-to-use microchip device is one of the most appealing advantages. However, microtechnology is complex and requires sophisticated manufacturing techniques, and the same is true for nanotechnology. Thus, the clinical laboratory must rely on the medical diagnostics industry to commercialize microchip-based assays and analyzers. Until now, most microchip companies have focused on the needs of the pharmaceutical industry in massively parallel assays for drug discovery. There are now signs that finally, the potential of microtechnology in medical diagnostics is being seriously evaluated, and the first steps are being taken in the development of diagnostic microchip-based products.",16.406158459274646,7.455567417771654
The implementation of new techniques,0.20961431608973144,2.4108693599700928,1.961773157119751,fee6bed6-5d08-4c04-ad2e-6be40626c874,"custom_license/c World Health Organization Intercountry Support Office, Ouagadougou, Burkina Faso d Expanded Program on Immunization, WHO Regional Office for Africa, Inter-Country Support Team","The polio laboratory network is the system that manages the processes and standards required to produce accurate reliable and timely results. The implementation of new techniques as it was the case needed dedicated and motivated staff, good quality management systems, safe environment, adequate infrastructure and a good supervisory role. The WHO funds spent on PEI has helped in investing in people, infrastructure and system successfully.",12.790950552606372,7.319050329520628
advanced organism detection offers the potential for early implementation of targeted therapy and the possibility for improved clinical outcomes in immunocompromised children,0.1983698972926848,1.8808577060699463,3.0833821296691895,65fb0b4a-f385-4dff-9552-48f332414797,custom_license/Clinical Infectious Diseases Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children,"In summary, we present an optimized mNGS assay that revealed a rich bacterial, fungal, and viral pulmonary microbiome in immunocompromised children and identified potential pathogens in half of clinically negative samples. As such, advanced organism detection offers the potential for early implementation of targeted therapy and the possibility for improved clinical outcomes in immunocompromised children. We invite the scientific and clinical community to participate in an ongoing multicenter collaborative clinical trial aimed at further refining this emerging technology [65] .",10.988478844694288,7.072723488873439
several commercial products are or were available for detection of (partially) overlapping panels of respiratory viruses,0.1637521111533851,1.9869112968444824,2.6931076049804688,66ba6d19-b050-4241-b15f-eca34aaf2209,custom_license/Microarrays as Research Tools and Diagnostic Devices,"There are many commercially available DNA microarray platforms for research applications as introduced in Sect. 1. However, arrays that are used for diagnostic purposes in the clinics are rare. DNA microarray-based systems often face problems like reproducibility, sensitivity, ease of use, and the contamination risk. However, there are several examples of DNA microarrays that made it into diagnostics. One example is the Amplichip Â® CYP450 from Roche, based on the Affymetrix system. It is the first microarray-based pharmacokinetic test cleared for clinical use. An excerpt from their homepage: ""The AmpliChip CYP450 Test provides comprehensive detection of gene variations-including deletions and duplications-for the CYP2D6 and CYP2C19 genes, which play a major role in the metabolism of an estimated 25 % of all prescription drugs. It is intended to be an aid to clinicians in determining therapeutic strategy and treatment dose for therapeutics metabolized by the CYP2D6 or CYP2C19 gene product"" (http://www. roche.com/products/product-details.htm?typeÂ¼product&idÂ¼17). The FDA-cleared 70-gene MammaPrint profile commercially available from Agendia as described above is one of the examples for a transcriptional profiling array that allows predicting the risk of metastasis formation for breast cancer. Biopsy-or formalin-embedded tissue is analyzed by expression analysis. Agendia also has several other cancer tests in their portfolio, e.g., for colon cancer recurrence or mutation analysis assays for EGFR, KRAS, BRAF, and PIK3CA to select appropriate patients for therapy (http://www.agendia.com/managed-care/). The ViroChip described above is an example of a diagnostic device for respiratory diseases, which however is not commercialized as such by a company but used as a research tool. Nevertheless, several commercial products are or were available for detection of (partially) overlapping panels of respiratory viruses, based on microarrays as the identification method (Miller and Tang 2009) . These products include the ResPlex II assay from Qiagen (Valencia, CA); the MultiCode-PLx RVP from EraGen Biosciences (Madison, WI); the Infiniti RVP from AutoGenomics, Inc. (Carlsbad, CA); the Ngen respiratory virus ASR assay from Nanogen (San Diego, CA); and the xTAG RVP from Luminex Molecular Diagnostics (Toronto, Canada).",11.371453208817744,7.022020909272429
stringent route management processes that help to avoid overlap with other carriers in the group,0.17555760468906312,2.416954278945923,2.1131458282470703,3821fd87-af98-47d1-ab1b-b2d6dc14cc17,custom_license/Review of Airline-within-Airline strategy: Case studies of the Singapore Airlines Group and Qantas Group,"The Singapore Airlines and Qantas Groups have acknowledged and overcome the issue of route cannibalisation raised by Gados and Gillen (2008) by incorporating multi-brand strategy solutions discussed by Batey (2008) and Morgan and Rego (2009) . The strategies include the implementation of stringent route management processes that help to avoid overlap with other carriers in the group, being the sole operator on a route where possible, and ensuring their AWAs operate to carefully selected destinations that fit their target markets and allow for strategic future growth.",11.322891552329436,6.907577112990748
Combining nucleic acid tests with galactomannan,0.14437190019083324,2.271929979324341,2.2565994262695312,fc892c4c-75f8-4004-b94f-1fd6a13f0f4b,custom_license/Clinical Infectious Diseases Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children,"Using optimized mechanical homogenization, Aspergillus RNA was detected in 34.1% of samples and no negative controls, suggesting that the lungs of immunocompromised children are frequently exposed to low levels of potentially viable Aspergillus organisms. These data are novel in the pediatric population and are congruous with surveillance data from neutropenic and nonneutropenic adults [38, 39] . However, as only 10% of samples originated from patients with suspected IPA, patient-specific factors such as antifungal pretreatment, immune reconstitution, alloreactive inflammation, and impaired mucociliary clearance remain crucial in determining which child might develop IPA [16] . While this study was not powered to assess performance characteristics of this assay for IPA, pan-fungal and Aspergillus-specific PCR have demonstrated 76%-79% sensitivity and 93%-95% specificity for probable/proven IPA [14, [40] [41] [42] [43] [44] [45] [46] [47] . Combining nucleic acid tests with galactomannan can hasten diagnosis and improve clinical outcomes in some populations [48] [49] [50] [51] ; further, incorporation of immune function may also improve discrimination of colonization and invasive mycosis [52] [53] [54] [55] [56] . Importantly, for all nucleic acid-based tests, measurable Aspergillus yield varies among species and according to life stage, cell wall characteristics, and hydrophobicity [57] . Therefore, any future clinical mNGS assay will need to be benchmarked against numerous Aspergillus species as well as other medically relevant fungi in order to have the broadest utility. Consistent with emerging data in pediatrics, we also detected herpesviruses such as CMV and HHV-6 in low abundance among many children in the cohort [58, 59] . Interestingly, a number of typically nonpathogenic viruses such as Torquetenovirus and KI Polyomavirus were present in more than half of the cohort. While data supporting the direct pathogenicity of these viruses are lacking, they may indicate immune dysfunction and predict numerous post-transplant infectious and alloimmune complications [60] [61] [62] . Future studies aimed at characterizing longitudinal changes in the pulmonary virome of immunocompromised children are warranted.",11.29208080069504,6.89577239387928
routine molecular diagnostics,0.4398385375258855,1.3246484994888306,1.745177984237671,bed8b5ab-8ae6-45df-91e9-ee47a5e73e28,custom_license/Miniaturized detection technology in molecular diagnostics,"Microtechnology encompasses devices that contain micrometer-sized features that are usually fabricated using methods developed in the microelectronics industry (e.g., photolithography and deposition). Nanotechnology is defined as 'the branch of engineering that deals with things smaller than 100 nm (especially with the manipulation of individual molecules)'. Nano-sized structures can be fabricated through a bottom-up process, where the object is built up molecule by molecule or atom by atom. Alternatively, a top-down approach can be utilized in which the structure is fabricated by removal of unwanted material from a larger block of material. Both microand nanotechnology are finding applications in many different areas of science and engineering [1] [2] [3] [4] . This article reviews recent advances in the application of both micro-and nanotechnology in molecular diagnostics. It surveys the current use of silicon-glass and plastic microchips, and nano-sized structures such as carbon nanotubes, nanopores and nanoparticles, and discusses their prospects and current barriers to implementation in routine molecular diagnostics. Key objectives for innovation in molecular diagnostics include rapid sequencing, multiplexed testing, integrated analysis that combine all steps in the analytical process from sample handling to read-out of the result, and assays that do not require an amplification step. Microchips and a range of nanostructures are gaining in importance as possible technological solutions that will lead to the realization of these ambitious objectives (TABLE 1) .",12.677801941869173,6.4326178940764365
"applications of molecular detection of viral infection, viral load monitoring and more complex and often also less standardized methods",0.13008322566963038,1.469963550567627,1.3647394180297852,68bdea58-f85f-4acf-9e01-0ba1400ca627,custom_license/Chapter 3 Virology,"In this chapter applications of molecular detection of viral infection, viral load monitoring and more complex and often also less standardized methods, like genotyping and resistance testing in clinical diagnostics, are discussed.",11.952172356686397,6.025817254428556
"photochemical oxidant, peroxydisulfate",0.1575157662936006,0.4838274419307709,1.5088093280792236,eaa7fef7-4880-426f-90b3-5e8c03df09a5,custom_license/The photooxidative destruction of C.I. Basic Yellow 2 using UV/S 2 O 8 2â process in a rectangular continuous photoreactor,"C.I. Basic Yellow 2 (4,4-dimethylaminobenzophenonimide) and its hydrochloride salt are used in the coloring of paper, textiles and leather [1] . International Agency for Research on Cancer included BY2 among chemicals for which there is sufficient evidence of carcinogenicity in experimental animals due to its bio-transformation to reactive species in target organs of both rats and humans [2] . The conventional methods used in sewage treatment, such as primary and secondary treatment systems, are insufficient in removing of dyeing and finishing agent, for example: adsorption and chemical coagulation processes are two common techniques of wastewater treatment. However, these methods merely transfer dyes from the liquid to the solid phase causing secondary pollution and requiring further treatment. Advanced oxidation processes (AOPs) are alternative techniques of destruction of dyes and many other organics in wastewater and effluents. These processes, generally, involve UV/H 2 O 2 , UV/O 3 or UV/Fenton's reagent for the oxidative degra-dation of contaminants. Semiconductor photocatalysis is another developed AOP, which can be conveniently applied to remove different organic pollutants [3, 4] . However, the potential of alternative AOPs to improve the removal performance is always of interest and the photochemical oxidant, peroxydisulfate, could be a good candidate for such a purpose.",11.103666483174539,5.181497169617584
"immunotherapy, mainly administration of hyperimmune colostrum, may improve the clinical status of patients",0.232922189115449,3.3969404697418213,3.751648187637329,9447f1fe-143b-4b51-8d39-12ee5f7c7566,custom_license/In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum,"Cryptosporidiosis is responsible for several intestinal disorders in a wide range of hosts. The infection is typically found in AIDS patients and in other immunocompromised persons. Cryptosporidium species are also common and dangerous waterborne pathogens. 1 Cryptosporidium parvum is one of the most frequent causes of enteritis and diarrhoea in postnatal calves, lambs, goat kids and in other agriculturally important animals. The economical, hygienic and zoohygienic impact of cryptosporidiosis is significant. 1, 2 Control of the infection in human and veterinary practice is complicated by a lack of effective therapy. Although immunotherapy, mainly administration of hyperimmune colostrum, may improve the clinical status of patients, chemotherapy is the main therapeutic approach. 3 However, none of the known anticryptosporidial drugs, such as paromomycin, azithromycin and nitazoxanide used mostly in humans, or halofuginone-lactate approved for anticryptosporidial therapy of calves, is absolutely effective. 4, 5 Better anticryptosporidial drugs with minimal residuality and toxicity are still needed in human and veterinary clinical practice.",15.124291935584896,9.940084804751162
The implementation of genomics and other innovative diagnostics for personalized medicine,0.15595666336352407,2.1078097820281982,1.6223348379135132,23488f45-f7e0-4264-8013-9a550152247c,custom_license/Translating Innovation in Diagnostics: Challenges and Opportunities,"There is a need to recognize the key role of technological innovation in closing translational gaps in medicine as compared to incremental improvements with current practice. However, signifi cant health gains can only occur when the fi delity with which medical advances are delivered is optimized. These two processes can sometimes be seen as competing ( Woolf and Johnson, 2005 ) , but in actuality represent two factors necessary for medical progress. There may be no area where this is more clearly demonstrated than in translational diagnostics, a fi eld driven by innovation ( Ratner, 2006 ) . The implementation of genomics and other innovative diagnostics for personalized medicine requires the translation of a vast array of technologies and therapeutic strategies from basic science to clinical application. Delivery of these diagnostics to patients requires physician and patient education, as well as evidence-based demonstration of effi cacy for healthcare uptake, payment, and regulatory approval.",20.649874984977913,9.652050247704382
products to address urgent public health needs and at-risk populations,0.2984901136300107,3.4195706844329834,5.0592756271362305,cb5a0f76-75cf-4ffb-898d-268047ebd343,custom_license/Translating Innovation in Diagnostics: Challenges and Opportunities,"The FDA plays a key regulatory role in medical practice and has promoted translational medicine. The FDA's Critical Path Initiative, subtitled ""Stagnation to Innovation, "" identifi ed key areas for development: better evaluation tools -Biomarkers and Disease Models; streamlining clinical trials; harnessing bioinformatics; moving manufacturing into the 21st century; and products to address urgent public health needs and at-risk populations ( FDA, 2006a ) . In early 2006, the FDA released The Critical Path Opportunities List, which outlined 76 science projects to bridge the translational research gap ( FDA, 2006b, c ) . Of note, the fi rst 33 items on the FDA's Opportunities List were in diagnostic-related areas, refl ecting the importance of diagnostics in driving innovation in medical practice ( Ratner, 2006 ) .",11.490194646767499,9.532818228888614
"oligoclonal combinations of antibodies to treat disease, focusing on identification of synergistic antibodies",0.13681208089283498,2.880326747894287,3.914736270904541,e5d07cc8-2366-4ecc-b056-9ed349221f40,custom_license/Back to the future: recombinant polyclonal antibody therapeutics,"Xian-zhe Wang 1 , Vincent W Coljee 2 and Jennifer A Maynard 3 Antibody therapeutics are one of the fastest growing classes of pharmaceuticals, with an annual US market over $20 billion, developed to treat a variety of diseases including cancer, auto-immune and infectious diseases. Most are currently administered as a single molecule to treat a single disease; however there is mounting evidence that cocktails of multiple antibodies, each with a unique binding specificity and protective mechanism, may improve clinical efficacy. Here, we review progress in the development of oligoclonal combinations of antibodies to treat disease, focusing on identification of synergistic antibodies. We then discuss the application of modern antibody engineering technologies to produce highly potent antibody preparations, including oligoclonal antibody cocktails and truly recombinant polyclonal antibodies. Specific examples illustrating the synergy conferred by multiple antibodies will be provided for diseases caused by botulinum toxin, cancer and immune thrombocytopenia. The bioprocessing and regulatory options for these preparations will be discussed.",12.853829141944175,8.9156311618997
Technologies for improving global health services are in great demand,0.18748295846288074,3.3542420864105225,3.8715434074401855,d055339a-42c0-4654-8582-033bad2ade71,custom_license/Critical overview on the application of sensors and biosensors for clinical analysis,"Technologies for improving global health services are in great demand, in the diagnosis, treatment and prevention of diseases [1] . Although effective, the laboratory techniques based primarily on the optical analytical principle, such as immunoassays, require sample enrichment and purification before analysis. Moreover, they are expensive and slow. Thus, strategies for signal amplification have been recently proposed to increase immunoassay sensitivity for further clinical diagnostics [2] . Sensors and biosensors have been extensively studied for their role in detecting and monitoring different types of analytes for food safety, environmental monitoring, clinical analysis and medical diagnosis [3] . Immunosensors have been considered in clinical diagnostics for the detection and identification of cardiac and cancer biomarkers. This is key to developing point-of-care technologies that can analyse real biological samples (for continuous monitoring of physiologically important analytes) in routine clinical use [4] .",11.919661938497633,8.868642249477132
Using a for clinical and diagnostic use in veterinary medicine biotinylated cDNA probe the assay was able to are increasing rapidly,0.19110611952727094,2.96647310256958,3.8984973430633545,2fcf3f00-0fc1-4826-8b9c-3cd6ac37fb8b,custom_license/Applications of genetic engineering in veterinary medicine,"Viremia with feline coronavirus does not necessarily lead to FIP and death, thus making a positive feline coronavirus of low prognostic and diagnostic value. However, the utility of a feline coronavirus-2. Veterinary applications specific PCR may be more reliable in samples of peripheral blood mononuclear cells (PBMCs) and 2.1. Diagnostics such a test can be used to further study the pathogenesis and epidemiology of FIP [8] . In a parallel The number of applications of nucleic acid probes study, a dot blot hybridization assay was found to be and DNA products such as monoclonal antibodies of value in coronavirus infected cats. Using a for clinical and diagnostic use in veterinary medicine biotinylated cDNA probe the assay was able to are increasing rapidly.",11.861815698670906,8.613866284196224
infectious diseases,0.18369001807273597,1.6125990152359009,3.2676644325256348,a6512610-3dd0-4306-bbfa-b09a5f0517c5,custom_license/Early days: genomics and human responses to infection,"From the genomic perspective, host-pathogen interactions involve the interplay of two (or more) distinct genomes. A more comprehensive study of these interactions will entail simultaneous monitoring of all of the associated genes and gene products [50, 51] . We believe that one of the most exciting prospects for this field lies in the integration of genome-wide data from multiple sources. Large-scale random shotgun sequencing efforts using samples from complex microbial communities provide an opportunity to discover and monitor the expression of genes directly from samples of these communities, whether they are host-associated or environment-associated. Community-wide patterns of gene transcript abundance and their variation with respect to time, space and perturbation will reveal fundamentally important aspects of microbial community ecology and physiology, and provide potentially useful diagnostic and prognostic information about the hosts in which communities play critical roles in health and disease. As we construct a high resolution and dynamic picture of the conversation between humans and microbes, we will not only enhance our understanding about fundamental aspects of human biology, but improve the clinical management of infectious diseases.",15.437153362488171,8.575174917915858
practical lessons learned from bringing innovative diagnostics to market at larger reference laboratories,0.19665507052732625,2.4610068798065186,4.136401653289795,16dc63fd-2613-49a8-ad7f-18795526dafd,custom_license/Translating Innovation in Diagnostics: Challenges and Opportunities,"With this in mind, this chapter will focus on translational diagnostics in the context of genomic and personalized medicine and on the practical lessons learned from bringing innovative diagnostics to market at larger reference laboratories. The large national labs in the United States -including Quest Diagnostics, Laboratory Corporation of America Holdings, Sonic Healthcare, Genzyme, Mayo Clinic, Associated Regional University Pathology (ARUP), and others -provide about 50% of all lab testing delivered in this country and complete several million assays a day in support of patient care. Understanding translational diagnostics as practiced by these national reference laboratories should shed light on both challenges and successes in bridging the translational diagnostics gap from bench to bedside. The potential for translational diagnostics in cancer, infectious disease, and other health care sectors will also be discussed.",11.414517416726563,8.2833966423669
to enhance the recovery of immunoglobulin G,0.1919428659814234,1.6369602680206299,3.1303539276123047,be35847c-e131-421c-930e-f884cadf5c12,custom_license/Modern Plasma Fractionation,"Protein products fractionated from human plasma are an essential class of therapeutics used, often as the only available option, in the prevention, management, and treatment of life-threatening conditions resulting from trauma, congenital deficiencies, immunologic disorders, or infections. Modern plasma product production technology remains largely based on the ethanol fractionation process, but much has evolved in the last few years to improve product purity, to enhance the recovery of immunoglobulin G, and to isolate new plasma proteins, such as a1protease inhibitor, von Willebrand factor, and protein C. Because of the human origin of the starting material and the pooling of 10 000 to 50 000 donations required for industrial processing, the major risk associated to plasma products is the transmission of blood-borne infectious agents. A complete set of measures-and, most particularly, the use of dedicated viral inactivation and removal treatments-has been implemented throughout the production chain of fractionated plasma products over the last 20 years to ensure optimal safety, in particular, and not exclusively, against HIV, hepatitis B virus, and hepatitis C virus. In this review, we summarize the practices of the modern plasma fractionation industry from the collection of the raw plasma material to the industrial manufacture of fractionated products. We describe the quality requirements of plasma for fractionation and the various treatments applied for the inactivation and removal of blood-borne infectious agents and provide examples of methods used for the purification of the various classes of plasma protein therapies. We also highlight aspects of the good manufacturing practices and the regulatory environment that govern the whole chain of production. In a regulated and professional environment, fractionated plasma products manufactured by modern processes are certainly among the lowest-risk therapeutic biological products in use today. A 2007 Elsevier Inc. All rights reserved.",11.927296778806602,7.273308099743717
"Diagnostic testing must address an unmet medical need, lead to an actionable event, and demonstrate its clinical utility",0.2602886720700112,2.415692090988159,2.7068734169006348,046e7b14-0976-403c-984c-c98b329f4a33,custom_license/Translating Innovation in Diagnostics: Challenges and Opportunities,"The future of innovative diagnostics holds great promise for providing rapid identifi cation of disease susceptibility and status, for monitoring disease progress and therapeutic effi cacy, for reducing ADRs and speeding appropriate therapy selection, for the development of personalized medicine, and for optimizing disease prevention and cures. To see this promise unfold, a number of challenges must be overcome. Diagnostic testing must address an unmet medical need, lead to an actionable event, and demonstrate its clinical utility. These diagnostics must also demonstrate high specifi city, sensitivity, and predictive value.",11.239014988817306,7.2633228262137735
the proper diagnostics of HBoV require additional attention,0.15304864596226653,1.9441559314727783,2.726440191268921,f9797fec-b274-47c3-b373-8c27d3a9c1f1,custom_license/The Role of the Human Bocavirus (HBoV) in Respiratory Infections,"In any cases, the proper diagnostics of HBoV require additional attention as does the need for HBoV to be evaluated in terms of its interaction with other respiratory viruses that may simultaneously be detected during clinical episodes.",11.928323995986979,7.210800878377547
rapid exchange of secretory products with the environment adjacent to this specialized cell process,0.3427796823304047,1.9579265117645264,3.1886892318725586,d51cfd7b-2311-4428-9434-dd98666f5649,custom_license/BRAIN RESEARCH Polarity of processes with Golgi apparatus in a subpopulation of type I astrocytes,"The present study demonstrates several unique structural features of the GA of astrocytes. There is a unique polarization and distribution of the GA in processes of a subset of type I astrocytes. Thus, a subpopulation of type I astrocytes exhibit a polarized cell process similar to the axons and dendrites in neurons. These astrocytic processes contain elements of the GA as dendrites do. However, unlike the polarized nature of neuronal processes, which may be recognized with a Nissl stain and do not require organelle specific stains, the recognition of the polarized nature of astrocytic processes requires immunohistochemical staining for the GA. Additional support for the existence of polarity in astrocytic processes is derived from the report of specific distribution of sodium ion channels in astrocytic processes. Astrocyte processes forming the glial limitans and surrounding blood vessels display reduced immunoreactivity for a sodium channel specific protein, compared to longitudinally oriented or perinodal astrocytic processes, while focal regions of the glial limitans exhibit robust immunostaining [5] . The finding of increased density of potassium ion channals in the endfeet of astrocytic processes [56] provides further support for the possibility that astrocytic processes are actively involved in specialized functions. The subset of astrocytes with a polarized process may be involved in specialized secretory functions requiring rapid exchange of secretory products with the environment adjacent to this specialized cell process. It has been suggested that the GA plays a major role in cell motility [38] , and that polarization of the GA in motile cells serves as a steering mechanism in the direction of cell migration [37] . Therefore type I astrocytes with polarized GA may belong to a subpopulation of astrocytes that are motile and capable of migration in response to injury. Taken together the above evidence strongly suggests that the polarization of the GA in certain cells is not a random and insignificant phenomenon. However, the functional significance of the polarization of the GA in astrocytes remains to be investigated. The differential expression of GA in processes in the two distinct astrocytic types further emphasizes the hypothesis that functional, anatomical, and morphological differences separate these two cells which express the same intermediate filaments (GFAP). Furthermore it provides further evidence of the heterogeneity that exists among type I astrocytes.",10.738524053793135,7.103783652191702
not a consistently effective chemotherapeutic agent for use in animals or in people,0.1040461004233815,1.075225591659546,2.284269332885742,1ff2a595-7797-43d9-9c5d-abceefc24b6c,custom_license/Description of fecal shedding of Cryptosporidium parvum oocysts in experimentally challenged dairy calves,"Cryptosporidiosis is the clinical syndrome of fever, diarrhea, and large volumes of fluid loss from the gastrointestinal tract (DuPont et al. 1995; Fayer 2004) . The severity of this diarrhea and its subsequent dehydration influence morbidity and mortality in people and animals (Anderson 1998; O'Handley et al. 1999) . Treatment of the illness poses a challenge as there is not a consistently effective chemotherapeutic agent for use in animals or in people (Amadi et al. 2002; Anderson and Curran 2007; Graczyk et al. 2011; Harp and Goff 1998; Mead 2002) . For example, nitazoxanide has shown efficacy in immune-competent but not immunecompromised children (Amadi et al. 2002) . In experimentally infected dairy calves, treatment with nitazoxanide reduces the duration of fecal oocyst shedding and improves clinical signs; however, there are no animal-labeled formulations at this time (Ollivett et al. 2009 ). Animal-labeled formulations of halofuginone are available. While halofuginone has been shown to improve clinical signs by delaying the onset of diarrhea and reducing fecal oocyst shedding, it does not prevent diarrhea and fecal shedding entirely (Jarvie et al. 2005) .",13.656652452347991,6.9635000592762335
portable diagnostics in the future.,0.11168874204900757,0.919083297252655,2.4136199951171875,97d1d440-b757-4f44-a425-06ef1d970f88,custom_license/Yeast surface display-based microfluidic immunoassay,"In this paper, we present a new microfluidic immunoassay platform, which is based on the synergistic combination of the yeast surface display (YSD) technique and the microfluidic technology. Utilizing the YSD technique, antigens specific to the target antibody are displayed on the surface of engineered yeast cells with intracellular fluorescent proteins. The displayed antigens are then used for the detection of the target antibody, with the yeast cells as fluorescent labels. Multiplex immunoassay can be readily realized by using yeast cells expressing different intracellular fluorescent proteins to display different antigens. The implementation of this YSD-based immunoassay on the microfluidic platform eliminates the need for the bulky, complex and expensive flow cytometer. To improve the detection sensitivity and to eliminate the need for pumping, a functionalized micro pillar array (MPA) is incorporated in the microfluidic chip, resulting in a detection limit of 5 ng/mL (or 1 ng in terms of amount) and enhanced compatibility with practical applications such as clinical biopsy. This new platform has a high potential to be integrated into microfluidic detection systems to enable portable diagnostics in the future.",13.113848732855669,6.756104196539882
One of the critical steps in the implementation of the competencies and the effective preparation of nurses is integrating content and skills into the nursing curriculum,0.20029374984081572,0.5352356433868408,1.3287640810012817,407b7b7e-3d0b-4a69-a61c-83b1117033b2,custom_license/Disaster Competency Development and Integration in Nursing Education,The dissemination and implementation of these national consensus-based competencies is ongoing. One of the critical steps in the implementation of the competencies and the effective preparation of nurses is integrating content and skills into the nursing curriculum.,10.967659880422502,5.050280779000155
help to improve the clinical practice and reduce fatality,0.20356207321090697,1.9806303977966309,3.834658145904541,e38b567c-a566-4cd8-b165-ca1c328113fa,custom_license/Journal Pre-proof Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up,"Till present there are rare reports in literature focusing on the clinical characteristics of the elderly patients with COVID-19, and the risk factors for poor outcomes remains to be elucidated. The present study aims to describe the clinical characteristics and to investigate the prognostic factors of the elderly patients with COVID-19, which might provide evidence for the risk stratification and help to improve the clinical practice and reduce fatality.",21.58362879062562,11.334207630124729
Better understanding of the pathogenesis of ICH-induced brain injury would contribute to improve the clinical outcome of ICH,0.26295191219704844,3.049250364303589,3.1432011127471924,921c2883-eed6-4eb8-b428-6d75e677cbc0,custom_license/Dysregulated expression of T cell immunoglobulin and mucin domain 3 is associated with the disease severity and the outcome of patients with spontaneous intracerebral hemorrhage,"Spontaneous intracerebral hemorrhage (ICH; nontraumatic and without any underlying lesion) is the most devastating type of stroke with limited effective therapies. It is characterized by spontaneous bleeding in the parenchymal tissue of the brain and is associated with a very high mortality and substantial morbidity [1] . Approximately 2 million cases of ICH occur worldwide each year [2] , and patients with ICH have nearly twice the risk of being severely disabled when compared to patients with ischemic stroke [3] . Treatment for ICH is primarily supportive, and the clinical outcome is poor with potential huge burden for the caretakers. Better understanding of the pathogenesis of ICH-induced brain injury would contribute to improve the clinical outcome of ICH.",18.027328079512774,10.334658287912479
Unremitting efforts to improve donor screening and serologic testing for infectious disease are needed to keep ahead of potential threats to the blood supply,0.28951401725897885,3.599782705307007,4.39230489730835,9011a74e-755e-483f-842e-424adc2f0a40,custom_license/THE PROCESS OF BLOOD DONATION Blood Donation and Collection,"At one time, all that was needed to collect blood was a collection set and a donor with suitable veins. Since then, thousands of transfusion medicine professionals have transformed the early donor rooms to a multibillion dollar industry collecting tens of millions of blood products per year. Their ceaseless efforts to improve transfusion safety have had remarkable success on the well-being of the blood recipient, donor, and even the collections staff. Unremitting efforts to improve donor screening and serologic testing for infectious disease are needed to keep ahead of potential threats to the blood supply.",12.334151486063211,9.511809961822106
to provide additional epidemiologic data on the circulation of gastrointestinal viruses in the hospital settings,0.27297939024175044,2.8633902072906494,3.485649347305298,c026f489-ddda-42cb-b420-fff3d17f5412,custom_license/Molecular detection of gastrointestinal viral infections in hospitalized patients,"In conclusion, the findings of this study show that HAdV, NoV, and RV are the leading cause of viral gastroenteritis in hospitalized patients. The investigation of all enteric viruses (including HAstV, EV, HPeV, HBoV, HCoV, SaV, HCoSV, and AiV) is needed to improve routine laboratory diagnostics and to provide additional epidemiologic data on the circulation of gastrointestinal viruses in the hospital settings.",13.261439982392004,8.768379704324566
to recognize common and emerging pathogens in a community,0.14360403223810142,2.4497125148773193,2.9491875171661377,c7a2a713-e79d-4c03-b64d-d8e69949c3f6,custom_license/6 Diagnosis of Viral Infections,"Accurate diagnosis of viral infections enhances the ability of the clinician to make decisions on appropriate treatment of patients, evaluate disease progression and prevent misuse of antibiotics. Knowledge of the pathogen involved also allow implementation of infection control and monitoring of success of antiviral treatments that may affect the prognosis of patients. Epidemiological data collected through accurate diagnostics play an important role in public health through identification and control of outbreaks, implementation of appropriate diagnostic tests, vaccination programs and treatment but also to recognize common and emerging pathogens in a community. It is key that the clinician have an understanding of appropriate specimens to send to the laboratory and the value of specific nucleic acid and serological testing for different viral pathogens. Molecular techniques have revolutionized viral diagnoses over the past decade and enhanced both the sensitivity and specificity of tests and the speed by which a diagnosis can be made and new tests be developed. The continued use of serology for viruses with a short viremia, or for chronic infections should however complement these tests. This chapter aims to provide an overview of the available tests, the principles of testing and appropriate tests to select for different viruses and syndromes. Also provided is a glimpse of new developments in diagnostics that may further enhance the capacity to make a conclusive diagnosis in the near future.",13.396649699005211,8.198112415480072
"Next generation molecular diagnostic techniques such as microarrays have been developed for the diagnosis of various infectious diseases, cancer and genetic disorders",0.26448240806485485,2.0806796550750732,2.934286117553711,13c32943-7a68-4007-874f-648146711016,custom_license/Sub-chapter A: Development and Validation of PCR-Based Diagnostic Test â¦,"PCR-based diagnostics: the business potential in India Market trends also indicate that the current screening tools involving antibody detection by the ELISA method will be replaced by detection based on molecular techniques such as PCR. Furthermore, the current molecular diagnostics products consist mainly of tests designed around a single biomarker associated with a disease state. Next generation molecular diagnostic techniques such as microarrays have been developed for the diagnosis of various infectious diseases, cancer and genetic disorders. This project will do the groundwork for tapping these opportunities.",13.669674166684954,8.044113710548444
improve and facilitate continuity of care for palliative cancer patients in and across all points of care,0.10191193757655055,1.0468523502349854,2.164069890975952,1cddaa4a-bb52-414b-9933-6da80f43b20c,custom_license/Palliative Care Integration Project (PCIP) Quality Improvement Strategy Evaluation,"The evaluation study addressed the following questions: Would the implementation and use of standardized assessment tools, CCPs, and symptom management guidelines improve and facilitate continuity of care for palliative cancer patients in and across all points of care? Would the use of common assessment tools, evidence-based CCPs, and symptom management guidelines by regulated and unregulated health care providers decrease variability of palliative care practice, improve efficiencies in patient care, improve access to palliative care services, and improve responsiveness of the system to meet the needs of palliative patients and their families?",15.105170129822472,7.373909002224973
"symptom management in cancer patients, caregiver burden and satisfaction with care delivery",0.1699656920361764,1.160715937614441,2.730175495147705,6be64f99-d483-4ee8-9d77-9d649448a77c,custom_license/Palliative Care Integration Project (PCIP) Quality Improvement Strategy Evaluation,"The PCIP outcome evaluation study applied a pre-post design to measure the impact that specific clinical practice changes had on symptom management in cancer patients, caregiver burden and satisfaction with care delivery. Two cohorts of patients, caregivers, and health professionals (one before implementation and one after implementation) were examined. Administrative data from each participating site were also examined for utilization trends.",13.56809613503945,7.277913078559202
community-based interventions,0.47329732819031606,2.2788000106811523,2.472787380218506,09b17d57-b5e3-49d1-8309-cbf630709c90,custom_license/Spatial epidemiology of networked metapopulation: an overview,"It thus becomes urgent to study the controllability of intrasubpopulation measures, such as the usage of vaccine or antiviral drugs, and the implementation of community-based interventions, which are typical containment strategies suggested by the World Health Organization (WHO) [55] . To estimate and also to improve the performance of disease response plans on decreasing the morbidity, large-scale computational simulations have been performed extensively to study various types of pharmaceutical interventions [4, 14, 56, 57, 60, 68, [134] [135] [136] [137] [138] [139] , which aid in identifying the targetedgroups and guiding the deployment of limited resources.",11.851299273739691,7.2364865498936695
The development and implementation of molecular methods is the single biggest recent advance in the diagnostics of respiratory infections,0.13579819091028225,0.9970081448554993,1.3191285133361816,432e2bb2-b9e0-47a4-bebb-07a09b8b48a1,custom_license/Microbiological Diagnosis of Respiratory Illness: Recent Advances,"The development and implementation of molecular methods is the single biggest recent advance in the diagnostics of respiratory infections. 4 While nucleic acid detection tests (NATs), such as PCR, have been used to detect respiratory pathogens for over two decades, the widespread adoption of these tests by diagnostic laboratories has occurred only recently, largely due to the increased availability of commercial assays. Table  22 .16 discusses some of the more commonly used molecular assays, and Table 22 .17 gives explanation of commonly used terms in molecular diagnostics.",15.791294617773609,7.032441944045355
look-back function,0.23611609419727894,1.238347053527832,1.7215811014175415,bf53bc1d-438d-4d96-9f70-db294c068eb5,custom_license/Technical Description of RODS: A Real-time Public Health Surveillance System,"Our future plans are to meet our initial design objective to develop early-warning capability for a large, outdoor release of anthrax, especially ensuring that the data and analysis produced by RODS are reviewed by public health. This goal will require improvements in the interfaces and the detection algorithms to reduce false alarms and to vastly improve the efficiency with which anomalies are evaluated by use of multiple types of data, better interfaces, and implementation of the look-back function. We would like to enlarge as quickly as possible the application service provider to include more states and more types of clinical data so that states will be in a position to prospectively evaluate the detection performance from different types of data on naturally occurring outbreaks.",13.52121903959888,6.6563799645741
improve the effectiveness of the FDA's regulatory program,0.17937128038247266,0.8717899322509766,2.6278457641601562,7d3db314-ee65-45f2-96e1-cb1bf2218f32,custom_license/THE PROCESS OF BLOOD DONATION Blood Donation and Collection,"On November 7, 2000, the FDA published a final rule 160 to amend the requirements of reporting errors and accidents in manufacturing of products. This rule was issued as part of a program to improve the effectiveness of the FDA's regulatory program. FDA replaced the term error and accident with the term biological product deviation (BPD).",12.402272374696306,6.615558533810944
"Pennsylvania F i g u r e 2. Sample HL7 admission, discharge, and transfer (ADT) message from an emergency department",0.19214849073442344,1.0333359241485596,1.8123489618301392,f781ddaf-0cb9-4a2a-8dd4-a14dbf455a44,custom_license/Technical Description of RODS: A Real-time Public Health Surveillance System,"All of the RODS processes can be run on a single computer, but in our current implementation-serving Pennsylvania F i g u r e 2. Sample HL7 admission, discharge, and transfer (ADT) message from an emergency department. The circled fields are age, gender, home zip code, admitted date and time, and free-text chief complaint, respectively.",13.562113729564697,6.596434981233798
early detection of disease outbreaks,0.20490816566588618,0.09266762435436249,1.9951014518737793,e319e7de-563f-4e45-ad23-995a4a2d8020,custom_license/Technical Description of RODS: A Real-time Public Health Surveillance System,"A b s t r a c t This report describes the design and implementation of the Real-time Outbreak and Disease Surveillance (RODS) system, a computer-based public health surveillance system for early detection of disease outbreaks. Hospitals send RODS data from clinical encounters over virtual private networks and leased lines using the Health Level 7 (HL7) message protocol. The data are sent in real time. RODS automatically classifies the registration chief complaint from the visit into one of seven syndrome categories using Bayesian classifiers. It stores the data in a relational database, aggregates the data for analysis using data warehousing techniques, applies univariate and multivariate statistical detection algorithms to the data, and alerts users of when the algorithms identify anomalous patterns in the syndrome counts. RODS also has a Web-based user interface that supports temporal and spatial analyses. RODS processes sales of over-the-counter health care products in a similar manner but receives such data in batch mode on a daily basis. RODS was used during the 2002 Winter Olympics and currently operates in two states-Pennsylvania and Utah. It has been and continues to be a resource for implementing, evaluating, and applying new methods of public health surveillance.",12.74384950148059,5.8173972250664985
"The sessions included outlining the project's objectives, processes and the administration of the assessment tools, CCPs, and symptom management guidelines",0.17681508938757662,0.43840184807777405,1.7407827377319336,8e69d229-465b-4652-9846-d1f9b44d9d6b,custom_license/Palliative Care Integration Project (PCIP) Quality Improvement Strategy Evaluation,"As part of the implementation strategy between 2002 and 2004, approximately 600 nurses and allied health professionals, and over 200 family physicians, including residents, were educated about this project. The sessions included outlining the project's objectives, processes and the administration of the assessment tools, CCPs, and symptom management guidelines. Education occurred in a variety of formats, including workshops with ''train-thetrainer'' sessions, community rounds, formal presentations, self-directed web-based learning, continuing professional development sessions, newsletters, and other print media.",12.011549794041576,5.620512408690861
Shunting of the fourth ventricle can improve clinical status,0.28293455604245704,2.0674140453338623,2.8259706497192383,aa3cb8b1-401a-4115-b1f6-9f4bb5f618cb,custom_license/Hydrocephalus in Animals,"In dogs with massive enlargement of the fourth ventricle, compression of the brainstem can cause tetraparesis. Shunting of the fourth ventricle can improve clinical status in these dogs. Internal hydrocephalus in combination with signs of abnormal cerebellar function is often not treated due to unfavorable long-term prognosis. ",20.50548011388676,10.357618091644882
We expect that these therapies will improve clinical outcomes in 2019-nCoV patients,0.20050414074660433,3.5351157188415527,4.08431339263916,02977e53-3502-47ee-b348-487eb7681d7d,custom_license/Coronavirus 2019-nCoV: A brief perspective from the front line,"As for monoclonal antibody (mAb), several researches showed that the combination of RDV and mAb would likely to be the ideal treatment for 2019-nCoV. Tian et al. reported for the first time that a SARS-CoV-specific human mAb, CR3022, could bind potently with 2019-nCoV receptor binding domain. 34 Therefore, CR3022 may be developed to prevent and treat new coronavirus infection. Additionally, The janus kinase inhibitor baricitinib, which can disrupt receptor mediated endocytosis and interrupt the passage of the virus into cells, was identified to reduce the ability of the virus to infect lung cells and be a potential treatment for 2019-nCoV. 35 In addition to the therapeutics discussed above, Chinese healthcare practitioners also have started clinical trails of stem cell infusion and traditional Chinese medicine for severe patients. We expect that these therapies will improve clinical outcomes in 2019-nCoV patients.",13.811716350105886,9.786729644999523
Ventriculoperitoneal shunting,0.24267704585917121,3.7288944721221924,3.468282461166382,1597a29c-de35-47e5-81e1-6c9daf576415,custom_license/Hydrocephalus in Animals,"Meningioma is the most commonly reported brain tumor in dogs and cats (Troxel et al. 2003) . Canine and feline meningiomas are mainly located at the region of the cerebral convexities, but as a special characteristic in the cat, meningiomas can arise from the tela choroidea within the ventricular system, in particular associated with the third ventricle (Troxel et al. 2003) . In this location, they often block CSF flow, and the first symptoms of this tumor can be due to rapid ventricular distension (Nafe 1990 ). Location of the meningioma ventral to the brainstem or in the cerebellopontine angle can block CSF pathways. Radiation therapy is currently the therapy of choice for these tumors owing to the limited surgical accessibility. Ventriculoperitoneal shunting is recommended to improve clinical status in these animals until the tumor mass is sufficiently reduced to restore patency of the ventricular outflow.",14.518232977375536,9.75954654871901
integration therapies,0.47827250199293064,1.8541200160980225,2.4351463317871094,b954b842-4a26-498f-a4c3-6a78914243c0,custom_license/Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process $,"Our research group has committed to a CPG development progress that incorporates text mining and bioinformatics approaches that will help to produce valid CPGs while optimizing the use of limited resources. Ultimately, we hope that these changes will improve the clinical outcomes of individuals with integration therapies.",18.784047278996784,9.36243967377421
This technique would facilitate cost-effective diagnosis and improve clinical management of respiratory tract symptoms in hospitalized infected children,0.14682531236570517,1.2273430824279785,1.888869047164917,37bb7fa6-fb7a-4b4b-8c37-aac5fe3fab8c,custom_license/Detection of human Coronavirus 229E in nasal specimens in large scale studies using an RT-PCR hybridization assay,"This technique would facilitate cost-effective diagnosis and improve clinical management of respiratory tract symptoms in hospitalized infected children, thereby limiting unnecessary antibiotic use. Such a technique will be invaluable in epidemiological studies that are needed to firmly establish the medical importance of human Coronaviruses.",20.372125142828928,9.155781684225506
BARDA is supporting work to improve diagnostics with the goal of recognizing illness before any symptoms develop,0.28005778529616016,3.2766473293304443,3.6152191162109375,2f6d06d7-994e-450c-abbd-ade364689ab9,custom_license/Advances in respiratory virus therapeutics -A meeting report from the 6th isirv Antiviral Group conference,"For any outbreak, the faster the identification, the faster and more robust the response. BARDA is supporting work to improve diagnostics with the goal of recognizing illness before any symptoms develop. This may include wearable diagnostics or biosensors. The high mortality associated with human infections with novel coronaviruses MERS-CoV and SARS-CoV and avian influenza strains (influenza A(H5N1) and A(H7N9)) have raised questions about the possible role of a dysregulated immune response, a so called ""cytokine storm"", in the pathogenesis of severe respiratory disease. As some patients may not respond to typical anti-pathogen therapeutics (e.g. antivirals), BARDA is pursuing therapeutics which target the host in order to modify the immune/host response. More work needs to be done to identify these host targets and develop therapeutics towards the dysregulated immune response. The field also needs better diagnostics to guide treatment as over-suppression of the immune response can be just as dangerous as over-stimulation.",12.532417221016102,8.866059216957535
integration therapies,0.2311979040860314,0.8549687266349792,2.184725761413574,749fc2fe-eb5d-4868-96ea-394cbddc9e7f,custom_license/Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process $,"Our research group has committed to a CPG development progress that incorporates text mining and bioinformatics approaches that will help to produce valid CPGs for integration of CM and biomedicine while optimizing the use of limited resources. Ultimately, we hope that these changes will improve the clinical outcomes of individuals with integration therapies.",18.131695614742807,8.321894882391542
preruminant catves,0.3092706079327163,1.8222975730895996,3.5602612495422363,126f8369-f859-46cb-afd2-de6feeb54817,custom_license/Effect of Protein Source in Calf Milk Replacers on Morphology and Absorptive Ability of Small Intestine 1,"Further research is needed to develop processing methods for soy products, which will enhance their utilization by preruminant catves. There is also much more to be learned about the pathophysiological processes, especially those involved in immunological reactions related to feeding soy proteins to calves.",12.093853187755855,7.7315118504252425
veterinary neurology and neurosurgery.,0.239627955415909,1.4440778493881226,3.0214123725891113,292e8903-e2c1-4387-87fd-b7ea2ee0f0ac,custom_license/Hydrocephalus in Animals,"The focus of veterinary profession has shifted significantly over the past 100 years. Paralleling societal development, the role and importance of animals in our society has been continually evolving with dogs, cats, and horses leading the way. Dogs and cats are no longer kept for companionship purely; they have grown into family members, for whom highly specialized state-ofthe-art medical care is a matter of course. Especially the relationship of people with their dogs is a unique affectionate bond. Also in large animal medicine, the treatment of the individual animal is gaining more and more interest over of the health of the whole population. The increasing clients' expectations have influenced the level of the service provided. Many diagnostic and therapeutic procedures have been adopted from human medicine or developed independently and are widely available for veterinary use. Along with the establishment of veterinary specialty associations, this provided a stimulus for the development of new diagnostic and therapeutic methods and the pursuit of research to perpetually improve clinical practice in veterinary neurology and neurosurgery.",13.343249148481537,7.57270584625374
"focusing on diseases affecting the developing world, prioritizing TB, HIV, and malaria",0.20892627714369497,1.4679136276245117,2.539140224456787,05bb13c2-5ca3-43a3-b03e-7c0061478e08,"custom_license/The art of partnerships for vaccines q,qq","D. Robinson (BMGF) commented that innovative simplified processes can translate into capital savings and product costs in the developing world. Further, the recently founded Gates Medical Research Institute (GMRI) will take a small biotech approach to innovation for drugs, diagnostics and vaccines, to be transferred to manufacturers, focusing on diseases affecting the developing world, prioritizing TB, HIV, and malaria.",13.098270928985976,7.188979828997936
"there is a difficulty for implementation in most of the laboratories due to the need for specialized facilities and expertise, relatively prolonged time to detection",0.1327773260123789,1.2814829349517822,1.9424762725830078,a8373ba9-220e-4356-bbe9-19bd1a354081,custom_license/Diagnostic approaches for viruses and prions in stem cell banks,"Several tests could be included in the screening of other biological products for a wide range of viruses: the in vitro cell culture assay and the study in animals (EMEA, 1997). These are long standing techniques that rely on the ability of many viruses to cause cytopathic changes in cell culture or clinical changes in animals. However, there is a difficulty for implementation in most of the laboratories due to the need for specialized facilities and expertise, relatively prolonged time to detection (e.g. can prove difficult to implement the testing of time critical products) and the high cost.",14.547909263678442,7.187341727185068
bioengineering and semisynthesis will be used more frequently in combination to optimize natural products,0.11623641770608975,1.4273567199707031,1.1879310607910156,35d8dcf6-451d-4c4f-8bcf-1221970ad219,custom_license/Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection NIH Public Access Author Manuscript,"We also anticipate that in the era of rapid genome sequencing and gene synthesis, bioengineering applications will continue to become more amenable and offer a more flexible route to improve natural products with potent inhibition of cellular targets, but with less than optimum drug-like properties. We hope that in the future, bioengineering and semisynthesis will be used more frequently in combination to optimize natural products with an aim to select candidates for clinical development. ",15.350262905881852,7.072529074553765
specificity and sensitivity,0.17353487298417733,1.2415333986282349,2.1670925617218018,fd84cf58-db91-481e-a93a-cc5827c55c8f,custom_license/Immunochromatographic test for detection of adenovirus from respiratory samples: Is it a real solution for pediatric emergency department?,"The Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain) assay could be a simple and rapid method for antigenic detection of adenovirus in pediatric respiratory samples although it would be necessary to improve the specificity and sensitivity of the test.",13.827082014378272,7.055085579259918
developing new therapeutics and vaccines against helminths,0.15847520478729601,1.2079455852508545,2.3796260356903076,91f63a37-a00e-4fea-9faa-92a68adad7dd,custom_license/Organoids -New Models for Host-Helminth Interactions Trends in Parasitology,"The implementation of organoid models promises major new avenues for developing new therapeutics and vaccines against helminths, for understanding the anti-inflammatory effects of helminth infections, and for using helminths or their products as alternative therapies to treat inflammatory diseases.",12.770290817070965,6.801523339586593
To investigate the etiology of viral respiratory tract infections,0.17692436788013888,0.9384430050849915,0.6180182099342346,7c349a8c-5c88-4fba-9c89-49d824873401,custom_license/Epidemiologic Analysis of Respiratory Viral Infections Mainly in Hospitalized Children and Adults in a Midwest University Medical Center After the Implementation of a 14-Virus Multiplex Nucleic Acid Amplification Test,"Objectives: To investigate the etiology of viral respiratory tract infections mainly in hospitalized children and adults over a 12-month consecutive period after implementation of a 14-virus multiplex nucleic acid amplification test. , a total of 2,237 respiratory samples were analyzed with the US Food and Drug Administration-cleared eSensor Respiratory Viral Panel (GenMark Diagnostics, Carlsbad, CA).",12.82810218450535,5.50153555433937
Bioterrorism,0.33792987171074834,2.723824977874756,3.670474052429199,4ee3dbe6-2f3d-4c47-9b22-dc108baa3643,custom_license/How Outbreaks of Infectious Disease are Detected: A Review of Surveillance Systems and Outbreaks,"The recent SARS outbreak provides a concrete example of the importance of all five components in the early detection of outbreaks. In the SARS outbreak, the infectious agent spread around the world at the speed of airplanes, but information spread faster. The large number of infections that resulted from a few index cases in Hanoi, Hong Kong, Singapore, and Toronto would have been replayed in numerous countries had it not been for prompt communication and resulting public health investigations and control measures. This work was funded by the Agency for Healthcare Research and Quality (AHRQ) Contract No. 290-00-0009 (Using Information Technology to Improve Clinical Preparedness for Bioterrorism).",15.331917183063963,9.522465383769958
it can potentially prevent virus spread and significantly improve the clinical diagnosis and treatment of viral infectious diseases.,0.20921001839774148,2.084827184677124,3.444481372833252,5047c81c-18d6-42ab-a7b4-d7434557d62a,custom_license/Point-of-Care Microdevices for Blood Plasma Analysis in Viral Infectious Diseases,"In the near future, based on the progresses being made among various research fields, we can imagine more detailed analyses beyond simple viral detection. For example, the genomic sequence of a virus can be determined rapidly on-chip to identify the virus and track its mutation and evolution. Similar to bacteria culture and antibiotic screening, personalized drug response tests for viral infectious diseases may improve the efficacy of the viral drug treatment. On the technological side, new functional materials such as carbon nanomaterials or biodegradable polymers can potentially break the barriers to achieve higher sensitivity, selectivity and speed. In addition, more efficient miniaturization of macroscopic viral detection systems may provide a shortcut to improve performances in the micro and nano scales. Today, the development of point-of-care microdevices for viral infectious diseases is an active field. If its promises are realized, it can potentially prevent virus spread and significantly improve the clinical diagnosis and treatment of viral infectious diseases.",15.732047531640035,9.100267198455755
The section needs to include some consideration to the provision of clinical data to support major changes to established manufacturing processes,0.1477290388140592,2.028351306915283,3.5456371307373047,1d01e869-6f8c-4b32-b3a4-134104bcc1b9,custom_license/WHO Working Group on Technical Specifications for Man-ufacture and Evaluation of Yellow Fever Vaccines,"Dr Mair Powell (MHRA -Medicines and Healthcare Products Regulatory Agency, UK) outlined the information needed in the clinical section of the document. This should include guidance to companies and NRAs that is specific to the clinical evaluation of YF vaccines. The section needs to include some consideration to the provision of clinical data to support major changes to established manufacturing processes.",15.568472893088497,9.072057997055156
"mechanical ventilation or inotropic support, either on admission or following failure to improve or clinical deterioration with conventional therapy",0.17174933841097711,2.2413830757141113,3.059706687927246,aa74bf71-4b66-4ab0-b9d6-69f1303769c7,"custom_license/Respiratory Infections, Acute","Admission to the ICU is most often because of requirement for mechanical ventilation or inotropic support, either on admission or following failure to improve or clinical deterioration with conventional therapy. The use of noninvasive ventilation, particularly in pneumonia occurring in the COPD population, may support some patients sufficiently to avoid ICU admission. The American Thoracic Society (ATS) guidelines for admission to ICU include either of the following two major criteria: the need for mechanical ventilation or the presence of septic shock; or two out of three of the following minor criteria: multilobar disease, PaO 2 :FiO 2 ratio less than 250, or a systolic blood pressure less than 90 mmHg.",15.77375617725691,8.966523008406801
epidemiological research,0.3567652098702335,2.5855329036712646,3.896251916885376,e6224d61-dccf-4468-994e-93976976f4fa,custom_license/Bead-Based Suspension Arrays for the Detection and Identi fi cation of Respiratory Viruses,"Molecular analysis of infectious organisms is widely applied in healthcare and numerous applications using xMAP technology have been described for the detection of bacterial, viral, fungal and parasitic pathogens. Several commercial products are available for multiplexed detection and identi fi cation of respiratory viruses using xMAP bead-based suspension arrays, including the ResPlexâ¢ II Panel from Qiagen, Inc. (Valencia, CA), and the xTAG RVP and xTAG RVP FAST assays from Luminex Molecular Diagnostics, Inc. (Toronto, ON) . Since their development, these assays are being increasingly used for clinical diagnostics and epidemiological research, and numerous studies utilizing bead-based suspension array assays for respiratory virus detection have been reported.",13.553559138419507,8.956905831808644
viral respiratory infections,0.1691594837818305,1.6019123792648315,2.271660089492798,64b92c3a-a906-4870-bd39-f370ab02e304,custom_license/Detection of Respiratory Viruses from ARTI Patients by xTAG RVP Fast v2 Assay and Conventional Methods,"Various monoplex polymerase chain reaction (PCR)-based techniques have been developed to overcome the limitations of low sensitivity and slow turnaround times of current detection methods. However, monoplex PCR assays require separate amplification of each virus of interest. Thus, the development of highly sensitive and specific multiplex molecular assays is needed to provide a cost-effective method of diagnosis and improve clinical management of viral respiratory infections.",16.824254873468632,8.40631131040648
"convalescent plasma or therapeutic monoclonal antibodies, which could improve clinical outcome or paradoxically cause immuno pathological damage to the recipient",0.195091644060021,1.706702709197998,4.127462387084961,4423ef6f-581d-4864-8e95-3802add9c4c0,custom_license/Articles Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study,"Anti-NP IgM proportion of patients in the current study also had earlier IgG than IgM seroconversion. However, this finding could also be accounted for by a lower sensitivity of the IgM EIA, which warrants investi gations with more patients. Serum antibody levels were not correlated with clinical severity. Notably, one patient with severe disease had an early antibody response 6 days after symptom onset. Deceased patients infected with SARS-CoV developed faster peak anti-spike antibody responses when compared with patients who recovered 25 and had subsequent reduced B-cell immunity with impaired neutralising ability. In a SARS-CoV macaque model, anti-spike IgG stimulated pulmonary proinflammatory responses and caused acute lung injury. 26 The detrimental effect of antispike IgG was attributable to the effect on wound-healing macrophages, which was mediated via the FcÎ³ receptor. Our findings showing correlation between antibody level detected by EIA and virus neutralisation titre are especially important for design of vaccine studies, and use of convalescent plasma or therapeutic monoclonal antibodies, which could improve clinical outcome or paradoxically cause immuno pathological damage to the recipient.",12.510211007843786,8.170781165329249
EPC Gen 2 RFID technology has been implemented to track all steps of the transfusion process from taking blood samples to the final blood transfusion,0.20698156285902744,1.2794451713562012,2.8529019355773926,278aa09e-41d6-47cb-9a3d-e7b686c4b7cd,custom_license/Real-time location and inpatient care systems based on passive RFID,"Identification of blood containers: Productivity and safety of the blood product supply chain can be greatly enhanced by means of RFID. In EPCGlobal (2005) , authors assessed tag readability and performance in this environment, as well as tested temperature and biological effects of RF energy on blood products. They concluded that HF RFID performs adequately and safely for blood products, RFID has an impact in productivity and quality gains due to less process errors, better inventory management and avoidance of product discards. Moreover, regarding return on investment, authors calculated a pay-back period of four years for a mid-size blood center collecting 225.000 units/year. Further practical implementation in the area includes a pilot in four Italian hospitals where EPC Gen 2 RFID technology has been implemented to track all steps of the transfusion process from taking blood samples to the final blood transfusion. As an output of this practical implementation, human mistakes which could turn into lethal results were dramatically reduced in the processes of drawing donated blood, transporting it and administering it to a patient, reporting an error reduction by 100 percent, as well as work-reduction times.",15.426851872426564,8.085423774856132
Bismuth subsalicylate can improve clinical symptoms of viral gastroenteritis [108] .,0.1810473254862259,2.178464651107788,2.6419880390167236,c539a70f-bcdc-418a-bb23-9adfec9968e6,custom_license/Severe acute diarrhea,"Viruses commonly cause diarrhea but it is rarely severe [106] . Norwalk virus, Rotavirus, Astrovirus, Calicivirus, Coronavirus, Enterovirus, and enteric adenovirus (type 40,41) are waterborne or foodborne illnesses with an incubation period of 1 to 3 days. Associated symptoms are abrupt onset of nausea and abdominal cramps followed by vomiting or diarrhea. Fevers occur in approximately 50% of affected individuals. Headache, myalgias, upper respiratory symptoms, and abdominal pain are common. Stool studies are negative for fecal leukocytes and blood. The illness is usually mild and lasts 1 or 2 days. Oral fluids are generally suggested; intravenous fluids are only needed in rare cases [107] . Bismuth subsalicylate can improve clinical symptoms of viral gastroenteritis [108] .",13.903889411626215,7.999655542650107
"radiofrequency identification systems, in addition to improve patient's security and reliability of processes",0.281384032995506,2.2371814250946045,2.735281467437744,12b67e5b-14e5-4409-9933-5ad4977b79ca,custom_license/Real-time location and inpatient care systems based on passive RFID,"Examples described here show an increasing interest by hospitals and health centers in integrating RFID technology in their processes. Recent initiatives have started to show that radiofrequency identification systems, in addition to improve patient's security and reliability of processes, are able to produce a return of investment as has been previously exposed. Based on these results, a larger number of healthcare applications will consider applying this technology.",12.851736842880783,7.730208775154301
production of food products and additives,0.11746894890247615,1.7056505680084229,2.4844541549682617,bd050cda-4190-4e57-a72a-7dc4b9409242,"custom_license/DEALING WITH BIO-AND ECOLOGICAL COMPLEXITY: CHALLENGES AND OPPORTUNITIES ""Status report prepared by the IFAC Coordinating committee on Bio-and Ecological Systems"" by","The goal of biotechnological processes is to optimise the performance of processes involving industrially important organisms (e.g. for the production of food products and additives), biomedically relevant species (e.g. for the production of antibiotics and other therapeutics) and the degradation of pollutants (e.g. wastewater treatment). This last area has been assuming ever-increasing importance during the past few years.",13.649730621282103,7.500973787383581
"help improve public confidence in the current control approaches which do work, with understanding that even better technologies are on the way.",0.10100514037624911,1.751664400100708,2.2375717163085938,4674b3cd-0f75-4ed0-90aa-9a6cb71d46ee,custom_license/Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries,"Globally, we now have an unbalanced situation, with some developed regions moving toward widespread implementation of vaccine programs for seasonal influenza while others are suspicious of current programs and not willing to use technologies that they can easily afford. The rest of the world, where most people live, is only gradually gaining awareness that a problem exists. This is an unsustainable situation. We should try to move to a more uniform global recognition of the importance of seasonal and pandemic influenza, and help improve public confidence in the current control approaches which do work, with understanding that even better technologies are on the way.",11.139081612830786,6.491682040156821
"Selected themes include advances in point-of-care diagnostic testing, glucose control, novel microbiological diagnostics and infection control measures",0.09290701737162131,2.3724656105041504,1.648877501487732,00e81b24-d55d-436f-8a8d-6c7404a319fc,custom_license/Canadian Coordinating Office for Health Technology Assessment (CCOHTA),"This commentary represents a selective survey of developments relevant to critical care. Selected themes include advances in point-of-care diagnostic testing, glucose control, novel microbiological diagnostics and infection control measures, and developments in information technology that have implications for intensive care. The latter encompasses an early example of an artificially intelligent clinical decision support mechanism, the introduction of a national health care information technology programme (UK NPfIT) and its implications, and exotic threats to patient safety due to emergent behaviour in complex information systems. Keywords glucose, health technology assessment, information technology, intensive care, point-of-care US Food and Drug Administration (FDA) http://www.fda.gov/ UK Medicines and Healthcare Products Regulatory Agency (MHRA)",10.800145249532926,6.393923860131247
competencies may vary with the mission and goals of each school,0.09471617017992603,-0.197818323969841,0.9911883473396301,3a5d3759-4920-44dd-a277-e1e5d0324136,custom_license/Human Resources for Health Learning Objectives,"The competencies are intended to serve as a resource and guide for improving the quality and accountability of public health education and training. They are not meant to prescribe the methods or processes for achievement, recognizing that implementation of the competencies may vary with the mission and goals of each school.",14.25795390145227,5.505974380698657
electronic medical records,0.2608124560498469,0.3268831670284271,0.18793749809265137,3b3d6eea-e5e0-45b0-ba30-94451fe3a3c4,custom_license/Canadian Coordinating Office for Health Technology Assessment (CCOHTA),"How much of this is relevant to critical care or to other countries? First, ICUs provide complex, time-sensitive care to highly dependent patients. They therefore require the successful convergence of multiple hospital systems, which makes them uniquely vulnerable to the consequences of system failures, whether in diagnostics, supplies, information flow, or indeed electrical power. Second, the currently stated UK NPfIT vision is that all ICU subsystems, including networked monitoring, telemetry and audit systems, will eventually be integrated into NPfIT, with control over equipment selection and data collection handed to the regional private sector consortia and to national audit bodies. Clinician engagement and choice may not feature highly on the agenda, and there are clear concerns over the future of independent research and audit. Finally, clinicians from other countries would be well advised to follow such developments because the UK is not unique in its desire to radically modernize and standardize health IT, starting with a drive toward electronic patient records. In April 2004, President Bush issued an executive order calling for US national implementation of electronic medical records within 10 years, from a current baseline of 19% implementation. In a series of presidential speeches he went on to further define health care objectives substantially similar to the UK NPfIT agenda [22] .",11.27059929230135,4.279343184634174
Culture-independent diagnostic tests represent the application of these advanced technologies to clinical diagnostics and disease surveillance,0.33121738834328435,2.513254404067993,3.091109037399292,5da7a204-e8ed-4583-a86f-27fdcc2663de,custom_license/Clinical Infectious Diseases Development and Implementation of Multiplex TaqMan Array Cards for Specimen Testing at Child Health and Mortality Prevention Surveillance Site Laboratories,"TAC has proven to be a useful modern tool for global disease surveillance and outbreak response, even in resourcelimited settings. However, infectious disease diagnostics rapidly evolve, and continual advancement is inevitable. The dramatic increase in widespread use of next-generation sequencing technology in clinical, academic, and public health laboratories worldwide signals a substantial shift in laboratory capacity. Culture-independent diagnostic tests represent the application of these advanced technologies to clinical diagnostics and disease surveillance. As CHAMPS moves forward, we will continue to pursue emerging advanced technologies for application to MITS specimen testing. Continual improvements in reagents, equipment, and analysis pipelines for targeted resequencing or metagenomics may enable more widespread use of these approaches in resource-limited settings, and CHAMPS sites are interested in pursuing their implementation. Deep sequencing analysis of specimens in which no pathogens are identified using TAC may provide a good starting point for implementation of these methods. However, next-generation sequencing methods are currently costprohibitive in many settings. Other technical barriers, such as laboratory infrastructure, equipment technical support, and reagent procurement may be restricting factors. Access to bioinformatics resources and high performance computing capacity is a major obstacle to implementation. Examination of specimens for unique biomarkers may also provide added value to cause of death determination. However, all of these methods require substantial further development prior to implementation with clinical specimens within laboratories in resource-limited settings.",17.211817063700813,9.66697220924902
the division of ARDS into specific subphenotypes will improve clinical outcomes,0.19841335665377438,2.5206458568573,2.7468011379241943,afb6a3f2-5eb6-46bf-9752-ee2de7141130,custom_license/Diagnostic workup for ARDS patients,"At the moment, the clinical impact of ARDS phenotype identification hinges on whether the division of ARDS into specific subphenotypes will improve clinical outcomes. Assessment of severity of ARDS using the PaO 2 /FiO 2 ratio already has important implications for clinical practice and should be carefully considered in all patients. For most of the other proposed subphenotypes of ARDS, the question of clinical impact remains open. Studies are ongoing to determine if patients with diffuse versus focal ARDS respond differently in a randomized controlled trial of mechanical ventilation practices (NCT02149589), and if the hyper-and hypo-inflammatory subtypes respond differently to randomly assigned therapies other than PEEP.",17.64580299056174,9.59987159330458
EMR exchange is necessary when a co-treating clinician is not able to access a patient's records directly,0.3794699844915615,1.700150489807129,2.28715181350708,8c20116a-ef1a-4856-ba13-594e9c4189b7,custom_license/Factors affecting cross-hospital exchange of Electronic Medical Records,"EMR exchange is necessary when a co-treating clinician is not able to access a patient's records directly [18] . Based on the survey of Shapiro et al. [16] , 97% emergency physicians believed that the exchange of health information would improve clinical care. But there were 86% emergency physicians who thought it would be difficult to obtain relevant clinical information from external sources.",19.600291977436598,9.451848689257044
previously healthy children. Rigorous evaluation of optimal antimicrobial and other therapeutic strategies,0.12828085429319977,2.094616651535034,1.8745290040969849,eda29da3-5a16-47be-a8da-d1671a159da3,custom_license/Clinical Infectious Diseases Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness ; for the Pediatric Intensive Care Influenza Investigators from the Pediatric Acute Lung Injury and Sepsis Investigator's Network,"previously healthy children. Rigorous evaluation of optimal antimicrobial and other therapeutic strategies to improve the clinical outcomes of this devastating combination is impeded by its sporadic occurrence and fulminant course. Although 838 children with confirmed or suspected 2009 pH1N1 were identified across 35 US pediatric intensive care units (PICUs) in 2009, only 34 cases of MRSA coinfection were reported [5] .",18.370530616114074,9.009630391800737
purified with affinity columns,0.1624399127871238,1.892115831375122,2.7067952156066895,043a033b-7470-49b9-ac0e-3a2a62ecfeca,custom_license/Biomedical Science Original Paper Early Detection of Antibodies against Various Structural Proteins of the SARS-Associated Coronavirus in SARS Patients,"HRP-conjugated goat antihuman immunoglobulins, IgA (c~ chain), IgG (3' chain), and IgM (g chain), were purchased from Savyon Diagnostics (Ashdod, Israel). These products were purified with affinity columns. ",14.303213020376237,7.99541673766986
improve clinical outcome.,0.1739661609529846,0.6716002821922302,2.2253379821777344,b9881f9c-fc0f-4fd0-b4c0-2c67ef4e1f36,custom_license/Complement inhibition in biomaterial-and biosurface-induced thromboinflammation,"Thromboinflammation is a major obstacle in modern therapeutic medicine. The term ""thromboinflammation"" refers to adverse inflammatory and thrombotic crosstalk-reactions, which are initiated and propagated by the different constituents of the innante immune system, which ultimately may result in thrombosis and/or chronic inflammation. Thromboinflammation is triggered by biomaterials, which lack the physiological inhibitors present on autologous cells, as well as by therapeutic cells in contact with blood. If uncontrolled, these adverse reactions may cause damage to an implant, a graft, and/or the recipient. Therefore, control of thromboinflammation is a major hurdle to overcome in order to improve results in a number of treatments using biomaterials and transplantation of cells and/or whole organs. Targeting the surface of biomaterials and the surface for therapeutic cells and solid organs with specific inhibitors is a promising approach to decrease thromboinflammation and thereby improve clinical outcome.",16.475790410504565,7.649536515517074
"technical support and performance verification for these products is limited, and panels are not customizable to include pathogens specific to the population under surveillance.",0.2105762782274689,2.3607473373413086,1.8972538709640503,d3eda7b1-4ded-4c17-a6ca-6b79433493a7,custom_license/Clinical Infectious Diseases Development and Implementation of Multiplex TaqMan Array Cards for Specimen Testing at Child Health and Mortality Prevention Surveillance Site Laboratories,"In recent years a variety of multipathogen detection methods have become commercially available, some of which have been evaluated and used in multisite surveillance studies [2, 3] . A number of platforms were considered for CHAMPS; each has both positive and negative attributes for use with CHAMPS specimen types and implementation in resource-limited settings. Biofire Film Array (bioMÃ©rieux), approved by the US Food and Drug Administration for clinical use, is increasingly common in clinical laboratories in the United States, particularly for respiratory and enteric pathogen detection. The entire testing procedure occurs within a single instrument without a separate step for nucleic acid extraction. Only a single sample can be tested at one time, making throughput a major drawback for implementation of this technology in surveillance studies. In addition, the panels are limited to a defined set of pathogen targets and cannot be customized to allow screening for pathogens specific to a geographic region or patient population. Fast Track Diagnostics (FTD) syndromic panels are commercially available multiplex real-time PCR panels amenable to surveillance applications. FTD respiratory panel 21 was recently used in a large multisite study for respiratory pathogens [4] , and diagnostic kits for a range of syndromes are available from this manufacturer. However, assay setup and analysis is complex and prone to operator error, in particular due to the open nature of the system in which the potential for cross-contamination is high. Lack of replicate reactions introduces further potential for unidentified erroneous results. Finally, technical support and performance verification for these products is limited, and panels are not customizable to include pathogens specific to the population under surveillance.",13.797316941797266,7.596761715027526
efficiency,0.2721909170544416,1.4930391311645508,3.3544845581054688,6b5f7f63-2037-4385-90af-e0da571be67c,custom_license/The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives,"Nature has designed the central scaffold of, e. g., Tetrodotoxin (1) to improve its efficiency, and the medicinal chemistry of adamantane derivatives can be regarded as an example for the design of primarily all-synthetic drugs to achieve the same ultimate goals, that is, high potency and selectivity. While the natural products hitherto mentioned stem from plant and animal sources, one must not forget that adamantane 13 4 and the higher diamondoids 90 up to at least undecamantane are found in trace amounts in most raw petroleums and are, therefore, natural products as well (Scheme 3).",12.341229194075495,7.470320615951936
quality control programmes and methods which reflect current best practices,0.15529391772656378,0.6048349738121033,0.8044797778129578,b9749838-7a83-456f-8cd4-87ba12801f12,custom_license/MINI-REVIEW Microbiological control in stem cell banks: approaches to standardisation,"Stem cell banks must assure the quality, traceability and safety of these products, and these aims are particularly important in the avoidance of transmissible diseases. This should be achieved with close attention to the standardisation of processes and the implementation of quality control programmes and methods which reflect current best practices.",18.61754554019221,7.432195527623564
"vaccine fermentation and purification processes are mostly animal component-free to avoid the potential BSE/TSE risks, especially for final products",0.19540210889390477,1.6773401498794556,2.7224411964416504,abe31511-2800-4a23-92f2-7d9807a70ca6,custom_license/Advances in Vaccines,"The raw materials and media used for vaccine fermentation and purification processes are mostly animal component-free to avoid the potential BSE/TSE risks, especially for final products.",12.637996824926041,7.283156763832833
more outpatient treatment of low-risk patients and higher compliance with antibiotic recommendations,0.2622146543405223,1.9694678783416748,2.5365989208221436,487353e7-f6a2-4309-ae01-8d587d2aa7b9,custom_license/Health Science Center and 4 South Texas Veterans Health Care System,"Yealy et al. [50] conducted a cluster-randomized trial of low-, moderate-, and high-intensity processes of guideline implementation in 32 EDs in the United States. Their guideline used the PSI for admission decision support and included recommendations for antibiotic therapy, timing of first antibiotic dose, measurement of oxygen saturation, and blood cultures for admitted patients. EDs with moderate-to high-intensity guideline implementation demonstrated more outpatient treatment of low-risk patients and higher compliance with antibiotic recommendations. No differences were found in mortality rate, rate of hospitalization, median time to return to work or usual activities, or patient satisfaction. This study differs from those reporting a mortality rate difference [19, 21] in that many hospitalized patients with pneumonia were not included. In addition, EDs with low-intensity guideline implementation formed the comparison group, rather than EDs practicing nonguideline, usual pneumonia care.",12.05852293532639,7.149426446820717
quality of care in the United States,0.19266556245073813,0.8443642258644104,2.5718748569488525,4e7797f2-6e43-4557-a894-3c1b0747bc3c,custom_license/The Future of Emergency Medicine Public Health Research,"The Institute of Medicine (IOM) outlined six aims to improve the quality of care in the United States [72] . The implication of each of these for future EM research was presented at an SAEM 2002 consensus conference [73] . These suggestions are very applicable to EM public health research. They suggest identifying whether ED care is effective (''based on the use of systematically acquired evidence to determine whether an intervention, such as a preventive service, diagnostic test, or therapy, produces better outcomes than alternativesdincluding the alternative of doing nothing'') [72, 74] , efficient (avoids the waste of equipment, supplies, money, ideas, or energy) [72] , timely (able to avoid delays caused by patient, provider, or system factors), safe (''when patients [can] avoid injury from the care that is intended to help them'') [72, 75] , patient-centered (care that promotes patient involvement in medical decision making and helps care providers ''in attending to their patients' physical and emotional needs, and maintaining or improving their quality of life'') [72] , and equitable (free of bias). To identify opportunities for research within each of these six quality domains, the authors classify current research into four research steps that build upon each other: (1) evidence does not exist and there is a need to generate rigorous research studies, (2) evidence exits but there is a need for synthesis of existing evidence into guidelines and quality measures, (3) there are existing evidence-based clinical guidelines and measures and a need for assessment of the quality of clinical practice compared with evidence-based guidelines and quality measures, and (4) there is a need to design and evaluate new interventions to improve clinical quality of care.",12.966269853912506,6.758749852697997
the process/product is tightly linked with clinical experiences and outcomes,0.153504373987331,0.9314708113670349,1.7989879846572876,3c451a6d-65dd-47c1-869f-fa26df05446e,custom_license/Advances in Vaccines,"During the manufacturing of biological products including vaccines, it is often considered that process is product, and the process/product is tightly linked with clinical experiences and outcomes. Major changes in manufacturing facilities or manufacturing processes may require regulatory approval or even conducting additional clinical trials. Thus for vaccine manufacturing, once a process is confirmed, it is usually not changed unless there is a strong reason to make a major change. This situation makes process improvements for existing vaccines challenging.",13.466730381794047,6.488153851043726
"Hypothesis decisions as a surrogate of the patient,",0.12586747343231383,0.3460898995399475,0.9983071684837341,fbeafc31-c8e6-4045-8ee0-f3a493a1c117,custom_license/Salutogenesis: The Defining Concept for a New Healthcare System,"Hypothesis decisions as a surrogate of the patient, to identify and use community agencies and services and to serve as knowledgeable informants to the clinician. They are an integral member of the care team and thus crucial to the patient's overall support system and well-being. [35] [36] [37] When healing relationships are embedded into the culture and leadership of an organization, it is possible to have a healing organization. Healing organizations create an expectation that staff are knowledgeable, skilled, caring practitioners who demonstrate mutual respect, practice honest communication, refer appropriately, share a commitment to the concept of healing, work as a team, create integrated plans of patient care, and focus on treating the whole person regardless of their individual specialty training. 38 Healing organizations have the ability to implement effective and efficient integrative care teams and to provide a range of interconnected services that support patients and their families seamlessly throughout the continuum of care. This is accomplished through transformational and mindful leadership, a clear and focused mission and values statement, and formal policies embracing a healing environment and fostering healing behaviors. A healing organization adopts a philosophy of person-centered care and participatory teamwork and provides the technology, equipment, facilities, and supplies that support healing practices and regular monitoring, evaluation, and continuous improvement. 2 These types of clinical teams are shown to cut costs, improve clinical outcomes, reduce mortality, enhance staff morale, and improve patient satisfaction. 39, 40 ",13.93695464935404,5.751792221489307
surface modification of biomaterials and cells with specific inhibitors in order to diminish thromboinflammation and improve clinical outcome.,0.12911481172345443,0.26381054520606995,1.9893721342086792,673ebda9-bed3-468b-ae80-0e7c5f76b92a,custom_license/Complement inhibition in biomaterial-and biosurface-induced thromboinflammation,"Therapeutic medicine today includes a vast number of procedures involving the use of biomaterials, transplantation of therapeutic cells or cell clusters, as well as of solid organs. These treatment modalities are obviously of great benefit to the patient, but also present a great challenge to the innate immune system, since they involve direct exposure of non-biological materials, cells of non-hematological origin as well as endothelial cells, damaged by ischemia-perfusion in solid organs to proteins and cells in the blood. The result of such an exposure may be an inappropriate activation of the complement and contact/kallikrein systems, which produce mediators capable of triggering the platelets and PMNs and monocytes, which can ultimately result in thrombotic and inflammatory (i.e., a thrombo-inflammatory) response to the treatment modality. In this concept review, we give an overview of the mechanisms of recognition within the innate immunity system, with the aim to identify suitable points for intervention. Finally, we discuss emerging and promising techniques for surface modification of biomaterials and cells with specific inhibitors in order to diminish thromboinflammation and improve clinical outcome.",11.751701039129301,5.577664105314843
a series of antibiotic drugs have failed to improve the clinical condition,0.18651927847685987,2.3293957710266113,2.6893343925476074,5b9fe2e7-39fc-4114-975e-6f2b3dfeed7a,"custom_license/5 Microbiology, Antimicrobial Susceptibility, and Antibiotic Treatment","Tympanocentesis with culture of MEF should be considered for bacteriologic diagnosis and susceptibility testing when a series of antibiotic drugs have failed to improve the clinical condition. If tympanocentesis is not available, a course of clindamycin may be used, with or without an antibiotic that covers nontypeable H. influenzae and M. catarrhalis, such as cefdinir, cefixime, or cefuroxime.",21.156803007664315,10.66705565900575
"ulcerative colitis, and hasten colon healing",0.2482436829966206,2.926501989364624,3.6180050373077393,70b1c490-4bda-4feb-a1a5-4f086218b7bd,custom_license/3.1-Examination for Disorders of the Gastrointestinal Tract Physical Examination,"One can add psyllium mucilloid to the diet (5 tablespoons once or twice daily) to increase the production of SCFAs in the colon. Amylase-resistant fermentable fiber such as psyllium is hydrolyzed by colonic bacteria to SCFAs such as butyrate, which represent a major energy source for colonocytes. Butyrate and other SCFAs hasten epithelial maturation and stimulate salt (and thus fluid) absorption in the colon, improve the clinical course of ulcerative colitis, and hasten colon healing. 226 Psyllium is itself a source of butyrate in the colon and also promotes the movement of amylase sensitive carbohydrates into the distal colon, which then are fermented to SCFAs. Thus psyllium is thought to be clinically useful for promoting mucosal healing in colitis.",16.453548694357664,10.012671610362219
"the administration of E-64 together with other traditional therapies, including immunoprophylaxis, may improve clinical outcomes.",0.1204984399495789,1.250449538230896,1.4076881408691406,3698758b-0655-441d-823f-01d1175be45f,custom_license/Dose-response inhibition of proteolytic activity by a cysteine protease inhibitor in a murine model of fasciolosis,"In summary, it is reasonable to suggest that the cysteine proteases of F. hepatica remain a promising target for the development of chemotherapeutic agents, and that the administration of E-64 together with other traditional therapies, including immunoprophylaxis, may improve clinical outcomes.",22.316662659282695,9.538621422163967
molecular diagnostics,0.45258779070769795,2.2783539295196533,2.5449886322021484,d6792871-3779-432f-a71d-9df2c7bca4a2,custom_license/Looking for Cryptosporidium: the application of advances in detection and diagnosis,"Expected advances for clinical diagnosis of Cryptosporidium infections may come from the direct application of next-generation sequencing to faecal samples because this platform will allow the detection of multiple pathogens and their variants based directly on the presence of their DNA. More imminent is the implementation of molecular diagnostics. However, adopting these new technologies in a clinical laboratory involves significant changes to the current workflows, as depicted in Figure 2 .",17.5199121921551,9.267141932373455
treatment with high-dose corticosteroids can improve the clinical course of viral CAP,0.16943926263934334,3.100755214691162,3.468475341796875,72dd9ea7-79c0-42d8-b16d-2354eec50b3c,custom_license/Review of Non-bacterial Infections in Respiratory Medicine: Viral Pneumonia à¬,"Until recently, only supportive treatment has been available. However, some antiviral medications are currently under investigation. The cytidine analog, cidofovir, originally developed as treatment for CMV, has shown success in vitro against adenoviruses, although the response in immunocompromised patients with several forms of severe pneumonia was poor. 101 Intravenous ribavirin has been used with success in lung transplant recipients with respiratory infections caused by metapneumovirus. 102 Pleconaril, which incorporates itself into the capsid of Rhinovirus and Enterovirus, has been successfully used in limited case series; it is not yet on the market and is limited to compassionate use. 103 There is little doubt that intravenous acyclovir is beneficial in the rare cases of varicella zoster pneumonia in immunocompromised patients. 85, 104 Lastly, treatment with high-dose corticosteroids can improve the clinical course of viral CAP, 85 although this application is still controversial.",13.630106774936547,9.040537232945015
"Sour milk, a product containing lactose-producing Streptococcus species, appears to improve the clinical course",0.23159231481798095,1.947873830795288,3.0813088417053223,3f62832d-9510-40b6-8236-fec0e176fdad,custom_license/3.1-Examination for Disorders of the Gastrointestinal Tract Physical Examination,"Because altered large intestinal flora appears to play an important role in the pathogenesis of equine intestinal clostridiosis or any antibiotic-associated diarrhea, probiotic preparations have been advocated to treat affected horses. Sour milk, a product containing lactose-producing Streptococcus species, appears to improve the clinical course greatly in horses suspected of having Clostridium perfringens type A infection. Sour milk may benefit the patient by altering the flora and antagonizing enterotoxigenic C. perfringens type A but also is reported to be bactericidal against C. perfringens type A. 78 Preparations of Saccharomyces boulardi are effective for reducing diarrhea and the frequency of C. difficile recurrence in human beings. 83 However, whether relapse is a problem in horses with C. difficile colitis is not clear. Lactobacillus preparations have a protective effect in human beings and decrease the severity and duration of antibioticassociated diarrhea. 242, 243 However, evidence of their clinical usefulness in horses is lacking.",14.296359224181948,8.272694465589078
Monoclonal and polyclonal antibodies against equine TNF,0.47338477449635563,2.4158847332000732,2.645392894744873,ee6d8077-bf3b-4f75-a033-c565995b153a,custom_license/3.1-Examination for Disorders of the Gastrointestinal Tract Physical Examination,"Monoclonal and polyclonal antibodies against equine TNF have been evaluated. [177] [178] [179] Administration of a monoclonal antibody preparation before lipopolysaccharide infusion resulted in significantly reduced plasma TNF-activity, improved clinical abnormality scores, lower heart rate, and higher leukocyte count compared with controls. 178 Furthermore, plasma concentrations of lactate and 6-keto-PGF 1Î± were reduced significantly, whereas TXA 2 production was not affected. 177 In another study, 179 administration of a rabbit polyclonal antibody against recombinant human TNF was unable to improve clinical and hematologic parameters when given shortly (15 minutes) after lipopolysaccharide infusion, although inhibition of TNF activity was present in vitro. 179, 180 Findings in horses are in agreement with studies in other species and suggest that beneficial effects of TNF inhibition may be limited to administration before lipopolysaccharide exposure. Widespread clinical use therefore is unlikely to become feasible. Clinical trials in human patients have not shown significant benefits of TNF antibody treatment. 181, 182 ",13.93858129363984,8.16833391093816
"obligate monomeric (Moulaei et al., 2010) or dimeric (Takahashi et al., 2011) proteins",0.19569451130487334,2.6393113136291504,2.47346830368042,50bbf065-674e-459a-ad3f-5b424157c912,custom_license/Antiviral lectins: Selective inhibitors of viral entry,"Other modifications affect the immunogenicity of antiviral proteins including the modification of CV-N with polyethylene glycol (PEG) to reduce immunogenicity and increase its half-life in serum (Zappe et al., 2008) and the genetic engineering of BanLec to reduce the presence of antigenic epitopes (Swanson et al., 2010 (Swanson et al., , 2015 and reduce its immunogenicity. The H84T mutation in Ban-Lec is thought to mediate mitogenicity by imparting decreased affinity for complex sugars. Hybrid lectins have also been produced from PFA and OAA to render a protein OPA with improved activity (Koharudin et al., 2012) . Other modifications in structure have produced obligate monomeric (Moulaei et al., 2010) or dimeric (Takahashi et al., 2011) proteins in an effort to improve clinical potential. Significant research into these potentially useful modifications is necessary to truly develop these agents for human use.",12.978277698332635,7.865703945667643
"carefully design, develop, and optimise diagnostics pipelines before attempting to apply them to clinical samples",0.14622771324885367,1.7118480205535889,3.2143049240112305,1f782491-69ce-455d-94f4-0ff15f5c3df2,custom_license/Speaker Presentations,"There are challenges in applying sequencing to infection diagnosis, however, including high human:pathogen nucleic acid ratios, low pathogen numbers and low quality nucleic acid, depending on the disease and the clinical sample type. It is, therefore, vital to carefully design, develop, and optimise diagnostics pipelines before attempting to apply them to clinical samples. I will describe how we develop our MinION based infectious diseases diagnostics pipelines with examples from our ongoing research on pneumonia, sepsis and UTIs.",13.233217026468315,7.833625373231042
to guide treatment programs and vaccine development,0.19409821261497295,2.386025905609131,2.7569549083709717,1b7dbd20-86dd-47ff-9e1b-c0e9553d92c0,custom_license/Genomic Analysis of Viral Outbreaks,"Applying molecular biology tools to traditional epidemiology has greatly improved outbreak monitoring and prevention for all types of viral diseases. These tools include genotypic and phenotypic methods to determine the specific strain or type of virus circulating in a population. They can be used to improve diagnostics, to guide treatment programs and vaccine development, and to trace the spread of pathogens [7] [8] [9] [10] .",12.808653948334372,7.825966411004097
high cost,0.21940273856537892,1.8143370151519775,1.6401125192642212,3307e364-68f7-4f8f-93f2-3de2e99b23ab,custom_license/Self-disinfecting surfaces and infection control,"There are still some issues to improve, like the long-term efficacy of the antimicrobial/anti-adhesive action, or the high cost of implementation of these surfaces in large areas.",15.700931068989506,7.740718071516856
"IVIG could transiently improve the clinical condition, HSCT is the most effective therapy for this disease at present.",0.1860067440461276,2.254136800765991,1.9940083026885986,cdf364ea-840d-4bae-b671-e63fec837654,custom_license/Heterozygous Mutations in OAS1 Cause Infantile-Onset Pulmonary Alveolar Proteinosis with Hypogammaglobulinemia,"Lung transplantation is a curative treatment for GPAP caused by mutations in genes encoding surfactant proteins or genes encoding a surfactant phospholipid transporter in alveolar type II epithelial cells. 34 On the other hand, HSCT is effective for GPAP caused by mutations in genes that could be responsible for surfactant catabolism in AMs. 35 In this study, two affected individuals (B-II-1 and C-II-1) received successful HSCT and recovered completely from PAP. C-II-1 has had cord blood engraftment for 2 years without any respiratory symptoms. It has been reported that AMs are derived from precursor cells in bone marrow. 36 Pulmonary transplantation of differentiated wild-type AMs derived from bone marrow in GM-CSF receptor-b-deficient mice showed long-term effectiveness due to proliferation of transplanted AMs. 37 Although IVIG could transiently improve the clinical condition, HSCT is the most effective therapy for this disease at present.",12.62605373569191,7.180413124737652
Scientists must learn from previous mistakes and combine efforts to improve preclinical-to-clinical translation,0.3594097608967944,1.7745716571807861,2.5097618103027344,88d6235e-476b-4f82-91f2-e24364e66959,custom_license/3D organ models-Revolution in pharmacological research?,"Organ models hold the potential to revolutionize preclinical research, although there is still a long road ahead and the predictivity of most organ models has yet to be proven. Pharmaceutical companies and regulatory authorities have recognized the importance of this technology and are highly engaged with them. Scientists must learn from previous mistakes and combine efforts to improve preclinical-to-clinical translation. In this regard political and financial support is pivotal. Furthermore, joint efforts of expert groups in academia, pharmaceutical industry, and regulatory authorities are now needed to approach and overcome current bottlenecks. Accordingly, governments initiatives are required to promote not only the development of organ (disease) models but also their implementation in preclinical drug testing, otherwise the full potential of organ models may never be realized.",12.26413570585259,7.077264250912695
resuscitation systems,0.19810508889501494,1.4348304271697998,1.743294596672058,16265a71-9104-4b74-889d-955f96a6b72b,custom_license/Part 1: executive summary: 2010 International Consensus on Cardiopul-monary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations,"Although extrapolation from randomised and observational studies of systems of care for other acute time-sensitive conditions (trauma, STEMI, stroke) suggests that specialised cardiac arrest centers and systems of care may be effective, there is insufficient direct evidence to recommend for or against their use. There is insufficient evidence to make recommendations supporting or refuting the effectiveness of specific performance measurement interventions to improve processes of care and clinical outcomes in resuscitation systems.",13.956405420455829,6.950523162656747
"Blood banks and transfusion services must have processes for identification, quarantine, retrieval, and recall",0.2488314059307048,1.7532414197921753,1.4342132806777954,98c59148-fc4b-4d91-ad6a-1b9170474e47,custom_license/Managing Recalls and Withdrawals of Blood Components,"In the 22nd edition of the Standards of the American Association of Blood Banks (AABB), effective November 2003, chapter 7 is on deviations, nonconformances, and complications. 25 Standard 7.0 requires policies, processes, procedures and defined responsibility for detecting, investigating, and reviewing deviations. Standard 7.1 and its subsections call for nonconforming products to be evaluated, traced, segregated if still present, and prevented from unintended use. Blood banks and transfusion services must have processes for identification, quarantine, retrieval, and recall. Nonconforming products that already have been released must be evaluated for quality, and when quality may have been affected, the nonconformance shall be reported to the customer. (The ""customer"" is defined elsewhere as the receiver of a product or service, either another organization or another department within the same organization. In this context of nonconforming products, the ""customer"" does not refer to the patient who received the product.) Records of product nonconformances and actions about them must be maintained for 5 years (reference standards 6.2A and 6.2C).",13.505095780569095,6.798629078504664
treat or prevent multiple viral and bacterial diseases,0.23158026430211343,2.499288320541382,4.981945037841797,204aae42-c98b-4b83-aa55-8839502fcceb,custom_license/History of Passive Antibody Administration for Prevention and Treatment of Infectious Diseases,"Purpose of the review-We describe the history of passive immunization to provide context for the series of articles to follow. The history of passive immunization with antibodies to prevent or treat infectious diseases is a story of different eras. There was an extraordinary era of discovery and clinical implementation before the chemical nature of antibodies was even known. This empirical process provided the resources and reagents used to describe and characterize humoral immunity, better define the chemical properties and structure of antibodies, and extend the clinical use of immunoglobulin products to treat or prevent multiple viral and bacterial diseases over the ensuing several decades. The next distinct era came with the discovery of processes to produce monoclonal antibodies (mAb), and development of more specific therapies. Interestingly, mAb technology resulted in many products to treat autoimmune and allergic diseases, but only one common infectious disease, respiratory syncytial virus, and only in a restricted population of highrisk infants.",16.529026337932237,10.64796090122535
IT systems that support the integration of electronic healthcare records (EHRs) can enhance the adoption and implementation of ASPs in healthcare settings,0.2293364158735197,2.2285335063934326,2.9467239379882812,56e058e6-7cb9-495b-8e9e-38fb6466bbb7,custom_license/Barriers to implementing antimicrobial stewardship programmes in three Saudi hospitals: Evidence from a qualitative study,"The lack of interdepartmental collaboration within Saudi hospitals is related to communication, which has also been identified as poor, and a significant organisation cultural barrier to quality improvement initiatives within Saudi hospitals [24] and others [22, 26] . IT can potentially improve interdepartmental communication and improve patient safety in hospitals [27] . Moreover, the use of sophisticated IT systems that include computerised clinical decision support systems can improve antimicrobial prescribing practices and reduce the rates of healthcare-associated Clostridium difficile infection [28] . Moreover, IT systems that support the integration of electronic healthcare records (EHRs) can enhance the adoption and implementation of ASPs in healthcare settings [29] .",16.06571734462198,8.986918409465806
to improve the safety of subjects relative to the risks associated with the study question,0.18717979027953657,1.879726767539978,3.421821117401123,f012d918-6d86-49e7-8955-c24d47f1eb06,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment","Traditional clinical research is also conducted in the context of these health-care risks. As in the case for clinical care, and as noted by several authors in this text, the conduct of clinical research is inherently associated with risk. During both the scientific and human subjects' protection review processes, great effort is expended to estimate, calculate, and articulate the relative risk associated with each study drug, device, and intervention. This intense scrutiny at the protocol level works to improve the safety of subjects relative to the risks associated with the study question.",14.749993596287442,8.60850388391232
"opening you to business opportunities that can improve your cash flow, turning a burden into an asset",0.1614345645612612,2.0215892791748047,3.49131441116333,43266353-d28f-4a84-8fc7-77b1e553235d,custom_license/Exercise Financial Prudence 197 11.1.3 Focus on Your Product not S&T 197 11.1.4 Make Good Business Decisions Especially Checking Overextension 197 11.1.5 Yet be Flexible 198 11.1.6 Be Alert 199 11.2 Sand Through the Hourglass,"A facility and accompanying QS is both a burden and an asset. It costs, and it takes a lot of effort to maintain the facility operational and the QS current. But you have direct control in manufacturing your own products, and you can also become a sub-contractor for others who want to develop medical devices, opening you to business opportunities that can improve your cash flow, turning a burden into an asset. Ensure no conflicts of interest exist between your own and the contractee's products.",12.790780868262942,8.060160702611817
National and regional legislation can improve the adoption and implementation of ASPs in hospitals,0.41044575099415703,2.01277756690979,2.094486951828003,c6aa7bec-d6e6-410f-9c3e-8efe20e360b5,custom_license/Barriers to implementing antimicrobial stewardship programmes in three Saudi hospitals: Evidence from a qualitative study,"National and regional legislation can improve the adoption and implementation of ASPs in hospitals [13] . However, despite the introduction of a national ASP strategy in 2014, adoption and implementation in Saudi MoH hospitals remains low and slow (the progress of implementation has recently been reviewed by Alomi [6] ). The national ASP strategy of 2014 has so far been merely 'academic' and it has not been accompanied by any enforcement measures. Furthermore, the lack of national surveillance for antimicrobial use and AMR rates in Saudi Arabia [10, 14] decreases motivation to reduce inappropriate antimicrobial use and marginalises the issue of resistance.",14.82858842241489,7.8597278850247765
improve the conduct of clinical research continually,0.1442175901709036,1.491104006767273,2.8310587406158447,58a9dffe-2f49-4212-8bbc-abdf58487aab,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment","In 2003, the leadership of the Rockefeller University Hospital Center for Clinical and Translational Science expressed interest in the NIH Clinical Center's survey and, subsequently, partnered with the NIH Clinical Center and the NRCePicker develop a valid and reliable survey instrument specifically to measure participants' perceptions of their clinical research experiences. 56 CONCLUSION Patient safety, clinical quality, and efficient and effective processes of care delivery are of equal import to clinical care and clinical research. Irrespective of the approach taken, we believe that researchers and institutions involved in clinical research must collect data from a variety of sources, including the solicitation of perceptions from participants and staff input about their research experiences, to improve the conduct of clinical research continually.",14.16705567698886,7.767875272745127
Development of better means to protect yolk antibodies from digestive processes,0.17099999515033826,1.7356396913528442,1.5190112590789795,5a609bf3-0249-40dd-898f-9da7e545f658,custom_license/Chapter Outline,"Protective effects of yolk antibodies are dependent on antibody titers in oral preparations (Marquardt, 2000) . Development of better means to protect yolk antibodies from digestive processes will improve both the efficacy and the economic viability of yolk antibodies for clinical applications (Kovacs-Nolan and Mine, 2012).",15.701955342285288,7.611207487580536
antimicrobial stewardship practices,0.22002976589886877,1.2039252519607544,2.6283719539642334,2fbfdfb2-8773-4b1c-8b5c-be4b28694086,custom_license/Barriers to implementing antimicrobial stewardship programmes in three Saudi hospitals: Evidence from a qualitative study,"Several barriers to ASP adoption and implementation in Saudi MoH hospitals were identified, including factors relating to the sociopolitical context of hospitals, organisational characteristics and healthcare professionals' barriers. The emphasis on enforcement of antimicrobial stewardship guidelines could not be more explicit; ASP adoption and implementation in Saudi hospitals must be formally endorsed by the MoH and enforced and supported by the hospital administration to relieve physicians' liability pressures and to improve their antimicrobial stewardship practices. The lack of human and health IT resources to support antimicrobial stewardship must be addressed before the benefits of ASP adoption and implementation can be realised.",14.516758603016125,7.571858694906886
a new research protocol,0.2044904094693112,1.5873526334762573,2.4476985931396484,cd92fc30-f3f8-4ef8-aaa2-f829f099bc7f,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment","The development of a complete listing of the essential clinical processes that need to be in place is a critical first step to prepare for the implementation of a new research protocol. As was the case with the SARS protocol, this process can be daunting. Focusing an organization's finite resources to assure that attention is paid to the most critical and potentially riskiest care processes is a challenge for most organizations. A variety of tools exist to guide the objective prioritization of what may ultimately be a very long list of critical issues that must be addressed. FMEA is a powerful risk assessment tool that provides a systems-based, human-factors-focused, and objective methodology for identifying and prioritizing risk, with the ultimate aim of reducing patient harm and enhancing clinical research. 19,21e28 Historically, FMEA has been used in the engineering environment to assess high-risk processes associated with power generation in the commercial nuclear power industry; in aviation to assess the acceptability of aircraft designs; and in the automotive industry to establish manufacturing requirements for cars and trucks. 19, 22, 24 DeRosier and colleagues at the Veteran's Administration's Center for Patient Safety are credited with moving the techniques of FMEA to the bedside, applying the concept of prospective risk analysis to health-care processes. 29, 30 In 2002, the use of FMEA in health care further expanded with the issuance of a Joint Commission requirement that all health-care organizations seeking accreditation conduct at least one proactive risk assessment on a high-risk clinical process every 18 months. 31 Clinical care practitioners as well as clinical research professionals can use FMEAs to identify risk and to avert adverse events, errors, and other system failures in a variety of health-care settings. 19, 20, 22, 23, 27, 28 In a complex care environment, where risk is compounded by the interplay of clinical medicine and clinical research, FMEA is a useful tool to guide risk mitigation by identifying critical risk points in clinical care and clinical research processes. In 2016, investigators at the National Institute of Mental Health initiated a clinical research protocol at the NIH CC to study the neurobiology of suicide and to identify risk factors for short and long-term suicidality. One of the study phases involved admitting actively suicidal patients. In response to this research protocol, the NIH CC set in motion a rigorous risk mitigation initiative. An interdisciplinary team comprised of patient safety professionals, research investigators, nurses, social workers, and hospital leadership used FMEA to evaluate potential risk points throughout the clinical research and patient care processes. The analysis was facilitated using QI Path, an FMEA software package. The team segregated the research protocol into three overarching care delivery processes as well as several subprocesses for analysis as illustrated in Fig. 36.1 .",13.531345975496189,7.358754388724005
better processes come into force,0.18195663168930362,1.6042170524597168,1.8733580112457275,4e7dff00-5887-42bb-8bc3-4db7b904da08,custom_license/Food Security in an Insecure Future,"Coming into force in 2004, the International Treaty on Plant Genetic Resources for Food and Agriculture (International Seed Treaty) was designed to complement the 1993 Convention on Biological Diversity (CBD) and was designed to guarantee food security by (a) conservation, exchange, and sustainable use of all types of plant genetic resources; (b) offering fair and equitable benefit-sharing; and (c) recognition of farmers' rights. Critics of the International Seed Treaty point to great variability across countries of access to collections and interpretation and implementation of farmers' rights. Moreover, in adopting the CBD's outlawing of biopiracy -the uncompensated commercialisation and profiteering of seeds, propagules, growing plants, and their products from source areas -has severely inhibited the acquisition and exchange arrangements in collections until better processes come into force.",14.286204915065218,7.260595511681365
How research subjects perceive the clinical research experience provides valuable insights for future improvement of both the clinical and scientific processes,0.26075428280457785,1.8327958583831787,2.3079593181610107,6bf7b8b4-4563-45d5-af5f-0e900bb01a7f,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment","The clinical research community can look to the healthcare industry for guidance in determining how to assess participants' experiences as research subjects. Although the processes of providing patient care in a hospital and the conduct of a clinical research study often differ, investigators and the care teams supporting the research must be mindful that at the center of these processes is a human being interacting with a health-care delivery system whether in a community hospital, a Clinical Translational Science Award unit, or an outpatient setting. How research subjects perceive the clinical research experience provides valuable insights for future improvement of both the clinical and scientific processes.",12.962561188143331,7.228387280603888
"infection control measures, medication management procedures, the design of the physical environment, and information management",0.16221686531070825,1.0807180404663086,1.5369318723678589,941b470c-2980-4c1c-853c-b26963b19b61,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment","Clinical research programs must, therefore, embrace a system's approach to managing risk associated with the conduct of clinical research. For the purposes of this chapter, the term ""conduct of clinical research"" refers both to activities outlined in the research study as well as those intrinsic clinical care activities that are essential to the successful implementation of a study but that may not be explicitly described in the research protocol. Examples of such clinical care activities include infection control measures, medication management procedures, the design of the physical environment, and information management. These critical clinical care functions often are assumed to be present and functioning at an optimal level to support the investigator's study; however, investigators and/or institutional review boards may lack formal processes to assess the capacity of the clinical environment to support the study under review. The research team must engage the clinical care organization proactively to assure that the appropriate infrastructure is in place to provide care safely and efficiently to study participants. In collaboration with the health-care team, the research team should have processes in place to",14.928625553146357,6.926491386943434
improvement tools creatively to manage the safe implementation of a broad spectrum of clinical research protocols effectively,0.20744307839024934,1.3786110877990723,1.5205844640731812,86e69b49-a94d-402c-81a6-7e0b6abb57f9,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment",improvement tools creatively to manage the safe implementation of a broad spectrum of clinical research protocols effectively.,12.960832916019779,6.420768629323887
structured approaches to identifying risk points prior to study implementation,0.19062124810202213,0.14934773743152618,1.3944554328918457,aa25309f-f2a6-4d0d-9899-90c48ef7773f,"custom_license/Identifying, Understanding, and Managing Patient Safety and Clinical Risks in the Clinical Research Environment","Developing clinical research programs that include structured approaches to collecting reliable information about factors that contribute to process failures and adverse events (including careful root cause analyses); mechanisms for assessing trends in process and outcome failures, structured approaches to identifying risk points prior to study implementation (e.g., FMEA); and obtaining participant insights about their perceptions of the clinical research experience will provide the necessary data to allow institutions and investigators to improve the clinical research experience. We believe these approaches to patient safety, clinical quality, and clinical research quality and safety will increase substantially the likelihood of successful completion of clinical studies.",15.283295100099291,6.3526253457449435
"implementation of TEM could improve the sensitivity for detecting viruses, atypical pathogens and mixed infections in BALF from patient of severe pneumonia",0.10315171763268052,0.534706711769104,1.4729863405227661,b5c9e2be-7570-43cb-8f0c-348cf72a28a5,custom_license/Transmission Electron Microscopy Improves the Diagnostic Sensitivity in Nonbacterial Etiology of Severe Pneumonia: A Retrospective Study,"Conclusions: Our data support that implementation of TEM could improve the sensitivity for detecting viruses, atypical pathogens and mixed infections in BALF from patient of severe pneumonia. Therefore, TEM may be used as an auxiliary diagnostic method of other microbiological tests in severe pneumonia.",13.403361936583,5.996177161793765
disease treatment and management,0.321852751343353,4.064587116241455,3.022854804992676,e2b2d0cf-08fb-4da3-905c-7f765c2641d1,custom_license/Estimating Absolute and Relative Case Fatality Ratios from Infectious Disease Surveillance Data HHS Public Access,"We also rely on the assumption that the true CFR is small in each of the population subgroups. This assumption enables us to make a key algebraic simplification. The impact of the assumption may be small for diseases such as influenza, whose CFR is thought to be on the order of 1 in 1000 (see Section 4.3 and Figure 2 ). However, an avenue for further research could be to find ways to adapt this method to work for diseases with larger CFRs. We also assume that the CFR does not change over time. This may not be case with an emerging pathogen, as disease treatment and management may improve as clinical and epidemiological understanding of the disease evolves (Yip et al., 2005) .",17.36083753365031,10.683130385579794
respiratory infections,0.2588784476142118,1.0459449291229248,1.5123165845870972,93b74287-31fb-4678-b965-07c9725f9b84,custom_license/Detection of respiratory pathogens in pediatric acute otitis media by PCR and comparison of findings in the middle ear and nasopharynx,"In conclusion, further implementation of sensitive, rapid, and multiplexed molecular methods would extend our understanding of the respiratory pathogen interplay and improve diagnostics of respiratory infections.",24.87483406280077,10.369061905891783
"In the clinical setting, input from both professions would improve assessments of the risk-benefit ratios of pet ownership",0.2140754291433488,3.4436511993408203,5.369172096252441,d7a832e6-739b-43a3-8539-9c0cdf184662,"custom_license/Confronting Zoonoses, Linking Human and Veterinary Medicine Zoonoses, Links between Human and Veterinary Medicine Emerging Infectious Diseases â¢ www","Many of the emerging infectious diseases, including those caused by bioterrorist agents, are zoonoses. Since zoonoses can infect both animals and humans, the medical and veterinary communities should work closely together in clinical, public health, and research settings. In the clinical setting, input from both professions would improve assessments of the risk-benefit ratios of pet ownership, particularly for pet owners who are immunocompromised. In public health, human and animal disease surveillance systems are important in tracking and controlling zoonoses such as avian influenza virus, West Nile virus, and foodborne pathogens. Comparative medicine is the study of disease processes across species, including humans. Physician and veterinarian comparative medicine research teams should be promoted and encouraged to study zoonotic agent-host interactions. These efforts would increase our understanding of how zoonoses expand their host range and would, ultimately, improve prevention and control strategies.",12.571679534011846,10.128422979039765
control measures,0.6102048136681619,3.0044515132904053,3.2631514072418213,c9b83e32-9c12-4894-9490-58a548fdae2c,custom_license/The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis $,ÃÃ Before implementation of control measures. 3 yy The symbol t denotes the time (in days) since onset of clinical symptoms.,13.12943961667631,8.669245764182655
accessibility,0.3112216199897009,2.106961488723755,3.4990477561950684,6d6c4c21-d9a8-4d2b-89c7-3cf184b9bcf4,custom_license/Using Naturally Occurring Data in Qualitative Health Research,"In a study, Cheung et al. (2010) conducted a policy analysis of the intended outcomes of chronic illness policy documents in New South Wales, specifically, the Chronic Care Program. The researchers included policy documents produced from 1999 to 2008. The aim of the study was to assess the alignment between policy 'determinants and outcomes' and therefore to make proposals about future health policy documents. Using document maps to measure this alignment, this study used naturally occurring policy documents to show ways in which more successful implementation of health policies might be possible and improve accessibility. The researchers used predefined criteria to analyse the documents. Notably, the researchers concluded that predefined criteria are useful for analysing policy development and the consistency (or lack thereof) between intended outcomes and successful implementation of policy.",11.96793614064979,7.832683658424662
they may also be used to improve deregulated immune responses and inflammatory processes,0.18206366336083893,2.1160342693328857,3.5201027393341064,1768863e-e894-4fdc-ad0d-db240e958a05,custom_license/Role of interferons in the treatment of severe acute respiratory syndrome Role of interferons in the treatment of severe acute respiratory syndrome 828,"In view of possible further SARS outbreaks, highly efficient therapeutic strategies are needed. Experimental and pilot clinical data strongly suggest that type I IFNs are promising candidates for SARS treatment protocols. Not only may they be used as inhibitors of SCV replication, but they may also be used to improve deregulated immune responses and inflammatory processes that are known to contribute to SARS. Although the majority of studies focus on the evaluation and clinical use of IFN-Î±, in the authors' hands, IFN-Î² was superior compared with IFN-Î± in terms of SCV replication inhibition. The fact that IFN-Î² elicits its inhibitory potential even after infection has already occurred further underlines the supposed therapeutic value. To be well prepared against possible future SARS outbreaks, the authors strongly recommend the evaluation and improvement of therapeutic strategies involving IFN-Î² preparations.",11.639539300786645,7.73732781090887
"tools to administer patents related to gene sequences, processes and methods",0.11851666855808156,1.3415961265563965,2.468393564224243,99972861-2ada-456c-8f6b-7739e357d395,custom_license/Patent pools and clearinghouses in the life sciences,"Patent pools and clearinghouses are considered especially promising for drug discovery, pharmaceuticals, diagnostics and genetic testing and, in particular, as tools to administer patents related to gene sequences, processes and methods.",14.578176897184715,7.578855213022066
introduce handwashing routines when processing foods,0.12570779617275898,1.9180870056152344,2.7087316513061523,1604693b-68be-4d50-97c1-5969e1882948,custom_license/Achievement V e Methods for breaking the transmission of pathogens along the food chain Detection of viruses in food,One issue would be to introduce handwashing routines when processing foods. Food handlers with clinical symptoms of gastroenteritis indicative of viral origin should be removed from food handling areas and not be allowed to reenter before after 48 h past the cessation of clinical symptoms or if better diagnostics becomes available 48 h since cessation of virus shedding and clinical symptoms.,12.938803448121416,7.536013333841396
Urine based proteomic profiling,0.1793517679424498,2.678544759750366,2.151700496673584,8603e703-9b99-46aa-9017-b6ba390e9a82,custom_license/Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis,"Urine based proteomic profiling is a novel approach that may lead to the discovery of non-invasive biomarkers for diagnosing patients with different diseases, with the aim to ultimately improve clinical outcomes [18] . Given new and emerging analytical technologies and data mining algorithms, the urine peptidome has become a rich resource for the discovery of naturally occurring peptide biomarkers. For pediatric diseases, urine is expected to become one of the most useful body fluids in clinical proteomics for diagnosis and risk-stratification. Mass spectrometry-based urinary protein and peptide profiling has led to the discovery of highly informative biomarkers for both urogenital and non-urogenital diseases [43] . At the current time, urine proteomics have been applied primarily to diseases affecting the kidney and urinary tract. Our focus on changes in urine that reflect systemic inflammation is novel and potentially of broad use [18] . One of our long-term goals is to use urine biomarkers to develop clinical tests that are non-invasive and feasible for frequent sampling and determination. With this in mind, urine peptidomes from SJIA patients were profiled to identify naturally processed urine peptide biomarkers and 17-urine peptides emerged as a candidate SJIA flare panel. This panel was found to be robust using statistical analyses. Nonetheless, the panel requires validation using a new sample set of sufficient size, guided by power analysis.",12.196163460791432,7.408316627952568
can take products right through to fill and finish,0.26912203499470216,1.6295406818389893,2.7852628231048584,c82c2349-3793-4312-92ff-24d22f34e5f7,custom_license/History and Promise of Plant-Made Vaccines for Animals,"The Fraunhofer USA Center for Molecular Biotechnology (http://www.fhcmb. org/) is a not-for-profit research and development organisation, that offers ""â¦ plant-based protein production, purification, scale-up and GMP manufacturing to support the development of vaccines, therapeutics and diagnostics"", also with proprietary expression platforms, and can take products right through to fill and finish. The Fraunhofer IME in Aachen also has a state-of-the-art mechanised plant production facility still under construction as of 2017.",12.154839585045334,7.123816132979368
The Biomedical Advanced Research and Development Authority (BARDA) is mandated to support the advanced development of medical countermeasures,0.14758185449889036,1.021758794784546,2.099062919616699,c6e9611e-2579-472a-86e2-8e8103bae93e,custom_license/Health security in 2014: building on preparedness knowledge for emerging health threats,"The regulations prioritised selected agents and toxins on the basis of risk to the public, established suitability standards for people with access to the most threatening (tier 1) agents and toxins, and established personal reliability measures to improve biosafety and biosecurity. â¢ The National Disaster Medical System has improved how it organises and deploys more than 75 of its nationally distributed disaster medical assistance teams, mortuary response teams, and veterinary response teams, in addition to other specialised units that provide medical response surge during disasters and emergencies through on-scene medical care, patient transport, and the delivery of defi nitive care through its participating hospitals. â¢ The Biomedical Advanced Research and Development Authority (BARDA) is mandated to support the advanced development of medical countermeasures, and has built a pipeline of more than 150 novel drugs or diagnostics for chemical, biological, radiological, and nuclear threats and pandemic infl uenza. Seven of these products have received approval from the Food and Drug Administration. BARDA has provided 12 new products under Project Bioshield that can be distributed in a public health emergency. â¢ The Strategic National Stockpile was authorised and expanded, ensuring the availability of key medical supplies. All states have plans to receive, distribute, and dispense these assets. Increasingly, the USA seeks to develop products that can address countermeasure requirements and also day-to-day needs. As a result, these government investments in products such as next-generation antimicrobials for biological threats can be supported by the market to address routine public health problems, such as antimicrobial resistance.",13.735906710089905,6.836101462892276
ready-to-eat products,0.31724107528843337,2.146493434906006,1.5369940996170044,d65902cf-098c-4c99-833e-007f084839e6,custom_license/Safety of Water Used in Food Production,"Water safety can never be taken lightly. Unsafe water, which results due to direct contamination or improper or inadequate water treatment processes, generally results in a contaminated food product. Even though all types of foods are at risk, the highest among them are ready-to-eat products.",12.11780507817598,6.63549867480155
ELISA kits,0.3311984303878249,1.1021268367767334,1.5654945373535156,096b2539-4d50-42d1-a4ba-b65aa30b25ff,custom_license/Comparison of six commercial kits for the diagnosis of rotavirus infection in man and calves,"The ELISA kits used were: RotaScreen EIA (Mercia Diagnostics Ltd., Guildford, Surrey, U.K.), Wellcozyme Rotavirus (Wellcome Diagnostics Ltd., Dartford, U.K.), Rotazyme II (Abbott Diagnostics Division, Maidenhead, Berkshire, U.K.), IDEIA Rotavirus Test (Boots-Celltech Diagnostics Ltd., Slough, U.K.).",13.208607953200882,6.35696667680497
"The major demand for water arises during diverse food processing operations such as transport of products, dissolving ingredients, treatment of products",0.1820295376363637,1.356287956237793,1.6994452476501465,c34acd1b-9813-45bb-a165-64223913f554,custom_license/Safety of Water Used in Food Production,"In food processing, there are broad range of possibilities with regard to water management, including increased promotion with increased efficiency of water reuse. This water reuse efficiency can be enhanced by tailoring the water quality requirements for a specific process. The major demand for water arises during diverse food processing operations such as transport of products, dissolving ingredients, treatment of products (e.g., alteration, separation), maintenance of appropriate water content in the final product, cooling processes, steam generation, and abnormal incidents (e.g., fire protection).",11.710346151485911,6.08484773554723
"LA kits used were: RotaScreen (Mercia Diagnostics Ltd.), The Wellcome Rotavirus Latex Test",0.19533504735245896,1.1061489582061768,1.4276964664459229,17be0216-8b2c-4100-b237-cd987e21b295,custom_license/Comparison of six commercial kits for the diagnosis of rotavirus infection in man and calves,"The LA kits used were: RotaScreen (Mercia Diagnostics Ltd.), The Wellcome Rotavirus Latex Test (Wellcome Diagnostics Ltd.).",11.806514985873697,5.779279771079659
ASP leaders can work with microbiologists to provide clinician education about specific diagnostics,0.23699958065984722,3.9823174476623535,3.74996280670166,52afd9cb-eba8-42d2-85dc-b37cd0e5b593,custom_license/Journal of the Pediatric Infectious Diseases Society Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next,"The clinical microbiology laboratory's role in stewardship activities has been limited to developing guidelines for appropriate specimen testing, antibiogram creation, and selective reporting (""blinding"") of antibiotic-susceptibility test results. However, the recent explosion of new technologies that enable both earlier identification of pathogens and detection of select antibiotic-resistance genes brings the clinical microbiology laboratory to the forefront of ASP activities. ASP leaders can work with microbiologists to provide clinician education about specific diagnostics before implementation. Table 1 summarizes the targets, turnaround times, and clinical outcomes associated with commonly used rapid diagnostic tests in the clinical microbiology laboratory. Table 1 The use of many of these diagnostic tests has been associated with decreased time to effective therapy [53] [54] [55] [56] [57] , shorter hospital lengths of stay [53, [56] [57] [58] [59] , reduced hospital costs [53, 54, 56, 57] , and reduced mortality rates [53, 59] . However, to optimize clinical outcomes, these novel diagnostics should ideally be implemented with clinical decision support that guides result interpretation and appropriate antibiotic prescribing [58] [59] [60] [61] [62] . Such decision support comes in many forms, from electronic comments within the microbiology result report to real-time auditing and feedback by an ASP.",13.429923065938855,9.726455238415209
improved handling and analysis times of DNA sequence tests,0.28063852082658336,3.3242504596710205,4.858933925628662,6c15e73e-93e2-4c59-9934-1be9b12243fd,custom_license/Micro-flow analysis by molecular tagging velocimetry and planar Raman-scattering,"Over the past few years, microfluidic systems have experienced a rapid development. Technological advancements in the manufacturing processes of microfluidic components have opened new pathways for a broad variety of technical applications (Erickson and Li 2004) . Especially chemical and biochemical analysis as well as medical diagnostics, where often only tiny sample amounts are available, strongly benefit from small system volumes and substantially faster analysis times enabled by microfluidic technologies (Burns and Ramshaw 2001; Lai et al. 2004; Nguyen and Wereley 2002) . The application of microfluidic systems improved handling and analysis times of DNA sequence tests (Paege et al. 2001; Srinivasan et al. 2004; Wang 2000) and led to improved detection systems for viruses like SARS (Zhou et al. 2004) . Recently, microfluidic systems also became interesting for chemical production processes. In particular the possibility to precisely define and control the physical boundary conditions inside micro channels with a huge surface to volume ratio leads to more efficient production processes with much less by-products. Due to the strongly increasing interest in microfluidic devices there is a growing demand for new diagnostic tools for the analysis of flow structures, mixture formation and reaction behavior directly inside the micro channels. In particular non-intrusive measurement techniques which do not influence the flow and reaction processes in the channels are badly needed. Several reviews are concerned with miscellaneous detection techniques (Mogensen et al. 2004; Sinton 2004; Viskari and Landers 2005) . The present work covers the development of two procedures, which provide comprehensive information about microfluidic flows.",12.24164427239429,9.603645345782795
The Task Force's recommendations are intended to improve clinical practice and promote the public health,0.49787762570259153,2.958050012588501,3.2763671875,0b246ecc-7626-47ab-ab64-2ae01c00d228,"custom_license/Physical, Social and Cultural, and Global Infl uences 146 6 Physical, Social and Cultural, and Global Infl uences The Defi nition of Health","The USPSTF is assigned the responsibility of making evidence-based recommendations that address primary and secondary preventive services targeting conditions that represent a substantial burden in the country, and that are provided in primary care delivery settings or made available through primary care referrals. The Task Force's recommendations are intended to improve clinical practice and promote the public health. Tertiary prevention measures are outside the scope of the USPSTF. Even though the main audience for Task Force recommendations is the primary care provider, the recommendations are also used to guide programmatic, funding, and reimbursement decisions by policy-makers, managed care organizations, public and private payers, quality improvement organizations, research institutions, and consumers.",15.770118455298238,9.57191263941191
improve the accuracy of the guess when precision is needed,0.18205862395965539,2.699660301208496,4.63671875,62debfe8-f3c6-4a44-aeac-a271d0c1bffc,custom_license/From: Bronchial Asthma: A Guide for Practical Understanding and Treatment,"In most of the twentieth century, the office or hospital diagnosis of viral respiratory infection was most often a good guess, a probability statement. Common and more affordable viral molecular diagnostics, especially reverse transcriptase PCR (RT-PCR), and viral culture can now improve the accuracy of the guess when precision is needed. Viruses may be detected in symptomatic or in asymptomatic patients.",12.594590308899981,9.176752991400516
"quality control monitoring, and regulatory compliance",0.25968029156099887,3.2069127559661865,3.6825368404388428,987d03d0-f057-4b74-a297-105150f31f6e,custom_license/Transfusion Risks and Transfusion-related Pro-inflammatory Responses HEMATOLOGY/ONCOLOGY CLINICS OF NORTH AMERICA,"Type I von Willebrand's disease Uremia-induced platelet dysfunction A platelet defect after cardiac surgery as identified using point-of-care platelet function tests [73, 74] Use and monitoring of point-of-care diagnostics to guide transfusion and pharmacologic management of bleeding also can be enhanced by means of a collaborative approach with the transfusion medicine service with respect to implementation, quality control monitoring, and regulatory compliance (eg, Joint Commission or College of American Pathologists). Future availability of blood substitutes may be critical in unique clinical situations such as in patients with multiple antibodies, with Jehovah's Witness patients, and in trauma settings. These agents also may enhance blood conservation techniques or organ preservation because of their ability to enhance tissue oxygenation.",12.598712609285883,8.887691650913329
Companies developing these products can take advantage of the provisions intended to improve the efficiency of drug development,0.38289235154399803,2.632438898086548,3.4443390369415283,0bb2117d-58a4-447c-87ed-adb53d60dd0f,custom_license/Endeavour,"Historically, biopharmaceutical products have tended to be treatments for small populations of patients and serious or life-threatening diseases. Companies developing these products can take advantage of the provisions intended to improve the efficiency of drug development that were included in US orphan-drug legislation and three legislative acts passed since 1992, which have modernized the Food and Drug Administration (FDA). We compared data for 65 new biopharmaceuticals, approved during two periods, 1996-2000 and 2001-2005 , to assess variations during time in product type and average clinical and approval phase lengths for various categories (e.g. orphan and priority-reviewed therapeutics). Our results suggest trends toward less development of orphan therapeutics but a continued emphasis on products for serious or lifethreatening diseases (Box 1). We also observed trends toward longer clinical and approval phases in all the product categories we examined.",13.95685654511377,8.834805448558068
"Diagnostics, devices and variants of existing products (e.g. new dosage, formulation or form of delivery) were excluded.",0.44500890430241735,2.0870275497436523,2.237027645111084,33caa3a0-cf60-40fe-bc6d-a4b0833b2ec5,custom_license/Endeavour,"Tufts CSDD maintains a database currently comprising records for O2000 biopharmaceutical therapeutic and vaccine products that have entered commercially sponsored clinical study. Clinical development and approval data included in the database for products approved by the Food and Drug Administration (FDA) were collected from company surveys and public documents. In this report, the following definitions are used: a new biopharmaceutical therapeutic is defined as a product composed of protein that is unique compared with any therapeutic previously approved for marketing in the USA; vaccine products are composed of new components or new combinations of components; and an innovative product is defined as a new product indicated for a previously unmet medical need. Diagnostics, devices and variants of existing products (e.g. new dosage, formulation or form of delivery) were excluded.",16.238980911344072,8.494279195626003
algorithms to identify sequences of viral origin without sequences comparison,0.2406643828259217,2.689201593399048,2.6086840629577637,6f790dd3-94d5-4dd9-b5f0-68fb3a201dd7,custom_license/Loeffler 4.0: Diagnostic Metagenomics,"The constantly growing number of available viral genome sequences will improve the chances of recognizing new pathogens. Moreover, the ongoing efforts for the implementation of algorithms to identify sequences of viral origin without sequences comparison will enable the identification of viruses even stronger deviating from those known.",12.887002817703145,7.954076662828028
to improve clinical outcomes and to select the most appropriate therapy,0.15665967950409587,1.4499402046203613,3.2188639640808105,0166a1be-f264-4188-80cd-af2e032a69f1,custom_license/Oral presentations New aspects of emerging Clostridium difficile infections (CDI) S2 Pros and cons of molecular fingerprinting for Clostridium difficile infections,"These findings indicate that in patients with septic shock PTX3 plasmaconcentrations are in part dependent on PTX3 genotype for the rs2305619 and rs3816527, but these SNPs do not affect susceptibility to meningococcal disease. Objective: Resistance to tuberculosis has been proposed as a mechanism for selection for high rates of mannose-binding lectin (MBL) deficiency. Mechanistically, low levels of this pattern recognition receptor may lead to relatively lower degrees of phagocytosis of Mycobacterium tuberculosis and protect against TB however evidence to date has been conflicting. We aimed to systematically review published literature on the effect of MBL2 genotype and/or MBL levels in tuberculosis infection, and perform meta-analysis considering its effect on susceptibility to infection. Serious Gram-positive infections are becoming increasingly difficult to treat because of the escalating incidence of multidrug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA). In order to improve clinical outcomes and to select the most appropriate therapy, it is essential to consider pharmacokinetic (PK) and pharmacodynamic (PD) parameters, such as PD targets and their relation to dosing and the use of PK parameters as measures of exposure. In addition, AUC/MIC ratios should be used to predict clinical efficacy, and the relationship between MICs and dosing requirements should be considered.",12.427904368350388,7.3844892385783965
microarrays are moving into clinical application,0.13232120479333248,2.2808966636657715,1.7226312160491943,a370f2cc-d23f-4432-9ae8-aa1f85332033,custom_license/Microarray technology in obstetrics and gynecology: A guide for clinicians,"Microarray Genomics Gene mapping Gene expression Microarrays can be constructed with dozens to millions of probes on their surface to allow highthroughput analyses of many biologic processes to be performed simultaneously on the same sample. Microarrays are now widely used for gene expression analysis, deoxyribonucleic acid resequencing, single-nucleotide polymorphism genotyping, and comparative genomic hybridization. Microarray technology is accelerating research in many fields and now microarrays are moving into clinical application. This review discusses the emerging role of microarrays in molecular diagnostics, pathogen detection, oncology, and pharmacogenomics.",13.200743931974396,7.222553498005766
65 Patients are likely to benefit from this research activity as it leads to improved genetic diagnostics,0.14466586918151916,0.9543031454086304,2.1963696479797363,c4bafc29-7fd8-4c28-a4dd-19d93f9f1a4d,custom_license/Microarray technology in obstetrics and gynecology: A guide for clinicians,"By providing global views of biological processes, microarrays enable systematic surveys of variations in DNA sequence and gene expression. Microarrays are fueling novel and expansive research. The current $2 billion per year market for microarrays in the United States is growing by more than 30% each year. 65 Patients are likely to benefit from this research activity as it leads to improved genetic diagnostics, personalized treatments, and more rapid and definitive testing of clinical specimens.",14.621717639136019,7.165538489400045
"l Provide data essential to the planning, implementation, and assessment of services for the prevention, control, and treatment of disease",0.24279210071406698,1.8285143375396729,2.195688247680664,c36ef0d5-2743-4e6e-8f33-857ce7de092a,"custom_license/Measuring, Monitoring, and Evaluating the Health of a Population Learning Objectives","Describe the distribution and size of disease problems in human populations. l Identify etiological (i.e., the cause of disease) processes and factors involved in the pathogenesis of disease. l Provide data essential to the planning, implementation, and assessment of services for the prevention, control, and treatment of disease and to establish priorities among these services.",12.228444299049736,6.895687185060627
stop further transmission and improve patient outcomes,0.16809957774005482,0.9933905005455017,2.915858745574951,2420a974-fe06-42d2-a0d8-60d88c770e5a,custom_license/Barriers to implementing infection prevention and control guidelines during crises: Experiences of health care professionals,"Which instructions are crucial? Outbreak control guidance consists of comprehensive instructions on case finding, contact tracing, diagnostics, surveillance, treatment, infection prevention, and health promotion. Under time pressure, those concerning infection prevention (eg, isolation, PPE), diagnostics, and treatment are the ones that matter most to the involved professionals, because they are essential to stop further transmission and improve patient outcomes. Especially in these areas, instructions must be not only definitive and imperative, but also easily identifiable by various professionals as to their own particular responsibility areas. Interestingly, Lo et al 3 found that adherence to crucial recommendations in hospital settings during routine infectious diseases consultations was significantly higher than adherence to noncrucial recommendations, which is consistent with our findings.",12.406380932751501,6.88324533644132
The primary focus of IPPC is on plants and plant products in worldwide trade,0.1364532916291246,1.2458844184875488,0.8381209969520569,a71dffd1-e55f-4177-a56a-f50555b8ba1a,custom_license/International Laws and Food-Borne Illness,"The IPPC also has provisions for exchange of information related to export and import requirements and pest status provided by each member state. Developing nations also receive technical help for its implementation. The primary focus of IPPC is on plants and plant products in worldwide trade. It also covers research materials, biological control organisms, germplasm banks, and vector for the spread of plant pests (e.g., packaging materials, soil, vessels, containers machinery and vehicles). The Convention provides assistance to developing nations to improve the effectiveness of their National Plant Protection Organizations (NPPOs) and to aid regional plant protection organizations to understand the welfare of safe trade (Forsythe, 2002; Lupien, 2002) .",14.011338002701642,6.258571820981318
"lack of political motivation, priorities, and active or passive resistance by professional or lobby groups with other agendas",0.2016116106705808,1.3854550123214722,1.5123666524887085,4be1f02c-4bb9-4537-8c13-b00cc5107489,"custom_license/Measuring, Monitoring, and Evaluating the Health of a Population Learning Objectives","The time lag between adequate scientific evidence and positive experience with good public health practices can be very long, and measures that can save or improve the quality of life for large numbers of people are delayed in implementation due to lack of political motivation, priorities, and active or passive resistance by professional or lobby groups with other agendas.",12.405271631624917,6.225429153195338
the only intervention demonstrated to improve clinical outcomes in ARDS is the use of a protective ventilatory strategy,0.18891698619953368,2.3705198764801025,2.408444881439209,a0efdd19-8e37-40cb-b3ce-bf71fac71fb3,custom_license/Lung Renin-Angiotensin System Components in the Lungs,"ARDS remains a serious clinical problem with the main treatment being supportive in the form of mechanical ventilation. However, if the mechanical ventilation is used improperly, it can exacerbate the tissue damage caused by ARDS, known as ventilator-induced lung injury (VILI). To date, the only intervention demonstrated to improve clinical outcomes in ARDS is the use of a protective ventilatory strategy that uses low tidal volumes (VT) of 6 mL/kg predicted body weight compared with traditionally applied VT of 12 mL/kg [5] .",18.11296498746205,9.44586483825927
more palatable.,0.2109446121273994,0.7438581585884094,2.1518659591674805,eb039c16-9636-4431-9c60-9b0864f2016e,custom_license/Ferret gastrointestinal and hepatic diseases Ferret gastrointestinal and hepatic diseases,"Treatment is mainly supportive. Antibiotics may reduce secondary bacterial enteritis and improve clinical signs, reducing nausea and diarrhoea. Often the stool becomes less green with antibiotic usage. Metronidazole in particular seems to improve stool color and consistency, possibly due in part to its anti-inflammatory effects -the usual dosage is 20 mg/kg p.o. b.i.d. Enrofloxacin (5 mg/kg p.o. b.i.d.) plus amoxicillin (10-20 mg/kg p.o. b.i.d.) also can produce clinical improvement and is more palatable.",20.874398693519275,9.188260219273074
chest physiotherapy using vibration and chest percussion did not improve clinical severity scores or reduce length of stay or requirement for oxygen supplementation,0.2637720627636194,1.4379100799560547,2.179821729660034,2a435846-cfac-4024-af2e-8213c221decf,custom_license/Acute viral bronchiolitis in children-a very common condition with few therapeutic options,Chest physiotherapy is used in respiratory conditions with excessive respiratory secretions to improve airway clearance. A systematic review including three trials of variable quality in infants who were hospitalized with acute bronchiolitis but did not require paediatric intensive care concluded that chest physiotherapy using vibration and chest percussion did not improve clinical severity scores or reduce length of stay or requirement for oxygen supplementation. 56 Intensive care management with non-invasive ventilation and with heliox,18.911736102659333,8.970633312181224
Combined use of traditional Chinese drug-therapy and WM could markedly improve the clinical symptoms and prognosis of SARS patients,0.14013085864225985,2.711230993270874,3.1279754638671875,734f7114-db62-467d-8ecb-cff952d0d54b,custom_license/Therapeutic Effect of Integrative Traditional Chinese and Western Medicine on 51 SARS Patients and Its Influence on Their T Lymphocyte Subsets*,"Death ocurred mostly at the peak of the epidemic process of this epieycle in Beijing, but at that time, traditional Chinese medicine and drugs had not yet been put to use widely. Data showed that the mortality of the WM group was higher than that of the ICWM group, suggesting that IC-WM treatment should be used right from the early stage and through the whole course, and stress put on dispelling evil pathogens, the therapeutic principles of supplementing essence and activating blood circulation in the early stage adopted, norishing Qi-Yin and clearing residual pathogen both carried out in the recovery stage, and the principle of ""treatment depending on Syndrome-Differentiation"" insisted on all the while. Combined use of traditional Chinese drug-therapy and WM could markedly improve the clinical symptoms and prognosis of SARS patients, lower the mortality and help the recovery of immune function in them.",14.475639394866521,8.861957985343022
mainly to meet asthma patients who do not respond well to current therapies,0.1543478575379172,1.819118857383728,2.863496780395508,aac288b2-40d6-4b15-b2c4-5b178074d2cd,custom_license/Lung Renin-Angiotensin System Components in the Lungs,"Epidemiological studies show that asthma is currently the most common chronic disease in children, being the major cause of missed days at school and, in adults, loss of working days. In addition, asthma is associated with a significant rate of mortality [74] . The large increase in incidence of asthma is becoming a major global health problem and has encouraged studies aimed at increasing the knowledge of the pathophysiology of asthma, as well as development of new treatments to improve clinical management of the disease, mainly to meet asthma patients who do not respond well to current therapies [51] .",16.20740113662425,8.71629056237499
Improve research and evaluation of effective interventions,0.18542320352727357,2.612255811691284,2.1804518699645996,3168fd8f-a794-472d-a74f-723c697350dd,custom_license/WHO Library Cataloguing-in-Publication Data CONCEPTUALIZATION AND GUIDANCE,"Improve the quality of clinical care and evidence-based clinical interventions, especially for individuals who present to hospital following a suicide attempt. Improve research and evaluation of effective interventions.",13.273087446002773,7.760840599177294
when given in the maximum acceptable dose to volunteers it did not improve the clinical or laboratory parameters of experimental influenza,0.1595167544010678,1.7721049785614014,2.436771869659424,4ad009fd-e79f-4d8d-849f-b2720cd46c10,custom_license/Mini-Review A view from the Common Cold Unit,"A third approach to enhancing the host's immunity would be to use locally administered immunomodulators. These might be effective irrespective of the biological or serological type of virus, and might be free of the local adverse effects of interferons. We have recently investigated two of these. One was a muramyl dipeptide derivative which protected mice and guinea pigs when given in small doses intranasally prior to large doses of influenza viruses. However, when given in the maximum acceptable dose to volunteers it did not improve the clinical or laboratory parameters of experimental influenza, even though the strain used was partly attenuated and the dose given was not large . A thioguanosine derivative has been found which protects mice against coronavirus infection by enhancing their resistance (rather than by a direct antiviral effect) and this has also been studied in volunteers using colds induced by a coronavirus; analysis indicates that either it was given in too low a dose, or that it does not enhance the primate response in the same way as that of the rodent (Higgins et al., 1991) . In this field we are at a similar stage to that of work on interferons between 1957 and 1973 -we know that there are attractive theoretical possibilities but we do not know whether any such method can be made to work in man or what the 'benchmarks' for the properties of a candidate drug should be.",12.334059990649859,7.052690948070987
"Implementation of pasteurization, and other initiatives to improve milk safety",0.21267313156508547,0.8062707185745239,1.2006051540374756,89b06307-18e6-4f1f-85d2-fa62c44e3096,custom_license/Perspectives in Foodbor ne Illness,"Pasteurization, a process involving heating followed by rapid cooling to reduce microbial populations to levels that do not cause illness and delay spoilage, was developed by Louis Pasteur and subsequently has been highly successfully applied to milk and milk products, and has virtually eliminated milk transmission of infections. Implementation of pasteurization, and other initiatives to improve milk safety from ""1870 to 1940 [launched] a vigorous public health movement to prevent the bacterial contamination of milk.In this period, the market milk supply gradually became safer, with improved sanitary conditions in dairy farms, pasteurization of milk, keeping milk at low temperatures during shipping and delivery, and prohibition of the sale of loose milk (unpackaged bulk milk stored in a large canister and sold using a dipper) in grocery stores."" 21 There are now several methods to improve milk safety. The classic method, referred to as high-temperature, short-time (HTST), involves heating to 71.7 C (161 F) for 15 to 20 seconds, and extends the refrigerated shelf life to 2 to 3 weeks. The introduction of ultrapasteurized milk, which involves heating milk to a temperature of 135 C (275 F) for a minimum of 1 second, has increased refrigerated stored life to 2 to 3 months. When ultrapasteurization is coupled with sterile handling and container technology, a shelf life of 6 to 9 months can be achieved, even without refrigeration. A third technology, referred to as extended shelf life (ESL), processes HTST milk through a microbial filtration step that further increases the useful shelf life of the product, although a lack of established standards for its production results in variable shelf life among products labeled as ESL.",16.393758589157365,7.042284823402877
improve the theoretical understanding of the DNA packaging processes and characterization of the corresponding CyDplexes,0.2648688591484482,1.8792963027954102,2.5561022758483887,370399d5-2ca8-47e5-860c-62cbbbaeff4f,custom_license/Interest of designed cyclodextrin-tools in gene delivery à¬ IntÃ©rÃªt des outils cyclodextrines-modÃ¨les dans la dÃ©livrance de gÃ¨nes,â¢ a persistent orders of magnitude poorer efficiency compared to viral vectors; â¢ growing understanding of the CyD-based gene delivery mechanisms; â¢ improve the theoretical understanding of the DNA packaging processes and characterization of the corresponding CyDplexes; â¢ ensure the best possible furtivity of the CyD-based vectors with respect to the immune system.,11.483926476194588,6.902383342786575
postprocess handling of the products.,0.15808847815179194,1.474123477935791,2.0247159004211426,46186c51-a029-498c-92ea-0aa74b95e80e,custom_license/Environmental and Safety Issues With Nanoparticles Nanoparticle Technology Handbook,"Most of these processes are performed in a closed reaction chamber installed in a cleanroom or associated controlled environment. Human exposure to these engineered particles does not take place during synthesis unless there is an unexpected system failure (e.g., rupture of a seal). Human exposure is more likely to occur after the manufacturing when opening the reaction chamber, drying the products, or in the postprocess handling of the products.",13.08893312895892,6.855372191067628
correct timing of specimen collection,0.10109777300234585,2.1759679317474365,1.834584355354309,3af8899a-da75-402b-8b19-5e3c9b99e1aa,custom_license/Diagnosis of Canine Viral Infections,"The diagnosis of canine viral infection frequently requires the correlation of clinical, hematologic, pathologic, and laboratory findings. When laboratory diagnostics are utilized, appropriate specimens must be collected. In addition, correct timing of specimen collection and the proper handling and transport of these specimens are essential.",11.231212116845388,6.537783227512021
"one or more of the specific viral inactivation, removal and purification steps in commercial plasma fractionation processes, would eliminate risk from derivatives",0.1905028759820416,1.1770975589752197,1.8918465375900269,fd1b85a7-9f89-4127-b6e1-8273f7cfa931,custom_license/The Emergence of Zoonotic Pathogens as Agents of Concern in Transfusion Medicine,"Appropriate studies of pathogen reduction for labile blood products have not been published for either Nipah or Hendra, but similar viruses (i.e., enveloped RNA viruses) are effectively inactivated by the processes being advanced for approval in the United States. Likewise, one would expect that one or more of the specific viral inactivation, removal and purification steps in commercial plasma fractionation processes, would eliminate risk from derivatives.",12.563970563510784,6.392203359996184
The implementation of a strong regulatory system,0.19710513788073328,1.8579349517822266,1.0266207456588745,85455216-e283-4c57-8535-865d7204c5fc,custom_license/Regulation and Testing of Vaccines,"The primary responsibility of NRAs is to ensure the quality, safety, and effectiveness of pharmaceutical products. The implementation of a strong regulatory system will facilitate these goals, which are especially critical for vaccines that are inherently more difficult to develop, characterize, and manufacture than most pharmaceutical products. The FDA has developed a managed review process that provides regulatory oversight through all phases of vaccine development. Advances across a wide range of scientific disciplines have enhanced the preparations to treat certain complications of smallpox vaccination have been approved. There is one licensed anthrax vaccine in the United States, anthrax vaccine adsorbed (Emergent BioSolutions' BioThrax).",12.507187902995494,6.252476969385139
Monitoring of responses to vaccination,0.1116519461438462,1.2986208200454712,2.251089096069336,e51f727c-851c-4bd6-99de-3aad5384d9c8,custom_license/Biomarkers of Infectious Diseases,â¢ Clinical suspicion of hepatitis B. â¢ Blood donors and blood products. â¢ Monitoring of responses to vaccination.,11.017930506476759,6.16358712274149
"a plan to improve data availability, comprehensiveness and quality",0.1877915003097409,0.3988094627857208,0.30738160014152527,68bef773-8047-455f-83f2-5093205551e9,custom_license/WHO Library Cataloguing-in-Publication Data CONCEPTUALIZATION AND GUIDANCE,"Improving the quality of suicide-related information is such an essential component of suicide prevention efforts and of every national suicide prevention strategy that a dedicated group (task force) should be assigned to focus on this activity. After a situation analysis of the current status of suicide-related data has been conducted, a plan to improve data availability, comprehensiveness and quality would be developed, its implementation monitored and the plan periodically updated.",11.899706939054777,4.623921619571882
Many research efforts are currently being undertaken to improve the clinical efficacy of DC-based cancer immunotherapy protocols,0.31544212949834444,3.9422552585601807,4.7660088539123535,780117a7-95ed-49ec-aa48-6546f3253964,custom_license/Tumoricidal activity of human dendritic cells,"Indirect antitumoral activity of killer DCs via amplification of the adaptive immune response In the past decade, clinical trials carried out by investigators worldwide have shown that vaccination with DCs loaded ex vivo with tumor peptides can induce tumorspecific immune responses in patients with advanced cancer [75] . However, the clinical results obtained so far have been rather disappointing, with only a minority of the treated patients showing long-lasting clinical responses. Many research efforts are currently being undertaken to improve the clinical efficacy of DC-based cancer immunotherapy protocols. Thus far, virtually all clinical trials were based on ex vivo generated DCs, either derived from monocytes or CD34 + progenitor cells. Only recently, the possibility has been explored to exploit scarce naturally circulating DCs such as pDCs to vaccinate end-stage melanoma patients, which showed promising results in terms of overall survival [2] .",16.01653433362497,11.266158689875887
appropriate empiric therapy should be instituted to improve clinical outcomes,0.2832407473777511,3.6539387702941895,3.8636474609375,14eaa957-b22a-4dc4-8a78-b66adf58c983,custom_license/41 Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD,"Community-acquired pneumonia is the seventh leading cause of death overall and the most common cause of death from infectious diseases in the United States [1, 2] . Based on their clinical condition, patients are admitted to the medical wards, or if severely ill to the ICU. ICU patients carry the highest mortality rates among all patients with CAP [3] . Multiple sets of clinical practice guidelines have been published in the past few years addressing the treatment of CAP, and they all agree that CAP patients admitted to the hospital represent a major concern, and appropriate empiric therapy should be instituted to improve clinical outcomes [3 -10] . We will review the current literature related to CAP patients admitted to the ICU; regarding epidemiology, risk factors, severity criteria and reasons to admit the hospitalized patient to the ICU, and the empiric and specific antibiotic therapeutic regimens employed.",15.278483500756925,10.23390027556552
"prenatal and neonatal screening and diagnostics, and upon clinical presentation",0.2881706119281706,2.920802116394043,2.6359353065490723,32997e2a-4272-4b0d-97ea-0cc3ab13189f,custom_license/New Technologies: Ethics of Genomics,"The translation of genome-based knowledge and technologies to improve population health will have significant implications for health systems, impacting on the delivery of health care to populations. Genomic's clinical utility will depend in part on developing analytics to read, expediently and error-free, vast and complex genotypes. This will be done at different stages, from embryos prior to implantation, through to prenatal and neonatal screening and diagnostics, and upon clinical presentation. It will require investment in data storage systems to handle the large amounts of information, and algorithms that can simultaneously process, synthesize, and interpret the interacting biological and environmental variables to create statistical associations between specific gene sequence patterns.",14.118956808276717,8.553514207809876
The combination of improved surveillance and diagnostics will further enhance regional patient care and sustainable technical competence,0.15055058964985482,2.6546857357025146,3.806561231613159,8ea2988f-4ec7-4433-9870-ca7c10986058,custom_license/Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic,"The establishment of centralized infrastructure for high-throughput sequencing in regions with high biological diversity in which new human infections are most likely to occur will allow the rapid detection of emerging pathogens. These centers could also serve as hubs from which to deploy resources to unexpected locations in response to new outbreaks. The same infrastructure and technologies could be used to probe the environment on an ongoing basis to define the spectrum of viral strains and species that exist within phylogenetic families known to infect humans and to thoroughly define all existing viruses via high-throughput sequencing. Improved capacity for surveillance can be leveraged to improve and develop diagnostics because of technology convergence, and justifies the investment in facilities, personnel and training. The combination of improved surveillance and diagnostics will further enhance regional patient care and sustainable technical competence.",12.22271426248886,8.47776052062629
development of platform technologies for antigen delivery,0.22460387254318068,2.771723985671997,3.628772497177124,9cdba6c9-6019-425e-96ef-4f8f80e5e0d3,custom_license/Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic,"Methods and infrastructure for rapid manufacturing and clinical evaluation of candidate vaccines will be needed, preferably before a pathogen emerges. This will be facilitated by the development of platform technologies for antigen delivery. Assays for monitoring product potency during manufacturing may differ substantially from preclinical research assays. In an outbreak setting in which high incidence rates might quickly wane, having defined immunological correlates of protection will determine the laboratory endpoints used for clinical evaluation of vaccine candidates and will facilitate the authorization of new products for outbreak control. Regional pre-approved protocols for testing efficacy in outbreak settings also improve the chances of meeting product-licensure criteria.",12.180638434790747,8.42354616602869
treatment of respiratory disease in calves,0.21721131571197616,1.9569242000579834,3.3920774459838867,a3b819d0-db61-45dc-9cbb-7490e52407ae,"custom_license/Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds","We have described the etiological agents of calf respiratory disease in all-in all-out calf-rearing units in an environment where the animals are non-medicated, non-vaccinated and free of IBR, BVD, bovine tuberculosis and, as shown here, free of M. bovis. The study produced a large collection of respiratory pathogens. Further studies will be conducted on susceptibility to antimicrobials, on molecular epidemiology of pathogens and on the genetic similarity of P. multocida phenotypic variants or respiratory and intestinal BCV strains. Combining the results of the present study with clinical data collected from calves, including levels of acute phase proteins, is anticipated to improve diagnostics and treatment of respiratory disease in calves.",12.166033456260596,7.734962779618424
antiviral effects of ribavirin are too weak to improve clinical symptoms,0.2428860067280549,1.441529393196106,2.2643065452575684,b53a30a4-07ef-4223-8bc6-3b2853d8c21c,custom_license/Development of antiviral therapy for severe acute respiratory syndrome,"Although most clinical trials do not support the use of ribavirin in SARS, this does not necessarily mean that ribavirin is without effect on virus replication in treated patients. Possibly, antiviral effects of ribavirin are too weak to improve clinical symptoms. A most recently published uncontrolled study reported that ribavirin reduced viral load in five of eight patients (Wang et al., 2004a) . Moreover, this study suggested that the peak inflammatory cytokine (IL-6 and IL-8) levels concurred with or after peak viral load and preceded or concurred with the maximum pulmonary infiltrates. Therefore, reduction of viral load during the early phase of SARS may reduce the activation of proinflammatory cytokines and subsequently result in a milder course of disease. These clinical findings together with the observation of antiviral activity of ribavirin in different SARS-CoV-infected cell lines show that ribavirin should be critically investigated in SARS animal models to allow a more detailed appraisal of its activity.",15.117139485224222,7.6997921798233655
improved patient care.,0.2516052588020375,2.1900277137756348,2.6057324409484863,01b2f0d6-c923-41de-b1d5-aa327c6506e6,custom_license/Under the microscope: From pathogens to probiotics and back Under the microscope: From pathogens to probiotics and back,"Molecular diagnostics is arguably one of the fastest growing areas in gastrointestinal research. Growth of the so called 'omics' technologies has, over the last decade, led to a gradual migration away from the culture based 'one test, one pathogen' paradigm, toward DNA based multiplex approaches to infectious disease diagnosis, which have in turn led to significant improvements in clinical diagnostics and improved patient care.",12.755956927830923,7.581829025311501
increasing the likelihood of effectiveness and reducing the risk of adverse affects from an associated companion therapeutic,0.13725195951487423,1.440796136856079,2.8481969833374023,323f1b23-6627-4b15-b097-4755fde19e62,custom_license/Clinical Perspectives on Targeting Therapies for Personalized Medicine,This review will consider the extent to which this promise may be met with respect to precision medicine-the application of molecular approaches to improving effectiveness and safety in the use of medicines within stratified groups of patients with well-defined genotypes and phenotypes. This review also discusses the importance of timely development of companion diagnostics to improve treatment planning in selected patients by increasing the likelihood of effectiveness and reducing the risk of adverse affects from an associated companion therapeutic.,11.992415631318455,6.985190999087221
The greatest impact on empiric medical management affected antimicrobial stewardship processes,0.1319078359724873,1.2562898397445679,2.0855491161346436,17faad76-edd5-4bc4-b3a2-16f8f5d8c746,custom_license/Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group,"Our experience demonstrates that providing the diagnosis nearer to patient presentation continues to be an actionable event that impacts medical management for 61% of cases. The greatest impact on empiric medical management affected antimicrobial stewardship processes, highlighting the relationship between rapid diagnostics and appropriate antibiotic and antiviral prescribing previously described [10, 5] . As developments in small molecule and monoclonal therapies for influenza infection grow [21] [22] [23] [24] , the importance of access to rapid, sensitive diagnostics capable of guiding antiviral prescribing and treatment decisions will become important, a finding supported by our experience. Requirements for diagnostic support of suspected influenza cases is particularly relevant given recent experience demonstrating that clinical recognition of influenza in presenting ED patients lacks sensitivity [25, 15] . Our experience confirms that of previous investigators who found that clinical sensitivity for influenza among ED patients was 36% [25] .",13.715980326568621,6.9727884356205045
"clinical records, knowledge representation, and aggregation and analysis",0.2728797665002298,1.4902901649475098,2.083744764328003,e01fbdcd-59af-429a-a7a1-4797a7e84b35,custom_license/A survey of SNOMED CT implementations,"The International Health Terminology Standards Development Organisation (IHTSDO) Technical Implementation Guide defines three types of implementation: clinical records, knowledge representation, and aggregation and analysis [7] . Clinical records refer to the handling of patient data and include services such as recording, storing, retrieving and communicating SNOMED CT-enabled data in a CIS. Knowledge representation refers to expressing clinical knowledge such as clinical guidelines and care pathways in SNOMED CT. Aggregation and analysis refers to the retrieval of data from CIS for the purpose of secondary analysis. For the purpose of this study, we define implementation as the design, use and maintenance of SNOMED CT in the context of a CIS. ''Design'' refers to compiling subsets, developing data entry interfaces, programming search algorithms, selecting a data storage method, incorporating cross maps and developing data retrieval functions. ''Use'' refers to clinicians interacting with the CIS, receiving training and accepting the system. ''Maintenance'' addresses the continued updating of SNOMED CT-enabled CIS.",12.340699797849012,6.642367633276237
working with the NHS and others to make effective use of these products and services,0.39020381160169826,1.1108934879302979,2.1927361488342285,60e7e6a9-ccb6-41b2-815f-1cf5d2336c14,"custom_license/Towards evidence-based, GIS-driven national spatial health information infrastructure and surveillance services in the United Kingdom","The NHS Information Authority (NHSIA), established as a special Health Authority in 1999, states as one of its strategic objectives the need ""to contribute to the implementation of Information for Health by establishing, maintaining, developing and supporting a national information infrastructure, national products, national standards, national services and working with the NHS and others to make effective use of these products and services"" [44] . Again it is astonishing that there is no explicit mention of the potential for geo-information and GIS in addressing these aims. Neither are GIS included in any of the policy documents produced by the Information Policy Unit (IPU -http://www.doh.gov.uk/ipu/), which has overall responsibility for delivering the Information for Health strategy [28] . However, this author was able to spot several local implementation documents on the Web mentioning the use of GIS. One of these documents published on NHSIA Electronic Records Development and Implementation Programme (ERDIP) Web site mentions the use of GIS techniques, mapping to deprivation indices, and linkage to non-medical data in the context of electronic patient records. It also refers to using GIS in matching of demand to location of surgery provision [45] . Two other documents published on IPU Web site also cite GIS [46, 47] .",12.395801664976082,6.485889846638571
"this provision shall not apply to products, in particular substances or compositions, for use in any of these methods.",0.16807811592972421,1.2321580648422241,1.0611259937286377,cfdd34e0-6996-43b6-8cf0-cbcd0b4b9a08,custom_license/IPR Issues and High Quality Genetic Testing,"(a) Inventions the commercial exploitation of which would be contrary to ""ordre public"" or morality; such exploitation shall not be deemed to be so contrary merely because it is prohibited by law or regulation in some or all of the Contracting States; (b) Plant or animal varieties or essentially biological processes for the production of plants or animals; this provision shall not apply to microbiological processes or the products thereof; (c) Methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body; this provision shall not apply to products, in particular substances or compositions, for use in any of these methods.",12.631390663703606,5.911621370367322
"Having a terminology team comprised of terminology experts, analysts, clinicians and programmers was necessary to ensure both clinical and technical viewpoints were represented",0.16632409321892916,0.5132770538330078,1.3984880447387695,53527a87-d30f-4cda-8133-3bb208583120,custom_license/A survey of SNOMED CT implementations,"Having a terminology team comprised of terminology experts, analysts, clinicians and programmers was necessary to ensure both clinical and technical viewpoints were represented. One the interviewees pointed to the lack of a reference implementation as one of the pitfalls of implementation and that it was important to contact other organisations that have implemented SNOMED CT to learn from their experience.",12.687338761635132,5.683215880643951
SNOMED CT implementation in clinical settings.,0.3473274626493017,0.10753965377807617,0.6312049627304077,eb3447bc-a6a9-4fff-8b75-b7348783252e,custom_license/A survey of SNOMED CT implementations,"The questions were submitted to the IHTSDO Chief Implementation and Innovation Officer (CIIO) for feedback and the first author conducted pilot tests with the other three co-authors, all of whom have been involved in SNOMED CT implementation in clinical settings.",13.602883963260659,5.241193387871745
early recognition and prognostication of illness severity,0.30972445760368145,3.5667550563812256,4.957658767700195,298e6edc-6349-43f0-9cd9-b6b6051dd6d8,custom_license/376 APACHE = Acute Physiology and Chronic Health Evaluation; ED = emergency department; GCS = Glasgow Come Scale; ICU = intensive care unit; MEDS = Mortality in Emergency Department Sepsis Score; MEES = Mainz Emergency Evaluation Systems; MODS = Multiple Organ Dysfunc- tion Score; RAPS = Rapid Acute Physiology Score; REMS = Rapid Emergency Medicine Score; ROC = receiver operating characteristic; SAPS = Simplified Acute Physiology Score; SARS = severe acute respiratory syndrome; SIRS = systemic inflammatory response syndrome; TISS = Thera- peutic Intervention Scoring System; TRISS = Trauma and Injury Severity Score. Bench-to-bedside review: Outcome predictions for critically ill patients in the emergency department,"The escalating number of emergency department (ED) visits, length of stay, and hospital overcrowding have been associated with an increasing number of critically ill patients cared for in the ED. Existing physiologic scoring systems have traditionally been used for outcome prediction, clinical research, quality of care analysis, and benchmarking in the intensive care unit (ICU) environment. However, there is limited experience with scoring systems in the ED, while early and aggressive intervention in critically ill patients in the ED is becoming increasingly important. Development and implementation of physiologic scoring systems specific to this setting is potentially useful in the early recognition and prognostication of illness severity. A few existing ICU physiologic scoring systems have been applied in the ED, with some success. Other ED specific scoring systems have been developed for various applications: recognition of patients at risk for infection; prediction of mortality after critical care transport; prediction of in-hospital mortality after admission; assessment of prehospital therapeutic efficacy; screening for severe acute respiratory syndrome; and prediction of pediatric hospital admission. Further efforts at developing unique physiologic assessment methodologies for use in the ED will improve quality of patient care, aid in resource allocation, improve prognostic accuracy, and objectively measure the impact of early intervention in the ED.",9.496823401547097,8.864757176194408
deep connections,0.23139440202400358,3.0703928470611572,4.001175403594971,9b1cb6b3-c04d-4c8b-af7b-aa8436bf90d4,"custom_license/Gene wiki review POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies","Interestingly, although much less developed than evidence of POLD1 involvement in MDPL or cancer, some provocative papers have suggested that altered expression or function of p125 may be relevant in additional pathogenic contexts. Some of the phenotypes of MDPL, such as lipodystrophy, have been linked to diabetes and insulin resistance (Vatier et al., 2013) . Although there has been no direct investigation of functional relationships, studies of changing gene expression in a rat model of diabetes progression identified a decrease in POLD1 expression at the onset of hyperglycemia (Zhou et al., 2011) . PolÎ´ activity can be promoted by activity of glycolytic enzymes including lactate dehydrogenase and 3-phosphoglycerate kinase (Popanda et al., 1998) . The POLD1 R648Q mutation identified in Novikoff rat hepatoma cells and described above as linked to defects in repair also modulated the stimulation of the PolÎ´ by lactate dehydrogenase (Popanda et al., 1998) . This is interesting, as the processes of glycolysis are altered in diabetes and in tumor development, a number of glycolytic enzymes have been identified at the replication fork, and depletion of specific proteins that mediate glycolysis and the tricarboxylic acid (TCA) cycle resulted in impairment of DNA synthesis (Konieczna et al., 2015a (Konieczna et al., , 2015b . MDPL and atypical Werner syndrome are associated with features of premature aging; studies of normal aging have more broadly connected decline in exonuclease function of polymerases associated or autonomous proofreaders such as TREX1 with clinical diseases associated with aging (Mason and Cox, 2012) . The pro-oncogenic miR-155, noted above as a regulator of POLD1 expression, has recently been found to be elevated in expression in obesity-induced inflammation in adipocytes (Karkeni et al., 2016) , and in inflammation-associated senescence (Olivieri et al., 2015) . While at present the functional linkages between POLD1, inflammation, diabetes, and aging remain speculative, investigation of these topics may reveal deep connections that improve clinical practice.",11.916530768324186,8.767305131839947
we are likely to gain a better knowledge of the burden of the various pneumonia pathogens,0.34329683001577016,3.6204330921173096,4.477884769439697,94b670ad-7a34-43ff-9f36-944c01064b08,custom_license/Personal View Atypical pneumonia-time to breathe new life into a useful term?,"As diagnostics improve, we are likely to gain a better knowledge of the burden of the various pneumonia pathogens. With use of nucleic acid detection methods we now have a better appreciation of the importance of viruses in both adult and childhood pneumonia. 78 Respiratory viruses (panel), often thought of as causes of atypical pneumonia syndrome, can be detected in about one-third of adults 79 and in over a half of children [80] [81] [82] [83] [84] admitted with community-acquired pneumonia. The situation is complicated further by the common fi nding 79, 85, 86 and the abundance of evidence supporting an interaction between respiratory viruses and bacteria in the pathogenesis of pneumonia. 87 As a result, defi ning atypical pneumonia by type of pathogen alone is problematic.",9.39127351901103,8.550852341665916
individual bird administration,0.2756205233661868,3.6690566539764404,4.0897321701049805,a311ae29-38ee-4c7d-af56-a622ae106210,custom_license/Newcastle disease vaccines-A solved problem or a continuous challenge?,"Inactivated vaccines became commercially available in the USA in 1945, but were not adopted by the poultry industry at that time as they were comparatively expensive, and were unable to prevent clinical disease to a sufficient level to merit wide spread use. The first live vaccines licensed in 1948 were formulated with strains now designated as virulent that produced disease in younger birds and were only applicable for use in chickens at least four-week old and needed to be applied with a wing-web application (Goldhaft, 1980) . During this time several laboratories were investigating NDV strains that could be used as a live vaccine with acceptable levels of post-vaccinal clinical disease symptoms. Within two years, two NDV strains of low virulence (B1 and LaSota) isolated from chickens from the USA were also licensed for use (Goldhaft, 1980; Hitchner, 1975) . Shortly after these products were available for individual bird administration, mass application techniques deemed necessary for larger commercial settings were investigated and implemented despite varying responses, because of uneven coverage in flocks and less than an optimal percentage of seroconverting birds (Lancaster, 1966) . Since the earliest implementation of live ND vaccination, the transfer of antibodies to offspring that can even partially neutralize the live ND vaccines, was known to be a complication. It was also evident that even the vaccines formulated with the more virulent vaccine strains would not provide lifelong immunity and that additional vaccinations would be necessary in layers and breeders. Unfortunately, many of the problems in controlling ND that were clear from the first few decades of ND vaccine use, continue in 2016.",9.502806536393322,8.369195023390587
"In the near future, it may be possible to exploit this information in several ways to improve clinical care",0.36366260008702517,1.5533393621444702,1.6286834478378296,a781965b-683f-429d-bdbc-23a935874a18,"custom_license/Gene wiki review POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies","The integration of high throughput sequencing technologies with functional studies probing protein function have assigned POLD1 an important role at the junction of DNA replication with repair and the maintenance of genome integrity. In the near future, it may be possible to exploit this information in several ways to improve clinical care. For instance, as mutation of the DNA repair protein BRCA1 predicts tumor sensitivity to specific DNA-damaging agents (O'Connor, 2015) , identification of damaging mutations in POLD1 may be used to optimize administration of DNA damaging chemoradiation and targeted therapies.",16.403344272406947,7.809485321830927
To enhance the efficacy of vaccines and to improve the immune responses,0.16840366580653743,3.204641580581665,2.8603458404541016,62c5ada5-e8b6-48a7-8f4e-e0776aa1b7b2,custom_license/Newcastle disease vaccines-A solved problem or a continuous challenge?,"Extensive use of currently available vaccines, strict quarantine combined with rapid diagnostics and biosecurity, and stamping out and other containment measures seem to keep ND under control in developed countries. However, as evident from the multiple outbreaks occurring worldwide, current vaccination strategies are not fully efficacious under different environmental conditions and the development of new concepts for vaccine generation are needed. To enhance the efficacy of vaccines and to improve the immune responses induced by them, investigation of innovative approaches together with the development of safe and novel strong adjuvants are necessary. Future ND vaccine systems that allow rapid development to target emerging NDV strains, and enable design of multiplexed vaccines, will have advantage over currently existing vaccines.",9.532701706499363,7.2786874209480255
recent improvements in drugs and vaccines,0.25686974384234706,1.8042857646942139,3.1081275939941406,466c826b-1681-42f5-b232-4edd554f76fe,custom_license/Viral surveillance and discovery,"The changing dynamics of emerging viruses has resulted in an increasingly important role for viral discovery and diagnostics in clinical medicine and public health. Globalization of travel and trade in domestic animals and animal products, bush meat trafficking, political instability and bioterrorism, as well as climate change and its effects on vector distribution have all facilitated the emergence and reemergence of zoonoses [1] [2] [3] . Viruses previously restricted to one host species or geographic region can now appear in unexpected locations, confounding clinicians who are unprepared to recognize new syndromes or to detect new pathogens with their existing diagnostic tests. Immunosuppression associated with organ transplantation, chemotherapy or HIV/AIDS has enabled viruses with limited virulence to become more pathogenic [4] [5] [6] [7] . The increased appreciation for the potential role of viruses in chronic cardiovascular, endocrine, neurodevelopmental and neoplastic disorders coupled with a growing repertoire of diagnostic tools and techniques has resulted in a re-energized quest for associated pathogens ( Figure 1 ) [8] [9] [10] . This burgeoning interest in discovery and diagnostics now also has practical applications given recent improvements in drugs and vaccines. The lack of effective therapies once made the diagnosis of viral infection primarily an academic exercise; however, the expanding armamentarium of countermeasures for specific viruses promises unprecedented opportunities to reduce morbidity, mortality and the economic costs of viral infections.",10.984285936221912,7.037568760825099
it is necessary to develop algorithms to improve the quality of search results,0.2140210027555466,2.555553913116455,3.390594959259033,62d747ca-9b29-48d2-a988-2c3e085321ed,custom_license/A relevance and quality-based ranking algorithm applied to evidence-base d me dicine,"Conclusions: Successful results have been achieved with the experiments, improving on other studies, but under different and even more complex circumstances. with real users [ 5 , 6 ]; nevertheless, there are studies that question whether technology applied to clinical information retrieval is useful and cast doubt on the ability of scientists to search appropriately [7] . Hence, it is necessary to develop algorithms to improve the quality of search results, especially as finding the best studies may suppose a better treatment for patients [8] .",8.874175045042882,6.970958032809076
"improve the accuracy of prognostic decisions, and objectively measure the impact of clinical interventions and pathways in the ED.",0.12501006256851568,1.9670674800872803,3.2514538764953613,7c82c78a-d5f0-480f-951d-a496cfa37cea,custom_license/376 APACHE = Acute Physiology and Chronic Health Evaluation; ED = emergency department; GCS = Glasgow Come Scale; ICU = intensive care unit; MEDS = Mortality in Emergency Department Sepsis Score; MEES = Mainz Emergency Evaluation Systems; MODS = Multiple Organ Dysfunc- tion Score; RAPS = Rapid Acute Physiology Score; REMS = Rapid Emergency Medicine Score; ROC = receiver operating characteristic; SAPS = Simplified Acute Physiology Score; SARS = severe acute respiratory syndrome; SIRS = systemic inflammatory response syndrome; TISS = Thera- peutic Intervention Scoring System; TRISS = Trauma and Injury Severity Score. Bench-to-bedside review: Outcome predictions for critically ill patients in the emergency department,"Most EDs are staffed for short-term stabilization of critically ill patients. Because of overcrowding and prolonged ED lengths of stay, the care provided to patients with such high acuity may vary and is limited by available equipment, training, and staff-patient ratios. Methodologies such as physiologic scoring systems to assess the quality and quantity of critical care delivered will serve as tools to help remedy the varying care delivered in the ED setting. Thus unique physiologic assessment methodologies should be developed to examine and improve the quality of patient care, enhance the precision of clinical research, aid in resource allocation, improve the accuracy of prognostic decisions, and objectively measure the impact of clinical interventions and pathways in the ED.",10.108873449327138,6.9301445890432145
Studies of this kind have allowed us to develop a general model of the decision and other processes that are carried out in complex medical domains,0.226614379966304,1.4231204986572266,1.451366662979126,884bb827-c848-4086-a200-a841e8a9db7b,"custom_license/Probability, logic and the cognitive foundations of rational belief","Studies of this kind have allowed us to develop a general model of the decision and other processes that are carried out in complex medical domains (Fig. 3) . The model has been described in detail elsewhere (e.g., [7] ) so suffice it to say here that according to this account clinical thinking can be well described as a collection of logical processes that reason over and update cognitive representations of general medical knowledge and specific clinical situations.",12.555505285426822,6.2628435049630164
Microarray hybridization,0.2553163559965561,2.176382064819336,1.7647351026535034,146c44f9-8c4e-4077-a0f7-6b8328d7279a,custom_license/Chapter 41 Respiratory Pathogens,"Microarray hybridization of randomly amplified PCR products from respiratory cultures and clinical samples has shown some success. 31 If the promise of early experiments is maintained when applied to large-scale clinical studies, this could answer some of the technical problems surrounding the use of multiplex systems. Microarray hybridization, while not currently as convenient as realtime PCR detection methods, potentially has the benefit of being able to resolve complex product mixtures and provide clinically valuable information.",9.040225942556217,5.725805238752022
the resulting application successfully supports this easy-to-use interface with the rich functionality provided by RNAVLab,0.17836311256476697,0.9170899987220764,2.191340446472168,374f47b9-c1f9-4090-96bc-6897a27cae38,custom_license/RNAVLab: A virtual laboratory for studying RNA secondary structures based on grid computing technology,"The RNAVLab user interface is designed and implemented around the RNAVLab computational environment with a strong focus on compatibility. The implementation idea is also derived from the key concept of encompassing high functionality within a simple but comprehensive interface. By maintaining these two design concepts throughout the process of implementation, the resulting application successfully supports this easy-to-use interface with the rich functionality provided by RNAVLab. The interface is developed in JAVA, thus in nature, preventing any operating system dependencies.",9.226693350039923,5.249822461890232
Consecutive nasopharyngeal aspirate (NPA) samples sent to the UCSF clinical laboratory for DFA,0.12910738604941763,0.865310788154602,1.9124184846878052,3d043d35-2618-40d2-8374-68e7a3b2fc0c,custom_license/Utility of DNA Microarrays for Detection of Viruses in Acute Respiratory Tract Infections in Children,"Consecutive nasopharyngeal aspirate (NPA) samples sent to the UCSF clinical laboratory for DFA were analyzed with the Light Diagnostics Respiratory DFA Viral Screening and Identification Kit (Chemicon International, Temecula, CA). This kit detects 7 common respiratory viruses: respiratory syncytial virus (RSV); influenza A and B (FluA and FluB); human parainfluenza virus types 1, 2, and 3 (HPIV-1, 2, and 3); and adenovirus (AdV). Remaining sample material was transferred into a sterile 14-mL conical tube, frozen, and stored at Ïª80Â°C.",9.06043336472123,4.9766757049999955
A governance system is needed to prioritise product development according to unmet health needs,0.19733373585820652,0.9694821238517761,1.4134141206741333,7f40c8b5-ec67-481e-8510-13bdee4f0d86,custom_license/Global health security: the wider lessons from the west African Ebola virus disease epidemic Europe PMC Funders Group Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts,"Obviously, products destined for epidemic and emerging diseases and antimicrobial resistance do not fall in this category, and the chronic crisis we are facing shows why we need alternative ways to conduct and finance research and development that prioritise public health needs and where the primary payback is improved global health security and the fulfilment of the individual right to health. This scenario means shifting from a system in which essential health products are regarded as profitable commodities and it is left to the private sector to decide which ones to develop, to a system where medicines are deemed public goods, and where it is incumbent on the public sector to define the public health priorities, and to create a conducive environment for product research and development, approval, and rational use. A governance system is needed to prioritise product development according to unmet health needs, and mechanisms that will allow diagnostics, drugs, and vaccines to be developed without an immediate financial reward, but, as conditions might warrant, left on the shelves until the next outbreak occurs, or kept in reserve until bacteria become resistant to first-line therapies. This arrangement is by sharp contrast with the current motive of maximising sales, which leads to massive overuse of some drugs, and necessitates regulation of the way drugs are deployed, prescribed, and used for instance to minimise the misuse of crucial antibiotics and prolong their lifespan.78",8.939893633089461,4.677845330523152
scenario design of SEIQRA,0.17855967154989738,-1.606242060661316,-1.2226752042770386,572685ad-5bf4-421b-91ba-eb468557712e,custom_license/Artificial infectious disease optimization: A SEIQR epidemic dynamic model-based function optimization algorithm,"According to the scenario design of SEIQRA, the implementation process of SEIQRA is described as follows.",8.970292055505471,1.3008059972169843
"medical staffs should carefully explain the clinical and epidemical characteristics, as the optimistic emotion can increase the immune ability, thus to improve clinical outcomes",0.1362113636796883,1.5904583930969238,3.0210444927215576,1e535f91-117e-44d1-a186-579031b911e8,custom_license/Short Term Outcome and Risk Factors for Mortality in Adults with Criti- cal Severe Acute Respiratory Syndrome (SARS),"Over psychological response causes over ex tension of sympathetic vasoconstrictor nerve and the increase of catecholamine, as a resuh, the whole system vascular bed constricts and amount of blood transfers to pulmonary circulation, the acute increase of pulmonary volume further reduces the lung compliance, increases the dyspnea, and increases the difficuhy to control pulmonary infection. Because of the characteristics c~f SARS such as high infection, congregalhm, and ~he rapid pro gress to death of partial patients, many patients with SARS have severe phobia, such as insomnia, poor appetite, palpitation, and repeatedly consult to medical officer, etc. For these reasons, medical staffs should carefully explain the clinical and epidemical characteristics, as the optimistic emotion can increase the immune ability, thus to improve clinical outcomes. The current study demonstrates that psychotherapy in the early stage is associated with reduced mortality of critical SARS.",17.791541602869664,9.224516436786395
immunomodulatory drugs should be considered in order to increase survival of allografts,0.12587078957180906,2.5465333461761475,2.90250825881958,067454cd-308f-42bd-ac3f-86db7414bccd,custom_license/MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination,"In conclusion, our findings provide evidence that allogeneic NPCs are not immune privileged upon transplantation into an established inflammatory environment. Rejection is rapid and involves T cell responses directed against NPC alloantigens, although CD4+ T cells are a more important mediator of immune-mediated rejection. In consideration of using NPCs for treating chronic neuroinflammatory diseases such as MS, the use of immunomodulatory drugs should be considered in order to increase survival of allografts in order to improve clinical outcome. The MFI for MHC I and II expression on GFP-NPCs following incubation with CD4 or CD8 CM was determined and divided by the MFI for MHC I and II following IFN-Î³ treatment to determine the fold increase in MFI. ",15.751670219090855,9.05496161992902
enable the interruption of transmission between humans and from dromedary camels to humans,0.37491561620373015,1.5673179626464844,4.2251667976379395,e8602960-fb87-4ca6-8181-7012d2e1d5e5,custom_license/A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation,"Drafting a research and product development roadmap for MERS-CoV R&D roadmaps have been used successfully in many sectors in which large-scale, collaborative efforts are required to deliver outcomes related to the innovation and development of new products. In all such processes, it is essential to start by clearly articulating and understanding the goals and markets for these products. High-level priority areas are first identified, after which an agreement on specific activities is decided. It is also crucial to first map out the baseline knowledge gaps and then to develop a strategic plan to address those deficiencies. This also requires an assessment of capacity needs that can support these activities. Project management and implementation structures are subsequently established to pursue agreed-upon activities to reach these goals. An example of this process can be found in the WHO Malaria Vaccine Technology Roadmap, which has culminated in a firstgeneration malaria vaccine and catalyzed the development of second-generation products (http://www.who.int/immunization/topics/ malaria/vaccine_roadmap/en/). At the meeting, four strategic goals were agreed upon in principle. The first is to establish a surveillance network of coronavirus laboratories as an early warning system to identify circulating species and strains in animal populations, new outbreaks in human populations and emerging strains in all populations. The second is to acquire a better understanding of MERS-CoV pathogenesis, natural history and veterinary and human epidemiology. The third is to develop, manufacture, test, license and use improved diagnostics, preventives and therapeutics that enable the interruption of transmission between humans and from dromedary camels to humans. The fourth, and perhaps most important, is for the global donor community to establish a mechanism that provides a lineof-sight for manufacturers from preclinical proof-of-concept studies to post-licensing procurement of MERS-CoV products, by initiating a public-health financial model for emerging pathogens prioritized by the WHO blueprint process.",14.836347668201963,8.957836778055562
screen blood and blood products,0.15473589882125757,2.0855658054351807,4.041032791137695,3da23bcf-d1ea-41ec-9697-e7c7316e9b6e,custom_license/Human and Animal Viruses,"Antigens used for viral diagnostic purposes must also be quality controlled and, in general, would also be produced from a virus seed lot system. Variation of quality or quantity of viral antigens in diagnostic kits and reagents may directly influence results in the diagnostic laboratory. Regulation of the manufacture of diagnostics is similar to those for vaccine manufacture. Regulations concerning the manufacture of biological products are published by the United States Public Health Service (21 CFR 600) and outline the requirements for control of reagents and raw materials in the manufacture of diagnostics to screen blood and blood products. For these purposes, it is essential to use viral seed stocks that are appropriately characterized and preserved by freezing.",14.198156985309119,8.951644032630561
implementation may be within reach for larger clinical and reference laboratories,0.36360048914376564,3.0395448207855225,4.082154273986816,c56628b9-bc85-4062-b332-40513035cfb8,custom_license/Review PCR-Electrospray Ionization Mass Spectrometry The Potential to Change Infectious Disease Diagnostics in Clinical and Public Health Laboratories,"Finally, an additional concern for PCR-ESI/MS is the expected cost and the feasibility of nonreference facilities acquiring the technology. The expected start-up cost for the PLEX-ID is higher than that which can readily be supported by most diagnostic laboratories. Additional costs include the attainment of assay kits, approximately $50 to $100 per sample, 32 which is similar to or greater than the cost of existing molecular assays. The combined expense of start-up and kits will make PCR-ESI/MS implementation into general laboratories difficult, but implementation may be within reach for larger clinical and reference laboratories. Further evaluation of the potential cost avoidance that may occur because of rapid identification of a wide variety of infections may offset the costs of PCR/ESI-MS; however, implementation practices remain to be described in the clinical literature.",12.180172039522416,8.892164625434866
better value addition,0.15507906392039247,2.6585190296173096,3.7284421920776367,3335e30b-3f4d-4db7-aa26-e0d95d4cf597,custom_license/Modification of Animal Products for Fat and Other Characteristics,"In addition, casein solubility could increase only with increasing in glycosylation, which could reduce the time for coagulation of rennet and expulsion of whey. This process would yield the firm curds from milk and would improve in cheese making. Alteration in other physical properties could improve the quality of food produce from milk, such as cheese with low fat and better taste. The production of milk along with processing and transportation cost of milk can be reduced with genetic engineering techniques. These techniques made this possible to use more milk and milk products with better value addition. These methods offered a better opportunity for the production of protein milk to improve animal agriculture and creation of new medicines in milk (Gottlieb and Wheeler 2011) .",11.857447665313831,8.301631476961557
to improve awareness of these diseases in the general population,0.1622809772928668,2.490016222000122,3.3583269119262695,cc7348e3-1b48-4536-994f-5b09e00e0d26,custom_license/The Lancet Gastroenterology & Hepatology Commission Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission,"With the launch of the National Viral Hepatitis Control Program in 2018, research should also focus on the development of low-cost point-of-contact testing kits for viral hepatitis. The effectiveness of potential interventions to prevent and treat NAFLD and alcoholrelated liver disease needs to be investigated. Finally, implementation research to improve the coverage and effectiveness of potential interventions and to improve awareness of these diseases in the general population is also needed.",12.790625178123255,8.278141849395293
"large-scale production, cost-effectiveness, GMO regulation, and consumer choice",0.270695885811294,3.008397102355957,2.7765555381774902,f45df22a-76e6-4014-a8ff-641772aa5900,custom_license/Modification of Animal Products for Fat and Other Characteristics,"The animal fat content, as a result of modern transgenic techniques, would be the most important future strategy to improve animal dairy and meat products for safe consumption by humans. These alterations will make such products more valuable and desirable for patients suffering from cancer or heart diseases. Moreover, these products can also reduce risk of lethal diseases such as chronic heart disease and cancer with consumption of animal product lower in bad or higher in good fat contents. Some additional benefits can also be achieved along with safe consumption of fat products of transgenic animals such as increased shelf life, or storage of animal fat to avoid rancidity and oxidation. Future development may make it possible to introduce the transgenes, knockout, and knockin with more precision. Issues related to transgenic products still need attention and further improvement is required, such as large-scale production, cost-effectiveness, GMO regulation, and consumer choice.",11.70299995942903,7.856269202146901
simplified management algorithms in settings where diagnostics are not available,0.23019759916283453,1.6601910591125488,3.1344220638275146,8b975a96-d618-4f63-a19d-42e5e2c2a172,custom_license/The Lancet Gastroenterology & Hepatology Commission Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission,"Since only a small proportion of patients with hepatitis B and C are ever diagnosed, the importance of screening and diagnostics need to be better emphasised. New approaches and tools are required for point-of-care diagnostics that are suitable for high-burden, lowresource countries. The 2018 establishment of a WHO Essential Diagnostics List 426 is a welcome recognition of this importance. A greater focus is now needed on prequalification (ie, evaluating diagnostic tests with standardised protocols for their quality, performance, and safety to guide procurement decisions by actors such as WHO Member States or UN agencies) to ensure provision of high-quality diagnostics and clinical evidence for simplified management algorithms in settings where diagnostics are not available. 4 We believe that governments should widely engage with all stakeholders, including individuals and organisations representing at-risk groups (eg, people who inject drugs, prisoners, and individuals with HIV), and also be liberal in approving and implementing new diagnostic devices.",13.174811656978921,7.727682609853663
improved patient care.,0.2516052588020375,2.1900277137756348,2.6057324409484863,086aa8a0-0a4e-44d3-98f2-3cc49d0b112c,custom_license/Under the microscope: From pathogens to probiotics and back Under the microscope: From pathogens to probiotics and back,"Molecular diagnostics is arguably one of the fastest growing areas in gastrointestinal research. Growth of the so called 'omics' technologies has, over the last decade, led to a gradual migration away from the culture based 'one test, one pathogen' paradigm, toward DNA based multiplex approaches to infectious disease diagnosis, which have in turn led to significant improvements in clinical diagnostics and improved patient care.",12.737507519305073,7.575371732327454
selection of tools for policy implementation,0.1940768528662422,1.3009663820266724,2.737382650375366,ecdb9b62-60df-4472-a531-eb2de8caf4b6,custom_license/The implications of the emerging disproportionate policy perspective for the new policy design studies,"Embracing the idea that a policy may be designed for purposes other than implementation Another central idea underlying the new policy design orientation is that the design of policies is undertaken in order to improve government actions through the selection of tools for policy implementation (Howlett 2014 ). An example is the idea of public interest nudges, which advance the construction of default rules in order to insulate individuals' decision-making from psychological and contextual effects (Thaler and Sunstein 2008; Leggett 2014 ). This is undertaken by a choice architect-''[anyone who] has the responsibility for organizing the context in which people make decisions'' (Thaler and Sunstein 2008 , 3)-with the aim of ''influenc[ing] people's behaviour in order to make their lives longer, healthier and better [â¦] to steer people's choices in directions that will improve their lives'' (Thaler and Sunstein 2008, 5) .",14.05839569577272,7.545365364581777
production of food products and additives,0.11746894890247615,1.7056505680084229,2.4844541549682617,975b8701-b4cf-491b-8a35-2abb840a14b3,custom_license/Dealing with bio-and ecological complexity: Challenges and opportunities Â§,"The goal of biotechnological processes is to optimise the performance of processes involving industrially important organisms (e.g. for the production of food products and additives), biomedically relevant species (e.g. for the production of antibiotics and other therapeutics) and the degradation of pollutants (e.g. wastewater treatment). This last area has been assuming ever-increasing importance during the past few years.",13.214751724481554,7.3487311735033884
change,0.24718672219792945,0.9335066676139832,1.981063723564148,c5955ed6-9272-4974-b1f2-a1de62a7a83b,custom_license/The Heart and Toxins,"A clinical audit is an essential component of clinical governance. It considers procedures adopted to diagnose, methods used to deliver health care and treatment, utilization of resources, and the effect of outcome along with quality of life of the patient. Principles for the best practice in clinical audit, published by the National Institute for Health and Clinical Excellence (NICE), 90 defines it as a quality improvement process that seeks to improve patient care and outcomes through systemic care delivered against explicit criteria and the implementation of change.",15.374108656490831,7.275408784037576
new drugs and diagnostics,0.13774871073535508,1.9809306859970093,1.4681822061538696,76b3f0e6-ea5f-48ef-8237-e9fa8b00b709,custom_license/C O M M E N TA RY Research on infectious diseases requires better coordination,"Most of the examples of significantly coordinated and managed health research for strategic impact on emergent infectious diseases occur at the level of knowledge generation (such as genome sequences) and tool development (such as new drugs and diagnostics). There are increasing examples of coordinated, multicenter trials to impact on drug policy 21, 22 . But there is a need for more significant and better coordinated research, aligned to health system needs, that can usefully inform national and international strategies and policies and lead to enhanced implementation in developing countries. It is incumbent upon the numerous research funding agencies and stakeholders, as well as individual scientists to ensure their research has impact to take the needs and stakeholdership of developing countries into account. There is a need to improve levels of international cooperation and coordination, both among agencies and with relevant national institutions.",14.353538141117674,7.265661729289258
the need to promote more equitable innovation and universal access,0.1753499940036004,2.06608510017395,2.756655216217041,0f85b888-7d2a-4458-8bd2-27cda36a7c95,custom_license/International Law and Public Health Policy,"In addition, globalization has expanded global interest in codifying new international commitments to protect the health status of poor states that have not benefited from globalization -the so-called losers of globalization. For example, the need to promote more equitable innovation and universal access in health-care products, including medicines, pharmaceuticals, diagnostics, and medical devices, is generating ongoing debate about the efficacy of codifying a new international instrument on medical research and design.",11.50789308364015,7.1625437849281965
establish prevention strategies,0.39085473564945467,3.405646562576294,4.847386360168457,11e7e0b3-2941-4309-ac2d-5b2a3170a2b9,custom_license/Original Article,"Each year, more than 16 million Japanese residents travel abroad and more than 19 million foreign people visit Japan according to Japan National Tourism Organization. The number of foreign tourists traveling to Japan has been increasing, with more patients visiting clinics in Japan after or during travel. There is a lack of published small case series regarding infectious and non-infectious diseases among patients visiting travel clinics in Japan [1e3]. Our clinic is a member of the global travel-associated disease surveillance network ""GeoSentinel,"" which has recently reported largescale studies on ill travelers [4] . However, most of the data are provided by European and North American clinics, and the report does not reveal the patients and diseases in real settings, such as the travel clinics in Japan. Accordingly, we evaluated the characteristics of patients visiting our travel clinic following recent travel abroad to help improve the clinical practice of Japanese doctors and establish prevention strategies.",13.638468415097313,10.137935345068147
computer technologies,0.2777452362410248,3.112485885620117,4.440997123718262,c5680cbc-e47a-4ba2-b00b-5ba009d863df,custom_license/Clinical Chemistry through Clinical Chemistry: A Journal Timeline,"The establishment of the modern discipline of clinical chemistry was concurrent with the foundation of the journal Clinical Chemistry and that of the American Association for Clinical Chemistry in the late 1940s and early 1950s. To mark the 50th volume of this Journal, I chronicle and highlight scientific milestones, and those within the discipline, as documented in the pages of Clinical Chemistry. Amazing progress has been made in the field of laboratory diagnostics over these five decades, in many cases paralleling-as well as being bolstered by-the rapid pace in the development of computer technologies. Specific areas of laboratory medicine particularly well represented in Clinical Chemistry include lipids, endocrinology, protein markers, quality of laboratory measurements, molecular diagnostics, and general advances in methodology and instrumentation.",13.634736054865414,9.681921575272842
rational modifications to improve the therapeutic index for these molecules.,0.21694320130162004,3.247347593307495,4.163773536682129,7c295b29-a055-4a5d-82b8-a2220b21b8e5,custom_license/Anti-infectives from the sea Marine natural products and their potential applications as anti-infective agents,"Most antifungal compounds from marine origin are cytotoxic. Consequently, they have not generally been considered promising antifungal agents for clinical applications. We have reviewed marine natural products that show potent antifungal activity, but evidence of cytotoxicity was not available for all. 11 In many cases, the assessment of whether antifungal activity outweighs cytotoxic effects will be required, followed by rational modifications to improve the therapeutic index for these molecules.",12.845874773147024,9.313284905094713
allowing prioritization and implementation of appropriate biosecurity measures during outbreaks,0.13463904092604084,2.643202066421509,3.325652837753296,7093051f-51bf-402d-a602-cd4cbb64a3bb,custom_license/Novel Molecular Diagnostics and Therapeutic Tools for Livestock Diseases,"Molecular diagnostic assays are becoming more popular for confirmation of fieldbased diagnosis of livestock diseases on the basis of clinical signs and symptoms. Recent advancements of diverse biotechnological tools promise for improvement in the speed and accuracy of diagnostics for both human and veterinary medicine. This can also support the development of advance epidemiological tools and data for various animal and human pathogens, thereby allowing prioritization and implementation of appropriate biosecurity measures during outbreaks more effectively and saving valuable national funds.",15.0024913965653,9.130627676511478
promotion of global clinical trials,0.1253339221593984,1.4503984451293945,2.295337677001953,5cf56045-89e0-4d00-a806-75d39f6adee2,custom_license/I State of Play and Review of Major Cooperation Initiatives,"The primary objective of this increase in international collaboration was to urgently resolve the ""drug lag"" www that has impacted the Japanese pharmaceutical market in the past (2.4 years in 2006). Many measures have been taken to improve the clinical testing environment (including the promotion of global clinical trials) and expedite drug approval decisions (via, among other measures, the increase of collaboration with the other worldwide DRAs). A global, simultaneous drug development approach has also been strongly recommended. Many actions, including release of guidelines, have been taken to facilitate such global development [277] .",18.58121462335651,8.938153597560154
"ribavirin (Hosoya et al., 2004) appears to improve clinical conditions and survival time",0.12873280568603065,1.062319278717041,3.5378634929656982,798616dd-9fc1-44b8-9e6d-91750d62426d,custom_license/Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference,"Subacute sclerosing panencephalitis (SSPE) is a rare, but fatal outcome of MeV infection. It has been estimated that approximately 10-20 out of a million MeV-infected individuals develop SSPE, which is caused by mutated MeV, or SSPE virus, after a prolonged incubation period of an average of 7 years (Okuno et al., 1989) . Although a combination therapy using interferon (IFN) and inosiplex (Anlar et al., 2004; Gascon, 2003) or ribavirin (Hosoya et al., 2004) appears to improve clinical conditions and survival time to some extent, there is currently no specific treatment available to cure patients with SSPE and a new treatment strategy for SSPE is greatly needed.",14.61113161252519,8.104014865977597
informed consent,0.339523687046086,2.023695707321167,2.477205753326416,baaca07b-c542-4eca-822e-0f834260603c,custom_license/Synopses of Research Articles,"There is considerable optimism that genomics research will result in new drugs, vaccines, diagnostics, and tools for malarial vector control. Strong linkages between genomics research and national malarial control programs will facilitate the translation of research findings into intervention tools. As it is for all new technologies, it might also be important for the communities in endemic countries to have a greater awareness and understanding of genomics research. This will enhance acceptance of the products and improve informed consent. There is therefore a unique opportunity for collaborations between social-economic scientists and genomics researchers. ",14.723728983845886,8.07889109376699
the LSIF promoted the development and implementation of focused efforts on harmonization towards international standards,0.11639334739392787,1.4375592470169067,2.527852773666382,5fd82b85-6d78-4b90-b00a-4f8821f46409,custom_license/I State of Play and Review of Major Cooperation Initiatives,"In 2008, the LSIF released an ""Enablers of Investment Checklist,"" a voluntary guidance tool for member economies to assess and improve their innovative life sciences sector investment opportunities. One of the six principles covered by the checklist is ""Efficient and Internationally Harmonized Regulatory Systems."" Under this principle, the LSIF promoted the development and implementation of focused efforts on harmonization towards international standards through recognized international organizations (i.e., ICH). Moreover, to support this objective, the LSIF also proposed development of the following: â¸ A regulatory framework (transparent, predictable, and science-based) that allows for the quick introduction of new innovative products â¸ An efficient clinical trial regulatory system focused on safety, efficacy, and ethical standards â¸ An adequate number and level of training programs for regulatory personnel â¸ The publication of proposed regulations for stakeholder comments (which should be taken into account) â¸ Laws providing for stakeholder consultation throughout the regulatory drafting and review process â¸ Participation in international joint clinical trials Performance metrics have also been defined to assess the implementation of the recommendations. Finally, some of the other principles on this checklist also support cooperation and convergence as they assess the resources, exchange programs, intellectual property rights, and interagency coordination of life science policy and regulation.",14.725829357353751,7.73155808851795
multinational clinical studies,0.11612610250934577,1.63744056224823,3.1919479370117188,8f9fe298-3190-4336-8880-fc7c6df45fff,custom_license/I State of Play and Review of Major Cooperation Initiatives,"The EU introduced a new Orphan Medicinal Product legislation in 2000 in order to provide incentives for the development of medicinal products for rare disorders. Harmonization of requirements for these types of products is critical to allow for multinational clinical studies and to limit the development challenges due to the small number of patients. Prior to this European legislation, a number of Member States had adopted specific measures to increase knowledge on rare diseases and improve their detection, diagnosis, prevention, and treatment. However, these initiatives were few and did not lead to any significant progress in research on rare diseases.",12.595748535625333,7.547614511987833
harmonized requirements across the Member States,0.17131801039922573,1.710606575012207,2.6819777488708496,f1ade71b-571e-424e-a8c5-872fcc84fed8,custom_license/I State of Play and Review of Major Cooperation Initiatives,"The procedures for clinical trials in Europe used to vary from one country to another. There were different national approaches regarding the approval and notification systems, documentation requirements, and timelines [136] . In October 2004, in order to coordinate the implementation of the new harmonized requirements across the Member States, the HMA established the Clinical Trials Facilitation Group (CTFG). The CTFG (attended by representatives from the National DRAs, EC, and the EMA) acts as a forum for discussion on the agreement of common principles and processes to be applied throughout Europe. It also promotes harmonization of clinical trial assessment decisions and administrative processes across the national DRAs. This group established a Voluntary Harmonization Procedure (VHP) for the assessment of multinational CTAs [138] . During this three-phase procedure, DRAs from all Member States involved assess the application, though each Member State remains ultimately responsible for the approval of the CTA in its own country. However, there is a coordinated validation phase (phase 1) and voluntary cooperation of the Member State during the assessment phase (phase 2) before the usual formal national process (phase 3). Phases 1 and 2 of the procedure are coordinated by a VHP coordinator. The ""acceptability statement"" obtained through this VHP procedure is then included in the subsequent national CTA applications.",12.934596558394157,7.382288605961941
strengthening of national DRAs through harmonization of processes and standards to improve and assure drug quality,0.12323662292604538,0.5917513966560364,2.129326343536377,f87d89a3-716d-4b3c-b36b-b5fe56e9bc50,custom_license/I State of Play and Review of Major Cooperation Initiatives,"PANDRH's scope of harmonization and cooperation includes technical guidelines, regulatory processes, and the strengthening of national DRAs through harmonization of processes and standards to improve and assure drug quality. By adopting its recommendations and standards, countries in this region can clearly improve the quality of their regulatory system and provide access to quality, safe, and effective drugs.",14.761545551753102,6.935241474238653
ensure their quality and their equivalence across manufacturers,0.1822610203251172,0.44753220677375793,2.1747517585754395,8d5d24ce-f754-4a91-b7ec-767c01c274ec,custom_license/I State of Play and Review of Major Cooperation Initiatives,"Biological medicinal products, such as vaccines, blood and blood products, diagnostics, gene therapy, biotechnology products, cytokines and growth factors, and cell and tissue products, rely heavily on international standardization to ensure their quality and their equivalence across manufacturers. This is especially true due to the increasing globalization in the production and distribution of these biological medicines.",14.335909745248912,6.722052988314097
Clinical Trials Directive.,0.17942112205436517,0.7512293457984924,1.3013893365859985,d237f6bf-08b3-47c2-b999-c0132480303f,custom_license/I State of Play and Review of Major Cooperation Initiatives,"In its 2009 consultation paper [161], the EC proposed options to improve the situation. One of the best options is to continue with the harmonization process. This would mean creating a real European system of authorization for clinical trials to avoid duplication of assessment. It would avoid the inconsistent assessment conclusions and requests, encourage appropriate use of resources and expertise (for both the sponsors and DRAs), and ensure common implementation of the principles laid down in the Clinical Trials Directive.",15.385948989252736,6.719284289788376
mechanically ventilated patients,0.19589944209851592,-0.28528448939323425,1.0802788734436035,89b101d7-d027-4c3d-a84b-83a131f58f47,"custom_license/Saudi Arabia e Medical Intensive Care Unit, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia f Trauma Intensive Care Unit, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia g Surgical Intensive Care Unit","Sustaining a safety culture should be a public health priority of all health care facilities. A strategic framework for preventing VAEs is to pair clinical bundle with practice behavior and culture change interventions. The implementation of a multipronged program like the CUSP 4MVP-VAP that places ownership on front-line staff, reduces APPENDIX A Early mobility protocol complexity, provides standardized tools, engages executives, and uses communication tools to strengthen teamwork could improve the care processes and outcomes of mechanically ventilated patients.",17.4629289781207,6.628771491974985
increased direct involvement of the EMA in the pharmacovigilance of nationally authorized products,0.22560804359762782,0.33191362023353577,0.9602383971214294,bd36c4e5-a92f-460c-a369-9b326e608859,custom_license/I State of Play and Review of Major Cooperation Initiatives,"The implementation of this new pharmacovigilance legislation required a lot of effort from the EMA [128]. This was a major activity because several processes needed to be established or amended (e.g., the establishment of a new Pharmacovigilance Risk Assessment Committee [PRAC] replacing the CHMP Pharmacovigilance Working Party). Also, an important change of the new legislation is the increased direct involvement of the EMA in the pharmacovigilance of nationally authorized products, in addition to the centrally authorized products. For example, the EMA has released the ""Guidelines on Good Pharmacovigilance Practice (GVP)"", which replace Volume 9 of EudraLex [129] . This new set of guidelines applies to all medicines authorized in the EU, whether centrally or nationally authorized.",14.231506418413181,5.820926057725341
success of implementation,0.44566712696973804,2.5347886085510254,2.0708608627319336,fcca85ba-31d6-4ed2-b6eb-4d2594f39ca5,"custom_license/Part 12: Education, implementation, and teams 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations à¬,à¬à¬","In communities where processes/guidelines are being implemented, does the use of any specific factors, compared with no such use, improve outcomes (e.g., success of implementation)?",22.07171647653081,10.718772923119706
We aimed to assess the effect of routine POCT on a broad range of clinical outcomes including antibiotic use,0.18613263835599053,2.7359445095062256,3.503068685531616,876a1c38-dd48-48ba-837d-d33038bc3b34,"custom_license/Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial","Background Respiratory virus infection is a common cause of hospitalisation in adults. Rapid point-of-care testing (POCT) for respiratory viruses might improve clinical care by reducing unnecessary antibiotic use, shortening length of hospital stay, improving influenza detection and treatment, and rationalising isolation facility use; however, insufficient evidence exists to support its use over standard clinical care. We aimed to assess the effect of routine POCT on a broad range of clinical outcomes including antibiotic use.",17.006192489853944,10.007525948223478
reducing workload on the clinicians who will be fully occupied with clinical responsibilities.,0.18173781206610173,3.009826421737671,3.536911725997925,7d0d24e3-a6d1-4cb0-897f-2db805a44fde,custom_license/Clinical Trials and Novel Pathogens: Lessons Learned from SARS,"A national or international collaborative research network consisting of infectious disease clinicians, microbiologists, epidemiologists, and clinical trial methodologists should be established. The network would facilitate the rapid initiation of trials during an outbreak through the advanced preparation of study protocols and by providing urgent assistance in the design and implementation of trials after recognition of an outbreak. A major role of the network would be to establish a communication system to connect front-line clinicians and network collaborators at multiple sites to facilitate an exchange of clinical information. This would allow accumulated clinical experience to be shared between sites and would provide a forum for the discussion of patient management issues. Furthermore, it could be used to identify and select hypotheses for evaluation, determine the feasibility of studies, and recruit clinicians to participate in trial design and implementation. The network would shoulder the burden of protocol development and implementation, including liaising directly with local or national ethics boards, thereby reducing workload on the clinicians who will be fully occupied with clinical responsibilities.",12.596536892936793,8.664167708556015
to better understand its antiviral mechanism of action to improve its clinical promotion,0.1976271995669172,2.1815335750579834,3.3706185817718506,1d10ddef-bb7b-4bc4-ae36-ada6b861de5e,custom_license/The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis,"In previous work, our results clarified the activity of ARB in both suppressing influenza virus propagation and modulating the expression of inflammatory cytokines in vitro and in vivo [21] . To explore the pharmacological activity of different ARB administration methods against other human infectious diseases and to better understand its antiviral mechanism of action to improve its clinical promotion, we first evaluated the in vitro efficacy of ARB against HSV-2 in nontoxic concentrations and determined its potential antiviral mechanisms. We then accessed the effect of ARB on pathological morphology, inflammatory cytokine levels, and changes in CD4 + and CD8 + peripheral blood T lymphocyte subsets in a mouse vaginitis model with HSV-2.",14.238141638193067,8.592248475306965
targeted therapy,0.3185491441581398,2.898176670074463,3.678107738494873,e5b3b29a-6628-4113-8dd4-40be83c29803,custom_license/Bronchiectasis and cough: An old relationship in need of renewed attention Chronic cough Bronchiectasis,"Bronchiectasis is an increasingly recognised respiratory syndrome defined by permanent and irreversible dilatation of the bronchi [1] . Cole's vicious cycle remains the central model of disease pathogenesis whereby a self-perpetuating cycle of infection and inflammation precipitates damage to the bronchial wall leading to impaired mucociliary clearance and predisposition to recurrent infection. The primary clinical presentation of bronchiectasis includes chronic cough and recurrent respiratory infections responsible for the increased inflammation, airway damage and shortness of breath with eventual lung function decline, respiratory failure and death [1] . An increased awareness of disease heterogeneity, including its presence in overlap syndromes has brought renewed focus upon potential underlying molecular endophenotypes that may better define specific disease traits and subtypes amenable to treatment [2] [3] [4] [5] . Endotypes represent disease presentations characterised by distinct functional or pathobiological mechanisms. Critically, a clinical phenotype can demonstrate multiple endotypes while a single endotype may be present in more than one clinical phenotype. This inherent disease heterogeneity and its geographic variability are recognised as a major barriers to success in clinical trials and questions remain over how to better stratify patients for targeted therapy to improve clinical outcomes [1, 6] . A recent example is the failure to reproduce findings between two replicate clinical trials that recruited from geographically different regions. RESPIRE1: recruited patients from Europe, North and South America, Australia and Japan while RESPIRE2 focused on Asian and Eastern Europeans [6] [7] [8] .",12.333486857372424,8.591305265650417
Which educational interventions improve clinical outcomes in low-income countries,0.2545251248647354,1.283623456954956,1.6372995376586914,9e2f4dd4-2077-45ec-adf3-19929cd68eb1,"custom_license/Part 12: Education, implementation, and teams 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations à¬,à¬à¬",â¢ Which strategies of conducting sustainable emergency medical training programs in low-income countries are cost-effective? â¢ Which validated educational assessment tools can be tailored to low-income countries? â¢ What is the relative effectiveness of various training methods in low-income countries? â¢ Which educational interventions improve clinical outcomes in low-income countries?,18.42095882047216,8.345935533664125
resuscitation systems,0.2197488591357313,1.818251371383667,1.8868608474731445,1a79d6ee-51e0-4c7c-a147-7517b0fac53f,"custom_license/Part 12: Education, implementation, and teams 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations à¬,à¬à¬",There is insufficient evidence to make recommendations supporting or refuting the effectiveness of specific performance measurement interventions to improve processes of care and/or clinical outcomes in resuscitation systems.,16.938175623635118,8.33668441052922
specificity and control the functions of antibodies,0.18255844717352557,2.0880706310272217,4.024389743804932,4040b1b5-7876-44ff-a60e-bbecb3624e29,custom_license/A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications,"Nobel laureates (1984) KÃ¶hler and Milstein devised the first and what has become the most freely available and, hence, widely used method to generate monoclonal antibodies (mAbs) [5] . However, extensive antibody engineering and optimization were required before effective antibodies were produced. The first antitumor mAb, rituximab [6] , was approved for use worldwide in 1997 and since then >35 mAbs have achieved regulatory approval for therapeutic use. Despite significant positive clinical results, especially in the case of hematological malignancies, adverse clinical outcomes and animal studies have highlighted underlying limitations of mAbs. Accordingly, many strategies have been developed in order to improve the specificity and control the functions of antibodies. One such important approach is the development of bsAbs and this review focuses on current and future avenues of research for bsAbs. In addition, the applicability of bsAbs for diagnostics is discussed and critically assessed.",12.391064142289036,8.309971693442062
the use of recombinant allergens will certainly improve the clinical management of allergic patients,0.29158338681957013,2.5685348510742188,2.538513422012329,6571cd17-a656-4e16-a988-483ec1b8962d,custom_license/The human IgE repertoire,"Allergic reactions are initiated through the specific interaction between allergens and IgE. Studies describing these interactions had for decades to rely largely on complex mixtures of allergens and IgE antibodies. Although such complex reagents are still in commonuse,researchandclinicaldiagnosisrelatedtoallergyhavesubstantiallymoved forwardthroughthedevelopmentofwell-definedallergens.Asmethodologiestopurify naturalallergensweredevelopedtheyprovidedaccesstomoredefinedpreparationsof suchproteinsthatbindtoIgE.Bythelate1980'iesacriticalbreakthroughoccurredas thefirstgenesencodingallergenswerecloned [7] [8] [9] [10] pavingthewayfortheproduction ofrecombinantallergensinhomogeneousform.Subsequently,numerousallergenshave beenclonedandcharacterizedinquitesubstantialdetailassummarizedforinstanceby theAllergome,AllFamandIUISallergendatabases [11] [12] [13] .Theseeffortstoclonegenes encoding individual allergens have allowed the development of component-resolved diagnosis [14, 15] , of tools able to achieve multiplexed analysis of IgE responses [16] , and of defined vaccines (reviewed by Valenta et al. [17] ). Therefore, the use of recombinant allergens will certainly improve the clinical management of allergic patients. 4 Our knowledge of IgE repertoires is however lagging behind our understanding of allergens.Monoclonalantibodytechnologyandinparticularmoderntoolsinmolecular engineering hold promise to reduce this gap by enhancing our knowledge of the IgE component.Weliveinanexcitingerawheresuchmoleculartoolshavethepotentialto revealseveralaspectsofallergyresearchandmoderniseclinicalpractice.Wewillherein discussthecurrentstatusandfutureprospectsofanalysisofhumanIgErepertoiresand how information on IgE and its reactivities can be used to support our understanding andmanagementofallergicconditions.",14.034726161967868,8.23173553419501
improve the resistance toward catalyst fouling,0.19750041363736168,1.573215126991272,2.5784878730773926,5a65e21a-c954-4300-b4b4-86f827803eaa,custom_license/The abatement of major pollutants in air and water by environmental catalysis,"The important practical challenges are to maximize the activity and selectivity for desired reduction products (N 2 in this case), improve the resistance toward catalyst fouling, and design reactors for full scale applications.",13.045752085123786,7.264620179837957
project team work,0.17705379254420767,1.2220262289047241,2.616657257080078,93b11378-63a8-4351-8889-51170e1c0e3f,"custom_license/Business transformation: Leadership, integration and innovation -A case study","Participant observation is a straightforward technique that involved the researcher immersing herself in the subject/project being studied, over a 6 month period of time associated with the project implementation. While there are limitations associated with participant observation as a data gathering technique, this approach is particularly appropriate to studies of group processes associated with project team work.",12.793730483413981,6.9729499350850155
effective educational strategies to ensure that resuscitation providers have the necessary knowledge and skills in combination with the provision of necessary infrastructure and resources,0.14544846131549294,1.2874083518981934,2.2791013717651367,ad637111-e7f3-4aeb-9f25-a598ce8782cd,"custom_license/Part 12: Education, implementation, and teams 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations à¬,à¬à¬","The best scientific evidence for resuscitation will have little impact on patient outcomes if it is not effectively translated into clinical practice. Successful implementation is dependent on effective educational strategies to ensure that resuscitation providers have the necessary knowledge and skills in combination with the provision of necessary infrastructure and resources. 293 Education itself is only one strategy for implementing changes. This section addresses the need for a framework for successful implementation of guidelines, including broad implementation strategies that include educational activities.",12.977187348973727,6.860246892521969
can protect public health,0.2696310539405431,0.5685797333717346,1.5404574871063232,5c361a03-8149-4ae7-952d-29741b741546,custom_license/Biosafety and Bioethics,"In the measures the products were designed and developed which can protect public health, are called medical countermeasures. These include public health and hygiene, diagnostics, vaccines, therapeutics, and development of biosafety level laboratories.",14.378188668067544,6.403240227134378
SARS management,0.2521495339453724,1.3367880582809448,1.7670403718948364,ee37692a-c54d-4572-9f5e-c33ae5787d47,custom_license/23 Response to SARS as a prototype for bioterrorism: Lessons in a Regional Hospital in Hong Kong,"The PYNEH Administrative Team played a coordinating role to ensure smooth implementation of the response plan. The wide scope of administrative services including general and patient support services; food services management; facilities management; procurement and materials management, is intricately linked to all clinical activities. Material and human resources were prioritized for SARS management. Non-medical wards were converted to medical wards as the latter were turned into cohort wards, with appropriate staff deployments. Resources were appropriately redeployed to purchase PPE, improve environmental ventilation, and employ additional support staff for infection control and security purposes.",12.072857781511901,6.242988703143423
"a public access AED program, as opposed to traditional EMS response, improve successful outcomes",0.15419222188528248,0.596213161945343,1.1650601625442505,d269a9da-554c-4b45-8b5d-0d9d6e5812fc,"custom_license/Part 12: Education, implementation, and teams 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations à¬,à¬à¬","In adults and children with out-of-hospital cardiac arrest (including residential settings), does implementation of a public access AED program, as opposed to traditional EMS response, improve successful outcomes (e.g., ROSC)?",13.620309839701005,5.911936104813587
by enabling treatment to begin early in the course of infection,0.27082697408458745,3.8844587802886963,5.360313415527344,7991476a-667c-48e7-bc6d-a5f6aec829f7,custom_license/International Association for Ecology and Health,"Laboratory tests that rapidly and reliably diagnose infections, ideally even in the early asymptomatic stages, often play a key role in outbreak containment strategies (Stamm 2015) . For maximum effectiveness, medical and veterinary diagnostic tests must be sensitive and specific, they must provide rapid results, they must be affordable, and they must use technology that is user-friendly and accessible in diverse settings (Stothard and Adams 2014) . Early diagnosis allows infected individuals to be isolated before they infect community members, provides HCWs with critical information about how to protect themselves and care for pa-tients, and may improve clinical outcomes by enabling treatment to begin early in the course of infection. Biomarker-based analyses that can be carried out at the pointof-care or in a central laboratory may also be useful for the early detection of infection in contacts of infected people and for the screening of community volunteers to establish geographic areas where an infection with an environmental reservoir might be present (Reed et al. 2014) .",14.511811383480476,11.088235911498593
Screening processes for blood products allow confirmatory testing and enable discarding of potentially contaminated blood,0.33356704014162614,3.0433895587921143,4.827335357666016,9d5dc186-e572-47fc-b9ee-bf00f40c259f,custom_license/Donor-derived infection-the challenge for transplant safety,"Reporting of suspected or documented donor-derived transmission events is required in the USA and voluntary in many other countries. Unexpected disease transmission occurs in less than 1% of solid organ recipients. 8, 9 By contrast, hepatitis C virus (HCV) or human immunodeficiency virus (HIV) is transmitted with screened blood products in less than one in 2-3 million units transfused. [1] [2] [3] Screening processes for blood products allow confirmatory testing and enable discarding of potentially contaminated blood, but the limited supply of organs and the urgent need to implant them to preserve organ function after procurement from deceased donors precludes prolonged screening processes or the discarding of potentially useful grafts. Few data are available that directly assess the risk of disease transmission with organ transplants; 1-3 such studies are difficult and costly to perform.",11.529042597813662,9.151136104932565
adequate regulations and intellectual property rights,0.23371664388617716,1.2490239143371582,2.1292054653167725,1069d2b9-3e3e-4ea5-91ef-1fc31f919868,"custom_license/Vaccines: Biotechnology Market, Coverage, and Regulatory Challenges for Achieving Sustainable Development Goals Biotechnology market Â· Emerging and neglected diseases Â· Sustainable Development Goals Â· Regulation and patents Â· Vaccine innovation system","The need to provide more flexible and expedite new vaccine products and processes resulting from biotechnology is challenging both developed and developing countries to accelerate the implementation of adequate regulations and intellectual property rights (Crager 2014; Possas et al. 2015) . IPR are granted by the state to individuals, enterprises, or organizations under temporary monopolistic conditions (patents) in order to compensate them for the investments made in their creations/innovations. In industry, a patent is clearly an instrument to guarantee the returns of the investments on R&D through the commercialization of the patented products and through the payment of property rights.",18.148363093738347,8.547776179583476
"improves our understanding of fundamental processes involved in diseases spread, and may improve as well forecasting potential of these models",0.11382474704529727,2.8956525325775146,3.869415521621704,a9b236a4-5965-48e4-8e22-303c62940a67,custom_license/Individual-Based Models for Public Health,"Nevertheless, the mathematical models have important limitations to explicitly model the mechanisms involved in the infectious processes at the individual level, such as evolution within large strain assemblages, complex spatial configuration shaping contacts, or heterogeneous individual behaviors facing an epidemic. Considering the huge amount of computational power we have access today, we have the opportunity to explore mechanisms of diseases spread, surveillance, and control at very fine scale (individuals), and how these mechanisms are related with what is observed at the population level. This improves our understanding of fundamental processes involved in diseases spread, and may improve as well forecasting potential of these models.",11.83423816328094,8.539277592377822
A range of hybridisation-based assays of varying design are already used in routine clinical practice for infectious disease diagnosis,0.26142716937804655,2.404817819595337,3.9467105865478516,adb22a0e-f418-4f35-ae4e-333357b139c5,custom_license/Molecular detection of CF lung pathogens: Current status and future potential,"Many molecular diagnostic methods do not require the growth and isolation of microorganisms, instead relying on the detection of target nucleic acids. There are three major approaches to microbial identification using nucleic acids extracted from clinical samples. The first uses sequence specific hybridisation of custom-designed primers and/or probes to detect the DNA or RNA of individual microbial targets, generally through PCR amplification. A range of hybridisation-based assays of varying design are already used in routine clinical practice for infectious disease diagnosis. The other two approaches, based on sequencing and PCR-mass spectrometry, are recently emerging technologies not yet adopted into routine clinical practice. Exceptions to this are two sequencing based assays, ViroSeqâ¢ HIV-1 Genotyping System (Celera Diagnostics) and TruGeneâ¢ HIV-1 Genotyping and Open Gene DNA Sequencing System (Siemens Healthcare Diagnostics), which have been developed for HIV drug resistance testing [64] .",11.754156219835824,8.242448140935611
experimental cultivations where environmental factors are of much concern,0.1519364748395207,2.0871100425720215,2.6619701385498047,a72cb4fd-58d1-4272-bf94-932514a71b30,custom_license/Medicinal Plant Active Compounds Produced by UV-B Exposure,"The continuous increasing demand of the global market for aromatic and medicinal plants led to the development of experimental cultivations where environmental factors are of much concern which can improve the quality of products of the studied 235 Medicinal Plant Active Compounds Produced by UV-B Exposure plants in relation to their commercial value. In this prospective, UV-B researches on medicinal plants have possessed a great deal of attention for researchers and pharmaceutics, as they show the positive involvement of UV-B on quality and yield of desired herbal products by inducing volatiles production and compounds of interest of secondary metabolism; phenolics, fl avonoids. It may be due to their special consequence on biosynthetic processes as they play a variety of ecological roles. They are having potency to enhance the level of terpenoids, phenylpropanoids, and natural antioxidants (Kumari and Agrawal 2010 ) .",14.334263175872005,8.10389422928439
Fecal Flotation Flotation methods are designed to improve the recovery of nematode ova and coccidial oocysts,0.23665697172691813,2.6560802459716797,3.4743380546569824,74f78d45-c7fd-424a-8420-c3f3d59dafdb,custom_license/Feline Infectious Diarrhea,"Fecal Flotation Flotation methods are designed to improve the recovery of nematode ova and coccidial oocysts. Centrifugation flotation methods substantially improve the sensitivity of the process, and should be routinely performed. Mix 1/2 of a teaspoon of fresh feces with 5 to 10 mL of flotation solution. Sheather's sugar solution is an appropriate choice for most purposes, but zinc sulfate should be used if Giardia is suspected. Strain the mixture through a tea strainer or cheesecloth, using more flotation solution, into a centrifuge tube. If a centrifuge with swinging buckets is available, fill the tube with enough solution to create a meniscus, and place a coverslip on top. Centrifuge for 10 minutes at 1500 rpm. If a fixed bucket centrifuge is used, add enough flotation solution to create a meniscus after spinning, and then place the coverslip on top. Let the sample stand for 3 to 4 minutes, and then transfer the meniscus to a slide for examination at 10Ï«. Preserving Samples A saline smear is only useful if performed on body temperature feces less than 30 minutes after manual collection or defecation. Trophozoites lose their motility and become unrecognizable after short periods outside the host, so this examination really needs to be performed in the clinic. If a flotation study cannot be performed immediately, it is acceptable to refrigerate the sample. Cysts, oocysts, and helminth ova are generally hardy, and can survive several days of careful storage. If samples are shipped elsewhere for microscopic examination, a preservative should be used; formalin or commercially available products such as Proto-Fix (AlphaTec Systems, Inc., Vancouver, WA, USA) and Ecofix (Meridian Diagnostics, Inc., Cincinnati, OH, USA) are appropriate choices. If an infectious zoonosis such as Cryptosporidium parvum is suspected, the outside of the container should be disinfected and the laboratory should be informed of possible risk.",11.3356491580026,7.95224910070954
"to optimize parameters of chip design, surface chemistry, oligonucleotide probe spotting, sample labeling, and DNA hybridization",0.11494897816680094,1.784663200378418,3.5714058876037598,10ba7c16-d036-4a21-96a9-78dd51bc05ff,custom_license/Viral Chip Technology in Genomic Medicine,"The main focus of clinical diagnostics with viral DNA chips will be to fi nd answers to a handful of questions about viruses safely, quickly and inexpensively. Clinical diagnostics approaches using viral DNA chip technology simply ask the question whether particular genes, which are indicative of particular viruses, are present in a sample or not. For example, the knowledge-based, low-density ""focused"" microarray is based on the molecular diagnostics of six human herpesvirus types: HSV-1, HSV-2, VZV, EBV, CMV, HHV-6 ( FÃ¶ldes-Papp et al., 2004 Striebel et al., 2004 ) . These studies attempted to optimize parameters of chip design, surface chemistry, oligonucleotide probe spotting, sample labeling, and DNA hybridization. The well-designed and tailored chip platform developed utilizes low-fl uorescence background coverslips, epoxy surface chemistry, standardized oligonucleotide probe spotting, PCR-labeling with Cy3 of isolated viral DNA, array hybridization, and detection of specifi c spot fl uorescence by an automatic microarray reader. Korimbocus et al. (2005) reported on the simultaneous detection of major CNS pathogens HSV-1, HSV-2, CMV; all serotypes of human enteroviruses, and fi ve fl aviviruses (West Nile virus, dengue viruses, and Langat virus) using amplifi cation by PCR and detection of amplifi ed products by a DNA microarray. Consensus primers for the amplifi cation of all members of each genus and sequences that are specifi c for the identifi cation of each virus species were selected from the sequence alignments of each target gene. A multiplex PCR-based DNA array for EBV, CMV, and Kaposi 's sarcoma-associated herpesvirus (KSHV) may serve as a rapid and reliable diagnostic tool for clinical applications ( Fujimuro et al., 2006 ) .",11.957699336445271,7.6666396749442605
pre-processing techniques are commonly employed before data analysis,0.17495891103266434,2.240215539932251,2.600358486175537,aeb3b4e2-05cc-484f-94d5-8cced5f5c9d2,custom_license/Spectroscopy with computational analysis in virological studies: A decade (2006e2016),"To correct this and improve the signal-to-noise ratio of the spectrum, pre-processing techniques are commonly employed before data analysis. To understand the functions of some commonly used pre-processes, a few examples are shown hereafter.",12.893228917934326,7.659003238247076
the adoption of open standards must ensure that products from different manufacturers can communicate with each other,0.23346086008809627,2.332754135131836,2.6441688537597656,73fae99b-e372-444e-b78d-63e1b0d715a9,custom_license/Prospect and application of Internet of Things technology for prevention of SARIs,"The current mIoT is not mature; there are numerous urgent problems to be resolved. However, it is expected to contribute considerably to the prevention and treatment of SARIs. This technology completely complies with the national control of diseases, the ''prevention and control of the forward, focus on sinking"" requirements. The issues related to ''borrowing"" the IoT technology are: (1) faster leaning and ensuring a high-quality implementation guideline; (2) better managing suspected patients; (3) effectively dealing with difficult patient consultations and improving the success rate of rescue; and (4) commanding and ensuring effective quality control. Moreover, the development and diffusion of the mIoT must address the following unresolved issues: (1) improve interoperability: the adoption of open standards must ensure that products from different manufacturers can communicate with each other; (2) ensure that there is no leakage; and (3) enhance the distribution network: sensors must communicate with services such as the Internet and wireless networks such that information can be relayed to remote health workers. 27 To solve these problems, there is an urgent requirement to develop a modern medical model -mIoT and to use this to improve the current telemedicine, coupled with mobile phones and other popular user terminals. This should be more conducive to achieving: ''easy to prevent, easy to diagnose, easy to treat diseases, and to easily communicate with experienced doctors."" Community physicians can be advised in real-time by medical center experts through the cloud-plus terminal mIoT technology to achieve early diagnosis and optimal co-management of SARI patients.",12.180582898782179,7.498203957353304
Misdiagnosis and delayed treatment are responsible for lack of safeguard implementation and the subsequent dissemination of bioterrorism agents in medical institutions,0.1464335209717578,1.2346820831298828,2.3688111305236816,65179565-a674-47a0-9626-9bbaf09bfbb5,custom_license/Application of UPT-POCT in Anti-bioterrorism and Biosecurity,"Diagnosis can be based on epidemiological history, clinical syndromes, etiology, and serology detection. Epidemiological history includes residency in the epidemic areas or entrance into these areas in the last two weeks before morbidity, bites by arthropods, and contact with or consumption of infected products or water. Clinical syndromes of some bioterrorism agents appear in isolation, however agents with many infection routes can cause various clinical syndromes. For example, the main clinical syndrome of cholera is diarrhea, however at least six syndromes have been found for tularaemia, including bubonic, pneumonic, gastrointestinal, and systemic (typhoidal and septicemic) tularaemia. The similarity of clinical syndromes between diseases caused by bioterrorism agents and by other factors, makes accurate pathogenesis diagnosis more difficult for doctors when the etiology is unknown. For example, patients with fever caused by F. tularensis are easily misdiagnosed with influenza (Simsek et al. 2012) , while there are no differences the in clinical syndromes between pneumonia caused by F. tularensis or that arising from other causes (Stralin et al. 2002) . Misdiagnosis and delayed treatment are responsible for lack of safeguard implementation and the subsequent dissemination of bioterrorism agents in medical institutions. Therefore, etiology detection is critical for determining and preventing infectious disease. However, the low numbers of pathogens in the initial stage of a disease are difficult to find by etiology detection, fortunately early diagnosis based on the detection of antibodies in blood is a plausible approach in practice.",11.546503922669796,6.383546961809245
new therapeutic and/or preventive strategies,0.1285427343919921,1.4158945083618164,2.6215126514434814,5cb8b485-bc3f-42cb-a81e-87f65be9e011,custom_license/8 Serine Proteases in the Lectin Pathway of the Complement System,"In conclusion, serine proteases of the LP have an essential role in maintaining physiological homeostasis. The activation of complement requires an effective regulatory system that is able to perform a complex checking mechanism in order to prevent pathological disorders. The impact of plasma MASP levels and its genetic polymorphisms in health and diseases processes should be encouraged in order to improve the knowledge about its real role in the maintenance of homeostasis and development of diseases. This may disclose new therapeutic and/or preventive strategies.",10.619300444479919,6.341069809441415
The addition of aerosolized to IV colistimethate,0.15899953513410214,1.756669282913208,1.845962405204773,721edac8-8c90-4c0a-986c-c4107b6f4a0e,custom_license/In the Literature Aerosol Antibiotic Administration in Ventilator-Associated Pneumonia,"It may be reasonable to conclude that, in a highly selected group of adults with nonbacteremic VAP due to P. aeruginosa, it may be possible to avoid IV therapy by administration of antibiotic combinations by nebulization alone. The addition of aerosolized to IV colistimethate, however, does not appear to improve clinical outcomes in patients with pneumonia due to gram-negative pathogens. Antibiotic administration by aerosolization, however, may more rapidly lead to bacterial eradication (although this may be an artifact resulting from antibiotic carry-over in cultures and was not seen in all studies) and may reduce the likelihood of emergence of drug resistance during therapy. The clinician must be aware of the important risk associated with the aerosol administration of at least some antibiotics-clogging of respiratory filters with the potential, as in the study of Lu et al, of serious adverse effects. Jansen et al performed a prospective case-control study in young children over 2 winter seasons to evaluate the relative prevalence and concentration of 14 respiratory viruses (RVs) in the nasal wash specimens from individuals with (cases) and without (controls) symptoms. Polymerase chain reaction detected nucleic acid at least 1 RV in 72% of cases, but also in 28% of controls. At least 1 RV was detected in 47% of control infants ,1 year of age. The most frequently detected RVs in cases were respiratory syncytial virus (RSV) (31%) and rhinovirus (25%), while in controls they were rhinovirus (53%) and human coronavirus (24%). Viral loads were lower in asymptomatic children than in symptomatic children.",11.016155886101052,6.197365157412055
1 initiation and 2 implementation,0.22579228676234553,1.6214046478271484,1.9344462156295776,30f1e1a1-aa46-4c3c-a51c-acd41afc88a0,custom_license/Success in the South Pacific: a case study of successful diffusion of an infection prevention and control program,"It has been argued in the literature that classical Diffusion of Innovations theory is limited in its application to organisational adoption of innovations. 12 It was generally accepted that classical theory was limited to explaining adoption of innovations by single individuals. After the first edition of 'Diffusion of Innovations' 13 was published, Everett Rogers began exploring innovation in organisations, resulting in the development of a clear description of how the classic theory is applied to organisations. 11, 15 Rogers suggests that the focus of research into innovation in organisations is on the innovation process itself. This is achieved by using a staged model. The process specific to organisations is a sequence of five stages, which are divided into two sub-processes: 1 initiation and 2 implementation.",10.618715353998226,6.027853435146251
"At enrollment, demographic information and clinical symptoms were collected by interview",0.13701017254038697,0.7637800574302673,1.2305865287780762,d150cc06-c528-4433-bdcc-744b6f98f05e,"custom_license/Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults","At enrollment, demographic information and clinical symptoms were collected by interview. A nasopharyngeal specimen was collected using a nylon flocked swab (Copan Diagnostics, Corona, CA). Participants returned at days 3Â±1, 7Â±2 and 28Â±7 for collection of clinical symptoms and a nasopharyngeal swab at each visit.",12.700645854762001,5.741564330202124
earlier treatment after diagnosis,0.2648117030513806,3.788022041320801,4.0889410972595215,3da81351-821f-44c7-8826-58ab5bf0a894,custom_license/Rapid detection and identification of 12 respiratory viruses using a dual priming oligonucleotide system-based multiplex PCR assay,"In conclusion, the Seeplex Respiratory Virus Detection assay has great potential for the detection and identification of common viral respiratory infections. It can be used as a supplement or alternative to the conventional methods. Furthermore, the results of the multiplex PCR can be obtained within 24 h, while for viral cultures, it takes usually up to a week. Overall, the multiplex PCR assay may help reduce the incidence of nosocomial transmissions, and improve clinical management by earlier treatment after diagnosis.",17.864822014754232,11.372713745241189
improvements in diagnostics and treatment are likely to improve the clinical situation at the individual patient level,0.16473065603462508,2.0346553325653076,3.357367992401123,f2dc7d8d-b117-4b86-874b-6eff4d7a3424,custom_license/Parasites in Food: From a Neglected Position to an Emerging Issue,"For each of the parasites, improvements in diagnostics and treatment are likely to improve the clinical situation at the individual patient level, and this is particularly so for those parasites for which lack of identification may result in devastating long-term or chronic diseases, such as AE due to infection with E. multilocularis, Chagas disease for T. cruzi, various prolonged gastrointestinal problems with anisakiasis, or CCA for Opisthorchis spp. Indeed, even for cryptosporidiosis, the potential for long-term sequelae has been reported (Osman et al., 2017; Rehn et al., 2015; Stiff, Davies, Mason, Hutchings, & Chalmers, 2017) ; although for most people infected it is more likely to manifest as an acute, but short-lived, self-limiting episode of diarrhea. However, for most of the parasites described here, such improvements are unlikely to have a significant direct impact on transmission at the community or population level, particularly for E. multilocularis and Anisakis spp., for which humans are a dead-end host, and therefore further transmission will not occur.",19.510936189294632,10.3336428274813
"proteomic studies were conducted to find the biomarkers, which could efficiently improve clinical diagnosis of HIV induced neurodegenerative disorders",0.13992311703194454,1.8567585945129395,3.5542144775390625,034af9c1-74c9-4d81-92b0-a22dbbce965e,custom_license/Mass spectrometry based proteomic studies on viruses and hosts -A review,"On the other hand, a large number of proteomic studies were conducted to find the biomarkers, which could efficiently improve clinical diagnosis of HIV induced neurodegenerative disorders, such as HIV-1 associated dementia (HAD). As patients' serum is the most convenient source for clinical diagnosis, Wiederin et al. employed SELDI-TOF-MS analysis, weak cation exchange chromatography, one-dimensional electrophoresis, and LC-MS/MS to target potential serum biomarkers for HAD. The study showed that gelsolin and prealbumin were differentially expressed in demented samples compared to non-demented controls and may serve as candidate biomarkers [93] .",17.632975478483274,9.688673914302948
improved management and survival related to childhood pneumonia and other common illnesses,0.2494662909188562,2.6452057361602783,4.543708324432373,bda2cba1-8d80-45c0-a613-cf5b392439f1,custom_license/Clinical care for severe influenza and other severe illness in resource-limited settings: the need for evidence and guidelines,"Evidence of the benefit of syndromic management of hospitalized patients in resource-limited settings comes from the WHO Integrated Management for Childhood Illness (IMCI) program. IMCI guidelines were developed using existing clinical evidence and expert opinion to standardize healthcare provider training and care delivery in resourcelimited settings. 49 The IMCI guidelines are designed to identify children in need of care by presenting signs and symptoms, and they do not require diagnostic tests that are likely unavailable in most austere settings. Studies evaluating training and implementation of IMCI guidelines have shown a substantial impact on improved management and survival related to childhood pneumonia and other common illnesses. [50] [51] [52] [53] [54] For example, a cluster randomized trial in Kenya evaluating the efficacy of a multi-faceted quality improvement intervention for the management of severely ill children resulted in improved quality of clinical care when compared with a less comprehensive approach. 50 Similarly, in a pediatric outpatient and emergency unit in Malawi, directed trainings based on IMCI to improve triage and emergency care resulted in streamlined healthcare delivery and a 10% decrease in pediatric in-hospital mortality. 51 Modifications of IMCI have also been shown to improve pneumonia outcomes when implemented in the community setting. [55] [56] [57] Moreover, economic analyses have found IMCI protocolized care to be cost effective and comparable to preventive interventions such as routine childhood pneumococcal conjugate immunization. 58 It is important to highlight that clinical management guidelines may have only modest effects on important outcomes in resource-limited settings for several reasons, including an incomplete evidence base and numerous challenges to implementation. 59 Further, some studies have shown limited or no effects of knowledge translation activities, such as clinical guideline implementation. 60, 61 Nevertheless, even modest treatment effects on a high burden disease can have a massive impact when widely implemented. The IMCI experience demonstrates the potential benefits of syndromic management for persons with severe respiratory infections in resource-limited settings.",13.439083013995202,9.376473194283545
cobalamin supplementation can improve clinical signs,0.22293556563493094,2.4115748405456543,2.7903401851654053,82dcf06f-8966-4c03-9257-ff99a579dd9d,custom_license/Diagnosis of Small Intestinal Disorders in Dogs and Cats INTRODUCTION: DIAGNOSTIC WORKUP OF SMALL INTESTINAL DISORDERS,"Serum cobalamin concentration has long been known to be an important negative prognostic factor in cats with chronic enteropathies. 15 The prevalence of decreased serum cobalamin concentrations in cats with chronic gastrointestinal signs has Small Intestinal Disorders in Dogs and Cats been reported to be up to 16.5%. 16 In cats, it has also been reported that cobalamin supplementation can improve clinical signs regardless of the underlying diagnosis, and even if given as the sole treatment for their disease. 15 It is therefore recommended that cats with chronic intestinal disease are supplemented with cobalamin regardless of whether a specific cause for the disease can be identified.",15.89933182755711,8.946010906357177
could significantly improve the care of children with CAP by decreasing the use of unnecessary antibiotics,0.11378821957064032,2.689526319503784,3.620241165161133,29e38d8e-639b-4cd9-92a1-dc81801d29c6,custom_license/Journal of the Pediatric Infectious Diseases Society Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia,"In this large cohort of 532 prospectively enrolled children with strictly defined, radiographically confirmed CAP who underwent extensive testing for etiology, PCT cutoffs of <0.1 and <0.25 ng/mL accurately identified children at lower risk of typical bacterial CAP. Our findings suggest that PCT may safely be incorporated into treatment algorithms for children with CAP to reduce antibiotic administration and duration. Implementation studies and clinical trials of PCT-guided therapy could significantly improve the care of children with CAP by decreasing the use of unnecessary antibiotics.",13.283310466403943,8.750507528273577
the use of recombinant allergens will certainly improve the clinical management of allergic patients,0.29158338681957013,2.5685348510742188,2.538513422012329,344cc414-963d-4244-bc9c-b30c6b221797,custom_license/The human IgE repertoire,"Allergic reactions are initiated through the specific interaction between allergens and IgE. Studies describing these interactions had for decades to rely largely on complex mixtures of allergens and IgE antibodies. Although such complex reagents are still in commonuse,researchandclinicaldiagnosisrelatedtoallergyhavesubstantiallymoved forwardthroughthedevelopmentofwell-definedallergens.Asmethodologiestopurify naturalallergensweredevelopedtheyprovidedaccesstomoredefinedpreparationsof suchproteinsthatbindtoIgE.Bythelate1980'iesacriticalbreakthroughoccurredas thefirstgenesencodingallergenswerecloned [7] [8] [9] [10] pavingthewayfortheproduction ofrecombinantallergensinhomogeneousform.Subsequently,numerousallergenshave beenclonedandcharacterizedinquitesubstantialdetailassummarizedforinstanceby theAllergome,AllFamandIUISallergendatabases [11] [12] [13] .Theseeffortstoclonegenes encoding individual allergens have allowed the development of component-resolved diagnosis [14, 15] , of tools able to achieve multiplexed analysis of IgE responses [16] , and of defined vaccines (reviewed by Valenta et al. [17] ). Therefore, the use of recombinant allergens will certainly improve the clinical management of allergic patients. 4 Our knowledge of IgE repertoires is however lagging behind our understanding of allergens.Monoclonalantibodytechnologyandinparticularmoderntoolsinmolecular engineering hold promise to reduce this gap by enhancing our knowledge of the IgE component.Weliveinanexcitingerawheresuchmoleculartoolshavethepotentialto revealseveralaspectsofallergyresearchandmoderniseclinicalpractice.Wewillherein discussthecurrentstatusandfutureprospectsofanalysisofhumanIgErepertoiresand how information on IgE and its reactivities can be used to support our understanding andmanagementofallergicconditions.",15.424180107918456,8.718044415277715
Early identification of patient-specific characteristics associated with its development may help in early identification of this complication and timely intervention to improve clinical outcomes,0.2251954254043965,2.647282838821411,3.5300049781799316,ff9b8cae-b1a7-490d-95df-1de25eff9e47,custom_license/An FcÎ³RIIa Polymorphism with Decreased C-Reactive Protein Binding is Associated with Sepsis and Decreased Monocyte HLA-DR Expression in Trauma Patients,"Post-traumatic sepsis is responsible for prolonged length of ICU stay, increased rates of organ failure and remains the leading cause of death in patients who survive the initial resuscitation (1) (2) (3) . A large retrospective analysis of severely injured patients in Germany between 1993 and 2008 revealed an overall incidence of post-traumatic sepsis in 10.2% of severely injured patients. While the overall mortality for trauma patients decreased over the study period, the mortality rates in the subgroup of septic trauma patients did not significantly decrease (4). Angus et al estimated average costs per case were $22,100 with annual total costs of $16.7 billion nationally in a 1995 review of national cases (5) . Consequently, post-traumatic sepsis remains a significant problem that requires further research. Early identification of patient-specific characteristics associated with its development may help in early identification of this complication and timely intervention to improve clinical outcomes.",12.622048229449938,8.43295396135835
oneto-one marketing strategy can improve profitability for companies,0.1735449531437204,2.9765655994415283,3.202530860900879,7012cb88-a5fe-41c0-af9a-aab550bb5e9d,custom_license/Feature-based recommendations for one-to-one marketing,"Most recommendation systems face challenges from products that change with time, such as popular or seasonal products, since traditional market basket analysis or collaborative filtering analysis are unable to recommend new products to customers due to the fact that the products are not yet purchased by customers. Although the recommendation systems can find customer groups that have similar interests as target customers, brand new products often lack ratings and comments. Similarly, products that are less often purchased, such as furniture and home appliances, have fewer records of ratings; therefore, the chances of being recommended are often lower. This research attempts to analyze customers' purchasing behaviors based on product features from transaction records and product feature databases. Customers' preferences toward particular features of products are analyzed and then rules of customer interest profiles are thus drawn in order to recommend customers products that have potential attraction with customers. The advantage of this research is its ability of recommending to customers brand new products or rarely purchased products as long as they fit customer interest profiles; a deduction which traditional market basket analysis and collaborative filtering methods are unable to do. This research uses a two-stage clustering technique to find customers that have similar interests as target customers and recommend products to fit customers' potential requirements. Customers' interest profiles can explain recommendation results and the interests on particular features of products can be referenced for product development, while a oneto-one marketing strategy can improve profitability for companies. q",11.591963144206538,8.073599799694854
"rapid response, surge in capacity, and rapid deployment and tracking of vaccine use for planning MGs",0.13530284143077012,0.6770362257957458,1.9923800230026245,65869be1-7a6b-4331-bea5-963576b9387c,custom_license/Mass Gatherings Health 6 Research agenda for mass gatherings: a call to action,"â¢ Enhance applications of existing vaccines against possible infectious diseases that are associated with MGs â¢ Assess the global vaccine supply and production to improve the processes of rapid response, surge in capacity, and rapid deployment and tracking of vaccine use for planning MGs â¢ Develop innovative clinical trial methods to study the eff ectiveness and safety of novel vaccines before and after licensing â¢ Develop new vaccines, platforms, and formulations that are safe with enhanced immunogenicity, especially in children and elderly people Series priorities, and provide the basis for enacting targeted policies and implementation of corrective interventions.",17.54945655348951,7.877430355440269
more rapid containment of VPD outbreaks at their source,0.11610409788390917,2.1222355365753174,2.7911601066589355,c7ba57e4-ce1d-4b21-bd2c-b7b511938810,"custom_license/Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola","CDC emergency vaccine implementation activities enhance global health security by enabling more rapid containment of VPD outbreaks at their source. These activities have built incountry response capacity and have provided valuable evidence to inform future emergency vaccine delivery for the countries involved and globally for other countries at risk for VPD outbreaks. CDC has contributed to development and updating of guidelines that countries and partners use for response planning efforts; examples include an updated WHO position paper for cholera vaccines expected in 2017, an updated WHO position paper for typhoid vaccines expected in 2018, and the WHO Global Ebola Vaccine Implementation Team guidance document for Ebola vaccine implementation (50) . Planning and evaluation of emergency vaccination present distinct challenges for predicting needs before an emergency, anticipating ways to expand vaccine availability during critical global shortages, and delivering and evaluating new products. The Ebola epidemic accelerated vaccine clinical trials and could set a precedent for rapid clinical development of countermeasures for future infectious disease outbreaks. Integration of vaccination with emergency response to VPD outbreaks will continue to augment global health security by reducing disease burden and mortality rates for vulnerable populations and by averting pathogen spread across international borders. Lessons learned from emergency vaccine implementation might inform response with new vaccines in the development pipeline, such as vaccines against Middle East respiratory syndrome coronavirus, Lassa virus, Marburg virus, and Zika virus, for which rapid response would also be required.",13.180771963679307,7.806977355390021
child health interventions is to improve child survival and reduce the overall burden of childhood diseases,0.1538580581078221,0.9281352162361145,1.9932912588119507,16fe8550-c4c0-4690-929d-9e20eb35ff3c,custom_license/Paediatrics in the Tropics,"The comprehensive goal of child health interventions is to improve child survival and reduce the overall burden of childhood diseases. Policies that govern the improvement of child survival need periodic renewal and assessment, since changing geo-political situations put the continuity of implementation strategies at risk.",12.984306227220122,6.443434388308285
CDC has contributed to the development of preliminary guidance for implementation of a licensed Ebola vaccine,0.1339150177854171,1.3859806060791016,2.2554736137390137,d7016889-a456-41df-84e0-f92c7b6b1370,"custom_license/Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola","Licensure of the rVSV-ZEBOV vaccine is not expected until 2019, and additional candidate vaccines continue to be studied in clinical trials (47) (48) (49) (50) (51) . During the prelicensure period, plans for emergency ring vaccination with the rVSV-ZEBOV vaccine should take into account new evidence and guidance to support use of alternate vaccine candidates or strategies. CDC has contributed to the development of preliminary guidance for implementation of a licensed Ebola vaccine as part of the Global Ebola Vaccine Implementation Team led by WHO (52) .",11.462501397871009,6.378820732136628
Further implementation efforts involve research as well as systematic integration of the approach in physical therapy curricula,0.15479604029065044,0.7264505624771118,2.2726292610168457,8eb6a4b6-e05d-4047-8cd7-076d62231539,custom_license/Abstracts from the 11th International Congress of Behavioral Medicine PM MULTILEVEL ANALYSES OF REPEATED AND CLUSTERED OBSERVATIONS: THE GENERALISATION FROM SIMPLE LINEAR MODELS TO LINEAR MIXED MODELS AND VARIANCE COMPONENT MODELS,"There is now ample evidence that psychosocial factors such as selfefficacy, fear of pain and/or movement/re-injury, catastrophizing, and social reinforcement contingencies contribute to the development of persistent pain and disability. In our research group at Uppsala University we have developed an integrated behavioral medicine and physical therapy treatment approach for patients with MSP that builds on basic motor and behavior learning principles and cognitivebehavioral principles. The approach comprises identification of problems and goals, monitoring of problems, functional behavioral analyses, basic and applied skills acquisition, generalization of skills, and relapse prevention. Evaluation of the approach involves clinical studies at both the individual level and group level and there are promising results at both short-term and long-term follow-up. Recent studies have focused on 1) targeting and tailoring of treatment based on screening of psychosocial factors and individual functional analyses, and 2) screening for psychosocial risk factors in telephone counseling. An emerging research area concerns implementation of the integrated approach in general clinical practice within PHC. Pilot work in our research group indicates that physical therapists may have greater difficulties in adopting this integrated approach than anticipated, lack of theoretical knowledge being one possible explanation. Further implementation efforts involve research as well as systematic integration of the approach in physical therapy curricula, the latter being done at two Swedish universities. Hypervigilance to pain and attentional bias are considered as key processes in understanding chronic pain, distress and suffering (Crombez et al., 2005; Pincus & Morley, 2001; Vlaeyen et al., 1995) .",11.498161419497693,5.973758382095265
medical humanistic care .,0.16779369942653624,0.22307565808296204,0.9365119934082031,d746dd5a-d01e-4569-b139-329f2c228f00,"custom_license/Journal Pre-proof A study on the psychological needs of nurses caring for patients with coronavirus disease 2019 from the perspective of the existence, relatedness, and growth theory A study on the psychological needs of nurses caring for patients with coronavirus disease 2019 from the perspective of the existenceï¼ ï¼ ï¼ ï¼relatednessï¼ ï¼ ï¼ ï¼and growth theory","In the exploration of nursing staff incentive mechanism, nurses' professional needs and patients' psychological needs, the existence, relatedness, and growth (ERG) theory has been used to establish a better nursing staff incentive mechanism, improve nurses' professional status and analyze the patient's psychological needs, more importantly, it promotes the development and implementation of medical humanistic care .",12.40796599376786,5.096520071288008
The use of these microarrays might improve the clinical management of patients and the prevention of nosocomial transmission in hospital departments,0.24785610133219935,3.8476288318634033,5.54563045501709,0a741748-c46f-428d-9601-295ef3ab3911,custom_license/The microarray technology: facts and controversies,"Recently, new techniques based on multiplex RT-PCR amplification followed by microarray analysis have been developed and evaluated in clinical samples [5] [6] [7] [8] . Microarrays are divided into high-density and low-density DNA-probe hybridization technologies. High-density microarrays can test for thousands of potential pathogens simultaneously, allowing the detection of novel or previously uncharacterized agents, but they are not yet applicable for daily diagnosis in clinical virology practice. Only low-density microarrays are currently CEmarked for the in vitro diagnosis of human viral diseases. These new assays can allow rapid detection and identification, including typing and subtyping, of a broad panel of common and newly discovered human viral pathogens. The use of these microarrays might improve the clinical management of patients and the prevention of nosocomial transmission in hospital departments, and might allow the development of new epidemiological survey systems for viral infections [1, 5, 8] .",13.632786002991661,10.877093637519401
Plasma exchange has been reported to improve the clinical status in some patients who fail to respond to high-dose intravenous glucocorticoids,0.39420019265830497,2.706287384033203,3.3411779403686523,b035d13a-4878-4c0c-9f84-6c480004c458,custom_license/Acute Disseminated Encephalomyelitis: Clinical and Pathogenesis Features,"Plasma exchange has been reported to improve the clinical status in some patients who fail to respond to high-dose intravenous glucocorticoids. This is perhaps through removal of antibodies that contribute to demyelination or by partly modifying the cytokine milieu in peripheral immune system, where self-reactive lymphocytes are being generated or reactivated. Plasmapheresis is usually regarded as a last resort, however, and there are no studies assessing its efficacy if used early in the course of disease [132] .",17.939345895576565,10.209623524313004
knowing the cause of CAP may enable use of pathogen-directed therapy or de-escalation of therapy,0.14511598598964978,1.9038444757461548,3.073699474334717,0ce01aac-4eac-4d13-9a7a-19aeeb7d791b,custom_license/Processes of care for community-acquired pneumonia,"Defining the cause of pneumonia may have significant implications for patient management. In hospitalized patients with pneumonia who clinically deteriorate, the initial microbiologic workup may identify a resistant or unusual organism that was not covered with the original empiric therapy. In this scenario, defining the cause of pneumonia will help with the selection of alternative therapy and improve clinical outcome. In patients who clinically improve, knowing the cause of CAP may enable use of pathogen-directed therapy or de-escalation of therapy.",19.54466678153125,10.076036941088503
antibacterial therapy will improve clinical signs,0.377748816250544,2.307199239730835,2.812692642211914,a3df45e6-175e-4e9c-b1b4-ce9204833d01,custom_license/Small Intestine STRUCTURE AND FUNCTION,"Although antibacterial therapy will improve clinical signs, appropriate treatment for the underlying condition is preferable. For EPI, pancreatic enzyme supplementation can reduce bacterial numbers because exogenous proteases have antibacterial properties. Experimental studies show that bacterial numbers in dogs with EPI decline with pancreatic enzyme supplementation alone (probably because enzymes are bactericidal and available substrate is reduced), suggesting that the problem will resolve of its own accord. However, in some clinical cases concurrent antibacterial therapy is necessary.",18.450815609219383,9.78571518648957
by using appropriate initial empiric therapy.,0.16473759949414812,2.3513472080230713,3.148777961730957,54321465-8fa5-4fcd-9995-7f7f22efed05,custom_license/Processes of care for community-acquired pneumonia,"A series of core organisms should be considered as potential pathogens in hospitalized patients with CAP. These organisms include S pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae, and L pneumophila. Because an initial empiric regimen that treats infection caused by the list of core organisms has been associated with better patient outcomes, several societies recommend such a regimen for all hospitalized patients with CAP [1] [2] [3] . The goal of this recommendation is to improve clinical outcome by using appropriate initial empiric therapy.",16.52752290650094,9.359714377615447
enhanced transparency,0.555244241670681,2.6892902851104736,3.478381633758545,635a7639-7a1f-47ae-b1bf-41a773ff8a21,custom_license/The Lancet Commissions Essential medicines for universal health coverage Executive summary,"This information can be further supplemented with information on the mean processing time of an application. Consumers might not be aware that some products are not regulated at all. In many low-income and middle-income countries the quality and safety of medical devices (including in-vitro diagnostics) and certain biological products (particularly blood and blood products) are subject to very weak, or even no, regulatory oversight. This information will also contribute to enhanced transparency.",13.867382700643923,8.862570692490234
Improving processes of care is a secure way to improve outcomes in hospitalized patients with CAP,0.24603636289837755,2.824841022491455,2.8643546104431152,1ac635b6-875b-4df6-bb70-7be354d29391,custom_license/Processes of care for community-acquired pneumonia,"Clinical and economic outcomes in hospitalized patients with CAP directly are related to the way that certain processes of care are executed at the local-hospital level. For each process of care, a clear and evidence-based recommended course of action should be stated. Having an unambiguous action plan helps to develop process-of-care indicators and to educate healthcare workers. Improving processes of care is a secure way to improve outcomes in hospitalized patients with CAP.",14.276745596501847,8.694838120183118
may significantly improve the clinical efficacy compared with intermittent administration and reduce the antibiotic dosage,0.12857534136030402,1.1218628883361816,3.1103835105895996,fa7939d2-27d7-49e9-ba63-84213e0dbf73,custom_license/P1 The conditioning of medical gases with hot water humidifiers P2 Use of a bougie during percutaneous tracheostomy,"We conclude that ceftazidime administered by continuous perfusion, for the treatment of ventilator-associated pneumonia, may significantly improve the clinical efficacy compared with intermittent administration and reduce the antibiotic dosage. Background and goal of study Most recently, administration modus for Î²-lactam antibiotics has become a matter of debate, and continuous infusion has been suggested [1] . We studied whether plasma concentrations of imipenem were sufficiently maintained using a loading dose and continuous infusion regimen, and that this regimen would be superior to a higher amount of drug given by the standard intermittent bolus regimen.",16.972774236452786,8.691431142060233
"Implementation of this project would provide technical support and safeguard measures for research, development, production, application, and operation management of green building materials and products",0.4711958605670363,3.0229876041412354,2.900294542312622,2f4bec43-0e0a-43f9-ab31-2ac133bce989,"custom_license/Indoor Air Pollution, 2 nd Edition","The project mainly focused on research of production and application technologies, regulations and standards, and technical and economic policies related with environment-friendly building materials and products, aiming at mastering key common technologies of building material industry, developing key technologies and equipment with independent intellectual property rights for production and application of environment-friendly building materials and products, and achieving ""leapfrog"" development by widely promoting the application of environment-friendly building materials and products. It also aimed to establish a research, development, and production base and a technological innovation system for environment-friendly building materials and products by promoting the partnership of industry-university-research institute, integrating the technologies, and building demonstration production lines. Implementation of this project would provide technical support and safeguard measures for research, development, production, application, and operation management of green building materials and products in China. 2. Key technologies for improving and ensuring the quality of urban living environments The living environment greatly affects people's quality of life, health, and productivity. It is an important indicator of a country's or region's economic development and living standards and also an important part of the key technology system for sustainable development of construction industry. In order to improve the quality of living environments to improve people's quality of life, a major project of the National Key Technologies R&D Program, ""Key technologies for improving and ensuring the quality of urban living environments,"" was launched by the Ministry of Science and Technology of the People's Republic of China.",13.148946451811183,8.452264653328921
"fully integrated devices, able to achieve sample-in answer-out processes",0.15335669800005072,2.6323187351226807,3.2549638748168945,6d8391cf-739f-474b-8877-0d09f1c14967,custom_license/The Many Roads to an Ideal Paper-based Device,"The ultimate goal in the paper-based diagnostics field is the development of fully integrated devices, able to achieve sample-in answer-out processes. But in the quest for the ideal paper-based devices, many obstacles remain. Here we survey some of the most recent and innovative paper-based diagnostics and the technologies that surround them, in hopes of helping to define what would be an ideal device. Accordingly, we review the areas of ongoing tool development, such as sample handling and preparation, sensitivity, and signal amplification, to frame our discussion and share advances in the field. However, the sensing modality employed in a device in many ways defines the challenges along the developmental path. Therefore, we will often discuss tool development for paper-based devices using antibody-based detection and those using nucleic acid amplification separately. This will be followed by a discussion of key technical aspects that we believe will lead the future directions of POC diagnostics, and then look at how, as a community, the vision of low cost and accessible diagnostics can be realized.",12.982499617132316,8.370608562457035
To improve outcomes in patients with CAP,0.17028395694853793,1.4012904167175293,2.1081762313842773,d1f671ad-669f-42f7-bd85-1159374fc1c6,custom_license/Processes of care for community-acquired pneumonia,"To improve outcomes in patients with CAP, several medical societies have published recommendations for improving processes of care and have suggested indicators to evaluate particular processes [1] [2] [3] . A clear and concise recommended course of action is important for each process of care. Although there is a consensus among CAP guidelines regarding the processes of care that are important, there are also disagreements regarding some recommended courses of action. Disagreements regarding how to best improve some processes mostly result from the lack of good scientific evidence in certain areas of CAP management.",15.161187249445756,7.5875688585721885
"the creation of nutrition education processes, development and promotion of sustainable food systems, and increased integration of food and nutrition in all levels of health care",0.1427200866244098,1.1396820545196533,1.523142695426941,b1c47578-1ffd-4253-99d7-84f456b599af,custom_license/Food Policies' Roles on Nutrition Goals and Outcomes: Connecting of Food and Public Health Systems,"The National Food and Nutrition Security Policy and the accompanying implementation plan take a comprehensive approach to improving food and nutrition Security in Brazil. The policy recognizes adequate food as a human right and seeks to sustainably improve access to food, especially among the most vulnerable members of society. Other policy objectives include: the creation of nutrition education processes, development and promotion of sustainable food systems, and increased integration of food and nutrition in all levels of health care. The plan also includes interventions targeting food production and supply, healthy eating education, and strengthening of family farming.",14.071853552834495,6.65598483095736
Anti-streptolysin O (ASO) antibody levels,0.254706784164196,1.5000163316726685,1.2274084091186523,9c62e6c9-8c42-45ae-ab3a-0255154fcd91,custom_license/Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection,"Anti-streptolysin O (ASO) antibody levels were determined using the RapiTex Ã ASL kit (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany) according to the manufacturer's instructions.",13.858873597678675,6.623431840701894
improve use of medicines,0.25156573887919476,0.5043186545372009,1.6674882173538208,b16d1371-882f-408e-a8bd-e6d3e98e224a,custom_license/The Lancet Commissions Essential medicines for universal health coverage Executive summary,"Many studies have assessed strategies intended to improve use of medicines by health-care providers and users in a wide range of settings, including public and private sector health-care facilities, pharmacies and drug shops, and communities. The various interventions have targeted a broad array of health workers, most commonly physicians, but also paramedics (clinical offi cers, nurses, and midwives), pharmacists and other dispensers, shop attendants, community health workers, and patients and community members. Interventions have focused on problem practices (eg, antibiotic use, injection use, or polypharmacy), care for specifi c conditions (eg, respiratory infections, malaria, diarrhoea, hyper tension, or diabetes), or on processes of care (eg, diagnosis, laboratory testing, communication, treat ment decision making, or explanations about medicines). However, key contextual factors and details about implementation are often poorly described in published reports. Summarising research on the eff ectiveness of many heterogeneous interventions done in diverse settings is therefore challenging.",13.461064700571175,6.1230471119290755
"ultrarapid, self-contained disposable cassettes",0.23694579903977392,0.8493646383285522,1.1913610696792603,285a7800-9587-41e7-88be-0c2724e14e71,custom_license/The Many Roads to an Ideal Paper-based Device,"Looking back over the contents of the book we are struck by the pace, scale, and diversity of ongoing work, as well as the realization that the field of POC diagnostics has grown beyond a scope that can be mastered by any one technique or investigator. This of course is exciting, but also daunting, for researchers as they seek to advance the field. The ASSURED criteria will provide ongoing guidance to the development of relevant tools, but of course it is important to recognize that each design feature should be considered in the context of the intended POC environment. In other words, the intended application of an ideal diagnostic device must be considered from the outset of design. When cost is not the main limiting factor to deployment, ultrarapid, self-contained disposable cassettes may be ideal. However in well-established but poor urban environments, other factors such as time or convenience may be less of a constraint on design in favor of being able to provide clinical-grade results. There may even be a future for applications where even sensitivity or specificity can be sacrificed in favor of strategies in which multiplexed detection and low cost provide redundancy for diagnosis of complex disease (e.g., paper-based gene expression profiling; [158] ). The key is that without a final set of applications and target population in mind, the complete design space available to build practical portable diagnostics may not be recognized ( Fig. 6.1) . Similarly, as developers of POC diagnostics we must also be held to account on implementation, including a workflow from sample through to answer. Steps toward implementation must follow technology development; otherwise our efforts become only an academic exercise, which must not happen. Unfortunately, the literature is replete with reports of incremental advances that have not been demonstrated with real samples and/or under real-field conditions. While the reasons for this are complex, future leaders in the field, and those who will see their designs catch the attention of the funders, will be the ones who take the time (and risk) to push the limits of their technology and iterate until their design criteria are met. This may require a series of studies and vertical integration of our laboratory efforts, but the responsibility is on us to demonstrate the value of our work at point of care.",13.513111724985666,6.056060813950062
"When administered during EAE, this cytokine has been shown to improve the clinical course of this disease",0.19700996800743942,1.9188858270645142,2.278106212615967,b6f8420f-0b98-4670-bd17-334997a5d29e,custom_license/Apoptosis in brain-specific autoimmune disease,"As part of the probable multifactorial induction of T-cell apoptosis, a third mechanism involved in T-cell elimination during the course of EAE may be cytokinemediated apoptosis. In particular TGF-[~ may be of importance (Fig. 1) . When administered during EAE, this cytokine has been shown to improve the clinical course of this disease [39, 40] . As seen in the in vitro studies by Weller et al.",20.451973174476684,9.886235436859153
Study personnel alleviated unnecessary suffering of infected animals by euthanizing clinically moribund animals,0.25885788888396677,3.8191893100738525,4.24083137512207,127bf264-5299-421f-a09b-ec8a31ced312,custom_license/Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys,"Animals were observed at least twice daily to monitor for disease signs, and animals that survived to day 28 were deemed to be protected. Study personnel alleviated unnecessary suffering of infected animals by euthanizing clinically moribund animals. The criteria used as the basis for euthanasia of moribund animals were defined prior to study initiation and included magnitude of responsiveness, reduced body temperature, and/or specified alterations to serum chemistry parameters 35 . Serum chemistry was analyzed using a Vitros 350 Chemistry System (Ortho Clinical Diagnostics), and coagulation parameters were evaluated using a Sysmex CA-1500 coagulation analyzer (Siemens Healthcare Diagnostics). Hematology analysis was conducted using a Siemens Advia 120 Hematology System with multispecies software (Siemens Healthcare Diagnostics). On days in which GS-5734 or vehicle dosing were scheduled with blood sample collection for clinical pathology or viremia analysis, blood samples were collected immediately prior to dose administration.",12.961106420538094,9.775400692565682
they could significantly improve the clinical course of severe infections,0.14054577221868905,1.2818984985351562,2.844991445541382,e228b554-c6a1-40df-a5cb-3fd719691ac0,"custom_license/No evidence for the effectiveness of systemic corticosteroids in acute pharyngitis, community-acquired pneumonia and acute otitis media","Attempts to use corticosteroids in infectious diseases have been made for more than 50 years. Early reports relating to typhoid fever [1] , tuberculous meningitis [2, and bacterial sepsis [3] clearly suggested that they could significantly improve the clinical course of severe infections, and led to the widespread use of corticosteroids in a number of other infectious diseases. However, subsequent findings that they may sometimes be ineffective or harmful due to their immunosuppressive or other potential negative effects have convinced many clinicians to avoid their universal use and to limit their prescription to the clinical conditions for which there are indisputable data concerning their efficacy, safety and tolerability [4] .",17.872178788148652,8.937741039501777
Testing glycan-mediated mechanisms of infection and disease susceptibility is now warranted to assess their inclusion in clinical and policy practices,0.3021135795997286,2.6786744594573975,3.102126121520996,8d5549d1-d384-4b79-85d0-d14d5c4932ac,custom_license/Infection's Sweet Tooth: How Glycans Mediate Infection and Disease Susceptibility,"We are now in the era where data repositories are available that combine genomic sequence data with clinical metadata from large cohorts [13] . The effect of genetic variation in genes that mediate mucosal glycosylation, such as SNPs in FUT2, increases our understanding of immunology at a population level, and creates opportunities to implement effective precision medicine. Testing glycan-mediated mechanisms of infection and disease susceptibility is now warranted to assess their inclusion in clinical and policy practices. Ultimately, precision medicine requires an integrated decision-making model that encompasses extrinsic factors, including diet, mental and physical health, the microbiome, and intrinsic factors, such as human genetics and subsequent phenotypes. While testing population-level variability remains challenging [2] , a better understanding of the factors by which glycans mediate disease susceptibility offers the potential to significantly improve clinical outcomes. With personal genome sequencing becoming increasingly common, might an individual's knowledge of their infection/disease susceptibility reduce incidence or late diagnosis?",14.742373063991431,8.917350950032956
feeding probiotics may improve the health and welfare of the birds,0.3155342605210205,2.008530378341675,3.121029853820801,f6b1ec60-b85d-4052-87a5-a48f2a5d3aac,custom_license/The Impact of Disease on Welfare,"In his recent review of probiotics in broiler production, Ghadban (2002) defines probiotics as ""biological products, which stimulate the immune system and increase its defensive activity against pathogenic bacteria"". Whereas research may be driven to solve problems of food-borne pathogens for humans, such as Salmonella, feeding probiotics may improve the health and welfare of the birds. The intended mode of action of microrganisms used as probiotics is competitive exclusion of pathogenic and toxicogenic organisms in the intestines of fowl and they must therefore be robust enough to survive the digestive processes of the crop and gizzard. Widespread use of probiotics may be limited in the future because of safety concerns about the large quantities of industrially produced cultures that can also be distributed into the environment (Reuter, 2001) .",13.984252528177759,8.228702535767823
"Predictive diagnostics, targeted prevention, and personalization of medical services",0.17539971580642394,2.258178234100342,2.203028917312622,e342a887-c149-4fdb-bfa3-a41d860c431f,"custom_license/Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine","In order to have a patient-tailored approach, choosing the right medication, the right dose at the right time point, the standardization and individualization should go hand in hand. Predictive diagnostics, targeted prevention, and personalization of medical services are the main objective of the predictive, preventive, and personalized medicine (PPPM). Translational medicine was introduced recently to emphasize the appropriate translation of knowledge from studies at the bench side to care at the bedside. Economic circumstances and missing political regulations are among the factors resulting in the blockage between the bench and bedside; to these, we should add the applicability of the bench studies as the foundation of clinical investigation and subsequent clinical trials. In order to efficiently indorse the translational medicine as the ""catalyzer"" for the practical implementation of the accumulated scientific achievements, an appropriate dialogue is essential between three clusters of ""clinician, clinical investigator, and PPPM relevant professional groups,"" ""the bench scientists,"" and ""industry and policy-makers"" [1, 2] .",14.500656302257303,7.975014354208483
the team will recommend clinical interventions and diagnostics based on their insights,0.15696145980313278,1.9205536842346191,2.591475009918213,3a27bdec-e5e5-49d7-ba36-3164d9ff7185,custom_license/The Journal of Infectious Diseases The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency,"Ultimately, with the additional guidance of the director of the Pathways Clinical Faculty, the team will recommend clinical interventions and diagnostics based on their insights, as well as propose basic research questions and experiments that would help further elucidate the nature of the patient's presentation and underlying mechanism of disease. If the patient consents, there is the potential to execute the proposed experiments at MGH, or with other collaborators. In addition, Pathways residents will have an option to attend ambulatory clinics (such as genetics, infectious diseases, and immunology) chosen to enhance their understanding of the clinical manifestation of disease as well as the application of disease diagnostics. By providing the time and resources to focus on understanding the mechanism of disease in a single patient, the goals of this program are to:",13.98391666806939,7.827189485023627
holistic healing and rejuvenation,0.3455763287030631,2.4314768314361572,2.5767812728881836,a5f5cd7b-4590-4e1f-b554-8e70bcf4aee4,custom_license/Contemporary Hospitality and Tourism Management Issues in China and India,"The WTCC's India Initiative identified new products that India could exploit to improve its position in world tourism. These new products and the markets that go with them will need careful marketing if they are to be a success. The potential new markets include cultural tourism (India has 22 world heritage sites), adventure tourism in the Himalayas, eco-tourism in the Himalayas and the Andaman and Nicobar islands and holistic healing and rejuvenation (Mintel, 2003) .",12.708255602869492,7.7032572288151435
successful implementation of rapid tests in the clinic,0.15927787866533324,2.070260763168335,2.3791303634643555,8ce0b4d8-2b18-4164-adbf-c11b19243e58,"custom_license/Clinical Infectious Diseases Rapid Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review and Meta-analysis","In the upcoming years, the nonmolecular rapid tests will still have a role in practical patient care. It is important for clinicians to be aware of their availability and performance characteristics. Our systematic review provides a helpful tool in this understanding. Although some studies have already evaluated the impact of rapid diagnostics on patient management [33] [34] [35] , randomized controlled trials are needed to assess the clinical relevance of rapid tests in terms of clinically relevant outcomes, such as antibiotic use, length of hospital stay, and cost efficiency. In addition, point-of-care testing requires novel strategies for logistics and organization [36] . For successful implementation of rapid tests in the clinic, a laboratory test validation is not sufficient and a high-quality evaluation at the point of care is required.",12.893390939857355,7.404791061261323
microarrays can be used to monitor differential expression profiles and for clinical diagnostics,0.16866219546775904,1.7491254806518555,2.781460762023926,181ba9dd-ff43-4b79-a5d4-72c18ce1607c,custom_license/Protein microarray technology,"These types of microarrays can be used to monitor differential expression profiles and for clinical diagnostics. Examples include profiling responses to environmental stress and healthy versus disease tissues (Sreekumar et al., 2001) .",12.693845480087104,7.387726975769745
evaluation of new products or procedures on patient outcomes,0.3707279807887649,1.1865270137786865,3.1390914916992188,e3b410a5-9b38-416c-83da-69a358d8ed13,custom_license/2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings,"Infection control and prevention professional (ICP). A person whose primary training is in either nursing, medical technology, microbiology, or epidemiology and who has acquired specialized training in infection control. Responsibilities may include collection, analysis, and feedback of infection data and trends to health care providers; consultation on infection risk assessment, prevention, and control strategies; performance of education and training activities; implementation of evidence-based infection control practices or those mandated by regulatory and licensing agencies; application of epidemiologic principles to improve patient outcomes; participation in planning renovation and construction projects (eg, to ensure appropriate containment of construction dust); evaluation of new products or procedures on patient outcomes; oversight of employee health services related to infection prevention; implementation of preparedness plans; communication within the health care setting, with local and state health departments, and with the community at large concerning infection control issues; and participation in research. Certification in infection control is available through the Certification Board of Infection Control and Epidemiology.",12.333959138746854,7.128537727122037
corticosteroids do not improve the clinical outcome of CAP,0.400843567435387,1.8375070095062256,1.6091614961624146,e7a2d25f-4275-404a-969d-e648a6ad1929,"custom_license/No evidence for the effectiveness of systemic corticosteroids in acute pharyngitis, community-acquired pneumonia and acute otitis media","Since 1956 [41] , a number of studies have been published [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] . However, only a few were prospective and methodologically appropriate because, in most of the cases, these studies were not randomised, double-blind and placebo-controlled [42] . Moreover, even the few high-quality studies were characterised by considerable heterogeneity in their populations, the aetiology of CAP, the severity of disease, the choice of drug and dosing regimens, the route of administration and outcome measures (see Table 2 for characteristics of the most relevant studies). This makes it difficult to compare the results and draw firm conclusions [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] , and also explains why, in some cases, studies reported conflicting results that have lead, in a recently performed meta-analysis, to conclude that corticosteroids do not improve the clinical outcome of CAP [55] .",12.786269039371179,6.715528692464529
suggestive clinical or epidemiologic studies or a theoretical rationale,0.17936049725157258,1.5677945613861084,1.5226432085037231,eec80862-c361-4e2a-adf7-c0e25e8f8afb,custom_license/2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings,Category II. Suggested for implementation and supported by suggestive clinical or epidemiologic studies or a theoretical rationale.,12.548120505359208,6.400626727304113
"well-designed experimental, clinical, or epidemiologic studies",0.26632568540634255,1.3112506866455078,1.6219544410705566,14492b7c-3177-4662-b82a-6ece3a5e770d,custom_license/2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings,"Category IA. Strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies.",12.177593455346006,6.168741042386544
"experimental, clinical, or epidemiologic studies",0.14593368598778406,0.8541982769966125,1.154769778251648,96186c0e-ff9b-44c7-9201-3df899b3d33f,custom_license/2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings,"Category IB. Strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies and a strong theoretical rationale.",12.177593455346006,5.567986945282471
optimal therapeutic solutions that could improve the clinical course of the patient.,0.22777340020270812,1.1335010528564453,2.585061550140381,ee07b440-a2af-4ca0-9f33-28e4193fb121,custom_license/P1 Infusion of sodium sulfide improves myocardial and endothelial function in a canine model of cardiopulmonary bypass P2 Cytoprotective and anti-inflammatory effects of hydrogen sulfide in macrophages and mice,"We observed an improvement of respiratory parameters and SOFA score in patients treated with DCO. Furthermore, patients with worse neurological conditions at admission do not undergo orthopaedic surgery because it could worsen the cerebral perfusion (risk related to transfer to a far operating room). The physician's decisions (and therefore the patient's prognosis), in our experience, are limited by access to optimal therapeutic solutions that could improve the clinical course of the patient.",18.745301235822108,8.977921124485675
"automation of sample handling and diagnostics, mandatory accreditation, and broadening microbiology staff competencies in order to improve the flexibility of the available workforce",0.2175569387600883,2.5079002380371094,3.7097420692443848,bc80ba79-37cc-4a14-92c6-9ac9bd1929ea,custom_license/Microbiology service centralization: a step too far,"In the UK, microbiologists are aware of present moves to create pathology networks, chiefly by centralization of laboratories. 1e3 'Centralization' can be defined as building up or relocating one 'central' laboratory while closing or downgrading one or more 'peripheral' or smaller laboratories in acute hospitals in a Trust or Health Board. Centralization and modernization of microbiology services has already taken place in some countries (e.g. the UK and Germany) or is being considered by a range of healthcare regions and countries. Current trends include concentration of resources (formation of larger microbiological units from the closing of smaller laboratories), amalgamation of services (creating multidisciplinary laboratory facilities), outsourcing of microbiology diagnostics, automation of sample handling and diagnostics, mandatory accreditation, and broadening microbiology staff competencies in order to improve the flexibility of the available workforce. 4 These encompass specimen reception, decontamination services, cleaning, ordering, secretarial work, blood science support and even mortuary duties, the latter an unwelcome addition for inexperienced laboratory assistants.",12.106682454372997,8.27880635876352
suitable protocols to minimise the spread of infection within a population,0.19559999793155078,1.8964041471481323,4.05277681350708,de20a0c2-47f5-4875-af0f-47ee2621d64d,custom_license/Streptococcus zooepidemicus: An emerging canine pathogen,"S. zooepidemicus can seriously affect the health of dogs. Treatment is often unsuccessful and vaccines are currently not available. In order to improve the control of this disease, it is crucial to raise awareness amongst veterinary clinicians and nurses to ensure that cases are recognised early. This will allow the implementation of suitable protocols to minimise the spread of infection within a population. Measures to protect staff and owners from zoonotic infection during treatment and patient care are also imperative.",12.008628701129723,8.069987669821291
routine diagnosis,0.4089298137342692,2.4053633213043213,3.387606620788574,6c70e094-e4d3-4c06-b0c5-39eeedf40ef6,custom_license/Biosensors and rapid diagnostic tests on the frontier between analytical and clinical chemistry for biomolecular diagnosis of dengue disease: A review,"In general, rapid tests for point-of-care analysis still suffer from skepticism from the world medical community, for which the questionable validity/usefulness of single-analyte measurements and the interpretation of results by non-clinicians have certainly contributed. In addition, proper validation and standardization of such tests are still required, without which regulatory approvals for testing and commercialization are hardly obtainable. Nevertheless, the suitability of rapid diagnostic tests demonstrated by the validation processes must be complemented with additional figures of merit for implementation in routine diagnosis. Dengue virus is difficult to cultivate and propagate in laboratory, probably due to its wide geographic serotypic and genotypic variability, which has been a major obstacle towards the development and implementation of rapid diagnostic tests for dengue infections. There is still a long way to run from in-the-bench schemes and prototypes to fully developed, commercially attractive biosensing devices, whose wider utilization is still shadowed by well-established and well-performing laboratory assays. Unfortunately, the experimental prerogative for using well-defined, pure synthetic samples has often hindered detailed studies and conclusions about the effect of potentially interfering substances. Cold-chain has supported massive and adequate delivery of rapid diagnostic tests to clinical settings and end-users in remote tropical regions, but is handicapped by frequent irregular power supply in such regions and by the huge costs associated to transportation. Despite all these challenges, rapid diagnostic tests must be considered valuable alternatives rather than competitors to laboratory-based analytical devices and methodologies, even if some loss of sensitivity or selectivity must be accepted in the point-of-care testing. In fact, rapid screening of large amounts of samples may speed up proper decision making by the clinician, while conventional lab-based bioanalytical techniques can be used afterwards for confirmation and better characterization of the infecting pathogen. Reusable diagnostic tests must be avoided when dealing with infectious pathogens, thus explaining the growing interest in the development of chip-based disposable tests. It has been consensual that an efficient rapid diagnostic test for dengue disease should be a multiplexed device for detection and identification of all four dengue serotypes. Future developments and advances in fundamental and engineering sciences will certainly enrich the whole pool of knowledge about rapid diagnostic tests and will also improve micro-and nanofabrication processes for their mass production at an increasing cost-effective basis as well.",11.831208184708471,7.906353327008347
"improving triage, treatment, and disposition planning",0.26872922176237046,2.059516668319702,3.7060062885284424,ff9e7e5d-2c81-4132-9954-c2eeb50ef947,custom_license/Respiratory Hygiene in the Emergency Department,"Rapid point-of-care diagnostics hold great potential for improving triage, treatment, and disposition planning. Future research will need to bridge the divide between the numerous point-of-care assays that are under development and the need to have a reliable, easy-to-use test that is adequately sensitive and specific for clinical decisionmaking. Although such development will likely take several years of investigation, 2 such diagnostics in early phases of development include a polymerase chain reaction-based respiratory pathogen panel 59 and a mass spectrophotometry platform that can rapidly evaluate polymerase chain reaction products to identify any potential new emerging threat. 60 There are also multiple practical issues related to ED evaluation requiring study, including development of more effective clinical decision guidelines for isolation and diagnosis and determination of the impact and best practice methods for care in ambient settings. The effectiveness of ED air filtration techniques also remains unclear, and educational research in this area is required. The numerous ethical, legal, and practical challenges associated with isolation and quarantining of patients will also require further study, with emphasis on ED-specific questions such as the role of EDs in care of ""routine"" emergencies, development of ED surge capacity, and optimization of methods for coordination of EDs with the public health sector.",11.804207585309817,7.87906257680973
more widespread use,0.20622998226429493,1.6018990278244019,1.48768150806427,99feae0a-5c28-4001-9301-b04ad66699c7,custom_license/P1 Infusion of sodium sulfide improves myocardial and endothelial function in a canine model of cardiopulmonary bypass P2 Cytoprotective and anti-inflammatory effects of hydrogen sulfide in macrophages and mice,"Based on these results it can be concluded that, despite limitations such as motion artifacts and influence of sedation on electrical signals, EEG impacts on clinical decision-making processes in critical care. Hence it is beneficial, and more widespread use would improve its diagnostic potential.",15.793238536717032,7.535860836178598
to improve clinical outcomes,0.18734352480177205,1.6019971370697021,3.884554862976074,08c633f9-cac6-4468-805e-ecbd5795c392,"custom_license/â¢ Wang et al Intensive Care Unit, Anhui No. 2 Province People's Hospital, 17 Intensive Care Unit","Corticosteroid therapy is commonly administrated in critically ill patients with influenza to reduce cytokine dysregulation and lung inflammation and to improve clinical outcomes [26] . However, most observational studies have reported that use of corticosteroids was associated with persistent viral shedding in patients with seasonal influenza, Middle East respiratory syndrome, or severe acute respiratory syndrome [10, 23, 27] . In addition, our previous observational study that used propensity-score matching showed that use of high-dose corticosteroids was associated with a fatal outcome among patients with pneumonia and A(H7N9) infection [20] . Our results are in accordance with the above findings that corticosteroid treatment, not only high-dose corticosteroid dosing, is associated with prolonged viral shedding duration and that prolonged viral shedding is associated with a fatal outcome. The mechanisms of delayed viral clearance due to corticosteroid treatment are not well defined but might be associated with impaired T-cell responses [10] . Taken together, our findings suggest that corticosteroids should not be given for treatment of A(H7N9) infection.",11.184281517856258,7.480757331279445
The implementation of alternative processes,0.20641839862498387,0.9621357917785645,0.949252188205719,e17e7540-983c-4584-a3c8-9bf714ec2cb7,custom_license/Journal Pre-proof Conducting phase 1 cancer clinical trials during COVID-19 pandemic Title: Conducting phase 1 cancer clinical trials during COVID-19 pandemic,"The implementation of alternative processes should be consistent with the protocol to the largest possible extent, and sponsors and clinical investigators should document the reasons for any 5 contingency measures disposed. Sponsors and clinical investigators should document how restrictions related to COVID-19 led to the changes in study conduct and duration of those changes and indicate which trial participants were impacted and how those trial participants were impacted.",17.75084338651842,7.455197372271231
rapid publication of genome sequences during emerging epidemics is important to improve genomic and epidemiological surveillance,0.12478957851604333,1.5914819240570068,2.319756507873535,2aebd850-4c3b-4f58-b2e8-f308db609848,custom_license/Population Genomics of Human Viruses,"Another limitation for phylogeographic analyses is the public availability of sequences. This depends, in part, on the relevance of the disease caused by the virus, the implementation of an efficient epidemiological surveillance, and the stage of the epidemics. For instance, in 2016 the number of genome sequences for Zika virus available in GenBank was very limited (Shen et al. 2016 ) as a result of being a recent epidemic and inefficient surveillance. On the contrary, the availability in the public domain of influenza A virus sequences is much higher (Pybus et al. 2015) . The rapid publication of genome sequences during emerging epidemics is important to improve genomic and epidemiological surveillance and to monitor the spread of the disease and the adaptive processes in the virus (Gire et al. 2014 ).",13.91283862176262,7.41179849837177
The development of a therapeutic can cost hundreds of millions of dollars and take years to find its way through the various stages of research and development,0.17961111934710533,2.637741804122925,1.7703784704208374,2a39329a-180d-4784-bdd0-8ab8d249ee6a,"custom_license/Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology","Not all infections are suitable for antibody therapies. The development of a therapeutic can cost hundreds of millions of dollars and take years to find its way through the various stages of research and development, clinical development, and the government regulatory approval processes. At the end of this process the manufacturing costs factor into the cost per dose of the final product (Table 4 ). Cheaper to manufacture antibiotics have an advantage in the post development and FDA approval processes. Until antibody products produced via novel recombinant expression systems gain regulatory approval, monoclonal antibody (mAb) manufacturing remains limited cell culture. Currently every FDA approved mAb has been manufactured using classical mammalian cell culture expression systems.",12.635697791439284,7.287772405457195
"well-designed experimental, clinical, or epidemiologic studies",0.26632568540634255,1.3112506866455078,1.6219544410705566,7dcb4d73-b959-4537-8b57-4bf6176618b7,custom_license/Respiratory Hygiene in the Emergency Department,"Category IA. Strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies.",12.740939990030755,6.365912329526206
H5N1 infection,0.13596740961014178,1.5463716983795166,1.9542843103408813,1bf896f0-6e79-4fb1-ad66-82ae30740ce3,custom_license/Neurologic aspects of influenza viruses,"Viral replication may not be specifically pathogenic in the brain. The alternative explanation is indicated by the numerous studies finding hyperinduction of cytokines and chemokines associated with multiorgan failure and death (Cheung et al., 2002; Peiris et al., 2004; de Jong et al., 2005 de Jong et al., , 2006 Uiprasertkul et al., 2005; To et al., 2010) . In 18 individuals with H5N1 infection the low blood T lymphocyte counts and high levels of proinflammatory cytokines and chemokines were correlated with high pharyngeal viral loads and detection of viral RNA in blood and rectum, particularly in fatal cases (de Jong et al., 2006) . Although suppression of the host inflammatory response may confer some therapeutic benefit, anecdotal experience with corticosteroids did not improve the clinical outcome in H5N1 infection (Oner et al., 2006) . In a murine model study anti-TNF-a antibodies reduced illness severity (Hussell et al., 2001) , suggesting more exploration of this strategy.",11.420513651575417,6.272606183719654
"Most previous studies paid attention only to those fragments of the viral genome that were of interest from a clinical perspective, for diagnostics",0.22827701109497195,1.6249713897705078,1.1077052354812622,f99b3eda-556a-41f5-87a5-0850a44e15b6,custom_license/Population Genomics of Human Viruses,"The development of fast and efficient sequencing methodologies has brought the opportunity for obtaining complete sequences of hundreds, even thousands, of viral genomes at affordable costs. This has led to a new interest in the analysis of viral populations, which, until recently, was usually linked to outbreaks and other health emergencies. Most previous studies paid attention only to those fragments of the viral genome that were of interest from a clinical perspective, for diagnostics, surveillance, or similar applications. Furthermore, most insights into the population genetics of viral populations were drawn from markers likely under the influence of selective forces, thus leading to distorted or biased views of viral population genetics. This situation is rapidly changing, and the availability of complete genome sequences is shifting the perspective from ""population genetics"" to ""population genomics,"" that is, the analysis of the processes and mechanisms that govern the population dynamics of genetic variation at the complete genome level and not only on a portion of it.",11.263052909278644,5.718308324661176
"collaborative partnership in epidemic disease control, diagnostics, and preparedness.",0.13150821154656916,0.37764039635658264,1.4089641571044922,45cd0ea8-b85b-4961-ad94-b463b911a047,custom_license/Clinical Infectious Diseases Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical,"The global SARS epidemic illustrated how increased international travel and trade introduce new risks for the rapid worldwide spread of new infectious pathogens. The World Health Organization International Health Regulations (IHR), issued in 2005, were officially adopted by 196 countries [31] . ID physicians remain crucial to ongoing IHR implementation efforts, including disease outbreak recognition, in-country training, and collaborative partnership in epidemic disease control, diagnostics, and preparedness.",12.144013746652732,5.411697771078154
Clinical signs of neurologic dysfunction often improve rapidly (within 2-8 weeks) following radiation therapy,0.1710800274771787,0.2623216211795807,0.8319684863090515,57552432-c4e4-493d-866a-b7199b74665a,custom_license/26 Diseases of the Brain and Cranial Nerves,â¢ Brain metastases may respond to radiation therapy. â¢ Clinical signs of neurologic dysfunction often improve rapidly (within 2-8 weeks) following radiation therapy. Tumor shrinkage is delayed (>4 months) and is not associated with early clinical improvement.,11.081836890625485,4.589931481586531
we are also improving assays all the time,0.25228951133015676,2.8104138374328613,2.744062662124634,b84ddc57-a724-4c35-a6d5-c768639e49e2,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","The discussion on these standards is as long as we are working in this field, but is not limited to molecular diagnostics. Think about the discussion of standards in serology, or even virus culture. However, if we focus on the implementation of molecular diagnostics in clinical virology, the fact is that we have to implement new assays on a regular basis. Assays have recently been introduced for the detection of SARS coronavirus, the new coronavirus NL-63, the human metapneumovirus, the detection of influenza H7N7 or H5N1. The list is long, and we are also improving assays all the time. But looking at the current literature in this journal or equivalents in the US, many authors do not use yet the entire possibilities for standardisation inherent to molecular diagnostics techniques. One particular aspect is the implementation of internal controls throughout the whole test process from nucleic acid isolation until quantitative detection. But working in clinical virology, we have to be confident in generating accurate and reliable results. Yet the lack of standards for realtime technology is not inevitable. It is fascinating to observe that investigators still focus so frequently on the use of plasmid standards for the generation of external standard curves needed for quantification of clinical samples. We have characterised extensively these external plasmid standards, while we know so little about the clinical samples we are analysing. Why are not all processes monitored internally, and why are these external plasmid standard curves not treated the same way as clinical material? There should be the same clinical matrix and the same isolation procedure.",22.797052481150565,11.58937809311507
The multiplex PCR is an excellent diagnostic tool that helps both to improve the clinical management and expand the understanding of the pathogenesis of viral LRTI,0.17981587575772257,2.894261598587036,4.048426628112793,aaec98fc-1846-46d2-b062-ced968aa08a2,custom_license/Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection,"According to our results the clinical course of viral LRTI in children may be affected by virus type, viral load and viral and bacterial co-infections. Clinical improvement was associated for most respiratory viruses with a reduction of viral quantity. The viral load had a significant impact on the infectious parameters in blood in case of RSV and adenovirus, but no effect on clinical correlates of disease severity. The multiplex PCR is an excellent diagnostic tool that helps both to improve the clinical management and expand the understanding of the pathogenesis of viral LRTI.",19.029621199595855,11.173114767213438
patients with various hematologic cancers receiving CD19 CAR T cells.,0.22895951465059503,2.624126434326172,3.908033847808838,7f210f82-51a8-4e7b-97fc-540fdf013ce8,custom_license/Clinical Infectious Diseases Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells,"In summary, infections are common in adults with relapsed B-ALL after CD19 CAR T-cell therapy and can co-occur during times of CRS, although infection-related deaths were low. Based on our observations of the frequency and timing of infections, antimicrobial prophylaxis probably will parallel that for highrisk neutropenic patients although local bacterial and fungal epidemiology should be considered. As we gain experience with the different CAR constructs in various hematologic cancers, further studies should be conducted so we can better understand acute and delayed infectious complications in order to develop optimal prophylactic and management strategies and improve clinical outcomes in patients with various hematologic cancers receiving CD19 CAR T cells.",16.016777353905233,9.851776257254588
laboratory tests,0.29400377345400636,3.137047529220581,3.250657081604004,83dc7e6f-76e7-4ed9-ae30-972ceaf41f29,"custom_license/We Cannot Do It Alone The Intersection of Public Health, Public Policy, and Clinical Microbiology Public health microbiology Epidemiology FoodNet Antimicrobial Resistant Laboratory Network FDA-CDC Biobank Laboratory-developed test New antibiotics Multidrug resistance KEY POINTS","An alternative and bolder strategy would be to lower the regulatory burden for approval of infectious disease diagnostics in areas of unmet need. Our proposal would be to lower the approval threshold for areas of focused need that would not normally be appealing for commercial development under current regulations. Specifically, companies would still have to establish robust analytical performance for their methodology, however, without the need for extensive and costly clinical trials to establish clinical performance/utility. This would spur innovation, development, and implementation of laboratory tests in areas such as detection of rare emerging diseases (MERS, Ebola, carbapenemase detection and discrimination, blood parasites, seasonal influenza subtyping for therapeutic discrimination, tick-borne bloodstream infection, and Candida auris to forestall hospital outbreaks). Transplant and immunocompromised host infectious disease testing could also be extended to the range of sample types of importance (eg, bronchoalveolar lavage fluid and other respiratory specimens for molecular detection of Pneumocystis jiroveci pneumonia (PJP) and toxoplasma among others). The European diagnostics market, for example, offers excellent diagnostic support for clinical care without the extra layer of regulatory burden.",15.536246173401512,9.589694157726509
blood safety and screening blood products,0.3755502709295202,2.652099847793579,3.400402069091797,d8ff3760-1d74-4eaf-a8ae-c4286c6ddb4b,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","There has been discussion over the last decade about standardisation, although mostly focussing on the detection of blood-born viruses, and in particular hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1). The reason was that the first generation of commercially available amplification assays for the quantification of these viruses had some problems in detecting the different viral genotypes with an equal sensitivity (Damen et al., 1996; Zaaijer et al., 1994) . The implementation of, and the discussion around, the international unit (IU) to improve standardisation has therefore particularly contributed to the discussion of blood safety and screening blood products (Holmes et al., 2001; Saldanha et al., 1999 Saldanha et al., , 2001 . It is disappointing that the clinical virology societies have not been leading these discussions. In clinical virology, absolute quantitation levels and changes in viral load are highly relevant, as numerous publications within the last years have shown; in blood screening, the problem is more focussed on standardising lower limit detection levels.",15.497042369118883,9.358091075167103
hepatic and renal dysfunction [57â¢] .,0.12436990091663756,2.8450677394866943,3.9975857734680176,76df9ada-90a8-4e09-a3d9-4ac3faf480aa,custom_license/Relevant Cytokines in the Management of Community-Acquired Pneumonia,"Statins have pleiotropic effects that impact immunomodulatory, anti-inflammatory, anti-thrombotic, and direct microbicidal action. Statins are known to down-regulate cytokines and transcription factors that are abnormally increased during sepsis. Several in vitro and in vivo studies have demonstrated that statins reduce the levels of TNF-Î±, IL-1, IL-6, IL-8, NF-ÎºB, and C-reactive protein. These effects inhibit the up-regulation of cytokines and potentially decrease inflammation and immune dysfunction. As a consequence, statins may decrease the severity of symptoms associated with sepsis [55] . A metaanalysis performed in 2013 included 28 studies and revealed an association between statins and the risk and mortality of CAP. However, the results constitute very low quality evidence, based on the GRADE framework, due to the observational study design, heterogeneity, and publication bias. Given the biological plausibility of these findings and the high burden and mortality of CAP, the meta-analysis results warranted additional and better-designed studies to define the utility of statins in CAP [56] . A recent multicenter, double blind, randomized clinical trial studied rosuvastatin versus a placebo in patients with sepsis-associated acute respiratory distress syndrome with 70 % of the cases due to pneumonia. Patients did not improve clinical outcomes with rosuvastatin but may have contributed to a higher degree of hepatic and renal dysfunction [57â¢] .",12.481778739413924,8.816347342215437
improve our knowledge of the interaction between the malaria parasite and the host red blood cell,0.14251081276999109,1.9568336009979248,3.9882688522338867,952e469b-08cd-4dda-8bd1-5659721708da,custom_license/The Malaria-Infected Red Blood Cell: Structural and Functional Changes,"Finally, if cytoadherence really is a virulence factor, then preventing or reversing adhesion with anti-adhesive substances should significantly ameliorate the severity of the disease. Laboratory studies have identified potential anti-adherence reagents including recombinant fragments of PfEMP1 (Cooke et al., 1998) , but these have not been subjected to clinical trial. Further work over the next few years will undoubtedly improve our knowledge of the interaction between the malaria parasite and the host red blood cell. This in turn may suggest further strategies that could interfere with processes critical for parasite survival.",13.000757191832587,8.414581611742083
novel strategies directed at attenuating inflammatory responses will likely improve clinical outcomes,0.20724074650948224,2.2735190391540527,2.545131206512451,37d9fd44-165f-41e7-af9a-b2533e53c8a9,custom_license/Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology,"High virus titers and subsequent exuberant inflammatory cytokine and chemokine responses correlate with high morbidity and mortality observed during pathogenic hCoV infections. A systematic review of therapeutic effects of several commonly used antiviral and immunomodulatory agents used during SARS outbreak showed inconclusive results [114] . Similarly, therapeutic interventions aimed towards reducing viral load were somewhat beneficial when administered early but not during later stages of MERS-CoV infection [115] [116] [117] . These results suggest that besides controlling viral load, novel strategies directed at attenuating inflammatory responses will likely improve clinical outcomes. Here, we describe agents that have the potential to mitigate hCoV-induced inflammation.",14.98841551670721,8.37806809053075
The implementation of molecular diagnostics in clinical virology has already made a big impact in patient and disease management,0.16991258627010503,1.9320347309112549,2.5275847911834717,40d3597d-32da-4ea6-bc9a-ce8e96c536ea,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","The implementation of molecular diagnostics in clinical virology has already made a big impact in patient and disease management. The treatment and monitoring of antiviral therapy for HIV-1 is one of the greatest examples in the last decade. However, guidelines related to standardisation, internal controls and validation should be more actively pursued. Not only for the blood-borne viruses, but definitely for detection and quantification of all viral targets recently described and -for sure-to be discovered or introduced in the (near) future. This is an important task for better patient management. But from what we see in our daily experience, it seems that these hurdles cannot be taken so easily.",15.401877621898146,8.289409857025923
CE marked assays,0.3019084318715656,1.5992019176483154,1.9474318027496338,ee55ef19-58a0-4c9e-8c73-66658e826126,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","The discussion around the nomenclature of assigning quantitative values is rather confusing. For instance, for the detection and quantification of HCV, we have the International Unit (with an assumption -where are the published data -that it is similar for all genotypes), copies, genome equivalents or SuperQuant copies. One would suggest that by implementing an international standard, using a consensus nomenclature, life in diagnostic clinical virology would become much more clear. It is particularly irritating that the conversion factor from international unit to copy or genome equivalent varies somewhere between 2.4 and 5.2 (determined for genotype 1). It is also intriguing that the implementation of an international unit and its use is accepted for HCV, while for the description of quantitative results in the field of HIV-1 diagnostics, this is absolutely not the case. Data presented by quality control in molecular diagnostics (QCMD) which provides external quality control programmes, indicate that in these QC schemes, 88% of the participants in 2002 have presented their results of HCV-quantification in IU, while for HIV-1 this was done by none of the participants. Why is this not surprising to us? Simply because there is in general a limited acceptance of these standards, and it seems to depend on the viral target involved. This remains true even with the current focus on implementation of CE marked assays, for which it is clearly stated in the guidelines and the IVD directive that values should be related to an international standard. Indeed, this should even be an ""accepted standard"". Within our own laboratories, the introduction and validation of COBAS TaqMan assays for HCV and HIV-1 on one instrument for IVD already shows this lack of consensus.",15.03623369112643,7.567993710152917
facilitating acceptance and implementation in the future of international standards,0.23149658927067704,1.0268917083740234,1.7455188035964966,8ff8bb7e-fcbe-4e0f-a158-78f1a984615c,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","We urgently ask the parties involved to discuss the issue of standards more openly, thereby facilitating acceptance and implementation in the future of international standards. The definition of an international standard should apply equally to those used for screening blood products or to those used in clinical diagnostic virology. Importantly, the diagnostic industry should also be involved in the discussion, since they are critical for CE marking or FDA approval.",15.89334363219815,7.36473710405019
The side stream of plant-based processes can double the revenue,0.15082031462268305,2.178896427154541,2.318909168243408,2cdc0894-924e-4365-a749-7e2e3b38c141,custom_license/Expression of Single Chain Variable Fragment (scFv) Molecules in Plants: A Comprehensive Update,"Tuse and co-workers used SuperPro Designer modeling software to predict the techno-economic advantage of the plant expression system using human butyrylcholinesterase and cellulose, two enzymes with diverse origin and application. The study proposed significant cost advantages with the plant expression compared to the conventional production systems for the above-said candidate molecules [146] . Buyel reviewed the additional streams which can be incorporated with the plant production platforms to increase its commercial potential. Other than the target proteins, the biomass can further be exploited to improve the revenue. The side stream of plant-based processes can double the revenue depending on the additional products developed in an integrated approach [147] . Plants are again endowed with additional features like rhizosecretion, which has not yet been exploited to its full potential [151] . The secret is in the selection of correct expression platform which is fast-growing, easy to manipulate genetically, needs less maintenance cost and have the provision to reduce downstream processing costs.",12.43431518854004,7.27558395299768
there are more clinical diagnostics laboratories than blood banks screening blood and blood products,0.13112562076557552,1.6657445430755615,2.287001609802246,c4542519-d8e9-44be-a193-4d120d470fc6,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","The international standards now available are not really ""standardised"" in our opinion, because there is a lack of consensus about them in the scientific community. Further, these standards only contain a single viral genotype. They are not widely available (some are even not available anymore). The recent publication about the HIV-1 standard contaminated with HBV (Shyamala et al., 2004) (and there were rumours about this a long time ago), clearly indicates that a more open discussion with all parties involved, is necessary. These parties should be the clinical virology societies (ESCV, ES-CMIID, PASCV), the blood banks and the diagnostic industry. The discussion should focus on quality control methods used for the manufacturing of these standards, issues related to stability, matrices used and methods used to assign these quantitative values. Since there are more clinical diagnostics laboratories than blood banks screening blood and blood products, and these clinical laboratories are using quantitation for more and more viruses (not only the blood-borne viruses mentioned above), it is logical and efficient to use the expertise of these clinical laboratories.",13.1455970852804,7.170243979218714
molecular diagnostics,0.13363360359105458,0.3274305760860443,0.7009752988815308,da520d1c-3eee-467c-9127-b003cfea77f1,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","The implementation of molecular diagnostics in clinical virology is inevitable, with good reason. Real-time technology has taken the laboratories a further step forward, since most viruses can now be quantified, whether this is absolute or relative. Of course, most instruments for real-time quantification currently available are for research use only, but one cannot deny that the majority of all laboratories are using these instruments also for the generation of clinically relevant diagnostic results.",17.286441541424878,6.718718358227631
international standard,0.2761049983463971,0.8238584995269775,1.675643801689148,b0599b87-1c43-4059-b5b1-4771dcb45a6c,"custom_license/Standardisation and controls, why can't we overcome the hurdles?","The clinical diagnostic laboratories and their Societies have not been actively involved in the discussion around the implementation of any international standard, which we believe is not satisfactory.",13.162448437785583,6.231533449015435
viral respiratory pathogens,0.2586502153306501,4.763065814971924,5.264521598815918,529c923b-4be4-4b7c-9178-4a15d3d6aee8,custom_license/Scientific Advances in the Diagnosis of Emerging and Reemerging Viral Human Pathogens Emerging and Reemerging Viral Pathogens EMERGING AND REEMERGING VIRAL PATHOGENS,"One of the most promising platforms in clinical microbiology laboratories is that of molecular diagnostics using multiplexing technology (Loeffelholz, 2004; Smithn et al., 1998) . The ability of real-time PCR to amplify and detect the product to be amplified, using specific probes at the same time, allows for multiple amplifications with the same clinical sample. The design of primers is the most critical step in multiplex PCR so that efficiency and specific amplification are not compromised. Real-time multiplex coupling PCR with liquid-stained microarrays provides the multiplex detection of pathogens from clinical syndromes. FDA-approved diagnostic products are already available for viral respiratory pathogens.",13.955780224614681,11.402454897577236
the breadth and potential clini cal utility of these applications are likely to transform the field of diagnostic microbiology in the near future,0.17721150619495035,3.0843989849090576,4.344814777374268,6b3ce910-19ee-42d4-b5f1-e6d7257061c1,custom_license/Clinical metagenomics M I C R O B I A L G E N O M I C S,"To date, applications of clinical metagenomics have included infectious disease diagnostics for a variety of syndromes and sample types, microbiome analyses in both diseased and healthy states, characterization of the human host response to infection by transcriptomics and the identification of tumour associated viruses and their genomic integration sites (fIG. 1; TAble 1) . Aside from infectious disease diagnostics, adoption of mNGS in clinical laboratories has been slow, and most applica tions have yet to be incorporated into routine clinical practice. Nonetheless, the breadth and potential clini cal utility of these applications are likely to transform the field of diagnostic microbiology in the near future.",13.068480679459181,9.402957183294875
human use,0.4518701199180563,3.300567388534546,4.378606796264648,2bacc23a-3e75-46a1-be95-7a0a73da767d,custom_license/Preclinical Toxicology of Vaccines 1,"Preclinical toxicology studies should be carefully designed to include not only the relevant species, but also an appropriate number of animals (e.g., 5 rabbits or 10 mice/sex/group for both main and recovery groups), route of administration of the test article (normally the same as the intended clinical route), dose level (same as the intended clinical dose), and number of doses (N Ã¾ 1, where N Â¼ number of clinical dose[s]). If the number of doses is not N Ã¾ 1, then the number employed should be justified. The number of animals in each group should 4 GLP system means the organizational structure, responsibilities, procedures, processes, and resources for implementing quality management in the conduct of nonclinical laboratory studies [58] . Part 58 in these regulations includes the specific GLP requirements for both in vivo and in vitro studies. Parts 11 and 809 of CFR 21 explain the GLP requirements for handling the toxicology study records and the requirements for diagnostic products for human use, respectively. be adequate to ensure reliable statistical analysis of the data can be performed, with sufficient statistical power to evaluate potential differences [65a] .",10.778616840969521,8.76397911445881
could lead to a better understanding of EV-D68 circulation and burden,0.19381626923958847,2.2673189640045166,3.215507745742798,5e489bea-e6ce-4175-a48d-a3c9a38140e1,custom_license/Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation,"We show that EV-D68 was a cause of widespread, severe respiratory illness during 2014, disproportionately aff ecting those with a history of asthma or reactive airway disease. As a result of this outbreak, a real-time EV-D68specifi c RT-PCR assay has been developed by US CDC that might substantially improve EV-D68 detection. Implementation in diagnostic laboratories nationwide, combined with increased reporting to enterovirus surveillance systems, could lead to a better understanding of EV-D68 circulation and burden.",10.920999856328587,7.38618731105076
"molecular diagnosis is an essential element in the development of personalized medicine, thus presenting punctual performance of diagnostic procedures",0.09746199305806055,2.3383679389953613,2.917032241821289,952a3438-a9a9-49e7-ba9b-2c864263616c,custom_license/Scientific Advances in the Diagnosis of Emerging and Reemerging Viral Human Pathogens Emerging and Reemerging Viral Pathogens EMERGING AND REEMERGING VIRAL PATHOGENS,"Nanotechnology is a broad term that encompasses several disciplines and techniques, some of which currently have or will have a major impact on health care. For the purpose of this review, nanobiotechnology and its applications in molecular diagnostics are discussed. Nanotechnology is the study of the control and manipulation of matter at the atomic and molecular scales (Johnson et al., 2008) , the materials used are 100 nm or less in at least one of the dimensions of the material. On the other hand, molecular diagnosis is an essential element in the development of personalized medicine, thus presenting punctual performance of diagnostic procedures. This report focuses on the application of several technologies in the clinical laboratory setting. The different interrelationships between nanotechnology and molecular diagnostics and their role in nanomedicine and personalized medicine are shown in Fig. 7 .1.",11.098957658890958,7.300645298142658
limit the negative impacts of infectious disease outbreaks,0.17359704027799497,1.0708916187286377,3.479541778564453,22ced02f-d70d-4b5c-9e29-f9724629671e,custom_license/SCIENCE CHINA â¢ INSIGHT â¢ China in action: national strategies to combat against emerging infectious diseases,"Through the implementation of these strategies, the largest network in the world for surveillance of a diverse spectrum of emerging pathogens was established. The network consists of over 800 laboratories with different hierarchical levels from national to provincial reference laboratories, as well as sentinel hospitals. Efforts involve the integration of rapid diagnostics in the clinic/laboratory and epidemiological investigations in the field, constituting a multi-faceted approach to limit the negative impacts of infectious disease outbreaks (Editorial, 2013). Early-warning, prevention of pathogen spread and prompt clinical treatment are the key characteristics of this coordinated, nation-wide disease control strategy in China. This is reflected through following two common features related to collaboration and innovation: (i) The surveillance system collected complementary data from different institutes/laboratories covering health, agriculture, military, universities and hospitals. (ii) The system is based on a three-tier system (national-provincial-municipal), covering all districts in China and allowing for the surveillance of pathogens with regional specificities.",12.044006165441395,7.173183866144997
they are able to improve economic and microbiological outcomes without compromising efficacy,0.30815625101209393,2.1178603172302246,2.757136106491089,159ce3dd-e021-4358-889f-c510481a15db,custom_license/Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy,"We recommend that clinical guidelines or protocols for empirical therapy of HAP/VAP should be introduced in certain clinical settings, as they are able to improve economic and microbiological outcomes without compromising efficacy. Recommendation Grade C",11.110862885323897,7.0575496852822175
RNA extractions were performed using High Pure Viral RNA kit,0.28408477574218655,2.3944993019104004,2.4269814491271973,1aab6be7-7cc4-4577-96a4-37179800d4db,custom_license/Scalable Transcriptional Analysis Routine-Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics,"All RNA samples derived from SARS corona virus (SARS-CoV)-infected Vero cells, 18 blinded clinical samples A through H, and normal human tissues were obtained from the Genome Institute of Singapore. RNA extractions were performed using High Pure Viral RNA kit (Roche Diagnostics, Mannheim, Germany). The copy number of SARS-CoV RNA was quantified against reference standards using the LightCycler SARS-CoV quantification kit (Roche Diagnostics).",11.140788157590254,7.0332383433310275
reduced the blood culture rate without affecting the 30day mortality and antibiotics regimen,0.24847493753245303,1.8984342813491821,2.6107659339904785,cdd0d93e-a5c0-4ede-822e-a730c352298a,custom_license/Original Contribution,"In conclusion, the implementation of the bacteremia prediction rule in CAP patients reduced the blood culture rate without affecting the 30day mortality and antibiotics regimen. And bacteremia prediction score was independently associated with a reduction in initial antibiotics administration time and ED length of stay. Further prospective multicenter studies should be performed to evaluate the impact of wide implementation of the clinical prediction rule.",11.668857899617176,7.015080404836791
benefi cial health strategies,0.16533254128106695,2.171473264694214,2.305147886276245,c9064d4c-18ab-43bb-9db4-73131bea4f97,custom_license/The Lancet Commissions The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015,"For low-income countries, however, the donor resources associated with the MDGs can be attractive to governments that are struggling to meet their own strategic targets. For example, the provision of antiretroviral treatment for HIV/AIDS-an element of MDG 6-has been favoured by donors such as PEPFAR, but not always as a priority in country-led health strategies. Panel 5 shows how the national health strategy of Zambia has shifted to improve incorporation of this and other MDG targets. Although this approach could be seen as donor-driven distortion of national strategy, it also is indicative of a pragmatic national desire to develop benefi cial health strategies that have a high chance of successful implementation.",10.702328816542794,6.6556188339207765
animal rule,0.16842788461815536,1.6093566417694092,2.4787611961364746,023c6824-f07a-4f45-868a-ab145d45831a,custom_license/Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases,"This session on, ''Prospecting non-traditional paths to demonstrating safety and clinical benefit of countermeasures,"" was led by Tom Monath, Crozet BioPharma. Key points that were covered included: (1) the effect of antigen drift in surveillance; (2) innovations in safety assessments; (3) implementation of the animal rule; (4) use of immune biomarkers to evaluate clinical efficacy; (5) the ethical challenges of human challenge models; (6) licensure standards; and (7) wildlife vaccination.",10.789088930006457,6.433457720141084
once the test has become embedded and trusted by clinicians,0.20951286734544747,1.0881201028823853,2.3131887912750244,1b55210c-460e-414a-bcc2-74775d256d6e,custom_license/Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward â,"Second, because of unfamiliarity with the POCT test, clinicians may have still relied on the RVP results to make clinical decisions. We believe our results are likely to underestimate the true effect that the implementation of the test could have once the test has become embedded and trusted by clinicians.",11.504623436791647,6.237468984079392
metagenomic NGS Implementation of mNGS in the clinical laboratory is a complex endeavour that requires customization of research protocols,0.15789717018623606,0.47461971640586853,1.1146844625473022,a15cf26e-8862-4110-a682-5f8853c86c1c,custom_license/Clinical metagenomics M I C R O B I A L G E N O M I C S,"Clinical implementation of metagenomic NGS Implementation of mNGS in the clinical laboratory is a complex endeavour that requires customization of research protocols using a quality management approach consistent with regulatory standards 90 . Library prepara tion reagents, sequencing instrumentation and bioin formatics tools are constantly changing in the research environment. However, in the clinical laboratory, assays need to be implemented following standardized (locked down) protocols. Changes made to any component of the",14.060414786704314,5.954192891666071
"derivation, validation",0.29966397365429964,1.2146587371826172,1.0013742446899414,390f7611-6c25-49b4-82fa-6ad4ea13244e,custom_license/Original Contribution,"For clinical decision rules to have an impact on standard treatment, the clinical decision rules should pass three stages: derivation, validation, and implementation [12, 13] . In our previous studies, we derived the bacteremia prediction model in CAP patients and tested the generalizability of the rule by a multicenter external validation [10, 14] .",11.64251126089077,5.515300379528933
"We will consider ownership of the MDGs at three levels-by the international development community, by civil society, and by national programmes in developing countries",0.15259650218237272,-1.3539063930511475,-0.49641475081443787,6f3e8e14-285b-40ad-a00b-367c14d94c28,custom_license/The Lancet Commissions The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015,"Multilateral and bilateral agencies were heavily involved in the early development of the MDG framework as it emerged from OECD DAC and UN processes. Although they were brought in at the later stages of the process, and were signatories to the MDG framework, thus agreeing to work towards their implementation, the involvement of developing countries in the initial development of the framework was small. As a result, meaningful national ownership by developing countries has been mixed and often weak. We will consider ownership of the MDGs at three levels-by the international development community, by civil society, and by national programmes in developing countries-and the problems associated with each.",11.266822648484004,2.7406791834567708
"improve the clinical experience gained during training and promote skills such as patient examination, clinical procedures, and clinical reasoning",0.12143549745961336,2.6451756954193115,4.297569751739502,e48ee660-7b58-4c08-8b6a-da6c19b332bd,custom_license/Combined infection training e should we be concerned about its impact on infection prevention and control training of microbiologists in the UK?,"The move to CIT re-focuses the emphasis of infection training toward clinical aspects of the diagnosis and management of infection. The duration of specialist training spent in outpatient and ward-based clinical placements will be significantly greater than for those trained in medical microbiology/ virology on the previous scheme(s). This should improve the clinical experience gained during training and promote skills such as patient examination, clinical procedures, and clinical reasoning. Trainees will have more face-to-face patient time and a greater training in general medicine. Future (CITaccredited) consultant microbiologists/virologists may even take on more clinical roles (e.g. joint outpatient clinics).",19.588530560428374,11.36877023680316
MANAGEMENT Early diagnosis and prompt supportive care,0.399139207748061,3.226112127304077,3.1862871646881104,b5aa0ce2-db41-4e9f-8e82-cd5a674ee8ab,custom_license/Special Report Global outbreak of severe acute respiratory syndrome (SARS),"The only means to show the existence of a live virus is cell culture. This is very demanding, but is considered the gold standard, as it is the only test that indicates (albeit in retrospect) the ability of an individual to transmit infection. MANAGEMENT Early diagnosis and prompt supportive care improve clinical prognosis. Management guidelines can be found at www.who.int/csr/sars/management, and are summarized as follows.",19.76302028017539,11.08511663785631
"They also provide a baseline for clinical audit, evaluation and education, and facilitate ongoing quality improvements",0.22406061606527114,1.4671984910964966,1.7450402975082397,47678395-32cb-4b11-96c5-5b40c6319e37,custom_license/epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England 1 Introductory section 1.1 Guideline Development Team,"How can these guidelines be used to improve your clinical effectiveness? In addition to informing the development of detailed local operational protocols, these guidelines can be used as a benchmark for determining appropriate infection prevention decisions and, as part of reflective practice, to assess clinical effectiveness. They also provide a baseline for clinical audit, evaluation and education, and facilitate ongoing quality improvements.",21.951551181754404,9.77099812620712
improve mucociliary clearance,0.212652681908463,1.7870688438415527,2.2317328453063965,af939c3b-0024-4e6c-9daa-94b5e540e25f,custom_license/Viral bronchiolitis,"Nebulised hypertonic saline is thought to reduce airway oedema, decrease mucus plugging, improve mucociliary clearance, and rehydrate the airway surface liquid in infants with bronchiolitis. 78 These physiological changes are extrapolated from the cystic fi brosis literature, 79, 80 and the pathophysiological processes in acute bronchiolitis are diff erent. Therefore, the theoretical benefi ts of hypertonic saline seen in cystic fi brosis might not be present in infants with acute viral bronchiolitis. Although initial trials demonstrated some ability of hypertonic saline to decrease hospital length of stay and transiently improve clinical severity score, 81-83 more recent trials demonstrated confl icting results. [84] [85] [86] [87] [88] [89] [90] The trials that showed the largest benefi t were done in hospitals with lengths of stay more than 72 h; thus, hypertonic saline for infants in countries and institutions in which the length of stay approaches or exceeds 72 h might be benefi cial at reducing length of stay. The confl icting results are ",17.98831366473753,8.908130880604302
"implementation of the DOTS strategy may, in turn, enhance infection control",0.2257800004402329,2.4854073524475098,3.619112968444824,31b321d4-3e8c-442c-994e-db1b601bd90b,custom_license/Nosocomial Tuberculosis in India,"Third, nosocomial TB must be addressed because it can help the healthcare system, particularly the private health sector, improve TB diagnosis and treatment and better align practices with the DOTS strategy. For example, detecting smear-positive TB with microscopy is a key component of the DOTS strategy and an important administrative infection control measure. However, several studies have shown that private practitioners in India tend to underutilize microscopy and rely more on chest radiographs for TB diagnosis (17) (18) (19) . Thus, implementation of infection control measures might motivate the private healthcare sector to adopt the DOTS strategy, and implementation of the DOTS strategy may, in turn, enhance infection control.",13.032307470521175,8.529245823262428
"by partnering with the private sector, RNTCP can improve the quality of case detection and treatment provided in the private sector",0.1445614433406558,2.2706573009490967,2.5354368686676025,bc024cf9-b047-43a4-98f3-b0c2e0931abb,custom_license/Nosocomial Tuberculosis in India,"Given these problems, we cannot envision a simple approach to implementing infection control programs in India. While technical guidance should come from international agencies such as WHO and the International Union Against Tuberculosis and Lung Disease, these guidelines need to be adapted to the Indian context by RNTCP. Ultimately, implementing adequate infection control measures is the responsibility of each healthcare facility. RNTCP may not have the regulatory authority to enforce implementation; however, by partnering with the private sector, RNTCP can improve the quality of case detection and treatment provided in the private sector, which can, by itself, improve infection control.",13.511547092601562,7.853002692661401
Meat and meat products are irradiated primarily to improve the safety,0.14297830289499966,2.1223347187042236,2.9476394653320312,f551ee68-8512-468a-a384-cf13447e0473,custom_license/Scientific Committee on Measures Relating to Veterinary Public Health (SCVPH) (2000) Opinion on Revision of Meat Inspection Procedures,"Meat and meat products are irradiated primarily to improve the safety of the products by reducing the potential presence of pathogenic bacteria. Most of the pathogenic bacteria that have been associated with meat, including Salmonella, Campylobacter, and the pathogenic Escherichia coli species, are readily inactivated by irradiation. The technology of irradiation provides the meat industry with the ability to provide a fresh, non-heat-treated product to consumers that is essentially free of pathogenic food-borne bacteria.",12.161638782101477,7.552056793359082
Such technologies certainly can improve the quality of Chinese herbal injections and their clinical safety,0.13970522423046558,0.5765119194984436,1.7489854097366333,bd227179-a484-4744-a2f2-92976aa587fb,custom_license/Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections,"TCM has long been regarded as integral to the Chinese national essence. And the development of injectable traditional Chinese medicines is considered to be a great achievement of modernization of TCM. Indeed, the herbal injections have already proven to be a profitable industry. However, the herbal injections have come under greater scrutiny, including calls for the SFDA to promptly admonish the use of Chinese herbal injections. To date, most suggestions regarding the development of Chinese herbal injections have focused mainly on improving production technologies, including calls for adopting Good Agriculture Practice and quality control measures such as Chinese medicine fingerprint technology which may provide precise quantization or consistent batch-tobatch quality and component proportion control Zeng et al., 2006) . Such technologies certainly can improve the quality of Chinese herbal injections and their clinical safety. In light of our analysis, it is our view that additional measures and changes should be made in order to improve clinical administration of Chinese herbal injections. Our suggestions, detailed below in Sections 4.1-4.5 are based squarely in consideration of patient safety.",15.826327975106352,7.050788055290023
systematic methods to improve the quality and safety of the entire blood service,0.22153073200181642,1.7746059894561768,2.7947373390197754,a3bace43-4b5d-427b-b477-e27a0669c855,custom_license/Challenges and Research in Managing Blood Supply in China â,"Transfusion Medicine Reviews j o u r n a l h o m e p a g e : w w w . t m r e v i e w s . c o m despite increasing blood donation rates and the high prevalence of transfusion-transmitted viral infections in the general population [2, [4] [5] [6] . This article focuses on 3 additional challenges that have received less attention: the sustainability of voluntary donations, blood service cost assessment and recovery, and systematic and objective evaluation of blood service safety. These challenges center on the determinants for sustainable motivation of blood donors, the means to financially secure the operation of blood establishments, and the implementation of systematic methods to improve the quality and safety of the entire blood service. Understanding these issues is important to gain a better understanding of China's current blood collection service, predict future trends, and plan a long-term strategy for sustainable and affordable blood services that can adequately meet clinical needs.",11.612222251927207,7.034350951683892
large-scale and standardization production,0.22023705186706954,1.4932568073272705,2.5761971473693848,eb35c674-023a-4fb6-9a6b-4f6b25aee716,custom_license/Applied modern biotechnology for cultivation of Ganoderma and development of their products,"Second, we must improve and consummate the quality standard of the fungus. Setting up the quality management system of Lingzhi products includes the identification and control of the bioactive components, and the hazardous and noxious substances such as heavy metals and residual pesticide, etc., which can promote the realization of large-scale and standardization production.",11.771785374938883,6.765269951781435
"choosing appropriate construction methods and techniques including effective management processes to transform abstract designs, concepts, and specifications into concrete sustainable physical artefacts.",0.12357361310469706,1.0109245777130127,2.218618392944336,c6f61799-6914-4cbd-8b05-590a39856219,custom_license/Sustainability appraisal in infrastructure projects (SUSAIP) Part 1. Development of indicators and computational methods,"There are several dictionary definitions of the word strategy most of which relate to military planning and operations. However, two related definitions considered contextually suitable for the purpose of this paper define it as ''a plan of action or policy to achieve something'' [11] , and ''skilful management in attaining an end . . . the method of conducting operations. . .'' [12] . These definitions indicate that there are several key elements required to develop effective strategies for sustainable construction environment. Three of these critical elements include (i) clear formulation and setting of objectives; (ii) identifying and evaluating alternatives in quantitative and/or qualitative terms; and (iii) effective implementation of a selected/ chosen alternative. In the broader context of sustainability of infrastructure systems, which is the focus of this paper, the strategic objectives are articulated at the macro-level to underpin national frameworks for achieving broader sustainable development including sustainable construction environment. The alternatives in (ii) are design options, while the implementation in (iii) translates to choosing appropriate construction methods and techniques including effective management processes to transform abstract designs, concepts, and specifications into concrete sustainable physical artefacts.",11.108123307300366,5.987046088482405
independency and judged relevance of the individual tests,0.2031981430175482,0.5913304090499878,2.266627788543701,62f9f229-24a9-4a14-a0b7-94005fc885e6,"custom_license/Towards Real Time Epidemiology: Data Assimilation, Modeling and Anomaly Detection of Health Surveillance Data Streams","The automatic detection of anomalies should prompt investigations potentially for faults in surveillance, or disease evolution or changes in the population structure. If several measurable quantities are available for prediction and anomaly detection, several statistical tests can be combined into a collective test. The implementation of this aggregated test can take different forms depending on the independency and judged relevance of the individual tests and is the subject of meta-analysis [26] . The changes in disease dynamics (anomalies), may result from co-evolutionary processes, that is, from the interplay between pathogen evolution and changing social landscapes and, consequently, while their detection may be possible, the identification of the underlying mechanisms may not be straightforward without further investigation.",11.248365163135908,5.794600635533466
fermentation technologies,0.22231948827578046,1.5219732522964478,1.300953984260559,7231ee3f-19b3-4e28-afdc-e5e093d20e92,custom_license/Marine compounds and their antiviral activities,"To date, more than 275 new compounds have been isolated from marine fungi and the number of compounds is on the increase (Bugni and Ireland, 2004) . Most of these metabolites are analogues of those discovered previously from terrestrial fungi. Some of these metabolites with potential clinical importance could be produced in bulk by total or semisynthetic pathways, through implementation of fermentation technologies and using (post) genomic technologies in which biosynthetic gene clusters are cloned and expressed in vector systems (Bhadury et al., 2006) . Marine fungal-derived compounds such as sargassamide, halimide and avrainvillamide have shown selective inhibition of cancer cell lines, and show in vivo activity in preclinical models (P-388 lymphocytic leukemia) (http://www.cancer.ucsd.edu/summaries/wfenical.asp). Two of the above potential drugs have been licensed to the pharmaceutical industry and are in preclinical development. The diversity of the natural products from marine fungi clearly demonstrates that there are potentials for transferring some of these compounds into clinical trials for future development of anti-infective drugs (Bhadury et al., 2006) .",11.098487190685333,5.719373220501921
Most clinical signs attributable to a stroke would be expected to improve with time,0.32283758102509624,1.1679484844207764,1.3476828336715698,9567043a-036d-4ea9-80d1-ae45035239fa,custom_license/2 Behavioural and Medical Differentials of Cognitive Decline and Dementia in Dogs and Cats 2.1 Differential Diagnosis of CDS 2.1.1 Behavioural Differentials of CDS in Dogs and Cats,"â¢ Mentation/behaviour changes with hysteria signs such as circling, pacing or decreased vision could be residual signs perceived by the owners as a decline in cognitive function. Most clinical signs attributable to a stroke would be expected to improve with time, although recurrent or multiple cerebrovascular accidents (CVAs) are possible and can complicate the clinical picture (Cain and Khalil 2002) . Clinical signs that overlap with CDS:",10.951664906205696,5.468243073932019
Meeting the urgent growing healthcare needs in Africa,0.2074047578958315,0.7754366993904114,1.0907559394836426,9c864810-95dc-4a51-b3cb-6d186b77dc8a,"custom_license/The value of China-Africa health development initiatives in strengthening ""One Health"" strategy R EVIEWS","Fostering surveillance capacity in laboratory, clinical, veterinary and allied health sciences in the Africa continent are critical to overcoming the growing burden of diseases and ensuring a healthy future of its citizens [14, 15] . Meeting the urgent growing healthcare needs in Africa requires strategic and technical approaches in the development and integration of sound and harmonized regulatory systems for diagnostic products, new drugs and vaccine R&D. While reinforcing the national and international public health laboratories networks are able to improve collaborative and participative early disease detection, early warning and surveillance research in guiding proactive vigilance and smart response activities.",11.444525634192065,5.218609187235358
Treatment,0.4135841638309641,2.864689588546753,3.0466148853302,dea7e0b8-0723-41a4-a172-482dfef958fd,"custom_license/Biology and Diseases of Ruminants: Sheep, Goats, and Cattle","Treatment. Because the condition is developmental, supplemental copper may improve clinical signs but not eliminate them.",27.043757353580183,13.307662981773083
increase the availability of quality source material,0.31181759995073344,3.6837170124053955,4.678873062133789,c5630bd7-d67b-49f4-a19e-5a3797695663,"custom_license/Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion","There are several advantages of using human blood products for SC expansion. First, due to their human origin, these products are devoid of immunological risks specifically associated with the use of xenoprotein-based products. Second, the infrastructure for blood collection and quality/safety testing is well established, at least in industrialized countries with an advanced blood-collection system and good national regulatory supervision. In countries like the US, Germany, Switzerland, France, and others, blood products are regulated as pharmaceutical/medicinal products and are produced following the principles of GMP, which contributes to optimized product consistency, viral safety, and traceability. Recent WHO guidelines encourage the concept of GMP implementation in blood establishments at the global level [54] which should increase the availability of quality source material.",12.544107113789075,9.826121038276646
"diagnostics provide critical insights at every stage of medical care prevention, detection, diagnosis, treatment and successful management of health conditions",0.25757316881301384,2.783466100692749,3.884747266769409,2d508521-3736-4ee3-a35c-9706a49a3faf,custom_license/Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine,"Our healthcare system is critically and crucially dependent upon diagnostics. Today's medical decision making is strongly based upon the diagnostics results. Right from the genetic tests that can help notify personalized cancer treatment to the microbial culture for recognition of right antibiotic combating an infection, diagnostics provide critical insights at every stage of medical care prevention, detection, diagnosis, treatment and successful management of health conditions. The main categories of diagnostics are clinical chemistry, immunology, hematology, microbiology and molecular diagnostics. The molecular diagnostics has attracted particular attention in recent years owing to deep insights it brings to diagnosis and treatment.",14.201681132388966,9.304927085186542
increased development costs and delays in testing and implementation,0.20843629883919673,3.05238676071167,3.835409641265869,8e7df011-ab72-48eb-8143-d0f6ce1254c0,custom_license/Systems Virology Why everybody wants to measure everything Chapter Outline,"Unfortunately, in addition to scientific challenges, the use of genomic profiles in clinical settings is facing increased regulatory hurdles as well. This comes primarily in response to the use of faulty (possibly fraudulent) genomic markers to select therapy for patients enrolled in a clinical trial to test alternative chemotherapy approaches to treat nonsmall-cell lung cancer (Kurzrock et al., 2014) . In the aftermath to this trial, the Institute of Medicine (an arm of the National Academy of Sciences that provides advice to policy makers) has recommended that diagnostic tests that use genomic data be viewed as devices rather than as laboratory-based tests. This designation requires that genomic-based diagnostics be subject to additional regulatory controls and be overseen by the Food and Drug Administration (FDA). These increased regulatory burdens are likely to result in increased development costs and delays in testing and implementation.",12.88036305429765,8.985194730289578
The implementation of molecular methods has resulted not only in an improvement in diagnostics for a number of viruses,0.16749596806599934,2.4968698024749756,2.8234376907348633,0518cb00-1f33-4e6a-897e-db15a41f8a49,custom_license/REVIEW Molecular and diagnostic clinical virology in real time,"The implementation of molecular methods has resulted not only in an improvement in diagnostics for a number of viruses, using the quantitative detection of nucleic acids and the monitoring of antiviral therapy, especially for HIV-1, HBV and HCV, but also in the development of an amplification assay for almost every human virus, including those viruses that can be cultured relatively easily, e.g., the herpesviruses HSV types 1 and 2 [29] . These new molecular methods have several advantages, especially in those settings in which routine virus culture is not available. However, it should also be noted that improved sensitivity over virus culture is observed in almost all instances. The introduction of molecular diagnostics into routine clinical diagnostic virology is proceeding rapidly, and it will ultimately replace or reduce the use of virus culture techniques. The implementation of automated extraction and detection methods, combined with an extensive quality control programme, should ultimately convince both clinicians and virologists that molecular diagnostics is important in clinical virology. A critical remark often made is that not all positive results will have clinical significance, but this will be countered by good clinical and epidemiological information, combined with quantitative information on the virus(es) present. However, the ability to exclude viral infections To monitor patients at risk for EBV PTLD, EBV DNA load was measured on a regular basis. At a level of 1000 copies â mL, the patients were recalled to the hospital, and PE therapy with rituximab (anti-CD20 therapy) was initiated. Monitoring was performed five times a week, until the EBV DNA level was twice below the limit of detection of the assay (50 copies â mL). If the signal did not decrease rapidly (or an increase was observed), a second infusion of rituximab or an infusion of donor lymphocytes (DLI) was given (see data represented by a thick line). The initiation of PE therapy is represented as day 0. Each line represents an individual patient.",14.793438624062265,8.635903389008188
the passive transfer of these sera could improve the clinical outcome of SARS,0.21438691695745704,1.8219335079193115,2.916856527328491,3b330da7-8226-4b7e-b4c2-f185d856590b,custom_license/Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV),"It has been reported that high titers of protective antibodies were present in the convalescent sera of SCV infected patients and the passive transfer of these sera could improve the clinical outcome of SARS (Li et al., 2003a; Pearson, 2004) . This implies that if a vaccine can elicit robust humoral immunity, it will be protective against SCV infection by eliminating or reducing the cell-free viral infectivity (Chantler and Davies, 1987; Burton, 1997; Maruyama et al., 1999; Roehrig et al., 2001; Burton et al., 2004) . To evaluate the neutralizing antibody activities in serum samples from either SCV infected hosts or those immunized with candidate SCV vaccines, it is critical to establish highly reproducible and quantitative in vitro virus neutralization assays.",14.640549473038806,8.204405838474655
laboratory diagnostics,0.4583556756015614,2.1814727783203125,1.7709711790084839,963ce601-69cc-4925-8f51-311fc8c5476f,custom_license/Surveillance and Response to Disease Emergence,"Areas of expertise considered critical to improve detection, monitoring and investigation of emerging infections include field epidemiology, clinical and veterinary sciences, laboratory diagnostics, field ecology (mammalogy and entomology), behavioural science, medical anthropology, risk communication, social mobilisation (behaviour change communication) and other related disciplines.",15.852358081482992,8.117413900782765
there is a large and growing list of viruses for which the implementation and use of nucleic acid methods is advantageous,0.15845838815534732,2.1568496227264404,2.379284143447876,df46bd73-0024-4e1a-abb6-f145a582d540,custom_license/REVIEW Molecular and diagnostic clinical virology in real time,"There are still several problems that must be solved before molecular diagnostics can be routinely implemented (Table 1) . First, it is recognised that commercially standardised assays for the clinical laboratory are available for only a limited number of targets (mainly HIV type 1, HBV and HCV, and, to a limited extent, cytomegalovirus (CMV) and human papilloma virus), and it is unlikely that the number of target viruses will increase rapidly in the near future. However, it should be emphasised that there is a large and growing list of viruses for which the implementation and use of nucleic acid methods is advantageous. In Table 2 , a tentative list of 'commercially interesting' viruses vs. viral targets with limited commercial interest is given.",13.53273346646603,7.6849436612764155
methodological improvements still play an important role in accelerating the image reconstruction,0.2734704912741441,2.437600612640381,2.8836162090301514,dfc57604-a141-4b5a-a763-d28f9aa38cc1,custom_license/Adaptive multiresolution method for MAP reconstruction in electron tomography,"The usability of the iterative reconstruction methods in electron tomography highly depend on their computation time. The opportunities provided by the modern computing technology (e.g. GPU [21] , SIMD extensions of the modern processors [22] ) can be utilized to improve the performance of the methods. We used the computer grid Techila (Techila Technologies Ltd., Tampere, Finland) for the reconstruction of the experimental data in this study. However, methodological improvements still play an important role in accelerating the image reconstruction besides these improvements in the software implementation level.",11.454513526126128,7.46787066822999
to improve the supply chain performance under some short-term selling seasons,0.17449978844796163,1.7535218000411987,2.5801403522491455,1735a40f-5860-424a-b918-7dbf85e1772c,custom_license/Warehouse capacity sharing via transshipment for an integrated two-echelon supply chain,"In an integrated inventory system, the vendor can arbitrarily move the products from one buyer to another, which is known as transshipment between buyers. Transshipment can also be achieved under the vendor managed inventory (VMI) system, in which the vendor has the authority to conduct transshipment between buyers. The advantage of transshipment is twofold. First, under uncertain demands, transshipment between buyers can improve the customer service level, and it is popular in many industries, such as automobile and consumer goods (refer to Anupindi et al., 2001) . In this case, transshipments transpire between a buyer with excess inventory and another with excess demand. To the best of our knowledge, most of existing studies on transshipment are motivated by this consideration. Second, under the transshipment policy, the vendor may improve the utilization ratio of the buyers' warehouse capacities by keeping products that exceed one buyer's warehouse capacity at other buyers' warehouses for a time. In this way, the vendor can move those products to that buyer at appropriate time points and benefit from this type of warehouse capacity sharing strategy. The above two examples reveal that this strategy has been implemented in the real world to improve the supply chain performance under some short-term selling seasons.",12.810286905633006,7.300480815960276
patient medical record information recommendations of the NCVHS 24 ;,0.11274572559792405,0.8519394397735596,1.1667848825454712,173b0170-2d8c-4509-b46f-32f7be2c13b9,custom_license/A Consensus Action Agenda for Achieving the National Health Information Infrastructure,"Virtually every breakout group-regardless of topicproduced at least one recommendation related to data standards. This reflects both the centrality of standards to the NHII and the desire to move rapidly to build on recent progress in designating U.S. standards and in providing federal support for the maintenance and free dissemination of clinical vocabularies. Attendees placed high priority on increasing the use of designated standards-not only to enhance data exchange and aggregation, but also to generate the broad feedback needed to improve the standards. There were recommendations to promote early adoption of standards by federal agencies and to provide standard identifiers and codes as close as possible to the source of data, e.g., devices or test kits. Participants also agreed on the need to continue the existing standards designation processes, i.e., the Consolidated Health Informatics (CHI) Initiative 23 and implementation of the patient medical record information recommendations of the NCVHS 24 ; to provide adequate ongoing funding for standards development; to bolster standards maintenance processes to respond to feedback from increasing use; and to ensure that designated vocabulary and messaging standards work together as a coherent set.",16.2161058944295,6.9878078725576955
Future hygiene trials need to be larger to model full-scale programme implementation,0.23994504168238567,2.751861333847046,1.9338818788528442,378023f6-9449-4998-9359-3b7448bce5f2,"custom_license/Hygiene: new hopes, new horizons","The biological plausibility of most hygiene interventions is high (table 1) ; there is, however, a major shortage of evidence from trials. Trials on this topic can be complex and the results misleading; it is hard to mask participants to the nature of the intervention, which can lead to bias in outcome reporting. One way to improve this situation is to use more objective out come measures, such as health-care seeking, assessments by health-care workers masked to intervention status, or mortality. Future hygiene trials need to be larger to model full-scale programme implementation and more intensive (and therefore costly) than previous trials to objectively assess outcomes. Large, adequately funded trials are urgently needed to assess the eff ects of intervening to improve three key practices in particular: handwashing, safe disposal of child stools, and promotion of food hygiene.",11.226973093152164,6.975173670858186
largescale implementation efforts,0.12254431265638578,1.1872926950454712,2.4079437255859375,d627ad4c-60ce-4ff6-8b06-7b88b49f0858,custom_license/Vaccines IMPACT OF VACCINATION PROGRAMS,"Roughly two dozen antigens have been cloned and tested as potential vaccine immunogens, and with a few exceptions the results have been disappointing. 44 One antigen, the circumsporozoite antigen, presented as a fusion with HBsAg (RTS,S), has shown modest promise in human studies. 45 This vaccine is now undergoing larger-scale clinical efficacy testing to determine if the magnitude of protection would justify largescale implementation efforts. Should 'proof of concept' be supported in these studies, but the absolute magnitude of efficacy be insufficient, future efforts will likely focus on the identification of an appropriate adjuvant to improve the magnitude and duration of immune responses. Alternative approaches include immunization with irradiated or genetically attenuated sporozoites. 46 definition of novel antigens expressed at specific stages of the parasite lifecycle, and evaluation of combinations of multiple parasite antigens.",11.51730502786797,6.367960433164205
Develop innovation and adaptive capacity,0.15731466905773106,1.6033791303634644,2.07611346244812,1b991f0e-2b1d-4ac4-8998-0b58f60afb60,custom_license/Integrated urban services: Experience from four cities on different continents,"In 2016, Mexico City launched the Resilience Strategy to build resilience in specific areas at the community level that includes the following 5 pillars: i) Foster regional coordination; ii) Promote water resilience as a new paradigm to manage water in the Mexico Basin; iii) Plan for urban and regional resilience; iv) Improve mobility through an integrated safe and sustainable system; and v) Develop innovation and adaptive capacity. In 2018, the Mayor of Mexico City announced the implementation of a contingency task force for water scarcity.",11.327453696176189,6.356278978989196
orphan drug development.,0.17436526265930324,0.987496554851532,1.8605718612670898,7b90bef6-63d8-48f6-9965-b01f3839bb8f,custom_license/Orphan drugs: Unmet societal need for non-profitable privately supplied new products,"Complexity is defined as ""the degree to which an innovation is perceived as being difficult to use"" (Moore and Benbasat, 1991) . As mentioned in Section 2, orphan drug development is relatively complex compared with the development of conventional drugs due to a lack of mechanistic knowledge about the disease, a lack of valid biomarkers, inappropriate diagnostics, and small patient groups for clinical trials. Rare diseases often have a genetic element, lack suitable animal models, and require more collaboration with other institutes than conventional drug development. Together, these factors indicate highly complex development processes and form a barrier to orphan drug development.",12.716356701026259,6.301969315836294
Quantitative PCR,0.7384411650406126,3.3375580310821533,4.178187370300293,cc5a18c2-9746-4c56-82a8-8f3343247ab9,custom_license/WHAT DOES THE FUTURE HOLD FOR CLINICAL MICROBIOLOGY?,"Quantitative PCR. The development of molecular beacons and other fluorescent probes (such as the TaqManÂ® probe that is produced by Roche Molecular Systems, Inc.) has made real-time monitoring of PCR amplification and quantification of nucleic acids in clinical specimens possible 21 . Beacons are hairpinshaped oligonucleotide probes that have a fluorophore that emits photons and is closely associated with a quencher, which absorbs the photons. In the presence of a complementary strand of DNA, the hairpin structure unfolds and fluorescence is emitted, and this can be measured to determine the amount of DNA that is present. Multiple targets can be monitored 22 using fluorophores with different emission spectra. This technology, which is highly sensitive, is commercially available as the TaqMan Â® (Applied Biosystems; Perkin-Elmer Corp.) and LightCycler Â® (Roche Diagnostics Corp.) systems. The advantages of real-time PCR are the rapidity of the assay (30-40 min), the ability to quantify and identify PCR products directly without the use of agarose gels, and the fact that contamination of the nucleic acids can be limited. Kits are available for the detection and quantification of DNA and RNA in clinical samples, and the technique has been specifically developed to enable the follow-up of patients with HIV and hepatitis C infections (Amplitech AME Bioscience; Bayer Diagnostics; Roche Diagnostics). Microscopy. Microscopy techniques have evolved with respect to three factors: the nature of the signal, the user-friendliness of the equipment, and the digitalization and computerized processing of the image. Electron microscopes -which were once complicated instruments that were only used in research -have been simplified and are now increasingly being used in clinical microbiology laboratories. They are useful for the rapid screening of routine clinical samples, such as stool samples, and also for detecting viruses in tissue cultures. With negative staining, a viral pathogen can be identified within 10 minutes of the arrival of a clinical or tissue-culture specimen in an electronmicroscopy laboratory 43 . Electron microscopy was used to rapidly identify Bacillus anthracis during the recent anthrax letters attack in the United States 43 and also to identify the genus (Coronavirus) of the SARS virus. The implementation of new technologies, such as automated pattern recognition 44 , remote operation of microscopes and telemicroscopy -which uses digital image acquisition and review of images through the internet 45 -will further increase the usefulness of electron microscopy.",14.67283981277021,10.020728445368164
improvement of language or motor functions,0.21787006913232915,2.7354300022125244,4.705337047576904,4679ef6a-6503-43d1-a8b5-41b68e7a3013,custom_license/Evolution of Intensive Care Unit Nursing,"Animal-assisted therapy (AAT) is defined as ""the use of human-animal bond to attenuate stress and improve mood"" [16] . AAT works on the interaction between humans and pets, with the aim to reduce stress and feelings of isolation and depression [16] . Areas of AAT implementation range from simple social well-being to the improvement of language or motor functions [16] . Dogs are the most frequent animals used for AAT, although rabbits and cats can also be employed, under the guidance of specially trained teams. Adequate procedures that address hygiene guidelines, times of use, and safety measures are needed [16] .",11.25333587784067,8.775166139607363
Protein microarrays are excellently suited for diagnostic purposes,0.27157238590358346,3.4117214679718018,3.7928876876831055,a7fc6c91-0478-427c-b721-29ff96202c8c,custom_license/Protein Microarrays for Personalized Medicine,"Protein microarrays are excellently suited for diagnostic purposes (12, 67 ) . Several diagnostic protein microarray products have been cleared by the US Food and Drug Administration (FDA) or CE-marked for use in the EU (9 ) . The diagnosis of autoimmune diseases is the focus of most of these protein microarrays, including the AtheNA Multi-Lyte Test System (Zeus Scientific; exclusively marketed by Inverness Medical Professional Diagnostics), the Bio-Plexâ¢ 2200 system (Bio-Rad Laboratories), the Immuno Solid-phase Allergen Chip (VBC Genomics Bioscience Research), and the QUANTA Plexâ¢ ANCA Profile (INOVA Diagnostics,). The AtheNA Multi-Lyte ANCA Test System, which performs multiple assays simultaneously from a single sample in a single well, can perform qualitative or semiquantitative detection of IgG-class antibodies to 2 separate antineutrophil cytoplasmic antibody (ANCA) antigens (myeloperoxidase and oroteinase 3). The intent is to aid the diagnosis of a number of autoimmune vasculitic disorders characterized by increased concentrations of ANCAs. The company's AtheNA Multi-Lyte ANA Test System simultaneously performs antinuclear antibody screening and reflex testing for 9 specific autoantibodies (SSA, SSB, Sm, RNP, Scl-70, Jo-1, dsDNA, centromere B, and histone) in a single well.",10.748138872559561,8.444844556571537
Educational interventions and workshops aiming to provide psychological stress management tools and improve interpersonal social and communication skills,0.3549212331441741,3.094106435775757,3.7684736251831055,4d471134-4646-4410-a446-1f9c125e5ee9,custom_license/Evolution of Intensive Care Unit Nursing,"The recent widespread implementation of the ""open ICU"" concept has exposed nurses to additional emotional stressors arising from the family's feelings and needs, because the relatives spend more time in ICU, at the patient's bedside. The consequent physical and emotional stress can cause depersonalization and/or avoidance behaviors, exhaustion, burnout, and higher turnover rates in ICU personnel [21] . Some proposed solutions rely on teamwork learning programs (with the focus on interprofessional relationships). Educational interventions and workshops aiming to provide psychological stress management tools and improve interpersonal social and communication skills have also been recommended [21] .",11.011909840853098,8.314845483921845
to promote knowledge transfer and implementation,0.128148246198673,-0.4861767590045929,0.4417465329170227,60b9357e-61b0-4fb3-96fd-133cf5a0180c,custom_license/Evolution of Intensive Care Unit Nursing,"â¢ Strategies to improve communication and coordination of care â¢ Tools, processes, and programs to promote knowledge transfer and implementation â¢ Factors related to an effective learning environment â¢ Strategies for the application of clinical risk management concepts and methods â¢ Assessment of the distressing effects of interventions on the patient and their family.",23.433285669736815,8.172770337450965
"Post-mortem diagnostics is most rapid with antigen detection or RT-PCR from the brain, virus isolation",0.12098703810993654,2.9494619369506836,2.3794803619384766,e6d74848-b6b8-4525-a471-258c34ac7e20,custom_license/Viral zoonoses in Europe,"Clinical suspicion of rabies in a case of encephalitis of unknown origin is the starting point. Ante mortem diagnostics can be achieved most easily with RT-PCR from saliva. In addition, rabies antigen can be detected in brain or nuchal skin biopsies, and in some cases antibodies in serum or CSF may be found. Post-mortem diagnostics is most rapid with antigen detection or RT-PCR from the brain, virus isolation is also possible.",13.024147254667385,8.022264033411538
"Funding BioFire Diagnostics, LLC. Provided Film Array Respiratory Pannel (RP) test kits for this study",0.1929031527328199,1.639587163925171,3.129688262939453,ee63ce28-f84d-4629-9827-de2563987e4c,custom_license/Respiratory Testing and Hospital Outcomes in Asymptomatic Infants Undergoing Heart Surgery,"Funding BioFire Diagnostics, LLC. Provided Film Array Respiratory Pannel (RP) test kits for this study. AJB collaborates with Bio Fire Diagnostics, LLC on federally funded studies has received research funding from Bio Fire Diagnostics for investigator-initiated research. AJB has intellectual property licensed to Bio Fire Diagnostics, LLC and receives royalties through the University of Utah.",12.591335405601866,7.506996419422659
to strengthen import-export control of transgenic agricultural products,0.1637298044374665,2.0760464668273926,3.037792682647705,0db3bde9-0186-4c9b-a993-cd47e354523c,custom_license/MINI-REVIEW Recent advances and safety issues of transgenic plant-derived vaccines,"Other strategies In addition to the above methods, there are other strategies, such as to improve the security management system of genetically modified organisms, to execute area-delimited management of production, to strengthen import-export control of transgenic agricultural products and to raise the level of safety consciousness of all people to transgenic foods.",11.78676200081263,7.449362147443233
it will be the basis to improve the usefulness and the accuracy of MALDI-TOF,0.13538690368109163,0.6567277312278748,1.3723886013031006,66c12a9f-cd95-49ca-874e-542d869b05e8,custom_license/The Use of Mass Spectrometry Technology (MALDI-TOF) in Clinical Microbiology,"It is essential for both to continuously improve the quality of the database and to introduce a quality control program for the MS device. The implementation of these programs can help to improve the quality of the overall procedure, so it will be the basis to improve the usefulness and the accuracy of MALDI-TOF.",17.087793870608582,7.2996534708581375
antitoxin therapy,0.2480241438396041,2.139185667037964,2.9252545833587646,9af36972-0ae6-4a56-aaa9-812689cfe12b,custom_license/2 Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine,The comparatively high titers of hybridoma-derived antibodies along with their potential for improved specificity could significantly improve the efficacy of antitoxin therapy when monoclonal antibodies are used instead of conventionally prepared antitoxin. Hybridoma technology could conceivably result in lower cost products of higher potency for therapeutic use.,11.06562871103073,7.164856211618629
patient medical record information recommendations of the NCVHS 24 ;,0.11274572559792405,0.8519394397735596,1.1667848825454712,c4ef7e6f-7646-43a0-bd82-30ca6dd362e9,custom_license/A Consensus Action Agenda for Achieving the National Health Information Infrastructure Consensus Action Agenda for Achieving the NHII,"Virtually every breakout group-regardless of topicproduced at least one recommendation related to data standards. This reflects both the centrality of standards to the NHII and the desire to move rapidly to build on recent progress in designating U.S. standards and in providing federal support for the maintenance and free dissemination of clinical vocabularies. Attendees placed high priority on increasing the use of designated standards-not only to enhance data exchange and aggregation, but also to generate the broad feedback needed to improve the standards. There were recommendations to promote early adoption of standards by federal agencies and to provide standard identifiers and codes as close as possible to the source of data, e.g., devices or test kits. Participants also agreed on the need to continue the existing standards designation processes, i.e., the Consolidated Health Informatics (CHI) Initiative 23 and implementation of the patient medical record information recommendations of the NCVHS 24 ; to provide adequate ongoing funding for standards development; to bolster standards maintenance processes to respond to feedback from increasing use; and to ensure that designated vocabulary and messaging standards work together as a coherent set.",16.128526970040006,6.957155249021373
avian influenza,0.15615881691813358,0.9459008574485779,1.8164931535720825,fa1609b9-d220-4819-b4b9-f64ba3797498,custom_license/Avian influenza e A review for doctors in travel medicine,"This review will focus on those aspects of H5N1 pertinent to the travel medicine doctors and will include the epidemiology, clinical features, diagnostics and management of a patient with avian influenza.",12.905324061405278,6.312419528655276
green and environmentally safe products,0.16579031755060583,1.0875496864318848,1.7511727809906006,55af70ac-78b0-4280-b626-75565a49320b,custom_license/Functional Polysaccharides for Biomedical Applications Green synthesis of polysaccharide- based inorganic nanoparticles and biomedical aspects,"In recent years, there has been an increasing interest in the development of green and environmentally safe products. Subsequently, green chemistry has fast become the primary focus of researchers to devise green and nonhazardous chemical processes using nontoxic solvents, biodegradable, and sustainable materials.",12.140257855332266,6.094259853190908
"improve communication and discussion, and share clear and structured clinical and organizational information",0.169555502172104,1.2710038423538208,1.7544203996658325,c7141bc4-64b8-4ab4-9485-1c8d2a275f90,custom_license/Evolution of Intensive Care Unit Nursing,"Therefore, the only way for the multidisciplinary ICU team to achieve better outcomes is to develop a high level of trust, improve communication and discussion, and share clear and structured clinical and organizational information [25] .",10.697805714349105,5.710757757334961
ICU teams to improve the relationship climate,0.13051811064467297,0.7843665480613708,1.023787021636963,86318a22-df30-48ac-91ed-2505ec686593,custom_license/Evolution of Intensive Care Unit Nursing,"Evidence on the influence of programs for the implementation of open ICUs on patient mortality, length of stay (LOS), infection risk, and the mental health of patients and their relatives is currently lacking, and the influence of such programs needs to be investigated [12] . Further, the efforts of ICU teams to improve the relationship climate inside the ICU will require addressing according to the indications arising from the research results.",12.409632652818647,5.518671248790444
effective antiviral agents are imperative to improve clinical outcomes,0.271177646089348,3.114281177520752,3.4464986324310303,beda0882-44ab-4366-a46f-a4f03a67cc3b,"noncomm_use_subset/A Phase II, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients","In summary, this study provided important lessons for the design of future clinical trials of drugs for RSV and other respiratory virus infections in HCT recipients. Although the coprimary endpoints were not achieved, presatovir treatment was associated with trends toward an antiviral effect and clinical benefit. Similar future trials should judiciously select suitable at-risk patients (ie, patients with lymphopenia, neutropenia, GVHD, or receiving corticosteroids) to maximize the potential benefits. Because having an LRTC increases the mortality risk, prompt diagnoses, early intervention for RSV URTIs in high-risk patients, and effective antiviral agents are imperative to improve clinical outcomes.",15.308232072936388,9.622388101996393
constipation,0.29009488730353666,3.427605152130127,4.8005242347717285,9aef93a1-f373-47ee-b1b7-eb5b24d99e58,"noncomm_use_subset/Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse","The primary function of the small intestine is to complete the chemical digestion of food
by pancreatic enzymes and bile salts and allow for efficient absorption of the products of
digestion. The primary functions of the large intestine are to allow for further digestion
by fermentation in the cecum, absorption of water, and temporary storage of waste material
in the rectum before defecation. Disease processes or test articles that interfere with
these processes will often produce diarrhea. Less commonly muscle function is compromised
leading to impaction of rectum and colon and clinical constipation. The mucosa of the
small intestine is a site of high enzyme activity and conjugation reactions and
consequently orally administered test articles may be metabolized, activated or
deactivated in the intestine. The GALT plays a primary role in the defense of the body
against invasion by micro-organisms in the food and those normally resident in the
lumen.",12.05031716725506,9.565895110025476
"most protein-based therapeutics, diagnostics and vaccines are made using traditional recombinant protein production platforms",0.39854168234941917,3.432598114013672,3.207383155822754,7ba3d04a-8aaa-46ee-9044-e5c500cac6e2,noncomm_use_subset/Techno-economic analysis of a transient plant-based platform for monoclonal antibody production,"Since the commercialization of the first therapeutic monoclonal antibody (mAb) in 1986, this class of biopharmaceutical products has grown exponentially. As of November 2014, forty-seven mAb products have been approved in the US or Europe for the treatment of a variety of diseases, and many of these products have also been approved for other global markets.1 At the current approval rate (an average of 4 new products per year), it is expected that over 70 mAb products will be on the market by 2020, and projected combined global sales by 2017 will be nearly $90 billion.2 Currently, most protein-based therapeutics, diagnostics and vaccines are made using traditional recombinant protein production platforms (e.g., mammalian or microbial cells cultured in stainless steel or single-use disposable bioreactor systems). The selling prices of pharmaceuticals are increasing along with global price inflation, and in turn, over half of the global population cannot afford critical medicines. Additionally, there is a growing need for manufacturing processes that can a) respond quickly to new or sudden medical needs (e.g., during the 2012â2015 Ebola and Middle East respiratory syndrome, and the 2016 Zika virus outbreaks), b) offer more rapid drug development, and c) lower drug prices to address emerging markets in less-developed areas of the world.",14.80434065784333,9.497507055638842
implementation in daily practice is difficult due to subjective criteria,0.19120106093369066,1.1898061037063599,1.9977089166641235,30711d4d-aec7-4115-bf99-1e0ea2c5dfaa,noncomm_use_subset/Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children,"Currently, there are clinical prediction rules to predict safe discharge, length of hospitalisation and ICU admission for children with acute respiratory viral infections based on demographic criteria and clinical symptoms.4 5 7â11 Although these clinical prediction rules show the potential to improve clinical judgement, validation in other cohorts is often lacking or implementation in daily practice is difficult due to subjective criteria.8 9 Moreover, children under 2 months of age were either excluded or the studies were designed in such a way that all patients in this age group were automatically admitted to the hospital. A more objective, reproducible and sensitive prediction of disease severity for all age groups may be achieved by using biochemical and haematological markers.12â16
",20.205734389364117,9.143891799518254
cardiac diagnostics and monitoring of therapy,0.4128155068095527,3.125166416168213,3.944915533065796,20e1da42-9b8e-418e-a518-fc128445c646,noncomm_use_subset/RESEARCH COMMUNICATIONS OF THE 28th ECVIMâCA CONGRESS,"Fibrosis and extracellular matrix remodeling has a causative role in the pathophysiology of cardiac diseases of different origin. At cellular level, fibrotic processes are prior to clinical manifestation of symptoms. Currently there is no biomarker, which is able to detect heartâspecific fibrosis and remodeling in the peripheral blood sample despite it's advantages in cardiac diagnostics and monitoring of therapy. Previously, using microarray method we identified heartâspecific gene expression profile representing fibrotic and inflammatory processes in the peripheral whole blood of tachypacingâinduced cardiomyopathy model dogs and we successfully selected a heartâspecific fibrosis related mRNAâpanel which gene expression levels in blood samples clearly differentiated clinical cases from healthy dogs. MicroRNAs are key regulators of gene expression and highly stable molecules thus ideal biomarker candidates.",12.490195658895738,8.967121747615614
In less severe cases conservative therapy can improve clinical signs.,0.2107590106348728,2.8804984092712402,2.7891507148742676,8aae73fc-d4c0-4c87-9b64-d9d71bc5b177,noncomm_use_subset/RESEARCH COMMUNICATIONS OF THE 28th ECVIMâCA CONGRESS,"HSPF might be an underestimated disease of the upper airways and clinician should be aware of this condition when evaluating brachycephalic and nonâbrachycephalic toy dogs with obstructive signs of the upper airways. It should also be considered that muscle relaxation induced by anaesthesia and mucosal oedema might overestimate the degree of HSPF and subsequently the degree of laryngeal collapse. When abduction of the pharyngeal fold by mean of a cotton swab results in significant improvement of laryngeal abduction, surgical correction of the HSPF should be considered in dogs with severe inspiratory dyspnea. In less severe cases conservative therapy can improve clinical signs.",14.993073219445066,8.932847557500352
The objective of this study was to correlate measurement of fT4ED,0.2222806157336105,1.7760183811187744,1.6036752462387085,d39232a6-6019-4058-bbd1-391e82c7c950,noncomm_use_subset/RESEARCH COMMUNICATIONS OF THE 28th ECVIMâCA CONGRESS,"The objective of this study was to correlate measurement of fT4ED (Free T4 by Equilibrium Dialysis, Antech Diagnostics, Irvine, CA, USA) and fT4CEIA (IMMULITEÂ® 2000 Veterinary Free T4, Siemens Healthcare Diagnostics Products Ltd., Lanberis, Gwynedd, UK) in cats before and one month after treatment with 131I.",15.036923505607067,7.459724084744837
The local implementation of the trial has built-in flexibility,0.1407227791545464,0.9966526627540588,1.6516116857528687,d31022b9-e3a5-44e3-bac0-7cb578949442,noncomm_use_subset/Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol,"The local implementation of the trial has built-in flexibility, and local network recruitment processes vary. For example, medical students may assist with recruitment tasks in certain practices, whereas others will incorporate triage systems or additional trial-specific clinics and/or research support staff in their recruitment processes.",16.230728412200005,7.402126770799504
to understand particular disease processes,0.15133837700909378,1.4102821350097656,2.0800108909606934,1b642c25-c19e-46e7-a2da-b06208e30400,noncomm_use_subset/Methods and approaches to disease mechanisms using systems kinomics,"In this current review, we provide an overview of some of the popular high-throughput methodologies, analysis tools and databases that are commonly used in kinase signaling studies and how they may be used to understand particular disease processes in virology, cancer and clinical diagnostics. Some important areas of current research include the purification and characterization of protein kinases (both natural and recombinant), the elucidation of biological functions and ligands of kinases and the development of specific kinase inhibitors.",13.668238425141242,7.052573915680233
implementing POC antibiotic resistance diagnostics into the GP practice,0.16640745737250925,1.3840343952178955,3.0937514305114746,68cf1ea6-5fe6-4dfa-abb3-7f639cb53d6d,noncomm_use_subset/Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice,"Choosing useful antibiotic resistance gene targets for use in POC diagnostics by general practitioners is not an easy task. Currently, the choice is particularly limited by: the diversity of antibiotic resistance mechanisms present in general practice; a lack of epidemiological information on the origin and spread of antibiotic resistance mechanisms within particular geographical locations and within particular communities; and limitations on currently available POC diagnostic technologies to rapidly detect the many different types of antibiotic resistance mechanisms known. Lesser problems include: the inaccuracy of predicting future trends in antibiotic resistance; and a lack of knowledge of the impact of the human microbiota on antibiotic resistance carriage and antibiotic treatment failure. It should be noted that, even if the above challenges are successfully overcome, the success or failure of the implementation of future POC antibiotic resistance diagnostics into general practice depends on many interacting factors. These factors include the behavioral decision-making process of individual general practitioners, time-to-result and the (perceived) added value of implementing POC antibiotic resistance diagnostics into the GP practice.",11.501358409141536,6.936036229923628
Disclosures,0.1891736406817662,1.2891713380813599,1.6600487232208252,a71fa7f7-c5d4-4e1c-9602-04a73dae1b57,noncomm_use_subset/Laboratory-Confirmed Human Coronavirus Infections Among Children: Does Type Matter?,"
Disclosures. A. J. Blaschke, BioFire Diagnostics, LLC: Advisor regarding risks associated with US Food and Drug Administration-cleared products and Collaborator, Consulting fee and Licensing agreement or royalty; A. L. Hersh, Merck: Grant Investigator, Research grant",13.99682994870263,6.81588352189234
outcome measurements,0.3708676958812758,2.6930124759674072,1.2595634460449219,33bedcbb-bbf7-4bab-b668-b3e0c3fa9a3a,noncomm_use_subset/Outpatient Antibiotic Stewardship: A Growing FrontierâCombining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use,"The value of inpatient antibiotic stewardship is embraced by many professional societies such as the IDSA and the Center for Disease Control and Prevention (CDC). There are presently several recommendations, guidelines, and requirements from some licensing organizations that continue to be updated as diagnostics evolve and outcome measurements improve [67]. The current focus on inpatients fits well with existing hospital surveillance programs and the ability to identify multiply drug-resistant organisms.",12.003337151642253,6.770342352382802
transgenic insecticidal and herbicide-tolerant plants,0.24321568031664806,1.3269331455230713,0.9711015820503235,552c41db-e4a3-474b-9488-e02cef79c01d,noncomm_use_subset/Lectins: production and practical applications,"In general, it seems that large-scale implementation of transgenic insecticidal and herbicide-tolerant plants does not display considerable negative effects on the environment. Moreover, at least some transgenic plants can improve the corresponding environments and human health because their production considerably reduces the load of chemical insecticides and herbicides (Velkov et al. 2005).",13.324860097171804,6.157423606932838
2Antech Diagnostics,0.2619394489574549,1.573648452758789,1.8243294954299927,cd50961f-f171-470f-8735-6e1ac8ddb78e,noncomm_use_subset/2016 ACVIM Forum Research Abstract Program,"
1Department of Clinical Sciences, Colorado State University Veterinary Teaching Hospital, Fort Collins, CO, USA, 2Antech Diagnostics, Lake Success, NY, USA",11.033074428750618,6.070261716385424
endotracheal intubation,0.23906912304387276,0.44696763157844543,0.6297162175178528,b91c1cb6-110d-460e-b429-a9b153ee277a,noncomm_use_subset/Recommendations for anesthesia in patients suspected of COVID-19 Coronavirus infection,"â¢ Early planning and implementation of endotracheal intubation should be considered. In the event of an unexpected emergency endotracheal intubation, PPE cannot be adequately donned; therefore, early implementation should be performed when possible.",11.057247533019666,4.569881138469476
Providing products to regions with high endemic disease rates can greatly improve costâbenefit analyses,0.27056237568000097,3.035205602645874,4.569022178649902,baeea607-9215-45d7-9c9a-b10108e8dbc1,"noncomm_use_subset/Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
","Routine implementation in highâincome countries where endemic disease and exposure are rare is likely to continue to be debated on the basis of cost and benefit. Advances in adoption are likely to result when these processes can serve lowâincome nations with significant blood safety concerns with affordable products made with high quality and low cost. Questions about implementation with patients who are most vulnerable and thus may benefit the most from these methods need to be asked. Such groups may include those receiving chronic transfusion support or pediatric patients where costâbenefit and riskâbenefit calculations are likely to have their most favorable outcomes.143 Providing products to regions with high endemic disease rates can greatly improve costâbenefit analyses but will require partnerships with nongovernmental organizations and longerâterm considerations of sustainability in these environments when supplementation of costs is no longer feasible.144
",20.538286122171836,12.131148200602397
highlight the need to improve the methods of controlling infectious diseases in domestic dogs,0.1948282930786972,3.099673271179199,4.818607807159424,88303d0a-70d2-4b79-97b4-08729263e78a,noncomm_use_subset/Identification of enteric viruses circulating in a dog population with low vaccine coverage,"In the present study, stool samples from dogs were evaluated for the presence of viral pathogens, and CPV-2 was found to be the most common. In contrast with previous studies, CDV was the second most common viral agent detected, probably since it is endemic to Brazil and not to the regions sampled in other studies. Moreover, the high frequency of co-infected dogs that was observed can increase the pathogenicity of the disease. The data presented herein can improve the clinical knowledge in regions with low vaccine coverage and highlight the need to improve the methods of controlling infectious diseases in domestic dogs.",16.088258188357923,10.777773066845377
esophageal contrast videofluoroscopy can be used to guide management of dogs to improve clinical signs and quality of life,0.2144503063795242,1.4165812730789185,2.693330764770508,4df8f020-aaac-4dfa-971e-5e43b5e80c30,noncomm_use_subset/2018 ACVIM Forum Research Abstract Program,"The aim of this study was to compare esophageal clearance times (ECT) of food with different consistencies in dogs with congenital idiopathic ME, and to assess if esophageal contrast videofluoroscopy can be used to guide management of dogs to improve clinical signs and quality of life.",19.058226934488353,9.341822251673051
the split rate of PI products increased to 2.10,0.15025664660179547,2.609915018081665,3.220445156097412,559b5002-c10f-497a-bb6f-307f88075984,"noncomm_use_subset/Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
","Approximately 65% of PLT products met the guard bands during the operational trial. Presplitting largely obviated the need for conducting volume reduction. The number of PR units currently labeled is less than 50% due to combination of demand, staffing, aggregates, and units exceeding 24 hours. Additional observations included a radical shift in type of PI kit used from predominantly dualâstorage kits to smallâvolume kits; the use of largeâvolume kits remained the same. Before implementation of mitigations, the split rate of PI products fell to 1.30. After implementation of mitigations the split rate of PI products increased to 2.10. Programming of Amicus devices was standardized, and collection volume increased; triples became eligible and products were not downgraded.",15.359392670386546,9.165521547851691
Combination treatment dosed QID for seven days has also been shown to improve clinical scores,0.4042685770568021,2.420098066329956,3.0343990325927734,641bacaf-2cb1-47d3-8264-fa519b3b4678,noncomm_use_subset/Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions,"Combination treatment dosed QID for seven days has also been shown to improve clinical scores for scleral inflammation, ocular neovascularization, eyelid inflammation, friability of vasculature, inflammatory discharge, and epiphora as compared to treatment with 0.5% cidofovir, tobramycin/dexamethasone ophthalmic suspension, and balanced salt solution in rabbit models.52 Moreover, PVI/dexamethasone combination has proven effective in reducing viral titers and delaying viral shedding.52",15.783507601275014,9.069650774746028
Productivity improved 52% after implementation of mitigation steps due to significant increase in products eligible for treatment with Increased batch sizes of eight to 12 products.,0.12338004593858777,1.5826685428619385,1.9039990901947021,32ae4c27-a9ee-4321-93b7-b0793b698b7a,"noncomm_use_subset/Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
",The labor required for PRT is greater than using the BacT/ALERT system with a single bottle. Time studies compared both processes. Demonstrated an 11.1% increase in the time required to complete tasks for unmitigated PI products as compared to the traditional process. There was a 22% increase in time required to complete tasks for mitigated PI products compared to traditional process. Productivity for the unmitigated PI process was poor because the volume of products eligible for treatment was low with batch sizes of two to four products. Productivity improved 52% after implementation of mitigation steps due to significant increase in products eligible for treatment with Increased batch sizes of eight to 12 products.,18.997009297657726,8.91528721566702
Combining milk pH with other diagnostic tests may improve the clinical utility of milk pH to detect quarters with increased SCM,0.16075766461904234,0.7038673162460327,2.733410358428955,ae1a9903-88de-4a15-a10e-d46c52d3dcd6,noncomm_use_subset/2017 ACVIM Forum Research Abstract Program,We conclude that milk pH does not provide a clinically useful primary method for diagnosing SCM at dry off in dairy cattle. Combining milk pH with other diagnostic tests may improve the clinical utility of milk pH to detect quarters with increased SCM.,18.528000818683225,8.71903077507787
"Treatment with higher prednisone doses is correlated with more severe adverse effects and worse QoL, but does not appear to improve clinical outcome",0.17714894734791192,1.0940935611724854,1.4592851400375366,9d65a0c3-4f8b-46ae-b66b-acd03d1f45c5,noncomm_use_subset/2018 ACVIM Forum Research Abstract Program,"These results suggest that Golden Retrievers and Wirehaired Pointing Griffons be considered among the breeds predisposed to SRMA. Treatment with higher prednisone doses is correlated with more severe adverse effects and worse QoL, but does not appear to improve clinical outcome. The relationship between CSF NCC and disease relapse warrants further investigation.",18.026479341591525,7.968963925343548
EID surveillance and response in China and beyond.,0.25737499996429125,2.1728036403656006,2.437020778656006,09428715-90d4-44ea-a1a5-a157f7ede582,noncomm_use_subset/A brief historical overview of emerging infectious disease response in China and the need for a One Health approach in future responses,"Finally, these activities need to be supported with investment. In order to successfully shift to a One Health approach investments are required in two key areas: research and implementation. Further research is required into novel surveillance approaches for identifying and addressing EID events [19]. Findings, however, also need to be translated to action, policy and practice. It is acknowledged, the successful implementation of a One Health system will require marked changes in the status quo, and significant investment. However, this shift has the potential to significantly improve EID surveillance and response in China and beyond.",13.560791386735179,7.742662857721356
Affected individuals may receive 'rescue' therapies,0.15247193877153803,0.8982254862785339,1.5938576459884644,2bd0ad11-64cf-4c6a-b820-f0d7ed976d15,noncomm_use_subset/Inhaled Nitric Oxide Therapy Fails to Improve Outcome in Experimental Severe Influenza,"Severe cases of influenza infection are often associated with multisystem organ failure and hypoxemic respiratory failure, including acute lung injury/acute respiratory distress syndrome (ALI/ARDS) requiring advanced mechanical ventilatory support 24, 25. Affected individuals may receive 'rescue' therapies, including iNO, in an attempt to improve outcome 25. However, iNO administration for ARDS secondary to viral pneumonia has not been specifically reported to improve clinical outcome 24, 25.",16.63736724754808,7.442932572615376
PRT PLT and plasma transfusions.,0.18938328972462667,1.3641436100006104,2.3515148162841797,782f3248-d764-48e4-b95f-f47d91298caa,"noncomm_use_subset/Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
","Costâeffectiveness estimates for PRT PLTs and plasma were reported.67 These products are considered no less costâeffective than other widely adopted interventions in the context of blood safety technologies. A budget gap is likely to remain until PRTs become available for WB or RBCs. Lowâ and middleâincome countries may require a mixed approach of needs assessment and targeted interventions.68 While PRT PLTs have been implemented nationwide in some countries69 in an effort to improve patient safety, reimbursement was noted as a key factor in the United States stalling the quicker implementation of PRT PLT and plasma transfusions.",14.164029937144944,7.372588455085843
to reduce viral burden or improve clinical outcome in severe influenza in vivo,0.09551347221187702,0.4891340136528015,1.9200266599655151,96b477db-e6bc-4a6e-83f2-97adeee08941,noncomm_use_subset/Inhaled Nitric Oxide Therapy Fails to Improve Outcome in Experimental Severe Influenza,"In conclusion, despite the demonstrated antimicrobial activity of NO against influenza A virus in vitro, the results of this study do not support the use of iNO as a prophylactic or treatment strategy to reduce viral burden or improve clinical outcome in severe influenza in vivo. Furthermore, it may be difficult to achieve viricidal concentrations of NO in the airways using iNO at concentrations that are safe in the living host.",16.166662113875603,7.2242861777083665
sepsis-associated coagulopathy,0.24486660596653417,0.85704106092453,2.247049331665039,4c6cb3c7-3b2b-469b-b360-5dddf56e1671,"noncomm_use_subset/Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular
Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular
Pathogenesis","However, we have to understand that inflammation and microthrombosis in endotheliopathy
are two separate processes, although their crosstalk mechanism has been popularized.
Their molecular pathogeneses are independent, which is illustrated in two-activation
theory of the endothelium (Figure
1). This is the very reason why clinical trials based on anti-inflammatory
regimens have had no impact on coagulation system and has failed to improve the outcome
as demonstrated in the management of sepsis-associated coagulopathy. In clinical
practice, inflammation alone is not the major factor causing poor outcome of the
patient, but clinical severity of MODS caused by VMTD is the main culprit for the demise
in severe sepsis.",13.593214394981104,6.775283793426606
concerns in each of these categories related to implementation remain and continue to be identified as these methods enter routine clinical use,0.12436608651864638,-1.0082509517669678,0.7121132612228394,a791045c-f1e1-4775-bd25-c564ad0ac338,"noncomm_use_subset/Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
","Significant efforts have been made by manufacturers to develop techniques that can be practically applied to treatment of PLT and plasma products in the routine blood bank setting. Such devices and processes need to account for practical factors including throughput, product specifications, media, product losses, timing of process steps, record keeping, and costs to manufacture disposables and equipment. Validation of these methods has required significant investment on the part of manufacturers yet concerns in each of these categories related to implementation remain and continue to be identified as these methods enter routine clinical use.142
",18.135686661159784,6.155000832552241
achieving universal and global health,0.2871648251706585,0.19608494639396667,1.593015432357788,0407db39-cc81-46e4-b281-6bc9e4464c2c,"noncomm_use_subset/âRunning the Gauntletâ: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a âCall to Actionâ","The translation of basic biomedical research discoveries into robust pipelines of products yielding licensed, appropriate, usable, affordable, equitable and accessible tools, such as diagnostics, vaccines, drugs or devices, is essential to achieving universal and global health.",13.977887552299235,6.0551758894933725
risk stratification and therapy monitoring,0.35110666186020595,4.27415132522583,4.749968528747559,e65b9855-49a9-46c1-b0d7-30934d0c38eb,noncomm_use_subset/Research Communications of the 25th ECVIMâCA Congress,"There is growing evidence that fibrosis plays an important role in the development of remodeling and heart failure during cardiac diseases. At cellular level, fibrotic processes are prior to clinical manifestation of symptoms. Fibrosis and extracellular matrix remodeling influences cardiac function in a negative manner. To our knowledge there is no biomarker, which is able to properly detect heartâspecific fibrotic processes and remodeling in the peripheral blood. Such a biomarker would be of great importance in cardiac diagnostics, risk stratification and therapy monitoring. In a preliminary study, using microarray method and pathway analysis in pooled samples, we were able to identify heart specific geneâexpression profile representing fibrotic and inflammatory processes in the peripheral blood of tachypacingâinduced cardiomyopathy model dogs. Our results were validated by histopathology and quantitative real time RTâPCR (qRTâPCR).",14.080965817730704,10.79401594128845
anti-TB treatment and DM routine care,0.41680138769670855,4.06956148147583,5.089479923248291,c415dfc7-d4b2-4a49-b19f-20e12961817b,noncomm_use_subset/Frequency of tuberculosis among diabetic patients in the Peopleâs Republic of China,"The frequency of TB among patients with DM in the Peopleâs Republic of China is about 958 per 100,000 people, which is much higher than that of the general population (78 per 100,000), as reported by the WHO in 2011.18 Active TB screening in patients with DM may increase earlier detection, facilitating better treatment of TB. It also may improve clinical outcomes with anti-TB treatment and DM routine care. Moreover, early diagnosis of TB in DM patients will reduce the risk of TB transmission. The introduction of active TB screening in DM patients may lead to better use of the well-established DOTS system to monitor, record, and report information about TB patients. Bidirectional screening for DM and TB should be of significant benefit in the Peopleâs Republic of China.",12.726873198534705,10.407782532557825
Combination therapies used in anti-influenza treatment may improve the clinical outcomes and enhance antiviral activity against drug-resistant strains,0.1708036875728342,2.496194362640381,4.913954734802246,37642a66-00d1-4f7f-812e-e2f56f50fe3d,noncomm_use_subset/Progress of small molecular inhibitors in the development of anti-influenza virus agents,"Combination therapies: Combination therapy is one of the prospective domains in the investigation for anti-flu agents. Combination therapies used in anti-influenza treatment may improve the clinical outcomes and enhance antiviral activity against drug-resistant strains. They can also reduce the risk of side effects, dose-related toxicity, mortality and morbidity 315-317. Therefore, combination therapies are recommend in clinical and can be classified in to early combination chemotherapy and sequential multidrug chemotherapy. A classical combination is M2 blockers and NA inhibitors to avoid drug-resistance. Many studies have been carried out to evaluate the efficacy of combination therapies and single-drug treatment, and most combination therapies showed superior outcomes in mice models 272, 318-321.",14.572224270870553,9.9168754081424
Increased physical exercise has been reported to improve the clinical symptoms of chronic enteropathies,0.20139093622710566,2.2510464191436768,2.1020069122314453,1894d679-2798-4a72-b84b-b29621949a6c,noncomm_use_subset/Research Communications of the 25th ECVIMâCA Congress,"Increased physical exercise has been reported to improve the clinical symptoms of chronic enteropathies, such as inflammatory bowel disease, in human patients. The aim of this investigation was to evaluate the impact of an intervention to increase physical exercise in dogs with chronic enteropathies.",19.720804272010866,9.731766160597632
"accelerated vaccine development, evaluation and implementation",0.17922586507430724,1.948258876800537,2.054680824279785,70969e4d-808c-4c74-8881-516aba6a2a0e,noncomm_use_subset/Importance of diagnostics in epidemic and pandemic preparedness,"Beyond enabling a multistakeholder engagement plan, there may be opportunities to leverage mechanisms in place to help address outbreak preparedness challenges in vaccines. Expanding these mechanisms to include diagnostics would be more efficient, making use of existing expertise and processes, and would allow for a more integrated approach to outbreak preparedness linking both diagnostics and vaccines, which are inherently connected. CEPI could act as a bridge between diagnostics needs and vaccine preparedness for research and development, and Gavi could dedicate resource to help generate market predictability. In fact, Gavi is already exploring how to best use its resources to enable more effective vaccine campaigns for yellow fever outbreaks through support of diagnostics. Moreover, FIND is already working with CEPI to ensure that diagnostics that can generate reliable surveillance data are available for priority pathogens including Lassa fever, Nipah, CCHF and Ebola, which will lead to accelerated vaccine development, evaluation and implementation. An exploration of lessons learnt from both of these experiences would be an appropriate topic for the first global forum.",18.063416465061177,8.924106568473622
Deterioration with gradual increased frequency of vomiting and lethargy occurred before presentation to the teaching hospital,0.14806439665790422,1.7811259031295776,3.320033073425293,320d45b9-2def-46a6-ac78-51f06a7f7b5d,noncomm_use_subset/Gastrointestinal granuloma due to Candida albicans in an immunocompetent cat,A 3.5 year-old domestic shorthair cat was referred to the University of Melbourne's Veterinary Teaching Hospital (Day 0) for investigation of chronic intermittent vomiting of 6 months duration. Vomiting occurred 2â3 h after eating every 2â3 days. Appetite was maintained and there was no weight loss. A dietary trial with a hypoallergenic diet (Hill's Z/d dry cat food) did not improve the clinical signs. No antibiotics had been prescribed and anti-inflammatory or intestinal worming treatments had not been administered in the previous 6 months. Deterioration with gradual increased frequency of vomiting and lethargy occurred before presentation to the teaching hospital.,15.344487234432671,8.686323866812101
Establishment of manufacturing lines specifically for the production of diagnostics for current outbreaks would help to guarantee sufficient supply,0.29018114191302374,2.5480122566223145,3.4693565368652344,6a6f9cdf-f2af-4753-8d5d-f212eb1245ed,noncomm_use_subset/Importance of diagnostics in epidemic and pandemic preparedness,"As discussed above, the recent yellow fever and Ebola outbreaks underline the impact of interruptions in supply on time to containment.2 7 To prepare for future outbreaks, it will be important to ensure that sufficient manufacturing capacity for diagnostic tests is in place. Preselection of suppliers to manufacture diagnostic tests for priority pathogens would ensure that companies that already have appropriate manufacturing capacity are enlisted to supply diagnostics during an outbreak scenario, but additional investment in manufacturing will be essential to allow urgent demands to be met without negative impact on other business commitments. Establishment of manufacturing lines specifically for the production of diagnostics for current outbreaks would help to guarantee sufficient supply and would offset costs for manufacturers who would otherwise need to stop production of other higher income-generating products to respond to a global health emergency. These manufacturing lines could be funded, for example, by a number of government donors; an overarching decision-making board to manage investments and prioritise products for manufacture would of course be required.",12.654045858685336,8.340205766306774
"There is an increasing prevalence of natural products, including marine products, that are used to improve body function and manage various ailments",0.15582904789765492,1.8432302474975586,3.336552619934082,3158747f-d39b-4d70-bc81-cd9abb60617e,"noncomm_use_subset/Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study","There is an increasing prevalence of natural products, including marine products, that are used to improve body function and manage various ailments due to their diverse pharmacological activity,1 although there is limited or sparse clinical evidence for their applications. In particular, there is a lack of data on molecular targets, mechanisms of action, pharmacokinetics (PKs, mainly focused on absorption, distribution, metabolism and excretion [ADME]), and toxicology for most natural products.2,3 On the other hand, many of the natural products have the ability to regulate important drug-metabolizing enzymes and drug transporters, such as the cytochrome P450 enzymes (CYPs) and P-glycoprotein. This has raised a safety concern regarding the use of natural products due to their modulatory effect on the activity and expression of drug-metabolizing enzymes and drug transporters, resulting in potentially harmful drug interactions and eventually adverse drug reactions.4",14.205812766952626,8.338893332263986
once fatalities occurred,0.21285523621601155,1.8184244632720947,3.491116762161255,54c83929-e5b4-46ab-ae55-ca722ca0f7ba,noncomm_use_subset/Genomics and Public Health Research: Can the State Allow Access to Genomic Databases?,"The institutional model was recognized by Justice Krever in the tainted blood report (32). He stated that additional precautionary measures, such as heating blood products and screening of blood donors to reduce the risk of HIV transmission via blood products should have been taken at an earlier point in the crisis. The cautious approach, which favours eradication of risks, can be associated with the implementation of quarantine measures once fatalities occurred (e.g. efforts to counter the threat of SARS).",12.954377295613039,7.9852338499962405
implementation alone was not sufficient to significantly influence clinician decision-making and patient outcomes,0.40597713162087945,1.7988296747207642,3.5104501247406006,7481b07b-70e2-42df-a6fa-f2d2601c621f,noncomm_use_subset/Rapid Multiplex Testing for Upper Respiratory Pathogens in the Emergency Department: A Randomized Controlled Trial,"Another interpretation of our results is that while multiplex testing does well identifying influenza and other URI-causing viruses in the ED, implementation alone was not sufficient to significantly influence clinician decision-making and patient outcomes. For example, influenza testing alone may be enough for clinical decision-making during influenza season [9]. It is likely that a thoughtful and comprehensive stewardship program around rapid diagnostics could be required to lead to meaningful changes in outcomes. It is also possible that deploying rapid diagnostic tools would lead to more significant changes if applied to an area that has higher baseline antibiotic prescription rates such as an urgent care setting.",12.680971311958604,7.889371828835399
implementation of Good Clinical Practices in the conduct of clinical trials on medicinal products for human use,0.2218166346119841,1.4412007331848145,3.127127170562744,abda1a0b-9eef-4463-9abf-f57685cb449f,noncomm_use_subset/Multicentre randomised controlled trial to investigate the usefulness of continuous pneumatic regulation of tracheal cuff pressure for reducing ventilator-associated pneumonia in mechanically ventilated severe trauma patients: the AGATE study protocol,"The clinical trial will be carried out in line with the principles of the Declaration of Helsinki and according to the Clinical Trials Directive 2001/20/EC of the European Parliament on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of Good Clinical Practices in the conduct of clinical trials on medicinal products for human use. Ethical aspects of this research project have been approved by the ethics committee of Poitiers University Hospital (France). The ethics committee of Poitiers approval cover all participant sites. The trial will be monitored by the research monitoring officer of Poitiers University Hospital.",13.862795648893087,7.821391614548494
"development and approval of new platforms to be accelerated, with several new diagnostics gaining authorisation for use in detection of the pandemic strain",0.13188652194215691,1.789827585220337,2.8478810787200928,70bd1579-a332-4e8c-95ca-0984b6d83eae,noncomm_use_subset/Importance of diagnostics in epidemic and pandemic preparedness,"In cases where diagnostics have not been developed in advance of an outbreak, the Ebola and Zika experiences highlight the importance of ensuring that the development process is condensed as much as possible. During the 2009â2010 H1N1 influenza pandemic, utilisation of processes for emergency use authorisation of diagnostic devices allowed development and approval of new platforms to be accelerated, with several new diagnostics gaining authorisation for use in detection of the pandemic strain (the majority of these were reverse transcriptase PCR based).32 36 The availability of these assays provided substantial surge capacity, and as some were designed for use on existing platforms, expenses for laboratories already equipped with these platforms were minimised.36 Expedited regulatory approval processes are therefore important to enable diagnostic tests to be brought into use as rapidly as possible after the initial development stage. However, mechanisms to approve such tests for routine use after declarations of public emergency have been closed are lacking, particularly as emergency use approvals can be granted based on sparse data.",12.864463863747552,7.517072983872922
A shared system open to both diagnostics and vaccines industries would ensure optimum efficiency,0.35238646960024556,2.130189895629883,2.4126880168914795,a0f37c20-88b3-4f8d-9f81-9b1f579f2ed8,noncomm_use_subset/Importance of diagnostics in epidemic and pandemic preparedness,"The establishment of a specimen sample bank, in the form of an online sample repository, would help to ensure that development for future outbreaks proceeds in a more timely and transparent manner and would allow for quality guarantees. In addition to providing information on specimens collected, ideally, this repository would also include storage locations and processes for access. A shared system open to both diagnostics and vaccines industries would ensure optimum efficiency. An example of an effective sample sharing initiative is the Pandemic Influenza Preparedness Framework, founded by WHO after the 2009â2010 H1N1 influenza pandemic, which establishes sharing agreements with industry partners involved in the WHO Global Influenza Surveillance and Response System, whereby WHO provides strain samples and industry stakeholders commit to provision of vaccines and diagnostics.31
",12.019293788125443,7.15962346898279
Analysis of data is only way to improve the prevention of future errors and induce reduction of costs of hospitalization,0.20361122544455043,0.5264641046524048,2.870999813079834,7804a435-9eee-4faf-8a8b-8dd036cc236c,"noncomm_use_subset/The Advantages and Limitations of International Classification of Diseases, Injuries and Causes of Death from Aspect of Existing Health Care System of Bosnia and Herzegovina",The health care provider institutions such as hospitals are subjects that should facilitate implementation of medical applications that follows the patient medical condition and facts connected with him. The list of procedures with their prices can be found in all hospitals and is used by economist but are of little help for medical workers. Database should provide the whole picture of current situation. It is very important that we have tools for analysis of clinical data. Analysis of data is only way to improve the prevention of future errors and induce reduction of costs of hospitalization. Using the database it is possible to reveal all advantages and disadvantages of some method.,12.454202049370364,6.567322263805583
models are refined to provide predictions that can ultimately be used to help identify therapeutic targets and improve clinical outcomes,0.25486486254657487,0.8082922101020813,2.2047905921936035,c78d59db-2904-47c8-b529-9f0fcf96db42,noncomm_use_subset/A Systems Biology Approach to Infectious Disease Research: Innovating the Pathogen-Host Research Paradigm,"Intrinsic to systems biology is the notion that biological systems have âemergent propertiesâ: that is, their sum is greater than their individual parts, and the biological outcomes of a system cannot be predicted by traditional reductionist methods that study only the individual components (1). Instead, an understanding of biological systems requires the integration of high-throughput multi-omics data (transcriptomics, proteomics, metabolomics, lipidomics, etc.), which are used to construct predictive models of the networks and dynamic interactions between the biological components of the complex pathogen-host system (2). Through iterative rounds of model development, testing, and filling in the gaps with experimental data, models are refined to provide predictions that can ultimately be used to help identify therapeutic targets and improve clinical outcomes. This iterative cycle of perturbation biology is key to the systems biology approach (Fig. 2) and requires the establishment of efficient interdisciplinary collaborations, the building of integrated computational infrastructures, and the generation of self-consistent, comprehensive, and model-specific experimental data (3).",12.285650567821634,6.258481520229767
CPX preparation programs during the fourth-year clerkship improve the clinical competency of students in terms of case specificity.,0.1366848370424455,2.5760984420776367,3.7979142665863037,6e79dbd7-e619-4c59-97e6-bcf1e67c10ad,noncomm_use_subset/Effects of Module Development and Role Play Course on Clinical Practice Examination Scores during a 4th Year Clerkship,"Medical schools in Korea, in an effort to ensure an increase in their KMLE pass rates, have reinforced experiential learning within their clinical clerkship education or programs that are used to prepare students for clinical skills test. These are taken prior to graduation with case studies in the form of CPX or role play. There is, however, a lack of studies regarding the effect of CPX preparation programs on the clinical competency of students. The purpose of this study was to investigate whether CPX preparation programs during the fourth-year clerkship improve the clinical competency of students in terms of case specificity.",17.414453764266412,10.238167078124805
bone repair,0.2519615505885323,2.530461549758911,4.804223537445068,d80a4719-ce44-45ce-8c59-0da1b19fa85d,"noncomm_use_subset/Corticosteroid-induced Osteonecrosis of the Femoral Head: Detection, Diagnosis, and Treatment in Earlier Stages","Nonvascularized bone grafting (NVBG) basically removes necrotic bones and replaces them with cancellous and/or cortical autografts. It rebuilds the structure of the femoral head and supports the subchondral bone and articular cartilage to avoid collapse. This technique has evolved from the Phemister technique to the Trapdoor technique and Lightbulb technique. Compared with the CD technique, NVBG is more indicated for ARCO stages II and III in the precollapse stage of ONFH. A comparative study that impacted bone graft with or without recombinant human BMP-2 (rhBMP-2) for ONFH using the lightbulb technique indicated that NVBG was an effective hip-preserving surgery in selected patients and that the rhBMP-2 might improve the clinical efficacy and quality of bone repair.[53] The definite indications are ONFH in the precollapse stages or at least in the early postcollapse stages with less than 2-mm collapse and intact articular surface.",14.104347515896691,9.704066937246429
to improve the efficacy and safety of vaccines,0.24881775464794945,3.668267011642456,4.764579772949219,77587005-f4be-462e-b9d4-2f5ccdd0cd8d,noncomm_use_subset/Clinical vaccine development,"Another focus is to improve the efficacy and safety of vaccines even further beyond the overwhelming successes of vaccines in the past several centuries. The most important keyword from the efficacy viewpoint is 'adjuvant' [25]. A number of vaccine products are licensed or under development in the form of a mixture of a vaccine and a certain adjuvant (Table 2). Most of the currently licensed adjuvanted vaccine products target influenza. The emphasis on the importance of adjuvants is gradually increasing with the aging of the population. Because they facilitate the immune response to vaccination in older people, many experts expect that adjuvants will be an essential component for widespread vaccine use in entire populations.",11.114080380023672,9.371278542992874
operational districts system,0.14588134231930683,2.6352813243865967,2.5343213081359863,dc679514-8899-411e-940b-02385fa535e9,noncomm_use_subset/A Comparison of the Cambodian and the South Korean Health Care System,"The comparison of the healthcare system between these two countries, we can obviously see the health status in South Korea is much better than in Cambodia which has been fighting against communicable diseases such as tuberculosis, malaria, HIV/AIDS, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).4 In order to improve the quality of healthcare in Cambodia, MOH has overall responsibility of the health sector, including: policies, legislation, strategic planning, resource mobilization and allocation, monitoring, evaluation, research, providing training to support the provinces, and coordination of external aid. The MOH's main objective in health sector reform has been to improve and extend primary health services through the implementation of the operational districts system.",11.291804432229615,7.312373262420044
Implementation research is particularly warranted to evaluate the effectiveness of various approaches in resourceâlimited settings,0.2317326804834777,1.4982898235321045,2.4636759757995605,5ab81c5d-ea43-4e66-90b6-3aae5b6ccc9b,noncomm_use_subset/Effect of effortâreward imbalance and burnout on infection control among Ecuadorian nurses,More research is necessary to better identify the specific organizational interventions needed to improve working conditions for healthcare professionals. Implementation research is particularly warranted to evaluate the effectiveness of various approaches in resourceâlimited settings.,13.492697368561743,7.297721848562192
"Integration of knowledge about microbiology and immunology, establishment of efficient vaccine development strategies, and streamlining of regulatory approval processes",0.16032752449038246,1.3640354871749878,2.1890692710876465,7f81777c-99fb-49e1-a364-292b3a67f68b,noncomm_use_subset/Clinical vaccine development,"Without doubt, the quantity and quality of clinical vaccine development will improve greatly in the future. Simultaneously, the coverage of vaccines against diverse diseases will be broadened faster than ever. Integration of knowledge about microbiology and immunology, establishment of efficient vaccine development strategies, and streamlining of regulatory approval processes may facilitate this trend. Doing so will increase the chances that human society will experience the continued benefits of vaccination.",14.191869212535664,7.276672317258194
public health accountability and performance management system,0.15502798738059512,0.3847179710865021,1.0883830785751343,f03df20a-145d-471c-a0ad-0c099ba90e3d,noncomm_use_subset/Assessing Continuous Quality Improvement in Public Health: Adapting Lessons from Healthcare,"This study examines the implementation of a public health accountability and performance management system featuring declared principles of continuous quality improvement (CQI) in Ontario, Canada. CQI is an approach to the management and improvement of organizational services and processes (Dilley et al. 2012; Nicolucci et al. 2010; Radawski 1999). The approach stands in contrast to quality control and assurance by virtue of its focus on identifying opportunities to improve work processes as opposed to identifying individualized problems and maintaining a status quo (Dever 1997). CQI relies heavily on performance measurement and analysis, as well as on the involvement of leadership and front-line staff in decision-making processes (Kosseff 1992; McLaughlin 1987; Radawski 1999).",17.78677502443103,7.182886940830923
study,0.3245505189783256,2.733963966369629,1.9848196506500244,64204977-21c8-4c54-a951-9992b2d5453d,noncomm_use_subset/A qualitative study of zoonotic risk factors among rural communities in southern China,"Participation in the study was strictly voluntary. Study staff reviewed the information sheet with potential participants and explained the details of the study. This included the voluntary nature of participation, inclusion and exclusion criteria, study implementation processes (e.g. that the interview would be audio-recorded), potential risks and benefits of participation, results sharing and that they could withdraw their participation at any time. It was also explained that an item as a token would be given as appreciation for their participation, which was identified by the study team and appropriate for the context of the study sites.",11.180720038092598,6.980461364395184
These strategies have the potential to improve both patient and staff safety,0.22102402855822206,0.8283683061599731,2.5774521827697754,537960e4-7974-4178-b903-6e72d1220738,noncomm_use_subset/Prevention of respiratory outbreaks in the rehabilitation setting,Our study highlights the impact of new processes of care that address barriers to following IPAC practices on the prevention of nosocomial outbreaks in the rehabilitation setting. These strategies have the potential to improve both patient and staff safety across these institutions.,13.103448119154987,6.799990159508582
Many studies have already discovered that clinical competency of an organ system cannot improve clinical competency of other systems,0.21723906238195395,1.182063102722168,1.5319559574127197,b10ade01-5d3a-4eac-97ca-e9655ee71127,noncomm_use_subset/Effects of Module Development and Role Play Course on Clinical Practice Examination Scores during a 4th Year Clerkship,"Many studies have already discovered that clinical competency of an organ system cannot improve clinical competency of other systems; this is referred to as case specificity.17) The case of vaginal discharge in this study appeared as case of candida vaginitis on the actual examination, and cases practiced by students were trichomonas vaginitis, bacterial vaginitis, and atrophic vaginitis. Scores during history taking were noticeably improved for this item because the practiced cases were of the same clinical presentation as the case used during actual examination. Students practiced cases of gastroesophageal reflux disease (GERD), chronic obstructive pulmonary disease, and asthma for cough symptoms, while a case of tuberculosis appeared on the actual examination. Diverse diseases can be developed into CPX modules in the case of cough, and GERD is a key diagnosis to implicate the digestive system, unlike other cough problems (respiratory system). Therefore, this result suggests that scores may not increase unless role play practice is done on a wide variety of diseases for each item. However, this case specificity alone would not fully explain how the CPX results of the group, which underwent a preparation course, were higher than those of the group that did not undergo a preparation course. Training experiences would have led to acquiring relevant working knowledge and subsequent improvements in clinical competency in general.",13.356792936928798,6.438989917012757
"non-governmental organisations and WHO agencies facilitated the implementation of IPC, personal protective equipment (PPE), sterilisation equipment",0.163825941583013,0.8990835547447205,0.6814419627189636,3609f6ab-2559-493c-b40d-f8ec36f7a618,"noncomm_use_subset/âFor this one, let me take the riskâ: why surgical staff continued to perform caesarean sections during the 2014â2016 Ebola epidemic in Sierra Leone","Participants often noted that their capacity to perform surgery increased when international actors started providing direct hospital support, towards the peak of the outbreak. Actors ranging from non-governmental organisations and WHO agencies facilitated the implementation of IPC, personal protective equipment (PPE), sterilisation equipment and diagnostics. They also brought materials for the theatre, including sutures, gloves, and occasionally advanced equipment such as suction and anaesthesia machines.",13.08403908720603,5.606755266873505
sustaining building capacity to improve alert warning alerts and best practices,0.1977960330166844,0.22820882499217987,1.0235036611557007,bae946a4-f60b-4184-b2a6-965f7702005a,noncomm_use_subset/Innovative Preventive and Resilience Approaches Against Aedes-linked Vector-borne Arboviral Diseases Threat and Epidemics Burden in Gulf Council Countries,"Establishing joint local and international experts, committee technical assistance to oversee, evaluate and monitor programs performance and impact on local dengue or potential pandemics threats situation and sustaining building capacity to improve alert warning alerts and best practices implementation is core.",13.492697368561743,5.536057194992732
rapid test,0.18627989885068477,0.8618613481521606,1.2194002866744995,64a0cd95-6331-40da-97d3-0028babfb70b,"noncomm_use_subset/Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies","Former studies assessing the effect of testing with conventional multiplex assays providing results within 24â48 hours showed no effect on antibiotic treatment and hospital length of stay [6, 44]. However, more rapid testing for respiratory viruses might improve the impact on clinical outcomes as results are available before any initial treatment or management is established by the treating physician. To our knowledge, this is the first review to specifically assess the clinical impact of rapid molecular tests, and not rapid antigen tests, without a restriction in the detection of influenza virus and RSV [45, 46]. The included studies, even the high-quality randomized studies [1, 20, 21, 24, 25], show heterogeneous results. The location of the rapid test, which was at the point of care in only 3 studies, may affect turnaround times and thereby clinical outcomes. Apart from other differences in design, and in analysis and power, differences in the implementation strategy might partially explain these discrepancies. First, education and training of personnel and physicians on the implemented rapid test, its diagnostic accuracy, and its potential effects on clinical outcomes may contribute to its effect on clinical outcomes [33]. Second, a combination of a rapid test and a result-based guideline on subsequent clinical management options might have more impact than a stand-alone diagnostic test, even though the 2 studies describing the implementation of a diagnostic bundle did not show any significant effects of their implementation, which might be partially explained by limited adherence to these guidelines [20, 21]. A complicating factor therein is that identification of a viral pathogen from a respiratory tract sample may not necessarily attribute causation [2]. Third, a combination of a rapid test and another diagnostic as procalcitonin [21, 30] or other biomarker-based assays [47] may increase the persuasiveness of the rapid viral test on whether there is a bacterial or viral causative pathogen. However, current evidence for the effect of the combination of respiratory viral testing and procalcitonin on clinical outcomes is disappointing [21].",11.896711683867359,5.516669151990905
evidence-based clinical practice guidelines is one of the effective mechanisms for improving the quality of care,0.21254203372369215,0.8571310639381409,1.2810513973236084,7be054e9-0032-43e4-84ca-a9640834ce6d,"noncomm_use_subset/Improving adherence to lung cancer guidelines: a quality improvement project that uses chart review, audit and feedback approach","Guidelines should provide a framework for managing patients. The implementation of evidence-based clinical practice guidelines is one of the effective mechanisms for improving the quality of care. A gap between guidelines and clinical practice often exists, resulting in suboptimal care and patient safety concerns.",11.261880682453011,5.331476838678691
detect their products,0.17220542424273516,-0.5257346034049988,1.4407634735107422,e883d114-2955-4c46-9c1b-c6bc57b90908,noncomm_use_subset/RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders,"As discussed in this review, mounting evidence demonstrates that simple repeat expansions causing several human neurological diseases trigger noncanonical translation initiation and elongation, and two unusual processes, RAN translation and frameshifting, are recognized across the repeats. Protein products of RAN translation and frameshifting were detected in patient tissues and in mouse and Drosophila models of the disorders in addition to numerous human cell lines after transfection with specific constructs. However, the methods used to study these processes and detect their products have limitations that give raise to concerns and further questions. For example, it cannot be excluded that some antibodies used to detect specific RAN translation or frameshifting products may recognize both entities. Thus, the results obtained with commonly used immunological methods need to be confirmed by other methods such as MS. Strong promoters used in genetic constructs may explain the higher frequency of frameshifting observed in cellular models compared with patient tissues as well as detection of RAN translation and frameshifting products in disease models expressing nonpathological numbers of repeats.",12.248991273152647,4.88191571117216
broad-spectrum viral diagnostics in the clinical laboratory,0.28911976638581066,3.921684980392456,3.102407455444336,40391ee2-c8e6-4291-8cff-41aaa0bdbcec,noncomm_use_subset/Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens,"The Virochip protocol as described here is complex and requires a meticulous and skilled research technician. Correct reagent concentrations and conditions for PCR, labeling, and hybridization are critical. The Virochip protocol can be easily modified to accommodate analysis of diseased tissues by use of a tissue extraction method such as TRIzol (Invitrogen) for nucleic acid extraction. Probes can be added or deleted as necessary to obtain the desired spectrum and breadth of coverage; for instance, probes for detection of nonviral targets such as bacteria and fungi can be designed and added ""on-the-fly"". Some applications of the Virochip assay currently under development include broad-spectrum viral diagnostics in the clinical laboratory, outbreak investigation, purity screening of drugs and vaccines, and novel viral pathogen discovery.",8.792146971117853,7.642911523185164
surveillance systems and enhanced diagnostics regarding emerging pathogens,0.22172451668977636,2.319051742553711,3.6794090270996094,2dd2cef6-aebc-4db8-8df4-a71830ff779f,"noncomm_use_subset/Emerging Zoonoses: the ""One Health Approach""","National and regional public health sectors should give priority to surveillance systems and enhanced diagnostics regarding emerging pathogens. A broad collaboration among clinicians, public health workers, veterinary medicine and veterinary public health officials is necessary for prompt response strategies ensuring the prevention and management of such infections [28]. Moreover, developed countries should invest in the establishment and strengthening of surveillance systems in resource-limited countries, considering the international significance of emerging zoonoses. Based on the new international health regulations, emphasis should be to build the appropriate awareness and response capacity in all countries and on promoting interdisciplinary collaboration and coordination. Integrating the early warning systems of international organizations should be undertaken to facilitate the detection of outbreaks of communicable diseases of international public health importance [6]. Finally, the reduction of zoonotic risks in farms should be a priority in order to improve the overall health of humans and animals. To achieve this purpose a close cooperation and interaction between veterinarians, occupational health physicians and public health operators is necessary.",8.160656543866509,6.755229290627936
"a combination of scores, as well as evaluation of frailty",0.25437266983602336,1.9673724174499512,2.7070178985595703,807d4f78-f466-4f3b-b8fa-574ca8a1858d,noncomm_use_subset/Approaches for patients with very high MELD scores,"At the present time, identification of potentially inappropriate LT candidates should not be based solely on available scores considering their statistical performance. However, a combination of scores, as well as evaluation of frailty, could improve the clinical management of patients with very high MELD scores who are candidates for LT.",8.65306807546982,6.0669275318206255
large-scale RCTs outside of China are warranted to improve the generalizability and applicability of this study results,0.1409581643187471,2.4242970943450928,2.680576801300049,41011e99-b295-4321-823e-9d9fc1047252,noncomm_use_subset/Use of noninvasive ventilation at the pulmonary infection control window for acute respiratory failure in AECOPD patients,"Considering that all identified studies were carried out in China, further rigorously designed and large-scale RCTs outside of China are warranted to improve the generalizability and applicability of this study results. Future study should report all harm data and withdrawals due to adverse effects. We recommend future study to investigate the long-term effect of noninvasive ventilation on quality of life. Future trials should also be reported according to Consolidated Standards of Reporting Trials Statement[59] to improve the quality of reporting.",6.57933776218137,5.620936248932821
evidence-based policies for the control of LTBI.,0.31147381889139236,1.947515845298767,2.4100887775421143,0b10398f-4ccb-4225-a1ca-0f49027d3d0d,noncomm_use_subset/Factors Influencing the Diagnosis and Treatment of Latent Tuberculosis among Contacts in Congregated Settings in Korea,"The present study investigated the states and influential factors along the process, extending from the diagnosis of latent TB to the completion of treatment in Korea. The findings showed that compared to schools, other facilities carried high risks of LTBI. Therefore, efforts should be made to enhance the early detection of the first patients with TB. In addition, efforts should be made to establish policies to determine the rates of treatment completion among latent TB cases in correctional institutions, medical institutions, and social welfare facilities, and to improve the treatment initiation rate in workplaces, particularly among those aged 35 years or older. There is a growing understanding of the need to manage LTBI, but the evidence for this is lacking. Further research is needed to facilitate the implementation of evidence-based policies for the control of LTBI.",7.510928236462609,5.461267887608486
Gene Set Variation Analysis,0.29059377025097854,1.848968744277954,2.0738673210144043,561e8424-e137-4a37-a1f6-86f666a1623d,noncomm_use_subset/ISG20 promotes local tumor immunity and contributes to poor survival in human glioma,"To validate this hypothesis, we further investigated which pathways were associated with ISG20 expression. The Gene Set Enrichment Analysis (GSEA) highlighted that the high expression of ISG20 was significantly enriched in multiple immune processes, especially in innate immunity (Fig S3B; Table S4). The correlationship of ISG20 expression with the above immune processes was further validated in detail using Gene Set Variation Analysis (GSVA; Fig S3C; Table S4).",7.7307205765758065,5.2555956442415654
seeking for projects and systems that reflect the characteristics of Korea will facilitate the efficient implementation of telemedicine.,0.24532030038785296,1.5661051273345947,2.1752662658691406,eec75a23-b302-4270-8cf4-ee100af74348,noncomm_use_subset/Prerequisites for Effective Implementation of Telemedicine: Focusing on Current Situations in Korea,"In the study of 2005 about the implementation of telemedicine services, the main factors associated with partial failure of service were lack of needs-driven planning and commitment to provide the service [13]. Therefore, as the technology develops, a clear system should be established to regulate and manage it. In addition, seeking for projects and systems that reflect the characteristics of Korea will facilitate the efficient implementation of telemedicine.",7.485680170493566,5.051879465255176
"HIV prevention, treatment and care and support.",0.2910130358657692,1.479458212852478,2.856218099594116,9db7acf7-892a-4d62-8266-9acc31b7eb29,noncomm_use_subset/Evolution of information-driven HIV/AIDS policies in China,"Chinaâs second 5-year action plan (2006â10) was drafted in a more supportive political environment in which public health was given a higher priority. First, there was much stronger political commitment and financial commitment for controlling HIV/AIDS from Chinese Central Government. In 2003, a new administration led by President Hu Jintao, Premier Wen Jiabao and Vice Premier and the then Health Minister Wu Yi put the implementation of evidence-based HIV policies high on the national agenda.18 Secondly, Chinaâs âFour Frees and One Careâ policy to increase access to anti-retroviral therapy (ART) was announced in late 2003 and had greatly facilitated implementation of HIV prevention, treatment and care and support.",6.211106045808187,4.992076719123151
the practice of telemedicine requires social interventions and systems for efficient implementation,0.11827980547127975,1.2844046354293823,1.47458016872406,ce1c13cb-ef88-40ca-82b8-dff4d841c61e,noncomm_use_subset/Prerequisites for Effective Implementation of Telemedicine: Focusing on Current Situations in Korea,"While there are loose restrictions on the scope and criteria for factors such as the target service base, standards, technical forms, and implementation of e-health and u-health, the practice of telemedicine requires social interventions and systems for efficient implementation. Further, it requires sufficient discussions among related parties because the purposes of telemedicine are diagnosis and treatment, and the participation of medical specialists is essential.",7.599793224202095,4.45326775117047
canonical immune processes,0.14833779444098438,0.4377744495868683,1.5024915933609009,d41d8c21-11be-460d-9e99-46770e0b8dbe,noncomm_use_subset/ISG20 promotes local tumor immunity and contributes to poor survival in human glioma,"Immune-related genes were collected from the canonical biological pathways in the Molecular Signatures Database v. 4.0 (MSigDB, http://www.broad.mit.edu/gsea/msigdb/),66,67 combined with genes identified in three publications from the Journal of Allergy and Clinical Immunology,68â70 and genes selected among those involved in canonical immune processes indicated in Janewayâs Immunobiology (9th edition). A total of 829 immune genes were confirmed by removing overlapping genes.",8.795615141925571,4.339638227589999
cleaning products,0.2222650447625874,0.26906299591064453,2.4521703720092773,2b0270ed-1cd3-464d-b278-412d4cdbc8d0,noncomm_use_subset/Asthma associated with denatonium benzoate in a healthcare worker in Taiwan,"Previous studies have shown an association between disinfectants and asthma.[11â15] The disinfectants, quaternary ammonium compounds (such as benzalkonium chloride), amine compounds, and fragrances are the main sensitizers presented in cleaning products. Bleach (sodium hypochlorite), hydrochloric acid, and alkaline agents (ammonia and sodium hydroxide), which are commonly mixed together, are considered the strongest airway irritants in cleaning products.[11,12,13,15] Exposure to the ingredients of cleaning products may give rise to both new-onset asthma, with or without a latency period, and work-exacerbated asthma.[12,13] Although it has been indicated that in many workers, respiratory tract symptoms induced by chemicals and fragrances cannot be explained by allergic or asthmatic reactions, these patients may have hyperactivity to inhaled irritants, which is known to reflect sensory reactivity.[12â14]",6.934443369370977,4.195856868427791
Annexin V-PE Apoptosis Detection Kit I,0.26359223470007825,1.5893747806549072,0.6503138542175293,081602b8-068d-451f-8009-0b180fd7d80d,noncomm_use_subset/Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor,"Apoptosis was determined by Annexin V staining after METH 72 h treatment. Cells were stained using an Annexin V (green) -FLUOS assay kit (Roche Diagnostics, Indianapolis,IN, USA), and nuclei (blue) with DAPI and analyzed by fluorescence microscopy. Images were recorded with a Nikon confocal microscope at Ã 400 magnification. In some experiments, Annexin V-PE Apoptosis Detection Kit I (BD Biosciences, San Diego, CA, USA) was used to detect apoptosis.",6.706472965887577,3.8030631507277355
"To elucidate the potential molecular mechanisms mediated by SOX2, SRPK1 expression was analyzed in BCC cells",0.20734395191850735,0.8004066348075867,1.1670104265213013,429c65bd-4861-40ba-ae43-b5a9fce182ad,noncomm_use_subset/SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1-mediated PI3K/AKT signaling pathway,"A previous study has indicated that SRPK1 is associated with human cancer metastasis (34). To elucidate the potential molecular mechanisms mediated by SOX2, SRPK1 expression was analyzed in BCC cells. The results demonstrated that SOX2 transfection promoted SRPK1 expression, while SOX2 knockdown inhibited SRPK1 expression in BCC cells (Fig. 4A and B). In addition, SRPK1 knockdown was observed to result in a marked reduction of cell migration and invasion (Fig. 4C and D). However, SRPK1 overexpression prominently canceled the SOX2 knockdown-inhibited migration and invasion of BCC cells compared to control (Fig. 4E and F). Furthermore, SRPK1 knockdown downregulated the EMT processes of BCC cells as observed by the increased E-cadherin and decreased the levels of Vimentin and Fibronectin (Fig. 4G). By contrast, SRPK1 overexpression canceled the SOX2 knockdown-inhibited EMT processes of BCC cells (Fig. 4H). These data suggest that SRPK1 is a direct target of SOX2-induced EMT processes in BCC cells.",6.735644102541732,3.6362965257533837
telemedicine in Korea,0.13809954194199509,0.1137249693274498,1.0265309810638428,4270b127-5a97-48ea-bcba-4ad5c853040c,noncomm_use_subset/Prerequisites for Effective Implementation of Telemedicine: Focusing on Current Situations in Korea,"Therefore, a comparison was conducted with overseas cases to discuss the prerequisites for the effective implementation of telemedicine in Korea under the current situation. We also examined the structural characteristics of the Korean medical community.",6.4982621466900135,3.0155581190958447
HIV/AIDS regulation varies in different articles and in different places. The most significant gap relates to stigma-related rights for receiving medical services and employment,0.23156821874393044,-0.03172772005200386,0.6063172221183777,2bf80942-0cac-4e6b-bb6e-6b9cecda134d,noncomm_use_subset/Evolution of information-driven HIV/AIDS policies in China,"However, implementation of HIV/AIDS regulation varies in different articles and in different places. The most significant gap relates to stigma-related rights for receiving medical services and employment. On 27 August 2010, the first case of a law suit concerning HIV-related stigma for employment was reported and has generated great discussion and concern.39 The most frequent cases of discrimination that people living with HIV/AIDS face are when seeking medical care in clinical settings. There is still a long way to go to achieve the goal of zero stigmas in Chinese society, though HIV/AIDS regulation is in place.",7.015489159613315,2.8289043822078033
hospitals will increasingly need to ration limited resources and improve clinical pathways to effectively prioritise patients with greatest clinical need,0.2765151115651441,3.786562919616699,4.758739948272705,7075d810-8e04-4a50-8787-1377a0af67ff,biorxiv_medrxiv/Title Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection,"The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 15.20035360 doi: medRxiv preprint (e.g. high dependency unit), earlier on, for patients at highest risk of severe infection. These can also be formalised within risk stratification tools to aid clinical decision-making, such as the CURB65 tool for community-acquired pneumonia (20) . As the number of hospitalised COVID-19 cases continues to increase, hospitals will increasingly need to ration limited resources and improve clinical pathways to effectively prioritise patients with greatest clinical need. This is important, as COVID-19 is already placing increased pressure on ICUs, and anticipation of future demand, based on local population characteristics, may enable more timely planning and resource mobilisation (21) . Identifying those at the highest risk will also facilitate better-informed discussions between clinicians, patients and patients' families about the anticipated clinical trajectory, allowing more accurate and timely advance care discussions to occur.",13.151899612900088,10.157611728643143
antibody analyses,0.47702216236524636,3.187516689300537,4.850429534912109,13c23330-ef1a-49b4-b123-1a7d8633c0b5,biorxiv_medrxiv/Deconvoluting Virome-Wide Antiviral Antibody Profiling Data,"The utility of antibody-based diagnostics has been constrained by an inability to robustly discriminate among infections by closely related viral pathogens 10 . An important example is the challenge of distinguishing between flavivirus infections, notably in the setting of the recent Zika virus outbreak 11 . Unbiased analysis of anti-viral antibodies using a robust algorithm that comprehensively considers potential cross-reactivity will dramatically improve the clinical utility of antibody analyses. Single time-point testing of IgG reactivity is difficult to interpret in the context of an ongoing or recent infection, as these antibodies may be due to long lived plasma cells induced by a historic infection. Quantifying an individual's change in IgG specificities over time, however, may provide clearer evidence of an evolving immune response. Similarly, comparing IgG specificities across distinct physiological compartments may provide evidence of an organ-specific infection (e.g., blood versus cerebrospinal fluid in the setting of encephalitis). Such pairwise VirScan comparisons would be particularly problematic for our previous analytical approach, because (i) a low number (but high proportion) of changing peptides may be observed during response to a single infection, and (ii) ongoing antibody responses may be more associated with broadly cross-reactive antibodies 12 . We have therefore developed the AVARDA algorithm using pairwise VirScan data generated longitudinally from patients with viral encephalitis. The predictions of the algorithm were found to agree with clinical nucleic acid or serology testing in most cases. In addition, utilizing VirScan/AVARDA analysis in conjunction with traditional nucleic acid testing resulted in a 62.5% increase in the diagnosis of viral encephalitis. Finally, we demonstrate the utility of AVARDA for epidemiological investigations by determining childhood infections acquired in the setting of a longitudinal cohort study.",10.96636951536938,9.062894376117503
"intervention measures and strategies, and assessments of intervention effectiveness in similar settings",0.1974582453038316,1.584592342376709,2.6720733642578125,69d4d397-4433-4f32-8a85-5f04d8ec8cbf,"biorxiv_medrxiv/Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Shenzhen, the Largest Migrant City of China","In this study, we reported the epidemiological and clinical characteristics of confirmed COVID-19 cases in Shenzhen, a large migrant city with the highest GDP per capita in mainland China. Our results can be used to improve the prediction of transmission risk, design and implementation of intervention measures and strategies, and assessments of intervention effectiveness in similar settings.",14.718453357221172,7.918291384339849
Biomarkers that accurately identify serious bacterial infection (SBI) could improve diagnosis and clinical management,0.23193896716483628,2.4564011096954346,2.651649236679077,53239bbd-e6d4-46b7-9311-8f05f240f7aa,biorxiv_medrxiv/Lipocalin-2 is a Sensitive and Specific Marker of Bacterial Infection in Children,"Introduction. Bacterial infection is the leading cause of death in children globally. Clinical algorithms to identify children who are likely to benefit from antimicrobial treatment remain suboptimal. Biomarkers that accurately identify serious bacterial infection (SBI) could improve diagnosis and clinical management. Lipocalin 2 (LCN2) and neutrophil collagenase (MMP-8) are neutrophil-derived biomarkers associated with bacterial infection. Methods: We evaluated LCN2 and MMP-8 as candidate biomarkers in 40 healthy controls and 151 febrile children categorised confirmed SBI, probable SBI, or viral infection. The diagnostic performance of LCN2 and MMP-8 to predict SBI was estimated by the area under the receiver operating characteristic curve (AUROC) and compared to the performance of C-reactive protein (CRP). Results. Plasma LCN2 and MMP-8 concentration were predictive of SBI. The AUROC (95% CI) for LCN2, MMP8 and CRP to predict SBI was 0.88 (0.82-0.94); 0.80 (0.72-0.87) and 0.89 (0.84-0.94), respectively. The diagnostic performance of LCN2 in combination with CRP was significantly superior to either marker alone: AUROC 0.92 (95% CI: 0.88-0.96). Conclusion. LCN2 is a sensitive and specific predictor of SBI in children which could be used to improve clinical management and antimicrobial stewardship. LCN2 should be further evaluated in prospective clinical studies.",12.893328086060748,7.832897555264694
expand the capabilities of LRTI diagnostics in HCT recipients with acute respiratory illnesses,0.17220004374252373,2.0541882514953613,3.731424331665039,0359dea8-58bc-4cee-88a5-74190ad67ed0,biorxiv_medrxiv/Title: Metagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients Running Title: mNGS Detects Respiratory Pathogens in HCT Patients,"Here we leverage continued improvements in metagenomic sequencing to expand the capabilities of LRTI diagnostics in HCT recipients with acute respiratory illnesses. We demonstrate that compared to current microbial diagnostics, mNGS has a greater capacity for detecting microbes and an ability to couple pathogen detection with simultaneous profiling of the All rights reserved. No reuse allowed without permission.",10.421156845826507,7.408053075093537
they should not be used for hand hygiene in healthcare settings,0.2356637753652127,2.833547353744507,2.6741437911987305,3573fabb-e4f4-4a17-bb0a-1a6cdca9c88f,biorxiv_medrxiv/Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care A rapid review of clinical practice guidelines,"hands are visibly soiled. Other types of waterless products may contain either no alcohol or alcohol in concentrations of less than 60%. There is no efficacy data on these products, and they should not be used for hand hygiene in healthcare settings.",10.918819090530729,7.401585925898859
to give patients more timely and appropriate treatments,0.35693898742372165,1.8621342182159424,3.5255980491638184,12dc2c48-47a3-4d50-b778-790748c2beff,biorxiv_medrxiv/Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study Summary Background,"Therefore, we suggested that LYM% should be used as an indicator for evaluating the effectiveness of clinical drugs or therapies. We suggest more medical staff apply and improve our proposed TLM to give patients more timely and appropriate treatments.",11.054938047261498,7.371254290338369
AT1R blocker valsartan has recently been reported to improve clinical outcomes for patients with chronic obstructive pulmonary disease (COPD),0.11259323039353299,2.179492712020874,2.951921224594116,44e052d6-beab-48c1-81fc-d7a12c6807ab,"biorxiv_medrxiv/ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism","Paradoxically, although ACE2 mediates viral entry to the host, its deficiency worsens lung injury by activating the renin-angiotensin system (RAS) in experimental models [6] . The circulating RAS regulates blood pressure and fluid homeostasis. Local tissue-based RAS exacerbates pulmonary hypertension, acute lung injury and experimental lung fibrosis [8] . Thus, blocking of the Angiotensin II receptor type I (AT1R) was associated with reduced SARS-CoV spike protein mediated lung injury [6] and reduced pulmonary hypertension in experimental models [9] . The AT1R blocker valsartan has recently been reported to improve clinical outcomes for patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary hypertension (DOI:10.1183/13993003.congress-2019.PA2469). In the PARADIGM-HF trial, valsartan and the All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",10.974811962745298,7.176603245760598
within 3 days after CP transfusion,0.10670875747124325,1.4169323444366455,3.5013439655303955,42068067-e7f8-452a-8715-a4365a17c35d,biorxiv_medrxiv/The feasibility of convalescent plasma therapy in severe COVID- 19 patients: a pilot study,"Currently, there are no approved specific antiviral agents for 2019 novel coronavirus disease . In this study, ten severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents. The primary endpoint was the safety of CP transfusion. The second endpoints were the improvement of clinical symptoms and laboratory parameters within 3 days after CP transfusion. The median time from onset of illness to CP transfusion was 16.5 days. After CP transfusion, the level of neutralizing antibody increased rapidly up to 1:640 in five cases, while that of the other four cases maintained at a high level (1:640). The clinical symptoms were significantly improved along with increase of oxyhemoglobin saturation within 3 days. Several parameters tended to improve as compared to pre-transfusion, including increased lymphocyte counts (0.65Ã10 9 /L vs. 0.76Ã10 9 /L) and decreased C-reactive protein (55.98 mg/L vs. 18.13 mg/L). Radiological examinations showed varying degrees of absorption of lung lesionswithin 7 days. The viral load was undetectable after transfusion in seven patients who had previous viremia. No severe adverse effects were observed. This study showed CP therapy was welltolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases. The optimal dose and time point, as well as the clinical benefit of CP therapy, needs further investigation in larger well-controlled trials.",10.94041201199577,7.026023805677096
"CP therapy, need to be further investigated in randomized clinical studies",0.12383589936500758,1.5503442287445068,2.5110056400299072,3d0f2cfc-8afd-4737-ad03-cc5e570d566e,biorxiv_medrxiv/The feasibility of convalescent plasma therapy in severe COVID- 19 patients: a pilot study,"The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03. 16.20036145 doi: medRxiv preprint antibodies can rapidly reduce the viral load and tends to improve clinical outcomes. The optimal dose and treatment time point, as well as the definite clinical benefits of CP therapy, need to be further investigated in randomized clinical studies. 2).Respiratory distress, RR â¥30 beats/min; 3).Oxygen saturation level less than 93% in resting state; 4). Partial pressure of oxygen (PaO2)/oxygen concentration (FiO2) â¤300 mmHg (1 mmHg=0.133 kPa). The exclusion criteria were as follows: 1). Previous allergic history to plasma or ingredients (Sodium Citrate); 2). Cases with serious general conditions, such as severe organ donor depending on the age and body weight, and each sample was divided and stored as 200 mL aliquots at 4â without any detergent or heat treatment. The CP was then treated with methylene blue and light treatment for 30 minutes in the medical plasma virus inactivation cabinet (Shandong Zhongbaokang Medical Appliance Co., Ltd).",11.87976192846592,6.797794089666441
universal transport media,0.28375688484651623,1.4747543334960938,2.4620141983032227,961a9e74-7bf1-4c92-95a5-1186d827a24a,biorxiv_medrxiv/A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage,"Samples obtained from the UCSF Clinical Microbiology Laboratory were nasopharyngeal and oropharyngeal swabs and placed in universal transport media (UTM, 350C, Copan Diagnostics, Murrieta, CA, USA). Samples obtained from the California Department of Public Health (CDPH) and SCDPH were nasopharyngeal and oropharyngeal swabs.",11.39956915319896,6.548748749289191
Standard of care,0.2629291276624611,2.845102071762085,1.6611980199813843,fc36507d-0f3c-4290-b29a-eab20cf22771,biorxiv_medrxiv/Title: Metagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients Running Title: mNGS Detects Respiratory Pathogens in HCT Patients,"Standard of care clinical BAL diagnostics performed at the study hospital (described above in Methods) identified microbes in seven of 22 (32%) patients, of which six were thought to represent etiologic pathogens by the treating physicians. These included HMPV (n=2), RSV (n=2), HHV-6 (n=1) and Stenotrophomonas maltophilia (n=1). CMV was identified by shell vial culture in subject 37 but thought to represent incidental carriage because of symptom resolution in the absence of intervention prior to the return of testing.",10.153279498840599,6.482742884227465
psychological impact on HWs can be alleviated by timely implementation of psychological protective measures,0.11480985931748082,1.0131709575653076,1.3171230554580688,55697bdc-65c2-4e06-ae12-80963ce3ea1e,biorxiv_medrxiv/COVID-19 in Wuhan: Immediate Psychological Impact on 5062 Health Workers,"Finally, we developed three effective, easy-to-use clinical screening tools to identify high-risk individuals of acute stress, depression, and anxiety among HWs. Further studies are needed to improve and validate these models. Tongji Hospital's experience suggests that psychological impact on HWs can be alleviated by timely implementation of psychological protective measures. We acknowledge all participants of this project and investigators for collecting data.",14.079456332949785,6.4425008249976194
SapI,0.25935035102809717,1.6451574563980103,2.7260913848876953,afedcc3d-148e-42d8-be23-566fcb5c6e41,biorxiv_medrxiv/MERS-CoV NSP16 necessary for IFN resistance and viral pathogenesis,CAACCTCAATACAAGCAGAC. The two resulting products were digested with SapI,10.241966412013014,6.425999991040263
RT-dPCR significantly improves accuracy and reduces the false negative rate,0.12845026365941264,1.7565513849258423,2.2417080402374268,c957f05a-fe2a-42df-a7fd-ff6a945a6aed,biorxiv_medrxiv/Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR,"This work demonstrates that RT-dPCR significantly improves accuracy and reduces the false negative rate of diagnostics of SARS-CoV-2, which could be a powerful complement to the current RT-qPCR. Furthermore, RT-dPCR is more sensitive and suitable for low virus load specimens from the patients under isolation and observation who may not be exhibiting clinical symptoms.",10.45817801776569,6.259230932574116
early admission and surveillance by CT,0.31277906958160173,2.5980207920074463,2.477139949798584,a50a57bc-66e3-4253-ae48-c899ca16a0b2,biorxiv_medrxiv/Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics,"Conclusion: CT severity score was associated with inflammatory levels and higher NLR and CT severity score on admission were independent risk factors for short-term progression in patients with NCP outside Wuhan. Furthermore, early admission and surveillance by CT should be recommended to improve clinical outcomes.",19.098663756122306,9.983386796816728
IBV diagnostics,0.21713671995184392,2.581275224685669,3.898959159851074,665135b8-fa1e-432c-9249-3496f77df0ed,"biorxiv_medrxiv/Real-time, MinION-based, amplicon sequencing for lineage typing of infectious bronchitis virus from upper respiratory samples","The advent of real-time, in-house, third generation sequencing represents a transformative opportunity for diagnostic laboratories, by offering the ability to more fully characterize PCR reactions beyond confirming amplicon size (e.g., routine electrophoresis), Sanger sequencing RT-PCR products, or by confirming a partial sequence through probe hybridization (e.g., probe-based qPCR). However, the interpretation of such large data sets represents a challenge to veterinary diagnosticians. Read-based classification software such as genotypes from single sample. Thus, the MinION-based AmpSeq coupled with the data analysis workflow for identification, differentiation, and accurate prediction of IBV genotypes from clinical swab samples can be used as an adjunct to other established rapid diagnostic assays 9,12 until extensive testing of this protocol is done to improve and validate AmpSeq for IBV diagnostics. Furthermore, AmpSeq-based assays can be, and are being applied to other viral pathogens, 3,37 demonstrating the power and utility of this method in the age of molecular diagnostics. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/634600 doi: bioRxiv preprint ",14.556856593042415,9.307052157513727
"Conference dining menu can improve by serving less meat, particularly beef and pork products and increasing relative representation of quality vegetarian and vegan options",0.2538826809904995,2.853755235671997,2.668360471725464,84513193-ddbb-4d60-baa5-4eeeeeea1cbb,biorxiv_medrxiv/Evaluating features of scientific conferences: A call for improvements,"Conference dining menu can improve by serving less meat, particularly beef and pork products and increasing relative representation of quality vegetarian and vegan options, prepared with locally sourced, in season, organic, and antibiotic/hormone free ingredients at the ",15.204302763463385,8.910881177020535
to potentially increase the amount of drug and drug carriers delivered to the CFTR-mutated epithelia to improve clinical outcomes,0.11497944881671145,0.9400454759597778,3.2849926948547363,4afba736-1185-4aa3-8cfb-da49bec30320,biorxiv_medrxiv/Title page â¢ Title A combinatorial biomolecular strategy to identify peptides for improved transport across the sputum of cystic fibrosis patients and the underlying epithelia â¢ Author names and affiliations,"Our findings demonstrate that using phage display libraries with high throughput sequencing may be an effective strategy to identify mucus-penetrating peptides with improved transport across CF sputum from patients and promote cell internalization of drug delivery systems. These peptides may effectively serve as conjugates or surface modifications to potentially increase the amount of drug and drug carriers delivered to the CFTR-mutated epithelia to improve clinical outcomes. Moreover, the combination regimen using different peptide-conjugated drug carriers could be used as an alternative to reduce potential immunogenic responses over long-term, repeated administration of therapeutics [28, 92] .",15.073156720770074,8.02187966329896
wet markets and change the prevalent habit of eating wild animal products in China,0.09149079590783438,1.936128854751587,3.1560704708099365,3b9ffc3e-a98a-482b-8b3d-93bb7d4e50f3,"biorxiv_medrxiv/Public Exposure to Live Animals, Behavioural Change, and Support in Containment Measures in response to COVID-19 Outbreak: a population-based cross sectional survey in China","Although permanent closure of LPMs was not fully backed by the public, it was still much higher than reported during the 2013 influenza A outbreak (27.3% in Wuhan, 39.3% in Shanghai). 15, 29 The strong support for this policy offers a great opportunity to improve regulations on wet markets and change the prevalent habit of eating wild animal products in China.",11.762942244415981,7.426959347160584
"Several of these processes are focused on either reproduction, such as the formation of a labyrinthine layer, or the very early developmental stages of life",0.22013221398672347,3.07332706451416,3.1577234268188477,299d05ee-4f2b-44ea-ab85-27df469a6683,biorxiv_medrxiv/Large-scale analysis of redox-sensitive conditionally disordered protein regions reveal their widespread nature and key roles in high-level eukaryotic processes,"At the organism level, the cellular functions involving redox-regulated conditionally disordered protein regions are typically embedded in a wide variety of developmental processes. Several of these processes are focused on either reproduction, such as the formation of a labyrinthine layer, or the very early developmental stages of life, such as somitogenesis, gastrulation, or endoderm formation. As these high level organismal processes typically rely on a large number of proteins, they do not show exclusivity towards either structural element. ",9.528018829332984,7.384989409632999
advanced organism detection offers the potential for early implementation of targeted therapy and the possibility for improved clinical outcomes in immunocompromised children,0.20779069705559522,2.332170248031616,3.567039966583252,2647b32d-b63a-4771-9102-ff39f536df0e,biorxiv_medrxiv/TITLE: Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised AFFILIATIONS,"In summary, we present a mNGS assay optimized to evaluate the pulmonary microbiome and detect potential pathogens in immunocompromised children. This assay is highly sensitive, reveals a rich bacterial, fungal, and viral pulmonary microbiome, and further identified potential pathogens in half of previously negative samples. As such, advanced organism detection offers the potential for early implementation of targeted therapy and the possibility for improved clinical outcomes in immunocompromised children. We invite the scientific and clinical community to participate in an ongoing multicenter collaborative clinical trial aimed at further refining this emerging technology (https://clinicaltrials.gov/ct2/show/NCT02926612).",10.067917667339165,7.358257823068372
siRNA-based therapeutics,0.24973617469943035,2.58341383934021,2.3060483932495117,e90a3c4b-19b1-4cf9-a39a-e37970b1c663,biorxiv_medrxiv/Designing Effective small interfering RNA for Post-Transcriptional Silencing of Human GREM1: A Comprehensive Bioinformatics Approach,"Despite the challenges, siRNA-based therapeutics have seen developments in the clinical setting [19] . Endogenous RNAi machinery processes exogenous siRNA to silence target genes.",11.818907285605716,7.314768001145319
can detect variations directly from clinical samples,0.42517557656464355,2.0400571823120117,2.4814341068267822,fee925a4-1217-4048-acce-63695ae7826b,biorxiv_medrxiv/Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and 1 other respiratory viruses 2 Introduction 38,"can detect variations directly from clinical samples. Whereas the detection throughput of NTS is not 274 high at present, the NTS method can be integrated into widely used automated or semi-automated 275 platforms to improve the detection throughput in the future 21-23 . In addition, because PCR is 276 included in NTS, processes involving opening the lid of the PCR tubes may cause mutual 277 contamination between samples 24, 25 . However, this situation also is inevitable in current nucleic 278 acid detection methods (e.g., qPCR) or other nucleic acid detection schemes (e.g., SHERLOCK 11, 12 279 or toehold switch biosensor 9, 10 ) that also involve PCR. The introduction of integration systems or 280 sealed devices such as microfluidics may avoid this situation 26, 27 . At present, our processes of 281 sequencing data analysis and interpretation of results are not mature; nevertheless, as the number of 282 test samples increases, additional test results will be collected and the process continuously 283 optimized to obtain more accurate results. 284",11.179793090945772,6.851896919771236
locally training the algorithms in each specific healthcare service will be crucial to improve predictive performance,0.22478031752817076,2.17258358001709,3.098196506500244,7a9ad2e4-ac91-4930-9d97-666d95a6557a,biorxiv_medrxiv/COVID-19 diagnosis prediction in emergency care patients: a machine learning approach,"In conclusion, we found evidence to suggest that targeted decisions for receiving COVID-19 tests in areas with a shortage of supply is possible with the use of machine learning algorithms. For future clinical applications, locally training the algorithms in each specific healthcare service will be crucial to improve predictive performance.",9.745474443726653,6.836923111540596
mNGS has significantly greater sensitivity for detecting potential pulmonary pathogens,0.2284090832795293,1.701155424118042,2.232609272003174,3dd1415e-277d-4d5a-b25d-54cdd57e2d4b,biorxiv_medrxiv/TITLE: Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised AFFILIATIONS,"The results of this analytical approach and our primary analytical approach showed strong agreement. In sum, these data demonstrate that mNGS has significantly greater sensitivity for detecting potential pulmonary pathogens than current clinical diagnostics (McNemar's p<0.001).",11.864825891711137,6.7096361145776875
communitybased interventions,0.44579472503836787,2.400543689727783,2.265951633453369,7fa535ec-52dc-48ef-8715-3d469e73e769,biorxiv_medrxiv/Spatial epidemiology of networked metapopulation: An overview,"It thus becomes urgent to study the controllability of intra-subpopulation measures, such as the usage of vaccine or antiviral drugs, and the implementation of communitybased interventions, which are typical containment strategies suggested by the World Health Organization (WHO) [55] . To estimate and also to improve the performance of disease response plans on decreasing the morbidity, large-scale computational simulations have been performed extensively to study various types of pharmaceutical interventions [4, 14, 56, 57, 60, 68, [134] [135] [136] [137] [138] [139] , which aid in identifying the targetedgroups and guiding the deployment of limited resources.",9.781597186907444,6.456780975485354
to improve the running time of the fitting and forward simulation,0.21757745682499158,0.8834788799285889,3.0361874103546143,c5c6e720-e835-447a-bb75-cb840e2d109d,biorxiv_medrxiv/Using Digital Surveillance Tools for Near Real-Time Mapping of the Risk of International Infectious Disease Spread: Ebola as a Case Study,"The framework presented in this paper was developed as a proof-ofconcept to use digital surveillance data for near real-time forecasting of the spatio-temporal spread of an outbreak. It has been implemented as a web-based tool called ""Mapping the Risk of International Infectious Disease Spread"" (MRIIDS) (see [32] for more information). To further develop such approaches, it is important to establish an automated pipeline from data collection to curation to analysis, which currently requires manual intervention at each of these steps. Another factor that could enhance the usability of our model in near real time is to improve the running time of the fitting and forward simulation. In the current implementation, the running time varies from approximately 0.5 CPU hours when 100 days of incidence data are being used to approximately 335 CPU hours using 462 days of incidence data using a 3.3 GHz Intel Xeon X5680 processor. Although the West African Ebola epidemic was of unusual scale and duration, there is a scope for optimising the model implementation.",9.518082333247717,5.879111905320784
GO,0.22389837112895963,2.2356936931610107,1.1324630975723267,684537f7-f3be-4d2b-944b-492dc385a30e,biorxiv_medrxiv/Title: Viruses are a dominant driver of protein adaptation in mammals,"GO processes with a strong excess of adaptation include cellular processes such as 17 transcription, signal transduction, apoptosis, or post-translational protein modification, 18 but also supracellular processes related to development ( Figure 2C and Table S3 ).",10.344948534176186,5.810033900938334
HCQ treatment,0.38105369762934943,1.3773462772369385,1.8946863412857056,a1ae79aa-98e1-4ad2-98a5-5596dce410a2,biorxiv_medrxiv/Reply to Gautret et al. 2020: A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19,"We find that computing the appropriate statistical tests for the effect of HCQ on viral load reduction, yields results that are highly sensitive to the assumptions about which patients are included and how. While this evidence is strong for the assumptions made by the original paper, for more conservative assumptions, the evidence is substantially weaker than originally reported. Performing the same analysis approach to the question of whether AZ improves HCQ treatment, we find moderate 1 https://diagnostics.roche.com/global/en/products/params/cobas-sars-cov-2-test.html . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",9.75738400889706,5.541905605153689
using hypnotics,0.274996536539697,1.6829042434692383,2.143916606903076,6aadf66c-b6ff-426a-8157-e4e3dbe24582,"biorxiv_medrxiv/Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","However, we have found that using hypnotics could significantly improve clinical outcome of COVID-19. We also found that some novel risk factors that could predict patient outcome, which can help in early decision making for improving treatment outcomes of COVID-19 patients.",21.17511206925468,9.898722776981142
swiftly conducting future 65 clinical trials aiming at investigating novel diagnostic and therapeutic options,0.21116508156779984,2.9890153408050537,3.7213211059570312,083892b7-dd30-4097-ad7c-c33fc201b2ce,"biorxiv_medrxiv/Jens Kleesiek, j.kleesiek@dkfz-heidelberg.de","We perceive an urgent need for systematic data collection, comprising imaging data and analysis, of 62 patients suffering from COVID-19 pneumonia. Therefore, we wish to initiate an open-access platform 63 for data collection using commonly developed criteria for multi-modal diagnostics, staging and 64 monitoring of the disease. This will serve as a mandatory foundation for swiftly conducting future 65 clinical trials aiming at investigating novel diagnostic and therapeutic options.",9.485027932771288,7.681478466865307
"By specifically comparing the standard treatment effect at the same disease status for each treatment ( Figure S2 ), we didn't see any standard therapy",0.198176589016115,1.2434413433074951,1.8636983633041382,61e17517-c78c-4f6d-a105-c5ede888ced9,"biorxiv_medrxiv/Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Up till now, several description studies have mentioned the non-effective function of current medication treatment no matter which stages or outcomes was 10, 12, 24 , and it was accord with our study analysis. By specifically comparing the standard treatment effect at the same disease status for each treatment ( Figure S2 ), we didn't see any standard therapy could improve clinical outcome in the study. However, since only about 25% of patients in our study took hypnotics, we assume that self-healing could be the major reason for the high recovery rate of patients in the non-severe and severe disease groups. That is, COVID-19 is most likely a selflimited disease in the majority of patients.",15.09863628576688,7.30416350931597
a checkpoint implementation for running longer simulations,0.22952265754252324,2.1029574871063232,2.680631160736084,c2c8ed40-42d5-471c-9c6a-15945eb6af80,biorxiv_medrxiv/The network structure and eco-evolutionary dynamics of CRISPR-induced immune diversification,(3) a checkpoint implementation for running longer simulations. Details on the implementation are in Supplementary Information.,11.391240640338147,7.096266845215916
"Serum chemistry analysis for total cholesterol (CHOL), TG",0.22423801873529306,2.891601800918579,2.3400774002075195,9be61a4c-93de-44a1-829b-a0259a2870ee,biorxiv_medrxiv/Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to metabolic stress,"Serum chemistry analysis for total cholesterol (CHOL), TG was performed using Wako Clinical Diagnostics kits (WakoUSA, Richmond, VA). Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured using Catachem VETSPEC Kits as recommended by the manufacturer (Catachem, Oxford, CT). Blood GLU levels were measured using a Contour blood GLU meter (Bayer, Mishawaka, IN) .",10.474016430543022,7.066497231422022
molecular diagnostics,0.2434758228248428,2.1722190380096436,2.975555181503296,f4590bad-c422-42d7-b83d-508841a907f4,biorxiv_medrxiv/Integrated Micropillar Polydimethylsiloxane Accurate CRISPR Detection (IMPACT) System for Rapid Viral DNA Sensing,"Alternatively, the emerging additive manufacturing technology can also be used to create such ultra-high aspect ratio microstructures as an efficient target capture platform. 27, 28 One of the main advantages of the IMPACT chip compared to traditional CRISPR assays is its ability to limit the background caused by dye-quencher probes, which is typically seen in CRISPR detection in the liquid state and needs to be designed around to lower the detection limit. 29, 30 Our device utilizing solid-phase CRISPR does not need to tether a quencher on the probe. The cleaved CRISPR products are sent to a separate reservoir for detection thus completely avoiding the fluorescence background caused by the tradition ""onepot"" detection. As shown in Fig. 5 , without the presence of ASFV target DNA, no fluorescence background signal was detected, demonstrating this powerful backgroundfree detection. This is an important improvement for molecular diagnostics, especially in low light settings in which the amount of background fluorescence present can significantly affect the detection limit . 31,32 Leveraging this advantage with increasing the aspect ratio either with PDMS or a silicon substrate will be able to further increase the accuracy and robustness of the device and improve the limit of detection.",10.621518025947013,7.063584551764865
monotherapy of LPV/r or arbidol might not improve the clinical outcome in treating with mild/moderate COVID-19.,0.14844990100026464,0.6414582133293152,2.238208770751953,9b1b46bb-e9a3-4fbd-a2e7-797c36b4efad,"biorxiv_medrxiv/An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)","The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.19.20038984 doi: medRxiv preprint conducted in Shanghai retrospectively observed 134 patients with COVID-19 and did not find any effects of LPV/r and arbidol on relieving symptoms or accelerating virus clearance after the treatment of 5 days [21] . Despite the small sample size, our study in another way indicates that monotherapy of LPV/r or arbidol might not improve the clinical outcome in treating with mild/moderate COVID-19.",14.746006313167964,7.032885749261611
confirmatory tests are often employed for diagnostics,0.27145903528563436,2.276686429977417,2.3095273971557617,3ca3366f-efb2-441d-b0c8-ee15688d2dc4,biorxiv_medrxiv/Evaluation of Group Testing for SARS-CoV-2 RNA,"10. Requiring two stages of qPCR might delay return of results. However, testing resource limitations are also causing delays in the current pandemic, and confirmatory tests are often employed for diagnostics. Finally, for the targeted subset of people who have COVID-19 but do not have severe symptoms, delays may have limited clinical significance or consequences for public health interventions.",11.501981874562315,7.006732643733376
simulations in an R package that is available at https:// gitlab.com/technopolymath/pooled-diagnostics,0.15367827565632375,0.5697140097618103,1.6145684719085693,aeb7ef60-85f6-4007-8251-b763294ab072,biorxiv_medrxiv/Evaluation of Group Testing for SARS-CoV-2 RNA,"First, we evaluated whether group testing might improve upon existing individual-test methodologies. Testing three pooling strategies -four-well pooling (pooling four adjacent wells in a single dimension), 96-well (8x12) plate column and row pooling, and 384-well (16x24) plate column and row pooling -we found that all improve significantly upon naive testing, and that each performed better for a particular prevalence, as expected ( Figure 2 ). All three required fewer tests than the naive method at prevalence less than 10%. We have implemented these simulations in an R package that is available at https:// gitlab.com/technopolymath/pooled-diagnostics, and an interactive web visualization is available at https://technopolymath.shinyapps.io/pooled_covid_testing/.",12.752174565169868,5.8830447108952
clinical trials for a new outbreak,0.2336144515116211,0.733428418636322,1.8674781322479248,58a71e3a-258c-404c-b593-7daa1fe8f1d8,biorxiv_medrxiv/A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19,"This important amount of work conducted by researchers is encouraging for the therapeutic research for this new disease. However, care should be taken when designing a clinical trial in this complicated context as robust results are needed in order to be able to find the appropriate treatment. Finding the best agents for rapid implementation in clinical trials for a new outbreak is challenging. Our study underlines the need to register as much details as possible on clinical trials registries during outbreaks in order to inform the development of future trials. The scientific background supporting the use of a treatment should be clear and detailed as much as possible. The dose and duration of drugs evaluated, as well as details on the study design, the population of interest and the primary outcome, are crucial elements that have to be shared in the context of the epidemic response. Reporting as much details as possible is key to have consistent clinical trials and to enhance the reproducibility of the results, especially as studies are more often associated with a low number of planned inclusions and composite or weak outcomes that can limit the efficacy assessment of the treatments. That is why transparency and consistency are crucial when reporting clinical trials in order to improve statistical power by conducting, for example, meta-analyses.",11.740773386245436,5.799859943260663
lockdown would improve air quality,0.4354872952879491,1.6869834661483765,1.9261672496795654,179c2bbe-e82f-420d-915b-9f2b13b00ab2,"biorxiv_medrxiv/COVID-19, City Lockdown, and Air Pollution: Evidence from China","where 1[%&'( *+%,-+./] !,""$ are a set of dummy variables indicating the treatment status at different periods. The dummy for = = â1 is omitted in Equation (2) so that the postlockdown effects are relative to the period immediately before the launch of the policy. The parameter of interest 2 $ estimates the effect of city lockdown = weeks after the implementation. We include leads of the treatment dummy in the equation, testing whether the treatment affects the air pollution levels before the launch of the policy. Intuitively, the coefficient 2 $ measures the difference in air quality between cities under lockdown and otherwise in period , relative to the difference one year before the lockdown. We expect lockdown would improve air quality with 2 $ being negative when , â¥ 0. If the paralleltrend assumption holds, 2 $ would be close to zero when , â¤ â2.",9.497973759734865,5.672838781195365
we identified highly connected subnetworks within hvPPI network,0.10513802281766162,1.6642436981201172,1.2327156066894531,d1f98840-ab29-43d9-b8b6-69003c4969fb,biorxiv_medrxiv/Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis,"To assess the signalling pathways and cellular processes within the hvPPI, we identified highly connected subnetworks within hvPPI network. We constructed a host-host interaction network based on the host targets in the hvPPI and identified a number of highly connected subnetworks/clusters (Fig. 3) . We then performed a gene-set enrichment analysis of significantly enriched biological processes. We found one or more enriched processes for each of this subnetwork including core cellular processes such as proteasome, spliceosome, protein translation, protein/RNA transport, and cell cycle. Next we listed the viruses that target one or more of these processes, and found that almost all the core pathways and processes are targeted by all the 17 viruses that are part of the hvPPI (Fig. S3 ). This analysis highlights the core components of the cellular process subnetworks which are targeted as part of the viral evasion strategies and thus could be broad-spectrum antiviral hot-spots from a therapeutic point of view.",9.57341473278285,5.233718704600218
"no conflict of interest and relationships with any companies, whose products or services may be related to the subject matter of the article",0.1996812075568338,1.1525821685791016,1.5623892545700073,b81397ec-5dfb-4e08-b35f-6079c4dc9a47,biorxiv_medrxiv/Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study Authors' names,"The authors of this manuscript no conflict of interest and relationships with any companies, whose products or services may be related to the subject matter of the article.",9.32452686807528,5.028315828873269
Defensive Importance Sampling technique,0.19462329571510625,1.115090250968933,1.3833950757980347,ca775641-741a-4b16-9841-5355a7dd190f,biorxiv_medrxiv/Bayesian mixture analysis for metagenomic community profiling,"Approximating the marginal likelihood is a task both difficult and time-consuming. We chose the Defensive Importance Sampling technique (Hesterberg, 1995) for the relative simple implementation compared to other approaches (Supplementary Text 1 for details of implementation). This is crucial as we perform this approximation numerous times, for every species combination we consider.",9.680311401016874,5.012124452754435
generated NovaScript,0.23947196443143462,0.040126848965883255,1.0665870904922485,c6705fb8-6438-4e48-af2c-9e8f33c3f39d,"biorxiv_medrxiv/A quantitative narrative on movement, disease and patch exploitation in nesting agent groups","The model we present here only incorporates the focal processes of interest and those 101 needed to attain a level of realism required to adequately address the questions at hand. 102 Thus, for example, we do not include agent age structure in the model even though age 103 structure is known to have important effects on population growth patterns [60], 104 persistence [61], and epidemics [62]. Agent age structure would certainly add complexity 105 to our narratives; but, whether its impacts are critical (i.e., it qualitatively changes the 106 structures we explain) or only elaborative (i.e., has quantitative but not qualitative 107 implications regarding the questions asked) is a issue to be examined in future studies. 108 For clarity, we enumerate below-without mathematical details-the processes 109 incorporated in our model, leaving such details to the Technical Methods Section at the 110 end of the paper. Aspects of the Numerus Model Builder construction of the model and 111 the generated NovaScript (extended JavaScript language) implementation are provided 112 in a Supporting Information file. 113 2.1 Model Outline 114",9.706704299531852,4.116710565483934
BioFVM,0.12444137145487659,1.86297607421875,1.9561165571212769,7e85c130-6578-4ca8-8dfe-89ec30fac842,biorxiv_medrxiv/Rapid community-driven development of a SARS-CoV-2 tissue simulator,"where D is the diffusion coefficient, Î» is the net decay rate (which can include other removal processes), U is the uptake rate (by adhering to ACE2 and initiating endocytosis), and E is the cell's virion export rate. (Here, delta is the Dirac delta function, Vi is the cell's volume, and xi is position of the cell's center.) Note that in the default BioFVM implementation, uptake processes are spread across the cell's volume.",14.519714787316186,7.564310385931682
"Total RNA degradation products were quantified using Image Guage (Fuji), the speed of cleavage",0.24820500464163808,3.630720853805542,3.0200681686401367,8d97f4b1-af76-4341-aed4-07876b169d0e,biorxiv_medrxiv/Arenaviridae exoribonuclease presents genomic RNA edition capacity,"After incubated at 37Â°C, the reactions were quenched at intervals between 0 and 30 minutes by the addition of an equal volume of loading buffer (formamide containing 10mM EDTA). The products were heated at 70Â°C for 5 minutes, rapidly cooled on ice for 3 minutes followed by separation in a 20% poly-acrylamide gel containing 8 M urea and buffered with 0,5X Tris-borate-EDTA. Gels were exposed overnight to a phosphor screen and then visualized with a phosphoimager FLA-3000 (Fuji). Total RNA degradation products were quantified using Image Guage (Fuji), the speed of cleavage determined and graphs plotted using GraphPad PRISM version 6.0. Experiments were carried out at least in triplicate and only representative gels are shown.",8.137771327756708,7.1712328293045395
Psychological intervention can be conducted in different ways to improve psychological pain and improve the treatment effect,0.34009515931251666,3.2148048877716064,3.6203525066375732,18166f05-0ed9-48a1-a53d-49105797a4c5,biorxiv_medrxiv/Analysis of psychological state and clinical psychological intervention model of patients with COVID-19 Running Title: Psychological state and intervention model in COVID-19 patients,"Background-Patients with the 2019 coronavirus disease have different degrees of psychological pain, such as anxiety and depression, which may related to their prognosis. Psychological intervention can be conducted in different ways to improve psychological pain and improve the treatment effect.",7.64651630662125,7.119133013683404
large-scale algorithms to improve parameter estimation,0.17570909390747053,3.0231122970581055,3.2686543464660645,5dcee5f9-b7f7-4a7e-9b5e-33a1aab1ec10,biorxiv_medrxiv/Rapid community-driven development of a SARS-CoV-2 tissue simulator,"We have utilized EMEWS for learning-accelerated exploration of the parameter spaces of agent-based models of immunosurveillance against heterogeneous tumors 91, 92 . The approach allowed for iterative and efficient discovery of optimal control and regression regions within biological and clinical constraints of the multi-scale biological systems. We have applied EMEWS across multiple science domains [101] [102] [103] [104] and developed large-scale algorithms to improve parameter estimation through approximate Bayesian computation (ABC) approaches 105 . These approaches, applied to the multi-scale modeling of SARS-CoV-2 dynamics, will provide the ability to robustly characterize model behaviors and produce improved capabilities for their interpretation.",6.771022459909343,6.45950617925898
Further clinical and laboratory data are needed for proper assessment,0.35514859037486224,1.8390398025512695,3.1224234104156494,986fa176-d8df-48a6-9d34-596eae424f0c,biorxiv_medrxiv/Title: Integrated Disease Surveillance and Response (IDSR) in Malawi: Implementation Gaps and Challenges for Timely Alert Submit journal: PLoS ONE,"We only focused on completeness and timeliness, and the accuracy attribute of the IDSR system performance was out of the scope of this study. Further clinical and laboratory data are needed for proper assessment. We only sampled one district to conduct qualitative assessment, however, we are confident that it is relevant for the Malawian context by the fact that the health care system is rather homogeneous in Malawi and the district we selected had a relatively good IDSR performance to generalize the implementation challenges.",9.157003610162143,6.4299023519852465
prodrugs,0.23410509764613427,0.935499370098114,2.669820785522461,fa3d10f3-9319-4f5c-aa00-02a821b1bfb5,biorxiv_medrxiv/Prodrug defiance reveals logic-based strategies for treating bacterial resistance,"Here, we quantitatively studied the mechanism of prodrug defiance and revealed logicbased strategies for successfully treating bacteria. We envision that this body of work will motivate 20 the development of new prodrugs and improve the clinical administration of existing prodrugs, ultimately helping to reduce the burden of antibiotic failure.",10.043694574327969,5.858751202168163
The department expected to use technology to improve timeliness and capability to early response,0.16146249060854972,2.0831685066223145,2.910733699798584,aa9ba076-ac93-46b5-a177-3f15cf6c4c6c,biorxiv_medrxiv/Title: Integrated Disease Surveillance and Response (IDSR) in Malawi: Implementation Gaps and Challenges for Timely Alert Submit journal: PLoS ONE,The department expected to use technology to improve timeliness and capability to early response.,7.137650491157358,5.744214106078659
The main ingredients are: I m (t) is the birthand-death processes,0.17690004314327534,2.462960958480835,1.5831398963928223,8d66cdba-7514-4c62-9f78-f99dccdf2d3c,biorxiv_medrxiv/Generic probabilistic modelling and non-homogeneity issues for the UK epidemic of COVID-19,"The model varies depending on purposes of the study. The main ingredients are: I m (t) is the birthand-death processes and R m (t) is the associated pure birth processes. The process of transmission is the Poisson process with intensity Î² (time to next transmission has the exponential density Î²e âÎ²t , t > 0). After the intervention (for t â¥ t 0 ), the Poisson process of transmission for m-the group has intensity Î² m . We treat this model as purely stochastic despite parts of it can be written it terms of systems of stochastic differential equations. Despite running pure simulation models taking longer than running combined models, they are simpler and less prone to certain errors.",7.3906680151261055,5.216699360962014
particle-specific degradation products,0.18345017239074538,1.7097432613372803,2.290055274963379,080b2974-6915-4407-a5ab-4dbdc268c15f,biorxiv_medrxiv/The alkyl side chain of PACA nanoparticles dictates the impact on cellular stress responses and the mode of particle-induced cell death,"Although the degradation of PACA NPs has been shown to be slow in vitro [18] , the differential NP cytotoxicity may be caused by release of particle-specific degradation products. Degradation of PACA particles releases cyanoacrylic acid and the corresponding alkyl alcohol, i.e. ethyl-butyl alcohol, butanol, or octanol [55]. It has been indicated that the alkyl chain length dictates the PACA particle degradation rate [18, 55] . POCA particles were shown to have the slowest in vitro degradation rate, yet they exert the highest cytotoxicity ( [11] and data from this study). Thus, it is tempting to speculate that either the degradation rate is faster when the particles are in contact with the cellular surface than in the absence of cells, and/or the liberated degradation products of the three particle types exert highly different cellular cytotoxicities. In line with this, the hydrophobicity of the released alkyl alcohols is different. The highly hydrophobic octanol will most likely insert into the lipid bilayer and affect membrane properties to a much higher extent than the hydrophilic butanol.",6.902950999168149,5.01590189830428
"Demographic information, symptoms, laboratory indicators, treatment processes, and clinical outcomes",0.2638713200416438,1.7911531925201416,1.7268762588500977,9187562e-9475-4cfb-96fd-70dec3ede001,"biorxiv_medrxiv/Article Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study","Methods: This single-center, retrospective, and observational study included 55 patients with COVID-19 who were transferred to Shenyang Sixth People's Hospital between January 20 and March 15, 2020. Demographic information, symptoms, laboratory indicators, treatment processes, and clinical outcomes were collected. Administered drugs and intervention times were compared in 47 and eight patients with mild and severe symptoms, respectively.",7.736672626370471,4.99455456262032
The computational implementation is shared as open source,0.11172280521586106,1.6313450336456299,1.9408296346664429,16431c40-dd10-4868-bcb7-d39916a6174b,biorxiv_medrxiv/Rapid community-driven development of a SARS-CoV-2 tissue simulator,"1) Community priorities: The community helps define the driving research questions, definition of the project scope, and selection of critical biological components to be modeled. 2) Consensus hypotheses: The community drives a shared, clearly-written consensus specification of the underlying biological hypotheses. 3) Mathematical modeling: The community helps develop, review and refine the mathematical interpretation of the biological hypotheses. 4) Computational implementation: The computational implementation is shared as open source, with community definition of specifications, unit tests, coding, and code review (via pull requests to the development branch). 5) Community feedback: Community feedback on the model realism, hypotheses, mathematics, computational implementation, and development techniques is encouraged throughout the development process. 6) Community parameter and data: Community contributions of parameter estimates and data contributions are aggregated to assist in model development and constraint. 3 Project scope While by definition the project scope can be refined by the community, the initial project scope is to:",6.458676558679954,4.582450329940832
mixed quantitative and qualitative methods to assess and understand the implementation gaps of IDSR system from each level of the health system in Malawi,0.1329831369936625,0.8319657444953918,1.7774930000305176,70e0bfc3-573a-4113-b83d-0134c0acc6dc,biorxiv_medrxiv/Title: Integrated Disease Surveillance and Response (IDSR) in Malawi: Implementation Gaps and Challenges for Timely Alert Submit journal: PLoS ONE,"This study mixed quantitative and qualitative methods to assess and understand the implementation gaps of IDSR system from each level of the health system in Malawi and focused on two key attributes, timeliness and completeness, of the surveillance system [24] .",6.58072831083282,3.9994030927333277
epidemic processes,0.1834562039717304,0.843540608882904,1.2801579236984253,4e418249-d863-4182-8fb3-7c2dd6ab1c90,biorxiv_medrxiv/COVID-19 attack rate increases with city size,"The most important quantity characterizing epidemic processes is the reproductive number, R, which measures the number of secondary cases induced by an infectious individual in a fully susceptible population. Recall that we expect that human population are thought to be wholly susceptible to COVID-19.",6.343212413464751,3.600528390890527
mHealth solutions to improve disease surveillance and health programmes,0.2452768821265031,0.9675556421279907,0.8206083178520203,d001d626-1230-4e20-b723-be513fc29d63,biorxiv_medrxiv/Title: Integrated Disease Surveillance and Response (IDSR) in Malawi: Implementation Gaps and Challenges for Timely Alert Submit journal: PLoS ONE,"We assessed the differences between IDSR technical guideline and actual practice in the health system in Malawi for the first time. According to the quantitative data, we observed relatively good completeness of IDSR monthly reports compared to timeliness. Timeliness is a general problem to countries implementing IDSR system across Africa, and this makes the public health authorities unable to take quick action and respond to the suspected health events [12, 25] . Facility level IDSR reports may not be sufficiently timely to pick up the outbreaks from community. The strengthened community level surveillance and verbal autopsy to detect unusual deaths can be a good approach to detect lower level health events and provide timely response [26] . In Malawi, a pilot study conducted in Lilongwe District in Central Region showed that mobile technologies had good opportunities to improve timeliness of HMIS reports [27] . However, concerning the different purposes of HMIS and IDSR system, a more integrated electronic IDSR system is essential for the health authorities to correspond the diverse demands. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/363713 doi: bioRxiv preprint African health ministries are quickly adopting mHealth solutions to improve disease surveillance and health programmes. Tanzania piloted an IDSR reporting system using SMS function and regular phones for report in 2011 [28] and further expanded it to be the national strategy for diseases surveillance using Unstructured Supplementary Service Data (USSD) technology linked with DHIS2 for the immediate reporting for IDSR [29] [30] [31] . Zambia tried to use DHIS2 mobile to enhance its malaria surveillance in Lusaka district and to improve case management and reporting [32] . Other mobile technologies including smartphone applications, patient monitoring devices, Personal Digital Assistants (PDAs), as well as laptops and tablets PCs connected with network service were piloted and implemented in various African countries [33] . Countries and development partners are eager to apply the mobile technology to capture real-time field data for surveillance and case management at the community level health care system [30, [34] [35] [36] [37] . However, notable issues were documented including technical, financial, infrastructural challenges, data security and medical supports during the design and implementation process of mHealth surveillance in sub-Saharan Africa countries [33] . Considering the complexity of public health works and needs of integration services at the community level [38] , the utilization of mobile technologies requires more rigorous studies to evaluate such innovations for programme implementation to become sustainable and scalable [39] .",6.362180148720495,3.3890696260391806
partial confinement,0.18318369224398234,0.43154236674308777,0.5396682024002075,346e00be-b998-4479-bc7f-e4e9412d5e1d,biorxiv_medrxiv/Derivation of the effective reproduction number R for COVID-19 in relation to mobility restrictions and con- finement,"We also show in Supplementary Figure 3 the distribution of R g i at three different stages of the epidemic spreading in Spain, according to our model: free spreading without containment (March 14, 2020); 10 days after the implementation of partial confinement, showing the initial effects of containment (March 24, 2020); and 21 days after the implementation of partial confinement (April 4, 2020).",7.319294846986404,3.1930400663883836
